data_2mqp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mqp _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 CA--C 1.532 0.273 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.6 t -128.71 142.08 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 C-N-CA 122.988 0.515 . . . . 0.0 110.924 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 84.7 mt -135.02 149.49 50.17 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 122.663 0.385 . . . . 0.0 111.884 -174.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 32.0 tp -102.72 136.67 42.12 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.576 0.75 . . . . 0.0 109.223 172.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -115.27 107.05 14.76 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.938 1.295 . . . . 0.0 114.465 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.05 127.76 38.69 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 175.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.5 mp -97.95 127.53 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 20.7 mt -89.37 -26.34 21.1 Favored 'General case' 0 CA--C 1.527 0.062 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -174.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -141.17 79.1 18.23 Favored Pre-proline 0 N--CA 1.453 -0.284 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -176.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -77.34 45.31 1.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 125.251 3.967 . . . . 0.0 111.988 -177.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.47 -4.2 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 O-C-N 121.877 -0.515 . . . . 0.0 110.597 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -136.52 155.84 49.41 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 66.3 m -67.85 113.2 5.39 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 33.6 mm -78.39 141.53 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.99 159.76 39.77 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.6 p -64.8 -15.41 61.68 Favored 'General case' 0 C--O 1.23 0.05 0 N-CA-C 114.314 1.228 . . . . 0.0 114.314 177.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -76.12 -46.52 28.41 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.676 0.274 . . . . 0.0 111.541 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.0 m -70.85 -31.1 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.1 mt -72.39 -35.17 68.37 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 176.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -70.6 -30.65 67.38 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 173.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.1 m -67.26 -34.56 77.7 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 43.9 pt -91.46 -21.73 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 118.405 0.548 . . . . 0.0 112.239 178.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 91.3 m -91.21 -25.87 19.31 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.457 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 31.8 t30 -63.82 -41.37 63.73 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 74.4 Cg_endo -69.27 -13.84 36.59 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 CA-C-N 120.857 1.342 . . . . 0.0 111.645 177.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 91.7 m -91.96 -4.49 54.53 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.787 0.435 . . . . 0.0 111.701 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 146.95 166.79 12.57 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 177.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.53 103.14 1.08 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.587 2.858 . . . . 0.0 110.17 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 64.8 t -69.51 146.82 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -114.44 -37.53 4.3 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 119.244 -0.408 . . . . 0.0 111.579 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 39.2 mtm-85 -149.95 151.87 34.06 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.574 0.625 . . . . 0.0 112.035 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 17.8 mt -146.12 140.97 21.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 C-N-CA 124.211 1.004 . . . . 0.0 109.527 177.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 59.7 t -146.78 156.51 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 47.6 mt -134.45 142.22 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 123.698 0.799 . . . . 0.0 110.009 -178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.297 3.2 p90 -143.28 159.22 42.75 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 176.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -128.76 15.52 6.41 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.989 0.516 . . . . 0.0 111.137 -173.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -62.86 -32.46 73.7 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -169.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -130.49 8.84 5.03 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 118.597 0.635 . . . . 0.0 112.239 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 159.92 -125.11 1.43 Allowed Glycine 0 C--N 1.335 0.516 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 -174.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.4 t -141.18 115.3 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -142.29 166.89 23.45 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.268 0.556 . . . . 0.0 110.956 -176.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.37 165.47 29.23 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.405 175.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 76.5 mmm -133.42 153.25 51.77 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 28.2 t -141.79 145.64 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 C-N-CA 123.292 0.637 . . . . 0.0 110.667 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -132.61 133.93 44.25 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.727 0.411 . . . . 0.0 110.126 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -105.51 161.75 14.07 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 -176.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -78.25 -14.65 59.35 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 82.6 p -155.11 157.98 38.32 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.25 0.548 . . . . 0.0 111.548 -177.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 53.8 t -66.38 -36.08 76.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -65.44 -32.17 73.65 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 122.354 -0.216 . . . . 0.0 110.711 -176.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 63.8 m -72.65 -34.84 67.53 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 121.27 -0.172 . . . . 0.0 110.639 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -73.45 -31.54 63.85 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 119.732 -0.175 . . . . 0.0 111.114 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -68.32 -44.14 76.02 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 118.199 0.454 . . . . 0.0 111.831 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 -77.29 -25.29 51.17 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 118.102 0.41 . . . . 0.0 111.34 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -72.06 -41.13 67.78 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 122.065 -0.397 . . . . 0.0 110.077 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -74.65 -21.26 59.53 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 122.974 0.51 . . . . 0.0 111.194 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -97.18 -10.52 25.73 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 44.2 t -116.12 -34.01 4.84 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 118.62 0.645 . . . . 0.0 112.594 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 50.7 mt -90.73 -6.95 53.76 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 122.139 -0.35 . . . . 0.0 111.837 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -72.26 132.4 44.01 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.25 -4.53 47.87 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 112.156 -0.378 . . . . 0.0 112.156 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.22 166.39 22.78 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 117.52 0.66 . . . . 0.0 110.187 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -123.61 139.61 53.83 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 85.1 mt -74.42 -41.51 49.77 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.36 44.0 m-85 -82.87 -11.47 58.18 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 117.037 2.236 . . . . 0.0 117.037 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 29.0 t 65.51 34.48 7.9 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.604 0.762 . . . . 0.0 111.059 -173.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 177.15 -23.96 0.05 OUTLIER Glycine 0 CA--C 1.528 0.881 0 C-N-CA 123.972 0.796 . . . . 0.0 111.158 177.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 96.8 m -145.92 -177.29 5.52 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.702 1.201 . . . . 0.0 109.52 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 88.0 m 58.64 37.0 25.33 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -176.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.96 151.39 6.76 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 175.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 73.6 mt -119.67 157.64 28.1 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -173.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -139.54 140.38 37.12 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.786 1.634 . . . . 0.0 107.294 168.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 38.4 mt -138.1 142.74 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 CA-C-O 120.848 0.356 . . . . 0.0 111.668 -173.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -158.57 161.87 37.31 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.04 176.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.265 41.5 m-85 -61.96 134.81 57.12 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 177.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -88.58 157.0 18.73 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.178 -178.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.442 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 23.2 pttp -90.14 -32.25 0.37 Allowed Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 117.413 -1.279 . . . . 0.0 114.307 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 68.2 Cg_endo -76.55 166.95 26.44 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 CA-C-N 121.893 1.712 . . . . 0.0 109.462 174.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.3 0.2 OUTLIER -130.04 0.47 4.73 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 -175.811 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 20.3 ttp180 -160.55 140.97 11.53 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.775 -0.578 . . . . 0.0 110.952 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 25.8 mt -85.25 171.47 11.91 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.115 0.966 . . . . 0.0 110.668 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -126.19 46.63 2.4 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 169.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.5 t -48.58 139.68 2.94 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -175.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . 0.278 6.2 p90 -120.37 -12.12 9.04 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 117.391 2.367 . . . . 0.0 117.391 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -163.6 173.91 12.41 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 122.853 0.461 . . . . 0.0 110.811 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -119.99 129.23 54.18 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.403 0.681 . . . . 0.0 110.544 176.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 39.5 p30 -160.5 -166.63 1.69 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.529 1.132 . . . . 0.0 108.824 176.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -68.36 -15.05 63.42 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -174.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -115.07 -12.19 11.98 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.49 139.17 35.06 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.832 0.853 . . . . 0.0 112.513 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 21.2 t-105 -161.17 154.48 21.53 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.473 -177.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -132.32 117.1 17.71 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.42 173.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.272 63.8 m-85 -81.71 8.6 9.58 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 117.362 2.356 . . . . 0.0 117.362 -172.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 11.3 t . . . . . 0 CA--C 1.527 0.08 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -179.296 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 66.7 m . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 25.1 t -130.9 140.53 48.46 Favored 'Isoleucine or valine' 0 C--N 1.338 0.108 0 C-N-CA 122.83 0.452 . . . . 0.0 110.777 176.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 93.7 mt -130.76 159.2 38.02 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 122.961 0.504 . . . . 0.0 111.128 -176.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.1 tt -115.87 135.61 53.83 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.109 174.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -115.99 105.7 12.94 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -87.18 137.08 32.65 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 174.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.3 mp -106.94 118.21 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -88.48 -17.87 29.44 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -171.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -142.56 78.9 15.78 Favored Pre-proline 0 CA--C 1.529 0.156 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -77.98 46.55 2.1 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 125.132 3.888 . . . . 0.0 112.405 -177.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.42 -3.83 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 O-C-N 121.873 -0.517 . . . . 0.0 110.505 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -136.67 159.08 42.88 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 176.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 70.2 m -70.91 113.11 7.63 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.638 0.256 . . . . 0.0 110.373 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 33.8 mm -78.27 140.47 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.96 159.36 40.96 Favored 'General case' 0 C--O 1.23 0.058 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.445 ' HG1' ' HB2' ' A' ' 280' ' ' TRP . 1.4 p -65.2 -14.89 61.72 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 176.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -76.91 -45.49 27.75 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.589 0.356 . . . . 0.0 110.657 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 1.7 m -71.2 -32.42 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.88 -34.57 69.28 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 177.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -71.57 -29.71 65.03 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 174.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 8.2 m -67.29 -35.02 78.62 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 37.9 pt -91.32 -24.08 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 119.177 -0.44 . . . . 0.0 111.758 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 86.9 m -88.99 -25.46 22.01 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.438 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 31.4 t30 -63.13 -44.82 85.2 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-O 118.518 -0.753 . . . . 0.0 112.907 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 68.7 Cg_endo -68.18 -15.69 43.17 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.356 1.371 . . . . 0.0 111.478 178.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 95.2 m -84.12 -15.34 47.61 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 117.918 0.327 . . . . 0.0 111.715 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 152.4 169.3 17.6 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -61.42 104.82 0.32 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.768 2.979 . . . . 0.0 111.922 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 73.6 t -76.34 145.13 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -116.81 -38.38 3.45 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-O 119.394 -0.336 . . . . 0.0 111.579 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 41.3 mtm-85 -148.88 151.48 34.77 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 21.7 mt -147.71 136.48 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 124.036 0.934 . . . . 0.0 109.748 177.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.41 160.21 22.13 Favored 'Isoleucine or valine' 0 C--N 1.337 0.062 0 C-N-CA 123.592 0.757 . . . . 0.0 110.9 174.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 48.4 mt -134.43 141.51 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 123.189 0.596 . . . . 0.0 110.491 -175.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.292 5.8 p90 -140.82 157.78 44.91 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -127.21 14.26 7.23 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.449 0.699 . . . . 0.0 110.755 -174.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -61.97 -31.56 71.92 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -169.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -130.7 7.88 4.85 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 118.634 0.652 . . . . 0.0 112.289 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 161.38 -124.33 1.3 Allowed Glycine 0 CA--C 1.521 0.465 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 -174.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 47.9 t -142.73 115.07 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -143.95 167.73 21.66 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.324 0.583 . . . . 0.0 110.589 -176.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.25 164.29 32.77 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.879 0.871 . . . . 0.0 109.067 175.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 81.6 mmm -131.71 153.01 50.48 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 26.3 t -139.6 143.38 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.097 0 C-N-CA 122.786 0.434 . . . . 0.0 111.067 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -127.49 132.17 50.02 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.035 0.534 . . . . 0.0 110.337 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -108.27 161.94 14.54 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -176.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -80.95 -11.81 59.5 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 30.7 t -155.28 152.45 29.25 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.386 0.539 . . . . 0.0 111.893 -175.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 54.1 t -67.74 -38.27 80.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -67.78 -27.33 66.67 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 122.348 -0.22 . . . . 0.0 110.953 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 69.0 m -72.59 -34.35 67.35 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 176.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -77.48 -29.86 52.86 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 111.425 0.157 . . . . 0.0 111.425 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -67.75 -43.27 80.3 Favored 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 121.932 -0.48 . . . . 0.0 111.539 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -77.85 -24.23 48.65 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-N 117.842 0.292 . . . . 0.0 110.797 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -72.81 -41.19 65.18 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.098 0.408 . . . . 0.0 110.283 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -74.98 -23.39 58.27 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.814 0.446 . . . . 0.0 111.392 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -92.39 -17.21 24.94 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 48.1 t -106.16 -36.51 6.88 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -177.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 72.1 mt -89.42 -9.11 51.44 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -69.95 133.8 47.67 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.28 -5.54 42.51 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 119.748 -0.473 . . . . 0.0 112.205 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.4 166.41 22.67 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.792 0.796 . . . . 0.0 110.289 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -123.52 138.37 54.58 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 82.3 mt -72.66 -41.65 62.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.346 45.8 m-85 -82.9 -12.27 57.51 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.9 t 66.08 33.93 7.22 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.709 0.766 . . . . 0.0 110.936 -174.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 178.23 -24.7 0.05 OUTLIER Glycine 0 CA--C 1.528 0.856 0 C-N-CA 123.986 0.803 . . . . 0.0 111.289 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 72.8 m -145.74 -176.97 5.34 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.532 1.133 . . . . 0.0 109.422 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 89.8 m 57.64 37.88 27.54 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.856 0.462 . . . . 0.0 112.04 -176.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.2 147.49 13.01 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 175.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 79.6 mt -114.11 155.58 25.75 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -173.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -138.77 138.63 37.79 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.163 1.385 . . . . 0.0 107.597 169.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 37.0 mt -139.02 142.69 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-O 120.744 0.307 . . . . 0.0 111.75 -171.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -158.49 163.13 37.4 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.348 0.659 . . . . 0.0 109.478 175.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.266 44.1 m-85 -62.51 138.17 58.41 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 176.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -87.37 154.31 20.77 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.484 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.403 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 23.2 pttp -88.35 -31.76 0.39 Allowed Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 117.489 -1.243 . . . . 0.0 114.255 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 48.1 Cg_endo -79.94 162.56 23.58 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.743 1.629 . . . . 0.0 109.861 174.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.282 0.2 OUTLIER -137.79 18.75 2.86 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 116.747 2.129 . . . . 0.0 116.747 -176.462 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.467 ' CZ ' ' HA ' ' A' ' 269' ' ' ARG . 1.3 tpm_? -155.37 106.48 2.56 Favored 'General case' 0 C--N 1.34 0.169 0 O-C-N 121.734 -0.604 . . . . 0.0 112.301 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 9.4 mt -75.96 158.41 32.0 Favored 'General case' 0 N--CA 1.458 -0.062 0 C-N-CA 122.747 0.419 . . . . 0.0 110.161 173.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -127.02 54.56 1.63 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.685 0.794 . . . . 0.0 109.781 172.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.5 t -54.61 143.93 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -177.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -126.94 -7.7 6.05 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 117.557 2.429 . . . . 0.0 117.557 -176.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -162.17 173.04 14.83 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 122.809 0.444 . . . . 0.0 110.001 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -125.46 123.05 38.37 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.589 0.756 . . . . 0.0 110.05 175.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 46.5 p30 -159.99 -166.39 1.71 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.959 0.904 . . . . 0.0 108.575 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -68.11 -15.13 63.46 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -175.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -114.76 -12.88 12.09 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.64 139.77 34.9 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.631 0.772 . . . . 0.0 112.547 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' TRP . . . . . 0.445 ' HB2' ' HG1' ' A' ' 205' ' ' THR . 20.2 t-105 -161.02 156.86 25.31 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.446 -178.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -136.46 116.32 13.16 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.553 172.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.275 66.4 m-85 -79.05 7.22 7.73 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 117.26 2.318 . . . . 0.0 117.26 -173.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.456 -0.169 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -179.798 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 CA--C 1.53 0.194 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 38.8 t -130.51 133.76 63.2 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 C-N-CA 122.88 0.472 . . . . 0.0 111.292 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -122.63 152.86 40.06 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 122.987 0.515 . . . . 0.0 111.066 -177.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 28.4 tp -103.31 134.04 47.37 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 170.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -111.86 110.97 21.6 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.49 131.55 40.09 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 173.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.6 mp -102.1 120.4 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -88.42 -20.38 25.31 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 119.307 -0.378 . . . . 0.0 111.898 -172.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -142.19 78.94 16.46 Favored Pre-proline 0 CA--C 1.529 0.156 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.89 46.4 2.05 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 125.086 3.857 . . . . 0.0 112.249 -177.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.66 -3.58 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 O-C-N 121.86 -0.525 . . . . 0.0 110.822 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -136.85 158.04 45.36 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 176.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 69.3 m -69.47 111.22 5.18 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 41.0 mm -78.34 139.06 19.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.14 161.82 33.82 Favored 'General case' 0 CA--C 1.523 -0.094 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.3 p -64.45 -18.44 64.75 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 177.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -73.41 -39.75 64.81 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 1.5 m -75.89 -33.79 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 97.0 mt -71.37 -33.07 69.21 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 176.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -72.15 -30.53 65.11 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 175.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 20.6 m -67.23 -34.79 78.22 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 43.5 pt -90.89 -22.13 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 119.045 -0.503 . . . . 0.0 111.887 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 84.1 m -91.26 -26.62 18.91 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.466 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 32.7 t30 -63.99 -40.44 54.42 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 70.3 Cg_endo -69.32 -14.52 37.62 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.494 1.462 . . . . 0.0 111.477 177.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 98.8 m -89.88 -8.56 51.63 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.575 0.35 . . . . 0.0 111.614 177.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 149.54 170.32 16.91 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 177.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.68 102.56 1.03 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.933 3.089 . . . . 0.0 110.736 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 73.4 t -71.17 146.81 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 176.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -115.47 -36.17 4.37 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 119.377 -0.344 . . . . 0.0 111.651 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -149.68 151.9 34.46 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.417 0.553 . . . . 0.0 112.192 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 25.3 mt -147.2 136.76 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 124.195 0.998 . . . . 0.0 109.883 177.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 1.2 m -140.47 160.7 24.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.08 0 C-N-CA 123.485 0.714 . . . . 0.0 111.803 174.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 55.3 mt -135.78 144.08 34.59 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 C-N-CA 123.434 0.693 . . . . 0.0 109.832 -176.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.291 3.3 p90 -144.54 157.18 44.34 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 177.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -127.7 15.22 7.0 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.18 0.592 . . . . 0.0 110.883 -172.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -64.09 -30.94 71.97 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -169.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -130.54 4.91 4.69 Favored 'General case' 0 CA--C 1.527 0.074 0 CA-C-N 118.596 0.634 . . . . 0.0 112.262 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 163.76 -124.47 1.28 Allowed Glycine 0 C--N 1.334 0.459 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 -173.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 61.8 t -142.99 114.63 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 175.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 -142.83 168.17 20.36 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.021 0.439 . . . . 0.0 111.009 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.15 165.74 29.96 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.675 0.79 . . . . 0.0 109.456 177.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 61.4 mmm -134.36 153.47 51.87 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 42.6 t -141.59 144.19 26.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 C-N-CA 122.676 0.39 . . . . 0.0 110.116 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -131.67 132.82 44.27 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 122.395 0.278 . . . . 0.0 110.571 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -104.42 162.54 13.14 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -81.89 -8.21 59.66 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 44.8 t -154.5 150.74 28.13 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.811 -0.556 . . . . 0.0 111.973 -176.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 52.0 t -67.66 -36.1 74.99 Favored 'Isoleucine or valine' 0 C--N 1.338 0.096 0 C-N-CA 123.279 0.632 . . . . 0.0 109.356 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -67.22 -28.65 68.25 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 118.295 0.498 . . . . 0.0 110.866 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 63.2 m -75.43 -30.45 60.02 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.83 -31.94 59.58 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.342 0.257 . . . . 0.0 111.3 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -70.69 -43.84 68.21 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -74.59 -26.45 59.93 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 117.792 0.269 . . . . 0.0 111.05 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -71.98 -41.51 67.6 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 118.087 0.403 . . . . 0.0 110.042 177.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -75.6 -20.57 58.47 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 122.603 0.361 . . . . 0.0 111.399 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -95.93 -13.12 24.13 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 47.1 t -113.28 -33.6 5.91 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 59.7 mt -90.56 -7.78 51.96 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 118.003 0.365 . . . . 0.0 111.816 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -71.87 133.69 45.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 177.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.36 -5.87 40.94 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.924 -0.47 . . . . 0.0 111.924 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.87 166.44 22.41 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.793 0.796 . . . . 0.0 110.473 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -123.7 139.65 53.78 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 84.4 mt -74.22 -41.69 51.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.351 42.8 m-85 -82.97 -11.82 57.81 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 178.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 23.2 t 65.71 35.48 6.87 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.631 0.772 . . . . 0.0 111.087 -174.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 176.17 -23.76 0.06 OUTLIER Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.127 0.87 . . . . 0.0 111.266 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 98.5 m -146.37 -177.23 5.51 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.628 1.171 . . . . 0.0 109.47 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 89.1 m 58.19 36.23 25.62 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -176.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.1 148.98 10.04 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 175.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 75.9 mt -116.28 154.75 29.61 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -173.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -138.45 138.32 38.03 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.065 1.346 . . . . 0.0 107.596 169.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 33.1 mt -137.74 143.28 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-O 120.685 0.278 . . . . 0.0 111.514 -171.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -158.23 163.25 37.64 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.312 0.645 . . . . 0.0 109.374 175.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.268 37.8 m-85 -62.63 134.31 56.16 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 177.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -84.38 161.03 20.52 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.351 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.451 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 64.0 pttt -93.56 -31.58 0.3 Allowed Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 178.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 86.1 Cg_endo -75.88 171.12 18.77 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.913 1.742 . . . . 0.0 110.295 175.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.96 -1.61 2.67 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 117.26 2.319 . . . . 0.0 117.26 -175.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.35 133.55 11.6 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-N 118.766 0.712 . . . . 0.0 111.727 -178.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 19.2 mt -92.31 157.76 16.47 Favored 'General case' 0 C--O 1.228 -0.04 0 C-N-CA 124.137 0.975 . . . . 0.0 111.516 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -120.97 47.76 1.76 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.734 0.813 . . . . 0.0 109.86 174.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.5 t -53.09 143.91 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.092 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -177.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . 0.26 10.2 p90 -128.22 -4.57 5.53 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 116.868 2.173 . . . . 0.0 116.868 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.14 172.35 18.26 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 123.245 0.618 . . . . 0.0 111.689 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -125.68 121.82 34.57 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.752 0.821 . . . . 0.0 109.65 175.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 49.3 p30 -159.27 -166.71 1.88 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.643 0.777 . . . . 0.0 109.653 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -68.21 -14.56 63.07 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -177.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -99.53 -34.91 10.05 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.15 150.46 42.82 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 178.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 22.2 t-105 -157.86 155.59 29.93 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -176.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -131.24 119.17 21.44 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.972 0.509 . . . . 0.0 111.629 175.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.28 67.1 m-85 -83.02 9.35 10.4 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -171.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 9.3 t . . . . . 0 CA--C 1.528 0.126 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -178.531 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 N--CA 1.464 0.226 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 38.4 t -131.8 142.47 42.95 Favored 'Isoleucine or valine' 0 C--N 1.337 0.059 0 C-N-CA 123.362 0.665 . . . . 0.0 110.505 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 83.5 mt -134.6 148.3 50.4 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 122.615 0.366 . . . . 0.0 111.236 -175.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 28.5 tp -99.54 134.36 42.54 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 172.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -112.7 106.76 15.21 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.2 m -90.06 139.99 30.08 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 174.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 3.9 mp -110.34 122.48 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -91.79 -18.47 23.81 Favored 'General case' 0 C--O 1.23 0.06 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -171.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -141.66 78.93 17.47 Favored Pre-proline 0 CA--C 1.529 0.158 0 C-N-CA 122.95 0.5 . . . . 0.0 109.679 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -77.29 50.07 3.04 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 124.926 3.751 . . . . 0.0 112.179 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.72 -6.5 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 O-C-N 121.761 -0.587 . . . . 0.0 110.011 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -142.67 155.43 44.91 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.148 1.379 . . . . 0.0 112.337 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 28.5 t -74.97 131.86 40.97 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 25.4 mm -78.66 152.06 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 122.983 0.513 . . . . 0.0 110.338 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.96 157.58 45.68 Favored 'General case' 0 C--N 1.338 0.076 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 39.4 p -68.73 -18.27 64.2 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -77.59 -47.23 19.91 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 118.192 0.451 . . . . 0.0 111.748 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 3.5 m -71.12 -32.2 47.08 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 99.2 mt -70.47 -35.63 73.41 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -71.06 -30.18 66.27 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 175.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.6 m -67.35 -33.38 75.11 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 36.7 pt -93.63 -22.29 5.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 118.486 0.585 . . . . 0.0 111.787 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 89.1 m -90.17 -26.02 20.36 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.454 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 32.4 t30 -63.46 -42.57 74.62 Favored Pre-proline 0 CA--C 1.535 0.38 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 -178.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 70.9 Cg_endo -69.1 -13.19 35.86 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 121.784 1.656 . . . . 0.0 111.644 178.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 91.5 m -88.68 -8.38 54.67 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.041 0.382 . . . . 0.0 111.788 176.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 145.02 169.72 13.63 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 177.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.34 107.61 0.5 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.715 2.943 . . . . 0.0 111.949 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 72.3 t -76.56 146.6 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -117.01 -40.54 3.11 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 119.259 -0.4 . . . . 0.0 111.556 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 65.8 mtm-85 -148.88 152.55 36.64 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 25.4 mt -148.28 136.85 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 C-N-CA 124.305 1.042 . . . . 0.0 110.054 176.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 3.8 m -142.4 159.76 19.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 123.9 0.88 . . . . 0.0 110.519 174.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 48.0 mt -132.13 142.93 41.55 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 122.575 0.35 . . . . 0.0 110.676 -175.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.298 4.8 p90 -142.76 158.39 43.69 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 116.002 1.853 . . . . 0.0 116.002 176.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -130.45 17.68 5.37 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.469 0.708 . . . . 0.0 110.991 -174.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -64.29 -31.21 72.32 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -169.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -130.42 7.47 4.93 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.584 0.629 . . . . 0.0 112.161 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 161.0 -123.62 1.23 Allowed Glycine 0 C--N 1.334 0.451 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 -175.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 41.2 t -140.68 113.97 5.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -144.13 167.24 22.86 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.3 0.571 . . . . 0.0 111.094 -176.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -149.1 165.88 30.42 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.137 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 72.6 mmm -131.68 152.79 50.61 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 39.8 t -140.89 145.1 25.81 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 123.003 0.521 . . . . 0.0 110.385 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -131.23 134.98 46.97 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.007 0.523 . . . . 0.0 110.11 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -109.1 161.96 14.7 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 116.5 2.037 . . . . 0.0 116.5 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -80.23 -10.22 59.75 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 41.0 t -155.59 151.75 27.93 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.694 -0.628 . . . . 0.0 112.131 -176.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 43.5 t -66.39 -38.93 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -68.05 -24.17 65.05 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.784 0.265 . . . . 0.0 111.141 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 65.2 m -75.48 -33.53 60.81 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 175.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -77.51 -31.61 53.62 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 122.37 -0.206 . . . . 0.0 110.96 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -66.2 -43.77 85.82 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 121.931 -0.481 . . . . 0.0 111.358 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -77.12 -25.24 51.9 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.817 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -71.82 -41.39 68.26 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.911 0.323 . . . . 0.0 110.271 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.49 -28.34 62.83 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 122.634 0.374 . . . . 0.0 110.717 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -90.25 -12.94 36.48 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 41.0 t -113.7 -35.71 5.1 Favored 'General case' 0 C--N 1.339 0.122 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -176.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 68.5 mt -88.19 -7.45 56.84 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.024 0.375 . . . . 0.0 111.628 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -71.32 134.66 46.9 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 75.79 -5.47 39.0 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 119.795 -0.447 . . . . 0.0 112.48 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.46 166.35 22.71 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 117.797 0.799 . . . . 0.0 110.408 177.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -123.42 140.83 52.61 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 84.8 mt -75.99 -42.25 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.379 45.2 m-85 -82.89 -10.58 58.76 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 27.3 t 65.71 36.5 6.28 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.6 0.76 . . . . 0.0 110.864 -175.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 174.36 -24.25 0.07 OUTLIER Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 178.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 75.9 m -145.62 -177.21 5.46 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.922 1.289 . . . . 0.0 109.367 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 98.6 m 58.26 37.83 26.09 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.83 148.15 13.69 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 175.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 82.2 mt -114.31 156.19 24.85 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -172.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -139.45 138.28 36.32 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.598 1.559 . . . . 0.0 107.2 169.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 31.8 mt -139.23 142.83 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 CA-C-O 120.686 0.279 . . . . 0.0 111.316 -171.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -157.69 160.49 38.01 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 122.927 0.491 . . . . 0.0 109.771 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.283 40.6 m-85 -59.88 135.42 57.69 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 176.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -89.24 159.11 17.59 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.173 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.412 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 23.4 pttp -94.24 -31.8 0.29 Allowed Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 49.1 Cg_endo -79.83 159.12 24.58 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 CA-C-N 121.881 1.708 . . . . 0.0 109.505 174.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.31 0.2 OUTLIER -134.8 15.33 3.62 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 -174.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -158.45 123.0 4.16 Favored 'General case' 0 C--N 1.338 0.074 0 O-C-N 121.931 -0.481 . . . . 0.0 111.559 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 18.9 mt -86.05 161.06 19.12 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 123.583 0.753 . . . . 0.0 110.408 174.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -121.2 51.24 1.29 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.846 171.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.3 t -51.8 144.87 2.56 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -129.62 -5.78 4.66 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 117.653 2.464 . . . . 0.0 117.653 -176.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . 0.522 ' HB3' ' HZ1' ' A' ' 274' ' ' LYS . 0.3 OUTLIER -160.66 170.91 19.85 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 122.558 0.343 . . . . 0.0 110.609 -179.026 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -125.81 119.6 28.32 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.743 0.817 . . . . 0.0 110.038 174.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -162.69 -167.98 1.69 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.362 1.065 . . . . 0.0 109.087 176.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -70.23 -8.18 48.05 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -176.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -109.26 -26.28 10.15 Favored 'General case' 0 C--N 1.338 0.092 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.08 140.8 31.06 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.275 1.03 . . . . 0.0 112.499 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 21.6 t-105 -157.95 156.26 30.93 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.418 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -137.19 114.08 10.53 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.397 173.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.259 66.0 m-85 -78.29 6.72 7.66 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 -173.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 5.4 t . . . . . 0 N--CA 1.455 -0.209 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -178.901 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 56.0 m . . . . . 0 CA--C 1.53 0.184 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 28.6 t -128.8 142.34 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.095 0 C-N-CA 122.833 0.453 . . . . 0.0 110.889 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 91.2 mt -133.95 149.14 51.25 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 122.832 0.453 . . . . 0.0 111.278 -175.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 32.2 tp -102.0 135.01 44.3 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 172.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -114.57 107.04 14.97 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.93 138.27 31.68 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 174.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.1 mp -108.73 118.18 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -90.92 -18.83 24.07 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 119.255 -0.403 . . . . 0.0 112.018 -171.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -142.12 79.01 16.51 Favored Pre-proline 0 CA--C 1.529 0.156 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -77.61 44.56 1.56 Allowed 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 125.19 3.927 . . . . 0.0 112.48 -176.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.06 -4.55 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 O-C-N 121.59 -0.693 . . . . 0.0 110.641 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -137.95 156.18 48.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 42.3 t -70.39 117.02 11.41 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 120.717 0.294 . . . . 0.0 110.212 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.1 mm -78.55 143.73 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 122.876 0.471 . . . . 0.0 109.807 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.99 159.16 41.6 Favored 'General case' 0 CA--C 1.526 0.031 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.5 p -66.01 -15.69 63.24 Favored 'General case' 0 C--N 1.335 -0.062 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -76.38 -44.93 34.16 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.504 0.192 . . . . 0.0 110.848 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 1.9 m -72.88 -32.01 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.9 mt -70.64 -34.75 72.41 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 175.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -72.02 -30.29 65.05 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 174.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.6 m -66.82 -34.44 77.81 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 45.4 pt -91.27 -23.24 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 118.201 0.455 . . . . 0.0 111.902 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 89.0 m -89.87 -25.34 21.06 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.444 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 30.1 t30 -63.69 -42.59 72.97 Favored Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 73.8 Cg_endo -69.34 -12.56 33.98 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.338 1.359 . . . . 0.0 111.474 177.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 89.4 m -91.92 -7.45 49.1 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 122.502 0.321 . . . . 0.0 111.673 176.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 149.47 168.81 15.26 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.54 101.08 0.84 Allowed 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.9 3.067 . . . . 0.0 110.51 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 87.4 t -69.11 145.69 13.16 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 123.37 0.668 . . . . 0.0 109.257 177.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -115.04 -40.6 3.46 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 119.064 -0.493 . . . . 0.0 111.6 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 63.0 mtm-85 -148.05 152.43 37.38 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 21.4 mt -149.16 137.73 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 124.093 0.957 . . . . 0.0 110.273 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.3 m -143.48 163.15 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 C-N-CA 123.846 0.858 . . . . 0.0 110.338 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 54.1 mt -133.68 142.63 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 C-N-CA 122.757 0.423 . . . . 0.0 110.528 -175.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.264 6.3 p90 -146.92 159.34 43.67 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 115.819 1.785 . . . . 0.0 115.819 176.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.64 31.91 2.05 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.163 0.585 . . . . 0.0 111.777 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -67.9 -29.45 68.55 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -174.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -130.57 3.61 4.6 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 123.307 0.643 . . . . 0.0 112.514 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 167.19 -127.04 1.51 Allowed Glycine 0 CA--C 1.522 0.472 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 -173.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.1 t -138.79 117.8 13.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 117.103 0.452 . . . . 0.0 110.239 174.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 11.1 mp0 -144.1 168.56 19.72 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.476 0.655 . . . . 0.0 111.119 -175.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -150.66 167.16 28.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.828 1.251 . . . . 0.0 108.643 175.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 73.1 mmm -135.06 154.04 51.84 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 38.2 t -140.9 144.29 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 122.946 0.499 . . . . 0.0 110.517 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -129.88 135.07 47.94 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.87 0.468 . . . . 0.0 110.099 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -108.55 163.83 12.88 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 116.264 1.95 . . . . 0.0 116.264 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -81.2 -12.74 59.09 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 92.2 p -155.73 155.58 33.37 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.11 0.481 . . . . 0.0 111.455 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 49.7 t -67.84 -34.77 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -64.21 -33.72 76.45 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 122.254 -0.279 . . . . 0.0 110.8 -177.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 57.7 m -72.86 -33.74 66.3 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 117.464 0.12 . . . . 0.0 110.723 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -74.17 -30.12 62.09 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 119.707 -0.187 . . . . 0.0 111.373 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -68.85 -45.11 71.93 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 118.343 0.519 . . . . 0.0 111.724 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -76.44 -25.61 54.58 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 118.046 0.384 . . . . 0.0 111.553 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -72.32 -40.39 67.48 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.034 0.379 . . . . 0.0 110.171 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.82 -22.91 58.45 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.565 0.346 . . . . 0.0 111.316 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -95.08 -12.12 27.08 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 45.4 t -111.4 -34.95 5.97 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 118.622 0.646 . . . . 0.0 112.567 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 66.9 mt -89.79 -7.95 53.22 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -70.61 133.29 46.56 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 75.94 -4.12 47.59 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 119.651 -0.527 . . . . 0.0 112.215 -177.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.99 166.28 21.74 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 117.878 0.839 . . . . 0.0 110.281 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -123.56 140.06 53.38 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 115.016 1.488 . . . . 0.0 115.016 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 89.9 mt -74.24 -41.27 51.06 Favored 'Isoleucine or valine' 0 C--N 1.339 0.135 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.364 44.0 m-85 -82.86 -10.57 58.78 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 23.3 t 65.8 33.2 8.3 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.513 0.725 . . . . 0.0 110.577 -173.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 176.84 -22.52 0.05 OUTLIER Glycine 0 CA--C 1.531 1.037 0 C-N-CA 123.677 0.656 . . . . 0.0 111.491 177.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 96.4 m -145.99 -177.9 5.84 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.567 1.147 . . . . 0.0 109.814 178.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 90.9 m 58.68 37.67 25.14 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -176.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.24 148.33 11.62 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 176.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 79.2 mt -115.71 155.75 27.18 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -172.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -138.85 138.16 37.23 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.37 1.468 . . . . 0.0 107.454 169.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 36.1 mt -138.67 142.91 33.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-O 120.842 0.353 . . . . 0.0 111.728 -171.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -158.38 163.0 37.67 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 175.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.267 42.5 m-85 -62.28 135.51 57.5 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 176.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -85.11 160.44 19.96 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.303 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.441 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 63.8 pttt -92.66 -31.81 0.32 Allowed Pre-proline 0 CA--C 1.537 0.452 0 CA-C-O 117.493 -1.241 . . . . 0.0 114.21 178.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 91.1 Cg_endo -76.45 173.48 14.41 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 CA-C-N 122.096 1.784 . . . . 0.0 110.088 173.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.8 -5.05 2.83 Favored 'General case' 0 N--CA 1.461 0.089 0 N-CA-C 117.699 2.481 . . . . 0.0 117.699 -175.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -157.75 131.21 7.78 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.988 0.813 . . . . 0.0 111.761 -178.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 30.4 mt -83.75 162.57 20.62 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.434 1.094 . . . . 0.0 111.065 175.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -115.53 49.38 1.09 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 169.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.4 t -49.73 142.42 2.43 Favored 'Isoleucine or valine' 0 C--N 1.341 0.233 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -177.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -127.42 -9.03 5.75 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 117.819 2.526 . . . . 0.0 117.819 -175.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -161.18 173.85 14.5 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.808 0.443 . . . . 0.0 110.356 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -125.72 119.96 29.38 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.327 0.651 . . . . 0.0 110.182 175.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 47.6 p30 -159.33 -167.92 2.18 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.263 1.025 . . . . 0.0 109.271 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -69.95 -10.56 59.01 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -175.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -113.26 -18.55 12.06 Favored 'General case' 0 N--CA 1.461 0.093 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.14 141.08 29.77 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 124.29 1.036 . . . . 0.0 112.51 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 20.4 t-105 -160.35 158.76 30.21 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 118.886 0.767 . . . . 0.0 110.871 -178.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -139.59 115.81 10.45 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.398 172.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.252 65.1 m-85 -79.17 5.42 12.14 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 -173.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.456 -0.134 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -178.93 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 59.6 m . . . . . 0 CA--C 1.53 0.183 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.1 t -129.63 135.57 61.12 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 C-N-CA 123.086 0.555 . . . . 0.0 111.209 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -124.83 150.6 46.22 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 123.015 0.526 . . . . 0.0 110.646 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 40.3 tp -100.03 136.15 40.37 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 170.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -114.25 107.37 15.51 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 178.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.54 136.42 33.0 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 173.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.0 mp -106.8 118.34 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.029 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -90.67 -18.16 25.55 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -171.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -142.1 79.01 16.56 Favored Pre-proline 0 CA--C 1.529 0.139 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -76.91 44.71 1.51 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 125.115 3.877 . . . . 0.0 112.673 -177.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.04 -5.01 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 O-C-N 121.542 -0.724 . . . . 0.0 110.6 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -138.89 156.54 47.2 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 43.6 t -69.8 118.75 13.04 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 31.0 mm -78.42 143.81 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 123.025 0.53 . . . . 0.0 109.58 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.02 158.24 44.04 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.42 ' HG1' ' HB2' ' A' ' 280' ' ' TRP . 1.4 p -65.64 -16.75 64.03 Favored 'General case' 0 CA--C 1.523 -0.096 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 176.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -76.09 -45.59 33.19 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.616 0.246 . . . . 0.0 110.713 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.1 m -72.32 -32.56 43.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.93 -34.56 71.62 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 175.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -72.46 -29.0 63.27 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 174.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.6 m -67.95 -34.0 75.74 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 44.7 pt -91.22 -23.6 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 118.399 0.545 . . . . 0.0 111.798 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 89.0 m -89.38 -26.58 20.96 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -178.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.447 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 33.8 t30 -64.14 -42.0 65.5 Favored Pre-proline 0 CA--C 1.537 0.457 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -178.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 71.9 Cg_endo -68.79 -12.92 35.8 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 121.335 1.357 . . . . 0.0 111.407 177.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 95.8 m -91.82 -6.25 52.01 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.531 0.332 . . . . 0.0 111.673 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 147.13 166.66 12.55 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.72 104.12 1.1 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 123.849 3.032 . . . . 0.0 110.663 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 74.3 t -71.49 147.11 11.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -115.82 -36.33 4.21 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 119.199 -0.429 . . . . 0.0 111.716 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 21.3 mtm180 -150.78 151.54 32.5 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.526 0.603 . . . . 0.0 112.275 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 20.6 mt -147.4 136.54 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 C-N-CA 124.323 1.049 . . . . 0.0 110.219 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 1.3 m -140.24 159.85 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.065 0 C-N-CA 123.548 0.739 . . . . 0.0 111.765 174.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 57.0 mt -132.08 142.62 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 C-N-CA 122.929 0.492 . . . . 0.0 110.021 -177.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.261 4.0 p90 -147.84 159.86 43.39 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 115.629 1.714 . . . . 0.0 115.629 176.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.1 31.35 2.18 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.017 0.527 . . . . 0.0 111.68 -177.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -67.63 -30.35 69.89 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -174.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -130.54 4.29 4.65 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 123.105 0.562 . . . . 0.0 112.498 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 166.36 -127.83 1.66 Allowed Glycine 0 C--N 1.333 0.368 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 -174.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 19.3 t -139.69 116.72 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-N 117.415 0.608 . . . . 0.0 110.336 174.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 9.6 mp0 -144.78 169.05 18.78 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.677 0.751 . . . . 0.0 111.123 -175.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -150.86 167.47 27.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.224 1.01 . . . . 0.0 108.621 175.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 53.5 mmm -135.01 154.83 51.59 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.618 0.367 . . . . 0.0 110.03 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 35.8 t -142.34 143.26 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 C-N-CA 123.219 0.608 . . . . 0.0 110.496 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -130.07 134.36 47.32 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 123.216 0.323 . . . . 0.0 110.263 177.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -105.01 163.62 12.41 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 -176.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -77.93 -16.48 58.15 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 86.4 p -153.48 157.15 39.42 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.222 0.534 . . . . 0.0 111.503 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 54.8 t -67.23 -33.98 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -64.9 -34.81 79.28 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 122.063 -0.398 . . . . 0.0 110.613 -177.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 65.6 m -72.58 -31.51 65.28 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 110.624 -0.139 . . . . 0.0 110.624 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -72.52 -31.68 65.53 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 111.328 0.122 . . . . 0.0 111.328 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -72.21 -45.82 58.74 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 117.979 0.354 . . . . 0.0 111.843 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 17.1 ptt180 -75.04 -26.02 59.13 Favored 'General case' 0 C--N 1.338 0.089 0 C-N-CA 120.659 -0.417 . . . . 0.0 111.317 -177.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -70.63 -40.73 72.94 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 117.934 0.334 . . . . 0.0 110.196 177.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -75.79 -25.87 56.8 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.494 0.317 . . . . 0.0 111.059 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -89.25 -10.46 46.87 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 47.0 t -115.92 -35.74 4.36 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 66.8 mt -89.31 -6.7 56.5 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -177.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -70.94 133.97 46.83 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.19 -4.6 47.09 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 119.767 -0.463 . . . . 0.0 112.346 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.61 166.43 22.54 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 117.872 0.836 . . . . 0.0 110.249 177.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -123.45 139.16 54.31 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 86.8 mt -73.77 -41.74 54.29 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.358 44.0 m-85 -82.83 -11.39 58.28 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.8 t 65.38 35.92 7.18 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 122.101 0.953 . . . . 0.0 110.685 -174.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 176.38 -24.55 0.06 OUTLIER Glycine 0 CA--C 1.528 0.877 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.202 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 87.2 m -147.21 -177.16 5.53 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.943 1.297 . . . . 0.0 109.659 178.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 94.9 m 58.54 37.7 25.47 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -175.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.93 147.43 12.26 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 175.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 80.1 mt -115.26 154.41 29.14 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -173.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -137.53 138.31 39.51 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.16 1.384 . . . . 0.0 107.448 169.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 36.6 mt -138.31 143.29 33.15 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.085 0 CA-C-O 120.781 0.324 . . . . 0.0 111.381 -171.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -158.71 161.66 37.09 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.789 175.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.272 33.5 m-85 -59.18 134.43 56.99 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 176.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -87.74 163.33 16.55 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.854 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.455 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 23.3 pttp -97.95 -29.83 0.25 Allowed Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 84.2 Cg_endo -76.23 170.88 19.15 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 CA-C-N 122.04 1.764 . . . . 0.0 110.277 175.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.41 -2.62 2.75 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 117.584 2.438 . . . . 0.0 117.584 -177.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.26 131.61 10.34 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 118.691 0.678 . . . . 0.0 111.879 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 17.0 mt -89.84 158.16 17.59 Favored 'General case' 0 C--N 1.337 0.065 0 C-N-CA 123.652 0.781 . . . . 0.0 111.325 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -121.84 46.04 2.18 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.549 0.739 . . . . 0.0 109.834 175.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.5 t -52.08 144.7 2.89 Favored 'Isoleucine or valine' 0 C--N 1.338 0.093 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . 0.317 8.2 p90 -123.54 -5.73 8.16 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 117.099 2.259 . . . . 0.0 117.099 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.84 172.33 16.28 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 123.382 0.673 . . . . 0.0 111.264 178.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -124.15 118.89 27.9 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.71 0.804 . . . . 0.0 110.067 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -159.09 -168.74 2.44 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.907 0.883 . . . . 0.0 109.379 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -69.63 -10.77 59.58 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -176.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -98.96 -38.35 9.03 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.4 p -143.04 146.05 33.48 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.66 0.784 . . . . 0.0 113.003 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' TRP . . . . . 0.42 ' HB2' ' HG1' ' A' ' 205' ' ' THR . 20.3 t-105 -154.73 152.85 30.39 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.165 0.507 . . . . 0.0 109.998 -174.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -127.6 117.42 21.99 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.559 174.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.286 65.0 m-85 -81.64 8.41 9.89 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 117.511 2.412 . . . . 0.0 117.511 -171.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 6.4 t . . . . . 0 CA--C 1.529 0.147 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -178.836 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 CA--C 1.531 0.224 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.5 t -133.08 134.57 57.73 Favored 'Isoleucine or valine' 0 C--N 1.341 0.198 0 C-N-CA 122.752 0.421 . . . . 0.0 110.672 177.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -123.14 152.49 41.09 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 122.781 0.433 . . . . 0.0 111.137 -176.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 28.0 tp -100.91 135.8 41.78 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 169.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -113.29 111.06 21.39 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.863 1.265 . . . . 0.0 114.248 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.31 132.69 38.65 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 173.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.3 mp -103.7 120.55 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -89.74 -18.1 27.0 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -171.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -143.08 78.95 14.79 Favored Pre-proline 0 CA--C 1.53 0.181 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -78.37 45.92 1.98 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 125.061 3.84 . . . . 0.0 112.131 -177.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.38 -3.86 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 O-C-N 121.924 -0.485 . . . . 0.0 110.553 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -137.32 157.74 45.96 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 176.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 67.5 m -69.88 113.6 7.27 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 33.7 mm -78.4 141.81 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.079 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.24 161.02 36.09 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.6 p -62.45 -21.04 65.13 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -74.02 -46.21 44.92 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.63 0.372 . . . . 0.0 111.717 -178.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 1.7 m -69.28 -32.74 54.75 Favored 'Isoleucine or valine' 0 C--O 1.23 0.043 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.9 mt -72.09 -35.82 69.32 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -69.2 -31.05 69.39 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 174.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 9.4 m -67.69 -34.05 76.13 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 38.6 pt -93.16 -21.32 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 119.027 -0.511 . . . . 0.0 111.916 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 92.0 m -90.34 -27.32 19.47 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 119.139 0.881 . . . . 0.0 113.278 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.456 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 35.1 t30 -63.36 -39.78 52.99 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -178.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 74.0 Cg_endo -69.35 -15.77 38.83 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 CA-C-N 121.216 1.47 . . . . 0.0 111.635 178.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 95.0 m -84.67 -13.29 51.92 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.041 0.382 . . . . 0.0 111.456 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 149.58 169.42 15.95 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.03 112.84 1.64 Allowed 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 123.578 2.852 . . . . 0.0 111.309 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.8 t -79.38 144.34 11.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 176.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -112.99 -39.57 4.19 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 119.381 -0.342 . . . . 0.0 111.189 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 23.3 mtm180 -150.06 153.16 35.98 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.131 0.423 . . . . 0.0 112.066 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 24.6 mt -144.07 143.6 23.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.261 1.024 . . . . 0.0 109.659 178.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 38.3 t -145.94 155.89 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 46.6 mt -138.65 141.52 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 123.894 0.878 . . . . 0.0 109.375 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.287 3.2 p90 -143.98 157.52 44.29 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 177.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -126.53 15.98 7.62 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.272 0.629 . . . . 0.0 110.733 -173.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -63.35 -33.18 74.96 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -169.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -130.35 7.86 5.0 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.568 0.622 . . . . 0.0 112.265 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 161.96 -125.35 1.41 Allowed Glycine 0 CA--C 1.522 0.469 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -174.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 47.0 t -141.9 114.9 4.16 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 174.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -142.16 168.31 20.04 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.256 0.551 . . . . 0.0 110.989 -176.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.05 164.26 34.37 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.951 176.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 67.4 mmm -132.39 151.27 51.94 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 41.2 t -141.63 144.31 26.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 C-N-CA 122.77 0.428 . . . . 0.0 110.326 -178.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -130.58 134.23 46.84 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 122.838 0.455 . . . . 0.0 110.498 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -106.6 163.43 12.89 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 116.765 2.135 . . . . 0.0 116.765 -175.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -76.64 -17.04 59.38 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.784 0.433 . . . . 0.0 109.879 178.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 83.8 p -154.87 158.34 39.21 Favored 'General case' 0 C--O 1.232 0.157 0 O-C-N 121.819 -0.551 . . . . 0.0 111.648 -178.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 54.4 t -66.29 -33.61 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -68.34 -30.05 68.92 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 121.918 -0.489 . . . . 0.0 110.719 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 68.9 m -73.48 -31.43 63.75 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 175.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.49 -34.51 58.64 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 122.482 0.313 . . . . 0.0 111.546 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -70.54 -42.26 71.42 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 118.104 0.411 . . . . 0.0 111.445 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -76.84 -25.66 53.45 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.489 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -70.44 -41.27 73.09 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -75.08 -19.93 59.74 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.567 0.347 . . . . 0.0 111.012 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -99.51 -4.24 31.69 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 38.6 t -124.28 -31.91 3.25 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.864 0.756 . . . . 0.0 112.803 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 61.6 mt -91.59 -6.66 51.96 Favored 'General case' 0 CA--C 1.527 0.071 0 O-C-N 121.998 -0.439 . . . . 0.0 111.527 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -73.28 134.75 44.32 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 74.44 -5.9 26.28 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 111.984 -0.447 . . . . 0.0 111.984 -178.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.19 166.46 22.17 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 117.663 0.731 . . . . 0.0 110.122 177.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -123.64 139.68 53.76 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 87.7 mt -73.33 -41.58 57.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.182 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.367 39.6 m-85 -82.93 -12.01 57.69 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 117.257 2.317 . . . . 0.0 117.257 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.7 t 65.8 35.26 6.85 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.748 0.785 . . . . 0.0 110.754 -174.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 176.0 -23.68 0.06 OUTLIER Glycine 0 CA--C 1.527 0.812 0 C-N-CA 123.947 0.784 . . . . 0.0 111.198 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 93.0 m -147.2 -177.02 5.45 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.916 1.286 . . . . 0.0 109.466 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 86.7 m 58.07 36.95 26.41 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -176.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.59 148.95 11.44 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 175.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 76.3 mt -115.9 155.23 28.33 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -173.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -138.38 138.38 38.21 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.313 1.445 . . . . 0.0 107.587 168.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 34.3 mt -138.34 142.37 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-O 120.657 0.265 . . . . 0.0 111.611 -170.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -158.67 162.25 37.21 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.38 0.672 . . . . 0.0 109.844 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -61.13 137.45 58.23 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -88.6 162.34 16.41 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.942 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -82.41 -54.25 0.61 Allowed Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 118.493 -0.765 . . . . 0.0 112.742 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -73.46 164.97 33.68 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.269 2.646 . . . . 0.0 111.347 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.274 0.2 OUTLIER -135.41 10.11 3.46 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 117.247 2.314 . . . . 0.0 117.247 -176.056 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.12 129.16 8.79 Favored 'General case' 0 C--N 1.339 0.11 0 O-C-N 121.646 -0.659 . . . . 0.0 111.642 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 30.9 mt -92.57 156.37 17.17 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 123.882 0.873 . . . . 0.0 110.916 177.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -118.58 49.12 1.33 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.861 0.864 . . . . 0.0 109.585 174.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.1 t -52.31 142.12 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -176.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -130.08 0.7 4.71 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 116.551 2.056 . . . . 0.0 116.551 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -160.58 164.31 32.03 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 122.89 0.476 . . . . 0.0 110.926 -176.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -125.73 118.72 26.19 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.617 0.767 . . . . 0.0 109.198 174.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 40.0 p30 -157.19 -168.04 2.5 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.823 0.849 . . . . 0.0 109.904 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -69.3 -11.95 61.25 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -104.29 -30.66 10.0 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 3.5 p -141.49 145.31 35.05 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 19.2 t-105 -157.67 153.24 26.4 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -176.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . 0.251 7.0 t0 -132.95 121.15 22.38 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 122.94 0.496 . . . . 0.0 112.197 176.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.25 67.2 m-85 -87.25 8.97 21.76 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 117.58 2.437 . . . . 0.0 117.58 -171.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 5.0 t . . . . . 0 C--O 1.231 0.11 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 -177.208 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 CA--C 1.529 0.151 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 20.2 t -128.09 140.37 49.35 Favored 'Isoleucine or valine' 0 C--N 1.338 0.081 0 C-N-CA 122.813 0.445 . . . . 0.0 111.192 176.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.7 mt -131.88 157.44 43.95 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.241 0.616 . . . . 0.0 110.958 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.0 tt -113.8 136.04 53.3 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.412 0.685 . . . . 0.0 109.288 174.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -114.34 102.59 10.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -85.96 135.72 33.55 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 174.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.2 mp -106.06 122.41 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -90.27 -20.34 23.07 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -172.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -141.23 78.87 18.37 Favored Pre-proline 0 CA--C 1.529 0.163 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -78.6 44.2 1.59 Allowed 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 124.984 3.789 . . . . 0.0 112.147 -177.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.05 -4.72 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 O-C-N 121.91 -0.494 . . . . 0.0 110.803 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -136.3 157.82 45.9 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 70.9 m -68.87 113.28 6.16 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.84 0.352 . . . . 0.0 110.32 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 40.0 mm -78.42 141.23 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 176.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.1 157.18 46.81 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.452 ' HG1' ' HB2' ' A' ' 280' ' ' TRP . 2.0 p -66.38 -15.86 63.62 Favored 'General case' 0 C--N 1.334 -0.088 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 175.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -79.87 -42.19 24.74 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.5 p -75.18 -32.41 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.1 mt -69.83 -33.95 73.0 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -71.23 -29.25 64.9 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 174.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.0 m -68.09 -32.2 72.35 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 45.3 pt -93.56 -22.36 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 118.291 0.496 . . . . 0.0 112.058 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 94.0 m -89.99 -26.07 20.55 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.457 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 35.1 t30 -63.89 -41.44 63.58 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 74.0 Cg_endo -69.09 -15.98 40.01 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.521 1.48 . . . . 0.0 111.27 177.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 97.6 m -86.15 -11.7 51.86 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.457 0.303 . . . . 0.0 111.467 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 151.5 167.69 15.17 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -68.01 103.67 0.92 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.913 3.075 . . . . 0.0 110.248 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.1 t -70.61 146.96 11.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -114.9 -39.0 3.77 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 119.13 -0.462 . . . . 0.0 111.561 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 22.5 mtm180 -149.54 151.45 33.89 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 118.61 0.641 . . . . 0.0 112.263 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 24.2 mt -148.66 137.65 15.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 124.053 0.941 . . . . 0.0 109.929 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 5.4 m -143.55 161.99 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 124.248 1.019 . . . . 0.0 110.559 174.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 46.4 mt -134.74 143.01 38.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 C-N-CA 122.929 0.491 . . . . 0.0 110.472 -175.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.3 4.4 p90 -142.3 158.44 43.71 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 176.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -128.61 15.14 6.51 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.591 0.756 . . . . 0.0 110.909 -173.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -62.6 -31.34 72.15 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 -169.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -130.41 4.0 4.69 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.609 0.64 . . . . 0.0 112.119 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 165.86 -124.45 1.24 Allowed Glycine 0 CA--C 1.521 0.429 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 -174.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.2 t -141.63 115.38 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.121 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 174.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -143.15 166.09 25.64 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.242 0.544 . . . . 0.0 111.11 -177.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -143.73 165.1 28.59 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.957 0.903 . . . . 0.0 108.836 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 80.7 mmm -133.13 150.82 52.02 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 31.6 t -140.49 145.65 25.51 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.061 0 C-N-CA 122.689 0.395 . . . . 0.0 110.882 -177.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -132.74 135.07 45.51 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 122.622 0.369 . . . . 0.0 110.628 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -107.42 163.84 12.7 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 115.934 1.828 . . . . 0.0 115.934 -176.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -78.32 -15.86 58.3 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 79.1 p -154.91 159.65 40.61 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.304 0.573 . . . . 0.0 111.665 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 54.3 t -67.51 -35.22 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -66.24 -30.88 71.41 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 122.375 -0.203 . . . . 0.0 110.954 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 74.4 m -72.83 -34.04 66.55 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 176.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.16 -31.34 58.5 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 122.43 -0.169 . . . . 0.0 111.2 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -68.51 -42.58 78.34 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 121.825 -0.547 . . . . 0.0 111.459 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -76.52 -26.57 55.38 Favored 'General case' 0 C--N 1.338 0.1 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.816 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -72.07 -41.55 67.23 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.186 0.448 . . . . 0.0 110.173 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -73.69 -20.11 60.63 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.742 0.417 . . . . 0.0 111.184 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -99.01 -9.3 24.13 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 46.4 t -116.32 -32.93 5.13 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 72.8 mt -91.9 -7.89 47.93 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.059 0.391 . . . . 0.0 111.902 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -73.04 133.04 44.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 77.06 -5.84 46.49 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.707 -0.496 . . . . 0.0 111.957 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.32 166.41 22.13 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 117.782 0.791 . . . . 0.0 110.384 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -123.49 140.65 52.79 Favored 'General case' 0 C--N 1.334 -0.099 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 87.1 mt -74.61 -42.39 48.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.359 39.7 m-85 -82.79 -12.16 57.71 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 32.6 t 65.54 36.12 6.78 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.658 0.742 . . . . 0.0 111.239 -174.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 175.6 -24.26 0.06 OUTLIER Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 96.9 m -145.81 -177.2 5.46 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.185 1.394 . . . . 0.0 109.801 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 88.1 m 57.89 37.93 26.96 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.22 148.96 13.38 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 175.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 81.2 mt -116.09 154.78 29.35 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -173.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 54.1 mttp -138.19 137.06 37.23 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.715 1.606 . . . . 0.0 107.484 169.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 56.0 mt -136.87 143.3 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-O 120.94 0.4 . . . . 0.0 111.384 -172.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -159.23 164.02 35.38 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.739 175.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.266 45.3 m-85 -61.71 135.46 57.62 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 176.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -88.27 156.36 19.24 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.347 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.41 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 64.6 pttt -89.44 -31.51 0.37 Allowed Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 50.1 Cg_endo -79.28 168.39 20.26 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 121.835 1.69 . . . . 0.0 110.136 175.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.281 0.2 OUTLIER -137.78 8.86 2.82 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 117.883 2.549 . . . . 0.0 117.883 -176.015 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.32 126.84 6.69 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 118.778 0.717 . . . . 0.0 111.799 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 27.4 mt -92.22 156.95 16.96 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 123.858 0.863 . . . . 0.0 110.747 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -116.67 53.31 0.89 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.504 0.722 . . . . 0.0 109.788 172.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.6 t -54.68 145.26 4.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -175.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -135.67 -0.25 2.63 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 117.022 2.23 . . . . 0.0 117.022 -176.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -160.53 159.08 30.26 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.584 0.354 . . . . 0.0 111.372 -173.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -123.12 112.23 17.48 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.834 0.854 . . . . 0.0 109.404 173.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 53.1 p30 -157.87 -166.28 1.94 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -66.9 -16.33 64.25 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -174.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -115.17 -13.36 11.79 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.29 139.29 37.29 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 123.815 0.846 . . . . 0.0 113.041 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' TRP . . . . . 0.452 ' HB2' ' HG1' ' A' ' 205' ' ' THR . 16.3 t-105 -162.95 155.34 18.62 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.25 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . 0.259 5.8 t0 -140.79 119.57 12.54 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.194 0.598 . . . . 0.0 112.102 172.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.252 66.8 m-85 -82.18 7.62 13.16 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 117.536 2.421 . . . . 0.0 117.536 -171.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 6.0 t . . . . . 0 C--O 1.232 0.143 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -177.381 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 71.2 m . . . . . 0 CA--C 1.532 0.27 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.3 t -132.97 133.26 58.92 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 CA-C-N 118.162 0.437 . . . . 0.0 110.875 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -121.76 155.01 36.17 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 122.954 0.502 . . . . 0.0 110.995 -176.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 29.1 tp -104.98 131.18 52.82 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 170.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -107.72 101.74 11.02 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 177.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.78 136.21 33.17 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 174.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.4 mp -105.67 130.61 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -92.65 -24.2 18.74 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -175.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -138.82 78.92 29.33 Favored Pre-proline 0 CA--C 1.529 0.147 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -77.01 49.59 2.84 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 124.865 3.71 . . . . 0.0 112.346 -178.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.13 -7.05 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 O-C-N 121.775 -0.578 . . . . 0.0 110.314 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -140.14 153.67 46.75 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.082 1.353 . . . . 0.0 113.081 175.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.4 t -73.55 128.14 34.68 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 120.811 0.338 . . . . 0.0 110.517 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 19.7 mm -78.71 148.69 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 122.724 0.409 . . . . 0.0 109.947 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.0 156.15 48.71 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 177.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.5 p -65.57 -16.37 63.63 Favored 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -74.73 -47.16 32.85 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.7 0.286 . . . . 0.0 111.703 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.5 m -71.41 -32.43 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.6 mt -69.91 -36.15 75.17 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 176.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -71.21 -30.67 66.66 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 12.6 m -66.31 -32.99 74.73 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 37.5 pt -94.05 -24.3 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 118.178 0.444 . . . . 0.0 112.02 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 90.1 m -88.29 -25.44 22.81 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.454 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 35.3 t30 -64.19 -43.16 72.66 Favored Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 67.4 Cg_endo -68.38 -15.3 41.88 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 121.411 1.407 . . . . 0.0 111.512 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 95.4 m -83.86 -15.14 49.29 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.047 0.385 . . . . 0.0 111.379 177.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 151.02 170.47 18.05 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -61.12 104.82 0.3 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.774 2.983 . . . . 0.0 111.732 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 72.5 t -75.72 145.54 10.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -117.79 -39.75 3.09 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 119.287 -0.387 . . . . 0.0 111.477 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 66.1 mtm-85 -148.05 151.22 35.32 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.484 0.584 . . . . 0.0 112.547 179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 20.3 mt -148.27 137.58 15.89 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 C-N-CA 124.105 0.962 . . . . 0.0 109.628 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 8.1 m -143.07 162.84 17.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 C-N-CA 123.735 0.814 . . . . 0.0 110.23 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 47.8 mt -135.96 142.88 37.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.093 0 C-N-CA 123.224 0.609 . . . . 0.0 110.409 -174.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.299 6.2 p90 -141.39 155.38 45.91 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 177.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -128.37 14.3 6.62 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.242 0.617 . . . . 0.0 110.788 -174.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -64.98 -30.68 71.68 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -169.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -130.37 5.8 4.82 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.793 0.724 . . . . 0.0 111.812 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 162.38 -126.29 1.54 Allowed Glycine 0 C--N 1.335 0.515 0 N-CA-C 107.966 -2.054 . . . . 0.0 107.966 -174.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 38.5 t -142.78 116.98 4.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 175.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -144.02 166.84 23.84 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.289 0.566 . . . . 0.0 110.631 -176.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.97 166.37 26.99 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.113 175.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 74.6 mmm -133.96 154.2 51.26 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 29.6 t -142.11 142.8 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 C-N-CA 122.781 0.432 . . . . 0.0 110.905 -178.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -129.36 133.16 47.26 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.155 0.582 . . . . 0.0 110.274 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -108.5 160.97 15.48 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 -176.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -79.55 -11.95 59.87 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 37.7 t -154.81 153.48 31.25 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 121.812 -0.555 . . . . 0.0 111.549 -176.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 56.6 t -68.01 -37.36 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -67.09 -27.53 67.43 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 122.039 -0.413 . . . . 0.0 111.025 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 52.2 m -74.32 -32.39 62.82 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 175.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.52 -31.74 57.84 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 122.567 0.347 . . . . 0.0 111.305 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -69.74 -45.39 68.24 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 117.949 0.34 . . . . 0.0 111.345 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -74.6 -26.57 60.0 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 117.953 0.342 . . . . 0.0 111.24 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -69.32 -42.81 74.86 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.414 ' HE3' ' HB3' ' A' ' 245' ' ' LYS . 0.8 OUTLIER -75.39 -21.24 58.42 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.825 0.45 . . . . 0.0 111.161 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -94.32 -9.0 37.32 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 40.9 t -118.4 -34.21 4.12 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -177.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 70.8 mt -89.1 -8.07 54.55 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 118.161 0.437 . . . . 0.0 111.999 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -71.15 136.3 48.07 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.58 -5.66 21.43 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 119.756 -0.469 . . . . 0.0 112.159 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -77.83 166.5 22.83 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 117.955 0.878 . . . . 0.0 110.003 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -122.59 139.17 54.22 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 86.2 mt -74.48 -41.58 49.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.361 44.8 m-85 -82.86 -9.96 59.07 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 117.045 2.239 . . . . 0.0 117.045 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 30.8 t 65.57 35.25 7.25 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.479 0.712 . . . . 0.0 111.08 -175.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 175.95 -24.6 0.06 OUTLIER Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.053 0.835 . . . . 0.0 111.243 177.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 82.0 m -145.83 -177.87 5.81 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.6 1.16 . . . . 0.0 109.354 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 97.3 m 58.6 38.96 25.16 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -174.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.32 150.37 8.79 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 174.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 97.1 mt -110.96 157.3 20.06 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -173.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.96 130.13 26.76 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.711 2.005 . . . . 0.0 106.331 170.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 30.7 mt -138.3 139.69 41.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-O 120.908 0.385 . . . . 0.0 111.295 -172.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -161.31 163.75 30.62 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.421 175.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.25 48.7 m-85 -59.89 141.91 54.58 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 177.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -96.21 162.08 13.68 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -176.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -78.14 -50.33 1.79 Allowed Pre-proline 0 CA--C 1.532 0.286 0 CA-C-O 118.318 -0.849 . . . . 0.0 112.282 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.51 169.01 23.26 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.656 2.237 . . . . 0.0 111.191 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.259 0.2 OUTLIER -134.51 3.13 3.29 Favored 'General case' 0 CA--C 1.527 0.071 0 N-CA-C 117.73 2.493 . . . . 0.0 117.73 -176.328 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -157.85 127.47 5.97 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 118.764 0.711 . . . . 0.0 112.063 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 21.9 mt -82.81 163.24 21.34 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.975 0.91 . . . . 0.0 111.015 175.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -121.8 51.98 1.29 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.69 0.796 . . . . 0.0 109.103 171.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.3 t -51.96 144.49 2.94 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -176.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -128.36 -7.52 5.27 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 117.476 2.399 . . . . 0.0 117.476 -177.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -161.46 171.37 18.28 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 122.728 0.411 . . . . 0.0 110.517 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -124.69 122.99 39.05 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.774 0.83 . . . . 0.0 109.667 174.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 45.1 p30 -160.58 -166.12 1.57 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.99 0.916 . . . . 0.0 108.728 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -68.17 -14.98 63.39 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -174.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -114.01 -13.18 12.52 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.01 139.87 34.23 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 123.68 0.792 . . . . 0.0 112.736 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 17.2 t-105 -160.34 156.14 25.78 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.328 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -135.86 116.04 13.43 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.542 172.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.267 67.2 m-85 -80.4 8.0 8.52 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 116.898 2.184 . . . . 0.0 116.898 -173.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.457 -0.118 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -179.516 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 CA--C 1.536 0.418 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 92.7 t -132.51 143.3 40.19 Favored 'Isoleucine or valine' 0 C--N 1.339 0.124 0 C-N-CA 123.669 0.788 . . . . 0.0 109.207 177.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 75.9 mt -136.38 149.64 48.43 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -173.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 38.8 tp -100.02 135.54 41.28 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 172.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -114.97 102.2 9.74 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.138 1.375 . . . . 0.0 114.485 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.42 134.33 33.6 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 174.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.2 mp -103.5 122.44 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -91.99 -18.12 24.12 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -171.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -143.29 78.72 14.69 Favored Pre-proline 0 CA--C 1.529 0.148 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -78.23 45.83 1.94 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 125.136 3.891 . . . . 0.0 112.102 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.95 -4.55 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 O-C-N 121.952 -0.467 . . . . 0.0 110.909 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -136.27 157.6 46.42 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 177.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 66.9 m -71.34 112.81 7.77 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 120.636 0.255 . . . . 0.0 110.466 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.3 mm -78.46 142.15 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.96 160.58 37.28 Favored 'General case' 0 N--CA 1.458 -0.064 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.2 p -66.6 -14.52 62.5 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 176.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -75.98 -44.29 40.41 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 120.813 0.339 . . . . 0.0 110.675 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.0 m -72.53 -33.52 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.8 mt -70.85 -35.11 72.28 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -69.74 -31.5 69.51 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 174.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.8 m -67.31 -31.81 72.36 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 43.4 pt -94.58 -25.47 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-O 118.982 -0.533 . . . . 0.0 112.027 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 98.0 m -86.59 -28.59 23.18 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 119.283 0.947 . . . . 0.0 113.263 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.46 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 38.8 t30 -68.12 -40.49 21.95 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -178.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 74.4 Cg_endo -69.42 -14.29 36.93 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 CA-C-N 121.045 1.409 . . . . 0.0 111.434 176.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 91.7 m -87.28 -8.97 56.17 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 117.896 0.317 . . . . 0.0 111.46 176.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 150.53 171.1 18.45 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 178.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -66.63 85.45 0.29 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 124.632 3.554 . . . . 0.0 110.928 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 10.7 p -68.39 148.48 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 123.874 0.87 . . . . 0.0 109.609 175.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -121.75 -36.23 3.07 Favored 'General case' 0 C--O 1.228 -0.077 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -174.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 66.2 mtm-85 -146.1 148.73 32.93 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.582 0.628 . . . . 0.0 112.353 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 35.2 mt -147.99 135.07 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 C-N-CA 123.998 0.919 . . . . 0.0 109.504 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 2.3 m -141.3 160.81 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.105 0 C-N-CA 123.633 0.773 . . . . 0.0 111.614 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 53.1 mt -134.6 144.17 35.69 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.046 0 C-N-CA 123.332 0.653 . . . . 0.0 110.327 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.297 4.6 p90 -143.31 155.99 44.6 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -127.13 13.13 7.21 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.509 0.724 . . . . 0.0 111.087 -173.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -64.31 -31.04 72.09 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -169.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -130.32 7.49 4.98 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 118.889 0.768 . . . . 0.0 112.114 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 161.08 -124.54 1.33 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 108.559 -1.816 . . . . 0.0 108.559 -174.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 59.4 t -144.25 114.63 2.11 Favored 'Isoleucine or valine' 0 C--O 1.23 0.051 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 175.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -142.89 168.05 20.63 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.123 0.487 . . . . 0.0 110.904 -176.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.65 166.99 24.9 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.846 0.858 . . . . 0.0 109.152 175.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 71.3 mmm -134.06 156.08 48.88 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 38.5 t -141.23 147.05 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 122.89 0.476 . . . . 0.0 110.747 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -135.55 134.93 39.93 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.005 0.522 . . . . 0.0 110.326 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -108.16 163.05 13.5 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -77.45 -14.52 59.67 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 84.9 p -154.54 153.43 31.43 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.462 0.649 . . . . 0.0 111.581 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 51.9 t -65.23 -32.11 56.82 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.347 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -65.54 -33.95 77.12 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.014 0.37 . . . . 0.0 110.454 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 69.1 m -72.13 -33.5 67.84 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 177.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -72.63 -31.8 65.41 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 122.376 -0.202 . . . . 0.0 111.206 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -68.93 -43.77 74.45 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.931 -0.481 . . . . 0.0 111.523 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -77.78 -25.77 49.29 Favored 'General case' 0 N--CA 1.458 -0.036 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.497 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -72.5 -40.73 66.62 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 118.084 0.402 . . . . 0.0 110.035 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -72.6 -25.34 61.28 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 122.416 0.286 . . . . 0.0 110.864 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -91.86 -10.31 40.18 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 47.1 t -114.08 -34.12 5.48 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 80.3 mt -90.12 -9.36 48.63 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -70.74 134.63 47.62 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 74.73 -3.22 44.59 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 119.72 -0.489 . . . . 0.0 112.151 -178.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.52 166.48 21.14 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 117.869 0.834 . . . . 0.0 110.069 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -123.6 140.08 53.36 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 81.9 mt -74.99 -41.17 45.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.365 40.7 m-85 -82.85 -12.01 57.77 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 117.4 2.371 . . . . 0.0 117.4 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 32.1 t 65.39 34.89 7.82 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.495 0.718 . . . . 0.0 110.926 -173.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 177.15 -24.44 0.05 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 86.0 m -146.89 -176.13 5.08 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.661 1.184 . . . . 0.0 109.5 178.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 89.1 m 58.2 37.24 26.2 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -176.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.27 149.08 13.36 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 176.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 81.2 mt -116.25 153.81 31.24 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -173.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -137.24 137.36 38.98 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 169.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 46.4 mt -139.6 141.64 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-O 120.734 0.302 . . . . 0.0 111.615 -170.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -161.36 163.92 30.36 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.043 176.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.277 49.8 m-85 -59.28 139.45 56.97 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 177.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -95.85 164.31 12.79 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -175.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -78.46 -50.05 1.69 Allowed Pre-proline 0 CA--C 1.535 0.395 0 CA-C-O 118.624 -0.703 . . . . 0.0 112.486 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -74.7 174.21 13.05 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.619 2.213 . . . . 0.0 110.686 178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 2.1 t -138.56 -2.48 1.77 Allowed 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 116.493 2.034 . . . . 0.0 116.493 -174.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.92 130.55 9.03 Favored 'General case' 0 C--N 1.34 0.176 0 O-C-N 121.546 -0.721 . . . . 0.0 111.624 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 17.0 mt -86.46 157.63 19.76 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 123.667 0.787 . . . . 0.0 111.127 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -119.74 47.36 1.74 Allowed 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.633 0.773 . . . . 0.0 109.59 173.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.2 t -50.38 143.03 2.52 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 -176.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -132.5 1.22 3.72 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 116.15 1.907 . . . . 0.0 116.15 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -156.4 153.32 28.72 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.163 0.585 . . . . 0.0 110.355 -171.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -122.18 118.65 29.13 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.364 0.666 . . . . 0.0 109.675 172.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 54.9 p30 -157.58 -167.28 2.23 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -69.21 -13.38 62.37 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -175.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -109.51 -22.6 11.92 Favored 'General case' 0 C--N 1.338 0.102 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.65 142.08 35.01 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 177.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 20.2 t-105 -159.3 155.55 27.09 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.155 0.502 . . . . 0.0 110.01 -175.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -129.93 117.22 19.78 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.496 171.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.277 66.5 m-85 -80.0 8.44 7.04 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 117.269 2.322 . . . . 0.0 117.269 -172.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 8.7 t . . . . . 0 C--O 1.231 0.105 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -179.438 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 70.9 m . . . . . 0 CA--C 1.532 0.265 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 96.3 t -142.37 136.63 28.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 C-N-CA 123.976 0.911 . . . . 0.0 108.655 -178.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -125.04 151.91 44.98 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 122.68 0.392 . . . . 0.0 111.309 -176.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 39.2 tp -95.54 136.29 36.12 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 169.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -113.95 102.77 10.51 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.899 1.279 . . . . 0.0 114.292 177.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.74 133.12 33.91 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 174.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.2 mp -104.06 121.31 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -89.03 -18.62 26.98 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -172.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -144.22 79.03 13.21 Favored Pre-proline 0 CA--C 1.529 0.142 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.74 46.03 1.93 Allowed 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.838 3.692 . . . . 0.0 112.247 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.88 -4.09 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 O-C-N 121.953 -0.467 . . . . 0.0 110.764 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -136.74 157.59 46.4 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 176.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 70.5 m -70.77 111.9 6.57 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.273 0.229 . . . . 0.0 110.552 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 32.2 mm -78.83 141.15 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 176.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.03 158.31 43.88 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 177.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.409 ' HG1' ' HB2' ' A' ' 280' ' ' TRP . 1.0 OUTLIER -65.67 -19.79 66.04 Favored 'General case' 0 C--O 1.23 0.057 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 178.314 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -77.63 -34.52 53.26 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 96.4 t -75.46 -41.22 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.27 -31.52 70.1 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -70.85 -29.53 65.67 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 174.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.4 m -68.42 -32.79 73.09 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 45.0 pt -92.88 -22.51 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 118.379 0.536 . . . . 0.0 112.073 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 92.5 m -90.61 -26.53 19.6 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.451 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 32.0 t30 -63.06 -42.83 79.35 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 74.3 Cg_endo -69.25 -11.8 32.35 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.378 1.386 . . . . 0.0 111.604 177.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 92.5 m -91.78 -5.82 52.87 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 145.44 168.66 13.18 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 177.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.21 104.63 0.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.851 3.034 . . . . 0.0 111.581 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 55.4 t -75.7 143.61 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -115.36 -40.08 3.49 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 119.415 -0.326 . . . . 0.0 111.045 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 65.2 mtm-85 -147.99 151.31 35.55 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 19.0 mt -146.72 135.9 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 124.144 0.978 . . . . 0.0 109.448 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 1.4 m -139.87 159.31 26.94 Favored 'Isoleucine or valine' 0 C--O 1.23 0.049 0 C-N-CA 123.301 0.64 . . . . 0.0 111.88 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 56.0 mt -135.23 142.78 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 C-N-CA 123.159 0.583 . . . . 0.0 109.628 -176.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.29 3.7 p90 -143.13 158.21 43.82 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 176.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -128.43 16.68 6.53 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.267 0.627 . . . . 0.0 110.393 -172.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -64.72 -30.7 71.72 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -169.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -130.43 5.8 4.8 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 118.563 0.62 . . . . 0.0 112.133 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 161.2 -122.41 1.11 Allowed Glycine 0 CA--C 1.522 0.472 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 -173.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 57.2 t -143.26 116.41 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 175.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -143.73 167.13 23.01 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.158 0.504 . . . . 0.0 110.557 -176.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.41 167.48 24.28 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 53.4 mmm -137.88 153.78 49.52 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 44.5 t -139.99 140.77 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 C-N-CA 122.791 0.436 . . . . 0.0 110.318 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -124.52 130.03 51.7 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.047 0.539 . . . . 0.0 110.421 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -105.84 163.34 12.8 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 -175.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -76.35 -15.59 59.93 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.5 0.32 . . . . 0.0 110.499 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 84.8 p -155.84 160.5 40.26 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.273 0.559 . . . . 0.0 111.694 -177.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 25.6 t -65.1 -35.25 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -66.61 -34.97 79.07 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 122.309 -0.244 . . . . 0.0 111.037 -176.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 60.7 m -71.58 -30.24 65.61 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 121.242 -0.183 . . . . 0.0 110.534 176.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.48 -29.85 59.71 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 119.806 -0.14 . . . . 0.0 111.175 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -69.75 -48.38 59.6 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 118.127 0.421 . . . . 0.0 111.805 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -72.82 -27.46 61.97 Favored 'General case' 0 C--N 1.337 0.053 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.087 -177.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -69.76 -40.8 75.89 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -76.15 -19.63 58.31 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 122.915 0.486 . . . . 0.0 110.988 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -102.16 -0.3 33.47 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 42.9 t -127.07 -30.42 2.69 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 118.68 0.673 . . . . 0.0 112.512 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 70.0 mt -92.96 -8.2 43.8 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.097 0.408 . . . . 0.0 111.618 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -73.19 134.23 44.3 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.09 -5.04 44.09 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 119.717 -0.49 . . . . 0.0 112.108 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.7 166.34 21.9 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 117.801 0.8 . . . . 0.0 110.017 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -123.02 136.61 54.91 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 178.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 95.9 mt -70.92 -43.25 76.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.358 34.4 m-85 -82.8 -11.38 58.31 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 117.232 2.308 . . . . 0.0 117.232 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.7 t 65.76 36.11 6.42 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.954 0.883 . . . . 0.0 111.285 -174.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 174.42 -23.45 0.06 OUTLIER Glycine 0 CA--C 1.529 0.954 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.077 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 93.5 m -146.51 -177.51 5.67 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.744 1.218 . . . . 0.0 109.212 177.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 89.0 m 58.46 35.72 24.88 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -176.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.86 148.21 10.7 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 175.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 84.1 mt -114.95 153.97 29.6 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -173.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -137.58 136.87 37.97 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.057 1.343 . . . . 0.0 107.426 169.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 40.9 mt -137.61 142.67 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 CA-C-O 120.723 0.297 . . . . 0.0 111.423 -171.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -159.67 161.88 35.0 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 122.988 0.515 . . . . 0.0 110.17 175.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.27 38.3 m-85 -59.2 135.77 57.75 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 176.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -88.57 164.83 15.21 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -89.18 -53.0 0.35 Allowed Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 123.617 0.767 . . . . 0.0 112.933 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -71.59 159.45 51.12 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.717 2.278 . . . . 0.0 110.503 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 1.4 t -127.15 0.25 6.46 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 -173.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -154.69 131.26 10.6 Favored 'General case' 0 C--N 1.339 0.134 0 O-C-N 121.857 -0.527 . . . . 0.0 111.472 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 29.1 mt -85.61 166.89 15.85 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.193 0.997 . . . . 0.0 111.304 177.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -121.87 44.76 2.49 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.434 170.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.2 t -48.02 140.3 2.21 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -177.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -129.52 0.93 5.02 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 -178.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -158.19 166.33 32.68 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.93 0.395 . . . . 0.0 110.965 -174.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -125.91 111.69 15.08 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.956 0.902 . . . . 0.0 109.063 171.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 56.9 p30 -154.31 -169.97 3.4 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -69.65 -11.73 61.08 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -176.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -99.53 -37.3 9.23 Favored 'General case' 0 CA--C 1.528 0.096 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.81 147.01 38.37 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 178.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' TRP . . . . . 0.409 ' HB2' ' HG1' ' A' ' 205' ' ' THR . 18.9 t-105 -157.32 155.84 31.35 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -175.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -128.37 117.97 22.35 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.85 0.46 . . . . 0.0 109.9 173.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.295 67.8 m-85 -80.6 8.61 7.52 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 117.032 2.234 . . . . 0.0 117.032 -173.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 CA--C 1.529 0.14 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 178.992 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 55.1 m . . . . . 0 CA--C 1.531 0.215 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 39.1 t -128.62 142.59 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 123.147 0.579 . . . . 0.0 110.867 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.0 mt -132.66 150.06 52.21 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.793 0.437 . . . . 0.0 110.37 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.0 tt -106.93 139.51 41.22 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -113.99 139.61 49.1 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -129.44 143.16 50.72 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 176.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.3 mp -119.86 117.73 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 20.5 mt -81.07 -24.35 37.85 Favored 'General case' 0 C--N 1.338 0.096 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -173.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -138.0 79.01 33.79 Favored Pre-proline 0 N--CA 1.455 -0.193 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -176.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -76.93 48.56 2.52 Favored 'Trans proline' 0 N--CA 1.455 -0.769 1 C-N-CA 125.357 4.038 . . . . 0.0 112.017 -177.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.57 -5.39 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 O-C-N 121.963 -0.46 . . . . 0.0 110.513 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -137.92 156.46 47.86 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 175.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 66.8 m -68.9 116.01 8.89 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 110.525 -0.176 . . . . 0.0 110.525 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.2 mm -78.79 142.72 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.16 162.49 31.99 Favored 'General case' 0 C--O 1.231 0.097 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 21.2 p -66.87 -20.38 65.91 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -72.7 -47.64 45.51 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.17 -33.03 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 97.0 mt -72.2 -34.67 68.57 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -70.79 -31.77 68.64 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 174.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 12.5 m -66.59 -33.94 76.78 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 36.7 pt -92.37 -23.59 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 118.497 0.59 . . . . 0.0 111.996 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 98.8 m -89.34 -25.99 21.32 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.455 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 33.7 t30 -63.51 -42.24 71.99 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 73.5 Cg_endo -70.53 -15.43 34.22 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.489 1.46 . . . . 0.0 111.488 177.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 94.0 m -83.12 -15.27 51.38 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 122.236 -0.29 . . . . 0.0 111.357 176.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 151.94 170.79 19.01 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.17 108.01 0.53 Allowed 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.505 2.803 . . . . 0.0 111.423 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 81.9 t -77.5 145.76 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -117.21 -34.33 4.38 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 119.163 -0.446 . . . . 0.0 111.179 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 83.2 mtt85 -151.52 156.1 39.87 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 118.437 0.562 . . . . 0.0 112.0 177.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 25.8 mt -144.7 142.51 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.298 1.039 . . . . 0.0 109.199 174.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 96.6 t -143.36 155.19 16.64 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.102 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 53.9 mt -138.14 141.09 39.1 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 C-N-CA 123.494 0.717 . . . . 0.0 109.455 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.295 5.3 p90 -144.47 155.87 43.92 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 176.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -126.31 15.49 7.76 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.3 0.64 . . . . 0.0 110.58 -173.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -66.18 -31.96 73.12 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -169.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -130.36 8.67 5.08 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 118.455 0.57 . . . . 0.0 112.113 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 160.37 -125.57 1.49 Allowed Glycine 0 C--N 1.336 0.533 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 -174.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 45.8 t -142.74 113.23 2.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -142.35 170.42 15.74 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.467 0.651 . . . . 0.0 111.426 -174.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -149.2 169.01 21.71 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.669 176.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 86.6 mmm -135.55 152.16 51.02 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 42.8 t -141.02 147.56 22.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 122.665 0.386 . . . . 0.0 110.208 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -134.62 135.37 42.1 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.616 0.366 . . . . 0.0 110.215 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -111.78 161.78 15.95 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 -175.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -81.29 -11.9 59.22 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.963 0.505 . . . . 0.0 109.742 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 41.1 t -154.67 153.72 31.78 Favored 'General case' 0 C--O 1.232 0.144 0 O-C-N 121.909 -0.494 . . . . 0.0 111.888 -175.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 55.3 t -67.8 -40.26 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -66.57 -26.22 67.01 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 117.811 0.278 . . . . 0.0 110.948 -178.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 67.6 m -73.78 -33.44 64.25 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 176.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -77.41 -30.86 53.74 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 122.485 -0.135 . . . . 0.0 111.23 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -67.56 -42.47 82.57 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 121.913 -0.492 . . . . 0.0 111.621 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -77.88 -26.61 49.32 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.922 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -70.16 -43.27 71.19 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.207 0.458 . . . . 0.0 109.787 176.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.423 ' HE3' ' HB3' ' A' ' 245' ' ' LYS . 1.2 tmmt? -72.8 -21.94 60.9 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.99 0.516 . . . . 0.0 111.294 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -95.55 -11.35 27.51 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 44.7 t -115.23 -33.39 5.35 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 112.783 0.661 . . . . 0.0 112.783 -177.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 81.4 mt -91.79 -10.68 39.01 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -71.15 135.66 47.73 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 121.999 -0.438 . . . . 0.0 109.888 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.49 -3.77 31.11 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 119.63 -0.539 . . . . 0.0 112.847 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -81.03 166.45 20.77 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 118.011 0.906 . . . . 0.0 110.507 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -108.45 140.0 42.39 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 74.2 mt -74.2 -42.59 51.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 174.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.351 51.4 m-85 -82.75 -12.72 57.32 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 117.26 2.318 . . . . 0.0 117.26 178.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 27.6 t 66.06 38.72 4.68 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.676 0.791 . . . . 0.0 110.748 -172.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 174.31 -21.34 0.06 OUTLIER Glycine 0 CA--C 1.529 0.93 0 C-N-CA 123.53 0.586 . . . . 0.0 111.903 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 78.2 m -147.46 -174.08 4.43 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.547 1.139 . . . . 0.0 109.096 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 93.4 m 57.44 43.16 23.48 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.71 0.634 . . . . 0.0 112.71 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -50.47 133.3 24.95 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 177.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 96.0 mt -95.64 152.01 18.83 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.465 0.65 . . . . 0.0 112.167 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -141.03 132.66 27.15 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.345 1.458 . . . . 0.0 107.071 169.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 47.8 mt -140.64 141.15 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 CA-C-O 120.641 0.258 . . . . 0.0 111.316 -172.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -161.75 165.44 28.01 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.271 0.628 . . . . 0.0 109.417 174.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -59.85 138.91 57.68 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 115.586 1.698 . . . . 0.0 115.586 177.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -93.91 160.03 14.92 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -176.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -76.89 -49.7 2.49 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 118.429 -0.796 . . . . 0.0 112.878 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -76.32 169.13 22.57 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.718 2.279 . . . . 0.0 111.104 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.282 0.2 OUTLIER -136.46 12.79 3.24 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 117.37 2.359 . . . . 0.0 117.37 -176.904 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -159.96 126.03 4.23 Favored 'General case' 0 C--N 1.338 0.096 0 O-C-N 121.677 -0.639 . . . . 0.0 111.805 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 28.5 mt -86.13 159.54 19.5 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 123.463 0.705 . . . . 0.0 110.944 174.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -125.23 47.7 2.13 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.826 0.85 . . . . 0.0 109.817 174.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.3 t -52.19 142.15 5.14 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -176.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . 0.253 6.1 p90 -120.81 -7.7 9.52 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 117.282 2.327 . . . . 0.0 117.282 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -162.52 168.04 22.5 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 122.689 0.396 . . . . 0.0 111.029 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -119.99 127.01 52.23 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.566 0.746 . . . . 0.0 110.03 176.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 41.0 p30 -161.03 -167.39 1.8 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.245 1.018 . . . . 0.0 109.542 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -70.4 -10.9 60.36 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -176.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -105.6 -29.57 10.05 Favored 'General case' 0 C--N 1.337 0.064 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -141.04 146.46 37.22 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 178.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 19.3 t-105 -156.53 154.15 29.86 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -176.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -132.76 117.58 17.99 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.201 0.6 . . . . 0.0 111.512 175.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.288 68.3 m-85 -83.26 10.41 8.53 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 117.366 2.358 . . . . 0.0 117.366 -171.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 12.9 t . . . . . 0 N--CA 1.455 -0.191 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -179.544 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 CA--C 1.53 0.174 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 30.7 t -130.76 134.3 62.09 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.092 0 C-N-CA 122.858 0.463 . . . . 0.0 111.103 177.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -122.94 154.2 38.69 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.098 0.559 . . . . 0.0 110.779 -176.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 39.0 tp -104.01 136.26 43.98 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 170.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -113.86 107.92 16.36 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.71 1.204 . . . . 0.0 114.122 177.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.99 141.01 29.02 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 174.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.4 mp -110.56 126.83 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -90.43 -23.67 20.96 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -173.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -140.34 78.98 21.81 Favored Pre-proline 0 CA--C 1.53 0.188 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -76.74 49.89 2.86 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 124.804 3.669 . . . . 0.0 112.113 -178.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.87 -5.86 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 O-C-N 121.749 -0.595 . . . . 0.0 110.251 178.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -142.1 154.58 45.02 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.2 1.4 . . . . 0.0 112.538 175.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.3 t -73.38 129.93 39.07 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.291 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 23.0 mm -79.16 148.4 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 123.073 0.549 . . . . 0.0 109.993 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.02 156.38 48.32 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.4 p -64.1 -17.3 63.29 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 177.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -76.52 -46.25 27.32 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.79 0.329 . . . . 0.0 111.812 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.6 m -71.29 -31.6 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.059 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.31 -36.95 74.64 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 176.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -70.83 -30.48 66.91 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 175.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 12.5 m -66.78 -33.4 75.55 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 41.1 pt -93.85 -21.59 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 118.399 0.545 . . . . 0.0 112.13 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 97.4 m -91.54 -25.73 19.1 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.463 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 35.4 t30 -64.65 -39.19 37.78 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 74.3 Cg_endo -69.94 -13.04 33.7 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 CA-C-N 121.023 1.401 . . . . 0.0 111.575 177.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 95.9 m -91.95 -5.41 53.16 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.669 0.388 . . . . 0.0 111.663 177.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 146.74 166.83 12.51 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 178.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.18 103.77 1.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.635 2.89 . . . . 0.0 110.657 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 75.6 t -70.37 146.28 12.29 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -114.34 -37.14 4.44 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 119.212 -0.423 . . . . 0.0 111.765 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -150.21 151.64 33.36 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 20.7 mt -147.87 136.96 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 C-N-CA 124.055 0.942 . . . . 0.0 109.975 177.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 6.1 m -142.61 159.43 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 123.729 0.812 . . . . 0.0 110.313 173.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 41.3 mt -132.68 143.61 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 123.018 0.527 . . . . 0.0 110.375 -175.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.316 3.8 p90 -140.32 154.65 46.86 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 115.718 1.748 . . . . 0.0 115.718 176.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -126.59 16.79 7.56 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.309 0.643 . . . . 0.0 110.06 -174.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -64.43 -31.91 73.31 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -169.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -130.46 8.62 5.03 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 118.346 0.521 . . . . 0.0 112.096 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 157.62 -124.12 1.37 Allowed Glycine 0 C--N 1.334 0.444 0 N-CA-C 108.336 -1.905 . . . . 0.0 108.336 -173.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 24.9 t -142.15 114.65 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-N 116.846 0.323 . . . . 0.0 110.18 176.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 8.4 mp0 -143.45 166.69 24.09 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.119 0.485 . . . . 0.0 110.671 -177.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.41 163.7 35.65 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.725 0.81 . . . . 0.0 109.788 176.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 56.0 mmm -130.76 151.31 51.34 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 41.4 t -140.74 144.26 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.067 0 C-N-CA 122.945 0.498 . . . . 0.0 110.399 -178.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -130.5 133.21 46.09 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.83 0.452 . . . . 0.0 110.64 178.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -104.21 163.21 12.57 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 116.334 1.975 . . . . 0.0 116.334 -177.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -78.92 -14.51 59.18 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 85.2 p -154.71 157.64 38.38 Favored 'General case' 0 N--CA 1.457 -0.081 0 O-C-N 121.744 -0.598 . . . . 0.0 111.262 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 53.4 t -67.76 -32.33 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -66.84 -34.83 78.68 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 121.878 -0.514 . . . . 0.0 110.733 -177.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 69.1 m -72.56 -31.05 64.95 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 176.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -74.08 -31.51 62.85 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 122.577 0.351 . . . . 0.0 111.441 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -71.79 -46.99 56.47 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 117.944 0.338 . . . . 0.0 111.788 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -73.19 -26.3 61.11 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 118.04 0.382 . . . . 0.0 111.345 -177.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -71.11 -41.4 70.64 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.92 -23.63 55.5 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.482 0.313 . . . . 0.0 110.998 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -91.32 -10.01 42.89 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 40.0 t -118.7 -35.08 3.79 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -177.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 66.0 mt -87.94 -7.27 57.36 Favored 'General case' 0 N--CA 1.457 -0.076 0 CA-C-N 118.118 0.417 . . . . 0.0 111.862 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -70.01 136.36 50.33 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 74.65 -4.98 32.68 Favored Glycine 0 CA--C 1.533 1.201 0 CA-C-O 119.769 -0.462 . . . . 0.0 112.431 -178.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -76.72 166.32 23.52 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 117.848 0.824 . . . . 0.0 110.302 177.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -123.6 140.47 52.97 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 67.4 mt -75.04 -42.5 45.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-O 120.92 0.391 . . . . 0.0 110.012 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.365 53.5 m-85 -82.66 -11.4 58.39 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 117.084 2.253 . . . . 0.0 117.084 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 30.7 t 65.99 35.1 6.61 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.664 0.786 . . . . 0.0 111.313 -175.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 176.52 -23.58 0.05 OUTLIER Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 178.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 81.6 m -145.93 -176.63 5.22 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.61 1.164 . . . . 0.0 108.876 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 87.5 m 57.84 38.71 27.24 Favored 'General case' 0 CA--C 1.527 0.087 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -176.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.96 141.56 21.8 Favored 'General case' 0 C--O 1.23 0.067 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 174.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 95.9 mt -102.09 158.24 16.3 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.49 0.662 . . . . 0.0 112.27 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -139.29 137.18 35.63 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 169.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 19.6 mt -138.23 139.51 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-O 121.089 0.471 . . . . 0.0 111.62 -173.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -159.48 161.9 35.48 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.242 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.262 41.0 m-85 -60.97 135.92 57.93 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 177.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -92.6 155.89 17.46 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.525 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.407 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 22.9 pttp -88.49 -29.93 0.37 Allowed Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 117.216 -1.373 . . . . 0.0 114.611 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 48.9 Cg_endo -79.87 165.12 22.37 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 CA-C-N 122.063 1.773 . . . . 0.0 110.093 176.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.279 0.2 OUTLIER -138.03 8.86 2.76 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 118.19 2.663 . . . . 0.0 118.19 -174.628 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.71 127.05 6.52 Favored 'General case' 0 C--N 1.338 0.073 0 O-C-N 121.408 -0.807 . . . . 0.0 111.858 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 24.6 mt -92.04 156.45 17.39 Favored 'General case' 0 C--N 1.337 0.052 0 C-N-CA 123.772 0.829 . . . . 0.0 111.107 176.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -117.31 53.42 0.92 Allowed 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.517 0.727 . . . . 0.0 109.594 172.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.4 t -53.04 145.35 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -176.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -130.12 -7.31 4.36 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 117.637 2.458 . . . . 0.0 117.637 -177.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -161.9 173.72 14.12 Favored 'General case' 0 N--CA 1.458 -0.07 0 C-N-CA 122.739 0.416 . . . . 0.0 110.281 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -125.69 117.75 24.15 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.025 0.93 . . . . 0.0 110.006 175.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 46.6 p30 -159.54 -166.22 1.73 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.979 0.912 . . . . 0.0 108.922 177.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -70.11 -9.62 56.12 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -174.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -115.98 -17.46 10.93 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.72 140.87 33.25 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.799 0.84 . . . . 0.0 112.966 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 19.4 t-105 -160.78 156.71 25.66 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 119.764 -0.774 . . . . 0.0 110.4 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -138.03 116.55 12.06 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.469 0.708 . . . . 0.0 110.977 174.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.284 66.7 m-85 -81.31 8.94 7.92 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 117.318 2.34 . . . . 0.0 117.318 -172.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.457 -0.096 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -179.538 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 55.9 m . . . . . 0 CA--C 1.531 0.233 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 28.3 t -130.02 134.07 63.43 Favored 'Isoleucine or valine' 0 C--N 1.339 0.115 0 CA-C-N 118.194 0.452 . . . . 0.0 111.089 177.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -121.14 153.59 37.3 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.053 0.541 . . . . 0.0 110.831 -177.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 25.0 tp -106.11 132.68 51.89 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 171.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -107.86 133.94 51.5 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.633 1.173 . . . . 0.0 114.141 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.29 133.27 55.5 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 174.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 3.8 mp -104.52 117.06 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -88.35 -18.04 29.29 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.165 -171.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -141.48 79.02 17.72 Favored Pre-proline 0 CA--C 1.529 0.138 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.9 44.25 1.53 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 125.2 3.933 . . . . 0.0 112.542 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.05 -4.76 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 121.693 -0.629 . . . . 0.0 110.523 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -138.47 158.33 44.47 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 177.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 45.2 t -70.83 117.87 12.9 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.0 mm -78.38 144.41 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.08 159.11 41.82 Favored 'General case' 0 N--CA 1.458 -0.064 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 43.3 p -66.87 -19.72 65.79 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -75.88 -47.24 26.23 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.7 m -70.29 -32.69 51.4 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.0 mt -70.94 -33.99 71.03 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 176.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -73.19 -29.11 62.59 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 174.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 7.2 m -67.99 -33.18 74.13 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 41.4 pt -91.68 -24.07 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 118.225 0.466 . . . . 0.0 111.785 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 94.6 m -89.0 -24.53 22.36 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.442 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.1 t30 -63.57 -42.37 72.43 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 73.7 Cg_endo -69.31 -16.42 39.45 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 CA-C-N 120.873 1.347 . . . . 0.0 111.192 177.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 80.5 m -84.01 -14.62 50.23 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 122.175 -0.328 . . . . 0.0 111.337 177.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 153.2 172.92 21.94 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.8 101.5 0.92 Allowed 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 124.007 3.138 . . . . 0.0 110.45 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 75.8 t -71.21 147.52 11.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -118.74 -35.98 3.57 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 119.178 -0.439 . . . . 0.0 111.721 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 25.8 mtm180 -150.37 151.72 33.28 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.693 0.679 . . . . 0.0 112.767 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 25.1 mt -148.74 137.92 15.59 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 124.132 0.973 . . . . 0.0 110.109 177.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.2 m -143.44 161.31 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 C-N-CA 124.127 0.971 . . . . 0.0 109.983 173.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 52.6 mt -131.36 143.27 41.11 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 C-N-CA 122.793 0.437 . . . . 0.0 110.737 -175.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.262 5.1 p90 -146.72 158.96 44.02 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 175.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -138.53 30.22 2.36 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.115 0.566 . . . . 0.0 111.82 -177.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -66.17 -30.11 70.52 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.323 0.861 . . . . 0.0 113.323 -174.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -130.55 1.24 4.49 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 171.85 -128.51 1.59 Allowed Glycine 0 CA--C 1.522 0.473 0 N-CA-C 108.65 -1.78 . . . . 0.0 108.65 -174.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 17.3 t -138.51 115.11 10.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 117.44 0.62 . . . . 0.0 110.351 174.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 9.4 mp0 -143.64 169.78 17.08 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.552 0.692 . . . . 0.0 111.924 -172.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -152.82 168.52 25.47 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.083 0.953 . . . . 0.0 108.818 175.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 68.9 mmm -134.34 151.5 51.27 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.767 -0.456 . . . . 0.0 109.767 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 40.3 t -141.62 144.5 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 C-N-CA 123.0 0.52 . . . . 0.0 110.433 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -131.92 136.28 47.27 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.616 0.366 . . . . 0.0 110.775 178.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -108.67 162.65 13.96 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 -177.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -83.98 -6.54 59.44 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 29.2 t -153.66 149.54 27.65 Favored 'General case' 0 N--CA 1.456 -0.13 0 O-C-N 121.954 -0.466 . . . . 0.0 111.785 -176.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 55.2 t -68.75 -35.69 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -68.16 -28.29 67.16 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.06 -0.4 . . . . 0.0 110.775 -178.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 61.4 m -74.88 -31.2 61.53 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 176.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.46 -33.53 60.85 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 122.411 0.284 . . . . 0.0 111.083 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -69.59 -43.94 71.78 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 117.904 0.32 . . . . 0.0 111.538 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -75.27 -25.17 57.77 Favored 'General case' 0 N--CA 1.457 -0.084 0 CA-C-N 117.815 0.28 . . . . 0.0 110.866 -177.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -71.48 -42.49 68.03 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 176.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.413 ' HE3' ' HB3' ' A' ' 245' ' ' LYS . 1.0 OUTLIER -75.4 -20.49 58.89 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.739 0.416 . . . . 0.0 111.262 -179.669 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -94.87 -12.07 27.61 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 45.1 t -113.58 -34.96 5.37 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 68.6 mt -89.95 -6.84 55.26 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 118.176 0.444 . . . . 0.0 111.963 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -71.9 131.96 43.7 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 177.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.59 -4.08 52.35 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.744 -0.476 . . . . 0.0 112.171 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.61 166.45 21.86 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 117.818 0.809 . . . . 0.0 110.303 178.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -123.33 139.9 53.57 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 84.8 mt -74.7 -41.36 47.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 N-CA-C 109.668 -0.494 . . . . 0.0 109.668 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.363 44.1 m-85 -82.8 -12.02 57.81 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 117.316 2.339 . . . . 0.0 117.316 178.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.7 t 66.31 34.66 6.31 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.627 0.727 . . . . 0.0 110.685 -174.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 175.97 -23.65 0.06 OUTLIER Glycine 0 CA--C 1.529 0.96 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 77.2 m -146.63 -177.15 5.49 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.711 1.204 . . . . 0.0 109.536 178.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 91.4 m 57.85 37.55 26.99 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -176.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.88 148.2 13.71 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 175.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 74.2 mt -115.98 156.04 26.96 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -172.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -138.57 140.15 38.92 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.398 1.479 . . . . 0.0 107.482 169.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 37.4 mt -141.79 141.49 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 CA-C-O 120.976 0.417 . . . . 0.0 111.72 -172.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 6.9 pm0 -156.59 164.21 38.45 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 174.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.273 41.2 m-85 -61.46 137.67 58.25 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 177.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -91.51 156.79 17.43 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.663 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.414 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 63.9 pttt -88.56 -31.57 0.39 Allowed Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 48.7 Cg_endo -79.65 167.73 20.38 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.006 1.804 . . . . 0.0 110.172 176.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.278 0.2 OUTLIER -137.25 8.45 2.92 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -175.829 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.66 128.46 7.24 Favored 'General case' 0 C--O 1.227 -0.12 0 O-C-N 121.416 -0.803 . . . . 0.0 111.942 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 20.1 mt -92.33 157.28 16.72 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 123.893 0.877 . . . . 0.0 110.722 176.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -117.34 54.52 0.88 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.704 0.802 . . . . 0.0 109.473 173.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.4 t -55.76 147.38 4.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -176.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -132.61 -2.94 3.35 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 116.934 2.198 . . . . 0.0 116.934 -176.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -161.89 160.85 28.48 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.316 0.246 . . . . 0.0 110.812 -174.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -123.18 111.02 16.0 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.606 0.762 . . . . 0.0 109.564 173.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 56.6 p30 -157.81 -169.98 3.03 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.334 1.054 . . . . 0.0 108.372 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -68.59 -10.8 58.16 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -174.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -111.58 -22.27 11.32 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.1 p -142.58 138.92 31.13 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.686 1.195 . . . . 0.0 112.295 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 21.0 t-105 -158.44 155.55 28.78 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 119.724 -0.791 . . . . 0.0 110.932 -177.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -135.39 116.49 14.34 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.725 0.81 . . . . 0.0 111.108 173.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.292 66.1 m-85 -79.99 9.17 5.74 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 117.524 2.416 . . . . 0.0 117.524 -172.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.456 -0.149 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -179.611 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 CA--C 1.529 0.165 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 39.8 t -130.54 132.77 64.36 Favored 'Isoleucine or valine' 0 C--N 1.338 0.091 0 CA-C-N 118.215 0.461 . . . . 0.0 111.17 177.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 8.1 mp -122.07 149.88 42.93 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 123.949 0.899 . . . . 0.0 110.563 -174.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 27.0 tp -102.56 135.8 43.53 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 170.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -115.93 104.18 11.35 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.102 1.361 . . . . 0.0 114.071 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.87 133.19 34.88 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 175.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.5 mp -102.76 124.23 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -90.49 -19.26 24.04 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -173.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -141.96 78.87 16.96 Favored Pre-proline 0 CA--C 1.53 0.178 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -77.34 45.73 1.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.764 1 C-N-CA 125.444 4.096 . . . . 0.0 112.275 -177.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.76 -4.09 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 O-C-N 121.818 -0.552 . . . . 0.0 110.508 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -137.39 156.55 48.07 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 175.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 66.4 m -69.11 112.95 6.05 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.3 mm -78.36 141.77 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.02 161.34 35.09 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.4 p -64.03 -17.67 63.58 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -75.07 -46.75 32.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.712 0.291 . . . . 0.0 111.572 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 1.6 m -70.1 -32.12 49.99 Favored 'Isoleucine or valine' 0 C--N 1.338 0.107 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.69 -34.93 70.06 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 176.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -71.08 -29.66 65.59 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 174.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 10.1 m -68.29 -34.19 75.71 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 42.0 pt -91.41 -22.98 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 118.41 0.55 . . . . 0.0 111.907 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 97.4 m -90.1 -23.6 21.34 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.439 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 26.6 t30 -63.88 -43.24 75.15 Favored Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 73.9 Cg_endo -69.51 -14.45 36.9 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.416 1.41 . . . . 0.0 111.32 177.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 96.8 m -85.43 -16.12 40.75 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 118.011 0.369 . . . . 0.0 111.48 176.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 154.75 171.71 21.81 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.613 -0.595 . . . . 0.0 111.613 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.27 98.86 0.66 Allowed 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.744 2.962 . . . . 0.0 110.633 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 63.9 t -69.45 145.91 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -115.12 -37.85 4.0 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 119.365 -0.35 . . . . 0.0 111.233 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 63.4 mtm-85 -147.66 152.34 37.69 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 25.5 mt -148.0 137.7 16.37 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 C-N-CA 124.144 0.978 . . . . 0.0 109.706 176.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 12.8 m -143.95 161.65 15.71 Favored 'Isoleucine or valine' 0 C--N 1.338 0.082 0 C-N-CA 123.553 0.741 . . . . 0.0 110.115 174.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 35.8 mt -135.67 141.91 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 122.824 0.45 . . . . 0.0 110.628 -175.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.316 4.1 p90 -138.15 156.84 47.34 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 176.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -128.5 15.59 6.55 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.425 0.69 . . . . 0.0 110.522 -173.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -63.58 -31.92 73.23 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -169.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -130.65 6.47 4.75 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 118.686 0.675 . . . . 0.0 112.494 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 163.02 -124.82 1.32 Allowed Glycine 0 CA--C 1.521 0.419 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 -174.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 45.5 t -141.97 114.93 4.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -142.45 166.07 25.68 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.904 0.383 . . . . 0.0 110.578 -177.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.15 164.88 30.82 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.583 0.753 . . . . 0.0 109.416 175.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 62.9 mmm -133.06 153.21 51.71 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 39.1 t -139.79 145.5 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 C-N-CA 122.838 0.455 . . . . 0.0 110.409 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -130.22 133.08 46.3 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.918 0.487 . . . . 0.0 110.529 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -108.02 161.35 15.03 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -82.92 -8.18 59.59 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 29.2 t -155.01 149.49 26.31 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 121.916 -0.49 . . . . 0.0 111.554 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 51.1 t -67.76 -35.9 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -68.14 -28.57 67.42 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.112 0.415 . . . . 0.0 111.137 -177.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 58.3 m -74.32 -32.34 62.8 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 176.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.71 -29.73 56.38 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.621 0.369 . . . . 0.0 110.934 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -69.98 -44.07 70.2 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.147 -0.345 . . . . 0.0 111.439 178.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -75.39 -25.09 57.33 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.878 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -70.97 -39.35 72.56 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.127 0.422 . . . . 0.0 110.255 176.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.08 -25.59 58.69 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 122.639 0.376 . . . . 0.0 110.298 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -91.2 -10.29 42.23 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 46.1 t -117.04 -36.48 3.8 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -176.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 78.7 mt -88.36 -8.29 55.31 Favored 'General case' 0 C--N 1.338 0.108 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -71.47 133.36 45.81 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.54 -5.28 46.28 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 119.681 -0.511 . . . . 0.0 112.298 -178.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.67 166.45 22.5 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 117.833 0.817 . . . . 0.0 110.253 177.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -123.65 139.84 53.6 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 87.0 mt -74.92 -41.53 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.373 42.7 m-85 -82.88 -11.81 57.9 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 117.151 2.278 . . . . 0.0 117.151 178.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 29.9 t 65.25 35.52 7.64 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.385 0.674 . . . . 0.0 110.74 -174.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 175.56 -23.98 0.06 OUTLIER Glycine 0 CA--C 1.53 1.028 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 72.0 m -145.32 -176.87 5.28 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.686 1.195 . . . . 0.0 109.199 178.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 84.3 m 57.74 36.93 27.04 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -176.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.35 149.55 9.96 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 114.471 1.285 . . . . 0.0 114.471 175.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 79.0 mt -116.87 154.35 30.92 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -172.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -137.0 137.65 39.66 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.276 1.43 . . . . 0.0 107.414 169.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 56.7 mt -139.57 142.78 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 CA-C-O 120.566 0.222 . . . . 0.0 111.578 -170.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -160.63 162.88 32.86 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.295 0.638 . . . . 0.0 109.622 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.264 50.8 m-85 -59.43 139.75 56.8 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 176.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -88.32 165.3 15.08 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -176.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -79.21 -51.55 1.26 Allowed Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 118.445 -0.788 . . . . 0.0 112.065 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.27 175.16 11.7 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.859 2.373 . . . . 0.0 111.303 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.45 -3.54 3.01 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -176.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -158.28 130.22 6.83 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 118.92 0.782 . . . . 0.0 112.564 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 23.7 mt -84.57 164.46 18.7 Favored 'General case' 0 N--CA 1.458 -0.055 0 C-N-CA 124.378 1.071 . . . . 0.0 111.651 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -120.77 54.06 1.09 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.386 170.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.7 t -53.0 147.44 2.07 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -175.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -138.07 -1.35 1.97 Allowed 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 116.92 2.193 . . . . 0.0 116.92 -176.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -159.11 161.57 36.38 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -172.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -125.6 108.35 11.49 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.199 0.999 . . . . 0.0 109.681 174.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -158.31 -166.17 1.87 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 177.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -68.64 -9.97 53.2 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -174.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -117.42 -17.32 10.1 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.16 141.85 34.09 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.772 0.829 . . . . 0.0 113.016 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 17.8 t-105 -163.63 156.63 18.43 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 118.554 0.615 . . . . 0.0 110.445 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -142.11 120.44 12.33 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.305 172.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -81.95 5.59 18.63 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 117.192 2.293 . . . . 0.0 117.192 -173.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 3.6 t . . . . . 0 CA--C 1.53 0.205 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -178.012 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 CA--C 1.532 0.268 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 37.2 t -128.4 143.55 40.67 Favored 'Isoleucine or valine' 0 C--N 1.339 0.116 0 C-N-CA 123.167 0.587 . . . . 0.0 110.79 178.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 82.6 mt -135.61 149.0 49.24 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.868 0.467 . . . . 0.0 111.104 -175.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 39.2 tp -101.11 135.45 42.54 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 172.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -113.57 101.37 9.27 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 125.148 1.379 . . . . 0.0 114.6 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.2 m -86.8 133.84 33.61 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 175.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.0 mp -103.94 126.0 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -94.06 -18.42 21.84 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -172.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -141.24 78.99 18.22 Favored Pre-proline 0 CA--C 1.529 0.164 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -77.41 49.03 2.74 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 125.003 3.802 . . . . 0.0 112.278 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.23 -6.78 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 O-C-N 121.787 -0.571 . . . . 0.0 110.224 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -141.73 154.68 45.45 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.158 1.383 . . . . 0.0 112.394 175.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.4 t -74.15 131.46 41.3 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.157 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 21.9 mm -81.14 148.37 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 122.923 0.489 . . . . 0.0 109.913 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.89 157.89 44.83 Favored 'General case' 0 C--O 1.231 0.079 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 177.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.3 p -63.88 -18.75 64.49 Favored 'General case' 0 N--CA 1.458 -0.057 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -73.4 -47.3 43.05 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.717 0.294 . . . . 0.0 111.544 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.5 m -71.06 -32.31 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.16 -36.61 72.09 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 176.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -70.82 -30.14 66.49 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 175.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 8.9 m -67.59 -33.76 75.66 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 38.6 pt -92.38 -24.31 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 118.585 0.63 . . . . 0.0 111.77 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 95.6 m -88.49 -26.39 22.08 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.441 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 35.1 t30 -64.71 -42.53 64.86 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 71.9 Cg_endo -70.29 -12.74 32.42 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.493 1.462 . . . . 0.0 111.262 177.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 96.4 m -90.43 -9.23 48.29 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.031 0.378 . . . . 0.0 111.665 176.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 151.41 167.72 15.16 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 178.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.26 103.03 1.01 Allowed 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.903 3.069 . . . . 0.0 110.584 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 71.9 t -70.67 145.25 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -113.74 -39.27 4.05 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 119.205 -0.426 . . . . 0.0 111.28 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -149.15 152.8 36.72 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.267 0.485 . . . . 0.0 112.046 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 23.6 mt -147.28 135.72 15.34 Favored 'Isoleucine or valine' 0 C--N 1.338 0.073 0 C-N-CA 124.025 0.93 . . . . 0.0 109.912 177.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 1.6 m -140.38 160.61 25.16 Favored 'Isoleucine or valine' 0 C--N 1.337 0.062 0 C-N-CA 123.55 0.74 . . . . 0.0 111.715 174.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 53.7 mt -135.82 144.02 34.71 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 C-N-CA 123.127 0.571 . . . . 0.0 110.163 -175.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.299 3.5 p90 -143.35 156.47 44.7 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 175.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 5.8 mmt180 -127.35 17.68 7.04 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.32 0.648 . . . . 0.0 110.002 -174.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -64.89 -31.74 73.12 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -169.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -130.47 5.89 4.79 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 118.606 0.639 . . . . 0.0 111.893 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 163.04 -124.35 1.28 Allowed Glycine 0 C--N 1.334 0.442 0 N-CA-C 108.696 -1.761 . . . . 0.0 108.696 -173.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 49.1 t -142.6 114.04 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 -142.86 166.07 25.65 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.117 0.484 . . . . 0.0 110.845 -176.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.09 164.99 31.29 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.487 175.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 57.9 mmm -132.42 152.82 51.33 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 39.1 t -141.12 146.03 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 C-N-CA 123.116 0.566 . . . . 0.0 110.37 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -132.52 135.59 46.09 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 122.536 0.335 . . . . 0.0 110.593 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -107.78 162.92 13.55 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 -176.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -75.74 -17.21 59.99 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 86.5 p -155.13 159.63 40.34 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.175 0.512 . . . . 0.0 111.263 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 54.8 t -67.34 -35.22 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -66.56 -28.18 68.32 Favored 'General case' 0 N--CA 1.456 -0.139 0 O-C-N 122.18 -0.325 . . . . 0.0 111.021 -177.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 74.4 m -75.94 -32.68 59.67 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 177.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.54 -32.63 58.34 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.416 -0.177 . . . . 0.0 111.086 178.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -66.76 -44.03 82.51 Favored 'General case' 0 C--N 1.338 0.09 0 O-C-N 122.036 -0.415 . . . . 0.0 111.558 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -75.59 -26.34 57.8 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.898 -178.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -74.16 -40.85 62.3 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.03 0.377 . . . . 0.0 110.148 178.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -73.57 -23.22 59.93 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.862 0.465 . . . . 0.0 111.063 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -92.4 -17.04 25.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 48.2 t -106.67 -36.17 6.8 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -176.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 76.7 mt -88.67 -8.03 55.3 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -70.78 134.27 47.26 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.65 -6.45 39.32 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 119.676 -0.513 . . . . 0.0 112.458 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -77.41 166.34 23.25 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 117.759 0.78 . . . . 0.0 110.187 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 5.0 p30 -123.24 140.56 52.89 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 80.8 mt -74.98 -43.03 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.071 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.36 50.2 m-85 -82.78 -10.05 59.05 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 29.1 t 66.38 34.78 6.11 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.629 0.772 . . . . 0.0 111.126 -175.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 175.47 -24.45 0.06 OUTLIER Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 178.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 81.4 m -144.69 -176.97 5.27 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.692 1.197 . . . . 0.0 109.264 178.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 96.2 m 57.4 39.18 28.41 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -175.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.04 146.4 18.18 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 175.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 89.1 mt -110.78 154.41 23.98 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -172.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -137.92 135.98 36.59 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.865 1.666 . . . . 0.0 106.679 169.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 44.6 mt -138.43 141.67 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-O 120.618 0.247 . . . . 0.0 111.142 -172.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -158.76 164.11 36.14 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 175.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.288 43.4 m-85 -61.75 135.38 57.58 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 177.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -85.35 162.85 18.89 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.369 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.436 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 63.4 pttt -94.06 -32.56 0.3 Allowed Pre-proline 0 CA--C 1.54 0.567 0 CA-C-O 117.29 -1.338 . . . . 0.0 114.225 178.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 86.3 Cg_endo -76.3 171.52 17.93 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 CA-C-N 122.04 1.764 . . . . 0.0 110.055 175.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.21 -1.91 2.33 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 117.72 2.489 . . . . 0.0 117.72 -175.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.15 130.95 9.98 Favored 'General case' 0 C--N 1.338 0.075 0 CA-C-N 119.145 0.884 . . . . 0.0 111.888 -177.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 25.1 mt -90.97 157.05 17.52 Favored 'General case' 0 C--N 1.338 0.069 0 C-N-CA 124.125 0.97 . . . . 0.0 111.408 178.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -120.85 50.99 1.28 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.836 0.854 . . . . 0.0 109.41 173.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 3.0 t -51.63 144.74 2.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -177.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -131.26 -0.15 4.08 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 116.472 2.027 . . . . 0.0 116.472 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -159.06 166.44 31.66 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.839 0.456 . . . . 0.0 111.374 -175.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -125.9 113.58 17.39 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.062 0.945 . . . . 0.0 109.05 172.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 57.1 p30 -156.3 -167.09 2.33 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -69.56 -13.83 62.53 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -176.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -100.02 -34.05 10.24 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.3 p -141.26 148.66 40.19 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 18.9 t-105 -157.54 154.98 29.47 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -176.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -135.07 118.92 17.26 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 122.873 0.469 . . . . 0.0 111.711 175.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.252 68.6 m-85 -84.19 6.44 22.59 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 117.263 2.32 . . . . 0.0 117.263 -171.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 C--O 1.232 0.143 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -176.326 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 41.2 p . . . . . 0 CA--C 1.535 0.368 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 45.1 t -130.27 139.56 51.08 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 123.516 0.727 . . . . 0.0 109.523 174.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 89.4 mt -128.51 158.04 39.51 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.843 0.354 . . . . 0.0 111.536 -173.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 9.7 tt -115.92 135.85 53.59 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.255 174.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -114.37 106.26 14.1 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 114.684 1.365 . . . . 0.0 114.684 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -88.23 142.8 27.46 Favored 'General case' 0 N--CA 1.458 -0.072 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 174.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.3 mp -115.34 124.14 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 21.0 mt -85.24 -24.92 27.6 Favored 'General case' 0 C--N 1.337 0.064 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -173.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -141.22 79.06 18.17 Favored Pre-proline 0 N--CA 1.456 -0.171 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -177.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -76.86 49.97 2.92 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 125.137 3.891 . . . . 0.0 112.153 -177.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.55 -7.23 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 O-C-N 121.954 -0.466 . . . . 0.0 110.019 177.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -140.2 152.15 45.77 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.238 1.415 . . . . 0.0 112.193 175.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 35.9 t -74.4 133.08 42.47 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 117.851 0.296 . . . . 0.0 110.56 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 24.2 mm -83.32 150.06 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 123.028 0.531 . . . . 0.0 109.841 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.87 155.73 49.35 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 177.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.5 p -64.38 -21.72 66.72 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -79.01 -35.97 41.95 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 75.8 t -72.97 -40.81 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.3 mt -69.01 -32.0 71.24 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -70.28 -29.52 66.31 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 174.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.2 m -69.47 -32.82 71.97 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 45.0 pt -92.32 -21.75 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 118.422 0.555 . . . . 0.0 112.264 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 97.7 m -92.56 -26.57 17.84 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -178.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.449 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 36.3 t30 -64.04 -40.87 58.11 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 73.3 Cg_endo -69.44 -10.98 30.22 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 121.535 1.49 . . . . 0.0 111.887 177.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 91.0 m -95.99 -6.26 39.3 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 177.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 151.0 167.59 14.82 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 111.801 -0.519 . . . . 0.0 111.801 178.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.38 101.66 0.88 Allowed 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 123.965 3.11 . . . . 0.0 110.408 178.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 83.5 t -70.79 144.63 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -112.51 -39.45 4.36 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 119.363 -0.351 . . . . 0.0 111.262 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 65.8 mtm-85 -148.01 153.08 38.49 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 25.2 mt -145.13 139.9 22.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 124.308 1.043 . . . . 0.0 109.18 176.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 41.0 t -145.38 153.02 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.066 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 48.8 mt -134.34 142.24 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 C-N-CA 123.087 0.555 . . . . 0.0 110.178 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.305 2.7 p90 -143.19 156.1 44.69 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 176.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 6.2 mmt180 -127.75 18.22 6.78 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.274 0.63 . . . . 0.0 110.134 -173.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -66.22 -30.92 71.47 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 114.717 1.376 . . . . 0.0 114.717 -169.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -130.48 5.46 4.75 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 118.61 0.641 . . . . 0.0 112.129 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 164.35 -126.51 1.52 Allowed Glycine 0 CA--C 1.521 0.461 0 N-CA-C 108.043 -2.023 . . . . 0.0 108.043 -173.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.5 t -142.5 114.67 3.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 175.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -144.42 168.91 18.99 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.271 0.558 . . . . 0.0 110.718 -176.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.04 167.79 22.51 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.372 174.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 79.4 mmm -134.01 150.6 51.25 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 32.5 t -140.21 147.46 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 C-N-CA 122.895 0.478 . . . . 0.0 110.727 -177.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -133.31 134.87 44.4 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.03 0.532 . . . . 0.0 110.49 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -108.59 163.31 13.35 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 116.479 2.029 . . . . 0.0 116.479 -176.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -74.43 -16.79 60.86 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 84.9 p -157.12 161.23 39.39 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.275 0.559 . . . . 0.0 111.235 -178.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 45.7 t -66.62 -33.92 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -67.28 -30.21 70.02 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 117.886 0.312 . . . . 0.0 110.82 -177.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 68.7 m -75.49 -31.32 60.17 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 177.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.83 -33.32 60.07 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 119.629 -0.224 . . . . 0.0 111.172 178.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -67.48 -43.49 80.87 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 118.445 0.566 . . . . 0.0 111.487 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -74.42 -28.32 61.02 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.166 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -74.38 -39.8 62.48 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 118.094 0.406 . . . . 0.0 110.69 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -74.64 -23.54 58.7 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 122.748 0.419 . . . . 0.0 111.165 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -93.9 -15.57 24.85 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 47.8 t -106.7 -36.23 6.77 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 75.9 mt -89.35 -8.15 53.8 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -176.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -70.88 135.88 48.28 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.53 -6.76 36.27 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.621 -0.544 . . . . 0.0 112.308 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -76.82 166.49 23.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 117.69 0.745 . . . . 0.0 109.727 176.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -123.49 138.6 54.54 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 84.2 mt -72.29 -43.83 64.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.372 41.4 m-85 -82.79 -11.15 58.5 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 117.336 2.347 . . . . 0.0 117.336 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.9 t 64.79 37.19 7.5 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.692 0.758 . . . . 0.0 110.817 -175.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 174.52 -23.95 0.07 OUTLIER Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.001 0.81 . . . . 0.0 111.086 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 90.8 m -146.62 -177.16 5.49 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.122 1.369 . . . . 0.0 109.159 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 95.2 m 58.62 37.62 25.28 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -177.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.59 146.05 10.74 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 175.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 86.1 mt -109.56 154.68 22.39 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -173.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -139.76 136.77 34.47 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.772 1.629 . . . . 0.0 106.913 169.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 37.0 mt -137.94 141.15 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-O 120.715 0.293 . . . . 0.0 111.277 -172.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -158.53 163.67 36.85 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.785 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.25 47.8 m-85 -63.02 136.36 57.78 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 176.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -86.76 159.55 19.09 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.611 0.364 . . . . 0.0 110.751 -179.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.432 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 23.1 pttp -92.79 -31.76 0.32 Allowed Pre-proline 0 CA--C 1.538 0.513 0 CA-C-O 117.363 -1.304 . . . . 0.0 114.066 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 69.2 Cg_endo -77.51 170.17 19.77 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 CA-C-N 121.966 1.738 . . . . 0.0 109.781 173.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.7 -1.07 3.11 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 117.798 2.518 . . . . 0.0 117.798 -174.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.55 130.65 9.42 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 118.873 0.76 . . . . 0.0 111.421 -178.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 20.1 mt -90.76 156.95 17.68 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 123.78 0.832 . . . . 0.0 111.017 177.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -115.42 50.88 0.96 Allowed 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.367 0.667 . . . . 0.0 109.86 173.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 3.1 t -52.23 145.22 2.69 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -134.54 -3.63 2.64 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 -177.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -159.32 162.62 36.01 Favored 'General case' 0 N--CA 1.456 -0.132 0 O-C-N 122.225 -0.297 . . . . 0.0 111.277 -171.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -125.39 110.81 14.4 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.769 0.828 . . . . 0.0 109.629 174.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 54.6 p30 -159.04 -165.95 1.73 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -67.84 -8.94 40.37 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -174.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -120.77 -15.35 8.39 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.34 140.9 35.69 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 123.923 0.889 . . . . 0.0 113.073 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 -163.55 156.91 18.93 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.644 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -141.52 118.58 11.27 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.654 171.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -81.94 4.35 22.95 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 -172.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 CA--C 1.529 0.152 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -177.494 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 54.5 m . . . . . 0 CA--C 1.531 0.241 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.1 t -131.85 133.71 60.84 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 CA-C-N 118.038 0.381 . . . . 0.0 111.018 176.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -121.56 153.32 38.18 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 122.817 0.447 . . . . 0.0 110.926 -176.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 22.8 tp -103.9 135.95 44.47 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 170.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -111.57 132.17 54.73 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.92 1.288 . . . . 0.0 114.419 176.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -121.58 130.09 53.28 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 175.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.4 mp -101.84 118.31 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -84.9 -19.37 32.38 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.027 0.531 . . . . 0.0 111.939 -171.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -141.72 78.99 17.3 Favored Pre-proline 0 CA--C 1.529 0.137 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -78.42 47.22 2.34 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 124.957 3.771 . . . . 0.0 111.926 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.24 -4.42 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 O-C-N 121.862 -0.524 . . . . 0.0 110.813 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -137.03 156.48 48.37 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 176.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 69.0 m -69.68 113.41 6.92 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 37.5 mm -78.26 141.8 14.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 177.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.11 160.88 36.45 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.5 p -64.84 -15.67 62.13 Favored 'General case' 0 CA--C 1.527 0.062 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -76.27 -44.98 34.8 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.785 0.326 . . . . 0.0 111.45 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 1.5 m -71.38 -32.62 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 179.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.4 mt -72.03 -34.16 68.58 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 176.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -71.64 -30.45 65.76 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 173.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.3 m -66.68 -33.92 76.72 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 42.9 pt -91.14 -24.94 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 118.352 0.523 . . . . 0.0 112.027 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 99.3 m -88.49 -25.54 22.52 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.093 0.86 . . . . 0.0 113.285 -178.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.439 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 31.9 t30 -64.51 -43.57 71.74 Favored Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 73.6 Cg_endo -69.85 -11.87 31.58 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.415 1.41 . . . . 0.0 111.519 177.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 94.4 m -92.28 -10.71 37.46 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.6 0.36 . . . . 0.0 111.847 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 155.09 169.56 19.76 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.767 -0.533 . . . . 0.0 111.767 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.88 96.88 0.7 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 124.138 3.226 . . . . 0.0 110.611 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 70.2 t -68.25 145.41 13.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -116.25 -39.93 3.33 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 119.147 -0.454 . . . . 0.0 111.32 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 63.4 mtm-85 -147.93 152.01 36.81 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 21.5 mt -148.42 137.14 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.272 1.029 . . . . 0.0 110.183 177.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 8.0 m -143.05 162.43 17.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 C-N-CA 123.778 0.831 . . . . 0.0 110.315 174.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 43.1 mt -134.34 143.18 38.77 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.075 0 C-N-CA 123.157 0.583 . . . . 0.0 110.486 -174.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.293 4.2 p90 -142.32 156.36 45.25 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 176.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -127.49 14.75 7.11 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.208 0.603 . . . . 0.0 110.905 -173.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -61.76 -32.58 72.84 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 -169.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -130.6 7.01 4.81 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.594 0.633 . . . . 0.0 112.278 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 163.41 -125.56 1.41 Allowed Glycine 0 C--N 1.336 0.551 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -174.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 24.2 t -140.99 112.02 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.152 0 C-N-CA 122.785 0.434 . . . . 0.0 109.915 175.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -141.8 168.03 20.72 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.212 0.529 . . . . 0.0 110.948 -175.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.98 169.2 21.14 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.75 0.82 . . . . 0.0 109.052 176.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 64.4 mmm -136.03 153.96 51.2 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 27.1 t -140.25 144.6 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.095 0 C-N-CA 123.063 0.545 . . . . 0.0 110.953 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -130.05 133.53 46.77 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.026 0.531 . . . . 0.0 110.252 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -108.9 161.32 15.25 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -177.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -80.62 -10.88 59.71 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 43.1 t -155.27 153.37 30.5 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 118.202 0.456 . . . . 0.0 111.864 -175.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 59.0 t -68.47 -38.52 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 123.0 0.52 . . . . 0.0 109.743 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -67.5 -26.61 66.43 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 122.153 -0.342 . . . . 0.0 111.08 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 48.8 m -75.88 -30.8 58.98 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 175.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.76 -33.21 58.09 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.579 0.352 . . . . 0.0 111.017 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -69.24 -44.14 72.56 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 122.228 -0.295 . . . . 0.0 111.665 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -74.12 -27.76 61.02 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 117.935 0.334 . . . . 0.0 111.105 -178.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -72.55 -39.82 67.18 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.177 0.444 . . . . 0.0 110.58 177.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.42 -23.75 54.0 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.433 0.293 . . . . 0.0 111.149 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -90.34 -14.73 32.51 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 48.2 t -109.51 -34.46 6.51 Favored 'General case' 0 C--N 1.338 0.068 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -177.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 78.3 mt -90.42 -7.92 51.92 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -70.93 132.57 45.41 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 75.66 -4.62 42.81 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.74 -0.478 . . . . 0.0 112.164 -177.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.26 166.4 22.18 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.859 0.829 . . . . 0.0 110.193 177.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -123.49 139.88 53.56 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 86.3 mt -73.71 -42.25 54.7 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.352 44.4 m-85 -82.86 -12.33 57.5 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 117.355 2.354 . . . . 0.0 117.355 178.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 23.1 t 65.14 36.34 7.29 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.69 0.757 . . . . 0.0 110.722 -174.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 176.05 -24.54 0.06 OUTLIER Glycine 0 CA--C 1.528 0.856 0 C-N-CA 123.792 0.71 . . . . 0.0 111.35 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 82.4 m -146.74 -176.57 5.24 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.897 1.279 . . . . 0.0 109.173 178.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 89.7 m 58.06 37.08 26.47 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.69 148.98 11.68 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 176.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 76.2 mt -115.54 155.31 27.8 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -172.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -139.08 138.17 36.85 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.141 1.376 . . . . 0.0 107.959 169.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 29.2 mt -140.17 143.69 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 CA-C-O 120.935 0.398 . . . . 0.0 111.388 -171.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -159.28 162.94 36.14 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.865 0.866 . . . . 0.0 109.518 175.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -62.22 138.5 58.43 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 115.933 1.827 . . . . 0.0 115.933 177.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -87.55 162.31 17.27 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 122.674 0.39 . . . . 0.0 111.722 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.402 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 53.7 mtmt -80.82 -52.62 0.87 Allowed Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 118.351 -0.833 . . . . 0.0 112.665 178.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 90.5 Cg_endo -72.28 171.09 17.63 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.104 2.536 . . . . 0.0 111.251 177.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.262 0.2 OUTLIER -136.16 2.72 2.82 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 117.844 2.535 . . . . 0.0 117.844 -175.6 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -157.7 130.35 7.37 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 121.635 -0.666 . . . . 0.0 112.106 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 36.4 mt -85.8 166.67 15.87 Favored 'General case' 0 CA--C 1.527 0.068 0 C-N-CA 124.445 1.098 . . . . 0.0 111.538 176.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -120.22 49.79 1.38 Allowed 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 169.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.5 t -49.32 143.05 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.249 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -176.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -127.4 -7.4 5.8 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 117.945 2.572 . . . . 0.0 117.945 -176.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -162.87 174.72 12.04 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 122.77 0.428 . . . . 0.0 110.523 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -125.82 116.22 21.23 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.86 0.864 . . . . 0.0 109.628 174.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 52.7 p30 -157.74 -168.4 2.53 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.284 1.034 . . . . 0.0 109.718 178.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -68.97 -11.44 60.72 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -175.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -113.33 -17.56 12.26 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -144.6 141.13 29.19 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.864 0.866 . . . . 0.0 112.768 -178.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 18.9 t-105 -160.89 158.24 27.92 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 119.671 -0.812 . . . . 0.0 110.738 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -139.21 116.44 11.12 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.557 0.743 . . . . 0.0 109.774 172.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.266 67.7 m-85 -79.36 6.24 10.57 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 117.297 2.332 . . . . 0.0 117.297 -173.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 5.6 t . . . . . 0 CA--C 1.53 0.185 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -179.565 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 69.6 m . . . . . 0 CA--C 1.533 0.305 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 90.2 t -141.0 134.27 31.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -122.14 153.07 39.23 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 122.663 0.385 . . . . 0.0 111.299 -175.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 24.8 tp -100.03 136.73 39.49 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 169.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -113.07 112.47 23.91 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 176.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.72 125.8 45.66 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 175.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.6 mp -96.96 124.81 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 22.0 mt -86.2 -25.94 25.37 Favored 'General case' 0 N--CA 1.458 -0.056 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -174.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -141.33 79.04 17.98 Favored Pre-proline 0 N--CA 1.455 -0.218 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -176.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -76.71 46.63 1.93 Allowed 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 125.182 3.921 . . . . 0.0 112.278 -177.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.99 -4.68 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 O-C-N 121.845 -0.534 . . . . 0.0 110.703 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -135.75 158.48 44.29 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 176.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 68.6 m -68.94 112.57 5.68 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 42.6 mm -78.5 139.72 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 176.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.06 159.95 39.25 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.4 p -64.92 -17.05 64.01 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 176.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -75.18 -45.97 37.15 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.366 0.266 . . . . 0.0 111.378 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.1 m -71.19 -32.05 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.53 -34.68 70.25 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 176.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -71.47 -30.97 66.61 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 174.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 10.7 m -66.92 -33.84 76.47 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 42.8 pt -91.74 -22.44 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 119.012 -0.518 . . . . 0.0 112.042 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 92.8 m -91.27 -25.57 19.41 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -178.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.453 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 32.2 t30 -64.0 -41.83 65.38 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-O 118.412 -0.804 . . . . 0.0 113.087 -179.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 72.9 Cg_endo -69.13 -13.44 36.27 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 CA-C-N 120.938 1.371 . . . . 0.0 111.669 178.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 97.1 m -89.39 -8.03 53.96 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 177.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 146.88 168.75 13.97 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.469 -0.653 . . . . 0.0 111.469 176.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.55 104.35 0.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.678 2.919 . . . . 0.0 111.966 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 75.8 t -75.53 143.77 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 175.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -115.64 -39.45 3.53 Favored 'General case' 0 C--O 1.227 -0.115 0 CA-C-O 119.431 -0.318 . . . . 0.0 111.39 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 66.8 mtm-85 -147.81 152.23 37.33 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 20.3 mt -148.51 137.15 15.14 Favored 'Isoleucine or valine' 0 C--N 1.339 0.13 0 C-N-CA 124.15 0.98 . . . . 0.0 109.927 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 3.9 m -142.73 160.79 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.087 0 C-N-CA 123.632 0.773 . . . . 0.0 110.568 174.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 45.4 mt -133.84 142.26 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 C-N-CA 122.591 0.356 . . . . 0.0 110.369 -175.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.295 4.1 p90 -140.96 157.24 45.63 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 177.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -128.03 15.61 6.8 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.271 0.628 . . . . 0.0 110.626 -174.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -62.85 -30.92 71.87 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -169.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -130.62 6.48 4.77 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.518 0.599 . . . . 0.0 112.144 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 161.62 -123.36 1.2 Allowed Glycine 0 C--N 1.333 0.373 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -173.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 50.9 t -143.23 114.94 2.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 175.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 8.3 mp0 -143.85 167.57 22.01 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.172 0.511 . . . . 0.0 110.786 -176.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.02 165.39 30.03 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.58 0.752 . . . . 0.0 109.215 175.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 59.5 mmm -133.36 152.13 51.9 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 39.4 t -139.39 142.64 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 122.788 0.435 . . . . 0.0 110.389 -178.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -128.06 131.87 49.09 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.842 0.457 . . . . 0.0 110.522 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -105.73 161.42 14.42 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 116.35 1.981 . . . . 0.0 116.35 -176.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -77.72 -13.03 60.02 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 45.2 t -155.81 155.82 33.67 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 121.813 -0.555 . . . . 0.0 111.872 -176.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 38.4 t -64.91 -42.11 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -67.7 -25.87 65.89 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 117.877 0.308 . . . . 0.0 111.657 -176.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 59.2 m -74.62 -31.8 62.11 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 175.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.04 -30.33 58.39 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.518 0.327 . . . . 0.0 111.157 178.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -68.64 -47.7 65.91 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 117.934 0.334 . . . . 0.0 111.297 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -73.75 -25.2 60.05 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 119.423 -0.322 . . . . 0.0 111.436 -177.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -71.87 -40.85 68.67 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.187 0.449 . . . . 0.0 110.087 176.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.422 ' HE3' ' HB3' ' A' ' 245' ' ' LYS . 1.0 OUTLIER -76.26 -24.96 54.52 Favored 'General case' 0 N--CA 1.458 -0.045 0 C-N-CA 122.961 0.504 . . . . 0.0 110.993 -179.808 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -90.69 -13.58 33.9 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 39.5 t -112.59 -35.26 5.58 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 118.631 0.651 . . . . 0.0 112.739 -177.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 59.8 mt -90.0 -7.16 54.62 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -177.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -70.78 133.19 46.34 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.78 -5.25 48.46 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 119.932 -0.371 . . . . 0.0 112.369 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.39 166.39 22.7 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 117.711 0.756 . . . . 0.0 110.131 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -123.44 139.61 53.85 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 88.5 mt -73.67 -41.47 55.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.356 45.3 m-85 -82.64 -11.79 58.11 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 117.114 2.265 . . . . 0.0 117.114 178.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 29.4 t 65.94 32.53 8.47 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.699 0.799 . . . . 0.0 111.012 -173.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 179.37 -24.61 0.05 OUTLIER Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 74.7 m -145.58 -177.38 5.54 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.707 1.203 . . . . 0.0 109.465 178.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 84.3 m 59.42 35.6 23.02 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -177.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.73 150.4 5.27 Favored 'General case' 0 C--N 1.338 0.095 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 175.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 78.3 mt -118.47 156.09 29.66 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -173.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -138.39 139.2 38.85 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.562 1.545 . . . . 0.0 107.14 169.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 31.9 mt -139.34 141.73 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 CA-C-O 120.747 0.308 . . . . 0.0 111.364 -172.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -158.9 161.19 36.77 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.962 176.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -60.55 136.15 57.97 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 177.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -88.28 162.32 16.67 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 122.973 0.509 . . . . 0.0 111.856 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -85.99 -52.82 0.45 Allowed Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 118.505 -0.759 . . . . 0.0 112.808 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -72.07 165.43 32.64 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.759 2.306 . . . . 0.0 110.27 176.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 1.5 t -138.95 7.38 2.47 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 -174.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -152.81 126.41 8.82 Favored 'General case' 0 C--N 1.338 0.068 0 O-C-N 121.778 -0.576 . . . . 0.0 111.771 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 24.6 mt -87.13 162.85 17.29 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 123.943 0.897 . . . . 0.0 111.467 176.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -121.77 54.67 1.14 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.804 0.842 . . . . 0.0 109.356 171.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.6 t -54.02 146.34 3.45 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -175.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -127.83 -7.23 5.57 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 117.625 2.454 . . . . 0.0 117.625 -176.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -164.48 172.87 12.76 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 117.995 0.362 . . . . 0.0 110.676 -178.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -125.5 116.8 22.36 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.017 0.927 . . . . 0.0 109.916 173.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 55.9 p30 -159.74 -166.95 1.87 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -68.35 -11.42 59.52 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -174.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -111.98 -20.34 12.02 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -143.39 143.31 31.58 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.691 0.796 . . . . 0.0 112.762 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 18.4 t-105 -161.0 156.11 24.25 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.277 -178.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -136.81 117.92 14.41 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.498 0.719 . . . . 0.0 110.165 173.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.256 64.1 m-85 -82.08 7.01 14.5 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 117.39 2.367 . . . . 0.0 117.39 -173.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.455 -0.223 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -178.113 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 54.5 m . . . . . 0 CA--C 1.53 0.211 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 35.8 t -126.56 143.05 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 C-N-CA 123.036 0.534 . . . . 0.0 110.483 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 84.5 mt -136.53 146.07 45.77 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 122.712 0.405 . . . . 0.0 111.162 -176.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 48.7 tp -95.36 136.53 35.61 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 172.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -116.13 101.22 8.53 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.003 1.321 . . . . 0.0 114.315 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.07 140.51 36.45 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 174.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 3.9 mp -110.66 116.24 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -90.46 -18.09 25.98 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -170.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -143.18 78.86 14.73 Favored Pre-proline 0 CA--C 1.528 0.127 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -76.98 42.7 1.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 125.206 3.937 . . . . 0.0 112.625 -177.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.77 -5.11 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 O-C-N 121.747 -0.595 . . . . 0.0 110.693 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -138.99 156.69 47.03 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 176.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 69.0 m -68.82 117.48 10.56 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 28.0 mm -78.28 145.41 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.02 160.42 37.8 Favored 'General case' 0 C--O 1.23 0.043 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 6.7 p -67.84 -22.98 65.11 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -73.63 -47.14 42.35 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.9 m -70.19 -31.91 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.9 mt -71.12 -35.25 71.68 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -71.36 -29.58 65.14 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 174.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.1 m -69.22 -33.43 73.29 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 42.2 pt -91.7 -22.06 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.95 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 95.1 m -93.42 -25.44 17.66 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -177.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.468 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 38.5 t30 -63.59 -39.56 49.16 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 67.0 Cg_endo -68.56 -14.15 38.96 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 CA-C-N 121.113 1.433 . . . . 0.0 111.954 177.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 92.8 m -89.23 -8.13 54.12 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.106 0.412 . . . . 0.0 111.57 176.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 147.8 166.95 13.0 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 178.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -68.61 105.25 1.25 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.535 2.823 . . . . 0.0 110.472 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 80.3 t -72.35 145.59 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -111.04 -36.81 5.54 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 119.369 -0.348 . . . . 0.0 111.58 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 25.6 mtm180 -149.52 154.02 38.11 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 118.128 0.422 . . . . 0.0 112.035 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 34.3 mt -144.7 143.8 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.035 0.934 . . . . 0.0 109.369 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 55.2 t -145.15 154.61 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 60.2 mt -133.43 140.13 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 C-N-CA 123.423 0.689 . . . . 0.0 109.65 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.253 4.8 p90 -148.18 160.62 42.74 Favored 'General case' 0 N--CA 1.458 -0.026 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 176.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.01 31.31 2.2 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.811 0.444 . . . . 0.0 111.985 -176.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -67.07 -29.81 69.69 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -174.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -130.52 3.32 4.6 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 167.83 -127.12 1.51 Allowed Glycine 0 C--N 1.334 0.443 0 N-CA-C 108.381 -1.888 . . . . 0.0 108.381 -173.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.2 t -139.6 117.94 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-N 117.252 0.526 . . . . 0.0 110.244 173.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 11.5 mp0 -144.19 168.7 19.42 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.651 0.739 . . . . 0.0 111.164 -175.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -150.18 163.96 36.9 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.95 175.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 59.6 mmm -134.54 152.55 51.86 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.633 0.373 . . . . 0.0 110.199 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.3 t -142.42 145.19 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 123.117 0.567 . . . . 0.0 110.047 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -129.06 132.5 47.45 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 122.555 0.342 . . . . 0.0 110.284 176.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -102.36 161.71 13.49 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -177.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -81.27 -10.44 59.58 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 30.6 t -154.51 151.34 28.8 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 121.761 -0.587 . . . . 0.0 112.106 -176.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 50.3 t -68.13 -38.22 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -178.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -67.06 -24.93 66.02 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.123 0.42 . . . . 0.0 111.151 -178.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 55.3 m -75.77 -32.84 60.12 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 176.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -78.08 -31.86 50.39 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 122.361 -0.212 . . . . 0.0 110.961 178.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -66.55 -41.74 88.19 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 121.993 -0.442 . . . . 0.0 111.474 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -77.08 -28.15 54.5 Favored 'General case' 0 CA--C 1.527 0.07 0 CA-C-N 117.937 0.335 . . . . 0.0 110.872 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -69.95 -41.24 74.81 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.05 0.387 . . . . 0.0 109.959 177.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -74.24 -20.63 60.1 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.618 0.367 . . . . 0.0 111.023 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -98.77 -5.08 31.96 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 42.6 t -124.16 -30.44 3.46 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 56.3 mt -93.83 -6.66 45.33 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.247 0.476 . . . . 0.0 111.479 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -72.45 131.66 42.87 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.97 -4.64 53.09 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 119.85 -0.417 . . . . 0.0 112.259 -178.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.9 166.56 22.25 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 117.817 0.809 . . . . 0.0 110.169 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -123.67 139.3 54.13 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 89.5 mt -74.43 -41.66 49.71 Favored 'Isoleucine or valine' 0 C--O 1.23 0.071 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.355 35.9 m-85 -82.82 -11.88 57.9 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 117.065 2.246 . . . . 0.0 117.065 178.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 30.1 t 65.74 34.02 7.82 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.533 0.733 . . . . 0.0 111.171 -173.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 177.44 -24.35 0.05 OUTLIER Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.11 0.862 . . . . 0.0 111.123 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 75.0 m -145.43 -175.74 4.84 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.527 1.131 . . . . 0.0 109.383 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 88.8 m 57.84 36.04 26.0 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -176.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.3 147.53 13.26 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 176.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 78.9 mt -114.35 156.85 23.68 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -173.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -139.32 138.2 36.47 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 169.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 46.5 mt -137.1 142.48 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.066 0 CA-C-O 120.66 0.267 . . . . 0.0 111.56 -172.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -159.51 161.82 35.39 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.094 176.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.287 35.6 m-85 -61.44 135.54 57.72 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 177.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -93.16 157.18 16.4 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.999 -177.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.415 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 23.2 pttp -91.19 -31.33 0.34 Allowed Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 50.3 Cg_endo -79.46 161.4 25.37 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 CA-C-N 121.766 1.666 . . . . 0.0 110.154 176.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.298 0.2 OUTLIER -135.5 13.56 3.47 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 -178.056 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -156.36 126.37 6.46 Favored 'General case' 0 C--O 1.227 -0.1 0 O-C-N 121.871 -0.518 . . . . 0.0 111.521 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 23.1 mt -88.32 163.99 15.79 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.69 0.796 . . . . 0.0 110.546 174.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -122.89 44.24 2.71 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.342 0.591 . . . . 0.0 110.361 171.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.1 t -48.1 140.0 2.41 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -176.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . 0.277 5.3 p90 -122.87 -6.27 8.5 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 117.267 2.321 . . . . 0.0 117.267 -177.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -163.37 167.98 21.01 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 122.956 0.503 . . . . 0.0 110.176 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -119.09 123.46 44.49 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.351 0.66 . . . . 0.0 109.734 174.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 50.6 p30 -159.32 -168.29 2.28 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.829 0.852 . . . . 0.0 108.93 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -70.41 -10.13 58.26 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -177.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -102.41 -33.63 9.47 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.5 p -142.68 145.75 33.72 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 124.257 1.023 . . . . 0.0 113.188 176.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 21.7 t-105 -153.62 153.73 32.87 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -176.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -131.32 116.8 18.05 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.252 0.621 . . . . 0.0 111.607 175.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.253 67.1 m-85 -83.16 7.67 15.4 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 117.449 2.388 . . . . 0.0 117.449 -172.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 CA--C 1.528 0.121 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -178.409 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 . . . . . 0 N--CA 1.475 0.778 0 CA-C-O 120.364 0.126 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -68.51 127.57 33.48 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 122.669 0.388 . . . . 0.0 110.484 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 94.4 mt -83.34 142.83 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 63.1 m -69.01 115.55 8.43 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 122.345 0.258 . . . . 0.0 110.724 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 61.3 mtt180 -150.93 145.86 18.64 Favored Pre-proline 0 C--N 1.337 0.062 0 C-N-CA 123.733 0.813 . . . . 0.0 110.281 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.82 149.58 60.38 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.136 2.557 . . . . 0.0 109.443 174.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 68.57 9.82 59.32 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 119.607 -0.552 . . . . 0.0 112.619 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -140.37 -45.6 0.41 Allowed 'General case' 0 C--O 1.232 0.181 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 74.2 m -69.52 153.3 43.7 Favored 'General case' 0 C--O 1.231 0.091 0 O-C-N 121.906 -0.496 . . . . 0.0 110.719 176.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -53.91 -36.57 62.86 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -76.73 7.29 4.81 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 116.158 1.911 . . . . 0.0 116.158 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 75.7 m -140.65 2.82 1.83 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -176.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -149.22 10.99 0.79 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 176.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 54.5 m -137.31 1.77 2.44 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.67 0.388 . . . . 0.0 111.973 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 1.9 m -80.08 122.3 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -130.84 10.41 5.06 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.7 0.8 . . . . 0.0 112.681 178.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 50.9 m 67.0 19.7 10.54 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -173.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.6 t -128.71 142.08 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 C-N-CA 122.988 0.515 . . . . 0.0 110.924 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 84.7 mt -135.02 149.49 50.17 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 122.663 0.385 . . . . 0.0 111.884 -174.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 32.0 tp -102.72 136.67 42.12 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.576 0.75 . . . . 0.0 109.223 172.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -115.27 107.05 14.76 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.938 1.295 . . . . 0.0 114.465 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.05 127.76 38.69 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 175.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.5 mp -97.95 127.53 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 20.7 mt -89.37 -26.34 21.1 Favored 'General case' 0 CA--C 1.527 0.062 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -174.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -141.17 79.1 18.23 Favored Pre-proline 0 N--CA 1.453 -0.284 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -176.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -77.34 45.31 1.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 125.251 3.967 . . . . 0.0 111.988 -177.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.47 -4.2 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 O-C-N 121.877 -0.515 . . . . 0.0 110.597 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -136.52 155.84 49.41 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 66.3 m -67.85 113.2 5.39 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 33.6 mm -78.39 141.53 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.99 159.76 39.77 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.6 p -64.8 -15.41 61.68 Favored 'General case' 0 C--O 1.23 0.05 0 N-CA-C 114.314 1.228 . . . . 0.0 114.314 177.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -76.12 -46.52 28.41 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.676 0.274 . . . . 0.0 111.541 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.0 m -70.85 -31.1 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.1 mt -72.39 -35.17 68.37 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 176.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -70.6 -30.65 67.38 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 173.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.1 m -67.26 -34.56 77.7 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 43.9 pt -91.46 -21.73 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 118.405 0.548 . . . . 0.0 112.239 178.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 91.3 m -91.21 -25.87 19.31 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.457 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 31.8 t30 -63.82 -41.37 63.73 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 74.4 Cg_endo -69.27 -13.84 36.59 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 CA-C-N 120.857 1.342 . . . . 0.0 111.645 177.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 91.7 m -91.96 -4.49 54.53 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.787 0.435 . . . . 0.0 111.701 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 146.95 166.79 12.57 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 177.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.53 103.14 1.08 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.587 2.858 . . . . 0.0 110.17 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 64.8 t -69.51 146.82 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -114.44 -37.53 4.3 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 119.244 -0.408 . . . . 0.0 111.579 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 39.2 mtm-85 -149.95 151.87 34.06 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.574 0.625 . . . . 0.0 112.035 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 17.8 mt -146.12 140.97 21.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 C-N-CA 124.211 1.004 . . . . 0.0 109.527 177.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 59.7 t -146.78 156.51 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 47.6 mt -134.45 142.22 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 123.698 0.799 . . . . 0.0 110.009 -178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.297 3.2 p90 -143.28 159.22 42.75 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 176.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -128.76 15.52 6.41 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.989 0.516 . . . . 0.0 111.137 -173.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -62.86 -32.46 73.7 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -169.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -130.49 8.84 5.03 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 118.597 0.635 . . . . 0.0 112.239 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 159.92 -125.11 1.43 Allowed Glycine 0 C--N 1.335 0.516 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 -174.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.4 t -141.18 115.3 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -142.29 166.89 23.45 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.268 0.556 . . . . 0.0 110.956 -176.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.37 165.47 29.23 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.405 175.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 76.5 mmm -133.42 153.25 51.77 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 28.2 t -141.79 145.64 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 C-N-CA 123.292 0.637 . . . . 0.0 110.667 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -132.61 133.93 44.25 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.727 0.411 . . . . 0.0 110.126 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -105.51 161.75 14.07 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 -176.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -78.25 -14.65 59.35 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 82.6 p -155.11 157.98 38.32 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.25 0.548 . . . . 0.0 111.548 -177.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 53.8 t -66.38 -36.08 76.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -65.44 -32.17 73.65 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 122.354 -0.216 . . . . 0.0 110.711 -176.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 63.8 m -72.65 -34.84 67.53 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 121.27 -0.172 . . . . 0.0 110.639 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -73.45 -31.54 63.85 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 119.732 -0.175 . . . . 0.0 111.114 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -68.32 -44.14 76.02 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 118.199 0.454 . . . . 0.0 111.831 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 -77.29 -25.29 51.17 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 118.102 0.41 . . . . 0.0 111.34 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -72.06 -41.13 67.78 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 122.065 -0.397 . . . . 0.0 110.077 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -74.65 -21.26 59.53 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 122.974 0.51 . . . . 0.0 111.194 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -97.18 -10.52 25.73 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 44.2 t -116.12 -34.01 4.84 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 118.62 0.645 . . . . 0.0 112.594 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 50.7 mt -90.73 -6.95 53.76 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 122.139 -0.35 . . . . 0.0 111.837 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -72.26 132.4 44.01 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.25 -4.53 47.87 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 112.156 -0.378 . . . . 0.0 112.156 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.22 166.39 22.78 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 117.52 0.66 . . . . 0.0 110.187 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -123.61 139.61 53.83 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 85.1 mt -74.42 -41.51 49.77 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.36 44.0 m-85 -82.87 -11.47 58.18 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 117.037 2.236 . . . . 0.0 117.037 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 29.0 t 65.51 34.48 7.9 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.604 0.762 . . . . 0.0 111.059 -173.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 177.15 -23.96 0.05 OUTLIER Glycine 0 CA--C 1.528 0.881 0 C-N-CA 123.972 0.796 . . . . 0.0 111.158 177.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 96.8 m -145.92 -177.29 5.52 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.702 1.201 . . . . 0.0 109.52 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 88.0 m 58.64 37.0 25.33 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -176.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.96 151.39 6.76 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 175.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 73.6 mt -119.67 157.64 28.1 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -173.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -139.54 140.38 37.12 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.786 1.634 . . . . 0.0 107.294 168.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 38.4 mt -138.1 142.74 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 CA-C-O 120.848 0.356 . . . . 0.0 111.668 -173.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -158.57 161.87 37.31 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.04 176.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.265 41.5 m-85 -61.96 134.81 57.12 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 177.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . 0.416 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -88.58 157.0 18.73 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.178 -178.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.442 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 23.2 pttp -90.14 -32.25 0.37 Allowed Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 117.413 -1.279 . . . . 0.0 114.307 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 68.2 Cg_endo -76.55 166.95 26.44 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 CA-C-N 121.893 1.712 . . . . 0.0 109.462 174.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.3 0.2 OUTLIER -130.04 0.47 4.73 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 -175.811 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 20.3 ttp180 -160.55 140.97 11.53 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.775 -0.578 . . . . 0.0 110.952 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 25.8 mt -85.25 171.47 11.91 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.115 0.966 . . . . 0.0 110.668 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.545 ' ND2' ' C2 ' ' B' ' 4' ' ' ' C' . 18.4 p30 -126.19 46.63 2.4 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 169.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.5 t -48.58 139.68 2.94 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -175.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . 0.278 6.2 p90 -120.37 -12.12 9.04 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 117.391 2.367 . . . . 0.0 117.391 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -163.6 173.91 12.41 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 122.853 0.461 . . . . 0.0 110.811 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -119.99 129.23 54.18 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.403 0.681 . . . . 0.0 110.544 176.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 39.5 p30 -160.5 -166.63 1.69 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.529 1.132 . . . . 0.0 108.824 176.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -68.36 -15.05 63.42 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -174.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -115.07 -12.19 11.98 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.49 139.17 35.06 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.832 0.853 . . . . 0.0 112.513 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 21.2 t-105 -161.17 154.48 21.53 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.473 -177.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -132.32 117.1 17.71 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.42 173.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.272 63.8 m-85 -81.71 8.6 9.58 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 117.362 2.356 . . . . 0.0 117.362 -172.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 11.3 t -138.06 -23.76 1.02 Allowed 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -95.41 113.25 61.29 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -80.44 -16.5 10.64 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.317 2.678 . . . . 0.0 112.245 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -71.91 -16.38 62.12 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -174.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 77.1 mt -86.03 -4.56 59.19 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.237 0.471 . . . . 0.0 111.886 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 46.1 t -72.5 -27.34 62.2 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 121.971 -0.456 . . . . 0.0 111.567 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -92.45 -4.58 65.95 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 119.715 -0.492 . . . . 0.0 112.643 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 63.8 mm-40 -89.18 5.38 44.95 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 117.577 0.688 . . . . 0.0 112.005 -177.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.123 0 CA-C-O 117.205 -1.886 . . . . 0.0 111.953 -177.25 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.742 0 C5'-C4'-C3' 110.385 -3.41 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.503 HO2' ' P ' ' B' ' 3' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.468 0 O4'-C1'-N19 111.978 3.778 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.503 ' P ' HO2' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.418 -2.927 3 O4'-C1'-N19 112.733 4.533 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ' C' . . . . . 0.545 ' C2 ' ' ND2' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.42 -2.791 1 C5'-C4'-C3' 108.825 -4.45 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.415 ' N3 ' " H2'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.732 0 C3'-C2'-C1' 105.01 3.9 OUTLIER-DELTA 0.016 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.591 0 O4'-C1'-N19 111.792 3.592 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 45.3 mm-40 . . . . . 0 N--CA 1.478 0.956 0 CA-C-O 120.473 0.178 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -67.63 150.36 48.86 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.959 0.504 . . . . 0.0 110.474 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 58.9 mt -65.79 142.99 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 122.876 0.471 . . . . 0.0 110.37 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 57.7 m -67.91 152.6 45.29 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.708 0.403 . . . . 0.0 111.153 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.405 ' N ' ' CD ' ' A' ' 179' ' ' PRO . 75.9 mtp85 -72.34 -40.65 7.38 Favored Pre-proline 0 CA--C 1.534 0.327 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.405 ' CD ' ' N ' ' A' ' 178' ' ' ARG . 52.3 Cg_exo -58.54 157.25 27.92 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.973 2.449 . . . . 0.0 112.519 178.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 77.39 0.96 73.96 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 119.722 -0.488 . . . . 0.0 112.622 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -149.14 -54.66 0.18 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 117.963 0.882 . . . . 0.0 112.861 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 44.0 t -68.31 152.65 45.14 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.459 0.304 . . . . 0.0 110.474 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -72.87 -5.44 38.31 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -69.46 -7.31 36.8 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 68.7 m -141.84 8.07 1.89 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -175.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -148.6 5.59 0.71 Allowed 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 65.5 m -147.16 10.5 1.0 Allowed 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 1.4 m -70.53 107.32 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -177.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 -130.62 10.38 5.16 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.187 0.595 . . . . 0.0 112.143 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 66.7 m 66.31 22.2 10.89 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.061 0.945 . . . . 0.0 113.435 -175.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 25.1 t -130.9 140.53 48.46 Favored 'Isoleucine or valine' 0 C--N 1.338 0.108 0 C-N-CA 122.83 0.452 . . . . 0.0 110.777 176.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 93.7 mt -130.76 159.2 38.02 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 122.961 0.504 . . . . 0.0 111.128 -176.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.1 tt -115.87 135.61 53.83 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.109 174.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -115.99 105.7 12.94 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -87.18 137.08 32.65 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 174.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.3 mp -106.94 118.21 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -88.48 -17.87 29.44 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -171.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -142.56 78.9 15.78 Favored Pre-proline 0 CA--C 1.529 0.156 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -77.98 46.55 2.1 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 125.132 3.888 . . . . 0.0 112.405 -177.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.42 -3.83 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 O-C-N 121.873 -0.517 . . . . 0.0 110.505 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -136.67 159.08 42.88 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 176.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 70.2 m -70.91 113.11 7.63 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.638 0.256 . . . . 0.0 110.373 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 33.8 mm -78.27 140.47 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.96 159.36 40.96 Favored 'General case' 0 C--O 1.23 0.058 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.445 ' HG1' ' HB2' ' A' ' 280' ' ' TRP . 1.4 p -65.2 -14.89 61.72 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 176.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -76.91 -45.49 27.75 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.589 0.356 . . . . 0.0 110.657 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 1.7 m -71.2 -32.42 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.88 -34.57 69.28 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 177.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -71.57 -29.71 65.03 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 174.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 8.2 m -67.29 -35.02 78.62 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 37.9 pt -91.32 -24.08 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 119.177 -0.44 . . . . 0.0 111.758 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 86.9 m -88.99 -25.46 22.01 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.438 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 31.4 t30 -63.13 -44.82 85.2 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-O 118.518 -0.753 . . . . 0.0 112.907 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 68.7 Cg_endo -68.18 -15.69 43.17 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.356 1.371 . . . . 0.0 111.478 178.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 95.2 m -84.12 -15.34 47.61 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 117.918 0.327 . . . . 0.0 111.715 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 152.4 169.3 17.6 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -61.42 104.82 0.32 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.768 2.979 . . . . 0.0 111.922 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 73.6 t -76.34 145.13 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -116.81 -38.38 3.45 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-O 119.394 -0.336 . . . . 0.0 111.579 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 41.3 mtm-85 -148.88 151.48 34.77 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 21.7 mt -147.71 136.48 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 124.036 0.934 . . . . 0.0 109.748 177.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.41 160.21 22.13 Favored 'Isoleucine or valine' 0 C--N 1.337 0.062 0 C-N-CA 123.592 0.757 . . . . 0.0 110.9 174.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 48.4 mt -134.43 141.51 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 123.189 0.596 . . . . 0.0 110.491 -175.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.292 5.8 p90 -140.82 157.78 44.91 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -127.21 14.26 7.23 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.449 0.699 . . . . 0.0 110.755 -174.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -61.97 -31.56 71.92 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -169.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -130.7 7.88 4.85 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 118.634 0.652 . . . . 0.0 112.289 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 161.38 -124.33 1.3 Allowed Glycine 0 CA--C 1.521 0.465 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 -174.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 47.9 t -142.73 115.07 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -143.95 167.73 21.66 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.324 0.583 . . . . 0.0 110.589 -176.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.25 164.29 32.77 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.879 0.871 . . . . 0.0 109.067 175.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 81.6 mmm -131.71 153.01 50.48 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 26.3 t -139.6 143.38 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.097 0 C-N-CA 122.786 0.434 . . . . 0.0 111.067 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -127.49 132.17 50.02 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.035 0.534 . . . . 0.0 110.337 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -108.27 161.94 14.54 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -176.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -80.95 -11.81 59.5 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 30.7 t -155.28 152.45 29.25 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.386 0.539 . . . . 0.0 111.893 -175.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 54.1 t -67.74 -38.27 80.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -67.78 -27.33 66.67 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 122.348 -0.22 . . . . 0.0 110.953 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 69.0 m -72.59 -34.35 67.35 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 176.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -77.48 -29.86 52.86 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 111.425 0.157 . . . . 0.0 111.425 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -67.75 -43.27 80.3 Favored 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 121.932 -0.48 . . . . 0.0 111.539 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -77.85 -24.23 48.65 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-N 117.842 0.292 . . . . 0.0 110.797 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -72.81 -41.19 65.18 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.098 0.408 . . . . 0.0 110.283 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -74.98 -23.39 58.27 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.814 0.446 . . . . 0.0 111.392 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -92.39 -17.21 24.94 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 48.1 t -106.16 -36.51 6.88 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -177.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 72.1 mt -89.42 -9.11 51.44 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -69.95 133.8 47.67 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.28 -5.54 42.51 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 119.748 -0.473 . . . . 0.0 112.205 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.4 166.41 22.67 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.792 0.796 . . . . 0.0 110.289 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -123.52 138.37 54.58 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 82.3 mt -72.66 -41.65 62.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.346 45.8 m-85 -82.9 -12.27 57.51 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.9 t 66.08 33.93 7.22 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.709 0.766 . . . . 0.0 110.936 -174.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 178.23 -24.7 0.05 OUTLIER Glycine 0 CA--C 1.528 0.856 0 C-N-CA 123.986 0.803 . . . . 0.0 111.289 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 72.8 m -145.74 -176.97 5.34 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.532 1.133 . . . . 0.0 109.422 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 89.8 m 57.64 37.88 27.54 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.856 0.462 . . . . 0.0 112.04 -176.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.2 147.49 13.01 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 175.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 79.6 mt -114.11 155.58 25.75 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -173.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -138.77 138.63 37.79 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.163 1.385 . . . . 0.0 107.597 169.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 37.0 mt -139.02 142.69 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-O 120.744 0.307 . . . . 0.0 111.75 -171.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -158.49 163.13 37.4 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.348 0.659 . . . . 0.0 109.478 175.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.266 44.1 m-85 -62.51 138.17 58.41 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 176.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -87.37 154.31 20.77 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.484 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.403 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 23.2 pttp -88.35 -31.76 0.39 Allowed Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 117.489 -1.243 . . . . 0.0 114.255 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 48.1 Cg_endo -79.94 162.56 23.58 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.743 1.629 . . . . 0.0 109.861 174.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.282 0.2 OUTLIER -137.79 18.75 2.86 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 116.747 2.129 . . . . 0.0 116.747 -176.462 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.467 ' CZ ' ' HA ' ' A' ' 269' ' ' ARG . 1.3 tpm_? -155.37 106.48 2.56 Favored 'General case' 0 C--N 1.34 0.169 0 O-C-N 121.734 -0.604 . . . . 0.0 112.301 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.474 ' HG ' ' C5 ' ' B' ' 3' ' ' ' A' . 9.4 mt -75.96 158.41 32.0 Favored 'General case' 0 N--CA 1.458 -0.062 0 C-N-CA 122.747 0.419 . . . . 0.0 110.161 173.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -127.02 54.56 1.63 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.685 0.794 . . . . 0.0 109.781 172.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.5 t -54.61 143.93 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -177.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -126.94 -7.7 6.05 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 117.557 2.429 . . . . 0.0 117.557 -176.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -162.17 173.04 14.83 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 122.809 0.444 . . . . 0.0 110.001 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -125.46 123.05 38.37 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.589 0.756 . . . . 0.0 110.05 175.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 46.5 p30 -159.99 -166.39 1.71 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.959 0.904 . . . . 0.0 108.575 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -68.11 -15.13 63.46 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -175.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -114.76 -12.88 12.09 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.64 139.77 34.9 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.631 0.772 . . . . 0.0 112.547 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' TRP . . . . . 0.445 ' HB2' ' HG1' ' A' ' 205' ' ' THR . 20.2 t-105 -161.02 156.86 25.31 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.446 -178.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -136.46 116.32 13.16 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.553 172.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.275 66.4 m-85 -79.05 7.22 7.73 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 117.26 2.318 . . . . 0.0 117.26 -173.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 5.8 t -137.77 -20.64 1.14 Allowed 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -95.4 113.11 60.97 Favored Pre-proline 0 CA--C 1.532 0.267 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 174.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -80.88 -15.22 10.74 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.582 2.854 . . . . 0.0 112.257 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -73.3 -12.6 60.9 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -174.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 54.3 mt -89.72 -9.07 50.79 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.249 0.477 . . . . 0.0 111.789 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 72.1 m -80.69 -17.96 49.44 Favored 'General case' 0 CA--C 1.526 0.037 0 CA-C-N 118.233 0.47 . . . . 0.0 112.056 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -91.27 -3.98 69.03 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 112.041 -0.424 . . . . 0.0 112.041 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -77.44 161.14 28.2 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.023 0.529 . . . . 0.0 111.217 -177.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 CA-C-O 117.516 -1.714 . . . . 0.0 111.43 -179.622 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.843 0 C3'-C2'-C1' 104.543 3.381 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.434 HO2' ' P ' ' B' ' 3' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.788 0 O4'-C1'-N19 111.167 2.967 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.474 ' C5 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.421 -2.672 2 C5'-C4'-C3' 109.424 -4.051 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.843 0 C5'-C4'-C3' 109.564 -3.957 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.448 ' N3 ' " H2'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.741 1 C3'-C2'-C1' 105.347 4.275 OUTLIER-DELTA 0.011 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.558 0 O4'-C1'-N19 112.033 3.833 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 . . . . . 0 N--CA 1.476 0.85 0 N-CA-C 110.754 -0.091 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -153.04 146.87 25.27 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 123.568 0.747 . . . . 0.0 109.789 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 46.9 mm -70.06 143.23 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 C-N-CA 122.431 0.292 . . . . 0.0 110.353 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 47.1 t -158.02 158.58 35.12 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 122.878 0.471 . . . . 0.0 110.064 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 33.5 ptt-85 -155.69 154.48 28.1 Favored Pre-proline 0 CA--C 1.53 0.194 0 C-N-CA 123.274 0.63 . . . . 0.0 109.765 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.31 160.47 49.43 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.368 2.712 . . . . 0.0 110.309 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -71.94 -12.8 75.41 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -85.06 -1.04 56.39 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 117.551 0.676 . . . . 0.0 109.33 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 42.7 t -68.05 149.3 49.85 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 121.794 -0.566 . . . . 0.0 111.122 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -57.63 -27.77 63.1 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.954 0.407 . . . . 0.0 110.252 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -84.1 9.82 11.66 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 74.6 m -141.79 -1.55 1.26 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -176.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 4.5 ppt_? -147.06 11.13 1.04 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.152 0.887 . . . . 0.0 113.283 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 52.8 m -140.74 5.8 2.0 Allowed 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.0 m -78.46 119.29 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -177.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 42.8 p30 -130.76 10.33 5.08 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.119 0.967 . . . . 0.0 112.773 177.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 57.8 m 66.26 19.77 11.05 Favored 'General case' 0 C--N 1.341 0.201 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -173.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 38.8 t -130.51 133.76 63.2 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 C-N-CA 122.88 0.472 . . . . 0.0 111.292 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -122.63 152.86 40.06 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 122.987 0.515 . . . . 0.0 111.066 -177.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 28.4 tp -103.31 134.04 47.37 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 170.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -111.86 110.97 21.6 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.49 131.55 40.09 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 173.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.6 mp -102.1 120.4 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -88.42 -20.38 25.31 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 119.307 -0.378 . . . . 0.0 111.898 -172.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -142.19 78.94 16.46 Favored Pre-proline 0 CA--C 1.529 0.156 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.89 46.4 2.05 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 125.086 3.857 . . . . 0.0 112.249 -177.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.66 -3.58 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 O-C-N 121.86 -0.525 . . . . 0.0 110.822 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -136.85 158.04 45.36 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 176.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 69.3 m -69.47 111.22 5.18 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 41.0 mm -78.34 139.06 19.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.14 161.82 33.82 Favored 'General case' 0 CA--C 1.523 -0.094 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.3 p -64.45 -18.44 64.75 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 177.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -73.41 -39.75 64.81 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 1.5 m -75.89 -33.79 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 97.0 mt -71.37 -33.07 69.21 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 176.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -72.15 -30.53 65.11 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 175.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 20.6 m -67.23 -34.79 78.22 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 43.5 pt -90.89 -22.13 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 119.045 -0.503 . . . . 0.0 111.887 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 84.1 m -91.26 -26.62 18.91 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.466 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 32.7 t30 -63.99 -40.44 54.42 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 70.3 Cg_endo -69.32 -14.52 37.62 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.494 1.462 . . . . 0.0 111.477 177.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 98.8 m -89.88 -8.56 51.63 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.575 0.35 . . . . 0.0 111.614 177.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 149.54 170.32 16.91 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 177.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.68 102.56 1.03 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.933 3.089 . . . . 0.0 110.736 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 73.4 t -71.17 146.81 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 176.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -115.47 -36.17 4.37 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 119.377 -0.344 . . . . 0.0 111.651 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -149.68 151.9 34.46 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.417 0.553 . . . . 0.0 112.192 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 25.3 mt -147.2 136.76 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 124.195 0.998 . . . . 0.0 109.883 177.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 1.2 m -140.47 160.7 24.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.08 0 C-N-CA 123.485 0.714 . . . . 0.0 111.803 174.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 55.3 mt -135.78 144.08 34.59 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 C-N-CA 123.434 0.693 . . . . 0.0 109.832 -176.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.291 3.3 p90 -144.54 157.18 44.34 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 177.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -127.7 15.22 7.0 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.18 0.592 . . . . 0.0 110.883 -172.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.413 ' HZ3' " H3'" ' B' ' 2' ' ' ' C' . 63.5 pttt -64.09 -30.94 71.97 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -169.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -130.54 4.91 4.69 Favored 'General case' 0 CA--C 1.527 0.074 0 CA-C-N 118.596 0.634 . . . . 0.0 112.262 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 163.76 -124.47 1.28 Allowed Glycine 0 C--N 1.334 0.459 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 -173.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 61.8 t -142.99 114.63 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 175.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 -142.83 168.17 20.36 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.021 0.439 . . . . 0.0 111.009 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.15 165.74 29.96 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.675 0.79 . . . . 0.0 109.456 177.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 61.4 mmm -134.36 153.47 51.87 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 42.6 t -141.59 144.19 26.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 C-N-CA 122.676 0.39 . . . . 0.0 110.116 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -131.67 132.82 44.27 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 122.395 0.278 . . . . 0.0 110.571 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -104.42 162.54 13.14 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -81.89 -8.21 59.66 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 44.8 t -154.5 150.74 28.13 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.811 -0.556 . . . . 0.0 111.973 -176.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 52.0 t -67.66 -36.1 74.99 Favored 'Isoleucine or valine' 0 C--N 1.338 0.096 0 C-N-CA 123.279 0.632 . . . . 0.0 109.356 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -67.22 -28.65 68.25 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 118.295 0.498 . . . . 0.0 110.866 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 63.2 m -75.43 -30.45 60.02 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.83 -31.94 59.58 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.342 0.257 . . . . 0.0 111.3 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -70.69 -43.84 68.21 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -74.59 -26.45 59.93 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 117.792 0.269 . . . . 0.0 111.05 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -71.98 -41.51 67.6 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 118.087 0.403 . . . . 0.0 110.042 177.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -75.6 -20.57 58.47 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 122.603 0.361 . . . . 0.0 111.399 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -95.93 -13.12 24.13 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 47.1 t -113.28 -33.6 5.91 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 59.7 mt -90.56 -7.78 51.96 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 118.003 0.365 . . . . 0.0 111.816 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -71.87 133.69 45.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 177.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.36 -5.87 40.94 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.924 -0.47 . . . . 0.0 111.924 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.87 166.44 22.41 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.793 0.796 . . . . 0.0 110.473 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -123.7 139.65 53.78 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 84.4 mt -74.22 -41.69 51.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.351 42.8 m-85 -82.97 -11.82 57.81 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 178.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 23.2 t 65.71 35.48 6.87 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.631 0.772 . . . . 0.0 111.087 -174.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 176.17 -23.76 0.06 OUTLIER Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.127 0.87 . . . . 0.0 111.266 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 98.5 m -146.37 -177.23 5.51 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.628 1.171 . . . . 0.0 109.47 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 89.1 m 58.19 36.23 25.62 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -176.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.1 148.98 10.04 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 175.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 75.9 mt -116.28 154.75 29.61 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -173.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -138.45 138.32 38.03 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.065 1.346 . . . . 0.0 107.596 169.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 33.1 mt -137.74 143.28 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-O 120.685 0.278 . . . . 0.0 111.514 -171.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -158.23 163.25 37.64 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.312 0.645 . . . . 0.0 109.374 175.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.268 37.8 m-85 -62.63 134.31 56.16 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 177.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . 0.436 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -84.38 161.03 20.52 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.351 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.451 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 64.0 pttt -93.56 -31.58 0.3 Allowed Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 178.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 86.1 Cg_endo -75.88 171.12 18.77 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.913 1.742 . . . . 0.0 110.295 175.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.96 -1.61 2.67 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 117.26 2.319 . . . . 0.0 117.26 -175.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.35 133.55 11.6 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-N 118.766 0.712 . . . . 0.0 111.727 -178.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.431 ' HG ' ' C6 ' ' B' ' 3' ' ' ' A' . 19.2 mt -92.31 157.76 16.47 Favored 'General case' 0 C--O 1.228 -0.04 0 C-N-CA 124.137 0.975 . . . . 0.0 111.516 177.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -120.97 47.76 1.76 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.734 0.813 . . . . 0.0 109.86 174.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.5 t -53.09 143.91 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.092 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -177.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . 0.26 10.2 p90 -128.22 -4.57 5.53 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 116.868 2.173 . . . . 0.0 116.868 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.14 172.35 18.26 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 123.245 0.618 . . . . 0.0 111.689 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -125.68 121.82 34.57 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.752 0.821 . . . . 0.0 109.65 175.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 49.3 p30 -159.27 -166.71 1.88 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.643 0.777 . . . . 0.0 109.653 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -68.21 -14.56 63.07 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -177.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -99.53 -34.91 10.05 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.15 150.46 42.82 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 178.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 22.2 t-105 -157.86 155.59 29.93 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -176.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -131.24 119.17 21.44 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.972 0.509 . . . . 0.0 111.629 175.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.28 67.1 m-85 -83.02 9.35 10.4 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -171.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 9.3 t -141.05 -23.06 0.77 Allowed 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -178.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -95.29 113.27 61.22 Favored Pre-proline 0 CA--C 1.532 0.273 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 174.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -79.65 -15.81 12.03 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.331 2.688 . . . . 0.0 112.357 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 66.1 m-80 -73.55 -15.37 61.3 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -173.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 70.7 mt -85.76 -2.42 58.2 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 117.928 0.331 . . . . 0.0 111.882 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 47.7 t -75.68 143.44 42.16 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.291 0.236 . . . . 0.0 110.682 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 70.53 -0.46 26.36 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 119.454 -0.637 . . . . 0.0 113.43 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 55.6 mm-40 -71.99 157.86 37.05 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 118.315 1.058 . . . . 0.0 110.962 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.31 0 CA-C-O 117.471 -1.739 . . . . 0.0 111.442 179.437 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.879 0 C5'-C4'-C3' 110.1 -3.6 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.49 HO2' ' P ' ' B' ' 3' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.723 0 C3'-C2'-C1' 98.25 -3.611 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.49 ' P ' HO2' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.417 -2.962 2 O4'-C1'-N19 112.527 4.327 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.915 1 C5'-C4'-C3' 109.321 -4.12 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.413 -3.301 0 C3'-C2'-C1' 105.02 3.911 OUTLIER-DELTA 0.113 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.786 0 O4'-C1'-N19 111.291 3.091 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 110.639 -0.134 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -67.85 139.39 56.54 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 122.641 0.376 . . . . 0.0 110.153 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 81.9 mt -74.15 142.47 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 122.7 0.4 . . . . 0.0 110.619 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 28.8 t -158.1 136.71 11.18 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.289 0.635 . . . . 0.0 110.32 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 32.0 ptt-85 -162.58 156.73 18.16 Favored Pre-proline 0 C--O 1.232 0.153 0 C-N-CA 122.844 0.458 . . . . 0.0 110.309 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -58.91 152.18 59.8 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 123.198 2.599 . . . . 0.0 111.569 175.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 76.25 5.67 81.88 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 119.775 -0.458 . . . . 0.0 112.194 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -142.67 -45.81 0.32 Allowed 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 75.5 m -66.95 152.18 46.22 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 176.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -61.23 -21.33 63.77 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 -172.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -79.92 8.48 6.85 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 99.7 p -146.39 3.24 0.88 Allowed 'General case' 0 C--O 1.233 0.186 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.45 9.19 0.54 Allowed 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 53.3 m -145.25 9.82 1.26 Allowed 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.5 m -70.53 123.45 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 38.8 p-10 -130.88 10.41 5.04 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.732 0.813 . . . . 0.0 112.44 177.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.5 m 66.34 22.0 10.88 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.261 1.024 . . . . 0.0 113.308 -173.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 38.4 t -131.8 142.47 42.95 Favored 'Isoleucine or valine' 0 C--N 1.337 0.059 0 C-N-CA 123.362 0.665 . . . . 0.0 110.505 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 83.5 mt -134.6 148.3 50.4 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 122.615 0.366 . . . . 0.0 111.236 -175.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 28.5 tp -99.54 134.36 42.54 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 172.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -112.7 106.76 15.21 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.2 m -90.06 139.99 30.08 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 174.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 3.9 mp -110.34 122.48 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -91.79 -18.47 23.81 Favored 'General case' 0 C--O 1.23 0.06 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -171.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -141.66 78.93 17.47 Favored Pre-proline 0 CA--C 1.529 0.158 0 C-N-CA 122.95 0.5 . . . . 0.0 109.679 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -77.29 50.07 3.04 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 124.926 3.751 . . . . 0.0 112.179 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.72 -6.5 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 O-C-N 121.761 -0.587 . . . . 0.0 110.011 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -142.67 155.43 44.91 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.148 1.379 . . . . 0.0 112.337 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 28.5 t -74.97 131.86 40.97 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 25.4 mm -78.66 152.06 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 122.983 0.513 . . . . 0.0 110.338 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.96 157.58 45.68 Favored 'General case' 0 C--N 1.338 0.076 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 39.4 p -68.73 -18.27 64.2 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -77.59 -47.23 19.91 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 118.192 0.451 . . . . 0.0 111.748 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 3.5 m -71.12 -32.2 47.08 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 99.2 mt -70.47 -35.63 73.41 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -71.06 -30.18 66.27 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 175.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.6 m -67.35 -33.38 75.11 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 36.7 pt -93.63 -22.29 5.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 118.486 0.585 . . . . 0.0 111.787 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 89.1 m -90.17 -26.02 20.36 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.454 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 32.4 t30 -63.46 -42.57 74.62 Favored Pre-proline 0 CA--C 1.535 0.38 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 -178.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 70.9 Cg_endo -69.1 -13.19 35.86 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 121.784 1.656 . . . . 0.0 111.644 178.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 91.5 m -88.68 -8.38 54.67 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.041 0.382 . . . . 0.0 111.788 176.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 145.02 169.72 13.63 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 177.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.34 107.61 0.5 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.715 2.943 . . . . 0.0 111.949 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 72.3 t -76.56 146.6 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -117.01 -40.54 3.11 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 119.259 -0.4 . . . . 0.0 111.556 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 65.8 mtm-85 -148.88 152.55 36.64 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 25.4 mt -148.28 136.85 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 C-N-CA 124.305 1.042 . . . . 0.0 110.054 176.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 3.8 m -142.4 159.76 19.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 123.9 0.88 . . . . 0.0 110.519 174.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 48.0 mt -132.13 142.93 41.55 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 122.575 0.35 . . . . 0.0 110.676 -175.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.298 4.8 p90 -142.76 158.39 43.69 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 116.002 1.853 . . . . 0.0 116.002 176.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -130.45 17.68 5.37 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.469 0.708 . . . . 0.0 110.991 -174.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -64.29 -31.21 72.32 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -169.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -130.42 7.47 4.93 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.584 0.629 . . . . 0.0 112.161 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 161.0 -123.62 1.23 Allowed Glycine 0 C--N 1.334 0.451 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 -175.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 41.2 t -140.68 113.97 5.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -144.13 167.24 22.86 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.3 0.571 . . . . 0.0 111.094 -176.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -149.1 165.88 30.42 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.137 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 72.6 mmm -131.68 152.79 50.61 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 39.8 t -140.89 145.1 25.81 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 123.003 0.521 . . . . 0.0 110.385 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -131.23 134.98 46.97 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.007 0.523 . . . . 0.0 110.11 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -109.1 161.96 14.7 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 116.5 2.037 . . . . 0.0 116.5 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -80.23 -10.22 59.75 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 41.0 t -155.59 151.75 27.93 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.694 -0.628 . . . . 0.0 112.131 -176.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 43.5 t -66.39 -38.93 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -68.05 -24.17 65.05 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.784 0.265 . . . . 0.0 111.141 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 65.2 m -75.48 -33.53 60.81 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 175.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -77.51 -31.61 53.62 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 122.37 -0.206 . . . . 0.0 110.96 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -66.2 -43.77 85.82 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 121.931 -0.481 . . . . 0.0 111.358 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -77.12 -25.24 51.9 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.817 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -71.82 -41.39 68.26 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.911 0.323 . . . . 0.0 110.271 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.49 -28.34 62.83 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 122.634 0.374 . . . . 0.0 110.717 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -90.25 -12.94 36.48 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 41.0 t -113.7 -35.71 5.1 Favored 'General case' 0 C--N 1.339 0.122 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -176.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 68.5 mt -88.19 -7.45 56.84 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.024 0.375 . . . . 0.0 111.628 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -71.32 134.66 46.9 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 75.79 -5.47 39.0 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 119.795 -0.447 . . . . 0.0 112.48 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.46 166.35 22.71 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 117.797 0.799 . . . . 0.0 110.408 177.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -123.42 140.83 52.61 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 84.8 mt -75.99 -42.25 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.379 45.2 m-85 -82.89 -10.58 58.76 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 27.3 t 65.71 36.5 6.28 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.6 0.76 . . . . 0.0 110.864 -175.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 174.36 -24.25 0.07 OUTLIER Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 178.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 75.9 m -145.62 -177.21 5.46 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.922 1.289 . . . . 0.0 109.367 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 98.6 m 58.26 37.83 26.09 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.83 148.15 13.69 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 175.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 82.2 mt -114.31 156.19 24.85 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -172.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -139.45 138.28 36.32 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.598 1.559 . . . . 0.0 107.2 169.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 31.8 mt -139.23 142.83 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 CA-C-O 120.686 0.279 . . . . 0.0 111.316 -171.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -157.69 160.49 38.01 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 122.927 0.491 . . . . 0.0 109.771 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.283 40.6 m-85 -59.88 135.42 57.69 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 176.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . 0.411 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -89.24 159.11 17.59 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.173 -178.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.412 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 23.4 pttp -94.24 -31.8 0.29 Allowed Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 49.1 Cg_endo -79.83 159.12 24.58 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 CA-C-N 121.881 1.708 . . . . 0.0 109.505 174.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.31 0.2 OUTLIER -134.8 15.33 3.62 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 -174.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -158.45 123.0 4.16 Favored 'General case' 0 C--N 1.338 0.074 0 O-C-N 121.931 -0.481 . . . . 0.0 111.559 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.443 ' HG ' ' C5 ' ' B' ' 3' ' ' ' A' . 18.9 mt -86.05 161.06 19.12 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 123.583 0.753 . . . . 0.0 110.408 174.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.419 ' C ' ' H61' ' B' ' 5' ' ' ' A' . 51.5 m-80 -121.2 51.24 1.29 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.846 171.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.3 t -51.8 144.87 2.56 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -129.62 -5.78 4.66 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 117.653 2.464 . . . . 0.0 117.653 -176.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . 0.522 ' HB3' ' HZ1' ' A' ' 274' ' ' LYS . 0.3 OUTLIER -160.66 170.91 19.85 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 122.558 0.343 . . . . 0.0 110.609 -179.026 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -125.81 119.6 28.32 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.743 0.817 . . . . 0.0 110.038 174.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -162.69 -167.98 1.69 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.362 1.065 . . . . 0.0 109.087 176.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -70.23 -8.18 48.05 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -176.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -109.26 -26.28 10.15 Favored 'General case' 0 C--N 1.338 0.092 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.08 140.8 31.06 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.275 1.03 . . . . 0.0 112.499 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 21.6 t-105 -157.95 156.26 30.93 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.418 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -137.19 114.08 10.53 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.397 173.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.259 66.0 m-85 -78.29 6.72 7.66 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 -173.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 5.4 t -137.3 -19.9 1.24 Allowed 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -95.37 113.2 61.14 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 174.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -80.49 -14.02 11.86 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.515 2.81 . . . . 0.0 112.368 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -75.25 -14.25 60.5 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -173.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 59.2 mt -88.97 -7.42 56.04 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 71.6 m -72.69 147.6 45.54 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 117.761 0.255 . . . . 0.0 110.698 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 74.26 -5.54 26.88 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 119.724 -0.486 . . . . 0.0 112.11 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 57.42 177.79 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.243 1.417 . . . . 0.0 112.76 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.189 0 CA-C-O 117.396 -1.78 . . . . 0.0 110.849 -179.952 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.816 0 C3'-C2'-C1' 104.187 2.986 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.433 HO2' ' P ' ' B' ' 3' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.648 0 O4'-C1'-N19 111.426 3.226 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.443 ' C5 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.423 -2.52 1 C5'-C4'-C3' 109.485 -4.01 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.783 0 C5'-C4'-C3' 109.644 -3.904 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.435 ' N3 ' " H2'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.759 1 C3'-C2'-C1' 105.483 4.425 OUTLIER-DELTA 0.024 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.669 0 O4'-C1'-N19 111.665 3.465 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -65.55 -29.95 70.64 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -173.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 20.0 tt -154.77 164.46 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 CA-C-N 118.35 0.523 . . . . 0.0 110.182 -175.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 67.3 m 53.53 42.25 31.96 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 122.951 0.5 . . . . 0.0 111.264 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.434 ' N ' ' HD2' ' A' ' 179' ' ' PRO . 75.7 mtt180 -56.9 -38.84 72.99 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -176.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 178' ' ' ARG . 69.6 Cg_endo -69.15 -13.24 35.85 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 CA-C-N 121.332 1.511 . . . . 0.0 111.373 177.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -91.98 8.71 77.77 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 174.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -130.97 -53.63 1.05 Allowed 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -176.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 93.7 p -70.77 157.02 38.78 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 7.8 p30 -84.15 -5.61 59.27 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -71.71 -0.48 11.04 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 116.288 1.958 . . . . 0.0 116.288 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 89.4 p -149.75 11.04 0.74 Allowed 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -177.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -146.9 5.52 0.87 Allowed 'General case' 0 C--N 1.34 0.154 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 58.6 m -147.73 12.72 1.02 Allowed 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.3 m -70.82 103.58 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -177.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 46.0 p30 -130.67 10.33 5.13 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.837 0.855 . . . . 0.0 112.085 177.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 56.0 m 66.06 21.28 11.24 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -176.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 28.6 t -128.8 142.34 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.095 0 C-N-CA 122.833 0.453 . . . . 0.0 110.889 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 91.2 mt -133.95 149.14 51.25 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 122.832 0.453 . . . . 0.0 111.278 -175.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 32.2 tp -102.0 135.01 44.3 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 172.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -114.57 107.04 14.97 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.93 138.27 31.68 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 174.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.1 mp -108.73 118.18 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -90.92 -18.83 24.07 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 119.255 -0.403 . . . . 0.0 112.018 -171.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -142.12 79.01 16.51 Favored Pre-proline 0 CA--C 1.529 0.156 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -77.61 44.56 1.56 Allowed 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 125.19 3.927 . . . . 0.0 112.48 -176.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.06 -4.55 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 O-C-N 121.59 -0.693 . . . . 0.0 110.641 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -137.95 156.18 48.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 42.3 t -70.39 117.02 11.41 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 120.717 0.294 . . . . 0.0 110.212 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.1 mm -78.55 143.73 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 122.876 0.471 . . . . 0.0 109.807 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.99 159.16 41.6 Favored 'General case' 0 CA--C 1.526 0.031 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.5 p -66.01 -15.69 63.24 Favored 'General case' 0 C--N 1.335 -0.062 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -76.38 -44.93 34.16 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.504 0.192 . . . . 0.0 110.848 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 1.9 m -72.88 -32.01 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.9 mt -70.64 -34.75 72.41 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 175.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -72.02 -30.29 65.05 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 174.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.6 m -66.82 -34.44 77.81 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 45.4 pt -91.27 -23.24 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 118.201 0.455 . . . . 0.0 111.902 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 89.0 m -89.87 -25.34 21.06 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.444 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 30.1 t30 -63.69 -42.59 72.97 Favored Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 73.8 Cg_endo -69.34 -12.56 33.98 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.338 1.359 . . . . 0.0 111.474 177.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 89.4 m -91.92 -7.45 49.1 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 122.502 0.321 . . . . 0.0 111.673 176.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 149.47 168.81 15.26 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.54 101.08 0.84 Allowed 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.9 3.067 . . . . 0.0 110.51 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 87.4 t -69.11 145.69 13.16 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 123.37 0.668 . . . . 0.0 109.257 177.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -115.04 -40.6 3.46 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 119.064 -0.493 . . . . 0.0 111.6 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 63.0 mtm-85 -148.05 152.43 37.38 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 21.4 mt -149.16 137.73 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 124.093 0.957 . . . . 0.0 110.273 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.3 m -143.48 163.15 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 C-N-CA 123.846 0.858 . . . . 0.0 110.338 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 54.1 mt -133.68 142.63 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 C-N-CA 122.757 0.423 . . . . 0.0 110.528 -175.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.264 6.3 p90 -146.92 159.34 43.67 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 115.819 1.785 . . . . 0.0 115.819 176.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.64 31.91 2.05 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.163 0.585 . . . . 0.0 111.777 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -67.9 -29.45 68.55 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -174.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -130.57 3.61 4.6 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 123.307 0.643 . . . . 0.0 112.514 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 167.19 -127.04 1.51 Allowed Glycine 0 CA--C 1.522 0.472 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 -173.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.1 t -138.79 117.8 13.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 117.103 0.452 . . . . 0.0 110.239 174.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 11.1 mp0 -144.1 168.56 19.72 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.476 0.655 . . . . 0.0 111.119 -175.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -150.66 167.16 28.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.828 1.251 . . . . 0.0 108.643 175.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 73.1 mmm -135.06 154.04 51.84 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 38.2 t -140.9 144.29 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 122.946 0.499 . . . . 0.0 110.517 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -129.88 135.07 47.94 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.87 0.468 . . . . 0.0 110.099 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -108.55 163.83 12.88 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 116.264 1.95 . . . . 0.0 116.264 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -81.2 -12.74 59.09 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 92.2 p -155.73 155.58 33.37 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.11 0.481 . . . . 0.0 111.455 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 49.7 t -67.84 -34.77 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -64.21 -33.72 76.45 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 122.254 -0.279 . . . . 0.0 110.8 -177.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 57.7 m -72.86 -33.74 66.3 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 117.464 0.12 . . . . 0.0 110.723 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -74.17 -30.12 62.09 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 119.707 -0.187 . . . . 0.0 111.373 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -68.85 -45.11 71.93 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 118.343 0.519 . . . . 0.0 111.724 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -76.44 -25.61 54.58 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 118.046 0.384 . . . . 0.0 111.553 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -72.32 -40.39 67.48 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.034 0.379 . . . . 0.0 110.171 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.82 -22.91 58.45 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.565 0.346 . . . . 0.0 111.316 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -95.08 -12.12 27.08 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 45.4 t -111.4 -34.95 5.97 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 118.622 0.646 . . . . 0.0 112.567 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 66.9 mt -89.79 -7.95 53.22 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -70.61 133.29 46.56 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 75.94 -4.12 47.59 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 119.651 -0.527 . . . . 0.0 112.215 -177.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.99 166.28 21.74 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 117.878 0.839 . . . . 0.0 110.281 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -123.56 140.06 53.38 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 115.016 1.488 . . . . 0.0 115.016 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 89.9 mt -74.24 -41.27 51.06 Favored 'Isoleucine or valine' 0 C--N 1.339 0.135 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.364 44.0 m-85 -82.86 -10.57 58.78 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 23.3 t 65.8 33.2 8.3 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.513 0.725 . . . . 0.0 110.577 -173.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 176.84 -22.52 0.05 OUTLIER Glycine 0 CA--C 1.531 1.037 0 C-N-CA 123.677 0.656 . . . . 0.0 111.491 177.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 96.4 m -145.99 -177.9 5.84 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.567 1.147 . . . . 0.0 109.814 178.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 90.9 m 58.68 37.67 25.14 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -176.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.24 148.33 11.62 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 176.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 79.2 mt -115.71 155.75 27.18 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -172.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -138.85 138.16 37.23 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.37 1.468 . . . . 0.0 107.454 169.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 36.1 mt -138.67 142.91 33.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-O 120.842 0.353 . . . . 0.0 111.728 -171.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -158.38 163.0 37.67 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 175.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.267 42.5 m-85 -62.28 135.51 57.5 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 176.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . 0.437 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -85.11 160.44 19.96 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.303 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.441 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 63.8 pttt -92.66 -31.81 0.32 Allowed Pre-proline 0 CA--C 1.537 0.452 0 CA-C-O 117.493 -1.241 . . . . 0.0 114.21 178.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 91.1 Cg_endo -76.45 173.48 14.41 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 CA-C-N 122.096 1.784 . . . . 0.0 110.088 173.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.8 -5.05 2.83 Favored 'General case' 0 N--CA 1.461 0.089 0 N-CA-C 117.699 2.481 . . . . 0.0 117.699 -175.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -157.75 131.21 7.78 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.988 0.813 . . . . 0.0 111.761 -178.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.437 ' HG ' ' C6 ' ' B' ' 3' ' ' ' A' . 30.4 mt -83.75 162.57 20.62 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.434 1.094 . . . . 0.0 111.065 175.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.541 ' ND2' ' C2 ' ' B' ' 4' ' ' ' C' . 19.9 p30 -115.53 49.38 1.09 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 169.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . 0.41 ' HA ' ' N1 ' ' B' ' 5' ' ' ' A' . 2.4 t -49.73 142.42 2.43 Favored 'Isoleucine or valine' 0 C--N 1.341 0.233 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -177.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -127.42 -9.03 5.75 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 117.819 2.526 . . . . 0.0 117.819 -175.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -161.18 173.85 14.5 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.808 0.443 . . . . 0.0 110.356 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -125.72 119.96 29.38 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.327 0.651 . . . . 0.0 110.182 175.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 47.6 p30 -159.33 -167.92 2.18 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.263 1.025 . . . . 0.0 109.271 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -69.95 -10.56 59.01 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -175.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -113.26 -18.55 12.06 Favored 'General case' 0 N--CA 1.461 0.093 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.14 141.08 29.77 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 124.29 1.036 . . . . 0.0 112.51 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 20.4 t-105 -160.35 158.76 30.21 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 118.886 0.767 . . . . 0.0 110.871 -178.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -139.59 115.81 10.45 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.398 172.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.252 65.1 m-85 -79.17 5.42 12.14 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 -173.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 4.2 t -137.41 -18.2 1.29 Allowed 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -95.23 113.18 60.96 Favored Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 174.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.01 -15.68 12.93 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.347 2.698 . . . . 0.0 112.296 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -73.92 -15.05 61.14 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -175.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 44.4 mt -91.27 -5.01 55.37 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 64.8 m -78.29 151.71 32.85 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 120.599 0.238 . . . . 0.0 110.946 176.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 73.63 -2.52 39.18 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.784 -0.454 . . . . 0.0 112.588 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 52.2 mm-40 -75.43 164.87 25.94 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 117.776 0.788 . . . . 0.0 109.975 177.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.13 0 CA-C-O 117.202 -1.888 . . . . 0.0 111.165 -179.974 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.928 0 C3'-C2'-C1' 104.264 3.071 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.463 HO2' ' P ' ' B' ' 3' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.559 0 O4'-C1'-N19 112.123 3.923 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.463 ' P ' HO2' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.422 -2.542 1 C5'-C4'-C3' 109.178 -4.215 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' ' C' . . . . . 0.541 ' C2 ' ' ND2' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.419 -2.858 1 C5'-C4'-C3' 109.472 -4.018 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.471 ' H61' ' C ' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.418 -2.911 0 C3'-C2'-C1' 105.06 3.956 OUTLIER-DELTA 0.015 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.583 0 O4'-C1'-N19 112.132 3.932 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 110.549 -0.167 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -69.17 154.46 42.02 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.058 0.543 . . . . 0.0 111.194 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 47.5 mm -68.51 111.56 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 174.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 46.5 t 59.84 152.3 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.814 1.245 . . . . 0.0 113.224 -175.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.576 ' H ' ' HD2' ' A' ' 179' ' ' PRO . 48.1 mtm105 -146.1 -53.53 0.02 OUTLIER Pre-proline 0 CA--C 1.529 0.171 0 CA-C-O 118.54 -0.743 . . . . 0.0 112.107 -178.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.576 ' HD2' ' H ' ' A' ' 178' ' ' ARG . 61.1 Cg_endo -67.6 140.48 51.99 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 121.216 1.277 . . . . 0.0 109.412 174.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 70.19 7.59 60.26 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 111.891 -0.483 . . . . 0.0 111.891 -176.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.84 -18.98 2.34 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 38.1 t -151.45 146.84 26.21 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.352 0.661 . . . . 0.0 109.427 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -65.14 -16.91 64.01 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -70.26 0.96 5.41 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 70.2 m -142.69 7.48 1.68 Allowed 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -177.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.54 4.52 0.68 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 35.8 m -141.95 6.99 1.81 Allowed 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 3.4 m -72.0 123.99 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-O 121.009 0.433 . . . . 0.0 112.062 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 42.2 p30 -130.68 10.38 5.13 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.984 0.914 . . . . 0.0 112.979 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 59.6 m 66.09 20.67 11.22 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -174.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.1 t -129.63 135.57 61.12 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 C-N-CA 123.086 0.555 . . . . 0.0 111.209 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -124.83 150.6 46.22 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 123.015 0.526 . . . . 0.0 110.646 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 40.3 tp -100.03 136.15 40.37 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 170.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -114.25 107.37 15.51 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 178.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.54 136.42 33.0 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 173.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.0 mp -106.8 118.34 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.029 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -90.67 -18.16 25.55 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -171.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -142.1 79.01 16.56 Favored Pre-proline 0 CA--C 1.529 0.139 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -76.91 44.71 1.51 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 125.115 3.877 . . . . 0.0 112.673 -177.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.04 -5.01 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 O-C-N 121.542 -0.724 . . . . 0.0 110.6 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -138.89 156.54 47.2 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 43.6 t -69.8 118.75 13.04 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 31.0 mm -78.42 143.81 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 123.025 0.53 . . . . 0.0 109.58 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.02 158.24 44.04 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.42 ' HG1' ' HB2' ' A' ' 280' ' ' TRP . 1.4 p -65.64 -16.75 64.03 Favored 'General case' 0 CA--C 1.523 -0.096 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 176.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -76.09 -45.59 33.19 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.616 0.246 . . . . 0.0 110.713 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.1 m -72.32 -32.56 43.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.93 -34.56 71.62 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 175.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -72.46 -29.0 63.27 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 174.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.6 m -67.95 -34.0 75.74 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 44.7 pt -91.22 -23.6 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 118.399 0.545 . . . . 0.0 111.798 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 89.0 m -89.38 -26.58 20.96 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -178.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.447 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 33.8 t30 -64.14 -42.0 65.5 Favored Pre-proline 0 CA--C 1.537 0.457 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -178.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 71.9 Cg_endo -68.79 -12.92 35.8 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 121.335 1.357 . . . . 0.0 111.407 177.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 95.8 m -91.82 -6.25 52.01 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.531 0.332 . . . . 0.0 111.673 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 147.13 166.66 12.55 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.72 104.12 1.1 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 123.849 3.032 . . . . 0.0 110.663 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 74.3 t -71.49 147.11 11.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -115.82 -36.33 4.21 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 119.199 -0.429 . . . . 0.0 111.716 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 21.3 mtm180 -150.78 151.54 32.5 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.526 0.603 . . . . 0.0 112.275 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 20.6 mt -147.4 136.54 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 C-N-CA 124.323 1.049 . . . . 0.0 110.219 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 1.3 m -140.24 159.85 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.065 0 C-N-CA 123.548 0.739 . . . . 0.0 111.765 174.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 57.0 mt -132.08 142.62 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 C-N-CA 122.929 0.492 . . . . 0.0 110.021 -177.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.261 4.0 p90 -147.84 159.86 43.39 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 115.629 1.714 . . . . 0.0 115.629 176.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.1 31.35 2.18 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.017 0.527 . . . . 0.0 111.68 -177.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.42 ' HZ3' " H3'" ' B' ' 2' ' ' ' C' . 62.7 pttt -67.63 -30.35 69.89 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -174.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -130.54 4.29 4.65 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 123.105 0.562 . . . . 0.0 112.498 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 166.36 -127.83 1.66 Allowed Glycine 0 C--N 1.333 0.368 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 -174.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 19.3 t -139.69 116.72 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-N 117.415 0.608 . . . . 0.0 110.336 174.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 9.6 mp0 -144.78 169.05 18.78 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.677 0.751 . . . . 0.0 111.123 -175.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -150.86 167.47 27.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.224 1.01 . . . . 0.0 108.621 175.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 53.5 mmm -135.01 154.83 51.59 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.618 0.367 . . . . 0.0 110.03 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 35.8 t -142.34 143.26 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 C-N-CA 123.219 0.608 . . . . 0.0 110.496 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -130.07 134.36 47.32 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 123.216 0.323 . . . . 0.0 110.263 177.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -105.01 163.62 12.41 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 -176.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -77.93 -16.48 58.15 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 86.4 p -153.48 157.15 39.42 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.222 0.534 . . . . 0.0 111.503 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 54.8 t -67.23 -33.98 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -64.9 -34.81 79.28 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 122.063 -0.398 . . . . 0.0 110.613 -177.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 65.6 m -72.58 -31.51 65.28 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 110.624 -0.139 . . . . 0.0 110.624 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -72.52 -31.68 65.53 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 111.328 0.122 . . . . 0.0 111.328 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -72.21 -45.82 58.74 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 117.979 0.354 . . . . 0.0 111.843 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 17.1 ptt180 -75.04 -26.02 59.13 Favored 'General case' 0 C--N 1.338 0.089 0 C-N-CA 120.659 -0.417 . . . . 0.0 111.317 -177.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -70.63 -40.73 72.94 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 117.934 0.334 . . . . 0.0 110.196 177.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -75.79 -25.87 56.8 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.494 0.317 . . . . 0.0 111.059 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -89.25 -10.46 46.87 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 47.0 t -115.92 -35.74 4.36 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 66.8 mt -89.31 -6.7 56.5 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -177.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -70.94 133.97 46.83 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.19 -4.6 47.09 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 119.767 -0.463 . . . . 0.0 112.346 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.61 166.43 22.54 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 117.872 0.836 . . . . 0.0 110.249 177.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -123.45 139.16 54.31 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 86.8 mt -73.77 -41.74 54.29 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.358 44.0 m-85 -82.83 -11.39 58.28 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.8 t 65.38 35.92 7.18 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 122.101 0.953 . . . . 0.0 110.685 -174.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 176.38 -24.55 0.06 OUTLIER Glycine 0 CA--C 1.528 0.877 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.202 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 87.2 m -147.21 -177.16 5.53 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.943 1.297 . . . . 0.0 109.659 178.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 94.9 m 58.54 37.7 25.47 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -175.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.93 147.43 12.26 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 175.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 80.1 mt -115.26 154.41 29.14 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -173.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -137.53 138.31 39.51 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.16 1.384 . . . . 0.0 107.448 169.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 36.6 mt -138.31 143.29 33.15 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.085 0 CA-C-O 120.781 0.324 . . . . 0.0 111.381 -171.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -158.71 161.66 37.09 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.789 175.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.272 33.5 m-85 -59.18 134.43 56.99 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 176.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . 0.443 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -87.74 163.33 16.55 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.854 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.455 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 23.3 pttp -97.95 -29.83 0.25 Allowed Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 84.2 Cg_endo -76.23 170.88 19.15 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 CA-C-N 122.04 1.764 . . . . 0.0 110.277 175.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.41 -2.62 2.75 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 117.584 2.438 . . . . 0.0 117.584 -177.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.26 131.61 10.34 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 118.691 0.678 . . . . 0.0 111.879 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.416 ' HG ' ' C5 ' ' B' ' 3' ' ' ' A' . 17.0 mt -89.84 158.16 17.59 Favored 'General case' 0 C--N 1.337 0.065 0 C-N-CA 123.652 0.781 . . . . 0.0 111.325 178.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -121.84 46.04 2.18 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.549 0.739 . . . . 0.0 109.834 175.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.5 t -52.08 144.7 2.89 Favored 'Isoleucine or valine' 0 C--N 1.338 0.093 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . 0.317 8.2 p90 -123.54 -5.73 8.16 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 117.099 2.259 . . . . 0.0 117.099 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.84 172.33 16.28 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 123.382 0.673 . . . . 0.0 111.264 178.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -124.15 118.89 27.9 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.71 0.804 . . . . 0.0 110.067 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -159.09 -168.74 2.44 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.907 0.883 . . . . 0.0 109.379 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -69.63 -10.77 59.58 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -176.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -98.96 -38.35 9.03 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.4 p -143.04 146.05 33.48 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.66 0.784 . . . . 0.0 113.003 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' TRP . . . . . 0.42 ' HB2' ' HG1' ' A' ' 205' ' ' THR . 20.3 t-105 -154.73 152.85 30.39 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.165 0.507 . . . . 0.0 109.998 -174.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -127.6 117.42 21.99 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.559 174.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.286 65.0 m-85 -81.64 8.41 9.89 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 117.511 2.412 . . . . 0.0 117.511 -171.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 6.4 t -140.54 -21.66 0.82 Allowed 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -95.34 113.37 61.49 Favored Pre-proline 0 CA--C 1.531 0.246 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 174.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -79.97 -15.38 11.84 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 123.418 2.746 . . . . 0.0 112.344 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -74.0 -16.29 61.07 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -175.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 82.3 mt -86.31 -7.4 58.52 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 74.5 m -75.36 143.73 42.69 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 122.09 -0.382 . . . . 0.0 110.901 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 73.15 -1.09 43.21 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 119.628 -0.54 . . . . 0.0 113.172 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 52.2 mm-40 -74.33 159.88 31.8 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 118.108 0.954 . . . . 0.0 110.89 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.248 0 CA-C-O 117.43 -1.761 . . . . 0.0 110.89 179.137 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.682 0 C3'-C2'-C1' 104.515 3.35 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.5 HO2' ' P ' ' B' ' 3' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.682 0 C3'-C2'-C1' 98.358 -3.491 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.5 ' P ' HO2' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.418 -2.92 1 C5'-C4'-C3' 109.257 -4.162 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.876 1 C5'-C4'-C3' 108.655 -4.564 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.239 1 C3'-C2'-C1' 105.118 4.02 OUTLIER-DELTA 0.177 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.753 0 O4'-C1'-N19 111.638 3.438 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 33.7 tp60 . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 111.437 0.162 . . . . 0.0 111.437 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -68.2 -24.59 64.96 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 122.682 0.393 . . . . 0.0 111.727 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 40.5 mm -131.68 150.19 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 123.552 0.741 . . . . 0.0 109.751 -178.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 90.4 p -155.05 164.22 39.18 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.757 0.823 . . . . 0.0 109.45 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.612 ' H ' ' CD ' ' A' ' 179' ' ' PRO . 88.3 mtt-85 -138.33 -38.24 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 CA-C-O 118.371 -0.823 . . . . 0.0 112.556 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.612 ' CD ' ' H ' ' A' ' 178' ' ' ARG . 52.0 Cg_exo -58.99 166.96 6.15 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.762 2.308 . . . . 0.0 111.842 175.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 73.24 18.4 79.24 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -178.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . 0.285 69.1 m-20 60.77 35.4 19.57 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -178.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 36.0 t -59.62 150.84 26.23 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -57.92 -22.25 47.75 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -176.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -73.16 6.73 2.56 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 90.3 p -147.18 -0.79 0.67 Allowed 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -144.35 9.77 1.43 Allowed 'General case' 0 C--N 1.341 0.234 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 37.1 m -142.38 2.54 1.46 Allowed 'General case' 0 C--O 1.231 0.128 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 3.6 m -73.03 129.29 36.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 122.581 0.352 . . . . 0.0 111.461 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -130.64 10.46 5.16 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.9 m 64.65 20.64 12.2 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -174.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.5 t -133.08 134.57 57.73 Favored 'Isoleucine or valine' 0 C--N 1.341 0.198 0 C-N-CA 122.752 0.421 . . . . 0.0 110.672 177.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -123.14 152.49 41.09 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 122.781 0.433 . . . . 0.0 111.137 -176.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 28.0 tp -100.91 135.8 41.78 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 169.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -113.29 111.06 21.39 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.863 1.265 . . . . 0.0 114.248 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.31 132.69 38.65 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 173.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.3 mp -103.7 120.55 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -89.74 -18.1 27.0 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -171.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -143.08 78.95 14.79 Favored Pre-proline 0 CA--C 1.53 0.181 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -78.37 45.92 1.98 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 125.061 3.84 . . . . 0.0 112.131 -177.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.38 -3.86 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 O-C-N 121.924 -0.485 . . . . 0.0 110.553 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -137.32 157.74 45.96 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 176.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 67.5 m -69.88 113.6 7.27 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 33.7 mm -78.4 141.81 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.079 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.24 161.02 36.09 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.6 p -62.45 -21.04 65.13 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -74.02 -46.21 44.92 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.63 0.372 . . . . 0.0 111.717 -178.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 1.7 m -69.28 -32.74 54.75 Favored 'Isoleucine or valine' 0 C--O 1.23 0.043 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.9 mt -72.09 -35.82 69.32 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -69.2 -31.05 69.39 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 174.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 9.4 m -67.69 -34.05 76.13 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 38.6 pt -93.16 -21.32 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 119.027 -0.511 . . . . 0.0 111.916 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 92.0 m -90.34 -27.32 19.47 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 119.139 0.881 . . . . 0.0 113.278 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.456 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 35.1 t30 -63.36 -39.78 52.99 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -178.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 74.0 Cg_endo -69.35 -15.77 38.83 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 CA-C-N 121.216 1.47 . . . . 0.0 111.635 178.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 95.0 m -84.67 -13.29 51.92 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.041 0.382 . . . . 0.0 111.456 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 149.58 169.42 15.95 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.03 112.84 1.64 Allowed 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 123.578 2.852 . . . . 0.0 111.309 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.8 t -79.38 144.34 11.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 176.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -112.99 -39.57 4.19 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 119.381 -0.342 . . . . 0.0 111.189 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 23.3 mtm180 -150.06 153.16 35.98 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.131 0.423 . . . . 0.0 112.066 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 24.6 mt -144.07 143.6 23.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.261 1.024 . . . . 0.0 109.659 178.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 38.3 t -145.94 155.89 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 46.6 mt -138.65 141.52 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 123.894 0.878 . . . . 0.0 109.375 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.287 3.2 p90 -143.98 157.52 44.29 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 177.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -126.53 15.98 7.62 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.272 0.629 . . . . 0.0 110.733 -173.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -63.35 -33.18 74.96 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -169.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -130.35 7.86 5.0 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.568 0.622 . . . . 0.0 112.265 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 161.96 -125.35 1.41 Allowed Glycine 0 CA--C 1.522 0.469 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -174.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 47.0 t -141.9 114.9 4.16 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 174.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -142.16 168.31 20.04 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.256 0.551 . . . . 0.0 110.989 -176.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.05 164.26 34.37 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.951 176.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 67.4 mmm -132.39 151.27 51.94 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 41.2 t -141.63 144.31 26.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 C-N-CA 122.77 0.428 . . . . 0.0 110.326 -178.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -130.58 134.23 46.84 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 122.838 0.455 . . . . 0.0 110.498 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -106.6 163.43 12.89 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 116.765 2.135 . . . . 0.0 116.765 -175.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -76.64 -17.04 59.38 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.784 0.433 . . . . 0.0 109.879 178.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 83.8 p -154.87 158.34 39.21 Favored 'General case' 0 C--O 1.232 0.157 0 O-C-N 121.819 -0.551 . . . . 0.0 111.648 -178.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 54.4 t -66.29 -33.61 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -68.34 -30.05 68.92 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 121.918 -0.489 . . . . 0.0 110.719 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 68.9 m -73.48 -31.43 63.75 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 175.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.49 -34.51 58.64 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 122.482 0.313 . . . . 0.0 111.546 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -70.54 -42.26 71.42 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 118.104 0.411 . . . . 0.0 111.445 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -76.84 -25.66 53.45 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.489 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -70.44 -41.27 73.09 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -75.08 -19.93 59.74 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.567 0.347 . . . . 0.0 111.012 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -99.51 -4.24 31.69 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 38.6 t -124.28 -31.91 3.25 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.864 0.756 . . . . 0.0 112.803 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 61.6 mt -91.59 -6.66 51.96 Favored 'General case' 0 CA--C 1.527 0.071 0 O-C-N 121.998 -0.439 . . . . 0.0 111.527 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -73.28 134.75 44.32 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 74.44 -5.9 26.28 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 111.984 -0.447 . . . . 0.0 111.984 -178.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.19 166.46 22.17 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 117.663 0.731 . . . . 0.0 110.122 177.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -123.64 139.68 53.76 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 87.7 mt -73.33 -41.58 57.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.182 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.367 39.6 m-85 -82.93 -12.01 57.69 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 117.257 2.317 . . . . 0.0 117.257 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.7 t 65.8 35.26 6.85 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.748 0.785 . . . . 0.0 110.754 -174.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 176.0 -23.68 0.06 OUTLIER Glycine 0 CA--C 1.527 0.812 0 C-N-CA 123.947 0.784 . . . . 0.0 111.198 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 93.0 m -147.2 -177.02 5.45 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.916 1.286 . . . . 0.0 109.466 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 86.7 m 58.07 36.95 26.41 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -176.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.59 148.95 11.44 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 175.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 76.3 mt -115.9 155.23 28.33 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -173.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -138.38 138.38 38.21 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.313 1.445 . . . . 0.0 107.587 168.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 34.3 mt -138.34 142.37 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-O 120.657 0.265 . . . . 0.0 111.611 -170.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -158.67 162.25 37.21 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.38 0.672 . . . . 0.0 109.844 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -61.13 137.45 58.23 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -88.6 162.34 16.41 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.942 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -82.41 -54.25 0.61 Allowed Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 118.493 -0.765 . . . . 0.0 112.742 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -73.46 164.97 33.68 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.269 2.646 . . . . 0.0 111.347 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.274 0.2 OUTLIER -135.41 10.11 3.46 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 117.247 2.314 . . . . 0.0 117.247 -176.056 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.12 129.16 8.79 Favored 'General case' 0 C--N 1.339 0.11 0 O-C-N 121.646 -0.659 . . . . 0.0 111.642 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.432 ' HG ' ' C6 ' ' B' ' 3' ' ' ' A' . 30.9 mt -92.57 156.37 17.17 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 123.882 0.873 . . . . 0.0 110.916 177.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -118.58 49.12 1.33 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.861 0.864 . . . . 0.0 109.585 174.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.1 t -52.31 142.12 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -176.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -130.08 0.7 4.71 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 116.551 2.056 . . . . 0.0 116.551 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -160.58 164.31 32.03 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 122.89 0.476 . . . . 0.0 110.926 -176.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -125.73 118.72 26.19 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.617 0.767 . . . . 0.0 109.198 174.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 40.0 p30 -157.19 -168.04 2.5 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.823 0.849 . . . . 0.0 109.904 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -69.3 -11.95 61.25 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -104.29 -30.66 10.0 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 3.5 p -141.49 145.31 35.05 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 19.2 t-105 -157.67 153.24 26.4 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -176.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . 0.251 7.0 t0 -132.95 121.15 22.38 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 122.94 0.496 . . . . 0.0 112.197 176.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.25 67.2 m-85 -87.25 8.97 21.76 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 117.58 2.437 . . . . 0.0 117.58 -171.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 5.0 t -142.49 -17.45 0.71 Allowed 'General case' 0 C--O 1.231 0.11 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 -177.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -94.82 113.36 61.02 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 176.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -77.59 -16.72 14.77 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.381 2.721 . . . . 0.0 111.986 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -73.33 -13.68 61.15 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -175.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 88.8 mt -90.89 -2.24 57.76 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 117.667 0.212 . . . . 0.0 111.561 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 46.2 t -77.19 146.59 36.95 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 117.768 0.258 . . . . 0.0 110.637 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 71.87 1.55 47.76 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.668 -0.518 . . . . 0.0 113.272 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 53.8 mm-40 -70.38 159.67 33.74 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.064 0.932 . . . . 0.0 111.023 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.186 0 CA-C-O 117.382 -1.788 . . . . 0.0 111.151 -179.701 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.922 0 C5'-C4'-C3' 110.939 -3.041 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.443 HO2' ' P ' ' B' ' 3' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.642 0 C3'-C2'-C1' 98.523 -3.308 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.443 ' P ' HO2' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.42 -2.73 1 C5'-C4'-C3' 109.486 -4.01 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.167 0 C5'-C4'-C3' 110.258 -3.494 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.109 0 C3'-C2'-C1' 104.985 3.872 . 0.043 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.841 1 O4'-C1'-N19 116.147 7.947 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 . . . . . 0 N--CA 1.474 0.767 0 N-CA-C 110.712 -0.107 . . . . 0.0 110.712 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -67.19 144.56 55.92 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.803 0.441 . . . . 0.0 110.043 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 86.3 mt -70.56 142.92 15.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 122.448 0.299 . . . . 0.0 110.684 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 95.0 p -156.08 158.72 38.23 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.321 0.648 . . . . 0.0 109.866 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 22.0 mtm180 -145.2 145.62 27.45 Favored Pre-proline 0 C--O 1.231 0.098 0 C-N-CA 123.122 0.569 . . . . 0.0 110.519 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.17 145.78 55.77 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 123.474 2.783 . . . . 0.0 110.199 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 70.71 10.52 67.53 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 112.024 -0.43 . . . . 0.0 112.024 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -138.49 -53.25 0.6 Allowed 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 71.1 m -71.08 151.02 44.94 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 175.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 13.2 p30 -63.16 -18.06 63.05 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -177.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -71.57 3.58 3.83 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 97.2 p -144.88 2.13 1.03 Allowed 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -176.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -148.77 8.74 0.77 Allowed 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 58.1 m -145.18 9.52 1.26 Allowed 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.2 m -71.6 104.27 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -130.49 10.43 5.22 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.425 0.69 . . . . 0.0 112.213 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 50.0 m 65.84 20.73 11.44 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -176.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 20.2 t -128.09 140.37 49.35 Favored 'Isoleucine or valine' 0 C--N 1.338 0.081 0 C-N-CA 122.813 0.445 . . . . 0.0 111.192 176.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.7 mt -131.88 157.44 43.95 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.241 0.616 . . . . 0.0 110.958 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.0 tt -113.8 136.04 53.3 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.412 0.685 . . . . 0.0 109.288 174.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -114.34 102.59 10.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -85.96 135.72 33.55 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 174.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.2 mp -106.06 122.41 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -90.27 -20.34 23.07 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -172.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -141.23 78.87 18.37 Favored Pre-proline 0 CA--C 1.529 0.163 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -78.6 44.2 1.59 Allowed 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 124.984 3.789 . . . . 0.0 112.147 -177.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.05 -4.72 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 O-C-N 121.91 -0.494 . . . . 0.0 110.803 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -136.3 157.82 45.9 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 70.9 m -68.87 113.28 6.16 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.84 0.352 . . . . 0.0 110.32 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 40.0 mm -78.42 141.23 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 176.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.1 157.18 46.81 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.452 ' HG1' ' HB2' ' A' ' 280' ' ' TRP . 2.0 p -66.38 -15.86 63.62 Favored 'General case' 0 C--N 1.334 -0.088 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 175.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -79.87 -42.19 24.74 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.5 p -75.18 -32.41 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.1 mt -69.83 -33.95 73.0 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -71.23 -29.25 64.9 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 174.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.0 m -68.09 -32.2 72.35 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 45.3 pt -93.56 -22.36 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 118.291 0.496 . . . . 0.0 112.058 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 94.0 m -89.99 -26.07 20.55 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.457 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 35.1 t30 -63.89 -41.44 63.58 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 74.0 Cg_endo -69.09 -15.98 40.01 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.521 1.48 . . . . 0.0 111.27 177.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 97.6 m -86.15 -11.7 51.86 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.457 0.303 . . . . 0.0 111.467 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 151.5 167.69 15.17 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -68.01 103.67 0.92 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.913 3.075 . . . . 0.0 110.248 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.1 t -70.61 146.96 11.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -114.9 -39.0 3.77 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 119.13 -0.462 . . . . 0.0 111.561 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 22.5 mtm180 -149.54 151.45 33.89 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 118.61 0.641 . . . . 0.0 112.263 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 24.2 mt -148.66 137.65 15.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 124.053 0.941 . . . . 0.0 109.929 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 5.4 m -143.55 161.99 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 124.248 1.019 . . . . 0.0 110.559 174.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 46.4 mt -134.74 143.01 38.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 C-N-CA 122.929 0.491 . . . . 0.0 110.472 -175.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.3 4.4 p90 -142.3 158.44 43.71 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 176.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -128.61 15.14 6.51 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.591 0.756 . . . . 0.0 110.909 -173.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.4 ' HZ2' " H3'" ' B' ' 2' ' ' ' C' . 63.8 pttt -62.6 -31.34 72.15 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 -169.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -130.41 4.0 4.69 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.609 0.64 . . . . 0.0 112.119 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 165.86 -124.45 1.24 Allowed Glycine 0 CA--C 1.521 0.429 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 -174.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.2 t -141.63 115.38 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.121 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 174.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -143.15 166.09 25.64 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.242 0.544 . . . . 0.0 111.11 -177.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -143.73 165.1 28.59 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.957 0.903 . . . . 0.0 108.836 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 80.7 mmm -133.13 150.82 52.02 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 31.6 t -140.49 145.65 25.51 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.061 0 C-N-CA 122.689 0.395 . . . . 0.0 110.882 -177.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -132.74 135.07 45.51 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 122.622 0.369 . . . . 0.0 110.628 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -107.42 163.84 12.7 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 115.934 1.828 . . . . 0.0 115.934 -176.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -78.32 -15.86 58.3 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 79.1 p -154.91 159.65 40.61 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.304 0.573 . . . . 0.0 111.665 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 54.3 t -67.51 -35.22 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -66.24 -30.88 71.41 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 122.375 -0.203 . . . . 0.0 110.954 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 74.4 m -72.83 -34.04 66.55 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 176.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.16 -31.34 58.5 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 122.43 -0.169 . . . . 0.0 111.2 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -68.51 -42.58 78.34 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 121.825 -0.547 . . . . 0.0 111.459 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -76.52 -26.57 55.38 Favored 'General case' 0 C--N 1.338 0.1 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.816 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -72.07 -41.55 67.23 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.186 0.448 . . . . 0.0 110.173 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -73.69 -20.11 60.63 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.742 0.417 . . . . 0.0 111.184 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -99.01 -9.3 24.13 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 46.4 t -116.32 -32.93 5.13 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 72.8 mt -91.9 -7.89 47.93 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.059 0.391 . . . . 0.0 111.902 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -73.04 133.04 44.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 77.06 -5.84 46.49 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.707 -0.496 . . . . 0.0 111.957 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.32 166.41 22.13 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 117.782 0.791 . . . . 0.0 110.384 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -123.49 140.65 52.79 Favored 'General case' 0 C--N 1.334 -0.099 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 87.1 mt -74.61 -42.39 48.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.359 39.7 m-85 -82.79 -12.16 57.71 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 32.6 t 65.54 36.12 6.78 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.658 0.742 . . . . 0.0 111.239 -174.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 175.6 -24.26 0.06 OUTLIER Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 96.9 m -145.81 -177.2 5.46 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.185 1.394 . . . . 0.0 109.801 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 88.1 m 57.89 37.93 26.96 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.22 148.96 13.38 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 175.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 81.2 mt -116.09 154.78 29.35 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -173.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 54.1 mttp -138.19 137.06 37.23 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.715 1.606 . . . . 0.0 107.484 169.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 56.0 mt -136.87 143.3 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-O 120.94 0.4 . . . . 0.0 111.384 -172.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -159.23 164.02 35.38 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.739 175.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.266 45.3 m-85 -61.71 135.46 57.62 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 176.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . 0.412 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -88.27 156.36 19.24 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.347 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.41 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 64.6 pttt -89.44 -31.51 0.37 Allowed Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 50.1 Cg_endo -79.28 168.39 20.26 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 121.835 1.69 . . . . 0.0 110.136 175.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.281 0.2 OUTLIER -137.78 8.86 2.82 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 117.883 2.549 . . . . 0.0 117.883 -176.015 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.32 126.84 6.69 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 118.778 0.717 . . . . 0.0 111.799 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.419 ' HG ' ' C5 ' ' B' ' 3' ' ' ' A' . 27.4 mt -92.22 156.95 16.96 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 123.858 0.863 . . . . 0.0 110.747 176.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.41 ' C ' ' H61' ' B' ' 5' ' ' ' A' . 57.8 m-80 -116.67 53.31 0.89 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.504 0.722 . . . . 0.0 109.788 172.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.6 t -54.68 145.26 4.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -175.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -135.67 -0.25 2.63 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 117.022 2.23 . . . . 0.0 117.022 -176.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -160.53 159.08 30.26 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.584 0.354 . . . . 0.0 111.372 -173.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -123.12 112.23 17.48 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.834 0.854 . . . . 0.0 109.404 173.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 53.1 p30 -157.87 -166.28 1.94 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -66.9 -16.33 64.25 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -174.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -115.17 -13.36 11.79 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.29 139.29 37.29 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 123.815 0.846 . . . . 0.0 113.041 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' TRP . . . . . 0.452 ' HB2' ' HG1' ' A' ' 205' ' ' THR . 16.3 t-105 -162.95 155.34 18.62 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.25 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . 0.259 5.8 t0 -140.79 119.57 12.54 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.194 0.598 . . . . 0.0 112.102 172.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.252 66.8 m-85 -82.18 7.62 13.16 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 117.536 2.421 . . . . 0.0 117.536 -171.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 6.0 t -140.6 -14.65 0.95 Allowed 'General case' 0 C--O 1.232 0.143 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -177.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -95.27 113.44 61.58 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 175.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -80.95 -14.33 11.09 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.737 2.958 . . . . 0.0 112.744 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -73.19 -14.69 61.4 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -173.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 48.4 mt -75.5 2.22 12.15 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 97.2 p -71.76 -8.29 53.31 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.623 0.369 . . . . 0.0 111.507 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 178.86 -5.17 0.03 OUTLIER Glycine 0 CA--C 1.527 0.842 0 CA-C-O 119.769 -0.462 . . . . 0.0 112.94 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 33.1 tp60 56.51 23.9 8.06 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.045 0.938 . . . . 0.0 111.71 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 CA-C-O 117.257 -1.857 . . . . 0.0 110.832 -179.5 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.086 0 C5'-C4'-C3' 110.256 -3.496 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.465 HO2' ' P ' ' B' ' 3' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.925 0 C3'-C2'-C1' 98.531 -3.299 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.465 ' P ' HO2' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.422 -2.616 1 C5'-C4'-C3' 109.31 -4.127 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.74 1 C5'-C4'-C3' 109.472 -4.019 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.421 ' N3 ' " H2'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -3.01 0 C3'-C2'-C1' 105.017 3.907 OUTLIER-DELTA 0.054 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.62 1 O4'-C1'-N19 112.219 4.019 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 111.199 0.074 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -151.62 145.54 25.17 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 123.153 0.581 . . . . 0.0 109.977 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 31.8 mm -138.5 149.04 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 C-N-CA 124.023 0.929 . . . . 0.0 109.284 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 48.3 t -155.65 157.48 36.76 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.115 0.566 . . . . 0.0 109.975 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 48.3 mtm180 -144.66 149.35 43.17 Favored Pre-proline 0 CA--C 1.529 0.157 0 C-N-CA 123.578 0.751 . . . . 0.0 110.038 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.94 -12.57 32.82 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.48 2.787 . . . . 0.0 111.781 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -74.19 -10.6 81.63 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 112.202 -0.359 . . . . 0.0 112.202 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -79.29 -19.13 51.26 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 62.4 m -71.4 149.54 45.87 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 121.846 -0.534 . . . . 0.0 109.668 178.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -61.9 -15.97 47.02 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -176.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -70.97 -3.0 17.12 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 68.0 m -140.25 3.84 1.98 Allowed 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 5.9 ppt_? -149.3 7.88 0.7 Allowed 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 58.9 m -147.2 12.4 1.07 Allowed 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 1.7 m -69.44 102.17 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -177.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 51.8 p-10 -130.39 10.51 5.27 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.234 0.614 . . . . 0.0 112.232 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 71.2 m 65.05 20.57 12.09 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 -177.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.3 t -132.97 133.26 58.92 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 CA-C-N 118.162 0.437 . . . . 0.0 110.875 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -121.76 155.01 36.17 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 122.954 0.502 . . . . 0.0 110.995 -176.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 29.1 tp -104.98 131.18 52.82 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 170.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -107.72 101.74 11.02 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 177.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.78 136.21 33.17 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 174.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.4 mp -105.67 130.61 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -92.65 -24.2 18.74 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -175.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -138.82 78.92 29.33 Favored Pre-proline 0 CA--C 1.529 0.147 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -77.01 49.59 2.84 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 124.865 3.71 . . . . 0.0 112.346 -178.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.13 -7.05 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 O-C-N 121.775 -0.578 . . . . 0.0 110.314 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -140.14 153.67 46.75 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.082 1.353 . . . . 0.0 113.081 175.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.4 t -73.55 128.14 34.68 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 120.811 0.338 . . . . 0.0 110.517 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 19.7 mm -78.71 148.69 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 122.724 0.409 . . . . 0.0 109.947 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.0 156.15 48.71 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 177.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.5 p -65.57 -16.37 63.63 Favored 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -74.73 -47.16 32.85 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.7 0.286 . . . . 0.0 111.703 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.5 m -71.41 -32.43 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.6 mt -69.91 -36.15 75.17 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 176.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -71.21 -30.67 66.66 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 12.6 m -66.31 -32.99 74.73 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 37.5 pt -94.05 -24.3 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 118.178 0.444 . . . . 0.0 112.02 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 90.1 m -88.29 -25.44 22.81 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.454 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 35.3 t30 -64.19 -43.16 72.66 Favored Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 67.4 Cg_endo -68.38 -15.3 41.88 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 121.411 1.407 . . . . 0.0 111.512 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 95.4 m -83.86 -15.14 49.29 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.047 0.385 . . . . 0.0 111.379 177.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 151.02 170.47 18.05 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -61.12 104.82 0.3 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.774 2.983 . . . . 0.0 111.732 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 72.5 t -75.72 145.54 10.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -117.79 -39.75 3.09 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 119.287 -0.387 . . . . 0.0 111.477 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 66.1 mtm-85 -148.05 151.22 35.32 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.484 0.584 . . . . 0.0 112.547 179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 20.3 mt -148.27 137.58 15.89 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 C-N-CA 124.105 0.962 . . . . 0.0 109.628 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 8.1 m -143.07 162.84 17.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 C-N-CA 123.735 0.814 . . . . 0.0 110.23 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 47.8 mt -135.96 142.88 37.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.093 0 C-N-CA 123.224 0.609 . . . . 0.0 110.409 -174.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.299 6.2 p90 -141.39 155.38 45.91 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 177.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -128.37 14.3 6.62 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.242 0.617 . . . . 0.0 110.788 -174.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -64.98 -30.68 71.68 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -169.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -130.37 5.8 4.82 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.793 0.724 . . . . 0.0 111.812 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 162.38 -126.29 1.54 Allowed Glycine 0 C--N 1.335 0.515 0 N-CA-C 107.966 -2.054 . . . . 0.0 107.966 -174.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 38.5 t -142.78 116.98 4.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 175.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -144.02 166.84 23.84 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.289 0.566 . . . . 0.0 110.631 -176.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.97 166.37 26.99 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.113 175.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 74.6 mmm -133.96 154.2 51.26 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 29.6 t -142.11 142.8 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 C-N-CA 122.781 0.432 . . . . 0.0 110.905 -178.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -129.36 133.16 47.26 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.155 0.582 . . . . 0.0 110.274 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -108.5 160.97 15.48 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 -176.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -79.55 -11.95 59.87 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 37.7 t -154.81 153.48 31.25 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 121.812 -0.555 . . . . 0.0 111.549 -176.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 56.6 t -68.01 -37.36 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -67.09 -27.53 67.43 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 122.039 -0.413 . . . . 0.0 111.025 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 52.2 m -74.32 -32.39 62.82 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 175.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.52 -31.74 57.84 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 122.567 0.347 . . . . 0.0 111.305 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -69.74 -45.39 68.24 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 117.949 0.34 . . . . 0.0 111.345 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -74.6 -26.57 60.0 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 117.953 0.342 . . . . 0.0 111.24 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -69.32 -42.81 74.86 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.414 ' HE3' ' HB3' ' A' ' 245' ' ' LYS . 0.8 OUTLIER -75.39 -21.24 58.42 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.825 0.45 . . . . 0.0 111.161 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -94.32 -9.0 37.32 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 40.9 t -118.4 -34.21 4.12 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -177.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 70.8 mt -89.1 -8.07 54.55 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 118.161 0.437 . . . . 0.0 111.999 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -71.15 136.3 48.07 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.58 -5.66 21.43 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 119.756 -0.469 . . . . 0.0 112.159 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -77.83 166.5 22.83 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 117.955 0.878 . . . . 0.0 110.003 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -122.59 139.17 54.22 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 86.2 mt -74.48 -41.58 49.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.361 44.8 m-85 -82.86 -9.96 59.07 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 117.045 2.239 . . . . 0.0 117.045 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 30.8 t 65.57 35.25 7.25 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.479 0.712 . . . . 0.0 111.08 -175.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 175.95 -24.6 0.06 OUTLIER Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.053 0.835 . . . . 0.0 111.243 177.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 82.0 m -145.83 -177.87 5.81 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.6 1.16 . . . . 0.0 109.354 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 97.3 m 58.6 38.96 25.16 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -174.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.32 150.37 8.79 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 174.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 97.1 mt -110.96 157.3 20.06 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -173.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.96 130.13 26.76 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.711 2.005 . . . . 0.0 106.331 170.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 30.7 mt -138.3 139.69 41.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-O 120.908 0.385 . . . . 0.0 111.295 -172.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -161.31 163.75 30.62 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.421 175.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.25 48.7 m-85 -59.89 141.91 54.58 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 177.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . 0.412 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -96.21 162.08 13.68 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -176.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -78.14 -50.33 1.79 Allowed Pre-proline 0 CA--C 1.532 0.286 0 CA-C-O 118.318 -0.849 . . . . 0.0 112.282 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.51 169.01 23.26 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.656 2.237 . . . . 0.0 111.191 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.259 0.2 OUTLIER -134.51 3.13 3.29 Favored 'General case' 0 CA--C 1.527 0.071 0 N-CA-C 117.73 2.493 . . . . 0.0 117.73 -176.328 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -157.85 127.47 5.97 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 118.764 0.711 . . . . 0.0 112.063 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.451 ' HG ' ' C5 ' ' B' ' 3' ' ' ' A' . 21.9 mt -82.81 163.24 21.34 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.975 0.91 . . . . 0.0 111.015 175.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.41 ' C ' ' H61' ' B' ' 5' ' ' ' A' . 58.6 m-80 -121.8 51.98 1.29 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.69 0.796 . . . . 0.0 109.103 171.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.3 t -51.96 144.49 2.94 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -176.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -128.36 -7.52 5.27 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 117.476 2.399 . . . . 0.0 117.476 -177.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -161.46 171.37 18.28 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 122.728 0.411 . . . . 0.0 110.517 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -124.69 122.99 39.05 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.774 0.83 . . . . 0.0 109.667 174.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 45.1 p30 -160.58 -166.12 1.57 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.99 0.916 . . . . 0.0 108.728 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -68.17 -14.98 63.39 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -174.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -114.01 -13.18 12.52 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.01 139.87 34.23 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 123.68 0.792 . . . . 0.0 112.736 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 17.2 t-105 -160.34 156.14 25.78 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.328 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -135.86 116.04 13.43 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.542 172.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.267 67.2 m-85 -80.4 8.0 8.52 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 116.898 2.184 . . . . 0.0 116.898 -173.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 5.8 t -137.8 -22.19 1.09 Allowed 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -95.29 113.17 61.0 Favored Pre-proline 0 N--CA 1.453 -0.318 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 174.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -80.93 -15.18 10.69 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.585 2.857 . . . . 0.0 112.681 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -74.29 -17.05 60.91 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -173.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 59.6 mt -83.71 -7.85 59.39 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 73.7 m -70.85 -11.45 60.97 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 122.034 -0.416 . . . . 0.0 111.87 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -82.17 -5.71 89.43 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 176.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 55.07 25.13 6.69 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.102 0.961 . . . . 0.0 112.758 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.173 0 CA-C-O 117.174 -1.903 . . . . 0.0 111.695 -179.786 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . 0.403 ' C8 ' H5'' ' B' ' 1' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.774 0 C5'-C4'-C3' 110.345 -3.436 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.412 ' N3 ' ' HA ' ' A' ' 265' ' ' ALA . . . . . . . . 0 O4'--C4' 1.421 -2.69 0 O4'-C1'-N19 112.059 3.859 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.451 ' C5 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.42 -2.779 0 O4'-C1'-N19 111.615 3.415 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.839 0 C5'-C4'-C3' 109.959 -3.694 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.457 ' N3 ' " H2'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.805 0 C3'-C2'-C1' 104.923 3.804 OUTLIER-DELTA 0.01 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.531 1 O4'-C1'-N19 112.309 4.109 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 . . . . . 0 N--CA 1.477 0.878 0 CA-C-O 120.426 0.155 . . . . 0.0 110.667 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -152.54 146.42 25.22 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 122.92 0.488 . . . . 0.0 110.02 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 82.1 mt -71.34 144.8 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 122.753 0.421 . . . . 0.0 110.49 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 97.8 p -157.34 162.2 39.09 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 122.96 0.504 . . . . 0.0 110.267 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 67.2 mtt85 -75.19 151.55 85.89 Favored Pre-proline 0 CA--C 1.53 0.173 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.25 -19.43 33.82 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.75 2.3 . . . . 0.0 110.857 177.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -88.47 -7.17 72.69 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 119.655 -0.525 . . . . 0.0 112.347 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -78.46 -5.61 52.98 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.5 t -71.2 155.45 40.71 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.816 0.446 . . . . 0.0 110.389 177.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -59.55 -22.6 61.93 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.287 -0.258 . . . . 0.0 111.646 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -78.67 2.46 19.42 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 58.7 m -140.96 -0.41 1.49 Allowed 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -176.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -148.18 10.49 0.89 Allowed 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 47.5 m -142.32 7.77 1.77 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 3.6 m -78.83 129.24 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 122.943 0.497 . . . . 0.0 111.824 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 42.3 p30 -130.73 10.31 5.1 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 23.2 t 64.43 23.01 12.87 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -175.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 92.7 t -132.51 143.3 40.19 Favored 'Isoleucine or valine' 0 C--N 1.339 0.124 0 C-N-CA 123.669 0.788 . . . . 0.0 109.207 177.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 75.9 mt -136.38 149.64 48.43 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -173.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 38.8 tp -100.02 135.54 41.28 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 172.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -114.97 102.2 9.74 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.138 1.375 . . . . 0.0 114.485 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.42 134.33 33.6 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 174.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.2 mp -103.5 122.44 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -91.99 -18.12 24.12 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -171.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -143.29 78.72 14.69 Favored Pre-proline 0 CA--C 1.529 0.148 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -78.23 45.83 1.94 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 125.136 3.891 . . . . 0.0 112.102 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.95 -4.55 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 O-C-N 121.952 -0.467 . . . . 0.0 110.909 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -136.27 157.6 46.42 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 177.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 66.9 m -71.34 112.81 7.77 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 120.636 0.255 . . . . 0.0 110.466 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.3 mm -78.46 142.15 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.96 160.58 37.28 Favored 'General case' 0 N--CA 1.458 -0.064 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.2 p -66.6 -14.52 62.5 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 176.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -75.98 -44.29 40.41 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 120.813 0.339 . . . . 0.0 110.675 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.0 m -72.53 -33.52 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.8 mt -70.85 -35.11 72.28 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -69.74 -31.5 69.51 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 174.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.8 m -67.31 -31.81 72.36 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 43.4 pt -94.58 -25.47 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-O 118.982 -0.533 . . . . 0.0 112.027 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 98.0 m -86.59 -28.59 23.18 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 119.283 0.947 . . . . 0.0 113.263 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.46 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 38.8 t30 -68.12 -40.49 21.95 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -178.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 74.4 Cg_endo -69.42 -14.29 36.93 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 CA-C-N 121.045 1.409 . . . . 0.0 111.434 176.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 91.7 m -87.28 -8.97 56.17 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 117.896 0.317 . . . . 0.0 111.46 176.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 150.53 171.1 18.45 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 178.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -66.63 85.45 0.29 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 124.632 3.554 . . . . 0.0 110.928 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 10.7 p -68.39 148.48 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 123.874 0.87 . . . . 0.0 109.609 175.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -121.75 -36.23 3.07 Favored 'General case' 0 C--O 1.228 -0.077 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -174.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 66.2 mtm-85 -146.1 148.73 32.93 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.582 0.628 . . . . 0.0 112.353 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 35.2 mt -147.99 135.07 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 C-N-CA 123.998 0.919 . . . . 0.0 109.504 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 2.3 m -141.3 160.81 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.105 0 C-N-CA 123.633 0.773 . . . . 0.0 111.614 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 53.1 mt -134.6 144.17 35.69 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.046 0 C-N-CA 123.332 0.653 . . . . 0.0 110.327 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.297 4.6 p90 -143.31 155.99 44.6 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -127.13 13.13 7.21 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.509 0.724 . . . . 0.0 111.087 -173.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -64.31 -31.04 72.09 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -169.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -130.32 7.49 4.98 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 118.889 0.768 . . . . 0.0 112.114 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 161.08 -124.54 1.33 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 108.559 -1.816 . . . . 0.0 108.559 -174.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 59.4 t -144.25 114.63 2.11 Favored 'Isoleucine or valine' 0 C--O 1.23 0.051 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 175.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -142.89 168.05 20.63 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.123 0.487 . . . . 0.0 110.904 -176.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.65 166.99 24.9 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.846 0.858 . . . . 0.0 109.152 175.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 71.3 mmm -134.06 156.08 48.88 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 38.5 t -141.23 147.05 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 122.89 0.476 . . . . 0.0 110.747 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -135.55 134.93 39.93 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.005 0.522 . . . . 0.0 110.326 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -108.16 163.05 13.5 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -77.45 -14.52 59.67 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 84.9 p -154.54 153.43 31.43 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.462 0.649 . . . . 0.0 111.581 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 51.9 t -65.23 -32.11 56.82 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.347 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -65.54 -33.95 77.12 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.014 0.37 . . . . 0.0 110.454 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 69.1 m -72.13 -33.5 67.84 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 177.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -72.63 -31.8 65.41 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 122.376 -0.202 . . . . 0.0 111.206 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -68.93 -43.77 74.45 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.931 -0.481 . . . . 0.0 111.523 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -77.78 -25.77 49.29 Favored 'General case' 0 N--CA 1.458 -0.036 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.497 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -72.5 -40.73 66.62 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 118.084 0.402 . . . . 0.0 110.035 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -72.6 -25.34 61.28 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 122.416 0.286 . . . . 0.0 110.864 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -91.86 -10.31 40.18 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 47.1 t -114.08 -34.12 5.48 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 80.3 mt -90.12 -9.36 48.63 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -70.74 134.63 47.62 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 74.73 -3.22 44.59 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 119.72 -0.489 . . . . 0.0 112.151 -178.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.52 166.48 21.14 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 117.869 0.834 . . . . 0.0 110.069 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -123.6 140.08 53.36 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 81.9 mt -74.99 -41.17 45.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.365 40.7 m-85 -82.85 -12.01 57.77 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 117.4 2.371 . . . . 0.0 117.4 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 32.1 t 65.39 34.89 7.82 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.495 0.718 . . . . 0.0 110.926 -173.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 177.15 -24.44 0.05 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 86.0 m -146.89 -176.13 5.08 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.661 1.184 . . . . 0.0 109.5 178.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 89.1 m 58.2 37.24 26.2 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -176.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.27 149.08 13.36 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 176.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 81.2 mt -116.25 153.81 31.24 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -173.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -137.24 137.36 38.98 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 169.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 46.4 mt -139.6 141.64 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-O 120.734 0.302 . . . . 0.0 111.615 -170.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -161.36 163.92 30.36 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.043 176.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.277 49.8 m-85 -59.28 139.45 56.97 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 177.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . 0.437 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -95.85 164.31 12.79 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -175.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -78.46 -50.05 1.69 Allowed Pre-proline 0 CA--C 1.535 0.395 0 CA-C-O 118.624 -0.703 . . . . 0.0 112.486 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -74.7 174.21 13.05 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.619 2.213 . . . . 0.0 110.686 178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 2.1 t -138.56 -2.48 1.77 Allowed 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 116.493 2.034 . . . . 0.0 116.493 -174.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.92 130.55 9.03 Favored 'General case' 0 C--N 1.34 0.176 0 O-C-N 121.546 -0.721 . . . . 0.0 111.624 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.474 ' HG ' ' C5 ' ' B' ' 3' ' ' ' A' . 17.0 mt -86.46 157.63 19.76 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 123.667 0.787 . . . . 0.0 111.127 177.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -119.74 47.36 1.74 Allowed 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.633 0.773 . . . . 0.0 109.59 173.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.2 t -50.38 143.03 2.52 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 -176.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -132.5 1.22 3.72 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 116.15 1.907 . . . . 0.0 116.15 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -156.4 153.32 28.72 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.163 0.585 . . . . 0.0 110.355 -171.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -122.18 118.65 29.13 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.364 0.666 . . . . 0.0 109.675 172.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 54.9 p30 -157.58 -167.28 2.23 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -69.21 -13.38 62.37 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -175.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -109.51 -22.6 11.92 Favored 'General case' 0 C--N 1.338 0.102 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.65 142.08 35.01 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 177.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 20.2 t-105 -159.3 155.55 27.09 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.155 0.502 . . . . 0.0 110.01 -175.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -129.93 117.22 19.78 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.496 171.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.277 66.5 m-85 -80.0 8.44 7.04 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 117.269 2.322 . . . . 0.0 117.269 -172.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 8.7 t -139.93 -22.51 0.86 Allowed 'General case' 0 C--O 1.231 0.105 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -95.35 113.22 61.17 Favored Pre-proline 0 CA--C 1.531 0.234 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 174.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -81.68 -14.35 10.22 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.571 2.847 . . . . 0.0 112.136 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -74.32 -12.14 60.46 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -173.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 55.1 mt -88.09 -10.08 51.25 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.275 0.489 . . . . 0.0 111.835 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 75.0 m -69.47 129.34 39.46 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 67.24 0.65 10.92 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.677 -0.513 . . . . 0.0 112.219 -176.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 55.2 19.77 3.07 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.46 1.104 . . . . 0.0 112.184 -177.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.183 0 CA-C-O 117.366 -1.796 . . . . 0.0 110.969 -179.462 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.784 0 C3'-C2'-C1' 104.583 3.425 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.437 ' N3 ' ' HA ' ' A' ' 265' ' ' ALA . . . . . . . . 0 O4'--C4' 1.419 -2.819 1 C3'-C2'-C1' 97.883 -4.019 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.474 ' C5 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.417 -3.003 0 O4'-C1'-N19 111.663 3.463 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.742 0 C5'-C4'-C3' 109.758 -3.828 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.428 ' N3 ' " H2'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.884 0 C3'-C2'-C1' 104.809 3.677 OUTLIER-DELTA 0.01 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.606 0 O4'-C1'-N19 111.726 3.526 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 . . . . . 0 N--CA 1.477 0.921 0 CA-C-O 120.405 0.145 . . . . 0.0 110.748 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -154.09 156.41 37.22 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.259 0.624 . . . . 0.0 109.823 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 84.0 mt -63.38 146.53 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 122.947 0.499 . . . . 0.0 110.032 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 43.9 t -67.59 164.44 19.08 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.573 0.749 . . . . 0.0 112.307 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.569 ' H ' ' CD ' ' A' ' 179' ' ' PRO . 83.3 mmt-85 -136.18 -39.06 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.225 0 CA-C-O 118.173 -0.917 . . . . 0.0 113.223 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.569 ' CD ' ' H ' ' A' ' 178' ' ' ARG . 44.0 Cg_exo -60.01 143.61 99.55 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.596 2.197 . . . . 0.0 111.412 175.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -83.29 -8.91 84.58 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 119.676 -0.513 . . . . 0.0 112.986 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -100.76 -3.18 30.56 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 117.844 0.822 . . . . 0.0 110.009 -178.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 74.1 m -83.84 142.21 30.78 Favored 'General case' 0 C--O 1.231 0.088 0 O-C-N 121.693 -0.629 . . . . 0.0 110.061 176.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -58.64 -25.27 62.55 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -73.64 10.52 1.07 Allowed 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 114.698 1.369 . . . . 0.0 114.698 177.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 32.8 t -143.9 -0.73 1.02 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -148.13 1.95 0.66 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 58.1 m -136.52 8.69 3.12 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 123.257 0.623 . . . . 0.0 111.932 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 33.0 m -66.29 132.0 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 C-N-CA 122.759 0.424 . . . . 0.0 109.892 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -130.75 5.25 4.62 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -177.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 70.9 m 56.14 13.85 1.32 Allowed 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -175.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 96.3 t -142.37 136.63 28.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 C-N-CA 123.976 0.911 . . . . 0.0 108.655 -178.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -125.04 151.91 44.98 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 122.68 0.392 . . . . 0.0 111.309 -176.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 39.2 tp -95.54 136.29 36.12 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 169.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -113.95 102.77 10.51 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.899 1.279 . . . . 0.0 114.292 177.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.74 133.12 33.91 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 174.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.2 mp -104.06 121.31 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -89.03 -18.62 26.98 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -172.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -144.22 79.03 13.21 Favored Pre-proline 0 CA--C 1.529 0.142 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.74 46.03 1.93 Allowed 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.838 3.692 . . . . 0.0 112.247 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.88 -4.09 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 O-C-N 121.953 -0.467 . . . . 0.0 110.764 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -136.74 157.59 46.4 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 176.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 70.5 m -70.77 111.9 6.57 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.273 0.229 . . . . 0.0 110.552 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 32.2 mm -78.83 141.15 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 176.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.03 158.31 43.88 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 177.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.409 ' HG1' ' HB2' ' A' ' 280' ' ' TRP . 1.0 OUTLIER -65.67 -19.79 66.04 Favored 'General case' 0 C--O 1.23 0.057 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 178.314 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -77.63 -34.52 53.26 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 96.4 t -75.46 -41.22 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.27 -31.52 70.1 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -70.85 -29.53 65.67 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 174.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.4 m -68.42 -32.79 73.09 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 45.0 pt -92.88 -22.51 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 118.379 0.536 . . . . 0.0 112.073 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 92.5 m -90.61 -26.53 19.6 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.451 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 32.0 t30 -63.06 -42.83 79.35 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 74.3 Cg_endo -69.25 -11.8 32.35 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.378 1.386 . . . . 0.0 111.604 177.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 92.5 m -91.78 -5.82 52.87 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 145.44 168.66 13.18 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 177.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.21 104.63 0.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.851 3.034 . . . . 0.0 111.581 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 55.4 t -75.7 143.61 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -115.36 -40.08 3.49 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 119.415 -0.326 . . . . 0.0 111.045 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 65.2 mtm-85 -147.99 151.31 35.55 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 19.0 mt -146.72 135.9 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 124.144 0.978 . . . . 0.0 109.448 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 1.4 m -139.87 159.31 26.94 Favored 'Isoleucine or valine' 0 C--O 1.23 0.049 0 C-N-CA 123.301 0.64 . . . . 0.0 111.88 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 56.0 mt -135.23 142.78 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 C-N-CA 123.159 0.583 . . . . 0.0 109.628 -176.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.29 3.7 p90 -143.13 158.21 43.82 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 176.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -128.43 16.68 6.53 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.267 0.627 . . . . 0.0 110.393 -172.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -64.72 -30.7 71.72 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -169.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -130.43 5.8 4.8 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 118.563 0.62 . . . . 0.0 112.133 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 161.2 -122.41 1.11 Allowed Glycine 0 CA--C 1.522 0.472 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 -173.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 57.2 t -143.26 116.41 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 175.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -143.73 167.13 23.01 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.158 0.504 . . . . 0.0 110.557 -176.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.41 167.48 24.28 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 53.4 mmm -137.88 153.78 49.52 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 44.5 t -139.99 140.77 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 C-N-CA 122.791 0.436 . . . . 0.0 110.318 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -124.52 130.03 51.7 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.047 0.539 . . . . 0.0 110.421 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -105.84 163.34 12.8 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 -175.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -76.35 -15.59 59.93 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.5 0.32 . . . . 0.0 110.499 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 84.8 p -155.84 160.5 40.26 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.273 0.559 . . . . 0.0 111.694 -177.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 25.6 t -65.1 -35.25 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -66.61 -34.97 79.07 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 122.309 -0.244 . . . . 0.0 111.037 -176.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 60.7 m -71.58 -30.24 65.61 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 121.242 -0.183 . . . . 0.0 110.534 176.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.48 -29.85 59.71 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 119.806 -0.14 . . . . 0.0 111.175 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -69.75 -48.38 59.6 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 118.127 0.421 . . . . 0.0 111.805 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -72.82 -27.46 61.97 Favored 'General case' 0 C--N 1.337 0.053 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.087 -177.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -69.76 -40.8 75.89 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -76.15 -19.63 58.31 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 122.915 0.486 . . . . 0.0 110.988 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -102.16 -0.3 33.47 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 42.9 t -127.07 -30.42 2.69 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 118.68 0.673 . . . . 0.0 112.512 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 70.0 mt -92.96 -8.2 43.8 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.097 0.408 . . . . 0.0 111.618 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -73.19 134.23 44.3 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.09 -5.04 44.09 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 119.717 -0.49 . . . . 0.0 112.108 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.7 166.34 21.9 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 117.801 0.8 . . . . 0.0 110.017 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -123.02 136.61 54.91 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 178.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 95.9 mt -70.92 -43.25 76.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.358 34.4 m-85 -82.8 -11.38 58.31 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 117.232 2.308 . . . . 0.0 117.232 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.7 t 65.76 36.11 6.42 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.954 0.883 . . . . 0.0 111.285 -174.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 174.42 -23.45 0.06 OUTLIER Glycine 0 CA--C 1.529 0.954 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.077 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 93.5 m -146.51 -177.51 5.67 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.744 1.218 . . . . 0.0 109.212 177.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 89.0 m 58.46 35.72 24.88 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -176.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.86 148.21 10.7 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 175.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 84.1 mt -114.95 153.97 29.6 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -173.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -137.58 136.87 37.97 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.057 1.343 . . . . 0.0 107.426 169.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 40.9 mt -137.61 142.67 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 CA-C-O 120.723 0.297 . . . . 0.0 111.423 -171.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -159.67 161.88 35.0 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 122.988 0.515 . . . . 0.0 110.17 175.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.27 38.3 m-85 -59.2 135.77 57.75 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 176.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . 0.427 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -88.57 164.83 15.21 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -89.18 -53.0 0.35 Allowed Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 123.617 0.767 . . . . 0.0 112.933 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -71.59 159.45 51.12 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.717 2.278 . . . . 0.0 110.503 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 1.4 t -127.15 0.25 6.46 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 -173.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -154.69 131.26 10.6 Favored 'General case' 0 C--N 1.339 0.134 0 O-C-N 121.857 -0.527 . . . . 0.0 111.472 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.481 ' HG ' ' C6 ' ' B' ' 3' ' ' ' A' . 29.1 mt -85.61 166.89 15.85 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.193 0.997 . . . . 0.0 111.304 177.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.547 ' ND2' ' C2 ' ' B' ' 4' ' ' ' C' . 19.0 p30 -121.87 44.76 2.49 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.434 170.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.2 t -48.02 140.3 2.21 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -177.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.435 ' CZ ' ' C2 ' ' B' ' 5' ' ' ' A' . 6.5 p90 -129.52 0.93 5.02 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 -178.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -158.19 166.33 32.68 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.93 0.395 . . . . 0.0 110.965 -174.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -125.91 111.69 15.08 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.956 0.902 . . . . 0.0 109.063 171.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 56.9 p30 -154.31 -169.97 3.4 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -69.65 -11.73 61.08 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -176.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -99.53 -37.3 9.23 Favored 'General case' 0 CA--C 1.528 0.096 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.81 147.01 38.37 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 178.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' TRP . . . . . 0.409 ' HB2' ' HG1' ' A' ' 205' ' ' THR . 18.9 t-105 -157.32 155.84 31.35 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -175.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -128.37 117.97 22.35 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.85 0.46 . . . . 0.0 109.9 173.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.295 67.8 m-85 -80.6 8.61 7.52 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 117.032 2.234 . . . . 0.0 117.032 -173.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 5.3 t -137.62 -24.09 1.06 Allowed 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -95.39 113.12 60.98 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 174.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -82.62 -13.08 9.77 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 123.708 2.939 . . . . 0.0 112.637 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -73.71 -16.45 61.19 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -172.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 45.2 mt -79.65 -8.12 59.01 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.186 0.448 . . . . 0.0 111.986 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 73.5 m -78.73 0.03 28.39 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.668 0.387 . . . . 0.0 111.582 176.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -76.52 -6.67 84.7 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 119.672 -0.516 . . . . 0.0 112.883 -178.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -70.4 158.88 35.2 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 117.978 0.889 . . . . 0.0 110.88 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 CA-C-O 117.512 -1.715 . . . . 0.0 110.876 -179.484 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.738 0 C5'-C4'-C3' 109.998 -3.668 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.427 ' N3 ' ' HA ' ' A' ' 265' ' ' ALA . . . . . . . . 0 O4'--C4' 1.422 -2.57 2 C3'-C2'-C1' 97.649 -4.279 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.481 ' C6 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.425 -2.347 2 C5'-C4'-C3' 107.285 -5.477 . 0.01 4s . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' ' C' . . . . . 0.547 ' C2 ' ' ND2' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.42 -2.771 1 C5'-C4'-C3' 108.337 -4.775 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.457 ' H61' ' C ' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.415 -3.165 1 C3'-C2'-C1' 105.152 4.058 OUTLIER-DELTA 0.154 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.597 0 O4'-C1'-N19 111.947 3.747 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 . . . . . 0 N--CA 1.476 0.866 0 N-CA-C 111.345 0.128 . . . . 0.0 111.345 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -151.46 146.68 26.1 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.085 0.554 . . . . 0.0 110.372 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 30.4 mm -138.77 147.98 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 124.529 1.132 . . . . 0.0 108.716 178.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 73.2 m -145.55 158.0 43.91 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.167 0.587 . . . . 0.0 110.553 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 82.2 mtt85 -144.19 151.46 51.82 Favored Pre-proline 0 CA--C 1.528 0.117 0 C-N-CA 123.942 0.897 . . . . 0.0 109.758 -178.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -68.79 -17.39 42.14 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.331 2.687 . . . . 0.0 111.622 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.56 -6.25 84.13 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 119.81 -0.439 . . . . 0.0 112.128 178.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -84.62 -6.82 59.39 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 41.0 t -73.01 141.82 47.7 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 121.669 -0.644 . . . . 0.0 110.077 177.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 16.4 p30 -67.77 -15.04 63.44 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -74.04 2.35 8.99 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 97.2 p -149.31 8.44 0.71 Allowed 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -178.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -144.15 -1.78 0.93 Allowed 'General case' 0 C--N 1.341 0.219 0 CA-C-N 118.388 0.54 . . . . 0.0 112.447 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 70.0 m -138.88 9.36 2.58 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 123.099 0.56 . . . . 0.0 111.947 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 10.6 m -70.57 104.79 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 -176.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -130.68 10.47 5.14 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.51 0.724 . . . . 0.0 112.019 177.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 55.1 m 65.05 21.73 12.29 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.262 1.025 . . . . 0.0 113.668 -177.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 39.1 t -128.62 142.59 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 123.147 0.579 . . . . 0.0 110.867 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.0 mt -132.66 150.06 52.21 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.793 0.437 . . . . 0.0 110.37 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.0 tt -106.93 139.51 41.22 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -113.99 139.61 49.1 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -129.44 143.16 50.72 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 176.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.3 mp -119.86 117.73 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 20.5 mt -81.07 -24.35 37.85 Favored 'General case' 0 C--N 1.338 0.096 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -173.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -138.0 79.01 33.79 Favored Pre-proline 0 N--CA 1.455 -0.193 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -176.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -76.93 48.56 2.52 Favored 'Trans proline' 0 N--CA 1.455 -0.769 1 C-N-CA 125.357 4.038 . . . . 0.0 112.017 -177.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.57 -5.39 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 O-C-N 121.963 -0.46 . . . . 0.0 110.513 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -137.92 156.46 47.86 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 175.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 66.8 m -68.9 116.01 8.89 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 110.525 -0.176 . . . . 0.0 110.525 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.2 mm -78.79 142.72 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.16 162.49 31.99 Favored 'General case' 0 C--O 1.231 0.097 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 21.2 p -66.87 -20.38 65.91 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -72.7 -47.64 45.51 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.17 -33.03 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 97.0 mt -72.2 -34.67 68.57 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -70.79 -31.77 68.64 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 174.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 12.5 m -66.59 -33.94 76.78 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 36.7 pt -92.37 -23.59 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 118.497 0.59 . . . . 0.0 111.996 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 98.8 m -89.34 -25.99 21.32 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.455 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 33.7 t30 -63.51 -42.24 71.99 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 73.5 Cg_endo -70.53 -15.43 34.22 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.489 1.46 . . . . 0.0 111.488 177.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 94.0 m -83.12 -15.27 51.38 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 122.236 -0.29 . . . . 0.0 111.357 176.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 151.94 170.79 19.01 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.17 108.01 0.53 Allowed 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.505 2.803 . . . . 0.0 111.423 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 81.9 t -77.5 145.76 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -117.21 -34.33 4.38 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 119.163 -0.446 . . . . 0.0 111.179 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 83.2 mtt85 -151.52 156.1 39.87 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 118.437 0.562 . . . . 0.0 112.0 177.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 25.8 mt -144.7 142.51 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.298 1.039 . . . . 0.0 109.199 174.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 96.6 t -143.36 155.19 16.64 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.102 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 53.9 mt -138.14 141.09 39.1 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 C-N-CA 123.494 0.717 . . . . 0.0 109.455 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.295 5.3 p90 -144.47 155.87 43.92 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 176.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -126.31 15.49 7.76 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.3 0.64 . . . . 0.0 110.58 -173.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -66.18 -31.96 73.12 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -169.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -130.36 8.67 5.08 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 118.455 0.57 . . . . 0.0 112.113 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 160.37 -125.57 1.49 Allowed Glycine 0 C--N 1.336 0.533 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 -174.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 45.8 t -142.74 113.23 2.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -142.35 170.42 15.74 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.467 0.651 . . . . 0.0 111.426 -174.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -149.2 169.01 21.71 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.669 176.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 86.6 mmm -135.55 152.16 51.02 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 42.8 t -141.02 147.56 22.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 122.665 0.386 . . . . 0.0 110.208 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -134.62 135.37 42.1 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.616 0.366 . . . . 0.0 110.215 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -111.78 161.78 15.95 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 -175.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -81.29 -11.9 59.22 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.963 0.505 . . . . 0.0 109.742 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 41.1 t -154.67 153.72 31.78 Favored 'General case' 0 C--O 1.232 0.144 0 O-C-N 121.909 -0.494 . . . . 0.0 111.888 -175.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 55.3 t -67.8 -40.26 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -66.57 -26.22 67.01 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 117.811 0.278 . . . . 0.0 110.948 -178.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 67.6 m -73.78 -33.44 64.25 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 176.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -77.41 -30.86 53.74 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 122.485 -0.135 . . . . 0.0 111.23 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -67.56 -42.47 82.57 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 121.913 -0.492 . . . . 0.0 111.621 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -77.88 -26.61 49.32 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.922 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -70.16 -43.27 71.19 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.207 0.458 . . . . 0.0 109.787 176.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.423 ' HE3' ' HB3' ' A' ' 245' ' ' LYS . 1.2 tmmt? -72.8 -21.94 60.9 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.99 0.516 . . . . 0.0 111.294 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -95.55 -11.35 27.51 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 44.7 t -115.23 -33.39 5.35 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 112.783 0.661 . . . . 0.0 112.783 -177.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 81.4 mt -91.79 -10.68 39.01 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -71.15 135.66 47.73 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 121.999 -0.438 . . . . 0.0 109.888 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.49 -3.77 31.11 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 119.63 -0.539 . . . . 0.0 112.847 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -81.03 166.45 20.77 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 118.011 0.906 . . . . 0.0 110.507 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -108.45 140.0 42.39 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 74.2 mt -74.2 -42.59 51.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 174.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.351 51.4 m-85 -82.75 -12.72 57.32 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 117.26 2.318 . . . . 0.0 117.26 178.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 27.6 t 66.06 38.72 4.68 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.676 0.791 . . . . 0.0 110.748 -172.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 174.31 -21.34 0.06 OUTLIER Glycine 0 CA--C 1.529 0.93 0 C-N-CA 123.53 0.586 . . . . 0.0 111.903 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 78.2 m -147.46 -174.08 4.43 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.547 1.139 . . . . 0.0 109.096 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 93.4 m 57.44 43.16 23.48 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.71 0.634 . . . . 0.0 112.71 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -50.47 133.3 24.95 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 177.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 96.0 mt -95.64 152.01 18.83 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.465 0.65 . . . . 0.0 112.167 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -141.03 132.66 27.15 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.345 1.458 . . . . 0.0 107.071 169.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 47.8 mt -140.64 141.15 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 CA-C-O 120.641 0.258 . . . . 0.0 111.316 -172.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -161.75 165.44 28.01 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.271 0.628 . . . . 0.0 109.417 174.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -59.85 138.91 57.68 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 115.586 1.698 . . . . 0.0 115.586 177.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -93.91 160.03 14.92 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -176.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -76.89 -49.7 2.49 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 118.429 -0.796 . . . . 0.0 112.878 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -76.32 169.13 22.57 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.718 2.279 . . . . 0.0 111.104 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.282 0.2 OUTLIER -136.46 12.79 3.24 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 117.37 2.359 . . . . 0.0 117.37 -176.904 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.436 ' N ' ' H62' ' B' ' 3' ' ' ' A' . 10.6 tpt180 -159.96 126.03 4.23 Favored 'General case' 0 C--N 1.338 0.096 0 O-C-N 121.677 -0.639 . . . . 0.0 111.805 178.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.422 ' HG ' ' C5 ' ' B' ' 3' ' ' ' A' . 28.5 mt -86.13 159.54 19.5 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 123.463 0.705 . . . . 0.0 110.944 174.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -125.23 47.7 2.13 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.826 0.85 . . . . 0.0 109.817 174.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.3 t -52.19 142.15 5.14 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -176.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . 0.253 6.1 p90 -120.81 -7.7 9.52 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 117.282 2.327 . . . . 0.0 117.282 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -162.52 168.04 22.5 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 122.689 0.396 . . . . 0.0 111.029 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -119.99 127.01 52.23 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.566 0.746 . . . . 0.0 110.03 176.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 41.0 p30 -161.03 -167.39 1.8 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.245 1.018 . . . . 0.0 109.542 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -70.4 -10.9 60.36 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -176.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -105.6 -29.57 10.05 Favored 'General case' 0 C--N 1.337 0.064 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -141.04 146.46 37.22 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 178.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 19.3 t-105 -156.53 154.15 29.86 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -176.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -132.76 117.58 17.99 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.201 0.6 . . . . 0.0 111.512 175.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.288 68.3 m-85 -83.26 10.41 8.53 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 117.366 2.358 . . . . 0.0 117.366 -171.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 12.9 t -138.83 -23.77 0.93 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -95.21 113.17 60.93 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 173.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -80.69 -14.2 11.51 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.471 2.781 . . . . 0.0 112.29 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -76.03 -15.43 60.13 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -174.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 68.4 mt -85.16 -6.71 59.28 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 118.111 0.414 . . . . 0.0 111.962 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 75.1 m -75.62 144.38 41.77 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 122.182 -0.324 . . . . 0.0 110.74 177.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 75.85 -1.37 58.93 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 119.946 -0.363 . . . . 0.0 112.732 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 43.0 mm-40 -85.23 10.14 13.22 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 117.742 0.771 . . . . 0.0 111.363 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.244 0 CA-C-O 116.981 -2.01 . . . . 0.0 111.929 -177.495 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.834 0 C3'-C2'-C1' 105.078 3.976 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.083 0 C3'-C2'-C1' 98.449 -3.39 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.436 ' H62' ' N ' ' A' ' 269' ' ' ARG . . . . . . . . 0 O4'--C4' 1.42 -2.789 0 O4'-C1'-N19 111.689 3.489 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.763 0 C5'-C4'-C3' 110.304 -3.464 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.419 ' N3 ' " H2'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.93 0 C3'-C2'-C1' 104.913 3.792 OUTLIER-DELTA 0.01 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.643 0 O4'-C1'-N19 112.014 3.814 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 . . . . . 0 N--CA 1.477 0.882 0 CA-C-O 120.49 0.186 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 63.2 mmtt -68.24 168.07 13.06 Favored 'General case' 0 N--CA 1.457 -0.085 0 CA-C-O 121.179 0.514 . . . . 0.0 112.232 178.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.1 pt -65.47 -17.8 22.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.46 0.704 . . . . 0.0 110.527 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 70.0 m -83.08 11.44 6.34 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 123.449 0.7 . . . . 0.0 112.554 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.82 148.01 83.73 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 122.87 0.468 . . . . 0.0 111.023 178.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -77.33 -4.13 14.4 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 124.08 3.187 . . . . 0.0 112.641 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -59.41 141.47 47.37 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 172.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 21.6 t0 62.43 21.02 12.31 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 30.2 t -68.58 146.39 53.1 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 121.385 -0.822 . . . . 0.0 109.8 175.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 13.9 p30 -70.64 -9.06 56.14 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -77.6 2.37 16.77 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 96.7 p -148.99 5.71 0.67 Allowed 'General case' 0 C--O 1.232 0.161 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -176.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -145.87 9.31 1.15 Allowed 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 64.2 p -155.12 17.88 0.42 Allowed 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 178.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.1 m -71.64 109.32 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -130.56 10.35 5.18 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.37 0.668 . . . . 0.0 112.267 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.1 m 65.49 21.16 11.79 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -176.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 30.7 t -130.76 134.3 62.09 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.092 0 C-N-CA 122.858 0.463 . . . . 0.0 111.103 177.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -122.94 154.2 38.69 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.098 0.559 . . . . 0.0 110.779 -176.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 39.0 tp -104.01 136.26 43.98 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 170.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -113.86 107.92 16.36 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.71 1.204 . . . . 0.0 114.122 177.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.99 141.01 29.02 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 174.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.4 mp -110.56 126.83 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -90.43 -23.67 20.96 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -173.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -140.34 78.98 21.81 Favored Pre-proline 0 CA--C 1.53 0.188 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -76.74 49.89 2.86 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 124.804 3.669 . . . . 0.0 112.113 -178.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.87 -5.86 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 O-C-N 121.749 -0.595 . . . . 0.0 110.251 178.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -142.1 154.58 45.02 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.2 1.4 . . . . 0.0 112.538 175.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.3 t -73.38 129.93 39.07 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.291 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 23.0 mm -79.16 148.4 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 123.073 0.549 . . . . 0.0 109.993 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.02 156.38 48.32 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.4 p -64.1 -17.3 63.29 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 177.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -76.52 -46.25 27.32 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.79 0.329 . . . . 0.0 111.812 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.6 m -71.29 -31.6 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.059 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.31 -36.95 74.64 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 176.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -70.83 -30.48 66.91 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 175.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 12.5 m -66.78 -33.4 75.55 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 41.1 pt -93.85 -21.59 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 118.399 0.545 . . . . 0.0 112.13 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 97.4 m -91.54 -25.73 19.1 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.463 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 35.4 t30 -64.65 -39.19 37.78 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 74.3 Cg_endo -69.94 -13.04 33.7 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 CA-C-N 121.023 1.401 . . . . 0.0 111.575 177.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 95.9 m -91.95 -5.41 53.16 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.669 0.388 . . . . 0.0 111.663 177.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 146.74 166.83 12.51 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 178.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.18 103.77 1.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.635 2.89 . . . . 0.0 110.657 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 75.6 t -70.37 146.28 12.29 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -114.34 -37.14 4.44 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 119.212 -0.423 . . . . 0.0 111.765 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -150.21 151.64 33.36 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 20.7 mt -147.87 136.96 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 C-N-CA 124.055 0.942 . . . . 0.0 109.975 177.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 6.1 m -142.61 159.43 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 123.729 0.812 . . . . 0.0 110.313 173.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 41.3 mt -132.68 143.61 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 123.018 0.527 . . . . 0.0 110.375 -175.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.316 3.8 p90 -140.32 154.65 46.86 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 115.718 1.748 . . . . 0.0 115.718 176.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -126.59 16.79 7.56 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.309 0.643 . . . . 0.0 110.06 -174.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -64.43 -31.91 73.31 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -169.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -130.46 8.62 5.03 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 118.346 0.521 . . . . 0.0 112.096 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 157.62 -124.12 1.37 Allowed Glycine 0 C--N 1.334 0.444 0 N-CA-C 108.336 -1.905 . . . . 0.0 108.336 -173.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 24.9 t -142.15 114.65 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-N 116.846 0.323 . . . . 0.0 110.18 176.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 8.4 mp0 -143.45 166.69 24.09 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.119 0.485 . . . . 0.0 110.671 -177.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.41 163.7 35.65 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.725 0.81 . . . . 0.0 109.788 176.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 56.0 mmm -130.76 151.31 51.34 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 41.4 t -140.74 144.26 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.067 0 C-N-CA 122.945 0.498 . . . . 0.0 110.399 -178.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -130.5 133.21 46.09 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.83 0.452 . . . . 0.0 110.64 178.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -104.21 163.21 12.57 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 116.334 1.975 . . . . 0.0 116.334 -177.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -78.92 -14.51 59.18 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 85.2 p -154.71 157.64 38.38 Favored 'General case' 0 N--CA 1.457 -0.081 0 O-C-N 121.744 -0.598 . . . . 0.0 111.262 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 53.4 t -67.76 -32.33 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -66.84 -34.83 78.68 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 121.878 -0.514 . . . . 0.0 110.733 -177.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 69.1 m -72.56 -31.05 64.95 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 176.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -74.08 -31.51 62.85 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 122.577 0.351 . . . . 0.0 111.441 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -71.79 -46.99 56.47 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 117.944 0.338 . . . . 0.0 111.788 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -73.19 -26.3 61.11 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 118.04 0.382 . . . . 0.0 111.345 -177.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -71.11 -41.4 70.64 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.92 -23.63 55.5 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.482 0.313 . . . . 0.0 110.998 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -91.32 -10.01 42.89 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 40.0 t -118.7 -35.08 3.79 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -177.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 66.0 mt -87.94 -7.27 57.36 Favored 'General case' 0 N--CA 1.457 -0.076 0 CA-C-N 118.118 0.417 . . . . 0.0 111.862 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -70.01 136.36 50.33 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 74.65 -4.98 32.68 Favored Glycine 0 CA--C 1.533 1.201 0 CA-C-O 119.769 -0.462 . . . . 0.0 112.431 -178.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -76.72 166.32 23.52 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 117.848 0.824 . . . . 0.0 110.302 177.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -123.6 140.47 52.97 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 67.4 mt -75.04 -42.5 45.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-O 120.92 0.391 . . . . 0.0 110.012 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.365 53.5 m-85 -82.66 -11.4 58.39 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 117.084 2.253 . . . . 0.0 117.084 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 30.7 t 65.99 35.1 6.61 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.664 0.786 . . . . 0.0 111.313 -175.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 176.52 -23.58 0.05 OUTLIER Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 178.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 81.6 m -145.93 -176.63 5.22 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.61 1.164 . . . . 0.0 108.876 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 87.5 m 57.84 38.71 27.24 Favored 'General case' 0 CA--C 1.527 0.087 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -176.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.96 141.56 21.8 Favored 'General case' 0 C--O 1.23 0.067 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 174.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 95.9 mt -102.09 158.24 16.3 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.49 0.662 . . . . 0.0 112.27 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -139.29 137.18 35.63 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 169.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 19.6 mt -138.23 139.51 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-O 121.089 0.471 . . . . 0.0 111.62 -173.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -159.48 161.9 35.48 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.242 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.262 41.0 m-85 -60.97 135.92 57.93 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 177.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . 0.413 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -92.6 155.89 17.46 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.525 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.407 ' N ' ' CD ' ' A' ' 267' ' ' PRO . 22.9 pttp -88.49 -29.93 0.37 Allowed Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 117.216 -1.373 . . . . 0.0 114.611 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 266' ' ' LYS . 48.9 Cg_endo -79.87 165.12 22.37 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 CA-C-N 122.063 1.773 . . . . 0.0 110.093 176.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.279 0.2 OUTLIER -138.03 8.86 2.76 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 118.19 2.663 . . . . 0.0 118.19 -174.628 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.71 127.05 6.52 Favored 'General case' 0 C--N 1.338 0.073 0 O-C-N 121.408 -0.807 . . . . 0.0 111.858 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.418 ' HG ' ' C6 ' ' B' ' 3' ' ' ' A' . 24.6 mt -92.04 156.45 17.39 Favored 'General case' 0 C--N 1.337 0.052 0 C-N-CA 123.772 0.829 . . . . 0.0 111.107 176.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.436 ' C ' ' H61' ' B' ' 5' ' ' ' A' . 57.2 m-80 -117.31 53.42 0.92 Allowed 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.517 0.727 . . . . 0.0 109.594 172.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.4 t -53.04 145.35 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -176.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -130.12 -7.31 4.36 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 117.637 2.458 . . . . 0.0 117.637 -177.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -161.9 173.72 14.12 Favored 'General case' 0 N--CA 1.458 -0.07 0 C-N-CA 122.739 0.416 . . . . 0.0 110.281 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.469 ' H ' ' NE2' ' A' ' 290' ' ' GLN . 99.4 m-20 -125.69 117.75 24.15 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.025 0.93 . . . . 0.0 110.006 175.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 46.6 p30 -159.54 -166.22 1.73 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.979 0.912 . . . . 0.0 108.922 177.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -70.11 -9.62 56.12 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -174.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -115.98 -17.46 10.93 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.72 140.87 33.25 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.799 0.84 . . . . 0.0 112.966 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 19.4 t-105 -160.78 156.71 25.66 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 119.764 -0.774 . . . . 0.0 110.4 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -138.03 116.55 12.06 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.469 0.708 . . . . 0.0 110.977 174.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.284 66.7 m-85 -81.31 8.94 7.92 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 117.318 2.34 . . . . 0.0 117.318 -172.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 7.1 t -137.99 -20.39 1.12 Allowed 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -95.12 113.28 61.09 Favored Pre-proline 0 CA--C 1.531 0.235 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 174.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -81.08 -13.26 11.47 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.485 2.79 . . . . 0.0 112.318 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -72.65 -19.45 61.44 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -174.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 54.3 mt -82.82 -6.7 59.55 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.927 -0.483 . . . . 0.0 111.569 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 73.9 m -87.71 5.74 38.36 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 122.951 0.501 . . . . 0.0 111.373 176.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -76.27 13.3 7.9 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 123.853 0.739 . . . . 0.0 112.736 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . 0.469 ' NE2' ' H ' ' A' ' 275' ' ' ASN . 4.3 pp0? -143.55 163.38 33.34 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.676 0.79 . . . . 0.0 110.537 -177.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.166 0 CA-C-O 117.294 -1.837 . . . . 0.0 110.84 -179.616 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.078 0 C3'-C2'-C1' 104.079 2.866 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.413 ' N3 ' ' HA ' ' A' ' 265' ' ' ALA . . . . . . . . 0 O4'--C4' 1.42 -2.752 0 C3'-C2'-C1' 98.356 -3.493 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.418 ' C6 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.42 -2.758 0 C5'-C4'-C3' 110.444 -3.371 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.873 0 C5'-C4'-C3' 109.893 -3.738 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.442 ' N3 ' " H2'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.81 1 C3'-C2'-C1' 105.337 4.264 OUTLIER-DELTA 0.013 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.731 0 O4'-C1'-N19 112.053 3.853 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.09 5.12 4.62 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -177.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 18.2 tt -153.94 154.36 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 C-N-CA 123.372 0.669 . . . . 0.0 109.459 178.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 93.4 p -155.85 170.43 22.11 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 122.744 0.418 . . . . 0.0 110.517 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 5.6 ppt_? -149.33 160.79 33.84 Favored Pre-proline 0 CA--C 1.531 0.24 0 C-N-CA 123.286 0.635 . . . . 0.0 109.966 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -58.54 154.21 43.68 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 124.04 3.16 . . . . 0.0 113.351 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -80.53 -4.27 90.11 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -74.66 -13.17 60.6 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.652 0.781 . . . . 0.0 109.855 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 73.3 m -67.25 148.25 51.97 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 121.72 -0.612 . . . . 0.0 109.72 175.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 16.2 p30 -60.68 -16.5 39.99 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 -175.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -72.52 -1.16 14.85 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 176.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 74.5 m -141.42 3.66 1.73 Allowed 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 113.612 0.968 . . . . 0.0 113.612 -177.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? -146.96 6.83 0.9 Allowed 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 56.2 m -147.07 12.38 1.08 Allowed 'General case' 0 CA--C 1.527 0.087 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 178.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 1.6 m -70.21 103.54 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -130.46 10.41 5.23 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.772 0.829 . . . . 0.0 111.822 177.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 55.9 m 64.81 21.34 12.34 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -176.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 28.3 t -130.02 134.07 63.43 Favored 'Isoleucine or valine' 0 C--N 1.339 0.115 0 CA-C-N 118.194 0.452 . . . . 0.0 111.089 177.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -121.14 153.59 37.3 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.053 0.541 . . . . 0.0 110.831 -177.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 25.0 tp -106.11 132.68 51.89 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 171.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -107.86 133.94 51.5 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.633 1.173 . . . . 0.0 114.141 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.29 133.27 55.5 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 174.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 3.8 mp -104.52 117.06 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -88.35 -18.04 29.29 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.165 -171.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -141.48 79.02 17.72 Favored Pre-proline 0 CA--C 1.529 0.138 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.9 44.25 1.53 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 125.2 3.933 . . . . 0.0 112.542 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.05 -4.76 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 121.693 -0.629 . . . . 0.0 110.523 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -138.47 158.33 44.47 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 177.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 45.2 t -70.83 117.87 12.9 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.0 mm -78.38 144.41 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.08 159.11 41.82 Favored 'General case' 0 N--CA 1.458 -0.064 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 43.3 p -66.87 -19.72 65.79 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -75.88 -47.24 26.23 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.7 m -70.29 -32.69 51.4 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.0 mt -70.94 -33.99 71.03 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 176.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -73.19 -29.11 62.59 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 174.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 7.2 m -67.99 -33.18 74.13 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 41.4 pt -91.68 -24.07 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 118.225 0.466 . . . . 0.0 111.785 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 94.6 m -89.0 -24.53 22.36 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.442 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.1 t30 -63.57 -42.37 72.43 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 73.7 Cg_endo -69.31 -16.42 39.45 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 CA-C-N 120.873 1.347 . . . . 0.0 111.192 177.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 80.5 m -84.01 -14.62 50.23 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 122.175 -0.328 . . . . 0.0 111.337 177.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 153.2 172.92 21.94 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.8 101.5 0.92 Allowed 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 124.007 3.138 . . . . 0.0 110.45 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 75.8 t -71.21 147.52 11.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -118.74 -35.98 3.57 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 119.178 -0.439 . . . . 0.0 111.721 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 25.8 mtm180 -150.37 151.72 33.28 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.693 0.679 . . . . 0.0 112.767 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 25.1 mt -148.74 137.92 15.59 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 124.132 0.973 . . . . 0.0 110.109 177.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.2 m -143.44 161.31 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 C-N-CA 124.127 0.971 . . . . 0.0 109.983 173.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 52.6 mt -131.36 143.27 41.11 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 C-N-CA 122.793 0.437 . . . . 0.0 110.737 -175.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.262 5.1 p90 -146.72 158.96 44.02 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 175.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -138.53 30.22 2.36 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.115 0.566 . . . . 0.0 111.82 -177.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -66.17 -30.11 70.52 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.323 0.861 . . . . 0.0 113.323 -174.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -130.55 1.24 4.49 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 171.85 -128.51 1.59 Allowed Glycine 0 CA--C 1.522 0.473 0 N-CA-C 108.65 -1.78 . . . . 0.0 108.65 -174.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 17.3 t -138.51 115.11 10.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 117.44 0.62 . . . . 0.0 110.351 174.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 9.4 mp0 -143.64 169.78 17.08 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.552 0.692 . . . . 0.0 111.924 -172.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -152.82 168.52 25.47 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.083 0.953 . . . . 0.0 108.818 175.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 68.9 mmm -134.34 151.5 51.27 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.767 -0.456 . . . . 0.0 109.767 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 40.3 t -141.62 144.5 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 C-N-CA 123.0 0.52 . . . . 0.0 110.433 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -131.92 136.28 47.27 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.616 0.366 . . . . 0.0 110.775 178.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -108.67 162.65 13.96 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 -177.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -83.98 -6.54 59.44 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 29.2 t -153.66 149.54 27.65 Favored 'General case' 0 N--CA 1.456 -0.13 0 O-C-N 121.954 -0.466 . . . . 0.0 111.785 -176.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 55.2 t -68.75 -35.69 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -68.16 -28.29 67.16 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.06 -0.4 . . . . 0.0 110.775 -178.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 61.4 m -74.88 -31.2 61.53 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 176.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.46 -33.53 60.85 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 122.411 0.284 . . . . 0.0 111.083 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -69.59 -43.94 71.78 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 117.904 0.32 . . . . 0.0 111.538 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -75.27 -25.17 57.77 Favored 'General case' 0 N--CA 1.457 -0.084 0 CA-C-N 117.815 0.28 . . . . 0.0 110.866 -177.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -71.48 -42.49 68.03 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 176.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.413 ' HE3' ' HB3' ' A' ' 245' ' ' LYS . 1.0 OUTLIER -75.4 -20.49 58.89 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.739 0.416 . . . . 0.0 111.262 -179.669 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -94.87 -12.07 27.61 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 45.1 t -113.58 -34.96 5.37 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 68.6 mt -89.95 -6.84 55.26 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 118.176 0.444 . . . . 0.0 111.963 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -71.9 131.96 43.7 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 177.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.59 -4.08 52.35 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.744 -0.476 . . . . 0.0 112.171 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.61 166.45 21.86 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 117.818 0.809 . . . . 0.0 110.303 178.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -123.33 139.9 53.57 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 84.8 mt -74.7 -41.36 47.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 N-CA-C 109.668 -0.494 . . . . 0.0 109.668 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.363 44.1 m-85 -82.8 -12.02 57.81 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 117.316 2.339 . . . . 0.0 117.316 178.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.7 t 66.31 34.66 6.31 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.627 0.727 . . . . 0.0 110.685 -174.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 175.97 -23.65 0.06 OUTLIER Glycine 0 CA--C 1.529 0.96 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 77.2 m -146.63 -177.15 5.49 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.711 1.204 . . . . 0.0 109.536 178.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 91.4 m 57.85 37.55 26.99 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -176.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.88 148.2 13.71 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 175.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 74.2 mt -115.98 156.04 26.96 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -172.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -138.57 140.15 38.92 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.398 1.479 . . . . 0.0 107.482 169.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 37.4 mt -141.79 141.49 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 CA-C-O 120.976 0.417 . . . . 0.0 111.72 -172.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 6.9 pm0 -156.59 164.21 38.45 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 174.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.273 41.2 m-85 -61.46 137.67 58.25 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 177.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . 0.437 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -91.51 156.79 17.43 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.663 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.414 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 63.9 pttt -88.56 -31.57 0.39 Allowed Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 48.7 Cg_endo -79.65 167.73 20.38 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.006 1.804 . . . . 0.0 110.172 176.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.278 0.2 OUTLIER -137.25 8.45 2.92 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -175.829 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.66 128.46 7.24 Favored 'General case' 0 C--O 1.227 -0.12 0 O-C-N 121.416 -0.803 . . . . 0.0 111.942 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.404 ' HG ' ' C6 ' ' B' ' 3' ' ' ' A' . 20.1 mt -92.33 157.28 16.72 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 123.893 0.877 . . . . 0.0 110.722 176.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.445 ' C ' ' H61' ' B' ' 5' ' ' ' A' . 55.6 m-80 -117.34 54.52 0.88 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.704 0.802 . . . . 0.0 109.473 173.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.4 t -55.76 147.38 4.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -176.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -132.61 -2.94 3.35 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 116.934 2.198 . . . . 0.0 116.934 -176.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -161.89 160.85 28.48 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.316 0.246 . . . . 0.0 110.812 -174.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -123.18 111.02 16.0 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.606 0.762 . . . . 0.0 109.564 173.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 56.6 p30 -157.81 -169.98 3.03 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.334 1.054 . . . . 0.0 108.372 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -68.59 -10.8 58.16 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -174.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -111.58 -22.27 11.32 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.1 p -142.58 138.92 31.13 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.686 1.195 . . . . 0.0 112.295 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 21.0 t-105 -158.44 155.55 28.78 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 119.724 -0.791 . . . . 0.0 110.932 -177.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -135.39 116.49 14.34 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.725 0.81 . . . . 0.0 111.108 173.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.292 66.1 m-85 -79.99 9.17 5.74 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 117.524 2.416 . . . . 0.0 117.524 -172.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 8.9 t -139.72 -20.68 0.91 Allowed 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -95.36 113.14 61.0 Favored Pre-proline 0 CA--C 1.532 0.264 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 174.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -82.04 -14.46 9.73 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.504 2.803 . . . . 0.0 112.462 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -72.26 -18.52 61.81 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -174.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 63.8 mt -84.38 -6.65 59.41 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.229 0.468 . . . . 0.0 111.904 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 73.0 m -76.84 -13.06 60.04 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 111.971 0.359 . . . . 0.0 111.971 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -84.41 -10.4 79.95 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -88.07 161.5 17.3 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.095 0.558 . . . . 0.0 110.959 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.133 0 CA-C-O 117.429 -1.762 . . . . 0.0 111.104 179.794 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . 0.403 ' C8 ' H5'' ' B' ' 1' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -3.022 0 C5'-C4'-C3' 110.508 -3.328 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.475 HO2' ' P ' ' B' ' 3' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.613 0 C3'-C2'-C1' 98.367 -3.482 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.475 ' P ' HO2' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.421 -2.665 2 C5'-C4'-C3' 108.823 -4.452 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.735 0 C5'-C4'-C3' 109.523 -3.985 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.445 ' H61' ' C ' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.416 -3.065 1 C3'-C2'-C1' 105.299 4.221 OUTLIER-DELTA 0.044 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.62 0 O4'-C1'-N19 111.68 3.48 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 110.704 -0.11 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? 61.48 154.48 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.113 1.365 . . . . 0.0 112.517 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 84.6 mt -70.68 147.34 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 122.948 0.499 . . . . 0.0 110.239 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 97.6 p -153.5 162.75 40.96 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 122.951 0.5 . . . . 0.0 110.143 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.407 ' N ' ' CD ' ' A' ' 179' ' ' PRO . 78.4 mtt85 -72.53 -38.35 5.11 Favored Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -177.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 178' ' ' ARG . 50.4 Cg_exo -57.78 145.55 89.8 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.624 2.216 . . . . 0.0 112.333 177.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 73.9 -3.0 38.98 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.405 -0.664 . . . . 0.0 113.491 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -81.55 -11.81 59.02 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.295 1.048 . . . . 0.0 109.566 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 71.0 m -67.36 149.35 50.43 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 121.955 -0.466 . . . . 0.0 110.184 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 27.3 p-10 -61.31 -23.1 65.47 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -175.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -81.55 8.26 10.07 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 70.7 m -137.44 -1.2 2.11 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -148.93 8.43 0.75 Allowed 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 57.8 m -145.74 17.39 1.45 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 122.981 0.512 . . . . 0.0 111.886 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.7 m -69.96 105.88 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 -178.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -130.44 10.48 5.25 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.757 0.823 . . . . 0.0 112.324 177.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 70.1 m 64.18 21.09 12.44 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 -176.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 39.8 t -130.54 132.77 64.36 Favored 'Isoleucine or valine' 0 C--N 1.338 0.091 0 CA-C-N 118.215 0.461 . . . . 0.0 111.17 177.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 8.1 mp -122.07 149.88 42.93 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 123.949 0.899 . . . . 0.0 110.563 -174.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 27.0 tp -102.56 135.8 43.53 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 170.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -115.93 104.18 11.35 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.102 1.361 . . . . 0.0 114.071 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.87 133.19 34.88 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 175.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.5 mp -102.76 124.23 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -90.49 -19.26 24.04 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -173.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -141.96 78.87 16.96 Favored Pre-proline 0 CA--C 1.53 0.178 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -77.34 45.73 1.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.764 1 C-N-CA 125.444 4.096 . . . . 0.0 112.275 -177.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.76 -4.09 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 O-C-N 121.818 -0.552 . . . . 0.0 110.508 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -137.39 156.55 48.07 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 175.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 66.4 m -69.11 112.95 6.05 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.3 mm -78.36 141.77 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.02 161.34 35.09 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.4 p -64.03 -17.67 63.58 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -75.07 -46.75 32.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.712 0.291 . . . . 0.0 111.572 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 1.6 m -70.1 -32.12 49.99 Favored 'Isoleucine or valine' 0 C--N 1.338 0.107 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.69 -34.93 70.06 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 176.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -71.08 -29.66 65.59 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 174.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 10.1 m -68.29 -34.19 75.71 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 42.0 pt -91.41 -22.98 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 118.41 0.55 . . . . 0.0 111.907 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 97.4 m -90.1 -23.6 21.34 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.439 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 26.6 t30 -63.88 -43.24 75.15 Favored Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 73.9 Cg_endo -69.51 -14.45 36.9 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.416 1.41 . . . . 0.0 111.32 177.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 96.8 m -85.43 -16.12 40.75 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 118.011 0.369 . . . . 0.0 111.48 176.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 154.75 171.71 21.81 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.613 -0.595 . . . . 0.0 111.613 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.27 98.86 0.66 Allowed 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.744 2.962 . . . . 0.0 110.633 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 63.9 t -69.45 145.91 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -115.12 -37.85 4.0 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 119.365 -0.35 . . . . 0.0 111.233 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 63.4 mtm-85 -147.66 152.34 37.69 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 25.5 mt -148.0 137.7 16.37 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 C-N-CA 124.144 0.978 . . . . 0.0 109.706 176.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 12.8 m -143.95 161.65 15.71 Favored 'Isoleucine or valine' 0 C--N 1.338 0.082 0 C-N-CA 123.553 0.741 . . . . 0.0 110.115 174.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 35.8 mt -135.67 141.91 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 122.824 0.45 . . . . 0.0 110.628 -175.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.316 4.1 p90 -138.15 156.84 47.34 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 176.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -128.5 15.59 6.55 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.425 0.69 . . . . 0.0 110.522 -173.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -63.58 -31.92 73.23 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -169.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -130.65 6.47 4.75 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 118.686 0.675 . . . . 0.0 112.494 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 163.02 -124.82 1.32 Allowed Glycine 0 CA--C 1.521 0.419 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 -174.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 45.5 t -141.97 114.93 4.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -142.45 166.07 25.68 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.904 0.383 . . . . 0.0 110.578 -177.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.15 164.88 30.82 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.583 0.753 . . . . 0.0 109.416 175.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 62.9 mmm -133.06 153.21 51.71 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 39.1 t -139.79 145.5 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 C-N-CA 122.838 0.455 . . . . 0.0 110.409 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -130.22 133.08 46.3 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.918 0.487 . . . . 0.0 110.529 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -108.02 161.35 15.03 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -82.92 -8.18 59.59 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 29.2 t -155.01 149.49 26.31 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 121.916 -0.49 . . . . 0.0 111.554 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 51.1 t -67.76 -35.9 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -68.14 -28.57 67.42 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.112 0.415 . . . . 0.0 111.137 -177.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 58.3 m -74.32 -32.34 62.8 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 176.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.71 -29.73 56.38 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.621 0.369 . . . . 0.0 110.934 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -69.98 -44.07 70.2 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.147 -0.345 . . . . 0.0 111.439 178.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -75.39 -25.09 57.33 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.878 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -70.97 -39.35 72.56 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.127 0.422 . . . . 0.0 110.255 176.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.08 -25.59 58.69 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 122.639 0.376 . . . . 0.0 110.298 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -91.2 -10.29 42.23 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 46.1 t -117.04 -36.48 3.8 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -176.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 78.7 mt -88.36 -8.29 55.31 Favored 'General case' 0 C--N 1.338 0.108 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -71.47 133.36 45.81 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.54 -5.28 46.28 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 119.681 -0.511 . . . . 0.0 112.298 -178.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.67 166.45 22.5 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 117.833 0.817 . . . . 0.0 110.253 177.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -123.65 139.84 53.6 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 87.0 mt -74.92 -41.53 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.373 42.7 m-85 -82.88 -11.81 57.9 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 117.151 2.278 . . . . 0.0 117.151 178.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 29.9 t 65.25 35.52 7.64 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.385 0.674 . . . . 0.0 110.74 -174.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 175.56 -23.98 0.06 OUTLIER Glycine 0 CA--C 1.53 1.028 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 72.0 m -145.32 -176.87 5.28 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.686 1.195 . . . . 0.0 109.199 178.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 84.3 m 57.74 36.93 27.04 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -176.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.35 149.55 9.96 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 114.471 1.285 . . . . 0.0 114.471 175.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 79.0 mt -116.87 154.35 30.92 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -172.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -137.0 137.65 39.66 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.276 1.43 . . . . 0.0 107.414 169.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 56.7 mt -139.57 142.78 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 CA-C-O 120.566 0.222 . . . . 0.0 111.578 -170.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -160.63 162.88 32.86 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.295 0.638 . . . . 0.0 109.622 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.264 50.8 m-85 -59.43 139.75 56.8 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 176.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . 0.462 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -88.32 165.3 15.08 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -176.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -79.21 -51.55 1.26 Allowed Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 118.445 -0.788 . . . . 0.0 112.065 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.27 175.16 11.7 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.859 2.373 . . . . 0.0 111.303 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.45 -3.54 3.01 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -176.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -158.28 130.22 6.83 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 118.92 0.782 . . . . 0.0 112.564 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.451 ' HG ' ' C6 ' ' B' ' 3' ' ' ' A' . 23.7 mt -84.57 164.46 18.7 Favored 'General case' 0 N--CA 1.458 -0.055 0 C-N-CA 124.378 1.071 . . . . 0.0 111.651 176.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -120.77 54.06 1.09 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.386 170.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.7 t -53.0 147.44 2.07 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -175.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -138.07 -1.35 1.97 Allowed 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 116.92 2.193 . . . . 0.0 116.92 -176.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -159.11 161.57 36.38 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -172.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -125.6 108.35 11.49 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.199 0.999 . . . . 0.0 109.681 174.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -158.31 -166.17 1.87 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 177.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -68.64 -9.97 53.2 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -174.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -117.42 -17.32 10.1 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.16 141.85 34.09 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.772 0.829 . . . . 0.0 113.016 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 17.8 t-105 -163.63 156.63 18.43 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 118.554 0.615 . . . . 0.0 110.445 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -142.11 120.44 12.33 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.305 172.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -81.95 5.59 18.63 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 117.192 2.293 . . . . 0.0 117.192 -173.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 3.6 t -141.18 -11.83 0.95 Allowed 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -178.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -95.37 113.34 61.44 Favored Pre-proline 0 CA--C 1.534 0.365 0 O-C-N 121.951 -0.468 . . . . 0.0 110.097 177.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -82.28 -13.72 9.83 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.649 2.899 . . . . 0.0 112.566 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -73.54 -7.18 50.82 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -173.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 46.3 mt -79.92 0.26 32.1 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 122.026 -0.421 . . . . 0.0 112.077 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 99.5 p -71.4 -3.31 20.15 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 122.834 0.453 . . . . 0.0 111.822 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -73.79 -9.52 79.23 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 119.869 -0.406 . . . . 0.0 112.342 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 43.2 mm-40 -72.17 161.63 30.6 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 117.87 0.835 . . . . 0.0 111.506 177.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.205 0 CA-C-O 117.38 -1.789 . . . . 0.0 110.814 179.928 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.009 0 C3'-C2'-C1' 104.435 3.261 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.462 ' N3 ' ' HA ' ' A' ' 265' ' ' ALA . . . . . . . . 0 O4'--C4' 1.418 -2.927 0 C3'-C2'-C1' 98.21 -3.656 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.451 ' C6 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.419 -2.804 0 O4'-C1'-N19 112.056 3.856 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.76 0 C5'-C4'-C3' 109.765 -3.823 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.42 ' N3 ' " H2'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -2.994 1 C3'-C2'-C1' 105.194 4.104 OUTLIER-DELTA 0.038 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.517 1 O4'-C1'-N19 112.318 4.118 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 . . . . . 0 N--CA 1.477 0.91 0 N-CA-C 110.858 -0.052 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -153.79 148.42 26.29 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 1.2 mt 54.62 22.02 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.652 0.781 . . . . 0.0 111.304 -173.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 68.5 m -70.71 156.73 39.12 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 122.028 -0.42 . . . . 0.0 110.837 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -141.36 151.71 61.97 Favored Pre-proline 0 CA--C 1.528 0.123 0 C-N-CA 123.567 0.747 . . . . 0.0 110.032 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -70.92 -13.25 31.64 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.562 2.841 . . . . 0.0 111.642 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -71.0 -1.41 40.28 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 123.302 0.477 . . . . 0.0 112.489 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -68.83 -20.28 64.3 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 117.601 0.701 . . . . 0.0 111.526 -178.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 34.2 t -157.95 151.17 23.2 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.302 0.641 . . . . 0.0 109.95 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.5 p30 -75.42 -7.22 53.49 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -71.83 0.88 7.96 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 99.2 p -146.82 7.49 0.94 Allowed 'General case' 0 C--O 1.231 0.131 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -177.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 4.5 ppt_? -146.42 5.09 0.93 Allowed 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 65.9 m -148.21 13.01 0.97 Allowed 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.4 m -70.75 104.63 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -177.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 49.8 p30 -130.77 10.54 5.11 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.718 0.807 . . . . 0.0 112.237 177.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 57.8 m 66.24 19.58 11.06 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -177.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 37.2 t -128.4 143.55 40.67 Favored 'Isoleucine or valine' 0 C--N 1.339 0.116 0 C-N-CA 123.167 0.587 . . . . 0.0 110.79 178.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 82.6 mt -135.61 149.0 49.24 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.868 0.467 . . . . 0.0 111.104 -175.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 39.2 tp -101.11 135.45 42.54 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 172.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -113.57 101.37 9.27 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 125.148 1.379 . . . . 0.0 114.6 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.2 m -86.8 133.84 33.61 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 175.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.0 mp -103.94 126.0 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -94.06 -18.42 21.84 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -172.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -141.24 78.99 18.22 Favored Pre-proline 0 CA--C 1.529 0.164 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -77.41 49.03 2.74 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 125.003 3.802 . . . . 0.0 112.278 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.23 -6.78 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 O-C-N 121.787 -0.571 . . . . 0.0 110.224 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -141.73 154.68 45.45 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.158 1.383 . . . . 0.0 112.394 175.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.4 t -74.15 131.46 41.3 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.157 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 21.9 mm -81.14 148.37 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 122.923 0.489 . . . . 0.0 109.913 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.89 157.89 44.83 Favored 'General case' 0 C--O 1.231 0.079 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 177.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.3 p -63.88 -18.75 64.49 Favored 'General case' 0 N--CA 1.458 -0.057 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -73.4 -47.3 43.05 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.717 0.294 . . . . 0.0 111.544 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.5 m -71.06 -32.31 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.16 -36.61 72.09 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 176.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -70.82 -30.14 66.49 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 175.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 8.9 m -67.59 -33.76 75.66 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 38.6 pt -92.38 -24.31 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 118.585 0.63 . . . . 0.0 111.77 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 95.6 m -88.49 -26.39 22.08 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.441 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 35.1 t30 -64.71 -42.53 64.86 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 71.9 Cg_endo -70.29 -12.74 32.42 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.493 1.462 . . . . 0.0 111.262 177.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 96.4 m -90.43 -9.23 48.29 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.031 0.378 . . . . 0.0 111.665 176.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 151.41 167.72 15.16 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 178.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.26 103.03 1.01 Allowed 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.903 3.069 . . . . 0.0 110.584 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 71.9 t -70.67 145.25 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -113.74 -39.27 4.05 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 119.205 -0.426 . . . . 0.0 111.28 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -149.15 152.8 36.72 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.267 0.485 . . . . 0.0 112.046 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 23.6 mt -147.28 135.72 15.34 Favored 'Isoleucine or valine' 0 C--N 1.338 0.073 0 C-N-CA 124.025 0.93 . . . . 0.0 109.912 177.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 1.6 m -140.38 160.61 25.16 Favored 'Isoleucine or valine' 0 C--N 1.337 0.062 0 C-N-CA 123.55 0.74 . . . . 0.0 111.715 174.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 53.7 mt -135.82 144.02 34.71 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 C-N-CA 123.127 0.571 . . . . 0.0 110.163 -175.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.299 3.5 p90 -143.35 156.47 44.7 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 175.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 5.8 mmt180 -127.35 17.68 7.04 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.32 0.648 . . . . 0.0 110.002 -174.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -64.89 -31.74 73.12 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -169.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -130.47 5.89 4.79 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 118.606 0.639 . . . . 0.0 111.893 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 163.04 -124.35 1.28 Allowed Glycine 0 C--N 1.334 0.442 0 N-CA-C 108.696 -1.761 . . . . 0.0 108.696 -173.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 49.1 t -142.6 114.04 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 -142.86 166.07 25.65 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.117 0.484 . . . . 0.0 110.845 -176.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.09 164.99 31.29 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.487 175.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 57.9 mmm -132.42 152.82 51.33 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 39.1 t -141.12 146.03 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 C-N-CA 123.116 0.566 . . . . 0.0 110.37 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -132.52 135.59 46.09 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 122.536 0.335 . . . . 0.0 110.593 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -107.78 162.92 13.55 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 -176.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -75.74 -17.21 59.99 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 86.5 p -155.13 159.63 40.34 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.175 0.512 . . . . 0.0 111.263 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 54.8 t -67.34 -35.22 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -66.56 -28.18 68.32 Favored 'General case' 0 N--CA 1.456 -0.139 0 O-C-N 122.18 -0.325 . . . . 0.0 111.021 -177.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 74.4 m -75.94 -32.68 59.67 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 177.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.54 -32.63 58.34 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.416 -0.177 . . . . 0.0 111.086 178.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -66.76 -44.03 82.51 Favored 'General case' 0 C--N 1.338 0.09 0 O-C-N 122.036 -0.415 . . . . 0.0 111.558 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -75.59 -26.34 57.8 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.898 -178.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -74.16 -40.85 62.3 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.03 0.377 . . . . 0.0 110.148 178.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -73.57 -23.22 59.93 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.862 0.465 . . . . 0.0 111.063 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -92.4 -17.04 25.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 48.2 t -106.67 -36.17 6.8 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -176.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 76.7 mt -88.67 -8.03 55.3 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -70.78 134.27 47.26 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.65 -6.45 39.32 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 119.676 -0.513 . . . . 0.0 112.458 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -77.41 166.34 23.25 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 117.759 0.78 . . . . 0.0 110.187 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 5.0 p30 -123.24 140.56 52.89 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 80.8 mt -74.98 -43.03 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.071 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.36 50.2 m-85 -82.78 -10.05 59.05 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 29.1 t 66.38 34.78 6.11 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.629 0.772 . . . . 0.0 111.126 -175.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 175.47 -24.45 0.06 OUTLIER Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 178.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 81.4 m -144.69 -176.97 5.27 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.692 1.197 . . . . 0.0 109.264 178.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 96.2 m 57.4 39.18 28.41 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -175.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.04 146.4 18.18 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 175.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 89.1 mt -110.78 154.41 23.98 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -172.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -137.92 135.98 36.59 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.865 1.666 . . . . 0.0 106.679 169.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 44.6 mt -138.43 141.67 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-O 120.618 0.247 . . . . 0.0 111.142 -172.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -158.76 164.11 36.14 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 175.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.288 43.4 m-85 -61.75 135.38 57.58 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 177.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . 0.431 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -85.35 162.85 18.89 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.369 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.436 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 63.4 pttt -94.06 -32.56 0.3 Allowed Pre-proline 0 CA--C 1.54 0.567 0 CA-C-O 117.29 -1.338 . . . . 0.0 114.225 178.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 86.3 Cg_endo -76.3 171.52 17.93 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 CA-C-N 122.04 1.764 . . . . 0.0 110.055 175.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.21 -1.91 2.33 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 117.72 2.489 . . . . 0.0 117.72 -175.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.15 130.95 9.98 Favored 'General case' 0 C--N 1.338 0.075 0 CA-C-N 119.145 0.884 . . . . 0.0 111.888 -177.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.431 ' HG ' ' C6 ' ' B' ' 3' ' ' ' A' . 25.1 mt -90.97 157.05 17.52 Favored 'General case' 0 C--N 1.338 0.069 0 C-N-CA 124.125 0.97 . . . . 0.0 111.408 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.441 ' C ' ' H61' ' B' ' 5' ' ' ' A' . 65.6 m-80 -120.85 50.99 1.28 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.836 0.854 . . . . 0.0 109.41 173.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 3.0 t -51.63 144.74 2.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -177.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.425 ' CZ ' ' C2 ' ' B' ' 5' ' ' ' A' . 6.6 p90 -131.26 -0.15 4.08 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 116.472 2.027 . . . . 0.0 116.472 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -159.06 166.44 31.66 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.839 0.456 . . . . 0.0 111.374 -175.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -125.9 113.58 17.39 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.062 0.945 . . . . 0.0 109.05 172.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 57.1 p30 -156.3 -167.09 2.33 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -69.56 -13.83 62.53 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -176.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -100.02 -34.05 10.24 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.3 p -141.26 148.66 40.19 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 18.9 t-105 -157.54 154.98 29.47 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -176.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -135.07 118.92 17.26 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 122.873 0.469 . . . . 0.0 111.711 175.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.252 68.6 m-85 -84.19 6.44 22.59 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 117.263 2.32 . . . . 0.0 117.263 -171.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 3.8 t -142.99 -16.25 0.68 Allowed 'General case' 0 C--O 1.232 0.143 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -176.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -95.26 113.22 61.08 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 118.399 0.545 . . . . 0.0 110.556 177.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -83.12 -12.18 9.54 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.613 2.875 . . . . 0.0 112.568 177.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -72.8 -9.59 58.83 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -173.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 80.2 mt -73.65 -24.72 60.04 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 118.386 0.539 . . . . 0.0 110.749 178.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 67.7 m 52.83 10.28 0.15 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.818 1.247 . . . . 0.0 114.151 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 62.9 17.43 58.39 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 118.534 0.606 . . . . 0.0 111.688 -177.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 56.02 20.82 4.56 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.079 0.951 . . . . 0.0 112.758 -173.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.133 0 CA-C-O 117.465 -1.742 . . . . 0.0 111.164 179.754 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.912 0 C5'-C4'-C3' 110.043 -3.638 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.456 HO2' ' P ' ' B' ' 3' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.544 0 O4'-C1'-N19 111.801 3.601 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.456 ' P ' HO2' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.422 -2.613 1 C5'-C4'-C3' 109.164 -4.224 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.178 0 C5'-C4'-C3' 110.163 -3.558 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.441 ' H61' ' C ' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.417 -3.034 0 C3'-C2'-C1' 104.777 3.641 . 0.016 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.607 0 O4'-C1'-N19 112.157 3.957 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 32.6 tp60 . . . . . 0 N--CA 1.476 0.838 0 CA-C-O 120.386 0.136 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -70.23 140.38 52.41 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.011 0.524 . . . . 0.0 110.558 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 47.3 mm -73.02 143.81 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 C-N-CA 122.953 0.501 . . . . 0.0 110.21 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 46.8 t -156.88 157.72 35.4 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 123.071 0.548 . . . . 0.0 109.768 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 86.1 mtt-85 -68.74 145.54 96.97 Favored Pre-proline 0 CA--C 1.529 0.166 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.22 167.68 26.61 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.48 2.787 . . . . 0.0 109.656 173.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -67.88 -8.79 54.65 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 177.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -78.45 -5.86 53.69 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 38.1 m -69.6 153.94 42.73 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-O 120.987 0.422 . . . . 0.0 111.188 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -54.11 -34.13 59.47 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -75.31 6.74 4.11 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 70.9 m -140.98 1.35 1.65 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -175.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -147.86 10.25 0.92 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 178.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 58.8 m -143.01 4.64 1.46 Allowed 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.2 m -76.46 123.67 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -130.88 10.39 5.04 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.282 0.633 . . . . 0.0 112.216 177.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 41.2 p 60.93 24.39 14.43 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.523 1.529 . . . . 0.0 113.518 -175.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 45.1 t -130.27 139.56 51.08 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 123.516 0.727 . . . . 0.0 109.523 174.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 89.4 mt -128.51 158.04 39.51 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.843 0.354 . . . . 0.0 111.536 -173.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 9.7 tt -115.92 135.85 53.59 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.255 174.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -114.37 106.26 14.1 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 114.684 1.365 . . . . 0.0 114.684 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -88.23 142.8 27.46 Favored 'General case' 0 N--CA 1.458 -0.072 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 174.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.3 mp -115.34 124.14 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 21.0 mt -85.24 -24.92 27.6 Favored 'General case' 0 C--N 1.337 0.064 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -173.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -141.22 79.06 18.17 Favored Pre-proline 0 N--CA 1.456 -0.171 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -177.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -76.86 49.97 2.92 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 125.137 3.891 . . . . 0.0 112.153 -177.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.55 -7.23 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 O-C-N 121.954 -0.466 . . . . 0.0 110.019 177.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -140.2 152.15 45.77 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.238 1.415 . . . . 0.0 112.193 175.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 35.9 t -74.4 133.08 42.47 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 117.851 0.296 . . . . 0.0 110.56 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 24.2 mm -83.32 150.06 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 123.028 0.531 . . . . 0.0 109.841 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.87 155.73 49.35 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 177.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.5 p -64.38 -21.72 66.72 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -79.01 -35.97 41.95 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 75.8 t -72.97 -40.81 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.3 mt -69.01 -32.0 71.24 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -70.28 -29.52 66.31 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 174.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.2 m -69.47 -32.82 71.97 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 45.0 pt -92.32 -21.75 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 118.422 0.555 . . . . 0.0 112.264 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 97.7 m -92.56 -26.57 17.84 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -178.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.449 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 36.3 t30 -64.04 -40.87 58.11 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 73.3 Cg_endo -69.44 -10.98 30.22 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 121.535 1.49 . . . . 0.0 111.887 177.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 91.0 m -95.99 -6.26 39.3 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 177.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 151.0 167.59 14.82 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 111.801 -0.519 . . . . 0.0 111.801 178.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.38 101.66 0.88 Allowed 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 123.965 3.11 . . . . 0.0 110.408 178.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 83.5 t -70.79 144.63 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -112.51 -39.45 4.36 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 119.363 -0.351 . . . . 0.0 111.262 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 65.8 mtm-85 -148.01 153.08 38.49 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 25.2 mt -145.13 139.9 22.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 124.308 1.043 . . . . 0.0 109.18 176.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 41.0 t -145.38 153.02 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.066 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 48.8 mt -134.34 142.24 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 C-N-CA 123.087 0.555 . . . . 0.0 110.178 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.305 2.7 p90 -143.19 156.1 44.69 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 176.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 6.2 mmt180 -127.75 18.22 6.78 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.274 0.63 . . . . 0.0 110.134 -173.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -66.22 -30.92 71.47 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 114.717 1.376 . . . . 0.0 114.717 -169.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -130.48 5.46 4.75 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 118.61 0.641 . . . . 0.0 112.129 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 164.35 -126.51 1.52 Allowed Glycine 0 CA--C 1.521 0.461 0 N-CA-C 108.043 -2.023 . . . . 0.0 108.043 -173.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.5 t -142.5 114.67 3.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 175.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -144.42 168.91 18.99 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.271 0.558 . . . . 0.0 110.718 -176.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.04 167.79 22.51 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.372 174.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 79.4 mmm -134.01 150.6 51.25 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 32.5 t -140.21 147.46 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 C-N-CA 122.895 0.478 . . . . 0.0 110.727 -177.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -133.31 134.87 44.4 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.03 0.532 . . . . 0.0 110.49 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -108.59 163.31 13.35 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 116.479 2.029 . . . . 0.0 116.479 -176.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -74.43 -16.79 60.86 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 84.9 p -157.12 161.23 39.39 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.275 0.559 . . . . 0.0 111.235 -178.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 45.7 t -66.62 -33.92 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -67.28 -30.21 70.02 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 117.886 0.312 . . . . 0.0 110.82 -177.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 68.7 m -75.49 -31.32 60.17 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 177.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.83 -33.32 60.07 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 119.629 -0.224 . . . . 0.0 111.172 178.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -67.48 -43.49 80.87 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 118.445 0.566 . . . . 0.0 111.487 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -74.42 -28.32 61.02 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.166 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -74.38 -39.8 62.48 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 118.094 0.406 . . . . 0.0 110.69 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -74.64 -23.54 58.7 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 122.748 0.419 . . . . 0.0 111.165 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -93.9 -15.57 24.85 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 47.8 t -106.7 -36.23 6.77 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 75.9 mt -89.35 -8.15 53.8 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -176.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -70.88 135.88 48.28 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.53 -6.76 36.27 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.621 -0.544 . . . . 0.0 112.308 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -76.82 166.49 23.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 117.69 0.745 . . . . 0.0 109.727 176.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -123.49 138.6 54.54 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 84.2 mt -72.29 -43.83 64.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.372 41.4 m-85 -82.79 -11.15 58.5 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 117.336 2.347 . . . . 0.0 117.336 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.9 t 64.79 37.19 7.5 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.692 0.758 . . . . 0.0 110.817 -175.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 174.52 -23.95 0.07 OUTLIER Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.001 0.81 . . . . 0.0 111.086 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 90.8 m -146.62 -177.16 5.49 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.122 1.369 . . . . 0.0 109.159 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 95.2 m 58.62 37.62 25.28 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -177.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.59 146.05 10.74 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 175.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 86.1 mt -109.56 154.68 22.39 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -173.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -139.76 136.77 34.47 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.772 1.629 . . . . 0.0 106.913 169.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 37.0 mt -137.94 141.15 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-O 120.715 0.293 . . . . 0.0 111.277 -172.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -158.53 163.67 36.85 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.785 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.25 47.8 m-85 -63.02 136.36 57.78 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 176.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -86.76 159.55 19.09 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.611 0.364 . . . . 0.0 110.751 -179.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.432 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 23.1 pttp -92.79 -31.76 0.32 Allowed Pre-proline 0 CA--C 1.538 0.513 0 CA-C-O 117.363 -1.304 . . . . 0.0 114.066 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 69.2 Cg_endo -77.51 170.17 19.77 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 CA-C-N 121.966 1.738 . . . . 0.0 109.781 173.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.7 -1.07 3.11 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 117.798 2.518 . . . . 0.0 117.798 -174.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.55 130.65 9.42 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 118.873 0.76 . . . . 0.0 111.421 -178.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.481 ' HG ' ' C6 ' ' B' ' 3' ' ' ' A' . 20.1 mt -90.76 156.95 17.68 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 123.78 0.832 . . . . 0.0 111.017 177.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.429 ' C ' ' H61' ' B' ' 5' ' ' ' A' . 59.2 m-80 -115.42 50.88 0.96 Allowed 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.367 0.667 . . . . 0.0 109.86 173.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 3.1 t -52.23 145.22 2.69 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -134.54 -3.63 2.64 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 -177.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -159.32 162.62 36.01 Favored 'General case' 0 N--CA 1.456 -0.132 0 O-C-N 122.225 -0.297 . . . . 0.0 111.277 -171.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -125.39 110.81 14.4 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.769 0.828 . . . . 0.0 109.629 174.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 54.6 p30 -159.04 -165.95 1.73 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -67.84 -8.94 40.37 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -174.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -120.77 -15.35 8.39 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.34 140.9 35.69 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 123.923 0.889 . . . . 0.0 113.073 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 -163.55 156.91 18.93 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.644 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -141.52 118.58 11.27 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.654 171.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -81.94 4.35 22.95 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 -172.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 3.0 t -140.89 -12.94 0.96 Allowed 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -177.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -95.2 113.48 61.62 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 118.014 0.37 . . . . 0.0 110.049 178.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -83.44 -14.28 8.15 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.646 2.898 . . . . 0.0 112.175 178.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -71.43 -8.83 56.37 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -172.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 69.8 mt -75.46 -18.54 59.84 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 118.234 0.47 . . . . 0.0 111.02 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 75.0 m 53.17 12.89 0.35 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.419 1.088 . . . . 0.0 113.728 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 67.36 5.74 37.14 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 119.676 -0.514 . . . . 0.0 112.371 -178.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 53.51 22.93 3.17 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.787 0.835 . . . . 0.0 112.564 -175.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.115 0 CA-C-O 117.42 -1.767 . . . . 0.0 111.089 -179.797 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.066 0 C5'-C4'-C3' 109.852 -3.765 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.434 HO2' ' P ' ' B' ' 3' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.727 0 O4'-C1'-N19 111.202 3.002 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.481 ' C6 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.42 -2.709 1 C5'-C4'-C3' 109.07 -4.286 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.797 1 C5'-C4'-C3' 109.185 -4.21 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.429 ' H61' ' C ' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.42 -2.755 1 C3'-C2'-C1' 105.187 4.097 OUTLIER-DELTA 0.054 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.615 0 O4'-C1'-N19 112.191 3.991 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 120.386 0.136 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -154.98 151.64 28.74 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 122.864 0.465 . . . . 0.0 109.84 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 85.1 mt -68.34 145.88 13.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 C-N-CA 122.839 0.456 . . . . 0.0 109.932 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 94.2 p -154.27 161.81 41.57 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.023 0.529 . . . . 0.0 109.712 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -145.16 157.99 52.56 Favored Pre-proline 0 CA--C 1.529 0.165 0 C-N-CA 123.59 0.756 . . . . 0.0 109.677 -178.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.01 -15.5 27.98 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.468 2.778 . . . . 0.0 113.382 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -82.09 -13.68 78.66 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 120.034 -0.315 . . . . 0.0 112.479 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -80.42 -64.28 1.22 Allowed 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 37.7 t -70.12 147.93 49.34 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 122.536 0.334 . . . . 0.0 110.606 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 8.2 p30 -74.14 -9.28 58.46 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -70.56 -2.83 15.39 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 67.1 m -141.93 6.32 1.78 Allowed 'General case' 0 C--O 1.231 0.119 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -176.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -148.47 5.15 0.71 Allowed 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 64.2 m -147.44 12.11 1.03 Allowed 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 1.9 m -69.11 104.36 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -178.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -130.58 10.54 5.19 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.515 0.726 . . . . 0.0 111.956 177.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 54.5 m 65.22 21.21 12.06 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -177.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.1 t -131.85 133.71 60.84 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 CA-C-N 118.038 0.381 . . . . 0.0 111.018 176.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -121.56 153.32 38.18 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 122.817 0.447 . . . . 0.0 110.926 -176.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 22.8 tp -103.9 135.95 44.47 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 170.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -111.57 132.17 54.73 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.92 1.288 . . . . 0.0 114.419 176.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -121.58 130.09 53.28 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 175.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.4 mp -101.84 118.31 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -84.9 -19.37 32.38 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.027 0.531 . . . . 0.0 111.939 -171.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -141.72 78.99 17.3 Favored Pre-proline 0 CA--C 1.529 0.137 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -78.42 47.22 2.34 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 124.957 3.771 . . . . 0.0 111.926 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.24 -4.42 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 O-C-N 121.862 -0.524 . . . . 0.0 110.813 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -137.03 156.48 48.37 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 176.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 69.0 m -69.68 113.41 6.92 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 37.5 mm -78.26 141.8 14.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 177.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.11 160.88 36.45 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.5 p -64.84 -15.67 62.13 Favored 'General case' 0 CA--C 1.527 0.062 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -76.27 -44.98 34.8 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.785 0.326 . . . . 0.0 111.45 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 1.5 m -71.38 -32.62 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 179.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.4 mt -72.03 -34.16 68.58 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 176.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -71.64 -30.45 65.76 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 173.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.3 m -66.68 -33.92 76.72 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 42.9 pt -91.14 -24.94 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 118.352 0.523 . . . . 0.0 112.027 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 99.3 m -88.49 -25.54 22.52 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.093 0.86 . . . . 0.0 113.285 -178.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.439 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 31.9 t30 -64.51 -43.57 71.74 Favored Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 73.6 Cg_endo -69.85 -11.87 31.58 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.415 1.41 . . . . 0.0 111.519 177.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 94.4 m -92.28 -10.71 37.46 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.6 0.36 . . . . 0.0 111.847 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 155.09 169.56 19.76 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.767 -0.533 . . . . 0.0 111.767 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.88 96.88 0.7 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 124.138 3.226 . . . . 0.0 110.611 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 70.2 t -68.25 145.41 13.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -116.25 -39.93 3.33 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 119.147 -0.454 . . . . 0.0 111.32 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 63.4 mtm-85 -147.93 152.01 36.81 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 21.5 mt -148.42 137.14 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.272 1.029 . . . . 0.0 110.183 177.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 8.0 m -143.05 162.43 17.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 C-N-CA 123.778 0.831 . . . . 0.0 110.315 174.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 43.1 mt -134.34 143.18 38.77 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.075 0 C-N-CA 123.157 0.583 . . . . 0.0 110.486 -174.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.293 4.2 p90 -142.32 156.36 45.25 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 176.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -127.49 14.75 7.11 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.208 0.603 . . . . 0.0 110.905 -173.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -61.76 -32.58 72.84 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 -169.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -130.6 7.01 4.81 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.594 0.633 . . . . 0.0 112.278 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 163.41 -125.56 1.41 Allowed Glycine 0 C--N 1.336 0.551 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -174.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 24.2 t -140.99 112.02 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.152 0 C-N-CA 122.785 0.434 . . . . 0.0 109.915 175.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -141.8 168.03 20.72 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.212 0.529 . . . . 0.0 110.948 -175.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.98 169.2 21.14 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.75 0.82 . . . . 0.0 109.052 176.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 64.4 mmm -136.03 153.96 51.2 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 27.1 t -140.25 144.6 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.095 0 C-N-CA 123.063 0.545 . . . . 0.0 110.953 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -130.05 133.53 46.77 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.026 0.531 . . . . 0.0 110.252 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -108.9 161.32 15.25 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -177.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -80.62 -10.88 59.71 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 43.1 t -155.27 153.37 30.5 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 118.202 0.456 . . . . 0.0 111.864 -175.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 59.0 t -68.47 -38.52 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 123.0 0.52 . . . . 0.0 109.743 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -67.5 -26.61 66.43 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 122.153 -0.342 . . . . 0.0 111.08 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 48.8 m -75.88 -30.8 58.98 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 175.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.76 -33.21 58.09 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.579 0.352 . . . . 0.0 111.017 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -69.24 -44.14 72.56 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 122.228 -0.295 . . . . 0.0 111.665 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -74.12 -27.76 61.02 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 117.935 0.334 . . . . 0.0 111.105 -178.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -72.55 -39.82 67.18 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.177 0.444 . . . . 0.0 110.58 177.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.42 -23.75 54.0 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.433 0.293 . . . . 0.0 111.149 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -90.34 -14.73 32.51 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 48.2 t -109.51 -34.46 6.51 Favored 'General case' 0 C--N 1.338 0.068 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -177.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 78.3 mt -90.42 -7.92 51.92 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -70.93 132.57 45.41 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 75.66 -4.62 42.81 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.74 -0.478 . . . . 0.0 112.164 -177.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.26 166.4 22.18 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.859 0.829 . . . . 0.0 110.193 177.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -123.49 139.88 53.56 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 86.3 mt -73.71 -42.25 54.7 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.352 44.4 m-85 -82.86 -12.33 57.5 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 117.355 2.354 . . . . 0.0 117.355 178.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 23.1 t 65.14 36.34 7.29 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.69 0.757 . . . . 0.0 110.722 -174.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 176.05 -24.54 0.06 OUTLIER Glycine 0 CA--C 1.528 0.856 0 C-N-CA 123.792 0.71 . . . . 0.0 111.35 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 82.4 m -146.74 -176.57 5.24 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.897 1.279 . . . . 0.0 109.173 178.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 89.7 m 58.06 37.08 26.47 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.69 148.98 11.68 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 176.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 76.2 mt -115.54 155.31 27.8 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -172.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -139.08 138.17 36.85 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.141 1.376 . . . . 0.0 107.959 169.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 29.2 mt -140.17 143.69 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 CA-C-O 120.935 0.398 . . . . 0.0 111.388 -171.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -159.28 162.94 36.14 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.865 0.866 . . . . 0.0 109.518 175.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -62.22 138.5 58.43 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 115.933 1.827 . . . . 0.0 115.933 177.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -87.55 162.31 17.27 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 122.674 0.39 . . . . 0.0 111.722 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.402 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 53.7 mtmt -80.82 -52.62 0.87 Allowed Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 118.351 -0.833 . . . . 0.0 112.665 178.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 90.5 Cg_endo -72.28 171.09 17.63 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.104 2.536 . . . . 0.0 111.251 177.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.262 0.2 OUTLIER -136.16 2.72 2.82 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 117.844 2.535 . . . . 0.0 117.844 -175.6 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -157.7 130.35 7.37 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 121.635 -0.666 . . . . 0.0 112.106 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.443 ' HG ' ' C6 ' ' B' ' 3' ' ' ' A' . 36.4 mt -85.8 166.67 15.87 Favored 'General case' 0 CA--C 1.527 0.068 0 C-N-CA 124.445 1.098 . . . . 0.0 111.538 176.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.543 ' ND2' ' C2 ' ' B' ' 4' ' ' ' C' . 20.2 p30 -120.22 49.79 1.38 Allowed 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 169.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . 0.415 ' HA ' ' N1 ' ' B' ' 5' ' ' ' A' . 2.5 t -49.32 143.05 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.249 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -176.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -127.4 -7.4 5.8 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 117.945 2.572 . . . . 0.0 117.945 -176.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -162.87 174.72 12.04 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 122.77 0.428 . . . . 0.0 110.523 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -125.82 116.22 21.23 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.86 0.864 . . . . 0.0 109.628 174.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 52.7 p30 -157.74 -168.4 2.53 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.284 1.034 . . . . 0.0 109.718 178.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -68.97 -11.44 60.72 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -175.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -113.33 -17.56 12.26 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -144.6 141.13 29.19 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.864 0.866 . . . . 0.0 112.768 -178.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 18.9 t-105 -160.89 158.24 27.92 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 119.671 -0.812 . . . . 0.0 110.738 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -139.21 116.44 11.12 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.557 0.743 . . . . 0.0 109.774 172.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.266 67.7 m-85 -79.36 6.24 10.57 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 117.297 2.332 . . . . 0.0 117.297 -173.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 5.6 t -136.03 -20.49 1.47 Allowed 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -95.33 113.11 60.9 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 174.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -80.55 -15.18 11.19 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.606 2.871 . . . . 0.0 112.319 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -74.16 -16.07 61.0 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -173.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 51.4 mt -85.07 -4.06 59.02 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -178.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 74.2 m -80.45 -0.87 39.14 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 122.588 0.355 . . . . 0.0 111.681 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 76.32 -173.79 53.9 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 61.0 mm-40 -71.14 159.33 34.87 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 122.548 -0.384 . . . . 0.0 110.922 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 CA-C-O 117.174 -1.903 . . . . 0.0 111.294 179.262 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.866 0 C3'-C2'-C1' 104.451 3.279 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.446 HO2' ' P ' ' B' ' 3' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.691 0 C3'-C2'-C1' 98.348 -3.503 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.446 ' P ' HO2' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.422 -2.551 1 O4'-C1'-N19 112.228 4.028 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' ' C' . . . . . 0.543 ' C2 ' ' ND2' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.418 -2.921 0 C5'-C4'-C3' 109.575 -3.95 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.473 ' H61' ' C ' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.42 -2.784 1 C3'-C2'-C1' 105.407 4.341 OUTLIER-DELTA 0.04 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.623 0 O4'-C1'-N19 112.023 3.823 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 . . . . . 0 N--CA 1.475 0.82 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -74.03 -9.83 59.02 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.005 0.522 . . . . 0.0 111.61 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 7.0 tp -153.09 155.15 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 123.38 0.672 . . . . 0.0 109.511 -176.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 47.6 t -155.39 156.85 36.13 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.269 0.628 . . . . 0.0 110.062 178.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -144.88 152.61 52.36 Favored Pre-proline 0 C--O 1.232 0.153 0 C-N-CA 123.701 0.8 . . . . 0.0 109.785 -177.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -66.24 148.38 84.71 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 123.008 2.472 . . . . 0.0 110.083 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 76.3 -13.5 7.73 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-O 119.502 -0.61 . . . . 0.0 112.429 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -106.21 -14.58 15.09 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 177.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 85.1 p -79.08 155.76 28.63 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.133 0.573 . . . . 0.0 110.413 178.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -60.47 -24.14 65.03 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -74.03 6.65 3.23 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 178.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 36.3 t -143.51 -6.28 0.81 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -177.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 4.1 ppt_? -145.68 10.15 1.21 Allowed 'General case' 0 C--N 1.339 0.138 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 58.3 m -143.96 9.89 1.52 Allowed 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.5 m -64.85 123.82 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 122.665 0.386 . . . . 0.0 111.951 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -130.82 4.53 4.54 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -176.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 69.6 m 57.02 12.21 1.17 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -174.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 90.2 t -141.0 134.27 31.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -122.14 153.07 39.23 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 122.663 0.385 . . . . 0.0 111.299 -175.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 24.8 tp -100.03 136.73 39.49 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 169.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -113.07 112.47 23.91 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 176.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.72 125.8 45.66 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 175.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.6 mp -96.96 124.81 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 22.0 mt -86.2 -25.94 25.37 Favored 'General case' 0 N--CA 1.458 -0.056 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -174.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -141.33 79.04 17.98 Favored Pre-proline 0 N--CA 1.455 -0.218 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -176.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -76.71 46.63 1.93 Allowed 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 125.182 3.921 . . . . 0.0 112.278 -177.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.99 -4.68 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 O-C-N 121.845 -0.534 . . . . 0.0 110.703 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -135.75 158.48 44.29 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 176.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 68.6 m -68.94 112.57 5.68 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 42.6 mm -78.5 139.72 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 176.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.06 159.95 39.25 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.4 p -64.92 -17.05 64.01 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 176.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -75.18 -45.97 37.15 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.366 0.266 . . . . 0.0 111.378 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.1 m -71.19 -32.05 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.53 -34.68 70.25 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 176.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -71.47 -30.97 66.61 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 174.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 10.7 m -66.92 -33.84 76.47 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 42.8 pt -91.74 -22.44 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 119.012 -0.518 . . . . 0.0 112.042 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 92.8 m -91.27 -25.57 19.41 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -178.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.453 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 32.2 t30 -64.0 -41.83 65.38 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-O 118.412 -0.804 . . . . 0.0 113.087 -179.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 72.9 Cg_endo -69.13 -13.44 36.27 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 CA-C-N 120.938 1.371 . . . . 0.0 111.669 178.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 97.1 m -89.39 -8.03 53.96 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 177.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 146.88 168.75 13.97 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.469 -0.653 . . . . 0.0 111.469 176.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.55 104.35 0.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.678 2.919 . . . . 0.0 111.966 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 75.8 t -75.53 143.77 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 175.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -115.64 -39.45 3.53 Favored 'General case' 0 C--O 1.227 -0.115 0 CA-C-O 119.431 -0.318 . . . . 0.0 111.39 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 66.8 mtm-85 -147.81 152.23 37.33 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 20.3 mt -148.51 137.15 15.14 Favored 'Isoleucine or valine' 0 C--N 1.339 0.13 0 C-N-CA 124.15 0.98 . . . . 0.0 109.927 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 3.9 m -142.73 160.79 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.087 0 C-N-CA 123.632 0.773 . . . . 0.0 110.568 174.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 45.4 mt -133.84 142.26 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 C-N-CA 122.591 0.356 . . . . 0.0 110.369 -175.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.295 4.1 p90 -140.96 157.24 45.63 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 177.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -128.03 15.61 6.8 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.271 0.628 . . . . 0.0 110.626 -174.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -62.85 -30.92 71.87 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -169.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -130.62 6.48 4.77 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.518 0.599 . . . . 0.0 112.144 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 161.62 -123.36 1.2 Allowed Glycine 0 C--N 1.333 0.373 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -173.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 50.9 t -143.23 114.94 2.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 175.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 8.3 mp0 -143.85 167.57 22.01 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.172 0.511 . . . . 0.0 110.786 -176.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.02 165.39 30.03 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.58 0.752 . . . . 0.0 109.215 175.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 59.5 mmm -133.36 152.13 51.9 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 39.4 t -139.39 142.64 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 122.788 0.435 . . . . 0.0 110.389 -178.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -128.06 131.87 49.09 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.842 0.457 . . . . 0.0 110.522 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -105.73 161.42 14.42 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 116.35 1.981 . . . . 0.0 116.35 -176.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -77.72 -13.03 60.02 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 45.2 t -155.81 155.82 33.67 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 121.813 -0.555 . . . . 0.0 111.872 -176.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 38.4 t -64.91 -42.11 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -67.7 -25.87 65.89 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 117.877 0.308 . . . . 0.0 111.657 -176.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 59.2 m -74.62 -31.8 62.11 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 175.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.04 -30.33 58.39 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.518 0.327 . . . . 0.0 111.157 178.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -68.64 -47.7 65.91 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 117.934 0.334 . . . . 0.0 111.297 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -73.75 -25.2 60.05 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 119.423 -0.322 . . . . 0.0 111.436 -177.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -71.87 -40.85 68.67 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.187 0.449 . . . . 0.0 110.087 176.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.422 ' HE3' ' HB3' ' A' ' 245' ' ' LYS . 1.0 OUTLIER -76.26 -24.96 54.52 Favored 'General case' 0 N--CA 1.458 -0.045 0 C-N-CA 122.961 0.504 . . . . 0.0 110.993 -179.808 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -90.69 -13.58 33.9 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 39.5 t -112.59 -35.26 5.58 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 118.631 0.651 . . . . 0.0 112.739 -177.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 59.8 mt -90.0 -7.16 54.62 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -177.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -70.78 133.19 46.34 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.78 -5.25 48.46 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 119.932 -0.371 . . . . 0.0 112.369 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.39 166.39 22.7 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 117.711 0.756 . . . . 0.0 110.131 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -123.44 139.61 53.85 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 88.5 mt -73.67 -41.47 55.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.356 45.3 m-85 -82.64 -11.79 58.11 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 117.114 2.265 . . . . 0.0 117.114 178.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 29.4 t 65.94 32.53 8.47 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.699 0.799 . . . . 0.0 111.012 -173.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 179.37 -24.61 0.05 OUTLIER Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 74.7 m -145.58 -177.38 5.54 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.707 1.203 . . . . 0.0 109.465 178.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 84.3 m 59.42 35.6 23.02 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -177.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.73 150.4 5.27 Favored 'General case' 0 C--N 1.338 0.095 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 175.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 78.3 mt -118.47 156.09 29.66 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -173.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -138.39 139.2 38.85 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.562 1.545 . . . . 0.0 107.14 169.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 31.9 mt -139.34 141.73 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 CA-C-O 120.747 0.308 . . . . 0.0 111.364 -172.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -158.9 161.19 36.77 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.962 176.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -60.55 136.15 57.97 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 177.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . 0.425 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -88.28 162.32 16.67 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 122.973 0.509 . . . . 0.0 111.856 -178.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -85.99 -52.82 0.45 Allowed Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 118.505 -0.759 . . . . 0.0 112.808 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -72.07 165.43 32.64 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.759 2.306 . . . . 0.0 110.27 176.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 1.5 t -138.95 7.38 2.47 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 -174.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -152.81 126.41 8.82 Favored 'General case' 0 C--N 1.338 0.068 0 O-C-N 121.778 -0.576 . . . . 0.0 111.771 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.482 ' HG ' ' C6 ' ' B' ' 3' ' ' ' A' . 24.6 mt -87.13 162.85 17.29 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 123.943 0.897 . . . . 0.0 111.467 176.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.433 ' C ' ' H61' ' B' ' 5' ' ' ' A' . 60.7 m-80 -121.77 54.67 1.14 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.804 0.842 . . . . 0.0 109.356 171.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . 0.445 ' HA ' ' N1 ' ' B' ' 5' ' ' ' A' . 2.6 t -54.02 146.34 3.45 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -175.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -127.83 -7.23 5.57 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 117.625 2.454 . . . . 0.0 117.625 -176.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -164.48 172.87 12.76 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 117.995 0.362 . . . . 0.0 110.676 -178.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -125.5 116.8 22.36 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.017 0.927 . . . . 0.0 109.916 173.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 55.9 p30 -159.74 -166.95 1.87 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -68.35 -11.42 59.52 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -174.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -111.98 -20.34 12.02 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -143.39 143.31 31.58 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.691 0.796 . . . . 0.0 112.762 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 18.4 t-105 -161.0 156.11 24.25 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.277 -178.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -136.81 117.92 14.41 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.498 0.719 . . . . 0.0 110.165 173.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.256 64.1 m-85 -82.08 7.01 14.5 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 117.39 2.367 . . . . 0.0 117.39 -173.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 5.8 t -139.61 -18.81 0.95 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -95.34 113.3 61.34 Favored Pre-proline 0 N--CA 1.453 -0.277 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 175.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.21 -16.77 13.7 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 123.341 2.694 . . . . 0.0 112.113 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -72.24 -15.05 61.92 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -176.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 78.7 mt -93.37 -8.29 42.29 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 46.6 t -78.55 -26.99 45.82 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.297 0.239 . . . . 0.0 111.423 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -81.73 -2.88 90.68 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-O 119.883 -0.398 . . . . 0.0 112.267 -179.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -81.47 -2.93 51.51 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 117.509 0.654 . . . . 0.0 111.646 -177.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.216 0 CA-C-O 117.324 -1.82 . . . . 0.0 111.458 179.999 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.869 0 C3'-C2'-C1' 104.355 3.172 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.425 ' N3 ' ' HA ' ' A' ' 265' ' ' ALA . . . . . . . . 0 O4'--C4' 1.422 -2.621 2 O4'-C1'-N19 112.639 4.439 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.482 ' C6 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.423 -2.47 2 C5'-C4'-C3' 106.928 -5.714 . 0.01 4s . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.619 2.587 1 C5'-C4'-C3' 109.084 -4.277 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.445 ' N1 ' ' HA ' ' A' ' 272' ' ' VAL . . . . . . . . 0 O4'--C4' 1.418 -2.889 1 C3'-C2'-C1' 105.331 4.257 OUTLIER-DELTA 0.019 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.688 2 O4'-C1'-N19 113.451 5.251 . 0.087 2[ . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -67.53 148.39 51.53 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.025 0.53 . . . . 0.0 110.797 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.415 HG21 ' H ' ' A' ' 178' ' ' ARG . 32.2 mt -127.79 147.41 32.5 Favored 'Isoleucine or valine' 0 C--O 1.23 0.068 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 73.1 m -96.25 8.11 44.74 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -175.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.415 ' H ' HG21 ' A' ' 176' ' ' ILE . 3.8 mpt_? -83.71 -41.24 0.78 Allowed Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' A' ' 178' ' ' ARG . 46.5 Cg_exo -60.4 156.28 42.07 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.171 2.58 . . . . 0.0 112.207 176.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -71.98 -15.5 76.32 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 178.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -77.19 -3.41 39.44 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 176.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 30.5 t -67.17 148.03 52.32 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 122.967 0.507 . . . . 0.0 110.655 178.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -61.55 -17.22 53.96 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -81.41 0.86 35.64 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 176.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 69.8 m -139.61 0.34 1.83 Allowed 'General case' 0 C--N 1.341 0.204 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -174.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -147.59 10.62 0.96 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 67.2 p -150.89 15.57 0.75 Allowed 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 176.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.7 m -71.68 109.72 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -130.46 10.39 5.23 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.345 0.658 . . . . 0.0 112.197 177.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 54.5 m 65.58 19.91 11.56 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.338 1.055 . . . . 0.0 113.639 -176.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 35.8 t -126.56 143.05 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 C-N-CA 123.036 0.534 . . . . 0.0 110.483 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 84.5 mt -136.53 146.07 45.77 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 122.712 0.405 . . . . 0.0 111.162 -176.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 48.7 tp -95.36 136.53 35.61 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 172.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -116.13 101.22 8.53 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.003 1.321 . . . . 0.0 114.315 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.07 140.51 36.45 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 174.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 3.9 mp -110.66 116.24 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -90.46 -18.09 25.98 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -170.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -143.18 78.86 14.73 Favored Pre-proline 0 CA--C 1.528 0.127 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -76.98 42.7 1.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 125.206 3.937 . . . . 0.0 112.625 -177.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.77 -5.11 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 O-C-N 121.747 -0.595 . . . . 0.0 110.693 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -138.99 156.69 47.03 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 176.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 69.0 m -68.82 117.48 10.56 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 28.0 mm -78.28 145.41 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.02 160.42 37.8 Favored 'General case' 0 C--O 1.23 0.043 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 6.7 p -67.84 -22.98 65.11 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -73.63 -47.14 42.35 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.9 m -70.19 -31.91 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.9 mt -71.12 -35.25 71.68 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -71.36 -29.58 65.14 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 174.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.1 m -69.22 -33.43 73.29 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 42.2 pt -91.7 -22.06 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.95 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 95.1 m -93.42 -25.44 17.66 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -177.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.468 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 38.5 t30 -63.59 -39.56 49.16 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 67.0 Cg_endo -68.56 -14.15 38.96 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 CA-C-N 121.113 1.433 . . . . 0.0 111.954 177.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 92.8 m -89.23 -8.13 54.12 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.106 0.412 . . . . 0.0 111.57 176.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 147.8 166.95 13.0 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 178.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -68.61 105.25 1.25 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.535 2.823 . . . . 0.0 110.472 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 80.3 t -72.35 145.59 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -111.04 -36.81 5.54 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 119.369 -0.348 . . . . 0.0 111.58 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 25.6 mtm180 -149.52 154.02 38.11 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 118.128 0.422 . . . . 0.0 112.035 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 34.3 mt -144.7 143.8 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.035 0.934 . . . . 0.0 109.369 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 55.2 t -145.15 154.61 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 60.2 mt -133.43 140.13 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 C-N-CA 123.423 0.689 . . . . 0.0 109.65 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.253 4.8 p90 -148.18 160.62 42.74 Favored 'General case' 0 N--CA 1.458 -0.026 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 176.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.01 31.31 2.2 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.811 0.444 . . . . 0.0 111.985 -176.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -67.07 -29.81 69.69 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -174.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -130.52 3.32 4.6 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 167.83 -127.12 1.51 Allowed Glycine 0 C--N 1.334 0.443 0 N-CA-C 108.381 -1.888 . . . . 0.0 108.381 -173.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.2 t -139.6 117.94 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-N 117.252 0.526 . . . . 0.0 110.244 173.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 11.5 mp0 -144.19 168.7 19.42 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.651 0.739 . . . . 0.0 111.164 -175.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -150.18 163.96 36.9 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.95 175.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 59.6 mmm -134.54 152.55 51.86 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.633 0.373 . . . . 0.0 110.199 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.3 t -142.42 145.19 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 123.117 0.567 . . . . 0.0 110.047 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -129.06 132.5 47.45 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 122.555 0.342 . . . . 0.0 110.284 176.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -102.36 161.71 13.49 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -177.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -81.27 -10.44 59.58 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 30.6 t -154.51 151.34 28.8 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 121.761 -0.587 . . . . 0.0 112.106 -176.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 50.3 t -68.13 -38.22 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -178.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -67.06 -24.93 66.02 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.123 0.42 . . . . 0.0 111.151 -178.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 55.3 m -75.77 -32.84 60.12 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 176.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -78.08 -31.86 50.39 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 122.361 -0.212 . . . . 0.0 110.961 178.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -66.55 -41.74 88.19 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 121.993 -0.442 . . . . 0.0 111.474 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -77.08 -28.15 54.5 Favored 'General case' 0 CA--C 1.527 0.07 0 CA-C-N 117.937 0.335 . . . . 0.0 110.872 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -69.95 -41.24 74.81 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.05 0.387 . . . . 0.0 109.959 177.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -74.24 -20.63 60.1 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.618 0.367 . . . . 0.0 111.023 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -98.77 -5.08 31.96 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 42.6 t -124.16 -30.44 3.46 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 56.3 mt -93.83 -6.66 45.33 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.247 0.476 . . . . 0.0 111.479 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -72.45 131.66 42.87 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.97 -4.64 53.09 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 119.85 -0.417 . . . . 0.0 112.259 -178.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.9 166.56 22.25 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 117.817 0.809 . . . . 0.0 110.169 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -123.67 139.3 54.13 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 89.5 mt -74.43 -41.66 49.71 Favored 'Isoleucine or valine' 0 C--O 1.23 0.071 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.355 35.9 m-85 -82.82 -11.88 57.9 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 117.065 2.246 . . . . 0.0 117.065 178.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 30.1 t 65.74 34.02 7.82 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.533 0.733 . . . . 0.0 111.171 -173.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 177.44 -24.35 0.05 OUTLIER Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.11 0.862 . . . . 0.0 111.123 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 75.0 m -145.43 -175.74 4.84 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.527 1.131 . . . . 0.0 109.383 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 88.8 m 57.84 36.04 26.0 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -176.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.3 147.53 13.26 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 176.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 78.9 mt -114.35 156.85 23.68 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -173.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -139.32 138.2 36.47 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 169.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 46.5 mt -137.1 142.48 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.066 0 CA-C-O 120.66 0.267 . . . . 0.0 111.56 -172.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -159.51 161.82 35.39 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.094 176.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.287 35.6 m-85 -61.44 135.54 57.72 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 177.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . 0.434 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -93.16 157.18 16.4 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.999 -177.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.415 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 23.2 pttp -91.19 -31.33 0.34 Allowed Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 50.3 Cg_endo -79.46 161.4 25.37 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 CA-C-N 121.766 1.666 . . . . 0.0 110.154 176.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.298 0.2 OUTLIER -135.5 13.56 3.47 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 -178.056 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -156.36 126.37 6.46 Favored 'General case' 0 C--O 1.227 -0.1 0 O-C-N 121.871 -0.518 . . . . 0.0 111.521 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 23.1 mt -88.32 163.99 15.79 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.69 0.796 . . . . 0.0 110.546 174.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.542 ' ND2' ' C2 ' ' B' ' 4' ' ' ' C' . 19.5 p30 -122.89 44.24 2.71 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.342 0.591 . . . . 0.0 110.361 171.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.1 t -48.1 140.0 2.41 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -176.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.418 ' CZ ' ' C2 ' ' B' ' 5' ' ' ' A' 0.277 5.3 p90 -122.87 -6.27 8.5 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 117.267 2.321 . . . . 0.0 117.267 -177.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -163.37 167.98 21.01 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 122.956 0.503 . . . . 0.0 110.176 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -119.09 123.46 44.49 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.351 0.66 . . . . 0.0 109.734 174.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 50.6 p30 -159.32 -168.29 2.28 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.829 0.852 . . . . 0.0 108.93 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -70.41 -10.13 58.26 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -177.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -102.41 -33.63 9.47 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.5 p -142.68 145.75 33.72 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 124.257 1.023 . . . . 0.0 113.188 176.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 21.7 t-105 -153.62 153.73 32.87 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -176.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -131.32 116.8 18.05 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.252 0.621 . . . . 0.0 111.607 175.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.253 67.1 m-85 -83.16 7.67 15.4 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 117.449 2.388 . . . . 0.0 117.449 -172.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 9.9 t -137.32 -21.85 1.17 Allowed 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -95.46 113.28 61.39 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 174.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.6 -16.19 15.04 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.273 2.649 . . . . 0.0 112.403 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -74.21 -15.71 60.99 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -174.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 81.4 mt -89.84 -4.98 57.31 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 117.889 0.313 . . . . 0.0 111.518 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 47.6 t -75.93 145.73 40.19 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 122.454 0.301 . . . . 0.0 110.738 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 69.92 2.57 39.0 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-O 119.653 -0.526 . . . . 0.0 113.39 176.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -69.35 149.81 48.01 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 118.33 1.065 . . . . 0.0 111.074 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 CA-C-O 117.195 -1.891 . . . . 0.0 110.87 178.883 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.818 0 C3'-C2'-C1' 104.342 3.158 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.51 HO2' ' P ' ' B' ' 3' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.735 0 O4'-C1'-N19 111.575 3.375 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.51 ' P ' HO2' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.418 -2.933 2 O4'-C1'-N19 112.96 4.76 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' ' C' . . . . . 0.542 ' C2 ' ' ND2' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.42 -2.756 1 C5'-C4'-C3' 108.032 -4.979 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.443 ' H61' ' C ' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.416 -3.075 1 C3'-C2'-C1' 105.148 4.054 OUTLIER-DELTA 0.136 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.704 0 O4'-C1'-N19 111.773 3.573 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 CA--C 1.532 0.273 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.6 t -128.71 142.08 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 C-N-CA 122.988 0.515 . . . . 0.0 110.924 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 84.7 mt -135.02 149.49 50.17 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 122.663 0.385 . . . . 0.0 111.884 -174.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 32.0 tp -102.72 136.67 42.12 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.576 0.75 . . . . 0.0 109.223 172.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -115.27 107.05 14.76 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.938 1.295 . . . . 0.0 114.465 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.05 127.76 38.69 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 175.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.5 mp -97.95 127.53 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 20.7 mt -89.37 -26.34 21.1 Favored 'General case' 0 CA--C 1.527 0.062 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -174.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -141.17 79.1 18.23 Favored Pre-proline 0 N--CA 1.453 -0.284 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -176.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -77.34 45.31 1.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 125.251 3.967 . . . . 0.0 111.988 -177.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.446 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -69.47 -4.2 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 O-C-N 121.877 -0.515 . . . . 0.0 110.597 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -136.52 155.84 49.41 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 66.3 m -67.85 113.2 5.39 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 33.6 mm -78.39 141.53 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.99 159.76 39.77 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.6 p -64.8 -15.41 61.68 Favored 'General case' 0 C--O 1.23 0.05 0 N-CA-C 114.314 1.228 . . . . 0.0 114.314 177.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -76.12 -46.52 28.41 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.676 0.274 . . . . 0.0 111.541 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.0 m -70.85 -31.1 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.1 mt -72.39 -35.17 68.37 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 176.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -70.6 -30.65 67.38 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 173.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.1 m -67.26 -34.56 77.7 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 43.9 pt -91.46 -21.73 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 118.405 0.548 . . . . 0.0 112.239 178.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 91.3 m -91.21 -25.87 19.31 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.499 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 31.8 t30 -63.82 -41.37 63.73 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 74.4 Cg_endo -69.27 -13.84 36.59 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 CA-C-N 120.857 1.342 . . . . 0.0 111.645 177.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 91.7 m -91.96 -4.49 54.53 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.787 0.435 . . . . 0.0 111.701 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 146.95 166.79 12.57 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 177.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.53 103.14 1.08 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.587 2.858 . . . . 0.0 110.17 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 64.8 t -69.51 146.82 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -114.44 -37.53 4.3 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 119.244 -0.408 . . . . 0.0 111.579 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 39.2 mtm-85 -149.95 151.87 34.06 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.574 0.625 . . . . 0.0 112.035 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 17.8 mt -146.12 140.97 21.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 C-N-CA 124.211 1.004 . . . . 0.0 109.527 177.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 59.7 t -146.78 156.51 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 47.6 mt -134.45 142.22 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 123.698 0.799 . . . . 0.0 110.009 -178.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.297 3.2 p90 -143.28 159.22 42.75 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 176.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -128.76 15.52 6.41 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.989 0.516 . . . . 0.0 111.137 -173.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -62.86 -32.46 73.7 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -169.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -130.49 8.84 5.03 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 118.597 0.635 . . . . 0.0 112.239 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 159.92 -125.11 1.43 Allowed Glycine 0 C--N 1.335 0.516 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 -174.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.4 t -141.18 115.3 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -142.29 166.89 23.45 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.268 0.556 . . . . 0.0 110.956 -176.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.37 165.47 29.23 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.405 175.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 76.5 mmm -133.42 153.25 51.77 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 28.2 t -141.79 145.64 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 C-N-CA 123.292 0.637 . . . . 0.0 110.667 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -132.61 133.93 44.25 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.727 0.411 . . . . 0.0 110.126 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -105.51 161.75 14.07 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 -176.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -78.25 -14.65 59.35 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 82.6 p -155.11 157.98 38.32 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.25 0.548 . . . . 0.0 111.548 -177.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 53.8 t -66.38 -36.08 76.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -65.44 -32.17 73.65 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 122.354 -0.216 . . . . 0.0 110.711 -176.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 63.8 m -72.65 -34.84 67.53 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 121.27 -0.172 . . . . 0.0 110.639 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -73.45 -31.54 63.85 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 119.732 -0.175 . . . . 0.0 111.114 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -68.32 -44.14 76.02 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 118.199 0.454 . . . . 0.0 111.831 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 -77.29 -25.29 51.17 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 118.102 0.41 . . . . 0.0 111.34 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -72.06 -41.13 67.78 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 122.065 -0.397 . . . . 0.0 110.077 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -74.65 -21.26 59.53 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 122.974 0.51 . . . . 0.0 111.194 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -97.18 -10.52 25.73 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 44.2 t -116.12 -34.01 4.84 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 118.62 0.645 . . . . 0.0 112.594 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 50.7 mt -90.73 -6.95 53.76 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 122.139 -0.35 . . . . 0.0 111.837 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -72.26 132.4 44.01 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.25 -4.53 47.87 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 112.156 -0.378 . . . . 0.0 112.156 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.22 166.39 22.78 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 117.52 0.66 . . . . 0.0 110.187 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -123.61 139.61 53.83 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 85.1 mt -74.42 -41.51 49.77 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.36 44.0 m-85 -82.87 -11.47 58.18 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 117.037 2.236 . . . . 0.0 117.037 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 29.0 t 65.51 34.48 7.9 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.604 0.762 . . . . 0.0 111.059 -173.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 177.15 -23.96 0.05 OUTLIER Glycine 0 CA--C 1.528 0.881 0 C-N-CA 123.972 0.796 . . . . 0.0 111.158 177.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' CYS . . . . . 0.446 ' HB3' HD12 ' A' ' 200' ' ' ILE . 96.8 m -145.92 -177.29 5.52 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.702 1.201 . . . . 0.0 109.52 178.006 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 88.0 m 58.64 37.0 25.33 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -176.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.96 151.39 6.76 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 175.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 73.6 mt -119.67 157.64 28.1 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -173.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -139.54 140.38 37.12 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.786 1.634 . . . . 0.0 107.294 168.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 38.4 mt -138.1 142.74 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 CA-C-O 120.848 0.356 . . . . 0.0 111.668 -173.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -158.57 161.87 37.31 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.04 176.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.265 41.5 m-85 -61.96 134.81 57.12 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 177.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -88.58 157.0 18.73 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.178 -178.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.476 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 23.2 pttp -90.14 -32.25 0.37 Allowed Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 117.413 -1.279 . . . . 0.0 114.307 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 68.2 Cg_endo -76.55 166.95 26.44 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 CA-C-N 121.893 1.712 . . . . 0.0 109.462 174.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.3 0.2 OUTLIER -130.04 0.47 4.73 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 -175.811 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 20.3 ttp180 -160.55 140.97 11.53 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.775 -0.578 . . . . 0.0 110.952 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 25.8 mt -85.25 171.47 11.91 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.115 0.966 . . . . 0.0 110.668 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -126.19 46.63 2.4 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 169.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.5 t -48.58 139.68 2.94 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -175.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . 0.278 6.2 p90 -120.37 -12.12 9.04 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 117.391 2.367 . . . . 0.0 117.391 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -163.6 173.91 12.41 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 122.853 0.461 . . . . 0.0 110.811 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -119.99 129.23 54.18 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.403 0.681 . . . . 0.0 110.544 176.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 39.5 p30 -160.5 -166.63 1.69 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.529 1.132 . . . . 0.0 108.824 176.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -68.36 -15.05 63.42 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -174.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -115.07 -12.19 11.98 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.49 139.17 35.06 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.832 0.853 . . . . 0.0 112.513 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 21.2 t-105 -161.17 154.48 21.53 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.473 -177.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -132.32 117.1 17.71 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.42 173.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.272 63.8 m-85 -81.71 8.6 9.58 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 117.362 2.356 . . . . 0.0 117.362 -172.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 11.3 t . . . . . 0 CA--C 1.527 0.08 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -179.296 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 66.7 m . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 25.1 t -130.9 140.53 48.46 Favored 'Isoleucine or valine' 0 C--N 1.338 0.108 0 C-N-CA 122.83 0.452 . . . . 0.0 110.777 176.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 93.7 mt -130.76 159.2 38.02 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 122.961 0.504 . . . . 0.0 111.128 -176.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.1 tt -115.87 135.61 53.83 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.109 174.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -115.99 105.7 12.94 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -87.18 137.08 32.65 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 174.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.3 mp -106.94 118.21 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -88.48 -17.87 29.44 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -171.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -142.56 78.9 15.78 Favored Pre-proline 0 CA--C 1.529 0.156 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -77.98 46.55 2.1 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 125.132 3.888 . . . . 0.0 112.405 -177.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.424 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -71.42 -3.83 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 O-C-N 121.873 -0.517 . . . . 0.0 110.505 179.322 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -136.67 159.08 42.88 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 176.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 70.2 m -70.91 113.11 7.63 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.638 0.256 . . . . 0.0 110.373 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 33.8 mm -78.27 140.47 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.96 159.36 40.96 Favored 'General case' 0 C--O 1.23 0.058 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.4 p -65.2 -14.89 61.72 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 176.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -76.91 -45.49 27.75 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.589 0.356 . . . . 0.0 110.657 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 1.7 m -71.2 -32.42 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.88 -34.57 69.28 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 177.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -71.57 -29.71 65.03 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 174.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 8.2 m -67.29 -35.02 78.62 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 37.9 pt -91.32 -24.08 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 119.177 -0.44 . . . . 0.0 111.758 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 86.9 m -88.99 -25.46 22.01 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.474 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 31.4 t30 -63.13 -44.82 85.2 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-O 118.518 -0.753 . . . . 0.0 112.907 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 68.7 Cg_endo -68.18 -15.69 43.17 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.356 1.371 . . . . 0.0 111.478 178.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 95.2 m -84.12 -15.34 47.61 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 117.918 0.327 . . . . 0.0 111.715 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 152.4 169.3 17.6 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -61.42 104.82 0.32 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.768 2.979 . . . . 0.0 111.922 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 73.6 t -76.34 145.13 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -116.81 -38.38 3.45 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-O 119.394 -0.336 . . . . 0.0 111.579 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 41.3 mtm-85 -148.88 151.48 34.77 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 21.7 mt -147.71 136.48 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 124.036 0.934 . . . . 0.0 109.748 177.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.41 160.21 22.13 Favored 'Isoleucine or valine' 0 C--N 1.337 0.062 0 C-N-CA 123.592 0.757 . . . . 0.0 110.9 174.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 48.4 mt -134.43 141.51 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 123.189 0.596 . . . . 0.0 110.491 -175.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.292 5.8 p90 -140.82 157.78 44.91 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -127.21 14.26 7.23 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.449 0.699 . . . . 0.0 110.755 -174.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -61.97 -31.56 71.92 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -169.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -130.7 7.88 4.85 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 118.634 0.652 . . . . 0.0 112.289 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 161.38 -124.33 1.3 Allowed Glycine 0 CA--C 1.521 0.465 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 -174.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 47.9 t -142.73 115.07 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -143.95 167.73 21.66 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.324 0.583 . . . . 0.0 110.589 -176.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.25 164.29 32.77 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.879 0.871 . . . . 0.0 109.067 175.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 81.6 mmm -131.71 153.01 50.48 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 26.3 t -139.6 143.38 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.097 0 C-N-CA 122.786 0.434 . . . . 0.0 111.067 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -127.49 132.17 50.02 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.035 0.534 . . . . 0.0 110.337 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -108.27 161.94 14.54 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -176.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -80.95 -11.81 59.5 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 30.7 t -155.28 152.45 29.25 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.386 0.539 . . . . 0.0 111.893 -175.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 54.1 t -67.74 -38.27 80.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -67.78 -27.33 66.67 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 122.348 -0.22 . . . . 0.0 110.953 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 69.0 m -72.59 -34.35 67.35 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 176.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -77.48 -29.86 52.86 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 111.425 0.157 . . . . 0.0 111.425 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -67.75 -43.27 80.3 Favored 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 121.932 -0.48 . . . . 0.0 111.539 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -77.85 -24.23 48.65 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-N 117.842 0.292 . . . . 0.0 110.797 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -72.81 -41.19 65.18 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.098 0.408 . . . . 0.0 110.283 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -74.98 -23.39 58.27 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.814 0.446 . . . . 0.0 111.392 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -92.39 -17.21 24.94 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 48.1 t -106.16 -36.51 6.88 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -177.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 72.1 mt -89.42 -9.11 51.44 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -69.95 133.8 47.67 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.28 -5.54 42.51 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 119.748 -0.473 . . . . 0.0 112.205 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.4 166.41 22.67 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.792 0.796 . . . . 0.0 110.289 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -123.52 138.37 54.58 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 82.3 mt -72.66 -41.65 62.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.346 45.8 m-85 -82.9 -12.27 57.51 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.9 t 66.08 33.93 7.22 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.709 0.766 . . . . 0.0 110.936 -174.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 178.23 -24.7 0.05 OUTLIER Glycine 0 CA--C 1.528 0.856 0 C-N-CA 123.986 0.803 . . . . 0.0 111.289 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' CYS . . . . . 0.424 ' HB3' HD12 ' A' ' 200' ' ' ILE . 72.8 m -145.74 -176.97 5.34 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.532 1.133 . . . . 0.0 109.422 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 89.8 m 57.64 37.88 27.54 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.856 0.462 . . . . 0.0 112.04 -176.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.2 147.49 13.01 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 175.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 79.6 mt -114.11 155.58 25.75 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -173.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -138.77 138.63 37.79 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.163 1.385 . . . . 0.0 107.597 169.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 37.0 mt -139.02 142.69 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-O 120.744 0.307 . . . . 0.0 111.75 -171.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -158.49 163.13 37.4 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.348 0.659 . . . . 0.0 109.478 175.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.266 44.1 m-85 -62.51 138.17 58.41 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 176.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -87.37 154.31 20.77 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.484 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.436 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 23.2 pttp -88.35 -31.76 0.39 Allowed Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 117.489 -1.243 . . . . 0.0 114.255 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 48.1 Cg_endo -79.94 162.56 23.58 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.743 1.629 . . . . 0.0 109.861 174.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.282 0.2 OUTLIER -137.79 18.75 2.86 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 116.747 2.129 . . . . 0.0 116.747 -176.462 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.469 ' CZ ' ' HA ' ' A' ' 269' ' ' ARG . 1.3 tpm_? -155.37 106.48 2.56 Favored 'General case' 0 C--N 1.34 0.169 0 O-C-N 121.734 -0.604 . . . . 0.0 112.301 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 9.4 mt -75.96 158.41 32.0 Favored 'General case' 0 N--CA 1.458 -0.062 0 C-N-CA 122.747 0.419 . . . . 0.0 110.161 173.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -127.02 54.56 1.63 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.685 0.794 . . . . 0.0 109.781 172.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 272' ' ' VAL . 2.5 t -54.61 143.93 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -177.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -126.94 -7.7 6.05 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 117.557 2.429 . . . . 0.0 117.557 -176.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -162.17 173.04 14.83 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 122.809 0.444 . . . . 0.0 110.001 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -125.46 123.05 38.37 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.589 0.756 . . . . 0.0 110.05 175.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 46.5 p30 -159.99 -166.39 1.71 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.959 0.904 . . . . 0.0 108.575 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -68.11 -15.13 63.46 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -175.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -114.76 -12.88 12.09 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.64 139.77 34.9 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.631 0.772 . . . . 0.0 112.547 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 20.2 t-105 -161.02 156.86 25.31 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.446 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -136.46 116.32 13.16 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.553 172.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.275 66.4 m-85 -79.05 7.22 7.73 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 117.26 2.318 . . . . 0.0 117.26 -173.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.456 -0.169 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -179.798 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 CA--C 1.53 0.194 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 38.8 t -130.51 133.76 63.2 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 C-N-CA 122.88 0.472 . . . . 0.0 111.292 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.429 HD21 ' HB1' ' A' ' 241' ' ' ALA . 2.5 mm? -122.63 152.86 40.06 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 122.987 0.515 . . . . 0.0 111.066 -177.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 28.4 tp -103.31 134.04 47.37 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 170.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -111.86 110.97 21.6 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.49 131.55 40.09 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 173.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.6 mp -102.1 120.4 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -88.42 -20.38 25.31 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 119.307 -0.378 . . . . 0.0 111.898 -172.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -142.19 78.94 16.46 Favored Pre-proline 0 CA--C 1.529 0.156 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.89 46.4 2.05 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 125.086 3.857 . . . . 0.0 112.249 -177.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.415 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -70.66 -3.58 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 O-C-N 121.86 -0.525 . . . . 0.0 110.822 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -136.85 158.04 45.36 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 176.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 69.3 m -69.47 111.22 5.18 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 41.0 mm -78.34 139.06 19.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.14 161.82 33.82 Favored 'General case' 0 CA--C 1.523 -0.094 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.3 p -64.45 -18.44 64.75 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 177.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -73.41 -39.75 64.81 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 1.5 m -75.89 -33.79 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 97.0 mt -71.37 -33.07 69.21 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 176.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -72.15 -30.53 65.11 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 175.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 20.6 m -67.23 -34.79 78.22 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 43.5 pt -90.89 -22.13 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 119.045 -0.503 . . . . 0.0 111.887 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 84.1 m -91.26 -26.62 18.91 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.506 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 32.7 t30 -63.99 -40.44 54.42 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 70.3 Cg_endo -69.32 -14.52 37.62 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.494 1.462 . . . . 0.0 111.477 177.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 98.8 m -89.88 -8.56 51.63 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.575 0.35 . . . . 0.0 111.614 177.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 149.54 170.32 16.91 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 177.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.68 102.56 1.03 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.933 3.089 . . . . 0.0 110.736 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 73.4 t -71.17 146.81 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 176.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -115.47 -36.17 4.37 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 119.377 -0.344 . . . . 0.0 111.651 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -149.68 151.9 34.46 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.417 0.553 . . . . 0.0 112.192 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 25.3 mt -147.2 136.76 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 124.195 0.998 . . . . 0.0 109.883 177.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 1.2 m -140.47 160.7 24.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.08 0 C-N-CA 123.485 0.714 . . . . 0.0 111.803 174.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 55.3 mt -135.78 144.08 34.59 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 C-N-CA 123.434 0.693 . . . . 0.0 109.832 -176.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.291 3.3 p90 -144.54 157.18 44.34 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 177.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -127.7 15.22 7.0 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.18 0.592 . . . . 0.0 110.883 -172.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -64.09 -30.94 71.97 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -169.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -130.54 4.91 4.69 Favored 'General case' 0 CA--C 1.527 0.074 0 CA-C-N 118.596 0.634 . . . . 0.0 112.262 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 163.76 -124.47 1.28 Allowed Glycine 0 C--N 1.334 0.459 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 -173.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 61.8 t -142.99 114.63 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 175.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 -142.83 168.17 20.36 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.021 0.439 . . . . 0.0 111.009 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.15 165.74 29.96 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.675 0.79 . . . . 0.0 109.456 177.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 61.4 mmm -134.36 153.47 51.87 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 42.6 t -141.59 144.19 26.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 C-N-CA 122.676 0.39 . . . . 0.0 110.116 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -131.67 132.82 44.27 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 122.395 0.278 . . . . 0.0 110.571 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -104.42 162.54 13.14 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -81.89 -8.21 59.66 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 44.8 t -154.5 150.74 28.13 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.811 -0.556 . . . . 0.0 111.973 -176.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 52.0 t -67.66 -36.1 74.99 Favored 'Isoleucine or valine' 0 C--N 1.338 0.096 0 C-N-CA 123.279 0.632 . . . . 0.0 109.356 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -67.22 -28.65 68.25 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 118.295 0.498 . . . . 0.0 110.866 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 63.2 m -75.43 -30.45 60.02 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.429 ' HB1' HD21 ' A' ' 192' ' ' LEU . . . -75.83 -31.94 59.58 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.342 0.257 . . . . 0.0 111.3 178.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -70.69 -43.84 68.21 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -74.59 -26.45 59.93 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 117.792 0.269 . . . . 0.0 111.05 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -71.98 -41.51 67.6 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 118.087 0.403 . . . . 0.0 110.042 177.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -75.6 -20.57 58.47 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 122.603 0.361 . . . . 0.0 111.399 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -95.93 -13.12 24.13 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 47.1 t -113.28 -33.6 5.91 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 59.7 mt -90.56 -7.78 51.96 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 118.003 0.365 . . . . 0.0 111.816 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -71.87 133.69 45.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 177.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.36 -5.87 40.94 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.924 -0.47 . . . . 0.0 111.924 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.87 166.44 22.41 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.793 0.796 . . . . 0.0 110.473 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -123.7 139.65 53.78 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 84.4 mt -74.22 -41.69 51.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.351 42.8 m-85 -82.97 -11.82 57.81 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 178.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 23.2 t 65.71 35.48 6.87 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.631 0.772 . . . . 0.0 111.087 -174.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 176.17 -23.76 0.06 OUTLIER Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.127 0.87 . . . . 0.0 111.266 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' CYS . . . . . 0.415 ' HB3' HD12 ' A' ' 200' ' ' ILE . 98.5 m -146.37 -177.23 5.51 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.628 1.171 . . . . 0.0 109.47 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 89.1 m 58.19 36.23 25.62 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -176.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.1 148.98 10.04 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 175.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 75.9 mt -116.28 154.75 29.61 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -173.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -138.45 138.32 38.03 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.065 1.346 . . . . 0.0 107.596 169.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 33.1 mt -137.74 143.28 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-O 120.685 0.278 . . . . 0.0 111.514 -171.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -158.23 163.25 37.64 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.312 0.645 . . . . 0.0 109.374 175.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.268 37.8 m-85 -62.63 134.31 56.16 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 177.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -84.38 161.03 20.52 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.351 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.487 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 64.0 pttt -93.56 -31.58 0.3 Allowed Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 178.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 86.1 Cg_endo -75.88 171.12 18.77 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.913 1.742 . . . . 0.0 110.295 175.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.96 -1.61 2.67 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 117.26 2.319 . . . . 0.0 117.26 -175.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.35 133.55 11.6 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-N 118.766 0.712 . . . . 0.0 111.727 -178.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 19.2 mt -92.31 157.76 16.47 Favored 'General case' 0 C--O 1.228 -0.04 0 C-N-CA 124.137 0.975 . . . . 0.0 111.516 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -120.97 47.76 1.76 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.734 0.813 . . . . 0.0 109.86 174.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.414 HG23 ' H ' ' A' ' 272' ' ' VAL . 2.5 t -53.09 143.91 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.092 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -177.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . 0.26 10.2 p90 -128.22 -4.57 5.53 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 116.868 2.173 . . . . 0.0 116.868 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.14 172.35 18.26 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 123.245 0.618 . . . . 0.0 111.689 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -125.68 121.82 34.57 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.752 0.821 . . . . 0.0 109.65 175.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 49.3 p30 -159.27 -166.71 1.88 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.643 0.777 . . . . 0.0 109.653 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -68.21 -14.56 63.07 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -177.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -99.53 -34.91 10.05 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.15 150.46 42.82 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 178.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 22.2 t-105 -157.86 155.59 29.93 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -176.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -131.24 119.17 21.44 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.972 0.509 . . . . 0.0 111.629 175.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.28 67.1 m-85 -83.02 9.35 10.4 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -171.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 9.3 t . . . . . 0 CA--C 1.528 0.126 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -178.531 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 N--CA 1.464 0.226 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 38.4 t -131.8 142.47 42.95 Favored 'Isoleucine or valine' 0 C--N 1.337 0.059 0 C-N-CA 123.362 0.665 . . . . 0.0 110.505 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 83.5 mt -134.6 148.3 50.4 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 122.615 0.366 . . . . 0.0 111.236 -175.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 28.5 tp -99.54 134.36 42.54 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 172.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -112.7 106.76 15.21 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.2 m -90.06 139.99 30.08 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 174.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 3.9 mp -110.34 122.48 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -91.79 -18.47 23.81 Favored 'General case' 0 C--O 1.23 0.06 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -171.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -141.66 78.93 17.47 Favored Pre-proline 0 CA--C 1.529 0.158 0 C-N-CA 122.95 0.5 . . . . 0.0 109.679 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -77.29 50.07 3.04 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 124.926 3.751 . . . . 0.0 112.179 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.45 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -69.72 -6.5 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 O-C-N 121.761 -0.587 . . . . 0.0 110.011 178.41 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -142.67 155.43 44.91 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.148 1.379 . . . . 0.0 112.337 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 28.5 t -74.97 131.86 40.97 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 25.4 mm -78.66 152.06 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 122.983 0.513 . . . . 0.0 110.338 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.96 157.58 45.68 Favored 'General case' 0 C--N 1.338 0.076 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 39.4 p -68.73 -18.27 64.2 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -77.59 -47.23 19.91 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 118.192 0.451 . . . . 0.0 111.748 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 3.5 m -71.12 -32.2 47.08 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 99.2 mt -70.47 -35.63 73.41 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -71.06 -30.18 66.27 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 175.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.6 m -67.35 -33.38 75.11 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 36.7 pt -93.63 -22.29 5.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 118.486 0.585 . . . . 0.0 111.787 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 89.1 m -90.17 -26.02 20.36 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.494 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 32.4 t30 -63.46 -42.57 74.62 Favored Pre-proline 0 CA--C 1.535 0.38 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 -178.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 70.9 Cg_endo -69.1 -13.19 35.86 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 121.784 1.656 . . . . 0.0 111.644 178.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 91.5 m -88.68 -8.38 54.67 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.041 0.382 . . . . 0.0 111.788 176.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 145.02 169.72 13.63 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 177.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.34 107.61 0.5 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.715 2.943 . . . . 0.0 111.949 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 72.3 t -76.56 146.6 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -117.01 -40.54 3.11 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 119.259 -0.4 . . . . 0.0 111.556 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 65.8 mtm-85 -148.88 152.55 36.64 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 25.4 mt -148.28 136.85 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 C-N-CA 124.305 1.042 . . . . 0.0 110.054 176.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 3.8 m -142.4 159.76 19.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 123.9 0.88 . . . . 0.0 110.519 174.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 48.0 mt -132.13 142.93 41.55 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 122.575 0.35 . . . . 0.0 110.676 -175.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.298 4.8 p90 -142.76 158.39 43.69 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 116.002 1.853 . . . . 0.0 116.002 176.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -130.45 17.68 5.37 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.469 0.708 . . . . 0.0 110.991 -174.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -64.29 -31.21 72.32 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -169.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -130.42 7.47 4.93 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.584 0.629 . . . . 0.0 112.161 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 161.0 -123.62 1.23 Allowed Glycine 0 C--N 1.334 0.451 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 -175.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 41.2 t -140.68 113.97 5.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -144.13 167.24 22.86 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.3 0.571 . . . . 0.0 111.094 -176.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -149.1 165.88 30.42 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.137 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 72.6 mmm -131.68 152.79 50.61 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 39.8 t -140.89 145.1 25.81 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 123.003 0.521 . . . . 0.0 110.385 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -131.23 134.98 46.97 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.007 0.523 . . . . 0.0 110.11 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -109.1 161.96 14.7 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 116.5 2.037 . . . . 0.0 116.5 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -80.23 -10.22 59.75 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 41.0 t -155.59 151.75 27.93 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.694 -0.628 . . . . 0.0 112.131 -176.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 43.5 t -66.39 -38.93 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -68.05 -24.17 65.05 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.784 0.265 . . . . 0.0 111.141 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 65.2 m -75.48 -33.53 60.81 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 175.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -77.51 -31.61 53.62 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 122.37 -0.206 . . . . 0.0 110.96 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -66.2 -43.77 85.82 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 121.931 -0.481 . . . . 0.0 111.358 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -77.12 -25.24 51.9 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.817 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -71.82 -41.39 68.26 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.911 0.323 . . . . 0.0 110.271 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.49 -28.34 62.83 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 122.634 0.374 . . . . 0.0 110.717 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -90.25 -12.94 36.48 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 41.0 t -113.7 -35.71 5.1 Favored 'General case' 0 C--N 1.339 0.122 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -176.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 68.5 mt -88.19 -7.45 56.84 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.024 0.375 . . . . 0.0 111.628 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -71.32 134.66 46.9 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 75.79 -5.47 39.0 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 119.795 -0.447 . . . . 0.0 112.48 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.46 166.35 22.71 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 117.797 0.799 . . . . 0.0 110.408 177.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -123.42 140.83 52.61 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 84.8 mt -75.99 -42.25 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.379 45.2 m-85 -82.89 -10.58 58.76 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 27.3 t 65.71 36.5 6.28 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.6 0.76 . . . . 0.0 110.864 -175.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 174.36 -24.25 0.07 OUTLIER Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 178.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' CYS . . . . . 0.45 ' HB3' HD12 ' A' ' 200' ' ' ILE . 75.9 m -145.62 -177.21 5.46 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.922 1.289 . . . . 0.0 109.367 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 98.6 m 58.26 37.83 26.09 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.83 148.15 13.69 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 175.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 82.2 mt -114.31 156.19 24.85 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -172.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -139.45 138.28 36.32 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.598 1.559 . . . . 0.0 107.2 169.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 31.8 mt -139.23 142.83 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 CA-C-O 120.686 0.279 . . . . 0.0 111.316 -171.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -157.69 160.49 38.01 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 122.927 0.491 . . . . 0.0 109.771 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.283 40.6 m-85 -59.88 135.42 57.69 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 176.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -89.24 159.11 17.59 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.173 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.443 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 23.4 pttp -94.24 -31.8 0.29 Allowed Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 49.1 Cg_endo -79.83 159.12 24.58 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 CA-C-N 121.881 1.708 . . . . 0.0 109.505 174.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.31 0.2 OUTLIER -134.8 15.33 3.62 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 -174.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -158.45 123.0 4.16 Favored 'General case' 0 C--N 1.338 0.074 0 O-C-N 121.931 -0.481 . . . . 0.0 111.559 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 18.9 mt -86.05 161.06 19.12 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 123.583 0.753 . . . . 0.0 110.408 174.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -121.2 51.24 1.29 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.846 171.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.403 ' H ' HG23 ' A' ' 272' ' ' VAL . 2.3 t -51.8 144.87 2.56 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -176.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -129.62 -5.78 4.66 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 117.653 2.464 . . . . 0.0 117.653 -176.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -160.66 170.91 19.85 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 122.558 0.343 . . . . 0.0 110.609 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -125.81 119.6 28.32 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.743 0.817 . . . . 0.0 110.038 174.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -162.69 -167.98 1.69 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.362 1.065 . . . . 0.0 109.087 176.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -70.23 -8.18 48.05 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -176.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -109.26 -26.28 10.15 Favored 'General case' 0 C--N 1.338 0.092 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.08 140.8 31.06 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.275 1.03 . . . . 0.0 112.499 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 21.6 t-105 -157.95 156.26 30.93 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.418 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -137.19 114.08 10.53 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.397 173.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.259 66.0 m-85 -78.29 6.72 7.66 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 -173.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 5.4 t . . . . . 0 N--CA 1.455 -0.209 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -178.901 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 56.0 m . . . . . 0 CA--C 1.53 0.184 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 28.6 t -128.8 142.34 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.095 0 C-N-CA 122.833 0.453 . . . . 0.0 110.889 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 91.2 mt -133.95 149.14 51.25 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 122.832 0.453 . . . . 0.0 111.278 -175.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 32.2 tp -102.0 135.01 44.3 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 172.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -114.57 107.04 14.97 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.93 138.27 31.68 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 174.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.1 mp -108.73 118.18 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -90.92 -18.83 24.07 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 119.255 -0.403 . . . . 0.0 112.018 -171.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -142.12 79.01 16.51 Favored Pre-proline 0 CA--C 1.529 0.156 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -77.61 44.56 1.56 Allowed 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 125.19 3.927 . . . . 0.0 112.48 -176.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.437 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -70.06 -4.55 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 O-C-N 121.59 -0.693 . . . . 0.0 110.641 179.767 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -137.95 156.18 48.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 42.3 t -70.39 117.02 11.41 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 120.717 0.294 . . . . 0.0 110.212 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.1 mm -78.55 143.73 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 122.876 0.471 . . . . 0.0 109.807 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.99 159.16 41.6 Favored 'General case' 0 CA--C 1.526 0.031 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.5 p -66.01 -15.69 63.24 Favored 'General case' 0 C--N 1.335 -0.062 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -76.38 -44.93 34.16 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.504 0.192 . . . . 0.0 110.848 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 1.9 m -72.88 -32.01 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.9 mt -70.64 -34.75 72.41 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 175.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -72.02 -30.29 65.05 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 174.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.6 m -66.82 -34.44 77.81 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 45.4 pt -91.27 -23.24 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 118.201 0.455 . . . . 0.0 111.902 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 89.0 m -89.87 -25.34 21.06 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.479 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 30.1 t30 -63.69 -42.59 72.97 Favored Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 73.8 Cg_endo -69.34 -12.56 33.98 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.338 1.359 . . . . 0.0 111.474 177.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 89.4 m -91.92 -7.45 49.1 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 122.502 0.321 . . . . 0.0 111.673 176.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 149.47 168.81 15.26 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.54 101.08 0.84 Allowed 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.9 3.067 . . . . 0.0 110.51 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 87.4 t -69.11 145.69 13.16 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 123.37 0.668 . . . . 0.0 109.257 177.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -115.04 -40.6 3.46 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 119.064 -0.493 . . . . 0.0 111.6 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 63.0 mtm-85 -148.05 152.43 37.38 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 21.4 mt -149.16 137.73 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 124.093 0.957 . . . . 0.0 110.273 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.3 m -143.48 163.15 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 C-N-CA 123.846 0.858 . . . . 0.0 110.338 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 54.1 mt -133.68 142.63 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 C-N-CA 122.757 0.423 . . . . 0.0 110.528 -175.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.264 6.3 p90 -146.92 159.34 43.67 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 115.819 1.785 . . . . 0.0 115.819 176.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.64 31.91 2.05 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.163 0.585 . . . . 0.0 111.777 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -67.9 -29.45 68.55 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -174.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -130.57 3.61 4.6 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 123.307 0.643 . . . . 0.0 112.514 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 167.19 -127.04 1.51 Allowed Glycine 0 CA--C 1.522 0.472 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 -173.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.1 t -138.79 117.8 13.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 117.103 0.452 . . . . 0.0 110.239 174.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 11.1 mp0 -144.1 168.56 19.72 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.476 0.655 . . . . 0.0 111.119 -175.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -150.66 167.16 28.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.828 1.251 . . . . 0.0 108.643 175.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 73.1 mmm -135.06 154.04 51.84 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 38.2 t -140.9 144.29 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 122.946 0.499 . . . . 0.0 110.517 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -129.88 135.07 47.94 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.87 0.468 . . . . 0.0 110.099 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -108.55 163.83 12.88 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 116.264 1.95 . . . . 0.0 116.264 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -81.2 -12.74 59.09 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 92.2 p -155.73 155.58 33.37 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.11 0.481 . . . . 0.0 111.455 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 49.7 t -67.84 -34.77 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -64.21 -33.72 76.45 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 122.254 -0.279 . . . . 0.0 110.8 -177.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 57.7 m -72.86 -33.74 66.3 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 117.464 0.12 . . . . 0.0 110.723 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -74.17 -30.12 62.09 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 119.707 -0.187 . . . . 0.0 111.373 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -68.85 -45.11 71.93 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 118.343 0.519 . . . . 0.0 111.724 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -76.44 -25.61 54.58 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 118.046 0.384 . . . . 0.0 111.553 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -72.32 -40.39 67.48 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.034 0.379 . . . . 0.0 110.171 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.82 -22.91 58.45 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.565 0.346 . . . . 0.0 111.316 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -95.08 -12.12 27.08 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 45.4 t -111.4 -34.95 5.97 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 118.622 0.646 . . . . 0.0 112.567 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 66.9 mt -89.79 -7.95 53.22 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -70.61 133.29 46.56 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 75.94 -4.12 47.59 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 119.651 -0.527 . . . . 0.0 112.215 -177.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.99 166.28 21.74 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 117.878 0.839 . . . . 0.0 110.281 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -123.56 140.06 53.38 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 115.016 1.488 . . . . 0.0 115.016 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 89.9 mt -74.24 -41.27 51.06 Favored 'Isoleucine or valine' 0 C--N 1.339 0.135 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.364 44.0 m-85 -82.86 -10.57 58.78 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 23.3 t 65.8 33.2 8.3 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.513 0.725 . . . . 0.0 110.577 -173.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 176.84 -22.52 0.05 OUTLIER Glycine 0 CA--C 1.531 1.037 0 C-N-CA 123.677 0.656 . . . . 0.0 111.491 177.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' CYS . . . . . 0.437 ' HB3' HD12 ' A' ' 200' ' ' ILE . 96.4 m -145.99 -177.9 5.84 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.567 1.147 . . . . 0.0 109.814 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 90.9 m 58.68 37.67 25.14 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -176.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.24 148.33 11.62 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 176.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 79.2 mt -115.71 155.75 27.18 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -172.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -138.85 138.16 37.23 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.37 1.468 . . . . 0.0 107.454 169.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 36.1 mt -138.67 142.91 33.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-O 120.842 0.353 . . . . 0.0 111.728 -171.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -158.38 163.0 37.67 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 175.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.267 42.5 m-85 -62.28 135.51 57.5 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 176.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -85.11 160.44 19.96 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.303 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.473 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 63.8 pttt -92.66 -31.81 0.32 Allowed Pre-proline 0 CA--C 1.537 0.452 0 CA-C-O 117.493 -1.241 . . . . 0.0 114.21 178.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 91.1 Cg_endo -76.45 173.48 14.41 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 CA-C-N 122.096 1.784 . . . . 0.0 110.088 173.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.8 -5.05 2.83 Favored 'General case' 0 N--CA 1.461 0.089 0 N-CA-C 117.699 2.481 . . . . 0.0 117.699 -175.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -157.75 131.21 7.78 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.988 0.813 . . . . 0.0 111.761 -178.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 30.4 mt -83.75 162.57 20.62 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.434 1.094 . . . . 0.0 111.065 175.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -115.53 49.38 1.09 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 169.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.406 ' H ' HG23 ' A' ' 272' ' ' VAL . 2.4 t -49.73 142.42 2.43 Favored 'Isoleucine or valine' 0 C--N 1.341 0.233 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -177.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -127.42 -9.03 5.75 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 117.819 2.526 . . . . 0.0 117.819 -175.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -161.18 173.85 14.5 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.808 0.443 . . . . 0.0 110.356 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -125.72 119.96 29.38 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.327 0.651 . . . . 0.0 110.182 175.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 47.6 p30 -159.33 -167.92 2.18 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.263 1.025 . . . . 0.0 109.271 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -69.95 -10.56 59.01 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -175.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -113.26 -18.55 12.06 Favored 'General case' 0 N--CA 1.461 0.093 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.14 141.08 29.77 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 124.29 1.036 . . . . 0.0 112.51 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 20.4 t-105 -160.35 158.76 30.21 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 118.886 0.767 . . . . 0.0 110.871 -178.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -139.59 115.81 10.45 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.398 172.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.252 65.1 m-85 -79.17 5.42 12.14 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 -173.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.456 -0.134 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -178.93 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 59.6 m . . . . . 0 CA--C 1.53 0.183 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.1 t -129.63 135.57 61.12 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 C-N-CA 123.086 0.555 . . . . 0.0 111.209 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -124.83 150.6 46.22 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 123.015 0.526 . . . . 0.0 110.646 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 40.3 tp -100.03 136.15 40.37 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 170.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -114.25 107.37 15.51 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 178.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.54 136.42 33.0 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 173.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.0 mp -106.8 118.34 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.029 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -90.67 -18.16 25.55 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -171.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -142.1 79.01 16.56 Favored Pre-proline 0 CA--C 1.529 0.139 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -76.91 44.71 1.51 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 125.115 3.877 . . . . 0.0 112.673 -177.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.444 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -70.04 -5.01 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 O-C-N 121.542 -0.724 . . . . 0.0 110.6 -179.651 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -138.89 156.54 47.2 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 43.6 t -69.8 118.75 13.04 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 31.0 mm -78.42 143.81 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 123.025 0.53 . . . . 0.0 109.58 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.02 158.24 44.04 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.4 p -65.64 -16.75 64.03 Favored 'General case' 0 CA--C 1.523 -0.096 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -76.09 -45.59 33.19 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.616 0.246 . . . . 0.0 110.713 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.1 m -72.32 -32.56 43.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.93 -34.56 71.62 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 175.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -72.46 -29.0 63.27 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 174.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.6 m -67.95 -34.0 75.74 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 44.7 pt -91.22 -23.6 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 118.399 0.545 . . . . 0.0 111.798 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 89.0 m -89.38 -26.58 20.96 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -178.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.484 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 33.8 t30 -64.14 -42.0 65.5 Favored Pre-proline 0 CA--C 1.537 0.457 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -178.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 71.9 Cg_endo -68.79 -12.92 35.8 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 121.335 1.357 . . . . 0.0 111.407 177.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 95.8 m -91.82 -6.25 52.01 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.531 0.332 . . . . 0.0 111.673 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 147.13 166.66 12.55 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.72 104.12 1.1 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 123.849 3.032 . . . . 0.0 110.663 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 74.3 t -71.49 147.11 11.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -115.82 -36.33 4.21 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 119.199 -0.429 . . . . 0.0 111.716 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 21.3 mtm180 -150.78 151.54 32.5 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.526 0.603 . . . . 0.0 112.275 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 20.6 mt -147.4 136.54 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 C-N-CA 124.323 1.049 . . . . 0.0 110.219 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 1.3 m -140.24 159.85 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.065 0 C-N-CA 123.548 0.739 . . . . 0.0 111.765 174.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 57.0 mt -132.08 142.62 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 C-N-CA 122.929 0.492 . . . . 0.0 110.021 -177.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.261 4.0 p90 -147.84 159.86 43.39 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 115.629 1.714 . . . . 0.0 115.629 176.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.1 31.35 2.18 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.017 0.527 . . . . 0.0 111.68 -177.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -67.63 -30.35 69.89 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -174.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -130.54 4.29 4.65 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 123.105 0.562 . . . . 0.0 112.498 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 166.36 -127.83 1.66 Allowed Glycine 0 C--N 1.333 0.368 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 -174.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 19.3 t -139.69 116.72 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-N 117.415 0.608 . . . . 0.0 110.336 174.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 9.6 mp0 -144.78 169.05 18.78 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.677 0.751 . . . . 0.0 111.123 -175.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -150.86 167.47 27.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.224 1.01 . . . . 0.0 108.621 175.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 53.5 mmm -135.01 154.83 51.59 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.618 0.367 . . . . 0.0 110.03 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 35.8 t -142.34 143.26 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 C-N-CA 123.219 0.608 . . . . 0.0 110.496 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -130.07 134.36 47.32 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 123.216 0.323 . . . . 0.0 110.263 177.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -105.01 163.62 12.41 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 -176.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -77.93 -16.48 58.15 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 86.4 p -153.48 157.15 39.42 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.222 0.534 . . . . 0.0 111.503 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 54.8 t -67.23 -33.98 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -64.9 -34.81 79.28 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 122.063 -0.398 . . . . 0.0 110.613 -177.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 65.6 m -72.58 -31.51 65.28 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 110.624 -0.139 . . . . 0.0 110.624 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -72.52 -31.68 65.53 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 111.328 0.122 . . . . 0.0 111.328 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -72.21 -45.82 58.74 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 117.979 0.354 . . . . 0.0 111.843 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 17.1 ptt180 -75.04 -26.02 59.13 Favored 'General case' 0 C--N 1.338 0.089 0 C-N-CA 120.659 -0.417 . . . . 0.0 111.317 -177.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -70.63 -40.73 72.94 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 117.934 0.334 . . . . 0.0 110.196 177.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -75.79 -25.87 56.8 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.494 0.317 . . . . 0.0 111.059 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -89.25 -10.46 46.87 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 47.0 t -115.92 -35.74 4.36 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 66.8 mt -89.31 -6.7 56.5 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -177.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -70.94 133.97 46.83 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.19 -4.6 47.09 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 119.767 -0.463 . . . . 0.0 112.346 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.61 166.43 22.54 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 117.872 0.836 . . . . 0.0 110.249 177.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -123.45 139.16 54.31 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 86.8 mt -73.77 -41.74 54.29 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.358 44.0 m-85 -82.83 -11.39 58.28 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.8 t 65.38 35.92 7.18 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 122.101 0.953 . . . . 0.0 110.685 -174.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 176.38 -24.55 0.06 OUTLIER Glycine 0 CA--C 1.528 0.877 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.202 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' CYS . . . . . 0.444 ' HB3' HD12 ' A' ' 200' ' ' ILE . 87.2 m -147.21 -177.16 5.53 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.943 1.297 . . . . 0.0 109.659 178.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 94.9 m 58.54 37.7 25.47 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -175.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.93 147.43 12.26 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 175.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 80.1 mt -115.26 154.41 29.14 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -173.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -137.53 138.31 39.51 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.16 1.384 . . . . 0.0 107.448 169.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 36.6 mt -138.31 143.29 33.15 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.085 0 CA-C-O 120.781 0.324 . . . . 0.0 111.381 -171.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -158.71 161.66 37.09 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.789 175.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.272 33.5 m-85 -59.18 134.43 56.99 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 176.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 265' ' ' ALA . . . . . 0.407 ' HB1' ' HD2' ' A' ' 267' ' ' PRO . . . -87.74 163.33 16.55 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.854 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.494 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 23.3 pttp -97.95 -29.83 0.25 Allowed Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 84.2 Cg_endo -76.23 170.88 19.15 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 CA-C-N 122.04 1.764 . . . . 0.0 110.277 175.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.41 -2.62 2.75 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 117.584 2.438 . . . . 0.0 117.584 -177.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.26 131.61 10.34 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 118.691 0.678 . . . . 0.0 111.879 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 17.0 mt -89.84 158.16 17.59 Favored 'General case' 0 C--N 1.337 0.065 0 C-N-CA 123.652 0.781 . . . . 0.0 111.325 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -121.84 46.04 2.18 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.549 0.739 . . . . 0.0 109.834 175.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 272' ' ' VAL . 2.5 t -52.08 144.7 2.89 Favored 'Isoleucine or valine' 0 C--N 1.338 0.093 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . 0.317 8.2 p90 -123.54 -5.73 8.16 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 117.099 2.259 . . . . 0.0 117.099 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.84 172.33 16.28 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 123.382 0.673 . . . . 0.0 111.264 178.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -124.15 118.89 27.9 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.71 0.804 . . . . 0.0 110.067 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -159.09 -168.74 2.44 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.907 0.883 . . . . 0.0 109.379 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -69.63 -10.77 59.58 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -176.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -98.96 -38.35 9.03 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.4 p -143.04 146.05 33.48 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.66 0.784 . . . . 0.0 113.003 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 20.3 t-105 -154.73 152.85 30.39 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.165 0.507 . . . . 0.0 109.998 -174.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -127.6 117.42 21.99 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.559 174.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.286 65.0 m-85 -81.64 8.41 9.89 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 117.511 2.412 . . . . 0.0 117.511 -171.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 6.4 t . . . . . 0 CA--C 1.529 0.147 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -178.836 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 CA--C 1.531 0.224 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.5 t -133.08 134.57 57.73 Favored 'Isoleucine or valine' 0 C--N 1.341 0.198 0 C-N-CA 122.752 0.421 . . . . 0.0 110.672 177.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.41 ' N ' HD22 ' A' ' 192' ' ' LEU . 2.4 mm? -123.14 152.49 41.09 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 122.781 0.433 . . . . 0.0 111.137 -176.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 28.0 tp -100.91 135.8 41.78 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 169.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -113.29 111.06 21.39 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.863 1.265 . . . . 0.0 114.248 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.31 132.69 38.65 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 173.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.3 mp -103.7 120.55 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -89.74 -18.1 27.0 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -171.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -143.08 78.95 14.79 Favored Pre-proline 0 CA--C 1.53 0.181 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -78.37 45.92 1.98 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 125.061 3.84 . . . . 0.0 112.131 -177.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.433 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -70.38 -3.86 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 O-C-N 121.924 -0.485 . . . . 0.0 110.553 179.779 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -137.32 157.74 45.96 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 176.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 67.5 m -69.88 113.6 7.27 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 33.7 mm -78.4 141.81 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.079 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.24 161.02 36.09 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.6 p -62.45 -21.04 65.13 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -74.02 -46.21 44.92 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.63 0.372 . . . . 0.0 111.717 -178.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 1.7 m -69.28 -32.74 54.75 Favored 'Isoleucine or valine' 0 C--O 1.23 0.043 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.9 mt -72.09 -35.82 69.32 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -69.2 -31.05 69.39 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 174.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 9.4 m -67.69 -34.05 76.13 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 38.6 pt -93.16 -21.32 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 119.027 -0.511 . . . . 0.0 111.916 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 92.0 m -90.34 -27.32 19.47 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 119.139 0.881 . . . . 0.0 113.278 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.496 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 35.1 t30 -63.36 -39.78 52.99 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -178.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 74.0 Cg_endo -69.35 -15.77 38.83 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 CA-C-N 121.216 1.47 . . . . 0.0 111.635 178.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 95.0 m -84.67 -13.29 51.92 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.041 0.382 . . . . 0.0 111.456 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 149.58 169.42 15.95 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.03 112.84 1.64 Allowed 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 123.578 2.852 . . . . 0.0 111.309 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.8 t -79.38 144.34 11.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 176.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -112.99 -39.57 4.19 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 119.381 -0.342 . . . . 0.0 111.189 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 23.3 mtm180 -150.06 153.16 35.98 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.131 0.423 . . . . 0.0 112.066 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 24.6 mt -144.07 143.6 23.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.261 1.024 . . . . 0.0 109.659 178.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 38.3 t -145.94 155.89 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 46.6 mt -138.65 141.52 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 123.894 0.878 . . . . 0.0 109.375 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.287 3.2 p90 -143.98 157.52 44.29 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 177.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -126.53 15.98 7.62 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.272 0.629 . . . . 0.0 110.733 -173.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -63.35 -33.18 74.96 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -169.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -130.35 7.86 5.0 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.568 0.622 . . . . 0.0 112.265 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 161.96 -125.35 1.41 Allowed Glycine 0 CA--C 1.522 0.469 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -174.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 47.0 t -141.9 114.9 4.16 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 174.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -142.16 168.31 20.04 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.256 0.551 . . . . 0.0 110.989 -176.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.05 164.26 34.37 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.951 176.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 67.4 mmm -132.39 151.27 51.94 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 41.2 t -141.63 144.31 26.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 C-N-CA 122.77 0.428 . . . . 0.0 110.326 -178.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -130.58 134.23 46.84 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 122.838 0.455 . . . . 0.0 110.498 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -106.6 163.43 12.89 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 116.765 2.135 . . . . 0.0 116.765 -175.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -76.64 -17.04 59.38 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.784 0.433 . . . . 0.0 109.879 178.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 83.8 p -154.87 158.34 39.21 Favored 'General case' 0 C--O 1.232 0.157 0 O-C-N 121.819 -0.551 . . . . 0.0 111.648 -178.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 54.4 t -66.29 -33.61 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -68.34 -30.05 68.92 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 121.918 -0.489 . . . . 0.0 110.719 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 68.9 m -73.48 -31.43 63.75 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 175.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.49 -34.51 58.64 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 122.482 0.313 . . . . 0.0 111.546 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -70.54 -42.26 71.42 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 118.104 0.411 . . . . 0.0 111.445 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -76.84 -25.66 53.45 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.489 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -70.44 -41.27 73.09 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -75.08 -19.93 59.74 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.567 0.347 . . . . 0.0 111.012 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -99.51 -4.24 31.69 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 38.6 t -124.28 -31.91 3.25 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.864 0.756 . . . . 0.0 112.803 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 61.6 mt -91.59 -6.66 51.96 Favored 'General case' 0 CA--C 1.527 0.071 0 O-C-N 121.998 -0.439 . . . . 0.0 111.527 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -73.28 134.75 44.32 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 74.44 -5.9 26.28 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 111.984 -0.447 . . . . 0.0 111.984 -178.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.19 166.46 22.17 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 117.663 0.731 . . . . 0.0 110.122 177.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -123.64 139.68 53.76 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 87.7 mt -73.33 -41.58 57.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.182 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.367 39.6 m-85 -82.93 -12.01 57.69 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 117.257 2.317 . . . . 0.0 117.257 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.7 t 65.8 35.26 6.85 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.748 0.785 . . . . 0.0 110.754 -174.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 176.0 -23.68 0.06 OUTLIER Glycine 0 CA--C 1.527 0.812 0 C-N-CA 123.947 0.784 . . . . 0.0 111.198 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' CYS . . . . . 0.433 ' HB3' HD12 ' A' ' 200' ' ' ILE . 93.0 m -147.2 -177.02 5.45 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.916 1.286 . . . . 0.0 109.466 178.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 86.7 m 58.07 36.95 26.41 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -176.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.59 148.95 11.44 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 175.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 76.3 mt -115.9 155.23 28.33 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -173.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -138.38 138.38 38.21 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.313 1.445 . . . . 0.0 107.587 168.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 34.3 mt -138.34 142.37 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-O 120.657 0.265 . . . . 0.0 111.611 -170.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -158.67 162.25 37.21 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.38 0.672 . . . . 0.0 109.844 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -61.13 137.45 58.23 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -88.6 162.34 16.41 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.942 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -82.41 -54.25 0.61 Allowed Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 118.493 -0.765 . . . . 0.0 112.742 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -73.46 164.97 33.68 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.269 2.646 . . . . 0.0 111.347 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.274 0.2 OUTLIER -135.41 10.11 3.46 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 117.247 2.314 . . . . 0.0 117.247 -176.056 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.12 129.16 8.79 Favored 'General case' 0 C--N 1.339 0.11 0 O-C-N 121.646 -0.659 . . . . 0.0 111.642 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 30.9 mt -92.57 156.37 17.17 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 123.882 0.873 . . . . 0.0 110.916 177.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -118.58 49.12 1.33 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.861 0.864 . . . . 0.0 109.585 174.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.409 HG23 ' H ' ' A' ' 272' ' ' VAL . 2.1 t -52.31 142.12 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -176.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -130.08 0.7 4.71 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 116.551 2.056 . . . . 0.0 116.551 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -160.58 164.31 32.03 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 122.89 0.476 . . . . 0.0 110.926 -176.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -125.73 118.72 26.19 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.617 0.767 . . . . 0.0 109.198 174.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 40.0 p30 -157.19 -168.04 2.5 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.823 0.849 . . . . 0.0 109.904 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -69.3 -11.95 61.25 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -104.29 -30.66 10.0 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 3.5 p -141.49 145.31 35.05 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 19.2 t-105 -157.67 153.24 26.4 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -176.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . 0.251 7.0 t0 -132.95 121.15 22.38 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 122.94 0.496 . . . . 0.0 112.197 176.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.25 67.2 m-85 -87.25 8.97 21.76 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 117.58 2.437 . . . . 0.0 117.58 -171.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 5.0 t . . . . . 0 C--O 1.231 0.11 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 -177.208 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 CA--C 1.529 0.151 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 20.2 t -128.09 140.37 49.35 Favored 'Isoleucine or valine' 0 C--N 1.338 0.081 0 C-N-CA 122.813 0.445 . . . . 0.0 111.192 176.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.7 mt -131.88 157.44 43.95 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.241 0.616 . . . . 0.0 110.958 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.0 tt -113.8 136.04 53.3 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.412 0.685 . . . . 0.0 109.288 174.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -114.34 102.59 10.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -85.96 135.72 33.55 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 174.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.2 mp -106.06 122.41 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -90.27 -20.34 23.07 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -172.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -141.23 78.87 18.37 Favored Pre-proline 0 CA--C 1.529 0.163 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -78.6 44.2 1.59 Allowed 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 124.984 3.789 . . . . 0.0 112.147 -177.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.438 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -69.05 -4.72 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 O-C-N 121.91 -0.494 . . . . 0.0 110.803 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -136.3 157.82 45.9 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 70.9 m -68.87 113.28 6.16 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.84 0.352 . . . . 0.0 110.32 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 40.0 mm -78.42 141.23 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 176.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.1 157.18 46.81 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.0 p -66.38 -15.86 63.62 Favored 'General case' 0 C--N 1.334 -0.088 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 175.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -79.87 -42.19 24.74 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.5 p -75.18 -32.41 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.1 mt -69.83 -33.95 73.0 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -71.23 -29.25 64.9 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 174.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.0 m -68.09 -32.2 72.35 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 45.3 pt -93.56 -22.36 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 118.291 0.496 . . . . 0.0 112.058 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 94.0 m -89.99 -26.07 20.55 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.494 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 35.1 t30 -63.89 -41.44 63.58 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 74.0 Cg_endo -69.09 -15.98 40.01 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.521 1.48 . . . . 0.0 111.27 177.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 97.6 m -86.15 -11.7 51.86 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.457 0.303 . . . . 0.0 111.467 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 151.5 167.69 15.17 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -68.01 103.67 0.92 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.913 3.075 . . . . 0.0 110.248 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.1 t -70.61 146.96 11.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -114.9 -39.0 3.77 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 119.13 -0.462 . . . . 0.0 111.561 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 22.5 mtm180 -149.54 151.45 33.89 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 118.61 0.641 . . . . 0.0 112.263 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 24.2 mt -148.66 137.65 15.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 124.053 0.941 . . . . 0.0 109.929 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 5.4 m -143.55 161.99 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 124.248 1.019 . . . . 0.0 110.559 174.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 46.4 mt -134.74 143.01 38.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 C-N-CA 122.929 0.491 . . . . 0.0 110.472 -175.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.3 4.4 p90 -142.3 158.44 43.71 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 176.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -128.61 15.14 6.51 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.591 0.756 . . . . 0.0 110.909 -173.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -62.6 -31.34 72.15 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 -169.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -130.41 4.0 4.69 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.609 0.64 . . . . 0.0 112.119 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 165.86 -124.45 1.24 Allowed Glycine 0 CA--C 1.521 0.429 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 -174.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.2 t -141.63 115.38 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.121 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 174.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -143.15 166.09 25.64 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.242 0.544 . . . . 0.0 111.11 -177.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -143.73 165.1 28.59 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.957 0.903 . . . . 0.0 108.836 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 80.7 mmm -133.13 150.82 52.02 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 31.6 t -140.49 145.65 25.51 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.061 0 C-N-CA 122.689 0.395 . . . . 0.0 110.882 -177.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -132.74 135.07 45.51 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 122.622 0.369 . . . . 0.0 110.628 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -107.42 163.84 12.7 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 115.934 1.828 . . . . 0.0 115.934 -176.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -78.32 -15.86 58.3 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 79.1 p -154.91 159.65 40.61 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.304 0.573 . . . . 0.0 111.665 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 54.3 t -67.51 -35.22 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -66.24 -30.88 71.41 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 122.375 -0.203 . . . . 0.0 110.954 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 74.4 m -72.83 -34.04 66.55 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 176.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.16 -31.34 58.5 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 122.43 -0.169 . . . . 0.0 111.2 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -68.51 -42.58 78.34 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 121.825 -0.547 . . . . 0.0 111.459 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -76.52 -26.57 55.38 Favored 'General case' 0 C--N 1.338 0.1 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.816 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -72.07 -41.55 67.23 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.186 0.448 . . . . 0.0 110.173 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -73.69 -20.11 60.63 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.742 0.417 . . . . 0.0 111.184 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -99.01 -9.3 24.13 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 46.4 t -116.32 -32.93 5.13 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 72.8 mt -91.9 -7.89 47.93 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.059 0.391 . . . . 0.0 111.902 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -73.04 133.04 44.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 77.06 -5.84 46.49 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.707 -0.496 . . . . 0.0 111.957 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.32 166.41 22.13 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 117.782 0.791 . . . . 0.0 110.384 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -123.49 140.65 52.79 Favored 'General case' 0 C--N 1.334 -0.099 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 87.1 mt -74.61 -42.39 48.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.359 39.7 m-85 -82.79 -12.16 57.71 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 32.6 t 65.54 36.12 6.78 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.658 0.742 . . . . 0.0 111.239 -174.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 175.6 -24.26 0.06 OUTLIER Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' CYS . . . . . 0.438 ' HB3' HD12 ' A' ' 200' ' ' ILE . 96.9 m -145.81 -177.2 5.46 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.185 1.394 . . . . 0.0 109.801 177.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 88.1 m 57.89 37.93 26.96 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.22 148.96 13.38 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 175.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 81.2 mt -116.09 154.78 29.35 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -173.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 54.1 mttp -138.19 137.06 37.23 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.715 1.606 . . . . 0.0 107.484 169.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 56.0 mt -136.87 143.3 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-O 120.94 0.4 . . . . 0.0 111.384 -172.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -159.23 164.02 35.38 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.739 175.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.266 45.3 m-85 -61.71 135.46 57.62 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 176.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -88.27 156.36 19.24 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.347 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.446 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 64.6 pttt -89.44 -31.51 0.37 Allowed Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 50.1 Cg_endo -79.28 168.39 20.26 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 121.835 1.69 . . . . 0.0 110.136 175.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.281 0.2 OUTLIER -137.78 8.86 2.82 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 117.883 2.549 . . . . 0.0 117.883 -176.015 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.32 126.84 6.69 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 118.778 0.717 . . . . 0.0 111.799 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 27.4 mt -92.22 156.95 16.96 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 123.858 0.863 . . . . 0.0 110.747 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -116.67 53.31 0.89 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.504 0.722 . . . . 0.0 109.788 172.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.6 t -54.68 145.26 4.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -175.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -135.67 -0.25 2.63 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 117.022 2.23 . . . . 0.0 117.022 -176.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -160.53 159.08 30.26 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.584 0.354 . . . . 0.0 111.372 -173.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -123.12 112.23 17.48 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.834 0.854 . . . . 0.0 109.404 173.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 53.1 p30 -157.87 -166.28 1.94 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -66.9 -16.33 64.25 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -174.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -115.17 -13.36 11.79 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.29 139.29 37.29 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 123.815 0.846 . . . . 0.0 113.041 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 16.3 t-105 -162.95 155.34 18.62 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.25 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . 0.259 5.8 t0 -140.79 119.57 12.54 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.194 0.598 . . . . 0.0 112.102 172.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.252 66.8 m-85 -82.18 7.62 13.16 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 117.536 2.421 . . . . 0.0 117.536 -171.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 6.0 t . . . . . 0 C--O 1.232 0.143 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -177.381 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 71.2 m . . . . . 0 CA--C 1.532 0.27 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.3 t -132.97 133.26 58.92 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 CA-C-N 118.162 0.437 . . . . 0.0 110.875 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.431 HD21 ' HB1' ' A' ' 241' ' ' ALA . 2.3 mm? -121.76 155.01 36.17 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 122.954 0.502 . . . . 0.0 110.995 -176.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 29.1 tp -104.98 131.18 52.82 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 170.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -107.72 101.74 11.02 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 177.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.78 136.21 33.17 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 174.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.4 mp -105.67 130.61 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -92.65 -24.2 18.74 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -175.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -138.82 78.92 29.33 Favored Pre-proline 0 CA--C 1.529 0.147 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -77.01 49.59 2.84 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 124.865 3.71 . . . . 0.0 112.346 -178.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.464 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -69.13 -7.05 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 O-C-N 121.775 -0.578 . . . . 0.0 110.314 178.467 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -140.14 153.67 46.75 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.082 1.353 . . . . 0.0 113.081 175.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.4 t -73.55 128.14 34.68 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 120.811 0.338 . . . . 0.0 110.517 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 19.7 mm -78.71 148.69 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 122.724 0.409 . . . . 0.0 109.947 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.0 156.15 48.71 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 177.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.5 p -65.57 -16.37 63.63 Favored 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -74.73 -47.16 32.85 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.7 0.286 . . . . 0.0 111.703 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.5 m -71.41 -32.43 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.6 mt -69.91 -36.15 75.17 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 176.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -71.21 -30.67 66.66 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 12.6 m -66.31 -32.99 74.73 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 37.5 pt -94.05 -24.3 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 118.178 0.444 . . . . 0.0 112.02 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 90.1 m -88.29 -25.44 22.81 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.49 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 35.3 t30 -64.19 -43.16 72.66 Favored Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 67.4 Cg_endo -68.38 -15.3 41.88 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 121.411 1.407 . . . . 0.0 111.512 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 95.4 m -83.86 -15.14 49.29 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.047 0.385 . . . . 0.0 111.379 177.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 151.02 170.47 18.05 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -61.12 104.82 0.3 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.774 2.983 . . . . 0.0 111.732 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 72.5 t -75.72 145.54 10.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -117.79 -39.75 3.09 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 119.287 -0.387 . . . . 0.0 111.477 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 66.1 mtm-85 -148.05 151.22 35.32 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.484 0.584 . . . . 0.0 112.547 179.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 20.3 mt -148.27 137.58 15.89 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 C-N-CA 124.105 0.962 . . . . 0.0 109.628 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 8.1 m -143.07 162.84 17.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 C-N-CA 123.735 0.814 . . . . 0.0 110.23 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 47.8 mt -135.96 142.88 37.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.093 0 C-N-CA 123.224 0.609 . . . . 0.0 110.409 -174.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.299 6.2 p90 -141.39 155.38 45.91 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 177.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -128.37 14.3 6.62 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.242 0.617 . . . . 0.0 110.788 -174.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -64.98 -30.68 71.68 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -169.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -130.37 5.8 4.82 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.793 0.724 . . . . 0.0 111.812 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 162.38 -126.29 1.54 Allowed Glycine 0 C--N 1.335 0.515 0 N-CA-C 107.966 -2.054 . . . . 0.0 107.966 -174.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 38.5 t -142.78 116.98 4.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 175.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -144.02 166.84 23.84 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.289 0.566 . . . . 0.0 110.631 -176.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.97 166.37 26.99 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.113 175.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 74.6 mmm -133.96 154.2 51.26 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 29.6 t -142.11 142.8 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 C-N-CA 122.781 0.432 . . . . 0.0 110.905 -178.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -129.36 133.16 47.26 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.155 0.582 . . . . 0.0 110.274 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -108.5 160.97 15.48 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 -176.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -79.55 -11.95 59.87 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 37.7 t -154.81 153.48 31.25 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 121.812 -0.555 . . . . 0.0 111.549 -176.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 56.6 t -68.01 -37.36 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -67.09 -27.53 67.43 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 122.039 -0.413 . . . . 0.0 111.025 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 52.2 m -74.32 -32.39 62.82 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 175.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.431 ' HB1' HD21 ' A' ' 192' ' ' LEU . . . -76.52 -31.74 57.84 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 122.567 0.347 . . . . 0.0 111.305 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -69.74 -45.39 68.24 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 117.949 0.34 . . . . 0.0 111.345 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -74.6 -26.57 60.0 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 117.953 0.342 . . . . 0.0 111.24 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -69.32 -42.81 74.86 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.435 ' HE3' ' HB3' ' A' ' 245' ' ' LYS . 0.8 OUTLIER -75.39 -21.24 58.42 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.825 0.45 . . . . 0.0 111.161 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -94.32 -9.0 37.32 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 40.9 t -118.4 -34.21 4.12 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -177.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 70.8 mt -89.1 -8.07 54.55 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 118.161 0.437 . . . . 0.0 111.999 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -71.15 136.3 48.07 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.58 -5.66 21.43 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 119.756 -0.469 . . . . 0.0 112.159 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -77.83 166.5 22.83 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 117.955 0.878 . . . . 0.0 110.003 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -122.59 139.17 54.22 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 86.2 mt -74.48 -41.58 49.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.361 44.8 m-85 -82.86 -9.96 59.07 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 117.045 2.239 . . . . 0.0 117.045 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 30.8 t 65.57 35.25 7.25 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.479 0.712 . . . . 0.0 111.08 -175.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 175.95 -24.6 0.06 OUTLIER Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.053 0.835 . . . . 0.0 111.243 177.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' CYS . . . . . 0.464 ' HB3' HD12 ' A' ' 200' ' ' ILE . 82.0 m -145.83 -177.87 5.81 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.6 1.16 . . . . 0.0 109.354 178.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 97.3 m 58.6 38.96 25.16 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -174.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.32 150.37 8.79 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 174.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 97.1 mt -110.96 157.3 20.06 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -173.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.96 130.13 26.76 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.711 2.005 . . . . 0.0 106.331 170.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 30.7 mt -138.3 139.69 41.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-O 120.908 0.385 . . . . 0.0 111.295 -172.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -161.31 163.75 30.62 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.421 175.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.25 48.7 m-85 -59.89 141.91 54.58 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 177.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -96.21 162.08 13.68 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -176.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.401 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 59.2 mttm -78.14 -50.33 1.79 Allowed Pre-proline 0 CA--C 1.532 0.286 0 CA-C-O 118.318 -0.849 . . . . 0.0 112.282 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 87.6 Cg_endo -75.51 169.01 23.26 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.656 2.237 . . . . 0.0 111.191 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.259 0.2 OUTLIER -134.51 3.13 3.29 Favored 'General case' 0 CA--C 1.527 0.071 0 N-CA-C 117.73 2.493 . . . . 0.0 117.73 -176.328 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -157.85 127.47 5.97 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 118.764 0.711 . . . . 0.0 112.063 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 21.9 mt -82.81 163.24 21.34 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.975 0.91 . . . . 0.0 111.015 175.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -121.8 51.98 1.29 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.69 0.796 . . . . 0.0 109.103 171.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.408 ' H ' HG23 ' A' ' 272' ' ' VAL . 2.3 t -51.96 144.49 2.94 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -176.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -128.36 -7.52 5.27 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 117.476 2.399 . . . . 0.0 117.476 -177.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -161.46 171.37 18.28 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 122.728 0.411 . . . . 0.0 110.517 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -124.69 122.99 39.05 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.774 0.83 . . . . 0.0 109.667 174.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 45.1 p30 -160.58 -166.12 1.57 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.99 0.916 . . . . 0.0 108.728 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -68.17 -14.98 63.39 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -174.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -114.01 -13.18 12.52 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.01 139.87 34.23 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 123.68 0.792 . . . . 0.0 112.736 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 17.2 t-105 -160.34 156.14 25.78 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.328 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -135.86 116.04 13.43 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.542 172.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.267 67.2 m-85 -80.4 8.0 8.52 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 116.898 2.184 . . . . 0.0 116.898 -173.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.457 -0.118 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -179.516 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 CA--C 1.536 0.418 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 92.7 t -132.51 143.3 40.19 Favored 'Isoleucine or valine' 0 C--N 1.339 0.124 0 C-N-CA 123.669 0.788 . . . . 0.0 109.207 177.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 75.9 mt -136.38 149.64 48.43 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -173.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 38.8 tp -100.02 135.54 41.28 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 172.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -114.97 102.2 9.74 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.138 1.375 . . . . 0.0 114.485 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.42 134.33 33.6 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 174.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.2 mp -103.5 122.44 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -91.99 -18.12 24.12 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -171.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -143.29 78.72 14.69 Favored Pre-proline 0 CA--C 1.529 0.148 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -78.23 45.83 1.94 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 125.136 3.891 . . . . 0.0 112.102 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.424 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -70.95 -4.55 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 O-C-N 121.952 -0.467 . . . . 0.0 110.909 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -136.27 157.6 46.42 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 177.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 66.9 m -71.34 112.81 7.77 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 120.636 0.255 . . . . 0.0 110.466 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.3 mm -78.46 142.15 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.96 160.58 37.28 Favored 'General case' 0 N--CA 1.458 -0.064 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.2 p -66.6 -14.52 62.5 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 176.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -75.98 -44.29 40.41 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 120.813 0.339 . . . . 0.0 110.675 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.0 m -72.53 -33.52 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.8 mt -70.85 -35.11 72.28 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -69.74 -31.5 69.51 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 174.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.8 m -67.31 -31.81 72.36 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 43.4 pt -94.58 -25.47 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-O 118.982 -0.533 . . . . 0.0 112.027 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 98.0 m -86.59 -28.59 23.18 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 119.283 0.947 . . . . 0.0 113.263 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.496 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 38.8 t30 -68.12 -40.49 21.95 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -178.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 74.4 Cg_endo -69.42 -14.29 36.93 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 CA-C-N 121.045 1.409 . . . . 0.0 111.434 176.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 91.7 m -87.28 -8.97 56.17 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 117.896 0.317 . . . . 0.0 111.46 176.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 150.53 171.1 18.45 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 178.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -66.63 85.45 0.29 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 124.632 3.554 . . . . 0.0 110.928 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 10.7 p -68.39 148.48 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 123.874 0.87 . . . . 0.0 109.609 175.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -121.75 -36.23 3.07 Favored 'General case' 0 C--O 1.228 -0.077 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -174.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 66.2 mtm-85 -146.1 148.73 32.93 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.582 0.628 . . . . 0.0 112.353 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 35.2 mt -147.99 135.07 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 C-N-CA 123.998 0.919 . . . . 0.0 109.504 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 2.3 m -141.3 160.81 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.105 0 C-N-CA 123.633 0.773 . . . . 0.0 111.614 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 53.1 mt -134.6 144.17 35.69 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.046 0 C-N-CA 123.332 0.653 . . . . 0.0 110.327 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.297 4.6 p90 -143.31 155.99 44.6 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -127.13 13.13 7.21 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.509 0.724 . . . . 0.0 111.087 -173.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -64.31 -31.04 72.09 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -169.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -130.32 7.49 4.98 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 118.889 0.768 . . . . 0.0 112.114 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 161.08 -124.54 1.33 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 108.559 -1.816 . . . . 0.0 108.559 -174.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 59.4 t -144.25 114.63 2.11 Favored 'Isoleucine or valine' 0 C--O 1.23 0.051 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 175.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -142.89 168.05 20.63 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.123 0.487 . . . . 0.0 110.904 -176.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.65 166.99 24.9 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.846 0.858 . . . . 0.0 109.152 175.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 71.3 mmm -134.06 156.08 48.88 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 38.5 t -141.23 147.05 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 122.89 0.476 . . . . 0.0 110.747 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -135.55 134.93 39.93 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.005 0.522 . . . . 0.0 110.326 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -108.16 163.05 13.5 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -77.45 -14.52 59.67 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 84.9 p -154.54 153.43 31.43 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.462 0.649 . . . . 0.0 111.581 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 51.9 t -65.23 -32.11 56.82 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.347 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -65.54 -33.95 77.12 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.014 0.37 . . . . 0.0 110.454 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 69.1 m -72.13 -33.5 67.84 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 177.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -72.63 -31.8 65.41 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 122.376 -0.202 . . . . 0.0 111.206 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -68.93 -43.77 74.45 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.931 -0.481 . . . . 0.0 111.523 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -77.78 -25.77 49.29 Favored 'General case' 0 N--CA 1.458 -0.036 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.497 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -72.5 -40.73 66.62 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 118.084 0.402 . . . . 0.0 110.035 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -72.6 -25.34 61.28 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 122.416 0.286 . . . . 0.0 110.864 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -91.86 -10.31 40.18 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 47.1 t -114.08 -34.12 5.48 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 80.3 mt -90.12 -9.36 48.63 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -70.74 134.63 47.62 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 74.73 -3.22 44.59 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 119.72 -0.489 . . . . 0.0 112.151 -178.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.52 166.48 21.14 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 117.869 0.834 . . . . 0.0 110.069 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -123.6 140.08 53.36 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 81.9 mt -74.99 -41.17 45.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.365 40.7 m-85 -82.85 -12.01 57.77 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 117.4 2.371 . . . . 0.0 117.4 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 32.1 t 65.39 34.89 7.82 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.495 0.718 . . . . 0.0 110.926 -173.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 177.15 -24.44 0.05 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' CYS . . . . . 0.424 ' HB3' HD12 ' A' ' 200' ' ' ILE . 86.0 m -146.89 -176.13 5.08 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.661 1.184 . . . . 0.0 109.5 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 89.1 m 58.2 37.24 26.2 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -176.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.27 149.08 13.36 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 176.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 81.2 mt -116.25 153.81 31.24 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -173.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -137.24 137.36 38.98 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 169.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 46.4 mt -139.6 141.64 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-O 120.734 0.302 . . . . 0.0 111.615 -170.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -161.36 163.92 30.36 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.043 176.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.277 49.8 m-85 -59.28 139.45 56.97 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 177.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -95.85 164.31 12.79 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -175.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.408 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 61.0 mttm -78.46 -50.05 1.69 Allowed Pre-proline 0 CA--C 1.535 0.395 0 CA-C-O 118.624 -0.703 . . . . 0.0 112.486 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 90.1 Cg_endo -74.7 174.21 13.05 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.619 2.213 . . . . 0.0 110.686 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 2.1 t -138.56 -2.48 1.77 Allowed 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 116.493 2.034 . . . . 0.0 116.493 -174.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.92 130.55 9.03 Favored 'General case' 0 C--N 1.34 0.176 0 O-C-N 121.546 -0.721 . . . . 0.0 111.624 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 17.0 mt -86.46 157.63 19.76 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 123.667 0.787 . . . . 0.0 111.127 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -119.74 47.36 1.74 Allowed 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.633 0.773 . . . . 0.0 109.59 173.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 272' ' ' VAL . 2.2 t -50.38 143.03 2.52 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 -176.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -132.5 1.22 3.72 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 116.15 1.907 . . . . 0.0 116.15 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -156.4 153.32 28.72 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.163 0.585 . . . . 0.0 110.355 -171.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -122.18 118.65 29.13 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.364 0.666 . . . . 0.0 109.675 172.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 54.9 p30 -157.58 -167.28 2.23 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -69.21 -13.38 62.37 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -175.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -109.51 -22.6 11.92 Favored 'General case' 0 C--N 1.338 0.102 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.65 142.08 35.01 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 177.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 20.2 t-105 -159.3 155.55 27.09 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.155 0.502 . . . . 0.0 110.01 -175.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -129.93 117.22 19.78 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.496 171.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.277 66.5 m-85 -80.0 8.44 7.04 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 117.269 2.322 . . . . 0.0 117.269 -172.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 8.7 t . . . . . 0 C--O 1.231 0.105 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -179.438 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 70.9 m . . . . . 0 CA--C 1.532 0.265 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 96.3 t -142.37 136.63 28.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 C-N-CA 123.976 0.911 . . . . 0.0 108.655 -178.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.451 ' N ' HD22 ' A' ' 192' ' ' LEU . 1.8 mm? -125.04 151.91 44.98 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 122.68 0.392 . . . . 0.0 111.309 -176.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 39.2 tp -95.54 136.29 36.12 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 169.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -113.95 102.77 10.51 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.899 1.279 . . . . 0.0 114.292 177.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.74 133.12 33.91 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 174.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.2 mp -104.06 121.31 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -89.03 -18.62 26.98 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -172.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -144.22 79.03 13.21 Favored Pre-proline 0 CA--C 1.529 0.142 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.74 46.03 1.93 Allowed 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.838 3.692 . . . . 0.0 112.247 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.419 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -70.88 -4.09 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 O-C-N 121.953 -0.467 . . . . 0.0 110.764 179.625 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -136.74 157.59 46.4 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 176.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 70.5 m -70.77 111.9 6.57 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.273 0.229 . . . . 0.0 110.552 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 32.2 mm -78.83 141.15 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 176.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.03 158.31 43.88 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 177.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.67 -19.79 66.04 Favored 'General case' 0 C--O 1.23 0.057 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -77.63 -34.52 53.26 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 96.4 t -75.46 -41.22 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.27 -31.52 70.1 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -70.85 -29.53 65.67 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 174.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.4 m -68.42 -32.79 73.09 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 45.0 pt -92.88 -22.51 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 118.379 0.536 . . . . 0.0 112.073 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 92.5 m -90.61 -26.53 19.6 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.49 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 32.0 t30 -63.06 -42.83 79.35 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 74.3 Cg_endo -69.25 -11.8 32.35 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.378 1.386 . . . . 0.0 111.604 177.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 92.5 m -91.78 -5.82 52.87 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 145.44 168.66 13.18 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 177.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.21 104.63 0.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.851 3.034 . . . . 0.0 111.581 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 55.4 t -75.7 143.61 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 -115.36 -40.08 3.49 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 119.415 -0.326 . . . . 0.0 111.045 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 65.2 mtm-85 -147.99 151.31 35.55 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 19.0 mt -146.72 135.9 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 124.144 0.978 . . . . 0.0 109.448 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 1.4 m -139.87 159.31 26.94 Favored 'Isoleucine or valine' 0 C--O 1.23 0.049 0 C-N-CA 123.301 0.64 . . . . 0.0 111.88 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 56.0 mt -135.23 142.78 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 C-N-CA 123.159 0.583 . . . . 0.0 109.628 -176.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.29 3.7 p90 -143.13 158.21 43.82 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 176.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -128.43 16.68 6.53 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.267 0.627 . . . . 0.0 110.393 -172.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -64.72 -30.7 71.72 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -169.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -130.43 5.8 4.8 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 118.563 0.62 . . . . 0.0 112.133 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 161.2 -122.41 1.11 Allowed Glycine 0 CA--C 1.522 0.472 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 -173.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 57.2 t -143.26 116.41 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 175.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -143.73 167.13 23.01 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.158 0.504 . . . . 0.0 110.557 -176.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.41 167.48 24.28 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 53.4 mmm -137.88 153.78 49.52 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 44.5 t -139.99 140.77 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 C-N-CA 122.791 0.436 . . . . 0.0 110.318 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -124.52 130.03 51.7 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.047 0.539 . . . . 0.0 110.421 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -105.84 163.34 12.8 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 -175.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -76.35 -15.59 59.93 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.5 0.32 . . . . 0.0 110.499 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 84.8 p -155.84 160.5 40.26 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.273 0.559 . . . . 0.0 111.694 -177.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 25.6 t -65.1 -35.25 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -66.61 -34.97 79.07 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 122.309 -0.244 . . . . 0.0 111.037 -176.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 60.7 m -71.58 -30.24 65.61 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 121.242 -0.183 . . . . 0.0 110.534 176.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.48 -29.85 59.71 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 119.806 -0.14 . . . . 0.0 111.175 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -69.75 -48.38 59.6 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 118.127 0.421 . . . . 0.0 111.805 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -72.82 -27.46 61.97 Favored 'General case' 0 C--N 1.337 0.053 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.087 -177.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -69.76 -40.8 75.89 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -76.15 -19.63 58.31 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 122.915 0.486 . . . . 0.0 110.988 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -102.16 -0.3 33.47 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 42.9 t -127.07 -30.42 2.69 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 118.68 0.673 . . . . 0.0 112.512 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 70.0 mt -92.96 -8.2 43.8 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.097 0.408 . . . . 0.0 111.618 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -73.19 134.23 44.3 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.09 -5.04 44.09 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 119.717 -0.49 . . . . 0.0 112.108 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.7 166.34 21.9 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 117.801 0.8 . . . . 0.0 110.017 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -123.02 136.61 54.91 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 178.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 95.9 mt -70.92 -43.25 76.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.358 34.4 m-85 -82.8 -11.38 58.31 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 117.232 2.308 . . . . 0.0 117.232 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.7 t 65.76 36.11 6.42 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.954 0.883 . . . . 0.0 111.285 -174.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 174.42 -23.45 0.06 OUTLIER Glycine 0 CA--C 1.529 0.954 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.077 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 257' ' ' CYS . . . . . 0.419 ' HB3' HD12 ' A' ' 200' ' ' ILE . 93.5 m -146.51 -177.51 5.67 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.744 1.218 . . . . 0.0 109.212 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 89.0 m 58.46 35.72 24.88 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -176.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.86 148.21 10.7 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 175.374 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 84.1 mt -114.95 153.97 29.6 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -173.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -137.58 136.87 37.97 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.057 1.343 . . . . 0.0 107.426 169.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 40.9 mt -137.61 142.67 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 CA-C-O 120.723 0.297 . . . . 0.0 111.423 -171.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -159.67 161.88 35.0 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 122.988 0.515 . . . . 0.0 110.17 175.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.27 38.3 m-85 -59.2 135.77 57.75 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 176.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -88.57 164.83 15.21 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -89.18 -53.0 0.35 Allowed Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 123.617 0.767 . . . . 0.0 112.933 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -71.59 159.45 51.12 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.717 2.278 . . . . 0.0 110.503 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 1.4 t -127.15 0.25 6.46 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 -173.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -154.69 131.26 10.6 Favored 'General case' 0 C--N 1.339 0.134 0 O-C-N 121.857 -0.527 . . . . 0.0 111.472 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 29.1 mt -85.61 166.89 15.85 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.193 0.997 . . . . 0.0 111.304 177.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.87 44.76 2.49 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.434 170.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.415 ' H ' HG23 ' A' ' 272' ' ' VAL . 2.2 t -48.02 140.3 2.21 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -177.128 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -129.52 0.93 5.02 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 -178.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -158.19 166.33 32.68 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.93 0.395 . . . . 0.0 110.965 -174.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -125.91 111.69 15.08 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.956 0.902 . . . . 0.0 109.063 171.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 56.9 p30 -154.31 -169.97 3.4 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -69.65 -11.73 61.08 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -176.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -99.53 -37.3 9.23 Favored 'General case' 0 CA--C 1.528 0.096 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.81 147.01 38.37 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 178.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 18.9 t-105 -157.32 155.84 31.35 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -175.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -128.37 117.97 22.35 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.85 0.46 . . . . 0.0 109.9 173.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.295 67.8 m-85 -80.6 8.61 7.52 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 117.032 2.234 . . . . 0.0 117.032 -173.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 CA--C 1.529 0.14 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 178.992 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 55.1 m . . . . . 0 CA--C 1.531 0.215 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 39.1 t -128.62 142.59 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 123.147 0.579 . . . . 0.0 110.867 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.0 mt -132.66 150.06 52.21 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.793 0.437 . . . . 0.0 110.37 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.0 tt -106.93 139.51 41.22 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -113.99 139.61 49.1 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -129.44 143.16 50.72 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 176.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.3 mp -119.86 117.73 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 20.5 mt -81.07 -24.35 37.85 Favored 'General case' 0 C--N 1.338 0.096 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -173.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -138.0 79.01 33.79 Favored Pre-proline 0 N--CA 1.455 -0.193 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -176.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -76.93 48.56 2.52 Favored 'Trans proline' 0 N--CA 1.455 -0.769 1 C-N-CA 125.357 4.038 . . . . 0.0 112.017 -177.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.57 -5.39 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 O-C-N 121.963 -0.46 . . . . 0.0 110.513 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -137.92 156.46 47.86 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 175.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 66.8 m -68.9 116.01 8.89 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 110.525 -0.176 . . . . 0.0 110.525 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.2 mm -78.79 142.72 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.16 162.49 31.99 Favored 'General case' 0 C--O 1.231 0.097 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 21.2 p -66.87 -20.38 65.91 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -72.7 -47.64 45.51 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.17 -33.03 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 97.0 mt -72.2 -34.67 68.57 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -70.79 -31.77 68.64 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 174.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 12.5 m -66.59 -33.94 76.78 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 36.7 pt -92.37 -23.59 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 118.497 0.59 . . . . 0.0 111.996 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 98.8 m -89.34 -25.99 21.32 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.489 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 33.7 t30 -63.51 -42.24 71.99 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 73.5 Cg_endo -70.53 -15.43 34.22 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.489 1.46 . . . . 0.0 111.488 177.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 94.0 m -83.12 -15.27 51.38 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 122.236 -0.29 . . . . 0.0 111.357 176.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 151.94 170.79 19.01 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.17 108.01 0.53 Allowed 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.505 2.803 . . . . 0.0 111.423 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 81.9 t -77.5 145.76 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 -117.21 -34.33 4.38 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 119.163 -0.446 . . . . 0.0 111.179 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 83.2 mtt85 -151.52 156.1 39.87 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 118.437 0.562 . . . . 0.0 112.0 177.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 25.8 mt -144.7 142.51 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.298 1.039 . . . . 0.0 109.199 174.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 96.6 t -143.36 155.19 16.64 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.102 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 53.9 mt -138.14 141.09 39.1 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 C-N-CA 123.494 0.717 . . . . 0.0 109.455 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.295 5.3 p90 -144.47 155.87 43.92 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 176.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -126.31 15.49 7.76 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.3 0.64 . . . . 0.0 110.58 -173.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -66.18 -31.96 73.12 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -169.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -130.36 8.67 5.08 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 118.455 0.57 . . . . 0.0 112.113 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 160.37 -125.57 1.49 Allowed Glycine 0 C--N 1.336 0.533 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 -174.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 45.8 t -142.74 113.23 2.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -142.35 170.42 15.74 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.467 0.651 . . . . 0.0 111.426 -174.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -149.2 169.01 21.71 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.669 176.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 86.6 mmm -135.55 152.16 51.02 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 42.8 t -141.02 147.56 22.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 122.665 0.386 . . . . 0.0 110.208 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -134.62 135.37 42.1 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.616 0.366 . . . . 0.0 110.215 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -111.78 161.78 15.95 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 -175.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -81.29 -11.9 59.22 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.963 0.505 . . . . 0.0 109.742 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 41.1 t -154.67 153.72 31.78 Favored 'General case' 0 C--O 1.232 0.144 0 O-C-N 121.909 -0.494 . . . . 0.0 111.888 -175.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 55.3 t -67.8 -40.26 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -66.57 -26.22 67.01 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 117.811 0.278 . . . . 0.0 110.948 -178.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 67.6 m -73.78 -33.44 64.25 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 176.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -77.41 -30.86 53.74 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 122.485 -0.135 . . . . 0.0 111.23 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -67.56 -42.47 82.57 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 121.913 -0.492 . . . . 0.0 111.621 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -77.88 -26.61 49.32 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.922 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -70.16 -43.27 71.19 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.207 0.458 . . . . 0.0 109.787 176.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.442 ' HE3' ' HB3' ' A' ' 245' ' ' LYS . 1.2 tmmt? -72.8 -21.94 60.9 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.99 0.516 . . . . 0.0 111.294 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -95.55 -11.35 27.51 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 44.7 t -115.23 -33.39 5.35 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 112.783 0.661 . . . . 0.0 112.783 -177.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 81.4 mt -91.79 -10.68 39.01 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -71.15 135.66 47.73 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 121.999 -0.438 . . . . 0.0 109.888 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.49 -3.77 31.11 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 119.63 -0.539 . . . . 0.0 112.847 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -81.03 166.45 20.77 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 118.011 0.906 . . . . 0.0 110.507 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -108.45 140.0 42.39 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 74.2 mt -74.2 -42.59 51.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 174.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.351 51.4 m-85 -82.75 -12.72 57.32 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 117.26 2.318 . . . . 0.0 117.26 178.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 27.6 t 66.06 38.72 4.68 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.676 0.791 . . . . 0.0 110.748 -172.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 174.31 -21.34 0.06 OUTLIER Glycine 0 CA--C 1.529 0.93 0 C-N-CA 123.53 0.586 . . . . 0.0 111.903 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 78.2 m -147.46 -174.08 4.43 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.547 1.139 . . . . 0.0 109.096 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 93.4 m 57.44 43.16 23.48 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.71 0.634 . . . . 0.0 112.71 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -50.47 133.3 24.95 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 177.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 96.0 mt -95.64 152.01 18.83 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.465 0.65 . . . . 0.0 112.167 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -141.03 132.66 27.15 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.345 1.458 . . . . 0.0 107.071 169.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 47.8 mt -140.64 141.15 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 CA-C-O 120.641 0.258 . . . . 0.0 111.316 -172.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -161.75 165.44 28.01 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.271 0.628 . . . . 0.0 109.417 174.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -59.85 138.91 57.68 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 115.586 1.698 . . . . 0.0 115.586 177.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -93.91 160.03 14.92 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -176.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.402 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 58.7 mttm -76.89 -49.7 2.49 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 118.429 -0.796 . . . . 0.0 112.878 -179.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 65.9 Cg_endo -76.32 169.13 22.57 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.718 2.279 . . . . 0.0 111.104 -178.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.282 0.2 OUTLIER -136.46 12.79 3.24 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 117.37 2.359 . . . . 0.0 117.37 -176.904 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -159.96 126.03 4.23 Favored 'General case' 0 C--N 1.338 0.096 0 O-C-N 121.677 -0.639 . . . . 0.0 111.805 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 28.5 mt -86.13 159.54 19.5 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 123.463 0.705 . . . . 0.0 110.944 174.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -125.23 47.7 2.13 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.826 0.85 . . . . 0.0 109.817 174.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.403 HG23 ' H ' ' A' ' 272' ' ' VAL . 2.3 t -52.19 142.15 5.14 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -176.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . 0.253 6.1 p90 -120.81 -7.7 9.52 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 117.282 2.327 . . . . 0.0 117.282 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -162.52 168.04 22.5 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 122.689 0.396 . . . . 0.0 111.029 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -119.99 127.01 52.23 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.566 0.746 . . . . 0.0 110.03 176.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 41.0 p30 -161.03 -167.39 1.8 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.245 1.018 . . . . 0.0 109.542 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -70.4 -10.9 60.36 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -176.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -105.6 -29.57 10.05 Favored 'General case' 0 C--N 1.337 0.064 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -141.04 146.46 37.22 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 178.084 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 19.3 t-105 -156.53 154.15 29.86 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -176.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -132.76 117.58 17.99 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.201 0.6 . . . . 0.0 111.512 175.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.288 68.3 m-85 -83.26 10.41 8.53 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 117.366 2.358 . . . . 0.0 117.366 -171.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 12.9 t . . . . . 0 N--CA 1.455 -0.191 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -179.544 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 CA--C 1.53 0.174 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 30.7 t -130.76 134.3 62.09 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.092 0 C-N-CA 122.858 0.463 . . . . 0.0 111.103 177.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.421 HD21 ' HB1' ' A' ' 241' ' ' ALA . 2.7 mm? -122.94 154.2 38.69 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.098 0.559 . . . . 0.0 110.779 -176.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 39.0 tp -104.01 136.26 43.98 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 170.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -113.86 107.92 16.36 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.71 1.204 . . . . 0.0 114.122 177.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.99 141.01 29.02 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 174.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.4 mp -110.56 126.83 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -90.43 -23.67 20.96 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -173.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -140.34 78.98 21.81 Favored Pre-proline 0 CA--C 1.53 0.188 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -76.74 49.89 2.86 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 124.804 3.669 . . . . 0.0 112.113 -178.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.402 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -68.87 -5.86 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 O-C-N 121.749 -0.595 . . . . 0.0 110.251 178.241 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -142.1 154.58 45.02 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.2 1.4 . . . . 0.0 112.538 175.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.3 t -73.38 129.93 39.07 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.291 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 23.0 mm -79.16 148.4 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 123.073 0.549 . . . . 0.0 109.993 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.02 156.38 48.32 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.4 p -64.1 -17.3 63.29 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 177.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -76.52 -46.25 27.32 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.79 0.329 . . . . 0.0 111.812 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.6 m -71.29 -31.6 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.059 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.31 -36.95 74.64 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 176.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -70.83 -30.48 66.91 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 175.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 12.5 m -66.78 -33.4 75.55 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 41.1 pt -93.85 -21.59 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 118.399 0.545 . . . . 0.0 112.13 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 97.4 m -91.54 -25.73 19.1 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.502 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 35.4 t30 -64.65 -39.19 37.78 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 74.3 Cg_endo -69.94 -13.04 33.7 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 CA-C-N 121.023 1.401 . . . . 0.0 111.575 177.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 95.9 m -91.95 -5.41 53.16 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.669 0.388 . . . . 0.0 111.663 177.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 146.74 166.83 12.51 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 178.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.18 103.77 1.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.635 2.89 . . . . 0.0 110.657 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 75.6 t -70.37 146.28 12.29 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -114.34 -37.14 4.44 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 119.212 -0.423 . . . . 0.0 111.765 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -150.21 151.64 33.36 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 20.7 mt -147.87 136.96 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 C-N-CA 124.055 0.942 . . . . 0.0 109.975 177.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 6.1 m -142.61 159.43 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 123.729 0.812 . . . . 0.0 110.313 173.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 41.3 mt -132.68 143.61 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 123.018 0.527 . . . . 0.0 110.375 -175.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.316 3.8 p90 -140.32 154.65 46.86 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 115.718 1.748 . . . . 0.0 115.718 176.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -126.59 16.79 7.56 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.309 0.643 . . . . 0.0 110.06 -174.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -64.43 -31.91 73.31 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -169.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -130.46 8.62 5.03 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 118.346 0.521 . . . . 0.0 112.096 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 157.62 -124.12 1.37 Allowed Glycine 0 C--N 1.334 0.444 0 N-CA-C 108.336 -1.905 . . . . 0.0 108.336 -173.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 24.9 t -142.15 114.65 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-N 116.846 0.323 . . . . 0.0 110.18 176.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 8.4 mp0 -143.45 166.69 24.09 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.119 0.485 . . . . 0.0 110.671 -177.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.41 163.7 35.65 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.725 0.81 . . . . 0.0 109.788 176.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 56.0 mmm -130.76 151.31 51.34 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 41.4 t -140.74 144.26 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.067 0 C-N-CA 122.945 0.498 . . . . 0.0 110.399 -178.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -130.5 133.21 46.09 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.83 0.452 . . . . 0.0 110.64 178.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -104.21 163.21 12.57 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 116.334 1.975 . . . . 0.0 116.334 -177.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -78.92 -14.51 59.18 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 85.2 p -154.71 157.64 38.38 Favored 'General case' 0 N--CA 1.457 -0.081 0 O-C-N 121.744 -0.598 . . . . 0.0 111.262 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 53.4 t -67.76 -32.33 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -66.84 -34.83 78.68 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 121.878 -0.514 . . . . 0.0 110.733 -177.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 69.1 m -72.56 -31.05 64.95 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 176.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.421 ' HB1' HD21 ' A' ' 192' ' ' LEU . . . -74.08 -31.51 62.85 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 122.577 0.351 . . . . 0.0 111.441 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -71.79 -46.99 56.47 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 117.944 0.338 . . . . 0.0 111.788 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -73.19 -26.3 61.11 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 118.04 0.382 . . . . 0.0 111.345 -177.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -71.11 -41.4 70.64 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.92 -23.63 55.5 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.482 0.313 . . . . 0.0 110.998 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -91.32 -10.01 42.89 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 40.0 t -118.7 -35.08 3.79 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -177.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 66.0 mt -87.94 -7.27 57.36 Favored 'General case' 0 N--CA 1.457 -0.076 0 CA-C-N 118.118 0.417 . . . . 0.0 111.862 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -70.01 136.36 50.33 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 74.65 -4.98 32.68 Favored Glycine 0 CA--C 1.533 1.201 0 CA-C-O 119.769 -0.462 . . . . 0.0 112.431 -178.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -76.72 166.32 23.52 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 117.848 0.824 . . . . 0.0 110.302 177.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -123.6 140.47 52.97 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 67.4 mt -75.04 -42.5 45.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-O 120.92 0.391 . . . . 0.0 110.012 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.365 53.5 m-85 -82.66 -11.4 58.39 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 117.084 2.253 . . . . 0.0 117.084 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 30.7 t 65.99 35.1 6.61 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.664 0.786 . . . . 0.0 111.313 -175.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 176.52 -23.58 0.05 OUTLIER Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 178.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 257' ' ' CYS . . . . . 0.402 ' HB3' HD12 ' A' ' 200' ' ' ILE . 81.6 m -145.93 -176.63 5.22 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.61 1.164 . . . . 0.0 108.876 178.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 87.5 m 57.84 38.71 27.24 Favored 'General case' 0 CA--C 1.527 0.087 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -176.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.96 141.56 21.8 Favored 'General case' 0 C--O 1.23 0.067 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 174.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 95.9 mt -102.09 158.24 16.3 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.49 0.662 . . . . 0.0 112.27 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -139.29 137.18 35.63 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 169.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 19.6 mt -138.23 139.51 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-O 121.089 0.471 . . . . 0.0 111.62 -173.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -159.48 161.9 35.48 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.242 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.262 41.0 m-85 -60.97 135.92 57.93 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 177.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -92.6 155.89 17.46 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.525 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.433 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 22.9 pttp -88.49 -29.93 0.37 Allowed Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 117.216 -1.373 . . . . 0.0 114.611 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 48.9 Cg_endo -79.87 165.12 22.37 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 CA-C-N 122.063 1.773 . . . . 0.0 110.093 176.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.279 0.2 OUTLIER -138.03 8.86 2.76 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 118.19 2.663 . . . . 0.0 118.19 -174.628 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.71 127.05 6.52 Favored 'General case' 0 C--N 1.338 0.073 0 O-C-N 121.408 -0.807 . . . . 0.0 111.858 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 24.6 mt -92.04 156.45 17.39 Favored 'General case' 0 C--N 1.337 0.052 0 C-N-CA 123.772 0.829 . . . . 0.0 111.107 176.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -117.31 53.42 0.92 Allowed 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.517 0.727 . . . . 0.0 109.594 172.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.41 ' H ' HG23 ' A' ' 272' ' ' VAL . 2.4 t -53.04 145.35 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -176.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -130.12 -7.31 4.36 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 117.637 2.458 . . . . 0.0 117.637 -177.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -161.9 173.72 14.12 Favored 'General case' 0 N--CA 1.458 -0.07 0 C-N-CA 122.739 0.416 . . . . 0.0 110.281 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -125.69 117.75 24.15 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.025 0.93 . . . . 0.0 110.006 175.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 46.6 p30 -159.54 -166.22 1.73 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.979 0.912 . . . . 0.0 108.922 177.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -70.11 -9.62 56.12 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -174.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -115.98 -17.46 10.93 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.72 140.87 33.25 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.799 0.84 . . . . 0.0 112.966 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 19.4 t-105 -160.78 156.71 25.66 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 119.764 -0.774 . . . . 0.0 110.4 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -138.03 116.55 12.06 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.469 0.708 . . . . 0.0 110.977 174.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.284 66.7 m-85 -81.31 8.94 7.92 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 117.318 2.34 . . . . 0.0 117.318 -172.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.457 -0.096 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -179.538 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 55.9 m . . . . . 0 CA--C 1.531 0.233 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 28.3 t -130.02 134.07 63.43 Favored 'Isoleucine or valine' 0 C--N 1.339 0.115 0 CA-C-N 118.194 0.452 . . . . 0.0 111.089 177.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.422 ' N ' HD22 ' A' ' 192' ' ' LEU . 2.4 mm? -121.14 153.59 37.3 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.053 0.541 . . . . 0.0 110.831 -177.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 25.0 tp -106.11 132.68 51.89 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 171.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -107.86 133.94 51.5 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.633 1.173 . . . . 0.0 114.141 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.29 133.27 55.5 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 174.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 3.8 mp -104.52 117.06 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -88.35 -18.04 29.29 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.165 -171.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -141.48 79.02 17.72 Favored Pre-proline 0 CA--C 1.529 0.138 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.9 44.25 1.53 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 125.2 3.933 . . . . 0.0 112.542 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.465 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -70.05 -4.76 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 121.693 -0.629 . . . . 0.0 110.523 179.453 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -138.47 158.33 44.47 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 177.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 45.2 t -70.83 117.87 12.9 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.0 mm -78.38 144.41 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.08 159.11 41.82 Favored 'General case' 0 N--CA 1.458 -0.064 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 43.3 p -66.87 -19.72 65.79 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -75.88 -47.24 26.23 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.7 m -70.29 -32.69 51.4 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.0 mt -70.94 -33.99 71.03 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 176.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -73.19 -29.11 62.59 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 174.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 7.2 m -67.99 -33.18 74.13 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 41.4 pt -91.68 -24.07 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 118.225 0.466 . . . . 0.0 111.785 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 94.6 m -89.0 -24.53 22.36 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.478 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.1 t30 -63.57 -42.37 72.43 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 73.7 Cg_endo -69.31 -16.42 39.45 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 CA-C-N 120.873 1.347 . . . . 0.0 111.192 177.258 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 80.5 m -84.01 -14.62 50.23 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 122.175 -0.328 . . . . 0.0 111.337 177.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 153.2 172.92 21.94 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.8 101.5 0.92 Allowed 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 124.007 3.138 . . . . 0.0 110.45 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 75.8 t -71.21 147.52 11.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -118.74 -35.98 3.57 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 119.178 -0.439 . . . . 0.0 111.721 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 25.8 mtm180 -150.37 151.72 33.28 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.693 0.679 . . . . 0.0 112.767 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 25.1 mt -148.74 137.92 15.59 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 124.132 0.973 . . . . 0.0 110.109 177.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.2 m -143.44 161.31 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 C-N-CA 124.127 0.971 . . . . 0.0 109.983 173.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 52.6 mt -131.36 143.27 41.11 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 C-N-CA 122.793 0.437 . . . . 0.0 110.737 -175.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.262 5.1 p90 -146.72 158.96 44.02 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 175.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -138.53 30.22 2.36 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.115 0.566 . . . . 0.0 111.82 -177.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -66.17 -30.11 70.52 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.323 0.861 . . . . 0.0 113.323 -174.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -130.55 1.24 4.49 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 171.85 -128.51 1.59 Allowed Glycine 0 CA--C 1.522 0.473 0 N-CA-C 108.65 -1.78 . . . . 0.0 108.65 -174.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 17.3 t -138.51 115.11 10.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 117.44 0.62 . . . . 0.0 110.351 174.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 9.4 mp0 -143.64 169.78 17.08 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.552 0.692 . . . . 0.0 111.924 -172.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -152.82 168.52 25.47 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.083 0.953 . . . . 0.0 108.818 175.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 68.9 mmm -134.34 151.5 51.27 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.767 -0.456 . . . . 0.0 109.767 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 40.3 t -141.62 144.5 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 C-N-CA 123.0 0.52 . . . . 0.0 110.433 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -131.92 136.28 47.27 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.616 0.366 . . . . 0.0 110.775 178.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -108.67 162.65 13.96 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 -177.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -83.98 -6.54 59.44 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 29.2 t -153.66 149.54 27.65 Favored 'General case' 0 N--CA 1.456 -0.13 0 O-C-N 121.954 -0.466 . . . . 0.0 111.785 -176.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 55.2 t -68.75 -35.69 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -68.16 -28.29 67.16 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.06 -0.4 . . . . 0.0 110.775 -178.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 61.4 m -74.88 -31.2 61.53 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 176.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.418 ' HB1' HD21 ' A' ' 192' ' ' LEU . . . -75.46 -33.53 60.85 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 122.411 0.284 . . . . 0.0 111.083 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -69.59 -43.94 71.78 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 117.904 0.32 . . . . 0.0 111.538 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -75.27 -25.17 57.77 Favored 'General case' 0 N--CA 1.457 -0.084 0 CA-C-N 117.815 0.28 . . . . 0.0 110.866 -177.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -71.48 -42.49 68.03 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 176.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.428 ' HE3' ' HB3' ' A' ' 245' ' ' LYS . 1.0 OUTLIER -75.4 -20.49 58.89 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.739 0.416 . . . . 0.0 111.262 -179.669 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -94.87 -12.07 27.61 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 45.1 t -113.58 -34.96 5.37 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 68.6 mt -89.95 -6.84 55.26 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 118.176 0.444 . . . . 0.0 111.963 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -71.9 131.96 43.7 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 177.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.59 -4.08 52.35 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.744 -0.476 . . . . 0.0 112.171 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.61 166.45 21.86 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 117.818 0.809 . . . . 0.0 110.303 178.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -123.33 139.9 53.57 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 84.8 mt -74.7 -41.36 47.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 N-CA-C 109.668 -0.494 . . . . 0.0 109.668 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.363 44.1 m-85 -82.8 -12.02 57.81 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 117.316 2.339 . . . . 0.0 117.316 178.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.7 t 66.31 34.66 6.31 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.627 0.727 . . . . 0.0 110.685 -174.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 175.97 -23.65 0.06 OUTLIER Glycine 0 CA--C 1.529 0.96 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 257' ' ' CYS . . . . . 0.465 ' HB3' HD12 ' A' ' 200' ' ' ILE . 77.2 m -146.63 -177.15 5.49 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.711 1.204 . . . . 0.0 109.536 178.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 91.4 m 57.85 37.55 26.99 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -176.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.88 148.2 13.71 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 175.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 74.2 mt -115.98 156.04 26.96 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -172.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -138.57 140.15 38.92 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.398 1.479 . . . . 0.0 107.482 169.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 37.4 mt -141.79 141.49 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 CA-C-O 120.976 0.417 . . . . 0.0 111.72 -172.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 6.9 pm0 -156.59 164.21 38.45 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 174.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.273 41.2 m-85 -61.46 137.67 58.25 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 177.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -91.51 156.79 17.43 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.663 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.445 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 63.9 pttt -88.56 -31.57 0.39 Allowed Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 48.7 Cg_endo -79.65 167.73 20.38 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.006 1.804 . . . . 0.0 110.172 176.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.278 0.2 OUTLIER -137.25 8.45 2.92 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -175.829 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.66 128.46 7.24 Favored 'General case' 0 C--O 1.227 -0.12 0 O-C-N 121.416 -0.803 . . . . 0.0 111.942 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 20.1 mt -92.33 157.28 16.72 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 123.893 0.877 . . . . 0.0 110.722 176.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -117.34 54.52 0.88 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.704 0.802 . . . . 0.0 109.473 173.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.4 t -55.76 147.38 4.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -176.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -132.61 -2.94 3.35 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 116.934 2.198 . . . . 0.0 116.934 -176.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -161.89 160.85 28.48 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.316 0.246 . . . . 0.0 110.812 -174.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -123.18 111.02 16.0 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.606 0.762 . . . . 0.0 109.564 173.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 56.6 p30 -157.81 -169.98 3.03 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.334 1.054 . . . . 0.0 108.372 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -68.59 -10.8 58.16 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -174.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -111.58 -22.27 11.32 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.1 p -142.58 138.92 31.13 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.686 1.195 . . . . 0.0 112.295 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 21.0 t-105 -158.44 155.55 28.78 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 119.724 -0.791 . . . . 0.0 110.932 -177.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -135.39 116.49 14.34 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.725 0.81 . . . . 0.0 111.108 173.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.292 66.1 m-85 -79.99 9.17 5.74 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 117.524 2.416 . . . . 0.0 117.524 -172.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.456 -0.149 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -179.611 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 CA--C 1.529 0.165 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 39.8 t -130.54 132.77 64.36 Favored 'Isoleucine or valine' 0 C--N 1.338 0.091 0 CA-C-N 118.215 0.461 . . . . 0.0 111.17 177.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 8.1 mp -122.07 149.88 42.93 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 123.949 0.899 . . . . 0.0 110.563 -174.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 27.0 tp -102.56 135.8 43.53 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 170.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -115.93 104.18 11.35 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.102 1.361 . . . . 0.0 114.071 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.87 133.19 34.88 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 175.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.5 mp -102.76 124.23 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -90.49 -19.26 24.04 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -173.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -141.96 78.87 16.96 Favored Pre-proline 0 CA--C 1.53 0.178 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -77.34 45.73 1.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.764 1 C-N-CA 125.444 4.096 . . . . 0.0 112.275 -177.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.42 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -69.76 -4.09 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 O-C-N 121.818 -0.552 . . . . 0.0 110.508 179.363 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -137.39 156.55 48.07 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 175.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 66.4 m -69.11 112.95 6.05 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.3 mm -78.36 141.77 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.02 161.34 35.09 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.4 p -64.03 -17.67 63.58 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -75.07 -46.75 32.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.712 0.291 . . . . 0.0 111.572 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 1.6 m -70.1 -32.12 49.99 Favored 'Isoleucine or valine' 0 C--N 1.338 0.107 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.69 -34.93 70.06 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 176.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -71.08 -29.66 65.59 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 174.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 10.1 m -68.29 -34.19 75.71 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 42.0 pt -91.41 -22.98 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 118.41 0.55 . . . . 0.0 111.907 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 97.4 m -90.1 -23.6 21.34 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.474 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 26.6 t30 -63.88 -43.24 75.15 Favored Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 73.9 Cg_endo -69.51 -14.45 36.9 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.416 1.41 . . . . 0.0 111.32 177.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 96.8 m -85.43 -16.12 40.75 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 118.011 0.369 . . . . 0.0 111.48 176.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 154.75 171.71 21.81 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.613 -0.595 . . . . 0.0 111.613 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.27 98.86 0.66 Allowed 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.744 2.962 . . . . 0.0 110.633 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 63.9 t -69.45 145.91 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -115.12 -37.85 4.0 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 119.365 -0.35 . . . . 0.0 111.233 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 63.4 mtm-85 -147.66 152.34 37.69 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 25.5 mt -148.0 137.7 16.37 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 C-N-CA 124.144 0.978 . . . . 0.0 109.706 176.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 12.8 m -143.95 161.65 15.71 Favored 'Isoleucine or valine' 0 C--N 1.338 0.082 0 C-N-CA 123.553 0.741 . . . . 0.0 110.115 174.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 35.8 mt -135.67 141.91 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 122.824 0.45 . . . . 0.0 110.628 -175.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.316 4.1 p90 -138.15 156.84 47.34 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 176.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -128.5 15.59 6.55 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.425 0.69 . . . . 0.0 110.522 -173.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -63.58 -31.92 73.23 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -169.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -130.65 6.47 4.75 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 118.686 0.675 . . . . 0.0 112.494 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 163.02 -124.82 1.32 Allowed Glycine 0 CA--C 1.521 0.419 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 -174.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 45.5 t -141.97 114.93 4.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -142.45 166.07 25.68 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.904 0.383 . . . . 0.0 110.578 -177.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.15 164.88 30.82 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.583 0.753 . . . . 0.0 109.416 175.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 62.9 mmm -133.06 153.21 51.71 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 39.1 t -139.79 145.5 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 C-N-CA 122.838 0.455 . . . . 0.0 110.409 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -130.22 133.08 46.3 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.918 0.487 . . . . 0.0 110.529 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -108.02 161.35 15.03 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -82.92 -8.18 59.59 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 29.2 t -155.01 149.49 26.31 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 121.916 -0.49 . . . . 0.0 111.554 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 51.1 t -67.76 -35.9 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -68.14 -28.57 67.42 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.112 0.415 . . . . 0.0 111.137 -177.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 58.3 m -74.32 -32.34 62.8 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 176.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.71 -29.73 56.38 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.621 0.369 . . . . 0.0 110.934 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -69.98 -44.07 70.2 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.147 -0.345 . . . . 0.0 111.439 178.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -75.39 -25.09 57.33 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.878 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -70.97 -39.35 72.56 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.127 0.422 . . . . 0.0 110.255 176.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.08 -25.59 58.69 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 122.639 0.376 . . . . 0.0 110.298 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -91.2 -10.29 42.23 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 46.1 t -117.04 -36.48 3.8 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -176.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 78.7 mt -88.36 -8.29 55.31 Favored 'General case' 0 C--N 1.338 0.108 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -71.47 133.36 45.81 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.54 -5.28 46.28 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 119.681 -0.511 . . . . 0.0 112.298 -178.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.67 166.45 22.5 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 117.833 0.817 . . . . 0.0 110.253 177.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -123.65 139.84 53.6 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 87.0 mt -74.92 -41.53 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.373 42.7 m-85 -82.88 -11.81 57.9 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 117.151 2.278 . . . . 0.0 117.151 178.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 29.9 t 65.25 35.52 7.64 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.385 0.674 . . . . 0.0 110.74 -174.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 175.56 -23.98 0.06 OUTLIER Glycine 0 CA--C 1.53 1.028 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 257' ' ' CYS . . . . . 0.42 ' HB3' HD12 ' A' ' 200' ' ' ILE . 72.0 m -145.32 -176.87 5.28 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.686 1.195 . . . . 0.0 109.199 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 84.3 m 57.74 36.93 27.04 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -176.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.35 149.55 9.96 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 114.471 1.285 . . . . 0.0 114.471 175.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 79.0 mt -116.87 154.35 30.92 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -172.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -137.0 137.65 39.66 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.276 1.43 . . . . 0.0 107.414 169.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 56.7 mt -139.57 142.78 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 CA-C-O 120.566 0.222 . . . . 0.0 111.578 -170.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -160.63 162.88 32.86 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.295 0.638 . . . . 0.0 109.622 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.264 50.8 m-85 -59.43 139.75 56.8 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 176.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -88.32 165.3 15.08 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -176.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.403 ' HB2' ' HD3' ' A' ' 267' ' ' PRO . 78.2 mttt -79.21 -51.55 1.26 Allowed Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 118.445 -0.788 . . . . 0.0 112.065 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' A' ' 266' ' ' LYS . 68.3 Cg_endo -76.27 175.16 11.7 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.859 2.373 . . . . 0.0 111.303 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.45 -3.54 3.01 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -176.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -158.28 130.22 6.83 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 118.92 0.782 . . . . 0.0 112.564 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 23.7 mt -84.57 164.46 18.7 Favored 'General case' 0 N--CA 1.458 -0.055 0 C-N-CA 124.378 1.071 . . . . 0.0 111.651 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -120.77 54.06 1.09 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.386 170.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.416 HG23 ' H ' ' A' ' 272' ' ' VAL . 2.7 t -53.0 147.44 2.07 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -175.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -138.07 -1.35 1.97 Allowed 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 116.92 2.193 . . . . 0.0 116.92 -176.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -159.11 161.57 36.38 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -172.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -125.6 108.35 11.49 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.199 0.999 . . . . 0.0 109.681 174.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -158.31 -166.17 1.87 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 177.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -68.64 -9.97 53.2 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -174.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -117.42 -17.32 10.1 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.16 141.85 34.09 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.772 0.829 . . . . 0.0 113.016 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 17.8 t-105 -163.63 156.63 18.43 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 118.554 0.615 . . . . 0.0 110.445 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -142.11 120.44 12.33 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.305 172.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -81.95 5.59 18.63 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 117.192 2.293 . . . . 0.0 117.192 -173.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 3.6 t . . . . . 0 CA--C 1.53 0.205 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -178.012 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 CA--C 1.532 0.268 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 37.2 t -128.4 143.55 40.67 Favored 'Isoleucine or valine' 0 C--N 1.339 0.116 0 C-N-CA 123.167 0.587 . . . . 0.0 110.79 178.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 82.6 mt -135.61 149.0 49.24 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.868 0.467 . . . . 0.0 111.104 -175.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 39.2 tp -101.11 135.45 42.54 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 172.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -113.57 101.37 9.27 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 125.148 1.379 . . . . 0.0 114.6 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.2 m -86.8 133.84 33.61 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 175.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.0 mp -103.94 126.0 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -94.06 -18.42 21.84 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -172.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -141.24 78.99 18.22 Favored Pre-proline 0 CA--C 1.529 0.164 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -77.41 49.03 2.74 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 125.003 3.802 . . . . 0.0 112.278 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.45 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -69.23 -6.78 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 O-C-N 121.787 -0.571 . . . . 0.0 110.224 178.163 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -141.73 154.68 45.45 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.158 1.383 . . . . 0.0 112.394 175.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.4 t -74.15 131.46 41.3 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.157 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 21.9 mm -81.14 148.37 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 122.923 0.489 . . . . 0.0 109.913 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.89 157.89 44.83 Favored 'General case' 0 C--O 1.231 0.079 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 177.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.3 p -63.88 -18.75 64.49 Favored 'General case' 0 N--CA 1.458 -0.057 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -73.4 -47.3 43.05 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.717 0.294 . . . . 0.0 111.544 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.5 m -71.06 -32.31 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.16 -36.61 72.09 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 176.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -70.82 -30.14 66.49 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 175.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 8.9 m -67.59 -33.76 75.66 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 38.6 pt -92.38 -24.31 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 118.585 0.63 . . . . 0.0 111.77 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 95.6 m -88.49 -26.39 22.08 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.478 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 35.1 t30 -64.71 -42.53 64.86 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 71.9 Cg_endo -70.29 -12.74 32.42 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.493 1.462 . . . . 0.0 111.262 177.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 96.4 m -90.43 -9.23 48.29 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.031 0.378 . . . . 0.0 111.665 176.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 151.41 167.72 15.16 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 178.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.26 103.03 1.01 Allowed 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.903 3.069 . . . . 0.0 110.584 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 71.9 t -70.67 145.25 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -113.74 -39.27 4.05 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 119.205 -0.426 . . . . 0.0 111.28 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -149.15 152.8 36.72 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.267 0.485 . . . . 0.0 112.046 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 23.6 mt -147.28 135.72 15.34 Favored 'Isoleucine or valine' 0 C--N 1.338 0.073 0 C-N-CA 124.025 0.93 . . . . 0.0 109.912 177.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 1.6 m -140.38 160.61 25.16 Favored 'Isoleucine or valine' 0 C--N 1.337 0.062 0 C-N-CA 123.55 0.74 . . . . 0.0 111.715 174.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 53.7 mt -135.82 144.02 34.71 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 C-N-CA 123.127 0.571 . . . . 0.0 110.163 -175.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.299 3.5 p90 -143.35 156.47 44.7 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 175.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 5.8 mmt180 -127.35 17.68 7.04 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.32 0.648 . . . . 0.0 110.002 -174.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -64.89 -31.74 73.12 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -169.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -130.47 5.89 4.79 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 118.606 0.639 . . . . 0.0 111.893 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 163.04 -124.35 1.28 Allowed Glycine 0 C--N 1.334 0.442 0 N-CA-C 108.696 -1.761 . . . . 0.0 108.696 -173.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 49.1 t -142.6 114.04 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 -142.86 166.07 25.65 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.117 0.484 . . . . 0.0 110.845 -176.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.09 164.99 31.29 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.487 175.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 57.9 mmm -132.42 152.82 51.33 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 39.1 t -141.12 146.03 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 C-N-CA 123.116 0.566 . . . . 0.0 110.37 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -132.52 135.59 46.09 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 122.536 0.335 . . . . 0.0 110.593 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -107.78 162.92 13.55 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 -176.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -75.74 -17.21 59.99 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 86.5 p -155.13 159.63 40.34 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.175 0.512 . . . . 0.0 111.263 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 54.8 t -67.34 -35.22 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -66.56 -28.18 68.32 Favored 'General case' 0 N--CA 1.456 -0.139 0 O-C-N 122.18 -0.325 . . . . 0.0 111.021 -177.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 74.4 m -75.94 -32.68 59.67 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 177.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.54 -32.63 58.34 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.416 -0.177 . . . . 0.0 111.086 178.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -66.76 -44.03 82.51 Favored 'General case' 0 C--N 1.338 0.09 0 O-C-N 122.036 -0.415 . . . . 0.0 111.558 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -75.59 -26.34 57.8 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.898 -178.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -74.16 -40.85 62.3 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.03 0.377 . . . . 0.0 110.148 178.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -73.57 -23.22 59.93 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.862 0.465 . . . . 0.0 111.063 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -92.4 -17.04 25.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 48.2 t -106.67 -36.17 6.8 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -176.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 76.7 mt -88.67 -8.03 55.3 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -70.78 134.27 47.26 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.65 -6.45 39.32 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 119.676 -0.513 . . . . 0.0 112.458 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -77.41 166.34 23.25 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 117.759 0.78 . . . . 0.0 110.187 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 5.0 p30 -123.24 140.56 52.89 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 80.8 mt -74.98 -43.03 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.071 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.36 50.2 m-85 -82.78 -10.05 59.05 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 29.1 t 66.38 34.78 6.11 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.629 0.772 . . . . 0.0 111.126 -175.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 175.47 -24.45 0.06 OUTLIER Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 178.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 257' ' ' CYS . . . . . 0.45 ' HB3' HD12 ' A' ' 200' ' ' ILE . 81.4 m -144.69 -176.97 5.27 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.692 1.197 . . . . 0.0 109.264 178.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 96.2 m 57.4 39.18 28.41 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -175.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.04 146.4 18.18 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 175.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 89.1 mt -110.78 154.41 23.98 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -172.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -137.92 135.98 36.59 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.865 1.666 . . . . 0.0 106.679 169.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 44.6 mt -138.43 141.67 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-O 120.618 0.247 . . . . 0.0 111.142 -172.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -158.76 164.11 36.14 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 175.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.288 43.4 m-85 -61.75 135.38 57.58 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 177.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -85.35 162.85 18.89 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.369 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.468 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 63.4 pttt -94.06 -32.56 0.3 Allowed Pre-proline 0 CA--C 1.54 0.567 0 CA-C-O 117.29 -1.338 . . . . 0.0 114.225 178.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 86.3 Cg_endo -76.3 171.52 17.93 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 CA-C-N 122.04 1.764 . . . . 0.0 110.055 175.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.21 -1.91 2.33 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 117.72 2.489 . . . . 0.0 117.72 -175.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.15 130.95 9.98 Favored 'General case' 0 C--N 1.338 0.075 0 CA-C-N 119.145 0.884 . . . . 0.0 111.888 -177.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 25.1 mt -90.97 157.05 17.52 Favored 'General case' 0 C--N 1.338 0.069 0 C-N-CA 124.125 0.97 . . . . 0.0 111.408 178.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -120.85 50.99 1.28 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.836 0.854 . . . . 0.0 109.41 173.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.401 HG23 ' H ' ' A' ' 272' ' ' VAL . 3.0 t -51.63 144.74 2.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -177.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -131.26 -0.15 4.08 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 116.472 2.027 . . . . 0.0 116.472 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -159.06 166.44 31.66 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.839 0.456 . . . . 0.0 111.374 -175.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -125.9 113.58 17.39 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.062 0.945 . . . . 0.0 109.05 172.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 57.1 p30 -156.3 -167.09 2.33 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -69.56 -13.83 62.53 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -176.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -100.02 -34.05 10.24 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.3 p -141.26 148.66 40.19 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 18.9 t-105 -157.54 154.98 29.47 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -176.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -135.07 118.92 17.26 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 122.873 0.469 . . . . 0.0 111.711 175.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.252 68.6 m-85 -84.19 6.44 22.59 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 117.263 2.32 . . . . 0.0 117.263 -171.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 C--O 1.232 0.143 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -176.326 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 41.2 p . . . . . 0 CA--C 1.535 0.368 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 45.1 t -130.27 139.56 51.08 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 123.516 0.727 . . . . 0.0 109.523 174.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 89.4 mt -128.51 158.04 39.51 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.843 0.354 . . . . 0.0 111.536 -173.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 9.7 tt -115.92 135.85 53.59 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.255 174.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -114.37 106.26 14.1 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 114.684 1.365 . . . . 0.0 114.684 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -88.23 142.8 27.46 Favored 'General case' 0 N--CA 1.458 -0.072 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 174.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.3 mp -115.34 124.14 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 21.0 mt -85.24 -24.92 27.6 Favored 'General case' 0 C--N 1.337 0.064 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -173.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -141.22 79.06 18.17 Favored Pre-proline 0 N--CA 1.456 -0.171 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -177.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -76.86 49.97 2.92 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 125.137 3.891 . . . . 0.0 112.153 -177.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.441 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -68.55 -7.23 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 O-C-N 121.954 -0.466 . . . . 0.0 110.019 177.867 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -140.2 152.15 45.77 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.238 1.415 . . . . 0.0 112.193 175.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 35.9 t -74.4 133.08 42.47 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 117.851 0.296 . . . . 0.0 110.56 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 24.2 mm -83.32 150.06 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 123.028 0.531 . . . . 0.0 109.841 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.87 155.73 49.35 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 177.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.5 p -64.38 -21.72 66.72 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -79.01 -35.97 41.95 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 75.8 t -72.97 -40.81 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.3 mt -69.01 -32.0 71.24 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -70.28 -29.52 66.31 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 174.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.2 m -69.47 -32.82 71.97 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 45.0 pt -92.32 -21.75 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 118.422 0.555 . . . . 0.0 112.264 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 97.7 m -92.56 -26.57 17.84 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -178.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.488 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 36.3 t30 -64.04 -40.87 58.11 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 73.3 Cg_endo -69.44 -10.98 30.22 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 121.535 1.49 . . . . 0.0 111.887 177.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 91.0 m -95.99 -6.26 39.3 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 177.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 151.0 167.59 14.82 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 111.801 -0.519 . . . . 0.0 111.801 178.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.38 101.66 0.88 Allowed 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 123.965 3.11 . . . . 0.0 110.408 178.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 83.5 t -70.79 144.63 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -112.51 -39.45 4.36 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 119.363 -0.351 . . . . 0.0 111.262 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 65.8 mtm-85 -148.01 153.08 38.49 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 25.2 mt -145.13 139.9 22.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 124.308 1.043 . . . . 0.0 109.18 176.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 41.0 t -145.38 153.02 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.066 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 48.8 mt -134.34 142.24 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 C-N-CA 123.087 0.555 . . . . 0.0 110.178 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.305 2.7 p90 -143.19 156.1 44.69 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 176.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 6.2 mmt180 -127.75 18.22 6.78 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.274 0.63 . . . . 0.0 110.134 -173.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -66.22 -30.92 71.47 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 114.717 1.376 . . . . 0.0 114.717 -169.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -130.48 5.46 4.75 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 118.61 0.641 . . . . 0.0 112.129 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 164.35 -126.51 1.52 Allowed Glycine 0 CA--C 1.521 0.461 0 N-CA-C 108.043 -2.023 . . . . 0.0 108.043 -173.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.5 t -142.5 114.67 3.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 175.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -144.42 168.91 18.99 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.271 0.558 . . . . 0.0 110.718 -176.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.04 167.79 22.51 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.372 174.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 79.4 mmm -134.01 150.6 51.25 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 32.5 t -140.21 147.46 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 C-N-CA 122.895 0.478 . . . . 0.0 110.727 -177.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -133.31 134.87 44.4 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.03 0.532 . . . . 0.0 110.49 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -108.59 163.31 13.35 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 116.479 2.029 . . . . 0.0 116.479 -176.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -74.43 -16.79 60.86 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 84.9 p -157.12 161.23 39.39 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.275 0.559 . . . . 0.0 111.235 -178.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 45.7 t -66.62 -33.92 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -67.28 -30.21 70.02 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 117.886 0.312 . . . . 0.0 110.82 -177.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 68.7 m -75.49 -31.32 60.17 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 177.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.83 -33.32 60.07 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 119.629 -0.224 . . . . 0.0 111.172 178.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -67.48 -43.49 80.87 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 118.445 0.566 . . . . 0.0 111.487 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -74.42 -28.32 61.02 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.166 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -74.38 -39.8 62.48 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 118.094 0.406 . . . . 0.0 110.69 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -74.64 -23.54 58.7 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 122.748 0.419 . . . . 0.0 111.165 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -93.9 -15.57 24.85 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 47.8 t -106.7 -36.23 6.77 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 75.9 mt -89.35 -8.15 53.8 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -176.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -70.88 135.88 48.28 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.53 -6.76 36.27 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.621 -0.544 . . . . 0.0 112.308 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -76.82 166.49 23.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 117.69 0.745 . . . . 0.0 109.727 176.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -123.49 138.6 54.54 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 84.2 mt -72.29 -43.83 64.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.372 41.4 m-85 -82.79 -11.15 58.5 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 117.336 2.347 . . . . 0.0 117.336 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.9 t 64.79 37.19 7.5 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.692 0.758 . . . . 0.0 110.817 -175.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 174.52 -23.95 0.07 OUTLIER Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.001 0.81 . . . . 0.0 111.086 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' CYS . . . . . 0.441 ' HB3' HD12 ' A' ' 200' ' ' ILE . 90.8 m -146.62 -177.16 5.49 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.122 1.369 . . . . 0.0 109.159 178.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 95.2 m 58.62 37.62 25.28 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -177.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.59 146.05 10.74 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 175.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 86.1 mt -109.56 154.68 22.39 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -173.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -139.76 136.77 34.47 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.772 1.629 . . . . 0.0 106.913 169.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 37.0 mt -137.94 141.15 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-O 120.715 0.293 . . . . 0.0 111.277 -172.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -158.53 163.67 36.85 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.785 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.25 47.8 m-85 -63.02 136.36 57.78 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 176.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -86.76 159.55 19.09 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.611 0.364 . . . . 0.0 110.751 -179.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.465 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 23.1 pttp -92.79 -31.76 0.32 Allowed Pre-proline 0 CA--C 1.538 0.513 0 CA-C-O 117.363 -1.304 . . . . 0.0 114.066 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 69.2 Cg_endo -77.51 170.17 19.77 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 CA-C-N 121.966 1.738 . . . . 0.0 109.781 173.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.7 -1.07 3.11 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 117.798 2.518 . . . . 0.0 117.798 -174.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.55 130.65 9.42 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 118.873 0.76 . . . . 0.0 111.421 -178.06 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 20.1 mt -90.76 156.95 17.68 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 123.78 0.832 . . . . 0.0 111.017 177.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -115.42 50.88 0.96 Allowed 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.367 0.667 . . . . 0.0 109.86 173.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 3.1 t -52.23 145.22 2.69 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -134.54 -3.63 2.64 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 -177.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -159.32 162.62 36.01 Favored 'General case' 0 N--CA 1.456 -0.132 0 O-C-N 122.225 -0.297 . . . . 0.0 111.277 -171.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -125.39 110.81 14.4 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.769 0.828 . . . . 0.0 109.629 174.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 54.6 p30 -159.04 -165.95 1.73 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -67.84 -8.94 40.37 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -174.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -120.77 -15.35 8.39 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.34 140.9 35.69 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 123.923 0.889 . . . . 0.0 113.073 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 -163.55 156.91 18.93 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.644 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -141.52 118.58 11.27 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.654 171.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -81.94 4.35 22.95 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 -172.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 CA--C 1.529 0.152 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -177.494 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 54.5 m . . . . . 0 CA--C 1.531 0.241 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.1 t -131.85 133.71 60.84 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 CA-C-N 118.038 0.381 . . . . 0.0 111.018 176.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.445 HD21 ' HB1' ' A' ' 241' ' ' ALA . 2.3 mm? -121.56 153.32 38.18 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 122.817 0.447 . . . . 0.0 110.926 -176.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 22.8 tp -103.9 135.95 44.47 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 170.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -111.57 132.17 54.73 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.92 1.288 . . . . 0.0 114.419 176.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -121.58 130.09 53.28 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 175.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.4 mp -101.84 118.31 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -84.9 -19.37 32.38 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.027 0.531 . . . . 0.0 111.939 -171.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -141.72 78.99 17.3 Favored Pre-proline 0 CA--C 1.529 0.137 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -78.42 47.22 2.34 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 124.957 3.771 . . . . 0.0 111.926 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.403 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -70.24 -4.42 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 O-C-N 121.862 -0.524 . . . . 0.0 110.813 179.68 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -137.03 156.48 48.37 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 176.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 69.0 m -69.68 113.41 6.92 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 37.5 mm -78.26 141.8 14.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 177.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.11 160.88 36.45 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.5 p -64.84 -15.67 62.13 Favored 'General case' 0 CA--C 1.527 0.062 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -76.27 -44.98 34.8 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.785 0.326 . . . . 0.0 111.45 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 1.5 m -71.38 -32.62 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 179.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.4 mt -72.03 -34.16 68.58 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 176.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -71.64 -30.45 65.76 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 173.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.3 m -66.68 -33.92 76.72 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 42.9 pt -91.14 -24.94 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 118.352 0.523 . . . . 0.0 112.027 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 99.3 m -88.49 -25.54 22.52 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.093 0.86 . . . . 0.0 113.285 -178.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.479 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 31.9 t30 -64.51 -43.57 71.74 Favored Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 73.6 Cg_endo -69.85 -11.87 31.58 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.415 1.41 . . . . 0.0 111.519 177.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 94.4 m -92.28 -10.71 37.46 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.6 0.36 . . . . 0.0 111.847 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 155.09 169.56 19.76 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.767 -0.533 . . . . 0.0 111.767 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.88 96.88 0.7 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 124.138 3.226 . . . . 0.0 110.611 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 70.2 t -68.25 145.41 13.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -116.25 -39.93 3.33 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 119.147 -0.454 . . . . 0.0 111.32 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 63.4 mtm-85 -147.93 152.01 36.81 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 21.5 mt -148.42 137.14 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.272 1.029 . . . . 0.0 110.183 177.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 8.0 m -143.05 162.43 17.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 C-N-CA 123.778 0.831 . . . . 0.0 110.315 174.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 43.1 mt -134.34 143.18 38.77 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.075 0 C-N-CA 123.157 0.583 . . . . 0.0 110.486 -174.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.293 4.2 p90 -142.32 156.36 45.25 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 176.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -127.49 14.75 7.11 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.208 0.603 . . . . 0.0 110.905 -173.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -61.76 -32.58 72.84 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 -169.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -130.6 7.01 4.81 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.594 0.633 . . . . 0.0 112.278 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 163.41 -125.56 1.41 Allowed Glycine 0 C--N 1.336 0.551 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -174.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 24.2 t -140.99 112.02 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.152 0 C-N-CA 122.785 0.434 . . . . 0.0 109.915 175.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -141.8 168.03 20.72 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.212 0.529 . . . . 0.0 110.948 -175.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.98 169.2 21.14 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.75 0.82 . . . . 0.0 109.052 176.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 64.4 mmm -136.03 153.96 51.2 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 27.1 t -140.25 144.6 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.095 0 C-N-CA 123.063 0.545 . . . . 0.0 110.953 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -130.05 133.53 46.77 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.026 0.531 . . . . 0.0 110.252 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -108.9 161.32 15.25 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -177.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -80.62 -10.88 59.71 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 43.1 t -155.27 153.37 30.5 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 118.202 0.456 . . . . 0.0 111.864 -175.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 59.0 t -68.47 -38.52 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 123.0 0.52 . . . . 0.0 109.743 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -67.5 -26.61 66.43 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 122.153 -0.342 . . . . 0.0 111.08 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 48.8 m -75.88 -30.8 58.98 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 175.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.445 ' HB1' HD21 ' A' ' 192' ' ' LEU . . . -76.76 -33.21 58.09 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.579 0.352 . . . . 0.0 111.017 179.086 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -69.24 -44.14 72.56 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 122.228 -0.295 . . . . 0.0 111.665 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -74.12 -27.76 61.02 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 117.935 0.334 . . . . 0.0 111.105 -178.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -72.55 -39.82 67.18 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.177 0.444 . . . . 0.0 110.58 177.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.42 -23.75 54.0 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.433 0.293 . . . . 0.0 111.149 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -90.34 -14.73 32.51 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 48.2 t -109.51 -34.46 6.51 Favored 'General case' 0 C--N 1.338 0.068 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -177.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 78.3 mt -90.42 -7.92 51.92 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -70.93 132.57 45.41 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 75.66 -4.62 42.81 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.74 -0.478 . . . . 0.0 112.164 -177.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.26 166.4 22.18 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.859 0.829 . . . . 0.0 110.193 177.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -123.49 139.88 53.56 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 86.3 mt -73.71 -42.25 54.7 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.352 44.4 m-85 -82.86 -12.33 57.5 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 117.355 2.354 . . . . 0.0 117.355 178.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 23.1 t 65.14 36.34 7.29 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.69 0.757 . . . . 0.0 110.722 -174.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 176.05 -24.54 0.06 OUTLIER Glycine 0 CA--C 1.528 0.856 0 C-N-CA 123.792 0.71 . . . . 0.0 111.35 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 257' ' ' CYS . . . . . 0.403 ' HB3' HD12 ' A' ' 200' ' ' ILE . 82.4 m -146.74 -176.57 5.24 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.897 1.279 . . . . 0.0 109.173 178.156 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 89.7 m 58.06 37.08 26.47 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.69 148.98 11.68 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 176.007 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 76.2 mt -115.54 155.31 27.8 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -172.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -139.08 138.17 36.85 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.141 1.376 . . . . 0.0 107.959 169.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 29.2 mt -140.17 143.69 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 CA-C-O 120.935 0.398 . . . . 0.0 111.388 -171.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -159.28 162.94 36.14 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.865 0.866 . . . . 0.0 109.518 175.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -62.22 138.5 58.43 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 115.933 1.827 . . . . 0.0 115.933 177.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -87.55 162.31 17.27 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 122.674 0.39 . . . . 0.0 111.722 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.423 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 53.7 mtmt -80.82 -52.62 0.87 Allowed Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 118.351 -0.833 . . . . 0.0 112.665 178.093 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 90.5 Cg_endo -72.28 171.09 17.63 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.104 2.536 . . . . 0.0 111.251 177.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.262 0.2 OUTLIER -136.16 2.72 2.82 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 117.844 2.535 . . . . 0.0 117.844 -175.6 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -157.7 130.35 7.37 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 121.635 -0.666 . . . . 0.0 112.106 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 36.4 mt -85.8 166.67 15.87 Favored 'General case' 0 CA--C 1.527 0.068 0 C-N-CA 124.445 1.098 . . . . 0.0 111.538 176.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.22 49.79 1.38 Allowed 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 169.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 272' ' ' VAL . . . . . 0.419 ' H ' HG23 ' A' ' 272' ' ' VAL . 2.5 t -49.32 143.05 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.249 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -176.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -127.4 -7.4 5.8 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 117.945 2.572 . . . . 0.0 117.945 -176.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -162.87 174.72 12.04 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 122.77 0.428 . . . . 0.0 110.523 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -125.82 116.22 21.23 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.86 0.864 . . . . 0.0 109.628 174.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 52.7 p30 -157.74 -168.4 2.53 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.284 1.034 . . . . 0.0 109.718 178.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -68.97 -11.44 60.72 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -175.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -113.33 -17.56 12.26 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -144.6 141.13 29.19 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.864 0.866 . . . . 0.0 112.768 -178.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 18.9 t-105 -160.89 158.24 27.92 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 119.671 -0.812 . . . . 0.0 110.738 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -139.21 116.44 11.12 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.557 0.743 . . . . 0.0 109.774 172.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.266 67.7 m-85 -79.36 6.24 10.57 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 117.297 2.332 . . . . 0.0 117.297 -173.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 5.6 t . . . . . 0 CA--C 1.53 0.185 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -179.565 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 69.6 m . . . . . 0 CA--C 1.533 0.305 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 90.2 t -141.0 134.27 31.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.438 ' N ' HD22 ' A' ' 192' ' ' LEU . 2.0 mm? -122.14 153.07 39.23 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 122.663 0.385 . . . . 0.0 111.299 -175.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 24.8 tp -100.03 136.73 39.49 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 169.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -113.07 112.47 23.91 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 176.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.72 125.8 45.66 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 175.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.6 mp -96.96 124.81 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 22.0 mt -86.2 -25.94 25.37 Favored 'General case' 0 N--CA 1.458 -0.056 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -174.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -141.33 79.04 17.98 Favored Pre-proline 0 N--CA 1.455 -0.218 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -176.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -76.71 46.63 1.93 Allowed 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 125.182 3.921 . . . . 0.0 112.278 -177.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.408 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -69.99 -4.68 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 O-C-N 121.845 -0.534 . . . . 0.0 110.703 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -135.75 158.48 44.29 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 176.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 68.6 m -68.94 112.57 5.68 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 42.6 mm -78.5 139.72 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 176.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.06 159.95 39.25 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.4 p -64.92 -17.05 64.01 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 176.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -75.18 -45.97 37.15 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.366 0.266 . . . . 0.0 111.378 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.1 m -71.19 -32.05 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.53 -34.68 70.25 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 176.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -71.47 -30.97 66.61 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 174.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 10.7 m -66.92 -33.84 76.47 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 42.8 pt -91.74 -22.44 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 119.012 -0.518 . . . . 0.0 112.042 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 92.8 m -91.27 -25.57 19.41 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -178.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.493 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 32.2 t30 -64.0 -41.83 65.38 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-O 118.412 -0.804 . . . . 0.0 113.087 -179.115 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 72.9 Cg_endo -69.13 -13.44 36.27 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 CA-C-N 120.938 1.371 . . . . 0.0 111.669 178.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 97.1 m -89.39 -8.03 53.96 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 177.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 146.88 168.75 13.97 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.469 -0.653 . . . . 0.0 111.469 176.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.55 104.35 0.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.678 2.919 . . . . 0.0 111.966 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 75.8 t -75.53 143.77 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 175.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -115.64 -39.45 3.53 Favored 'General case' 0 C--O 1.227 -0.115 0 CA-C-O 119.431 -0.318 . . . . 0.0 111.39 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 66.8 mtm-85 -147.81 152.23 37.33 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 20.3 mt -148.51 137.15 15.14 Favored 'Isoleucine or valine' 0 C--N 1.339 0.13 0 C-N-CA 124.15 0.98 . . . . 0.0 109.927 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 3.9 m -142.73 160.79 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.087 0 C-N-CA 123.632 0.773 . . . . 0.0 110.568 174.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 45.4 mt -133.84 142.26 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 C-N-CA 122.591 0.356 . . . . 0.0 110.369 -175.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.295 4.1 p90 -140.96 157.24 45.63 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 177.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -128.03 15.61 6.8 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.271 0.628 . . . . 0.0 110.626 -174.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -62.85 -30.92 71.87 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -169.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -130.62 6.48 4.77 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.518 0.599 . . . . 0.0 112.144 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 161.62 -123.36 1.2 Allowed Glycine 0 C--N 1.333 0.373 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -173.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 50.9 t -143.23 114.94 2.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 175.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 8.3 mp0 -143.85 167.57 22.01 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.172 0.511 . . . . 0.0 110.786 -176.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.02 165.39 30.03 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.58 0.752 . . . . 0.0 109.215 175.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 59.5 mmm -133.36 152.13 51.9 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 39.4 t -139.39 142.64 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 122.788 0.435 . . . . 0.0 110.389 -178.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -128.06 131.87 49.09 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.842 0.457 . . . . 0.0 110.522 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -105.73 161.42 14.42 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 116.35 1.981 . . . . 0.0 116.35 -176.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -77.72 -13.03 60.02 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 45.2 t -155.81 155.82 33.67 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 121.813 -0.555 . . . . 0.0 111.872 -176.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 38.4 t -64.91 -42.11 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -67.7 -25.87 65.89 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 117.877 0.308 . . . . 0.0 111.657 -176.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 59.2 m -74.62 -31.8 62.11 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 175.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.422 ' HB1' HD21 ' A' ' 192' ' ' LEU . . . -76.04 -30.33 58.39 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.518 0.327 . . . . 0.0 111.157 178.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -68.64 -47.7 65.91 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 117.934 0.334 . . . . 0.0 111.297 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -73.75 -25.2 60.05 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 119.423 -0.322 . . . . 0.0 111.436 -177.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -71.87 -40.85 68.67 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.187 0.449 . . . . 0.0 110.087 176.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.26 -24.96 54.52 Favored 'General case' 0 N--CA 1.458 -0.045 0 C-N-CA 122.961 0.504 . . . . 0.0 110.993 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -90.69 -13.58 33.9 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 39.5 t -112.59 -35.26 5.58 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 118.631 0.651 . . . . 0.0 112.739 -177.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 59.8 mt -90.0 -7.16 54.62 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -177.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -70.78 133.19 46.34 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.78 -5.25 48.46 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 119.932 -0.371 . . . . 0.0 112.369 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.39 166.39 22.7 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 117.711 0.756 . . . . 0.0 110.131 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -123.44 139.61 53.85 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 88.5 mt -73.67 -41.47 55.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.356 45.3 m-85 -82.64 -11.79 58.11 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 117.114 2.265 . . . . 0.0 117.114 178.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 29.4 t 65.94 32.53 8.47 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.699 0.799 . . . . 0.0 111.012 -173.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 179.37 -24.61 0.05 OUTLIER Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 257' ' ' CYS . . . . . 0.408 ' HB3' HD12 ' A' ' 200' ' ' ILE . 74.7 m -145.58 -177.38 5.54 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.707 1.203 . . . . 0.0 109.465 178.129 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 84.3 m 59.42 35.6 23.02 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -177.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.73 150.4 5.27 Favored 'General case' 0 C--N 1.338 0.095 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 175.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 78.3 mt -118.47 156.09 29.66 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -173.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -138.39 139.2 38.85 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.562 1.545 . . . . 0.0 107.14 169.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 31.9 mt -139.34 141.73 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 CA-C-O 120.747 0.308 . . . . 0.0 111.364 -172.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -158.9 161.19 36.77 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.962 176.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -60.55 136.15 57.97 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 177.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -88.28 162.32 16.67 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 122.973 0.509 . . . . 0.0 111.856 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -85.99 -52.82 0.45 Allowed Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 118.505 -0.759 . . . . 0.0 112.808 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -72.07 165.43 32.64 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.759 2.306 . . . . 0.0 110.27 176.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 1.5 t -138.95 7.38 2.47 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 -174.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -152.81 126.41 8.82 Favored 'General case' 0 C--N 1.338 0.068 0 O-C-N 121.778 -0.576 . . . . 0.0 111.771 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 24.6 mt -87.13 162.85 17.29 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 123.943 0.897 . . . . 0.0 111.467 176.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -121.77 54.67 1.14 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.804 0.842 . . . . 0.0 109.356 171.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.6 t -54.02 146.34 3.45 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -175.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -127.83 -7.23 5.57 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 117.625 2.454 . . . . 0.0 117.625 -176.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -164.48 172.87 12.76 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 117.995 0.362 . . . . 0.0 110.676 -178.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -125.5 116.8 22.36 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.017 0.927 . . . . 0.0 109.916 173.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 55.9 p30 -159.74 -166.95 1.87 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -68.35 -11.42 59.52 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -174.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -111.98 -20.34 12.02 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -143.39 143.31 31.58 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.691 0.796 . . . . 0.0 112.762 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 18.4 t-105 -161.0 156.11 24.25 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.277 -178.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -136.81 117.92 14.41 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.498 0.719 . . . . 0.0 110.165 173.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.256 64.1 m-85 -82.08 7.01 14.5 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 117.39 2.367 . . . . 0.0 117.39 -173.26 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.455 -0.223 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -178.113 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 54.5 m . . . . . 0 CA--C 1.53 0.211 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 35.8 t -126.56 143.05 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 C-N-CA 123.036 0.534 . . . . 0.0 110.483 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 84.5 mt -136.53 146.07 45.77 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 122.712 0.405 . . . . 0.0 111.162 -176.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 48.7 tp -95.36 136.53 35.61 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 172.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -116.13 101.22 8.53 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.003 1.321 . . . . 0.0 114.315 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.07 140.51 36.45 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 174.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 3.9 mp -110.66 116.24 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -90.46 -18.09 25.98 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -170.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -143.18 78.86 14.73 Favored Pre-proline 0 CA--C 1.528 0.127 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -76.98 42.7 1.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 125.206 3.937 . . . . 0.0 112.625 -177.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.469 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -69.77 -5.11 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 O-C-N 121.747 -0.595 . . . . 0.0 110.693 -179.504 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -138.99 156.69 47.03 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 176.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 69.0 m -68.82 117.48 10.56 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 28.0 mm -78.28 145.41 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.02 160.42 37.8 Favored 'General case' 0 C--O 1.23 0.043 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 6.7 p -67.84 -22.98 65.11 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -73.63 -47.14 42.35 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.9 m -70.19 -31.91 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.9 mt -71.12 -35.25 71.68 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -71.36 -29.58 65.14 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 174.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.1 m -69.22 -33.43 73.29 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 42.2 pt -91.7 -22.06 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.95 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 95.1 m -93.42 -25.44 17.66 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -177.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.508 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 38.5 t30 -63.59 -39.56 49.16 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 67.0 Cg_endo -68.56 -14.15 38.96 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 CA-C-N 121.113 1.433 . . . . 0.0 111.954 177.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 92.8 m -89.23 -8.13 54.12 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.106 0.412 . . . . 0.0 111.57 176.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 147.8 166.95 13.0 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 178.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -68.61 105.25 1.25 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.535 2.823 . . . . 0.0 110.472 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 80.3 t -72.35 145.59 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -111.04 -36.81 5.54 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 119.369 -0.348 . . . . 0.0 111.58 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 25.6 mtm180 -149.52 154.02 38.11 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 118.128 0.422 . . . . 0.0 112.035 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 34.3 mt -144.7 143.8 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.035 0.934 . . . . 0.0 109.369 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 55.2 t -145.15 154.61 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 60.2 mt -133.43 140.13 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 C-N-CA 123.423 0.689 . . . . 0.0 109.65 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.253 4.8 p90 -148.18 160.62 42.74 Favored 'General case' 0 N--CA 1.458 -0.026 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 176.208 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.01 31.31 2.2 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.811 0.444 . . . . 0.0 111.985 -176.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -67.07 -29.81 69.69 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -174.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -130.52 3.32 4.6 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 167.83 -127.12 1.51 Allowed Glycine 0 C--N 1.334 0.443 0 N-CA-C 108.381 -1.888 . . . . 0.0 108.381 -173.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.2 t -139.6 117.94 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-N 117.252 0.526 . . . . 0.0 110.244 173.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 11.5 mp0 -144.19 168.7 19.42 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.651 0.739 . . . . 0.0 111.164 -175.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -150.18 163.96 36.9 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.95 175.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 59.6 mmm -134.54 152.55 51.86 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.633 0.373 . . . . 0.0 110.199 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.3 t -142.42 145.19 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 123.117 0.567 . . . . 0.0 110.047 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -129.06 132.5 47.45 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 122.555 0.342 . . . . 0.0 110.284 176.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -102.36 161.71 13.49 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -177.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -81.27 -10.44 59.58 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 30.6 t -154.51 151.34 28.8 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 121.761 -0.587 . . . . 0.0 112.106 -176.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 50.3 t -68.13 -38.22 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -178.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -67.06 -24.93 66.02 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.123 0.42 . . . . 0.0 111.151 -178.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 55.3 m -75.77 -32.84 60.12 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 176.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -78.08 -31.86 50.39 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 122.361 -0.212 . . . . 0.0 110.961 178.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -66.55 -41.74 88.19 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 121.993 -0.442 . . . . 0.0 111.474 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -77.08 -28.15 54.5 Favored 'General case' 0 CA--C 1.527 0.07 0 CA-C-N 117.937 0.335 . . . . 0.0 110.872 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -69.95 -41.24 74.81 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.05 0.387 . . . . 0.0 109.959 177.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -74.24 -20.63 60.1 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.618 0.367 . . . . 0.0 111.023 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -98.77 -5.08 31.96 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 42.6 t -124.16 -30.44 3.46 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 56.3 mt -93.83 -6.66 45.33 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.247 0.476 . . . . 0.0 111.479 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -72.45 131.66 42.87 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.97 -4.64 53.09 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 119.85 -0.417 . . . . 0.0 112.259 -178.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.9 166.56 22.25 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 117.817 0.809 . . . . 0.0 110.169 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -123.67 139.3 54.13 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 89.5 mt -74.43 -41.66 49.71 Favored 'Isoleucine or valine' 0 C--O 1.23 0.071 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.355 35.9 m-85 -82.82 -11.88 57.9 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 117.065 2.246 . . . . 0.0 117.065 178.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 30.1 t 65.74 34.02 7.82 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.533 0.733 . . . . 0.0 111.171 -173.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 177.44 -24.35 0.05 OUTLIER Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.11 0.862 . . . . 0.0 111.123 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 257' ' ' CYS . . . . . 0.469 ' HB3' HD12 ' A' ' 200' ' ' ILE . 75.0 m -145.43 -175.74 4.84 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.527 1.131 . . . . 0.0 109.383 178.057 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 88.8 m 57.84 36.04 26.0 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -176.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.3 147.53 13.26 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 176.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 78.9 mt -114.35 156.85 23.68 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -173.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -139.32 138.2 36.47 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 169.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 46.5 mt -137.1 142.48 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.066 0 CA-C-O 120.66 0.267 . . . . 0.0 111.56 -172.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -159.51 161.82 35.39 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.094 176.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.287 35.6 m-85 -61.44 135.54 57.72 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 177.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 265' ' ' ALA . . . . . 0.408 ' HB1' ' HD2' ' A' ' 267' ' ' PRO . . . -93.16 157.18 16.4 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.999 -177.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.447 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 23.2 pttp -91.19 -31.33 0.34 Allowed Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 50.3 Cg_endo -79.46 161.4 25.37 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 CA-C-N 121.766 1.666 . . . . 0.0 110.154 176.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.298 0.2 OUTLIER -135.5 13.56 3.47 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 -178.056 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -156.36 126.37 6.46 Favored 'General case' 0 C--O 1.227 -0.1 0 O-C-N 121.871 -0.518 . . . . 0.0 111.521 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 23.1 mt -88.32 163.99 15.79 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.69 0.796 . . . . 0.0 110.546 174.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -122.89 44.24 2.71 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.342 0.591 . . . . 0.0 110.361 171.14 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.1 t -48.1 140.0 2.41 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -176.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . 0.277 5.3 p90 -122.87 -6.27 8.5 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 117.267 2.321 . . . . 0.0 117.267 -177.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -163.37 167.98 21.01 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 122.956 0.503 . . . . 0.0 110.176 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -119.09 123.46 44.49 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.351 0.66 . . . . 0.0 109.734 174.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 50.6 p30 -159.32 -168.29 2.28 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.829 0.852 . . . . 0.0 108.93 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -70.41 -10.13 58.26 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -177.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -102.41 -33.63 9.47 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.5 p -142.68 145.75 33.72 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 124.257 1.023 . . . . 0.0 113.188 176.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 21.7 t-105 -153.62 153.73 32.87 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -176.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -131.32 116.8 18.05 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.252 0.621 . . . . 0.0 111.607 175.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.253 67.1 m-85 -83.16 7.67 15.4 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 117.449 2.388 . . . . 0.0 117.449 -172.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 CA--C 1.528 0.121 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -178.409 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 . . . . . 0 N--CA 1.475 0.778 0 CA-C-O 120.364 0.126 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -68.51 127.57 33.48 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 122.669 0.388 . . . . 0.0 110.484 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 94.4 mt -83.34 142.83 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 63.1 m -69.01 115.55 8.43 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 122.345 0.258 . . . . 0.0 110.724 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 61.3 mtt180 -150.93 145.86 18.64 Favored Pre-proline 0 C--N 1.337 0.062 0 C-N-CA 123.733 0.813 . . . . 0.0 110.281 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.82 149.58 60.38 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.136 2.557 . . . . 0.0 109.443 174.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 68.57 9.82 59.32 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 119.607 -0.552 . . . . 0.0 112.619 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -140.37 -45.6 0.41 Allowed 'General case' 0 C--O 1.232 0.181 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 74.2 m -69.52 153.3 43.7 Favored 'General case' 0 C--O 1.231 0.091 0 O-C-N 121.906 -0.496 . . . . 0.0 110.719 176.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -53.91 -36.57 62.86 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -76.73 7.29 4.81 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 116.158 1.911 . . . . 0.0 116.158 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 75.7 m -140.65 2.82 1.83 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -176.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -149.22 10.99 0.79 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 176.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 54.5 m -137.31 1.77 2.44 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.67 0.388 . . . . 0.0 111.973 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 1.9 m -80.08 122.3 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -130.84 10.41 5.06 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.7 0.8 . . . . 0.0 112.681 178.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 50.9 m 67.0 19.7 10.54 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -173.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.6 t -128.71 142.08 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 C-N-CA 122.988 0.515 . . . . 0.0 110.924 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 84.7 mt -135.02 149.49 50.17 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 122.663 0.385 . . . . 0.0 111.884 -174.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 32.0 tp -102.72 136.67 42.12 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.576 0.75 . . . . 0.0 109.223 172.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -115.27 107.05 14.76 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.938 1.295 . . . . 0.0 114.465 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.05 127.76 38.69 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 175.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.5 mp -97.95 127.53 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 20.7 mt -89.37 -26.34 21.1 Favored 'General case' 0 CA--C 1.527 0.062 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -174.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -141.17 79.1 18.23 Favored Pre-proline 0 N--CA 1.453 -0.284 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -176.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -77.34 45.31 1.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 125.251 3.967 . . . . 0.0 111.988 -177.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.446 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -69.47 -4.2 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 O-C-N 121.877 -0.515 . . . . 0.0 110.597 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -136.52 155.84 49.41 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 66.3 m -67.85 113.2 5.39 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 33.6 mm -78.39 141.53 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.99 159.76 39.77 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.6 p -64.8 -15.41 61.68 Favored 'General case' 0 C--O 1.23 0.05 0 N-CA-C 114.314 1.228 . . . . 0.0 114.314 177.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -76.12 -46.52 28.41 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.676 0.274 . . . . 0.0 111.541 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.0 m -70.85 -31.1 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.1 mt -72.39 -35.17 68.37 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 176.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -70.6 -30.65 67.38 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 173.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.1 m -67.26 -34.56 77.7 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 43.9 pt -91.46 -21.73 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 118.405 0.548 . . . . 0.0 112.239 178.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 91.3 m -91.21 -25.87 19.31 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.499 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 31.8 t30 -63.82 -41.37 63.73 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 74.4 Cg_endo -69.27 -13.84 36.59 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 CA-C-N 120.857 1.342 . . . . 0.0 111.645 177.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 91.7 m -91.96 -4.49 54.53 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.787 0.435 . . . . 0.0 111.701 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 146.95 166.79 12.57 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 177.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.53 103.14 1.08 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.587 2.858 . . . . 0.0 110.17 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 64.8 t -69.51 146.82 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -114.44 -37.53 4.3 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 119.244 -0.408 . . . . 0.0 111.579 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 39.2 mtm-85 -149.95 151.87 34.06 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.574 0.625 . . . . 0.0 112.035 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 17.8 mt -146.12 140.97 21.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 C-N-CA 124.211 1.004 . . . . 0.0 109.527 177.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 59.7 t -146.78 156.51 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 47.6 mt -134.45 142.22 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 123.698 0.799 . . . . 0.0 110.009 -178.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.297 3.2 p90 -143.28 159.22 42.75 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 176.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -128.76 15.52 6.41 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.989 0.516 . . . . 0.0 111.137 -173.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -62.86 -32.46 73.7 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -169.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -130.49 8.84 5.03 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 118.597 0.635 . . . . 0.0 112.239 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 159.92 -125.11 1.43 Allowed Glycine 0 C--N 1.335 0.516 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 -174.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.4 t -141.18 115.3 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -142.29 166.89 23.45 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.268 0.556 . . . . 0.0 110.956 -176.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.37 165.47 29.23 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.405 175.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 76.5 mmm -133.42 153.25 51.77 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 28.2 t -141.79 145.64 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 C-N-CA 123.292 0.637 . . . . 0.0 110.667 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -132.61 133.93 44.25 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.727 0.411 . . . . 0.0 110.126 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -105.51 161.75 14.07 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 -176.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -78.25 -14.65 59.35 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 82.6 p -155.11 157.98 38.32 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.25 0.548 . . . . 0.0 111.548 -177.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 53.8 t -66.38 -36.08 76.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -65.44 -32.17 73.65 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 122.354 -0.216 . . . . 0.0 110.711 -176.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 63.8 m -72.65 -34.84 67.53 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 121.27 -0.172 . . . . 0.0 110.639 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -73.45 -31.54 63.85 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 119.732 -0.175 . . . . 0.0 111.114 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -68.32 -44.14 76.02 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 118.199 0.454 . . . . 0.0 111.831 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 -77.29 -25.29 51.17 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 118.102 0.41 . . . . 0.0 111.34 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -72.06 -41.13 67.78 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 122.065 -0.397 . . . . 0.0 110.077 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -74.65 -21.26 59.53 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 122.974 0.51 . . . . 0.0 111.194 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -97.18 -10.52 25.73 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 44.2 t -116.12 -34.01 4.84 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 118.62 0.645 . . . . 0.0 112.594 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 50.7 mt -90.73 -6.95 53.76 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 122.139 -0.35 . . . . 0.0 111.837 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -72.26 132.4 44.01 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.25 -4.53 47.87 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 112.156 -0.378 . . . . 0.0 112.156 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.22 166.39 22.78 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 117.52 0.66 . . . . 0.0 110.187 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -123.61 139.61 53.83 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 85.1 mt -74.42 -41.51 49.77 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.36 44.0 m-85 -82.87 -11.47 58.18 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 117.037 2.236 . . . . 0.0 117.037 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 29.0 t 65.51 34.48 7.9 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.604 0.762 . . . . 0.0 111.059 -173.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 177.15 -23.96 0.05 OUTLIER Glycine 0 CA--C 1.528 0.881 0 C-N-CA 123.972 0.796 . . . . 0.0 111.158 177.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' CYS . . . . . 0.446 ' HB3' HD12 ' A' ' 200' ' ' ILE . 96.8 m -145.92 -177.29 5.52 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.702 1.201 . . . . 0.0 109.52 178.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 88.0 m 58.64 37.0 25.33 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -176.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.96 151.39 6.76 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 175.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 73.6 mt -119.67 157.64 28.1 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -173.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -139.54 140.38 37.12 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.786 1.634 . . . . 0.0 107.294 168.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 38.4 mt -138.1 142.74 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 CA-C-O 120.848 0.356 . . . . 0.0 111.668 -173.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -158.57 161.87 37.31 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.04 176.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.265 41.5 m-85 -61.96 134.81 57.12 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 177.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' ALA . . . . . 0.432 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -88.58 157.0 18.73 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.178 -178.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.476 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 23.2 pttp -90.14 -32.25 0.37 Allowed Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 117.413 -1.279 . . . . 0.0 114.307 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 68.2 Cg_endo -76.55 166.95 26.44 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 CA-C-N 121.893 1.712 . . . . 0.0 109.462 174.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.3 0.2 OUTLIER -130.04 0.47 4.73 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 -175.811 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 20.3 ttp180 -160.55 140.97 11.53 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.775 -0.578 . . . . 0.0 110.952 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 25.8 mt -85.25 171.47 11.91 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.115 0.966 . . . . 0.0 110.668 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.424 ' C ' ' H61' ' B' ' 5' ' ' ' A' . 0.7 OUTLIER -126.19 46.63 2.4 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 169.85 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.5 t -48.58 139.68 2.94 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -175.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . 0.278 6.2 p90 -120.37 -12.12 9.04 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 117.391 2.367 . . . . 0.0 117.391 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -163.6 173.91 12.41 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 122.853 0.461 . . . . 0.0 110.811 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -119.99 129.23 54.18 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.403 0.681 . . . . 0.0 110.544 176.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 39.5 p30 -160.5 -166.63 1.69 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.529 1.132 . . . . 0.0 108.824 176.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -68.36 -15.05 63.42 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -174.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -115.07 -12.19 11.98 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.49 139.17 35.06 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.832 0.853 . . . . 0.0 112.513 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 21.2 t-105 -161.17 154.48 21.53 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.473 -177.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -132.32 117.1 17.71 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.42 173.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.272 63.8 m-85 -81.71 8.6 9.58 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 117.362 2.356 . . . . 0.0 117.362 -172.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 11.3 t -138.06 -23.76 1.02 Allowed 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -95.41 113.25 61.29 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -80.44 -16.5 10.64 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.317 2.678 . . . . 0.0 112.245 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -71.91 -16.38 62.12 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -174.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 77.1 mt -86.03 -4.56 59.19 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.237 0.471 . . . . 0.0 111.886 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 46.1 t -72.5 -27.34 62.2 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 121.971 -0.456 . . . . 0.0 111.567 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -92.45 -4.58 65.95 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 119.715 -0.492 . . . . 0.0 112.643 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 63.8 mm-40 -89.18 5.38 44.95 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 117.577 0.688 . . . . 0.0 112.005 -177.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.123 0 CA-C-O 117.205 -1.886 . . . . 0.0 111.953 -177.25 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.742 0 C5'-C4'-C3' 110.385 -3.41 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.432 ' N3 ' ' HA ' ' A' ' 265' ' ' ALA . . . . . . . . 0 O4'--C4' 1.423 -2.468 0 O4'-C1'-N19 111.978 3.778 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.927 3 O4'-C1'-N19 112.733 4.533 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.791 1 C5'-C4'-C3' 108.825 -4.45 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.424 ' H61' ' C ' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.42 -2.732 0 C3'-C2'-C1' 105.01 3.9 OUTLIER-DELTA 0.016 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.591 0 O4'-C1'-N19 111.792 3.592 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 45.3 mm-40 . . . . . 0 N--CA 1.478 0.956 0 CA-C-O 120.473 0.178 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -67.63 150.36 48.86 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.959 0.504 . . . . 0.0 110.474 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 58.9 mt -65.79 142.99 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 122.876 0.471 . . . . 0.0 110.37 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 57.7 m -67.91 152.6 45.29 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.708 0.403 . . . . 0.0 111.153 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.405 ' N ' ' CD ' ' A' ' 179' ' ' PRO . 75.9 mtp85 -72.34 -40.65 7.38 Favored Pre-proline 0 CA--C 1.534 0.327 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.405 ' CD ' ' N ' ' A' ' 178' ' ' ARG . 52.3 Cg_exo -58.54 157.25 27.92 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.973 2.449 . . . . 0.0 112.519 178.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 77.39 0.96 73.96 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 119.722 -0.488 . . . . 0.0 112.622 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -149.14 -54.66 0.18 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 117.963 0.882 . . . . 0.0 112.861 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 44.0 t -68.31 152.65 45.14 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.459 0.304 . . . . 0.0 110.474 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -72.87 -5.44 38.31 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -69.46 -7.31 36.8 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 68.7 m -141.84 8.07 1.89 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -175.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -148.6 5.59 0.71 Allowed 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 65.5 m -147.16 10.5 1.0 Allowed 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.407 ' H ' HG22 ' A' ' 188' ' ' VAL . 1.4 m -70.53 107.32 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -177.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 -130.62 10.38 5.16 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.187 0.595 . . . . 0.0 112.143 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 66.7 m 66.31 22.2 10.89 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.061 0.945 . . . . 0.0 113.435 -175.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 25.1 t -130.9 140.53 48.46 Favored 'Isoleucine or valine' 0 C--N 1.338 0.108 0 C-N-CA 122.83 0.452 . . . . 0.0 110.777 176.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 93.7 mt -130.76 159.2 38.02 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 122.961 0.504 . . . . 0.0 111.128 -176.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.1 tt -115.87 135.61 53.83 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.109 174.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -115.99 105.7 12.94 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -87.18 137.08 32.65 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 174.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.3 mp -106.94 118.21 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -88.48 -17.87 29.44 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -171.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -142.56 78.9 15.78 Favored Pre-proline 0 CA--C 1.529 0.156 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -77.98 46.55 2.1 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 125.132 3.888 . . . . 0.0 112.405 -177.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.424 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -71.42 -3.83 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 O-C-N 121.873 -0.517 . . . . 0.0 110.505 179.322 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -136.67 159.08 42.88 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 176.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 70.2 m -70.91 113.11 7.63 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.638 0.256 . . . . 0.0 110.373 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 33.8 mm -78.27 140.47 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.96 159.36 40.96 Favored 'General case' 0 C--O 1.23 0.058 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.4 p -65.2 -14.89 61.72 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 176.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -76.91 -45.49 27.75 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.589 0.356 . . . . 0.0 110.657 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 1.7 m -71.2 -32.42 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.88 -34.57 69.28 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 177.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -71.57 -29.71 65.03 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 174.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 8.2 m -67.29 -35.02 78.62 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 37.9 pt -91.32 -24.08 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 119.177 -0.44 . . . . 0.0 111.758 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 86.9 m -88.99 -25.46 22.01 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.474 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 31.4 t30 -63.13 -44.82 85.2 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-O 118.518 -0.753 . . . . 0.0 112.907 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 68.7 Cg_endo -68.18 -15.69 43.17 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.356 1.371 . . . . 0.0 111.478 178.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 95.2 m -84.12 -15.34 47.61 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 117.918 0.327 . . . . 0.0 111.715 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 152.4 169.3 17.6 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -61.42 104.82 0.32 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.768 2.979 . . . . 0.0 111.922 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 73.6 t -76.34 145.13 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -116.81 -38.38 3.45 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-O 119.394 -0.336 . . . . 0.0 111.579 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 41.3 mtm-85 -148.88 151.48 34.77 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 21.7 mt -147.71 136.48 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 124.036 0.934 . . . . 0.0 109.748 177.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.41 160.21 22.13 Favored 'Isoleucine or valine' 0 C--N 1.337 0.062 0 C-N-CA 123.592 0.757 . . . . 0.0 110.9 174.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 48.4 mt -134.43 141.51 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 123.189 0.596 . . . . 0.0 110.491 -175.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.292 5.8 p90 -140.82 157.78 44.91 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -127.21 14.26 7.23 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.449 0.699 . . . . 0.0 110.755 -174.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -61.97 -31.56 71.92 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -169.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -130.7 7.88 4.85 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 118.634 0.652 . . . . 0.0 112.289 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 161.38 -124.33 1.3 Allowed Glycine 0 CA--C 1.521 0.465 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 -174.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 47.9 t -142.73 115.07 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -143.95 167.73 21.66 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.324 0.583 . . . . 0.0 110.589 -176.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.25 164.29 32.77 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.879 0.871 . . . . 0.0 109.067 175.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 81.6 mmm -131.71 153.01 50.48 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 26.3 t -139.6 143.38 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.097 0 C-N-CA 122.786 0.434 . . . . 0.0 111.067 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -127.49 132.17 50.02 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.035 0.534 . . . . 0.0 110.337 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -108.27 161.94 14.54 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -176.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -80.95 -11.81 59.5 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 30.7 t -155.28 152.45 29.25 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.386 0.539 . . . . 0.0 111.893 -175.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 54.1 t -67.74 -38.27 80.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -67.78 -27.33 66.67 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 122.348 -0.22 . . . . 0.0 110.953 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 69.0 m -72.59 -34.35 67.35 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 176.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -77.48 -29.86 52.86 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 111.425 0.157 . . . . 0.0 111.425 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -67.75 -43.27 80.3 Favored 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 121.932 -0.48 . . . . 0.0 111.539 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -77.85 -24.23 48.65 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-N 117.842 0.292 . . . . 0.0 110.797 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -72.81 -41.19 65.18 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.098 0.408 . . . . 0.0 110.283 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -74.98 -23.39 58.27 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.814 0.446 . . . . 0.0 111.392 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -92.39 -17.21 24.94 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 48.1 t -106.16 -36.51 6.88 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -177.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 72.1 mt -89.42 -9.11 51.44 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -69.95 133.8 47.67 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.28 -5.54 42.51 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 119.748 -0.473 . . . . 0.0 112.205 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.4 166.41 22.67 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.792 0.796 . . . . 0.0 110.289 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -123.52 138.37 54.58 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 82.3 mt -72.66 -41.65 62.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.346 45.8 m-85 -82.9 -12.27 57.51 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.9 t 66.08 33.93 7.22 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.709 0.766 . . . . 0.0 110.936 -174.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 178.23 -24.7 0.05 OUTLIER Glycine 0 CA--C 1.528 0.856 0 C-N-CA 123.986 0.803 . . . . 0.0 111.289 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' CYS . . . . . 0.424 ' HB3' HD12 ' A' ' 200' ' ' ILE . 72.8 m -145.74 -176.97 5.34 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.532 1.133 . . . . 0.0 109.422 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 89.8 m 57.64 37.88 27.54 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.856 0.462 . . . . 0.0 112.04 -176.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.2 147.49 13.01 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 175.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 79.6 mt -114.11 155.58 25.75 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -173.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -138.77 138.63 37.79 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.163 1.385 . . . . 0.0 107.597 169.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 37.0 mt -139.02 142.69 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-O 120.744 0.307 . . . . 0.0 111.75 -171.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -158.49 163.13 37.4 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.348 0.659 . . . . 0.0 109.478 175.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.266 44.1 m-85 -62.51 138.17 58.41 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 176.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -87.37 154.31 20.77 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.484 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.436 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 23.2 pttp -88.35 -31.76 0.39 Allowed Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 117.489 -1.243 . . . . 0.0 114.255 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 48.1 Cg_endo -79.94 162.56 23.58 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.743 1.629 . . . . 0.0 109.861 174.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.282 0.2 OUTLIER -137.79 18.75 2.86 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 116.747 2.129 . . . . 0.0 116.747 -176.462 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.469 ' CZ ' ' HA ' ' A' ' 269' ' ' ARG . 1.3 tpm_? -155.37 106.48 2.56 Favored 'General case' 0 C--N 1.34 0.169 0 O-C-N 121.734 -0.604 . . . . 0.0 112.301 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.474 ' HG ' ' C5 ' ' B' ' 3' ' ' ' A' . 9.4 mt -75.96 158.41 32.0 Favored 'General case' 0 N--CA 1.458 -0.062 0 C-N-CA 122.747 0.419 . . . . 0.0 110.161 173.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -127.02 54.56 1.63 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.685 0.794 . . . . 0.0 109.781 172.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 272' ' ' VAL . 2.5 t -54.61 143.93 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -177.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -126.94 -7.7 6.05 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 117.557 2.429 . . . . 0.0 117.557 -176.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -162.17 173.04 14.83 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 122.809 0.444 . . . . 0.0 110.001 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -125.46 123.05 38.37 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.589 0.756 . . . . 0.0 110.05 175.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 46.5 p30 -159.99 -166.39 1.71 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.959 0.904 . . . . 0.0 108.575 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -68.11 -15.13 63.46 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -175.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -114.76 -12.88 12.09 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.64 139.77 34.9 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.631 0.772 . . . . 0.0 112.547 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 20.2 t-105 -161.02 156.86 25.31 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.446 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -136.46 116.32 13.16 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.553 172.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.275 66.4 m-85 -79.05 7.22 7.73 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 117.26 2.318 . . . . 0.0 117.26 -173.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 5.8 t -137.77 -20.64 1.14 Allowed 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -95.4 113.11 60.97 Favored Pre-proline 0 CA--C 1.532 0.267 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 174.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -80.88 -15.22 10.74 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.582 2.854 . . . . 0.0 112.257 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -73.3 -12.6 60.9 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -174.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 54.3 mt -89.72 -9.07 50.79 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.249 0.477 . . . . 0.0 111.789 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 72.1 m -80.69 -17.96 49.44 Favored 'General case' 0 CA--C 1.526 0.037 0 CA-C-N 118.233 0.47 . . . . 0.0 112.056 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -91.27 -3.98 69.03 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 112.041 -0.424 . . . . 0.0 112.041 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -77.44 161.14 28.2 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.023 0.529 . . . . 0.0 111.217 -177.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 CA-C-O 117.516 -1.714 . . . . 0.0 111.43 -179.622 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.843 0 C3'-C2'-C1' 104.543 3.381 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.788 0 O4'-C1'-N19 111.167 2.967 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.474 ' C5 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.421 -2.672 2 C5'-C4'-C3' 109.424 -4.051 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.843 0 C5'-C4'-C3' 109.564 -3.957 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.437 ' N3 ' " H2'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.741 1 C3'-C2'-C1' 105.347 4.275 OUTLIER-DELTA 0.011 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.558 0 O4'-C1'-N19 112.033 3.833 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 . . . . . 0 N--CA 1.476 0.85 0 N-CA-C 110.754 -0.091 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -153.04 146.87 25.27 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 123.568 0.747 . . . . 0.0 109.789 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 46.9 mm -70.06 143.23 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 C-N-CA 122.431 0.292 . . . . 0.0 110.353 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 47.1 t -158.02 158.58 35.12 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 122.878 0.471 . . . . 0.0 110.064 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 33.5 ptt-85 -155.69 154.48 28.1 Favored Pre-proline 0 CA--C 1.53 0.194 0 C-N-CA 123.274 0.63 . . . . 0.0 109.765 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.31 160.47 49.43 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.368 2.712 . . . . 0.0 110.309 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -71.94 -12.8 75.41 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -85.06 -1.04 56.39 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 117.551 0.676 . . . . 0.0 109.33 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 42.7 t -68.05 149.3 49.85 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 121.794 -0.566 . . . . 0.0 111.122 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -57.63 -27.77 63.1 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.954 0.407 . . . . 0.0 110.252 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -84.1 9.82 11.66 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 74.6 m -141.79 -1.55 1.26 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -176.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 4.5 ppt_? -147.06 11.13 1.04 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.152 0.887 . . . . 0.0 113.283 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 52.8 m -140.74 5.8 2.0 Allowed 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.0 m -78.46 119.29 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -177.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 42.8 p30 -130.76 10.33 5.08 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.119 0.967 . . . . 0.0 112.773 177.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 57.8 m 66.26 19.77 11.05 Favored 'General case' 0 C--N 1.341 0.201 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -173.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 38.8 t -130.51 133.76 63.2 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 C-N-CA 122.88 0.472 . . . . 0.0 111.292 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.429 HD21 ' HB1' ' A' ' 241' ' ' ALA . 2.5 mm? -122.63 152.86 40.06 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 122.987 0.515 . . . . 0.0 111.066 -177.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 28.4 tp -103.31 134.04 47.37 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 170.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -111.86 110.97 21.6 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.49 131.55 40.09 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 173.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.6 mp -102.1 120.4 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -88.42 -20.38 25.31 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 119.307 -0.378 . . . . 0.0 111.898 -172.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -142.19 78.94 16.46 Favored Pre-proline 0 CA--C 1.529 0.156 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.89 46.4 2.05 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 125.086 3.857 . . . . 0.0 112.249 -177.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.415 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -70.66 -3.58 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 O-C-N 121.86 -0.525 . . . . 0.0 110.822 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -136.85 158.04 45.36 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 176.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 69.3 m -69.47 111.22 5.18 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 41.0 mm -78.34 139.06 19.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.14 161.82 33.82 Favored 'General case' 0 CA--C 1.523 -0.094 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.3 p -64.45 -18.44 64.75 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 177.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -73.41 -39.75 64.81 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 1.5 m -75.89 -33.79 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 97.0 mt -71.37 -33.07 69.21 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 176.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -72.15 -30.53 65.11 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 175.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 20.6 m -67.23 -34.79 78.22 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 43.5 pt -90.89 -22.13 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 119.045 -0.503 . . . . 0.0 111.887 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 84.1 m -91.26 -26.62 18.91 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.506 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 32.7 t30 -63.99 -40.44 54.42 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 70.3 Cg_endo -69.32 -14.52 37.62 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.494 1.462 . . . . 0.0 111.477 177.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 98.8 m -89.88 -8.56 51.63 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.575 0.35 . . . . 0.0 111.614 177.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 149.54 170.32 16.91 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 177.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.68 102.56 1.03 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.933 3.089 . . . . 0.0 110.736 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 73.4 t -71.17 146.81 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 176.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -115.47 -36.17 4.37 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 119.377 -0.344 . . . . 0.0 111.651 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -149.68 151.9 34.46 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.417 0.553 . . . . 0.0 112.192 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 25.3 mt -147.2 136.76 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 124.195 0.998 . . . . 0.0 109.883 177.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 1.2 m -140.47 160.7 24.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.08 0 C-N-CA 123.485 0.714 . . . . 0.0 111.803 174.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 55.3 mt -135.78 144.08 34.59 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 C-N-CA 123.434 0.693 . . . . 0.0 109.832 -176.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.291 3.3 p90 -144.54 157.18 44.34 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 177.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -127.7 15.22 7.0 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.18 0.592 . . . . 0.0 110.883 -172.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -64.09 -30.94 71.97 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -169.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -130.54 4.91 4.69 Favored 'General case' 0 CA--C 1.527 0.074 0 CA-C-N 118.596 0.634 . . . . 0.0 112.262 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 163.76 -124.47 1.28 Allowed Glycine 0 C--N 1.334 0.459 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 -173.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 61.8 t -142.99 114.63 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 175.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 -142.83 168.17 20.36 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.021 0.439 . . . . 0.0 111.009 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.15 165.74 29.96 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.675 0.79 . . . . 0.0 109.456 177.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 61.4 mmm -134.36 153.47 51.87 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 42.6 t -141.59 144.19 26.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 C-N-CA 122.676 0.39 . . . . 0.0 110.116 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -131.67 132.82 44.27 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 122.395 0.278 . . . . 0.0 110.571 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -104.42 162.54 13.14 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -81.89 -8.21 59.66 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 44.8 t -154.5 150.74 28.13 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.811 -0.556 . . . . 0.0 111.973 -176.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 52.0 t -67.66 -36.1 74.99 Favored 'Isoleucine or valine' 0 C--N 1.338 0.096 0 C-N-CA 123.279 0.632 . . . . 0.0 109.356 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -67.22 -28.65 68.25 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 118.295 0.498 . . . . 0.0 110.866 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 63.2 m -75.43 -30.45 60.02 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.429 ' HB1' HD21 ' A' ' 192' ' ' LEU . . . -75.83 -31.94 59.58 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.342 0.257 . . . . 0.0 111.3 178.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -70.69 -43.84 68.21 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -74.59 -26.45 59.93 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 117.792 0.269 . . . . 0.0 111.05 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -71.98 -41.51 67.6 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 118.087 0.403 . . . . 0.0 110.042 177.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -75.6 -20.57 58.47 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 122.603 0.361 . . . . 0.0 111.399 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -95.93 -13.12 24.13 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 47.1 t -113.28 -33.6 5.91 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 59.7 mt -90.56 -7.78 51.96 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 118.003 0.365 . . . . 0.0 111.816 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -71.87 133.69 45.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 177.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.36 -5.87 40.94 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.924 -0.47 . . . . 0.0 111.924 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.87 166.44 22.41 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.793 0.796 . . . . 0.0 110.473 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -123.7 139.65 53.78 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 84.4 mt -74.22 -41.69 51.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.351 42.8 m-85 -82.97 -11.82 57.81 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 178.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 23.2 t 65.71 35.48 6.87 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.631 0.772 . . . . 0.0 111.087 -174.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 176.17 -23.76 0.06 OUTLIER Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.127 0.87 . . . . 0.0 111.266 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' CYS . . . . . 0.415 ' HB3' HD12 ' A' ' 200' ' ' ILE . 98.5 m -146.37 -177.23 5.51 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.628 1.171 . . . . 0.0 109.47 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 89.1 m 58.19 36.23 25.62 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -176.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.1 148.98 10.04 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 175.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 75.9 mt -116.28 154.75 29.61 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -173.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -138.45 138.32 38.03 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.065 1.346 . . . . 0.0 107.596 169.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 33.1 mt -137.74 143.28 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-O 120.685 0.278 . . . . 0.0 111.514 -171.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -158.23 163.25 37.64 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.312 0.645 . . . . 0.0 109.374 175.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.268 37.8 m-85 -62.63 134.31 56.16 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 177.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' ALA . . . . . 0.449 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -84.38 161.03 20.52 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.351 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.487 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 64.0 pttt -93.56 -31.58 0.3 Allowed Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 178.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 86.1 Cg_endo -75.88 171.12 18.77 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.913 1.742 . . . . 0.0 110.295 175.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.96 -1.61 2.67 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 117.26 2.319 . . . . 0.0 117.26 -175.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.35 133.55 11.6 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-N 118.766 0.712 . . . . 0.0 111.727 -178.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.431 ' HG ' ' C6 ' ' B' ' 3' ' ' ' A' . 19.2 mt -92.31 157.76 16.47 Favored 'General case' 0 C--O 1.228 -0.04 0 C-N-CA 124.137 0.975 . . . . 0.0 111.516 177.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.411 ' C ' ' H61' ' B' ' 5' ' ' ' A' . 65.2 m-80 -120.97 47.76 1.76 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.734 0.813 . . . . 0.0 109.86 174.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.414 HG23 ' H ' ' A' ' 272' ' ' VAL . 2.5 t -53.09 143.91 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.092 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -177.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . 0.26 10.2 p90 -128.22 -4.57 5.53 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 116.868 2.173 . . . . 0.0 116.868 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.14 172.35 18.26 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 123.245 0.618 . . . . 0.0 111.689 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -125.68 121.82 34.57 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.752 0.821 . . . . 0.0 109.65 175.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 49.3 p30 -159.27 -166.71 1.88 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.643 0.777 . . . . 0.0 109.653 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -68.21 -14.56 63.07 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -177.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -99.53 -34.91 10.05 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.15 150.46 42.82 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 178.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 22.2 t-105 -157.86 155.59 29.93 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -176.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -131.24 119.17 21.44 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.972 0.509 . . . . 0.0 111.629 175.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.28 67.1 m-85 -83.02 9.35 10.4 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -171.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 9.3 t -141.05 -23.06 0.77 Allowed 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -178.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -95.29 113.27 61.22 Favored Pre-proline 0 CA--C 1.532 0.273 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 174.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -79.65 -15.81 12.03 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.331 2.688 . . . . 0.0 112.357 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 66.1 m-80 -73.55 -15.37 61.3 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -173.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 70.7 mt -85.76 -2.42 58.2 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 117.928 0.331 . . . . 0.0 111.882 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 47.7 t -75.68 143.44 42.16 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.291 0.236 . . . . 0.0 110.682 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 70.53 -0.46 26.36 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 119.454 -0.637 . . . . 0.0 113.43 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 55.6 mm-40 -71.99 157.86 37.05 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 118.315 1.058 . . . . 0.0 110.962 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.31 0 CA-C-O 117.471 -1.739 . . . . 0.0 111.442 179.437 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.879 0 C5'-C4'-C3' 110.1 -3.6 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.449 ' N3 ' ' HA ' ' A' ' 265' ' ' ALA . . . . . . . . 0 O4'--C4' 1.42 -2.723 0 C3'-C2'-C1' 98.25 -3.611 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.431 ' C6 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.417 -2.962 2 O4'-C1'-N19 112.527 4.327 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.915 1 C5'-C4'-C3' 109.321 -4.12 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.411 ' H61' ' C ' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.413 -3.301 0 C3'-C2'-C1' 105.02 3.911 OUTLIER-DELTA 0.113 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.786 0 O4'-C1'-N19 111.291 3.091 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 110.639 -0.134 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -67.85 139.39 56.54 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 122.641 0.376 . . . . 0.0 110.153 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 81.9 mt -74.15 142.47 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 122.7 0.4 . . . . 0.0 110.619 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 28.8 t -158.1 136.71 11.18 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.289 0.635 . . . . 0.0 110.32 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 32.0 ptt-85 -162.58 156.73 18.16 Favored Pre-proline 0 C--O 1.232 0.153 0 C-N-CA 122.844 0.458 . . . . 0.0 110.309 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -58.91 152.18 59.8 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 123.198 2.599 . . . . 0.0 111.569 175.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 76.25 5.67 81.88 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 119.775 -0.458 . . . . 0.0 112.194 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -142.67 -45.81 0.32 Allowed 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 75.5 m -66.95 152.18 46.22 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 176.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -61.23 -21.33 63.77 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 -172.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -79.92 8.48 6.85 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 99.7 p -146.39 3.24 0.88 Allowed 'General case' 0 C--O 1.233 0.186 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.45 9.19 0.54 Allowed 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 53.3 m -145.25 9.82 1.26 Allowed 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.5 m -70.53 123.45 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 38.8 p-10 -130.88 10.41 5.04 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.732 0.813 . . . . 0.0 112.44 177.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.5 m 66.34 22.0 10.88 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.261 1.024 . . . . 0.0 113.308 -173.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 38.4 t -131.8 142.47 42.95 Favored 'Isoleucine or valine' 0 C--N 1.337 0.059 0 C-N-CA 123.362 0.665 . . . . 0.0 110.505 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 83.5 mt -134.6 148.3 50.4 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 122.615 0.366 . . . . 0.0 111.236 -175.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 28.5 tp -99.54 134.36 42.54 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 172.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -112.7 106.76 15.21 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.2 m -90.06 139.99 30.08 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 174.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 3.9 mp -110.34 122.48 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -91.79 -18.47 23.81 Favored 'General case' 0 C--O 1.23 0.06 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -171.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -141.66 78.93 17.47 Favored Pre-proline 0 CA--C 1.529 0.158 0 C-N-CA 122.95 0.5 . . . . 0.0 109.679 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -77.29 50.07 3.04 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 124.926 3.751 . . . . 0.0 112.179 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.45 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -69.72 -6.5 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 O-C-N 121.761 -0.587 . . . . 0.0 110.011 178.41 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -142.67 155.43 44.91 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.148 1.379 . . . . 0.0 112.337 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 28.5 t -74.97 131.86 40.97 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 25.4 mm -78.66 152.06 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 122.983 0.513 . . . . 0.0 110.338 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.96 157.58 45.68 Favored 'General case' 0 C--N 1.338 0.076 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 39.4 p -68.73 -18.27 64.2 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -77.59 -47.23 19.91 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 118.192 0.451 . . . . 0.0 111.748 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 3.5 m -71.12 -32.2 47.08 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 99.2 mt -70.47 -35.63 73.41 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -71.06 -30.18 66.27 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 175.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.6 m -67.35 -33.38 75.11 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 36.7 pt -93.63 -22.29 5.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 118.486 0.585 . . . . 0.0 111.787 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 89.1 m -90.17 -26.02 20.36 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.494 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 32.4 t30 -63.46 -42.57 74.62 Favored Pre-proline 0 CA--C 1.535 0.38 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 -178.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 70.9 Cg_endo -69.1 -13.19 35.86 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 121.784 1.656 . . . . 0.0 111.644 178.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 91.5 m -88.68 -8.38 54.67 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.041 0.382 . . . . 0.0 111.788 176.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 145.02 169.72 13.63 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 177.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.34 107.61 0.5 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.715 2.943 . . . . 0.0 111.949 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 72.3 t -76.56 146.6 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -117.01 -40.54 3.11 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 119.259 -0.4 . . . . 0.0 111.556 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 65.8 mtm-85 -148.88 152.55 36.64 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 25.4 mt -148.28 136.85 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 C-N-CA 124.305 1.042 . . . . 0.0 110.054 176.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 3.8 m -142.4 159.76 19.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 123.9 0.88 . . . . 0.0 110.519 174.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 48.0 mt -132.13 142.93 41.55 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 122.575 0.35 . . . . 0.0 110.676 -175.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.298 4.8 p90 -142.76 158.39 43.69 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 116.002 1.853 . . . . 0.0 116.002 176.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -130.45 17.68 5.37 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.469 0.708 . . . . 0.0 110.991 -174.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -64.29 -31.21 72.32 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -169.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -130.42 7.47 4.93 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.584 0.629 . . . . 0.0 112.161 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 161.0 -123.62 1.23 Allowed Glycine 0 C--N 1.334 0.451 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 -175.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 41.2 t -140.68 113.97 5.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -144.13 167.24 22.86 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.3 0.571 . . . . 0.0 111.094 -176.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -149.1 165.88 30.42 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.137 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 72.6 mmm -131.68 152.79 50.61 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 39.8 t -140.89 145.1 25.81 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 123.003 0.521 . . . . 0.0 110.385 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -131.23 134.98 46.97 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.007 0.523 . . . . 0.0 110.11 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -109.1 161.96 14.7 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 116.5 2.037 . . . . 0.0 116.5 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -80.23 -10.22 59.75 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 41.0 t -155.59 151.75 27.93 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.694 -0.628 . . . . 0.0 112.131 -176.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 43.5 t -66.39 -38.93 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -68.05 -24.17 65.05 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.784 0.265 . . . . 0.0 111.141 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 65.2 m -75.48 -33.53 60.81 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 175.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -77.51 -31.61 53.62 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 122.37 -0.206 . . . . 0.0 110.96 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -66.2 -43.77 85.82 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 121.931 -0.481 . . . . 0.0 111.358 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -77.12 -25.24 51.9 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.817 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -71.82 -41.39 68.26 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.911 0.323 . . . . 0.0 110.271 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.49 -28.34 62.83 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 122.634 0.374 . . . . 0.0 110.717 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -90.25 -12.94 36.48 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 41.0 t -113.7 -35.71 5.1 Favored 'General case' 0 C--N 1.339 0.122 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -176.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 68.5 mt -88.19 -7.45 56.84 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.024 0.375 . . . . 0.0 111.628 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -71.32 134.66 46.9 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 75.79 -5.47 39.0 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 119.795 -0.447 . . . . 0.0 112.48 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.46 166.35 22.71 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 117.797 0.799 . . . . 0.0 110.408 177.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -123.42 140.83 52.61 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 84.8 mt -75.99 -42.25 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.379 45.2 m-85 -82.89 -10.58 58.76 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 27.3 t 65.71 36.5 6.28 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.6 0.76 . . . . 0.0 110.864 -175.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 174.36 -24.25 0.07 OUTLIER Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 178.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' CYS . . . . . 0.45 ' HB3' HD12 ' A' ' 200' ' ' ILE . 75.9 m -145.62 -177.21 5.46 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.922 1.289 . . . . 0.0 109.367 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 98.6 m 58.26 37.83 26.09 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.83 148.15 13.69 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 175.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 82.2 mt -114.31 156.19 24.85 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -172.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -139.45 138.28 36.32 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.598 1.559 . . . . 0.0 107.2 169.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 31.8 mt -139.23 142.83 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 CA-C-O 120.686 0.279 . . . . 0.0 111.316 -171.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -157.69 160.49 38.01 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 122.927 0.491 . . . . 0.0 109.771 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.283 40.6 m-85 -59.88 135.42 57.69 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 176.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' ALA . . . . . 0.427 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -89.24 159.11 17.59 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.173 -178.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.443 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 23.4 pttp -94.24 -31.8 0.29 Allowed Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 49.1 Cg_endo -79.83 159.12 24.58 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 CA-C-N 121.881 1.708 . . . . 0.0 109.505 174.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.31 0.2 OUTLIER -134.8 15.33 3.62 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 -174.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -158.45 123.0 4.16 Favored 'General case' 0 C--N 1.338 0.074 0 O-C-N 121.931 -0.481 . . . . 0.0 111.559 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.443 ' HG ' ' C5 ' ' B' ' 3' ' ' ' A' . 18.9 mt -86.05 161.06 19.12 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 123.583 0.753 . . . . 0.0 110.408 174.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.443 ' C ' ' H61' ' B' ' 5' ' ' ' A' . 51.5 m-80 -121.2 51.24 1.29 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.846 171.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.403 ' H ' HG23 ' A' ' 272' ' ' VAL . 2.3 t -51.8 144.87 2.56 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -176.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -129.62 -5.78 4.66 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 117.653 2.464 . . . . 0.0 117.653 -176.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -160.66 170.91 19.85 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 122.558 0.343 . . . . 0.0 110.609 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -125.81 119.6 28.32 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.743 0.817 . . . . 0.0 110.038 174.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -162.69 -167.98 1.69 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.362 1.065 . . . . 0.0 109.087 176.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -70.23 -8.18 48.05 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -176.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -109.26 -26.28 10.15 Favored 'General case' 0 C--N 1.338 0.092 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.08 140.8 31.06 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.275 1.03 . . . . 0.0 112.499 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 21.6 t-105 -157.95 156.26 30.93 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.418 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -137.19 114.08 10.53 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.397 173.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.259 66.0 m-85 -78.29 6.72 7.66 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 -173.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 5.4 t -137.3 -19.9 1.24 Allowed 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -95.37 113.2 61.14 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 174.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -80.49 -14.02 11.86 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.515 2.81 . . . . 0.0 112.368 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -75.25 -14.25 60.5 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -173.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 59.2 mt -88.97 -7.42 56.04 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 71.6 m -72.69 147.6 45.54 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 117.761 0.255 . . . . 0.0 110.698 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 74.26 -5.54 26.88 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 119.724 -0.486 . . . . 0.0 112.11 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 57.42 177.79 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.243 1.417 . . . . 0.0 112.76 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.189 0 CA-C-O 117.396 -1.78 . . . . 0.0 110.849 -179.952 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.816 0 C3'-C2'-C1' 104.187 2.986 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.427 ' N3 ' ' HA ' ' A' ' 265' ' ' ALA . . . . . . . . 0 O4'--C4' 1.421 -2.648 0 O4'-C1'-N19 111.426 3.226 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.443 ' C5 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.423 -2.52 1 C5'-C4'-C3' 109.485 -4.01 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.783 0 C5'-C4'-C3' 109.644 -3.904 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.443 ' H61' ' C ' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.42 -2.759 1 C3'-C2'-C1' 105.483 4.425 OUTLIER-DELTA 0.024 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.669 0 O4'-C1'-N19 111.665 3.465 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -65.55 -29.95 70.64 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -173.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 20.0 tt -154.77 164.46 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 CA-C-N 118.35 0.523 . . . . 0.0 110.182 -175.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 67.3 m 53.53 42.25 31.96 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 122.951 0.5 . . . . 0.0 111.264 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.476 ' N ' ' HD2' ' A' ' 179' ' ' PRO . 75.7 mtt180 -56.9 -38.84 72.99 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -176.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 178' ' ' ARG . 69.6 Cg_endo -69.15 -13.24 35.85 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 CA-C-N 121.332 1.511 . . . . 0.0 111.373 177.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -91.98 8.71 77.77 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 174.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -130.97 -53.63 1.05 Allowed 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -176.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 93.7 p -70.77 157.02 38.78 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 7.8 p30 -84.15 -5.61 59.27 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -71.71 -0.48 11.04 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 116.288 1.958 . . . . 0.0 116.288 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 89.4 p -149.75 11.04 0.74 Allowed 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -177.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -146.9 5.52 0.87 Allowed 'General case' 0 C--N 1.34 0.154 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 58.6 m -147.73 12.72 1.02 Allowed 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.411 ' H ' HG22 ' A' ' 188' ' ' VAL . 2.3 m -70.82 103.58 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -177.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 46.0 p30 -130.67 10.33 5.13 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.837 0.855 . . . . 0.0 112.085 177.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 56.0 m 66.06 21.28 11.24 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -176.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 28.6 t -128.8 142.34 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.095 0 C-N-CA 122.833 0.453 . . . . 0.0 110.889 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 91.2 mt -133.95 149.14 51.25 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 122.832 0.453 . . . . 0.0 111.278 -175.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 32.2 tp -102.0 135.01 44.3 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 172.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -114.57 107.04 14.97 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.93 138.27 31.68 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 174.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.1 mp -108.73 118.18 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -90.92 -18.83 24.07 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 119.255 -0.403 . . . . 0.0 112.018 -171.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -142.12 79.01 16.51 Favored Pre-proline 0 CA--C 1.529 0.156 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -77.61 44.56 1.56 Allowed 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 125.19 3.927 . . . . 0.0 112.48 -176.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.437 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -70.06 -4.55 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 O-C-N 121.59 -0.693 . . . . 0.0 110.641 179.767 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -137.95 156.18 48.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 42.3 t -70.39 117.02 11.41 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 120.717 0.294 . . . . 0.0 110.212 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.1 mm -78.55 143.73 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 122.876 0.471 . . . . 0.0 109.807 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.99 159.16 41.6 Favored 'General case' 0 CA--C 1.526 0.031 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.5 p -66.01 -15.69 63.24 Favored 'General case' 0 C--N 1.335 -0.062 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -76.38 -44.93 34.16 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.504 0.192 . . . . 0.0 110.848 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 1.9 m -72.88 -32.01 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.9 mt -70.64 -34.75 72.41 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 175.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -72.02 -30.29 65.05 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 174.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.6 m -66.82 -34.44 77.81 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 45.4 pt -91.27 -23.24 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 118.201 0.455 . . . . 0.0 111.902 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 89.0 m -89.87 -25.34 21.06 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.479 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 30.1 t30 -63.69 -42.59 72.97 Favored Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 73.8 Cg_endo -69.34 -12.56 33.98 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.338 1.359 . . . . 0.0 111.474 177.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 89.4 m -91.92 -7.45 49.1 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 122.502 0.321 . . . . 0.0 111.673 176.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 149.47 168.81 15.26 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.54 101.08 0.84 Allowed 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.9 3.067 . . . . 0.0 110.51 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 87.4 t -69.11 145.69 13.16 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 123.37 0.668 . . . . 0.0 109.257 177.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -115.04 -40.6 3.46 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 119.064 -0.493 . . . . 0.0 111.6 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 63.0 mtm-85 -148.05 152.43 37.38 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 21.4 mt -149.16 137.73 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 124.093 0.957 . . . . 0.0 110.273 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.3 m -143.48 163.15 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 C-N-CA 123.846 0.858 . . . . 0.0 110.338 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 54.1 mt -133.68 142.63 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 C-N-CA 122.757 0.423 . . . . 0.0 110.528 -175.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.264 6.3 p90 -146.92 159.34 43.67 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 115.819 1.785 . . . . 0.0 115.819 176.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.64 31.91 2.05 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.163 0.585 . . . . 0.0 111.777 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -67.9 -29.45 68.55 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -174.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -130.57 3.61 4.6 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 123.307 0.643 . . . . 0.0 112.514 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 167.19 -127.04 1.51 Allowed Glycine 0 CA--C 1.522 0.472 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 -173.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.1 t -138.79 117.8 13.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 117.103 0.452 . . . . 0.0 110.239 174.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 11.1 mp0 -144.1 168.56 19.72 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.476 0.655 . . . . 0.0 111.119 -175.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -150.66 167.16 28.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.828 1.251 . . . . 0.0 108.643 175.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 73.1 mmm -135.06 154.04 51.84 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 38.2 t -140.9 144.29 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 122.946 0.499 . . . . 0.0 110.517 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -129.88 135.07 47.94 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.87 0.468 . . . . 0.0 110.099 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -108.55 163.83 12.88 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 116.264 1.95 . . . . 0.0 116.264 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -81.2 -12.74 59.09 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 92.2 p -155.73 155.58 33.37 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.11 0.481 . . . . 0.0 111.455 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 49.7 t -67.84 -34.77 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -64.21 -33.72 76.45 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 122.254 -0.279 . . . . 0.0 110.8 -177.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 57.7 m -72.86 -33.74 66.3 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 117.464 0.12 . . . . 0.0 110.723 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -74.17 -30.12 62.09 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 119.707 -0.187 . . . . 0.0 111.373 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -68.85 -45.11 71.93 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 118.343 0.519 . . . . 0.0 111.724 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -76.44 -25.61 54.58 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 118.046 0.384 . . . . 0.0 111.553 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -72.32 -40.39 67.48 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.034 0.379 . . . . 0.0 110.171 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.82 -22.91 58.45 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.565 0.346 . . . . 0.0 111.316 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -95.08 -12.12 27.08 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 45.4 t -111.4 -34.95 5.97 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 118.622 0.646 . . . . 0.0 112.567 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 66.9 mt -89.79 -7.95 53.22 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -70.61 133.29 46.56 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 75.94 -4.12 47.59 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 119.651 -0.527 . . . . 0.0 112.215 -177.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.99 166.28 21.74 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 117.878 0.839 . . . . 0.0 110.281 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -123.56 140.06 53.38 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 115.016 1.488 . . . . 0.0 115.016 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 89.9 mt -74.24 -41.27 51.06 Favored 'Isoleucine or valine' 0 C--N 1.339 0.135 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.364 44.0 m-85 -82.86 -10.57 58.78 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 23.3 t 65.8 33.2 8.3 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.513 0.725 . . . . 0.0 110.577 -173.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 176.84 -22.52 0.05 OUTLIER Glycine 0 CA--C 1.531 1.037 0 C-N-CA 123.677 0.656 . . . . 0.0 111.491 177.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' CYS . . . . . 0.437 ' HB3' HD12 ' A' ' 200' ' ' ILE . 96.4 m -145.99 -177.9 5.84 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.567 1.147 . . . . 0.0 109.814 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 90.9 m 58.68 37.67 25.14 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -176.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.24 148.33 11.62 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 176.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 79.2 mt -115.71 155.75 27.18 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -172.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -138.85 138.16 37.23 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.37 1.468 . . . . 0.0 107.454 169.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 36.1 mt -138.67 142.91 33.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-O 120.842 0.353 . . . . 0.0 111.728 -171.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -158.38 163.0 37.67 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 175.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.267 42.5 m-85 -62.28 135.51 57.5 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 176.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' ALA . . . . . 0.447 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -85.11 160.44 19.96 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.303 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.473 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 63.8 pttt -92.66 -31.81 0.32 Allowed Pre-proline 0 CA--C 1.537 0.452 0 CA-C-O 117.493 -1.241 . . . . 0.0 114.21 178.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 91.1 Cg_endo -76.45 173.48 14.41 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 CA-C-N 122.096 1.784 . . . . 0.0 110.088 173.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.8 -5.05 2.83 Favored 'General case' 0 N--CA 1.461 0.089 0 N-CA-C 117.699 2.481 . . . . 0.0 117.699 -175.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -157.75 131.21 7.78 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.988 0.813 . . . . 0.0 111.761 -178.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.435 ' HG ' ' C6 ' ' B' ' 3' ' ' ' A' . 30.4 mt -83.75 162.57 20.62 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.434 1.094 . . . . 0.0 111.065 175.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.503 ' C ' ' H61' ' B' ' 5' ' ' ' A' . 0.7 OUTLIER -115.53 49.38 1.09 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 169.918 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.414 ' HA ' ' N1 ' ' B' ' 5' ' ' ' A' . 2.4 t -49.73 142.42 2.43 Favored 'Isoleucine or valine' 0 C--N 1.341 0.233 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -177.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -127.42 -9.03 5.75 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 117.819 2.526 . . . . 0.0 117.819 -175.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -161.18 173.85 14.5 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.808 0.443 . . . . 0.0 110.356 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -125.72 119.96 29.38 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.327 0.651 . . . . 0.0 110.182 175.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 47.6 p30 -159.33 -167.92 2.18 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.263 1.025 . . . . 0.0 109.271 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -69.95 -10.56 59.01 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -175.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -113.26 -18.55 12.06 Favored 'General case' 0 N--CA 1.461 0.093 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.14 141.08 29.77 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 124.29 1.036 . . . . 0.0 112.51 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 20.4 t-105 -160.35 158.76 30.21 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 118.886 0.767 . . . . 0.0 110.871 -178.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -139.59 115.81 10.45 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.398 172.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.252 65.1 m-85 -79.17 5.42 12.14 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 -173.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 4.2 t -137.41 -18.2 1.29 Allowed 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -95.23 113.18 60.96 Favored Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 174.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.01 -15.68 12.93 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.347 2.698 . . . . 0.0 112.296 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -73.92 -15.05 61.14 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -175.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 44.4 mt -91.27 -5.01 55.37 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 64.8 m -78.29 151.71 32.85 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 120.599 0.238 . . . . 0.0 110.946 176.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 73.63 -2.52 39.18 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.784 -0.454 . . . . 0.0 112.588 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 52.2 mm-40 -75.43 164.87 25.94 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 117.776 0.788 . . . . 0.0 109.975 177.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.13 0 CA-C-O 117.202 -1.888 . . . . 0.0 111.165 -179.974 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.928 0 C3'-C2'-C1' 104.264 3.071 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.447 ' N3 ' ' HA ' ' A' ' 265' ' ' ALA . . . . . . . . 0 O4'--C4' 1.422 -2.559 0 O4'-C1'-N19 112.123 3.923 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.435 ' C6 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.422 -2.542 1 C5'-C4'-C3' 109.178 -4.215 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.858 1 C5'-C4'-C3' 109.472 -4.018 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.503 ' H61' ' C ' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.418 -2.911 0 C3'-C2'-C1' 105.06 3.956 OUTLIER-DELTA 0.015 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.583 0 O4'-C1'-N19 112.132 3.932 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 110.549 -0.167 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -69.17 154.46 42.02 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.058 0.543 . . . . 0.0 111.194 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 47.5 mm -68.51 111.56 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 174.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 46.5 t 59.84 152.3 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.814 1.245 . . . . 0.0 113.224 -175.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.654 ' H ' ' HD2' ' A' ' 179' ' ' PRO . 48.1 mtm105 -146.1 -53.53 0.02 OUTLIER Pre-proline 0 CA--C 1.529 0.171 0 CA-C-O 118.54 -0.743 . . . . 0.0 112.107 -178.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.654 ' HD2' ' H ' ' A' ' 178' ' ' ARG . 61.1 Cg_endo -67.6 140.48 51.99 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 121.216 1.277 . . . . 0.0 109.412 174.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 70.19 7.59 60.26 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 111.891 -0.483 . . . . 0.0 111.891 -176.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.84 -18.98 2.34 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 38.1 t -151.45 146.84 26.21 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.352 0.661 . . . . 0.0 109.427 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -65.14 -16.91 64.01 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -70.26 0.96 5.41 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 70.2 m -142.69 7.48 1.68 Allowed 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -177.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.54 4.52 0.68 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 35.8 m -141.95 6.99 1.81 Allowed 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 3.4 m -72.0 123.99 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-O 121.009 0.433 . . . . 0.0 112.062 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 42.2 p30 -130.68 10.38 5.13 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.984 0.914 . . . . 0.0 112.979 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 59.6 m 66.09 20.67 11.22 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -174.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.1 t -129.63 135.57 61.12 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 C-N-CA 123.086 0.555 . . . . 0.0 111.209 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -124.83 150.6 46.22 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 123.015 0.526 . . . . 0.0 110.646 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 40.3 tp -100.03 136.15 40.37 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 170.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -114.25 107.37 15.51 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 178.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.54 136.42 33.0 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 173.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.0 mp -106.8 118.34 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.029 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -90.67 -18.16 25.55 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -171.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -142.1 79.01 16.56 Favored Pre-proline 0 CA--C 1.529 0.139 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -76.91 44.71 1.51 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 125.115 3.877 . . . . 0.0 112.673 -177.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.444 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -70.04 -5.01 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 O-C-N 121.542 -0.724 . . . . 0.0 110.6 -179.651 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -138.89 156.54 47.2 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 43.6 t -69.8 118.75 13.04 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 31.0 mm -78.42 143.81 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 123.025 0.53 . . . . 0.0 109.58 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.02 158.24 44.04 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.4 p -65.64 -16.75 64.03 Favored 'General case' 0 CA--C 1.523 -0.096 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -76.09 -45.59 33.19 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.616 0.246 . . . . 0.0 110.713 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.1 m -72.32 -32.56 43.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.93 -34.56 71.62 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 175.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -72.46 -29.0 63.27 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 174.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.6 m -67.95 -34.0 75.74 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 44.7 pt -91.22 -23.6 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 118.399 0.545 . . . . 0.0 111.798 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 89.0 m -89.38 -26.58 20.96 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -178.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.484 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 33.8 t30 -64.14 -42.0 65.5 Favored Pre-proline 0 CA--C 1.537 0.457 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -178.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 71.9 Cg_endo -68.79 -12.92 35.8 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 121.335 1.357 . . . . 0.0 111.407 177.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 95.8 m -91.82 -6.25 52.01 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.531 0.332 . . . . 0.0 111.673 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 147.13 166.66 12.55 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.72 104.12 1.1 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 123.849 3.032 . . . . 0.0 110.663 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 74.3 t -71.49 147.11 11.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -115.82 -36.33 4.21 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 119.199 -0.429 . . . . 0.0 111.716 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 21.3 mtm180 -150.78 151.54 32.5 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.526 0.603 . . . . 0.0 112.275 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 20.6 mt -147.4 136.54 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 C-N-CA 124.323 1.049 . . . . 0.0 110.219 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 1.3 m -140.24 159.85 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.065 0 C-N-CA 123.548 0.739 . . . . 0.0 111.765 174.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 57.0 mt -132.08 142.62 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 C-N-CA 122.929 0.492 . . . . 0.0 110.021 -177.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.261 4.0 p90 -147.84 159.86 43.39 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 115.629 1.714 . . . . 0.0 115.629 176.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.1 31.35 2.18 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.017 0.527 . . . . 0.0 111.68 -177.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -67.63 -30.35 69.89 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -174.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -130.54 4.29 4.65 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 123.105 0.562 . . . . 0.0 112.498 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 166.36 -127.83 1.66 Allowed Glycine 0 C--N 1.333 0.368 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 -174.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 19.3 t -139.69 116.72 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-N 117.415 0.608 . . . . 0.0 110.336 174.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 9.6 mp0 -144.78 169.05 18.78 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.677 0.751 . . . . 0.0 111.123 -175.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -150.86 167.47 27.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.224 1.01 . . . . 0.0 108.621 175.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 53.5 mmm -135.01 154.83 51.59 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.618 0.367 . . . . 0.0 110.03 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 35.8 t -142.34 143.26 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 C-N-CA 123.219 0.608 . . . . 0.0 110.496 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -130.07 134.36 47.32 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 123.216 0.323 . . . . 0.0 110.263 177.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -105.01 163.62 12.41 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 -176.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -77.93 -16.48 58.15 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 86.4 p -153.48 157.15 39.42 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.222 0.534 . . . . 0.0 111.503 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 54.8 t -67.23 -33.98 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -64.9 -34.81 79.28 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 122.063 -0.398 . . . . 0.0 110.613 -177.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 65.6 m -72.58 -31.51 65.28 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 110.624 -0.139 . . . . 0.0 110.624 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -72.52 -31.68 65.53 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 111.328 0.122 . . . . 0.0 111.328 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -72.21 -45.82 58.74 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 117.979 0.354 . . . . 0.0 111.843 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 17.1 ptt180 -75.04 -26.02 59.13 Favored 'General case' 0 C--N 1.338 0.089 0 C-N-CA 120.659 -0.417 . . . . 0.0 111.317 -177.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -70.63 -40.73 72.94 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 117.934 0.334 . . . . 0.0 110.196 177.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -75.79 -25.87 56.8 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.494 0.317 . . . . 0.0 111.059 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -89.25 -10.46 46.87 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 47.0 t -115.92 -35.74 4.36 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 66.8 mt -89.31 -6.7 56.5 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -177.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -70.94 133.97 46.83 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.19 -4.6 47.09 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 119.767 -0.463 . . . . 0.0 112.346 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.61 166.43 22.54 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 117.872 0.836 . . . . 0.0 110.249 177.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -123.45 139.16 54.31 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 86.8 mt -73.77 -41.74 54.29 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.358 44.0 m-85 -82.83 -11.39 58.28 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.8 t 65.38 35.92 7.18 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 122.101 0.953 . . . . 0.0 110.685 -174.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 176.38 -24.55 0.06 OUTLIER Glycine 0 CA--C 1.528 0.877 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.202 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' CYS . . . . . 0.444 ' HB3' HD12 ' A' ' 200' ' ' ILE . 87.2 m -147.21 -177.16 5.53 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.943 1.297 . . . . 0.0 109.659 178.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 94.9 m 58.54 37.7 25.47 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -175.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.93 147.43 12.26 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 175.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 80.1 mt -115.26 154.41 29.14 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -173.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -137.53 138.31 39.51 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.16 1.384 . . . . 0.0 107.448 169.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 36.6 mt -138.31 143.29 33.15 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.085 0 CA-C-O 120.781 0.324 . . . . 0.0 111.381 -171.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -158.71 161.66 37.09 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.789 175.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.272 33.5 m-85 -59.18 134.43 56.99 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 176.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' ALA . . . . . 0.456 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -87.74 163.33 16.55 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.854 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.494 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 23.3 pttp -97.95 -29.83 0.25 Allowed Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 84.2 Cg_endo -76.23 170.88 19.15 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 CA-C-N 122.04 1.764 . . . . 0.0 110.277 175.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.41 -2.62 2.75 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 117.584 2.438 . . . . 0.0 117.584 -177.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.26 131.61 10.34 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 118.691 0.678 . . . . 0.0 111.879 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.421 ' HG ' ' C5 ' ' B' ' 3' ' ' ' A' . 17.0 mt -89.84 158.16 17.59 Favored 'General case' 0 C--N 1.337 0.065 0 C-N-CA 123.652 0.781 . . . . 0.0 111.325 178.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -121.84 46.04 2.18 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.549 0.739 . . . . 0.0 109.834 175.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 272' ' ' VAL . 2.5 t -52.08 144.7 2.89 Favored 'Isoleucine or valine' 0 C--N 1.338 0.093 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . 0.317 8.2 p90 -123.54 -5.73 8.16 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 117.099 2.259 . . . . 0.0 117.099 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.84 172.33 16.28 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 123.382 0.673 . . . . 0.0 111.264 178.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -124.15 118.89 27.9 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.71 0.804 . . . . 0.0 110.067 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -159.09 -168.74 2.44 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.907 0.883 . . . . 0.0 109.379 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -69.63 -10.77 59.58 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -176.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -98.96 -38.35 9.03 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.4 p -143.04 146.05 33.48 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.66 0.784 . . . . 0.0 113.003 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 20.3 t-105 -154.73 152.85 30.39 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.165 0.507 . . . . 0.0 109.998 -174.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -127.6 117.42 21.99 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.559 174.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.286 65.0 m-85 -81.64 8.41 9.89 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 117.511 2.412 . . . . 0.0 117.511 -171.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 6.4 t -140.54 -21.66 0.82 Allowed 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -95.34 113.37 61.49 Favored Pre-proline 0 CA--C 1.531 0.246 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 174.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -79.97 -15.38 11.84 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 123.418 2.746 . . . . 0.0 112.344 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -74.0 -16.29 61.07 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -175.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 82.3 mt -86.31 -7.4 58.52 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 74.5 m -75.36 143.73 42.69 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 122.09 -0.382 . . . . 0.0 110.901 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 73.15 -1.09 43.21 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 119.628 -0.54 . . . . 0.0 113.172 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 52.2 mm-40 -74.33 159.88 31.8 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 118.108 0.954 . . . . 0.0 110.89 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.248 0 CA-C-O 117.43 -1.761 . . . . 0.0 110.89 179.137 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.682 0 C3'-C2'-C1' 104.515 3.35 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.456 ' N3 ' ' HA ' ' A' ' 265' ' ' ALA . . . . . . . . 0 O4'--C4' 1.421 -2.682 0 C3'-C2'-C1' 98.358 -3.491 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.421 ' C5 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.418 -2.92 1 C5'-C4'-C3' 109.257 -4.162 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 4' ' ' ' C' . . . . . 0.4 " H4'" " H5'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.876 1 C5'-C4'-C3' 108.655 -4.564 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.4 " H5'" " H4'" ' B' ' 4' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.414 -3.239 1 C3'-C2'-C1' 105.118 4.02 OUTLIER-DELTA 0.177 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.753 0 O4'-C1'-N19 111.638 3.438 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 33.7 tp60 . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 111.437 0.162 . . . . 0.0 111.437 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -68.2 -24.59 64.96 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 122.682 0.393 . . . . 0.0 111.727 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 40.5 mm -131.68 150.19 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 123.552 0.741 . . . . 0.0 109.751 -178.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 90.4 p -155.05 164.22 39.18 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.757 0.823 . . . . 0.0 109.45 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.679 ' H ' ' CD ' ' A' ' 179' ' ' PRO . 88.3 mtt-85 -138.33 -38.24 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 CA-C-O 118.371 -0.823 . . . . 0.0 112.556 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.679 ' CD ' ' H ' ' A' ' 178' ' ' ARG . 52.0 Cg_exo -58.99 166.96 6.15 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.762 2.308 . . . . 0.0 111.842 175.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 73.24 18.4 79.24 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -178.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . 0.285 69.1 m-20 60.77 35.4 19.57 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -178.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 36.0 t -59.62 150.84 26.23 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -57.92 -22.25 47.75 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -176.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -73.16 6.73 2.56 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 90.3 p -147.18 -0.79 0.67 Allowed 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -144.35 9.77 1.43 Allowed 'General case' 0 C--N 1.341 0.234 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 37.1 m -142.38 2.54 1.46 Allowed 'General case' 0 C--O 1.231 0.128 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 3.6 m -73.03 129.29 36.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 122.581 0.352 . . . . 0.0 111.461 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -130.64 10.46 5.16 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.9 m 64.65 20.64 12.2 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -174.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.5 t -133.08 134.57 57.73 Favored 'Isoleucine or valine' 0 C--N 1.341 0.198 0 C-N-CA 122.752 0.421 . . . . 0.0 110.672 177.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.41 ' N ' HD22 ' A' ' 192' ' ' LEU . 2.4 mm? -123.14 152.49 41.09 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 122.781 0.433 . . . . 0.0 111.137 -176.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.404 HD22 ' C6 ' ' B' ' 2' ' ' ' C' . 28.0 tp -100.91 135.8 41.78 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 169.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -113.29 111.06 21.39 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.863 1.265 . . . . 0.0 114.248 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.31 132.69 38.65 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 173.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.3 mp -103.7 120.55 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -89.74 -18.1 27.0 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -171.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -143.08 78.95 14.79 Favored Pre-proline 0 CA--C 1.53 0.181 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -78.37 45.92 1.98 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 125.061 3.84 . . . . 0.0 112.131 -177.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.433 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -70.38 -3.86 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 O-C-N 121.924 -0.485 . . . . 0.0 110.553 179.779 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -137.32 157.74 45.96 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 176.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 67.5 m -69.88 113.6 7.27 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 33.7 mm -78.4 141.81 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.079 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.24 161.02 36.09 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.6 p -62.45 -21.04 65.13 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -74.02 -46.21 44.92 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.63 0.372 . . . . 0.0 111.717 -178.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 1.7 m -69.28 -32.74 54.75 Favored 'Isoleucine or valine' 0 C--O 1.23 0.043 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.9 mt -72.09 -35.82 69.32 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -69.2 -31.05 69.39 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 174.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 9.4 m -67.69 -34.05 76.13 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 38.6 pt -93.16 -21.32 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 119.027 -0.511 . . . . 0.0 111.916 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 92.0 m -90.34 -27.32 19.47 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 119.139 0.881 . . . . 0.0 113.278 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.496 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 35.1 t30 -63.36 -39.78 52.99 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -178.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 74.0 Cg_endo -69.35 -15.77 38.83 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 CA-C-N 121.216 1.47 . . . . 0.0 111.635 178.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 95.0 m -84.67 -13.29 51.92 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.041 0.382 . . . . 0.0 111.456 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 149.58 169.42 15.95 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.03 112.84 1.64 Allowed 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 123.578 2.852 . . . . 0.0 111.309 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.8 t -79.38 144.34 11.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 176.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -112.99 -39.57 4.19 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 119.381 -0.342 . . . . 0.0 111.189 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 23.3 mtm180 -150.06 153.16 35.98 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.131 0.423 . . . . 0.0 112.066 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 24.6 mt -144.07 143.6 23.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.261 1.024 . . . . 0.0 109.659 178.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 38.3 t -145.94 155.89 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 46.6 mt -138.65 141.52 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 123.894 0.878 . . . . 0.0 109.375 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.287 3.2 p90 -143.98 157.52 44.29 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 177.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -126.53 15.98 7.62 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.272 0.629 . . . . 0.0 110.733 -173.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -63.35 -33.18 74.96 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -169.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -130.35 7.86 5.0 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.568 0.622 . . . . 0.0 112.265 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 161.96 -125.35 1.41 Allowed Glycine 0 CA--C 1.522 0.469 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -174.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 47.0 t -141.9 114.9 4.16 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 174.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -142.16 168.31 20.04 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.256 0.551 . . . . 0.0 110.989 -176.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.05 164.26 34.37 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.951 176.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 67.4 mmm -132.39 151.27 51.94 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 41.2 t -141.63 144.31 26.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 C-N-CA 122.77 0.428 . . . . 0.0 110.326 -178.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -130.58 134.23 46.84 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 122.838 0.455 . . . . 0.0 110.498 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -106.6 163.43 12.89 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 116.765 2.135 . . . . 0.0 116.765 -175.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -76.64 -17.04 59.38 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.784 0.433 . . . . 0.0 109.879 178.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 83.8 p -154.87 158.34 39.21 Favored 'General case' 0 C--O 1.232 0.157 0 O-C-N 121.819 -0.551 . . . . 0.0 111.648 -178.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 54.4 t -66.29 -33.61 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -68.34 -30.05 68.92 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 121.918 -0.489 . . . . 0.0 110.719 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 68.9 m -73.48 -31.43 63.75 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 175.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.49 -34.51 58.64 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 122.482 0.313 . . . . 0.0 111.546 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -70.54 -42.26 71.42 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 118.104 0.411 . . . . 0.0 111.445 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -76.84 -25.66 53.45 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.489 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -70.44 -41.27 73.09 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -75.08 -19.93 59.74 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.567 0.347 . . . . 0.0 111.012 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -99.51 -4.24 31.69 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 38.6 t -124.28 -31.91 3.25 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.864 0.756 . . . . 0.0 112.803 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 61.6 mt -91.59 -6.66 51.96 Favored 'General case' 0 CA--C 1.527 0.071 0 O-C-N 121.998 -0.439 . . . . 0.0 111.527 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -73.28 134.75 44.32 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 74.44 -5.9 26.28 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 111.984 -0.447 . . . . 0.0 111.984 -178.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.19 166.46 22.17 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 117.663 0.731 . . . . 0.0 110.122 177.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -123.64 139.68 53.76 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 87.7 mt -73.33 -41.58 57.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.182 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.367 39.6 m-85 -82.93 -12.01 57.69 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 117.257 2.317 . . . . 0.0 117.257 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.7 t 65.8 35.26 6.85 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.748 0.785 . . . . 0.0 110.754 -174.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 176.0 -23.68 0.06 OUTLIER Glycine 0 CA--C 1.527 0.812 0 C-N-CA 123.947 0.784 . . . . 0.0 111.198 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' CYS . . . . . 0.433 ' HB3' HD12 ' A' ' 200' ' ' ILE . 93.0 m -147.2 -177.02 5.45 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.916 1.286 . . . . 0.0 109.466 178.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 86.7 m 58.07 36.95 26.41 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -176.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.59 148.95 11.44 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 175.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 76.3 mt -115.9 155.23 28.33 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -173.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -138.38 138.38 38.21 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.313 1.445 . . . . 0.0 107.587 168.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 34.3 mt -138.34 142.37 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-O 120.657 0.265 . . . . 0.0 111.611 -170.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -158.67 162.25 37.21 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.38 0.672 . . . . 0.0 109.844 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -61.13 137.45 58.23 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -88.6 162.34 16.41 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.942 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -82.41 -54.25 0.61 Allowed Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 118.493 -0.765 . . . . 0.0 112.742 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -73.46 164.97 33.68 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.269 2.646 . . . . 0.0 111.347 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.274 0.2 OUTLIER -135.41 10.11 3.46 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 117.247 2.314 . . . . 0.0 117.247 -176.056 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.12 129.16 8.79 Favored 'General case' 0 C--N 1.339 0.11 0 O-C-N 121.646 -0.659 . . . . 0.0 111.642 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.427 ' HG ' ' C6 ' ' B' ' 3' ' ' ' A' . 30.9 mt -92.57 156.37 17.17 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 123.882 0.873 . . . . 0.0 110.916 177.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.417 ' C ' ' H61' ' B' ' 5' ' ' ' A' . 63.5 m-80 -118.58 49.12 1.33 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.861 0.864 . . . . 0.0 109.585 174.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.409 HG23 ' H ' ' A' ' 272' ' ' VAL . 2.1 t -52.31 142.12 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -176.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -130.08 0.7 4.71 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 116.551 2.056 . . . . 0.0 116.551 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -160.58 164.31 32.03 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 122.89 0.476 . . . . 0.0 110.926 -176.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -125.73 118.72 26.19 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.617 0.767 . . . . 0.0 109.198 174.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 40.0 p30 -157.19 -168.04 2.5 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.823 0.849 . . . . 0.0 109.904 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -69.3 -11.95 61.25 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -104.29 -30.66 10.0 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 3.5 p -141.49 145.31 35.05 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 19.2 t-105 -157.67 153.24 26.4 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -176.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . 0.251 7.0 t0 -132.95 121.15 22.38 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 122.94 0.496 . . . . 0.0 112.197 176.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.25 67.2 m-85 -87.25 8.97 21.76 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 117.58 2.437 . . . . 0.0 117.58 -171.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 5.0 t -142.49 -17.45 0.71 Allowed 'General case' 0 C--O 1.231 0.11 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 -177.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -94.82 113.36 61.02 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 176.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -77.59 -16.72 14.77 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.381 2.721 . . . . 0.0 111.986 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -73.33 -13.68 61.15 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -175.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 88.8 mt -90.89 -2.24 57.76 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 117.667 0.212 . . . . 0.0 111.561 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 46.2 t -77.19 146.59 36.95 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 117.768 0.258 . . . . 0.0 110.637 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 71.87 1.55 47.76 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.668 -0.518 . . . . 0.0 113.272 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 53.8 mm-40 -70.38 159.67 33.74 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.064 0.932 . . . . 0.0 111.023 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.186 0 CA-C-O 117.382 -1.788 . . . . 0.0 111.151 -179.701 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.922 0 C5'-C4'-C3' 110.939 -3.041 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.404 ' C6 ' HD22 ' A' ' 193' ' ' LEU . . . . . . . . 0 O4'--C4' 1.421 -2.642 0 C3'-C2'-C1' 98.523 -3.308 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.427 ' C6 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.42 -2.73 1 C5'-C4'-C3' 109.486 -4.01 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.167 0 C5'-C4'-C3' 110.258 -3.494 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.417 ' H61' ' C ' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.416 -3.109 0 C3'-C2'-C1' 104.985 3.872 . 0.043 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.841 1 O4'-C1'-N19 116.147 7.947 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 . . . . . 0 N--CA 1.474 0.767 0 N-CA-C 110.712 -0.107 . . . . 0.0 110.712 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -67.19 144.56 55.92 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.803 0.441 . . . . 0.0 110.043 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 86.3 mt -70.56 142.92 15.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 122.448 0.299 . . . . 0.0 110.684 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 95.0 p -156.08 158.72 38.23 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.321 0.648 . . . . 0.0 109.866 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 22.0 mtm180 -145.2 145.62 27.45 Favored Pre-proline 0 C--O 1.231 0.098 0 C-N-CA 123.122 0.569 . . . . 0.0 110.519 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.17 145.78 55.77 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 123.474 2.783 . . . . 0.0 110.199 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 70.71 10.52 67.53 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 112.024 -0.43 . . . . 0.0 112.024 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -138.49 -53.25 0.6 Allowed 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 71.1 m -71.08 151.02 44.94 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 175.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 13.2 p30 -63.16 -18.06 63.05 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -177.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -71.57 3.58 3.83 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 97.2 p -144.88 2.13 1.03 Allowed 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -176.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -148.77 8.74 0.77 Allowed 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 58.1 m -145.18 9.52 1.26 Allowed 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.412 ' H ' HG22 ' A' ' 188' ' ' VAL . 2.2 m -71.6 104.27 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -130.49 10.43 5.22 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.425 0.69 . . . . 0.0 112.213 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 50.0 m 65.84 20.73 11.44 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -176.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 20.2 t -128.09 140.37 49.35 Favored 'Isoleucine or valine' 0 C--N 1.338 0.081 0 C-N-CA 122.813 0.445 . . . . 0.0 111.192 176.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.7 mt -131.88 157.44 43.95 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.241 0.616 . . . . 0.0 110.958 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.0 tt -113.8 136.04 53.3 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.412 0.685 . . . . 0.0 109.288 174.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -114.34 102.59 10.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -85.96 135.72 33.55 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 174.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.2 mp -106.06 122.41 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -90.27 -20.34 23.07 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -172.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -141.23 78.87 18.37 Favored Pre-proline 0 CA--C 1.529 0.163 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -78.6 44.2 1.59 Allowed 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 124.984 3.789 . . . . 0.0 112.147 -177.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.438 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -69.05 -4.72 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 O-C-N 121.91 -0.494 . . . . 0.0 110.803 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -136.3 157.82 45.9 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 70.9 m -68.87 113.28 6.16 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.84 0.352 . . . . 0.0 110.32 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 40.0 mm -78.42 141.23 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 176.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.1 157.18 46.81 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.0 p -66.38 -15.86 63.62 Favored 'General case' 0 C--N 1.334 -0.088 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 175.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -79.87 -42.19 24.74 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.5 p -75.18 -32.41 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.1 mt -69.83 -33.95 73.0 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -71.23 -29.25 64.9 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 174.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.0 m -68.09 -32.2 72.35 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 45.3 pt -93.56 -22.36 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 118.291 0.496 . . . . 0.0 112.058 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 94.0 m -89.99 -26.07 20.55 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.494 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 35.1 t30 -63.89 -41.44 63.58 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 74.0 Cg_endo -69.09 -15.98 40.01 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.521 1.48 . . . . 0.0 111.27 177.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 97.6 m -86.15 -11.7 51.86 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.457 0.303 . . . . 0.0 111.467 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 151.5 167.69 15.17 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -68.01 103.67 0.92 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.913 3.075 . . . . 0.0 110.248 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.1 t -70.61 146.96 11.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -114.9 -39.0 3.77 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 119.13 -0.462 . . . . 0.0 111.561 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 22.5 mtm180 -149.54 151.45 33.89 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 118.61 0.641 . . . . 0.0 112.263 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 24.2 mt -148.66 137.65 15.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 124.053 0.941 . . . . 0.0 109.929 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 5.4 m -143.55 161.99 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 124.248 1.019 . . . . 0.0 110.559 174.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 46.4 mt -134.74 143.01 38.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 C-N-CA 122.929 0.491 . . . . 0.0 110.472 -175.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.3 4.4 p90 -142.3 158.44 43.71 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 176.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -128.61 15.14 6.51 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.591 0.756 . . . . 0.0 110.909 -173.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -62.6 -31.34 72.15 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 -169.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -130.41 4.0 4.69 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.609 0.64 . . . . 0.0 112.119 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 165.86 -124.45 1.24 Allowed Glycine 0 CA--C 1.521 0.429 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 -174.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.2 t -141.63 115.38 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.121 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 174.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -143.15 166.09 25.64 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.242 0.544 . . . . 0.0 111.11 -177.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -143.73 165.1 28.59 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.957 0.903 . . . . 0.0 108.836 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 80.7 mmm -133.13 150.82 52.02 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 31.6 t -140.49 145.65 25.51 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.061 0 C-N-CA 122.689 0.395 . . . . 0.0 110.882 -177.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -132.74 135.07 45.51 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 122.622 0.369 . . . . 0.0 110.628 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -107.42 163.84 12.7 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 115.934 1.828 . . . . 0.0 115.934 -176.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -78.32 -15.86 58.3 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 79.1 p -154.91 159.65 40.61 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.304 0.573 . . . . 0.0 111.665 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 54.3 t -67.51 -35.22 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -66.24 -30.88 71.41 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 122.375 -0.203 . . . . 0.0 110.954 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 74.4 m -72.83 -34.04 66.55 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 176.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.16 -31.34 58.5 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 122.43 -0.169 . . . . 0.0 111.2 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -68.51 -42.58 78.34 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 121.825 -0.547 . . . . 0.0 111.459 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -76.52 -26.57 55.38 Favored 'General case' 0 C--N 1.338 0.1 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.816 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -72.07 -41.55 67.23 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.186 0.448 . . . . 0.0 110.173 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -73.69 -20.11 60.63 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.742 0.417 . . . . 0.0 111.184 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -99.01 -9.3 24.13 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 46.4 t -116.32 -32.93 5.13 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 72.8 mt -91.9 -7.89 47.93 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.059 0.391 . . . . 0.0 111.902 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -73.04 133.04 44.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 77.06 -5.84 46.49 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.707 -0.496 . . . . 0.0 111.957 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.32 166.41 22.13 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 117.782 0.791 . . . . 0.0 110.384 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -123.49 140.65 52.79 Favored 'General case' 0 C--N 1.334 -0.099 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 87.1 mt -74.61 -42.39 48.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.359 39.7 m-85 -82.79 -12.16 57.71 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 32.6 t 65.54 36.12 6.78 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.658 0.742 . . . . 0.0 111.239 -174.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 175.6 -24.26 0.06 OUTLIER Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' CYS . . . . . 0.438 ' HB3' HD12 ' A' ' 200' ' ' ILE . 96.9 m -145.81 -177.2 5.46 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.185 1.394 . . . . 0.0 109.801 177.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 88.1 m 57.89 37.93 26.96 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.22 148.96 13.38 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 175.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 81.2 mt -116.09 154.78 29.35 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -173.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 54.1 mttp -138.19 137.06 37.23 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.715 1.606 . . . . 0.0 107.484 169.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 56.0 mt -136.87 143.3 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-O 120.94 0.4 . . . . 0.0 111.384 -172.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -159.23 164.02 35.38 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.739 175.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.266 45.3 m-85 -61.71 135.46 57.62 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 176.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' ALA . . . . . 0.424 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -88.27 156.36 19.24 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.347 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.446 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 64.6 pttt -89.44 -31.51 0.37 Allowed Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 50.1 Cg_endo -79.28 168.39 20.26 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 121.835 1.69 . . . . 0.0 110.136 175.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.281 0.2 OUTLIER -137.78 8.86 2.82 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 117.883 2.549 . . . . 0.0 117.883 -176.015 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.32 126.84 6.69 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 118.778 0.717 . . . . 0.0 111.799 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.425 ' HG ' ' C5 ' ' B' ' 3' ' ' ' A' . 27.4 mt -92.22 156.95 16.96 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 123.858 0.863 . . . . 0.0 110.747 176.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.438 ' C ' ' H61' ' B' ' 5' ' ' ' A' . 57.8 m-80 -116.67 53.31 0.89 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.504 0.722 . . . . 0.0 109.788 172.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.6 t -54.68 145.26 4.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -175.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -135.67 -0.25 2.63 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 117.022 2.23 . . . . 0.0 117.022 -176.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -160.53 159.08 30.26 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.584 0.354 . . . . 0.0 111.372 -173.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -123.12 112.23 17.48 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.834 0.854 . . . . 0.0 109.404 173.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 53.1 p30 -157.87 -166.28 1.94 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -66.9 -16.33 64.25 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -174.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -115.17 -13.36 11.79 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.29 139.29 37.29 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 123.815 0.846 . . . . 0.0 113.041 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 16.3 t-105 -162.95 155.34 18.62 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.25 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . 0.259 5.8 t0 -140.79 119.57 12.54 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.194 0.598 . . . . 0.0 112.102 172.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.252 66.8 m-85 -82.18 7.62 13.16 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 117.536 2.421 . . . . 0.0 117.536 -171.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 6.0 t -140.6 -14.65 0.95 Allowed 'General case' 0 C--O 1.232 0.143 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -177.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -95.27 113.44 61.58 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 175.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -80.95 -14.33 11.09 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.737 2.958 . . . . 0.0 112.744 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -73.19 -14.69 61.4 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -173.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 48.4 mt -75.5 2.22 12.15 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 97.2 p -71.76 -8.29 53.31 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.623 0.369 . . . . 0.0 111.507 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 178.86 -5.17 0.03 OUTLIER Glycine 0 CA--C 1.527 0.842 0 CA-C-O 119.769 -0.462 . . . . 0.0 112.94 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 33.1 tp60 56.51 23.9 8.06 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.045 0.938 . . . . 0.0 111.71 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 CA-C-O 117.257 -1.857 . . . . 0.0 110.832 -179.5 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.086 0 C5'-C4'-C3' 110.256 -3.496 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.424 ' N3 ' ' HA ' ' A' ' 265' ' ' ALA . . . . . . . . 0 O4'--C4' 1.418 -2.925 0 C3'-C2'-C1' 98.531 -3.299 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.425 ' C5 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.422 -2.616 1 C5'-C4'-C3' 109.31 -4.127 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.74 1 C5'-C4'-C3' 109.472 -4.019 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.438 ' H61' ' C ' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.417 -3.01 0 C3'-C2'-C1' 105.017 3.907 OUTLIER-DELTA 0.054 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.62 1 O4'-C1'-N19 112.219 4.019 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 111.199 0.074 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -151.62 145.54 25.17 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 123.153 0.581 . . . . 0.0 109.977 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 31.8 mm -138.5 149.04 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 C-N-CA 124.023 0.929 . . . . 0.0 109.284 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 48.3 t -155.65 157.48 36.76 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.115 0.566 . . . . 0.0 109.975 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 48.3 mtm180 -144.66 149.35 43.17 Favored Pre-proline 0 CA--C 1.529 0.157 0 C-N-CA 123.578 0.751 . . . . 0.0 110.038 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.94 -12.57 32.82 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.48 2.787 . . . . 0.0 111.781 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -74.19 -10.6 81.63 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 112.202 -0.359 . . . . 0.0 112.202 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -79.29 -19.13 51.26 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 62.4 m -71.4 149.54 45.87 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 121.846 -0.534 . . . . 0.0 109.668 178.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -61.9 -15.97 47.02 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -176.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -70.97 -3.0 17.12 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 68.0 m -140.25 3.84 1.98 Allowed 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 5.9 ppt_? -149.3 7.88 0.7 Allowed 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 58.9 m -147.2 12.4 1.07 Allowed 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.404 ' H ' HG22 ' A' ' 188' ' ' VAL . 1.7 m -69.44 102.17 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -177.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 51.8 p-10 -130.39 10.51 5.27 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.234 0.614 . . . . 0.0 112.232 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 71.2 m 65.05 20.57 12.09 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 -177.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.3 t -132.97 133.26 58.92 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 CA-C-N 118.162 0.437 . . . . 0.0 110.875 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.431 HD21 ' HB1' ' A' ' 241' ' ' ALA . 2.3 mm? -121.76 155.01 36.17 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 122.954 0.502 . . . . 0.0 110.995 -176.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 29.1 tp -104.98 131.18 52.82 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 170.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -107.72 101.74 11.02 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 177.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.78 136.21 33.17 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 174.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.4 mp -105.67 130.61 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -92.65 -24.2 18.74 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -175.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -138.82 78.92 29.33 Favored Pre-proline 0 CA--C 1.529 0.147 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -77.01 49.59 2.84 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 124.865 3.71 . . . . 0.0 112.346 -178.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.464 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -69.13 -7.05 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 O-C-N 121.775 -0.578 . . . . 0.0 110.314 178.467 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -140.14 153.67 46.75 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.082 1.353 . . . . 0.0 113.081 175.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.4 t -73.55 128.14 34.68 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 120.811 0.338 . . . . 0.0 110.517 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 19.7 mm -78.71 148.69 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 122.724 0.409 . . . . 0.0 109.947 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.0 156.15 48.71 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 177.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.5 p -65.57 -16.37 63.63 Favored 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -74.73 -47.16 32.85 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.7 0.286 . . . . 0.0 111.703 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.5 m -71.41 -32.43 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.6 mt -69.91 -36.15 75.17 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 176.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -71.21 -30.67 66.66 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 12.6 m -66.31 -32.99 74.73 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 37.5 pt -94.05 -24.3 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 118.178 0.444 . . . . 0.0 112.02 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 90.1 m -88.29 -25.44 22.81 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.49 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 35.3 t30 -64.19 -43.16 72.66 Favored Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 67.4 Cg_endo -68.38 -15.3 41.88 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 121.411 1.407 . . . . 0.0 111.512 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 95.4 m -83.86 -15.14 49.29 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.047 0.385 . . . . 0.0 111.379 177.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 151.02 170.47 18.05 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -61.12 104.82 0.3 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.774 2.983 . . . . 0.0 111.732 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 72.5 t -75.72 145.54 10.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -117.79 -39.75 3.09 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 119.287 -0.387 . . . . 0.0 111.477 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 66.1 mtm-85 -148.05 151.22 35.32 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.484 0.584 . . . . 0.0 112.547 179.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 20.3 mt -148.27 137.58 15.89 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 C-N-CA 124.105 0.962 . . . . 0.0 109.628 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 8.1 m -143.07 162.84 17.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 C-N-CA 123.735 0.814 . . . . 0.0 110.23 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 47.8 mt -135.96 142.88 37.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.093 0 C-N-CA 123.224 0.609 . . . . 0.0 110.409 -174.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.299 6.2 p90 -141.39 155.38 45.91 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 177.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -128.37 14.3 6.62 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.242 0.617 . . . . 0.0 110.788 -174.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -64.98 -30.68 71.68 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -169.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -130.37 5.8 4.82 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.793 0.724 . . . . 0.0 111.812 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 162.38 -126.29 1.54 Allowed Glycine 0 C--N 1.335 0.515 0 N-CA-C 107.966 -2.054 . . . . 0.0 107.966 -174.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 38.5 t -142.78 116.98 4.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 175.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -144.02 166.84 23.84 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.289 0.566 . . . . 0.0 110.631 -176.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.97 166.37 26.99 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.113 175.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 74.6 mmm -133.96 154.2 51.26 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 29.6 t -142.11 142.8 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 C-N-CA 122.781 0.432 . . . . 0.0 110.905 -178.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -129.36 133.16 47.26 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.155 0.582 . . . . 0.0 110.274 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -108.5 160.97 15.48 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 -176.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -79.55 -11.95 59.87 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 37.7 t -154.81 153.48 31.25 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 121.812 -0.555 . . . . 0.0 111.549 -176.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 56.6 t -68.01 -37.36 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -67.09 -27.53 67.43 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 122.039 -0.413 . . . . 0.0 111.025 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 52.2 m -74.32 -32.39 62.82 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 175.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.431 ' HB1' HD21 ' A' ' 192' ' ' LEU . . . -76.52 -31.74 57.84 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 122.567 0.347 . . . . 0.0 111.305 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -69.74 -45.39 68.24 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 117.949 0.34 . . . . 0.0 111.345 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -74.6 -26.57 60.0 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 117.953 0.342 . . . . 0.0 111.24 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -69.32 -42.81 74.86 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.435 ' HE3' ' HB3' ' A' ' 245' ' ' LYS . 0.8 OUTLIER -75.39 -21.24 58.42 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.825 0.45 . . . . 0.0 111.161 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -94.32 -9.0 37.32 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 40.9 t -118.4 -34.21 4.12 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -177.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 70.8 mt -89.1 -8.07 54.55 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 118.161 0.437 . . . . 0.0 111.999 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -71.15 136.3 48.07 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.58 -5.66 21.43 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 119.756 -0.469 . . . . 0.0 112.159 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -77.83 166.5 22.83 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 117.955 0.878 . . . . 0.0 110.003 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -122.59 139.17 54.22 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 86.2 mt -74.48 -41.58 49.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.361 44.8 m-85 -82.86 -9.96 59.07 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 117.045 2.239 . . . . 0.0 117.045 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 30.8 t 65.57 35.25 7.25 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.479 0.712 . . . . 0.0 111.08 -175.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 175.95 -24.6 0.06 OUTLIER Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.053 0.835 . . . . 0.0 111.243 177.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' CYS . . . . . 0.464 ' HB3' HD12 ' A' ' 200' ' ' ILE . 82.0 m -145.83 -177.87 5.81 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.6 1.16 . . . . 0.0 109.354 178.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 97.3 m 58.6 38.96 25.16 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -174.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.32 150.37 8.79 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 174.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 97.1 mt -110.96 157.3 20.06 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -173.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.96 130.13 26.76 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.711 2.005 . . . . 0.0 106.331 170.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 30.7 mt -138.3 139.69 41.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-O 120.908 0.385 . . . . 0.0 111.295 -172.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -161.31 163.75 30.62 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.421 175.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.25 48.7 m-85 -59.89 141.91 54.58 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 177.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' ALA . . . . . 0.418 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -96.21 162.08 13.68 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -176.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.401 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 59.2 mttm -78.14 -50.33 1.79 Allowed Pre-proline 0 CA--C 1.532 0.286 0 CA-C-O 118.318 -0.849 . . . . 0.0 112.282 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 87.6 Cg_endo -75.51 169.01 23.26 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.656 2.237 . . . . 0.0 111.191 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.259 0.2 OUTLIER -134.51 3.13 3.29 Favored 'General case' 0 CA--C 1.527 0.071 0 N-CA-C 117.73 2.493 . . . . 0.0 117.73 -176.328 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -157.85 127.47 5.97 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 118.764 0.711 . . . . 0.0 112.063 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.451 ' HG ' ' C5 ' ' B' ' 3' ' ' ' A' . 21.9 mt -82.81 163.24 21.34 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.975 0.91 . . . . 0.0 111.015 175.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.437 ' C ' ' H61' ' B' ' 5' ' ' ' A' . 58.6 m-80 -121.8 51.98 1.29 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.69 0.796 . . . . 0.0 109.103 171.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.408 ' H ' HG23 ' A' ' 272' ' ' VAL . 2.3 t -51.96 144.49 2.94 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -176.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -128.36 -7.52 5.27 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 117.476 2.399 . . . . 0.0 117.476 -177.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -161.46 171.37 18.28 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 122.728 0.411 . . . . 0.0 110.517 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -124.69 122.99 39.05 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.774 0.83 . . . . 0.0 109.667 174.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 45.1 p30 -160.58 -166.12 1.57 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.99 0.916 . . . . 0.0 108.728 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -68.17 -14.98 63.39 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -174.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -114.01 -13.18 12.52 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.01 139.87 34.23 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 123.68 0.792 . . . . 0.0 112.736 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 17.2 t-105 -160.34 156.14 25.78 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.328 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -135.86 116.04 13.43 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.542 172.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.267 67.2 m-85 -80.4 8.0 8.52 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 116.898 2.184 . . . . 0.0 116.898 -173.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 5.8 t -137.8 -22.19 1.09 Allowed 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -95.29 113.17 61.0 Favored Pre-proline 0 N--CA 1.453 -0.318 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 174.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -80.93 -15.18 10.69 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.585 2.857 . . . . 0.0 112.681 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -74.29 -17.05 60.91 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -173.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 59.6 mt -83.71 -7.85 59.39 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 73.7 m -70.85 -11.45 60.97 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 122.034 -0.416 . . . . 0.0 111.87 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -82.17 -5.71 89.43 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 176.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 55.07 25.13 6.69 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.102 0.961 . . . . 0.0 112.758 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.173 0 CA-C-O 117.174 -1.903 . . . . 0.0 111.695 -179.786 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . 0.404 ' C8 ' H5'' ' B' ' 1' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.774 0 C5'-C4'-C3' 110.345 -3.436 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.418 ' N3 ' ' HA ' ' A' ' 265' ' ' ALA . . . . . . . . 0 O4'--C4' 1.421 -2.69 0 O4'-C1'-N19 112.059 3.859 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.451 ' C5 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.42 -2.779 0 O4'-C1'-N19 111.615 3.415 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.839 0 C5'-C4'-C3' 109.959 -3.694 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.444 ' N3 ' " H2'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.805 0 C3'-C2'-C1' 104.923 3.804 OUTLIER-DELTA 0.01 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.531 1 O4'-C1'-N19 112.309 4.109 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 . . . . . 0 N--CA 1.477 0.878 0 CA-C-O 120.426 0.155 . . . . 0.0 110.667 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -152.54 146.42 25.22 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 122.92 0.488 . . . . 0.0 110.02 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 82.1 mt -71.34 144.8 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 122.753 0.421 . . . . 0.0 110.49 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 97.8 p -157.34 162.2 39.09 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 122.96 0.504 . . . . 0.0 110.267 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 67.2 mtt85 -75.19 151.55 85.89 Favored Pre-proline 0 CA--C 1.53 0.173 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.25 -19.43 33.82 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.75 2.3 . . . . 0.0 110.857 177.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -88.47 -7.17 72.69 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 119.655 -0.525 . . . . 0.0 112.347 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -78.46 -5.61 52.98 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.5 t -71.2 155.45 40.71 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.816 0.446 . . . . 0.0 110.389 177.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -59.55 -22.6 61.93 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.287 -0.258 . . . . 0.0 111.646 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -78.67 2.46 19.42 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 58.7 m -140.96 -0.41 1.49 Allowed 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -176.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -148.18 10.49 0.89 Allowed 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 47.5 m -142.32 7.77 1.77 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 3.6 m -78.83 129.24 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 122.943 0.497 . . . . 0.0 111.824 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 42.3 p30 -130.73 10.31 5.1 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 23.2 t 64.43 23.01 12.87 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -175.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 92.7 t -132.51 143.3 40.19 Favored 'Isoleucine or valine' 0 C--N 1.339 0.124 0 C-N-CA 123.669 0.788 . . . . 0.0 109.207 177.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 75.9 mt -136.38 149.64 48.43 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -173.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 38.8 tp -100.02 135.54 41.28 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 172.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -114.97 102.2 9.74 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.138 1.375 . . . . 0.0 114.485 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.42 134.33 33.6 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 174.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.2 mp -103.5 122.44 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -91.99 -18.12 24.12 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -171.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -143.29 78.72 14.69 Favored Pre-proline 0 CA--C 1.529 0.148 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -78.23 45.83 1.94 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 125.136 3.891 . . . . 0.0 112.102 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.424 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -70.95 -4.55 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 O-C-N 121.952 -0.467 . . . . 0.0 110.909 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -136.27 157.6 46.42 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 177.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 66.9 m -71.34 112.81 7.77 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 120.636 0.255 . . . . 0.0 110.466 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.3 mm -78.46 142.15 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.96 160.58 37.28 Favored 'General case' 0 N--CA 1.458 -0.064 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.2 p -66.6 -14.52 62.5 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 176.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -75.98 -44.29 40.41 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 120.813 0.339 . . . . 0.0 110.675 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.0 m -72.53 -33.52 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.8 mt -70.85 -35.11 72.28 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -69.74 -31.5 69.51 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 174.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.8 m -67.31 -31.81 72.36 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 43.4 pt -94.58 -25.47 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-O 118.982 -0.533 . . . . 0.0 112.027 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 98.0 m -86.59 -28.59 23.18 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 119.283 0.947 . . . . 0.0 113.263 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.496 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 38.8 t30 -68.12 -40.49 21.95 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -178.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 74.4 Cg_endo -69.42 -14.29 36.93 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 CA-C-N 121.045 1.409 . . . . 0.0 111.434 176.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 91.7 m -87.28 -8.97 56.17 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 117.896 0.317 . . . . 0.0 111.46 176.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 150.53 171.1 18.45 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 178.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -66.63 85.45 0.29 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 124.632 3.554 . . . . 0.0 110.928 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 10.7 p -68.39 148.48 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 123.874 0.87 . . . . 0.0 109.609 175.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -121.75 -36.23 3.07 Favored 'General case' 0 C--O 1.228 -0.077 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -174.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 66.2 mtm-85 -146.1 148.73 32.93 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.582 0.628 . . . . 0.0 112.353 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 35.2 mt -147.99 135.07 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 C-N-CA 123.998 0.919 . . . . 0.0 109.504 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 2.3 m -141.3 160.81 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.105 0 C-N-CA 123.633 0.773 . . . . 0.0 111.614 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 53.1 mt -134.6 144.17 35.69 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.046 0 C-N-CA 123.332 0.653 . . . . 0.0 110.327 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.297 4.6 p90 -143.31 155.99 44.6 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -127.13 13.13 7.21 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.509 0.724 . . . . 0.0 111.087 -173.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -64.31 -31.04 72.09 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -169.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -130.32 7.49 4.98 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 118.889 0.768 . . . . 0.0 112.114 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 161.08 -124.54 1.33 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 108.559 -1.816 . . . . 0.0 108.559 -174.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 59.4 t -144.25 114.63 2.11 Favored 'Isoleucine or valine' 0 C--O 1.23 0.051 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 175.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -142.89 168.05 20.63 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.123 0.487 . . . . 0.0 110.904 -176.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.65 166.99 24.9 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.846 0.858 . . . . 0.0 109.152 175.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 71.3 mmm -134.06 156.08 48.88 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 38.5 t -141.23 147.05 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 122.89 0.476 . . . . 0.0 110.747 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -135.55 134.93 39.93 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.005 0.522 . . . . 0.0 110.326 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -108.16 163.05 13.5 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -77.45 -14.52 59.67 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 84.9 p -154.54 153.43 31.43 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.462 0.649 . . . . 0.0 111.581 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 51.9 t -65.23 -32.11 56.82 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.347 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -65.54 -33.95 77.12 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.014 0.37 . . . . 0.0 110.454 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 69.1 m -72.13 -33.5 67.84 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 177.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -72.63 -31.8 65.41 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 122.376 -0.202 . . . . 0.0 111.206 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -68.93 -43.77 74.45 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.931 -0.481 . . . . 0.0 111.523 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -77.78 -25.77 49.29 Favored 'General case' 0 N--CA 1.458 -0.036 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.497 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -72.5 -40.73 66.62 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 118.084 0.402 . . . . 0.0 110.035 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -72.6 -25.34 61.28 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 122.416 0.286 . . . . 0.0 110.864 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -91.86 -10.31 40.18 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 47.1 t -114.08 -34.12 5.48 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 80.3 mt -90.12 -9.36 48.63 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -70.74 134.63 47.62 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 74.73 -3.22 44.59 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 119.72 -0.489 . . . . 0.0 112.151 -178.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.52 166.48 21.14 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 117.869 0.834 . . . . 0.0 110.069 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -123.6 140.08 53.36 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 81.9 mt -74.99 -41.17 45.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.365 40.7 m-85 -82.85 -12.01 57.77 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 117.4 2.371 . . . . 0.0 117.4 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 32.1 t 65.39 34.89 7.82 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.495 0.718 . . . . 0.0 110.926 -173.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 177.15 -24.44 0.05 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' CYS . . . . . 0.424 ' HB3' HD12 ' A' ' 200' ' ' ILE . 86.0 m -146.89 -176.13 5.08 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.661 1.184 . . . . 0.0 109.5 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 89.1 m 58.2 37.24 26.2 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -176.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.27 149.08 13.36 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 176.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 81.2 mt -116.25 153.81 31.24 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -173.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -137.24 137.36 38.98 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 169.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 46.4 mt -139.6 141.64 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-O 120.734 0.302 . . . . 0.0 111.615 -170.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -161.36 163.92 30.36 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.043 176.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.277 49.8 m-85 -59.28 139.45 56.97 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 177.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' ALA . . . . . 0.44 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -95.85 164.31 12.79 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -175.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.408 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 61.0 mttm -78.46 -50.05 1.69 Allowed Pre-proline 0 CA--C 1.535 0.395 0 CA-C-O 118.624 -0.703 . . . . 0.0 112.486 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 90.1 Cg_endo -74.7 174.21 13.05 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.619 2.213 . . . . 0.0 110.686 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 2.1 t -138.56 -2.48 1.77 Allowed 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 116.493 2.034 . . . . 0.0 116.493 -174.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.92 130.55 9.03 Favored 'General case' 0 C--N 1.34 0.176 0 O-C-N 121.546 -0.721 . . . . 0.0 111.624 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.478 ' HG ' ' C5 ' ' B' ' 3' ' ' ' A' . 17.0 mt -86.46 157.63 19.76 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 123.667 0.787 . . . . 0.0 111.127 177.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -119.74 47.36 1.74 Allowed 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.633 0.773 . . . . 0.0 109.59 173.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 272' ' ' VAL . 2.2 t -50.38 143.03 2.52 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 -176.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -132.5 1.22 3.72 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 116.15 1.907 . . . . 0.0 116.15 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -156.4 153.32 28.72 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.163 0.585 . . . . 0.0 110.355 -171.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -122.18 118.65 29.13 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.364 0.666 . . . . 0.0 109.675 172.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 54.9 p30 -157.58 -167.28 2.23 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -69.21 -13.38 62.37 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -175.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -109.51 -22.6 11.92 Favored 'General case' 0 C--N 1.338 0.102 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.65 142.08 35.01 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 177.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 20.2 t-105 -159.3 155.55 27.09 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.155 0.502 . . . . 0.0 110.01 -175.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -129.93 117.22 19.78 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.496 171.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.277 66.5 m-85 -80.0 8.44 7.04 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 117.269 2.322 . . . . 0.0 117.269 -172.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 8.7 t -139.93 -22.51 0.86 Allowed 'General case' 0 C--O 1.231 0.105 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -95.35 113.22 61.17 Favored Pre-proline 0 CA--C 1.531 0.234 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 174.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -81.68 -14.35 10.22 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.571 2.847 . . . . 0.0 112.136 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -74.32 -12.14 60.46 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -173.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 55.1 mt -88.09 -10.08 51.25 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.275 0.489 . . . . 0.0 111.835 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 75.0 m -69.47 129.34 39.46 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 67.24 0.65 10.92 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.677 -0.513 . . . . 0.0 112.219 -176.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 55.2 19.77 3.07 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.46 1.104 . . . . 0.0 112.184 -177.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.183 0 CA-C-O 117.366 -1.796 . . . . 0.0 110.969 -179.462 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.784 0 C3'-C2'-C1' 104.583 3.425 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.44 ' N3 ' ' HA ' ' A' ' 265' ' ' ALA . . . . . . . . 0 O4'--C4' 1.419 -2.819 1 C3'-C2'-C1' 97.883 -4.019 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.478 ' C5 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.417 -3.003 0 O4'-C1'-N19 111.663 3.463 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.742 0 C5'-C4'-C3' 109.758 -3.828 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.419 ' N3 ' " H2'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.884 0 C3'-C2'-C1' 104.809 3.677 OUTLIER-DELTA 0.01 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.606 0 O4'-C1'-N19 111.726 3.526 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 . . . . . 0 N--CA 1.477 0.921 0 CA-C-O 120.405 0.145 . . . . 0.0 110.748 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -154.09 156.41 37.22 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.259 0.624 . . . . 0.0 109.823 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 84.0 mt -63.38 146.53 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 122.947 0.499 . . . . 0.0 110.032 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 43.9 t -67.59 164.44 19.08 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.573 0.749 . . . . 0.0 112.307 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.638 ' H ' ' CD ' ' A' ' 179' ' ' PRO . 83.3 mmt-85 -136.18 -39.06 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.225 0 CA-C-O 118.173 -0.917 . . . . 0.0 113.223 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.638 ' CD ' ' H ' ' A' ' 178' ' ' ARG . 44.0 Cg_exo -60.01 143.61 99.55 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.596 2.197 . . . . 0.0 111.412 175.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -83.29 -8.91 84.58 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 119.676 -0.513 . . . . 0.0 112.986 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -100.76 -3.18 30.56 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 117.844 0.822 . . . . 0.0 110.009 -178.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 74.1 m -83.84 142.21 30.78 Favored 'General case' 0 C--O 1.231 0.088 0 O-C-N 121.693 -0.629 . . . . 0.0 110.061 176.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -58.64 -25.27 62.55 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -73.64 10.52 1.07 Allowed 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 114.698 1.369 . . . . 0.0 114.698 177.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 32.8 t -143.9 -0.73 1.02 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -148.13 1.95 0.66 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 58.1 m -136.52 8.69 3.12 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 123.257 0.623 . . . . 0.0 111.932 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 33.0 m -66.29 132.0 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 C-N-CA 122.759 0.424 . . . . 0.0 109.892 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -130.75 5.25 4.62 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -177.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 70.9 m 56.14 13.85 1.32 Allowed 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -175.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 96.3 t -142.37 136.63 28.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 C-N-CA 123.976 0.911 . . . . 0.0 108.655 -178.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.451 ' N ' HD22 ' A' ' 192' ' ' LEU . 1.8 mm? -125.04 151.91 44.98 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 122.68 0.392 . . . . 0.0 111.309 -176.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 39.2 tp -95.54 136.29 36.12 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 169.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -113.95 102.77 10.51 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.899 1.279 . . . . 0.0 114.292 177.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.74 133.12 33.91 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 174.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.2 mp -104.06 121.31 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -89.03 -18.62 26.98 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -172.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -144.22 79.03 13.21 Favored Pre-proline 0 CA--C 1.529 0.142 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.74 46.03 1.93 Allowed 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.838 3.692 . . . . 0.0 112.247 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.419 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -70.88 -4.09 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 O-C-N 121.953 -0.467 . . . . 0.0 110.764 179.625 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -136.74 157.59 46.4 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 176.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 70.5 m -70.77 111.9 6.57 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.273 0.229 . . . . 0.0 110.552 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 32.2 mm -78.83 141.15 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 176.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.03 158.31 43.88 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 177.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.67 -19.79 66.04 Favored 'General case' 0 C--O 1.23 0.057 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -77.63 -34.52 53.26 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 96.4 t -75.46 -41.22 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.27 -31.52 70.1 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -70.85 -29.53 65.67 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 174.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.4 m -68.42 -32.79 73.09 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 45.0 pt -92.88 -22.51 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 118.379 0.536 . . . . 0.0 112.073 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 92.5 m -90.61 -26.53 19.6 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.49 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 32.0 t30 -63.06 -42.83 79.35 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 74.3 Cg_endo -69.25 -11.8 32.35 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.378 1.386 . . . . 0.0 111.604 177.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 92.5 m -91.78 -5.82 52.87 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 145.44 168.66 13.18 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 177.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.21 104.63 0.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.851 3.034 . . . . 0.0 111.581 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 55.4 t -75.7 143.61 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 -115.36 -40.08 3.49 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 119.415 -0.326 . . . . 0.0 111.045 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 65.2 mtm-85 -147.99 151.31 35.55 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 19.0 mt -146.72 135.9 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 124.144 0.978 . . . . 0.0 109.448 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 1.4 m -139.87 159.31 26.94 Favored 'Isoleucine or valine' 0 C--O 1.23 0.049 0 C-N-CA 123.301 0.64 . . . . 0.0 111.88 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 56.0 mt -135.23 142.78 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 C-N-CA 123.159 0.583 . . . . 0.0 109.628 -176.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.29 3.7 p90 -143.13 158.21 43.82 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 176.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -128.43 16.68 6.53 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.267 0.627 . . . . 0.0 110.393 -172.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -64.72 -30.7 71.72 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -169.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -130.43 5.8 4.8 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 118.563 0.62 . . . . 0.0 112.133 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 161.2 -122.41 1.11 Allowed Glycine 0 CA--C 1.522 0.472 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 -173.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 57.2 t -143.26 116.41 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 175.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -143.73 167.13 23.01 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.158 0.504 . . . . 0.0 110.557 -176.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.41 167.48 24.28 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 53.4 mmm -137.88 153.78 49.52 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 44.5 t -139.99 140.77 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 C-N-CA 122.791 0.436 . . . . 0.0 110.318 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -124.52 130.03 51.7 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.047 0.539 . . . . 0.0 110.421 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -105.84 163.34 12.8 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 -175.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -76.35 -15.59 59.93 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.5 0.32 . . . . 0.0 110.499 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 84.8 p -155.84 160.5 40.26 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.273 0.559 . . . . 0.0 111.694 -177.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 25.6 t -65.1 -35.25 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -66.61 -34.97 79.07 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 122.309 -0.244 . . . . 0.0 111.037 -176.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 60.7 m -71.58 -30.24 65.61 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 121.242 -0.183 . . . . 0.0 110.534 176.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.48 -29.85 59.71 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 119.806 -0.14 . . . . 0.0 111.175 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -69.75 -48.38 59.6 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 118.127 0.421 . . . . 0.0 111.805 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -72.82 -27.46 61.97 Favored 'General case' 0 C--N 1.337 0.053 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.087 -177.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -69.76 -40.8 75.89 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -76.15 -19.63 58.31 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 122.915 0.486 . . . . 0.0 110.988 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -102.16 -0.3 33.47 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 42.9 t -127.07 -30.42 2.69 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 118.68 0.673 . . . . 0.0 112.512 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 70.0 mt -92.96 -8.2 43.8 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.097 0.408 . . . . 0.0 111.618 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -73.19 134.23 44.3 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.09 -5.04 44.09 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 119.717 -0.49 . . . . 0.0 112.108 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.7 166.34 21.9 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 117.801 0.8 . . . . 0.0 110.017 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -123.02 136.61 54.91 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 178.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 95.9 mt -70.92 -43.25 76.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.358 34.4 m-85 -82.8 -11.38 58.31 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 117.232 2.308 . . . . 0.0 117.232 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.7 t 65.76 36.11 6.42 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.954 0.883 . . . . 0.0 111.285 -174.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 174.42 -23.45 0.06 OUTLIER Glycine 0 CA--C 1.529 0.954 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.077 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' CYS . . . . . 0.419 ' HB3' HD12 ' A' ' 200' ' ' ILE . 93.5 m -146.51 -177.51 5.67 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.744 1.218 . . . . 0.0 109.212 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 89.0 m 58.46 35.72 24.88 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -176.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.86 148.21 10.7 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 175.374 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 84.1 mt -114.95 153.97 29.6 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -173.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -137.58 136.87 37.97 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.057 1.343 . . . . 0.0 107.426 169.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 40.9 mt -137.61 142.67 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 CA-C-O 120.723 0.297 . . . . 0.0 111.423 -171.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -159.67 161.88 35.0 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 122.988 0.515 . . . . 0.0 110.17 175.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.27 38.3 m-85 -59.2 135.77 57.75 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 176.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 265' ' ' ALA . . . . . 0.436 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -88.57 164.83 15.21 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -89.18 -53.0 0.35 Allowed Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 123.617 0.767 . . . . 0.0 112.933 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -71.59 159.45 51.12 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.717 2.278 . . . . 0.0 110.503 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 1.4 t -127.15 0.25 6.46 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 -173.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -154.69 131.26 10.6 Favored 'General case' 0 C--N 1.339 0.134 0 O-C-N 121.857 -0.527 . . . . 0.0 111.472 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.479 ' HG ' ' C6 ' ' B' ' 3' ' ' ' A' . 29.1 mt -85.61 166.89 15.85 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.193 0.997 . . . . 0.0 111.304 177.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.483 ' C ' ' H61' ' B' ' 5' ' ' ' A' . 0.7 OUTLIER -121.87 44.76 2.49 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.434 170.111 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.415 ' H ' HG23 ' A' ' 272' ' ' VAL . 2.2 t -48.02 140.3 2.21 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -177.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.435 ' CZ ' ' C2 ' ' B' ' 5' ' ' ' A' . 6.5 p90 -129.52 0.93 5.02 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 -178.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -158.19 166.33 32.68 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.93 0.395 . . . . 0.0 110.965 -174.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -125.91 111.69 15.08 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.956 0.902 . . . . 0.0 109.063 171.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 56.9 p30 -154.31 -169.97 3.4 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -69.65 -11.73 61.08 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -176.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -99.53 -37.3 9.23 Favored 'General case' 0 CA--C 1.528 0.096 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.81 147.01 38.37 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 178.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 18.9 t-105 -157.32 155.84 31.35 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -175.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -128.37 117.97 22.35 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.85 0.46 . . . . 0.0 109.9 173.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.295 67.8 m-85 -80.6 8.61 7.52 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 117.032 2.234 . . . . 0.0 117.032 -173.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 5.3 t -137.62 -24.09 1.06 Allowed 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -95.39 113.12 60.98 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 174.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -82.62 -13.08 9.77 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 123.708 2.939 . . . . 0.0 112.637 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -73.71 -16.45 61.19 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -172.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 45.2 mt -79.65 -8.12 59.01 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.186 0.448 . . . . 0.0 111.986 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 73.5 m -78.73 0.03 28.39 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.668 0.387 . . . . 0.0 111.582 176.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -76.52 -6.67 84.7 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 119.672 -0.516 . . . . 0.0 112.883 -178.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -70.4 158.88 35.2 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 117.978 0.889 . . . . 0.0 110.88 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 CA-C-O 117.512 -1.715 . . . . 0.0 110.876 -179.484 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.738 0 C5'-C4'-C3' 109.998 -3.668 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.436 ' N3 ' ' HA ' ' A' ' 265' ' ' ALA . . . . . . . . 0 O4'--C4' 1.422 -2.57 2 C3'-C2'-C1' 97.649 -4.279 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.479 ' C6 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.425 -2.347 2 C5'-C4'-C3' 107.285 -5.477 . 0.01 4s . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 4' ' ' ' C' . . . . . 0.404 ' C2 ' ' OD1' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.42 -2.771 1 C5'-C4'-C3' 108.337 -4.775 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.483 ' H61' ' C ' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.415 -3.165 1 C3'-C2'-C1' 105.152 4.058 OUTLIER-DELTA 0.154 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.597 0 O4'-C1'-N19 111.947 3.747 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 . . . . . 0 N--CA 1.476 0.866 0 N-CA-C 111.345 0.128 . . . . 0.0 111.345 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -151.46 146.68 26.1 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.085 0.554 . . . . 0.0 110.372 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 30.4 mm -138.77 147.98 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 124.529 1.132 . . . . 0.0 108.716 178.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 73.2 m -145.55 158.0 43.91 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.167 0.587 . . . . 0.0 110.553 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 82.2 mtt85 -144.19 151.46 51.82 Favored Pre-proline 0 CA--C 1.528 0.117 0 C-N-CA 123.942 0.897 . . . . 0.0 109.758 -178.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -68.79 -17.39 42.14 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.331 2.687 . . . . 0.0 111.622 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.56 -6.25 84.13 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 119.81 -0.439 . . . . 0.0 112.128 178.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -84.62 -6.82 59.39 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 41.0 t -73.01 141.82 47.7 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 121.669 -0.644 . . . . 0.0 110.077 177.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 16.4 p30 -67.77 -15.04 63.44 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -74.04 2.35 8.99 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 97.2 p -149.31 8.44 0.71 Allowed 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -178.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -144.15 -1.78 0.93 Allowed 'General case' 0 C--N 1.341 0.219 0 CA-C-N 118.388 0.54 . . . . 0.0 112.447 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 70.0 m -138.88 9.36 2.58 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 123.099 0.56 . . . . 0.0 111.947 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 10.6 m -70.57 104.79 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 -176.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -130.68 10.47 5.14 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.51 0.724 . . . . 0.0 112.019 177.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 55.1 m 65.05 21.73 12.29 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.262 1.025 . . . . 0.0 113.668 -177.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 39.1 t -128.62 142.59 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 123.147 0.579 . . . . 0.0 110.867 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.0 mt -132.66 150.06 52.21 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.793 0.437 . . . . 0.0 110.37 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.0 tt -106.93 139.51 41.22 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -113.99 139.61 49.1 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -129.44 143.16 50.72 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 176.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.3 mp -119.86 117.73 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 20.5 mt -81.07 -24.35 37.85 Favored 'General case' 0 C--N 1.338 0.096 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -173.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -138.0 79.01 33.79 Favored Pre-proline 0 N--CA 1.455 -0.193 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -176.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -76.93 48.56 2.52 Favored 'Trans proline' 0 N--CA 1.455 -0.769 1 C-N-CA 125.357 4.038 . . . . 0.0 112.017 -177.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.57 -5.39 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 O-C-N 121.963 -0.46 . . . . 0.0 110.513 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -137.92 156.46 47.86 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 175.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 66.8 m -68.9 116.01 8.89 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 110.525 -0.176 . . . . 0.0 110.525 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.2 mm -78.79 142.72 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.16 162.49 31.99 Favored 'General case' 0 C--O 1.231 0.097 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 21.2 p -66.87 -20.38 65.91 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -72.7 -47.64 45.51 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.17 -33.03 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 97.0 mt -72.2 -34.67 68.57 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -70.79 -31.77 68.64 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 174.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 12.5 m -66.59 -33.94 76.78 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 36.7 pt -92.37 -23.59 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 118.497 0.59 . . . . 0.0 111.996 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 98.8 m -89.34 -25.99 21.32 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.489 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 33.7 t30 -63.51 -42.24 71.99 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 73.5 Cg_endo -70.53 -15.43 34.22 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.489 1.46 . . . . 0.0 111.488 177.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 94.0 m -83.12 -15.27 51.38 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 122.236 -0.29 . . . . 0.0 111.357 176.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 151.94 170.79 19.01 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.17 108.01 0.53 Allowed 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.505 2.803 . . . . 0.0 111.423 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 81.9 t -77.5 145.76 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 -117.21 -34.33 4.38 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 119.163 -0.446 . . . . 0.0 111.179 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 83.2 mtt85 -151.52 156.1 39.87 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 118.437 0.562 . . . . 0.0 112.0 177.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 25.8 mt -144.7 142.51 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.298 1.039 . . . . 0.0 109.199 174.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 96.6 t -143.36 155.19 16.64 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.102 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 53.9 mt -138.14 141.09 39.1 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 C-N-CA 123.494 0.717 . . . . 0.0 109.455 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.295 5.3 p90 -144.47 155.87 43.92 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 176.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -126.31 15.49 7.76 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.3 0.64 . . . . 0.0 110.58 -173.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -66.18 -31.96 73.12 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -169.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -130.36 8.67 5.08 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 118.455 0.57 . . . . 0.0 112.113 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 160.37 -125.57 1.49 Allowed Glycine 0 C--N 1.336 0.533 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 -174.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 45.8 t -142.74 113.23 2.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -142.35 170.42 15.74 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.467 0.651 . . . . 0.0 111.426 -174.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -149.2 169.01 21.71 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.669 176.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 86.6 mmm -135.55 152.16 51.02 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 42.8 t -141.02 147.56 22.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 122.665 0.386 . . . . 0.0 110.208 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -134.62 135.37 42.1 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.616 0.366 . . . . 0.0 110.215 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -111.78 161.78 15.95 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 -175.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -81.29 -11.9 59.22 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.963 0.505 . . . . 0.0 109.742 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 41.1 t -154.67 153.72 31.78 Favored 'General case' 0 C--O 1.232 0.144 0 O-C-N 121.909 -0.494 . . . . 0.0 111.888 -175.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 55.3 t -67.8 -40.26 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -66.57 -26.22 67.01 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 117.811 0.278 . . . . 0.0 110.948 -178.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 67.6 m -73.78 -33.44 64.25 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 176.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -77.41 -30.86 53.74 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 122.485 -0.135 . . . . 0.0 111.23 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -67.56 -42.47 82.57 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 121.913 -0.492 . . . . 0.0 111.621 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -77.88 -26.61 49.32 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.922 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -70.16 -43.27 71.19 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.207 0.458 . . . . 0.0 109.787 176.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.442 ' HE3' ' HB3' ' A' ' 245' ' ' LYS . 1.2 tmmt? -72.8 -21.94 60.9 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.99 0.516 . . . . 0.0 111.294 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -95.55 -11.35 27.51 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 44.7 t -115.23 -33.39 5.35 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 112.783 0.661 . . . . 0.0 112.783 -177.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 81.4 mt -91.79 -10.68 39.01 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -71.15 135.66 47.73 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 121.999 -0.438 . . . . 0.0 109.888 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.49 -3.77 31.11 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 119.63 -0.539 . . . . 0.0 112.847 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -81.03 166.45 20.77 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 118.011 0.906 . . . . 0.0 110.507 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -108.45 140.0 42.39 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 74.2 mt -74.2 -42.59 51.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 174.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.351 51.4 m-85 -82.75 -12.72 57.32 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 117.26 2.318 . . . . 0.0 117.26 178.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 27.6 t 66.06 38.72 4.68 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.676 0.791 . . . . 0.0 110.748 -172.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 174.31 -21.34 0.06 OUTLIER Glycine 0 CA--C 1.529 0.93 0 C-N-CA 123.53 0.586 . . . . 0.0 111.903 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 78.2 m -147.46 -174.08 4.43 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.547 1.139 . . . . 0.0 109.096 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 93.4 m 57.44 43.16 23.48 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.71 0.634 . . . . 0.0 112.71 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -50.47 133.3 24.95 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 177.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 96.0 mt -95.64 152.01 18.83 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.465 0.65 . . . . 0.0 112.167 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -141.03 132.66 27.15 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.345 1.458 . . . . 0.0 107.071 169.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 47.8 mt -140.64 141.15 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 CA-C-O 120.641 0.258 . . . . 0.0 111.316 -172.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -161.75 165.44 28.01 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.271 0.628 . . . . 0.0 109.417 174.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -59.85 138.91 57.68 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 115.586 1.698 . . . . 0.0 115.586 177.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -93.91 160.03 14.92 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -176.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.402 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 58.7 mttm -76.89 -49.7 2.49 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 118.429 -0.796 . . . . 0.0 112.878 -179.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 65.9 Cg_endo -76.32 169.13 22.57 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.718 2.279 . . . . 0.0 111.104 -178.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.282 0.2 OUTLIER -136.46 12.79 3.24 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 117.37 2.359 . . . . 0.0 117.37 -176.904 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.447 ' N ' ' H62' ' B' ' 3' ' ' ' A' . 10.6 tpt180 -159.96 126.03 4.23 Favored 'General case' 0 C--N 1.338 0.096 0 O-C-N 121.677 -0.639 . . . . 0.0 111.805 178.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.422 ' HG ' ' C5 ' ' B' ' 3' ' ' ' A' . 28.5 mt -86.13 159.54 19.5 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 123.463 0.705 . . . . 0.0 110.944 174.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -125.23 47.7 2.13 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.826 0.85 . . . . 0.0 109.817 174.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.403 HG23 ' H ' ' A' ' 272' ' ' VAL . 2.3 t -52.19 142.15 5.14 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -176.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . 0.253 6.1 p90 -120.81 -7.7 9.52 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 117.282 2.327 . . . . 0.0 117.282 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -162.52 168.04 22.5 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 122.689 0.396 . . . . 0.0 111.029 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -119.99 127.01 52.23 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.566 0.746 . . . . 0.0 110.03 176.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 41.0 p30 -161.03 -167.39 1.8 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.245 1.018 . . . . 0.0 109.542 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -70.4 -10.9 60.36 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -176.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -105.6 -29.57 10.05 Favored 'General case' 0 C--N 1.337 0.064 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -141.04 146.46 37.22 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 178.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 19.3 t-105 -156.53 154.15 29.86 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -176.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -132.76 117.58 17.99 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.201 0.6 . . . . 0.0 111.512 175.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.288 68.3 m-85 -83.26 10.41 8.53 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 117.366 2.358 . . . . 0.0 117.366 -171.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 12.9 t -138.83 -23.77 0.93 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -95.21 113.17 60.93 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 173.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -80.69 -14.2 11.51 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.471 2.781 . . . . 0.0 112.29 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -76.03 -15.43 60.13 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -174.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 68.4 mt -85.16 -6.71 59.28 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 118.111 0.414 . . . . 0.0 111.962 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 75.1 m -75.62 144.38 41.77 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 122.182 -0.324 . . . . 0.0 110.74 177.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 75.85 -1.37 58.93 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 119.946 -0.363 . . . . 0.0 112.732 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 43.0 mm-40 -85.23 10.14 13.22 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 117.742 0.771 . . . . 0.0 111.363 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.244 0 CA-C-O 116.981 -2.01 . . . . 0.0 111.929 -177.495 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.834 0 C3'-C2'-C1' 105.078 3.976 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.083 0 C3'-C2'-C1' 98.449 -3.39 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.447 ' H62' ' N ' ' A' ' 269' ' ' ARG . . . . . . . . 0 O4'--C4' 1.42 -2.789 0 O4'-C1'-N19 111.689 3.489 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.763 0 C5'-C4'-C3' 110.304 -3.464 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.406 ' N3 ' " H2'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.93 0 C3'-C2'-C1' 104.913 3.792 OUTLIER-DELTA 0.01 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.643 0 O4'-C1'-N19 112.014 3.814 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 . . . . . 0 N--CA 1.477 0.882 0 CA-C-O 120.49 0.186 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 63.2 mmtt -68.24 168.07 13.06 Favored 'General case' 0 N--CA 1.457 -0.085 0 CA-C-O 121.179 0.514 . . . . 0.0 112.232 178.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.403 HG23 ' H ' ' A' ' 176' ' ' ILE . 3.1 pt -65.47 -17.8 22.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.46 0.704 . . . . 0.0 110.527 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 70.0 m -83.08 11.44 6.34 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 123.449 0.7 . . . . 0.0 112.554 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.82 148.01 83.73 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 122.87 0.468 . . . . 0.0 111.023 178.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -77.33 -4.13 14.4 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 124.08 3.187 . . . . 0.0 112.641 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -59.41 141.47 47.37 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 172.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 21.6 t0 62.43 21.02 12.31 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 30.2 t -68.58 146.39 53.1 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 121.385 -0.822 . . . . 0.0 109.8 175.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 13.9 p30 -70.64 -9.06 56.14 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -77.6 2.37 16.77 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 96.7 p -148.99 5.71 0.67 Allowed 'General case' 0 C--O 1.232 0.161 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -176.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -145.87 9.31 1.15 Allowed 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 64.2 p -155.12 17.88 0.42 Allowed 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 178.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.1 m -71.64 109.32 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -130.56 10.35 5.18 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.37 0.668 . . . . 0.0 112.267 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.1 m 65.49 21.16 11.79 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -176.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 30.7 t -130.76 134.3 62.09 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.092 0 C-N-CA 122.858 0.463 . . . . 0.0 111.103 177.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.421 HD21 ' HB1' ' A' ' 241' ' ' ALA . 2.7 mm? -122.94 154.2 38.69 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.098 0.559 . . . . 0.0 110.779 -176.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 39.0 tp -104.01 136.26 43.98 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 170.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -113.86 107.92 16.36 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.71 1.204 . . . . 0.0 114.122 177.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.99 141.01 29.02 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 174.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.4 mp -110.56 126.83 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -90.43 -23.67 20.96 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -173.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -140.34 78.98 21.81 Favored Pre-proline 0 CA--C 1.53 0.188 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -76.74 49.89 2.86 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 124.804 3.669 . . . . 0.0 112.113 -178.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.402 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -68.87 -5.86 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 O-C-N 121.749 -0.595 . . . . 0.0 110.251 178.241 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -142.1 154.58 45.02 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.2 1.4 . . . . 0.0 112.538 175.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.3 t -73.38 129.93 39.07 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.291 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 23.0 mm -79.16 148.4 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 123.073 0.549 . . . . 0.0 109.993 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.02 156.38 48.32 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.4 p -64.1 -17.3 63.29 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 177.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -76.52 -46.25 27.32 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.79 0.329 . . . . 0.0 111.812 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.6 m -71.29 -31.6 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.059 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.31 -36.95 74.64 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 176.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -70.83 -30.48 66.91 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 175.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 12.5 m -66.78 -33.4 75.55 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 41.1 pt -93.85 -21.59 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 118.399 0.545 . . . . 0.0 112.13 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 97.4 m -91.54 -25.73 19.1 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.502 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 35.4 t30 -64.65 -39.19 37.78 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 74.3 Cg_endo -69.94 -13.04 33.7 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 CA-C-N 121.023 1.401 . . . . 0.0 111.575 177.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 95.9 m -91.95 -5.41 53.16 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.669 0.388 . . . . 0.0 111.663 177.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 146.74 166.83 12.51 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 178.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.18 103.77 1.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.635 2.89 . . . . 0.0 110.657 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 75.6 t -70.37 146.28 12.29 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -114.34 -37.14 4.44 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 119.212 -0.423 . . . . 0.0 111.765 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -150.21 151.64 33.36 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 20.7 mt -147.87 136.96 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 C-N-CA 124.055 0.942 . . . . 0.0 109.975 177.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 6.1 m -142.61 159.43 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 123.729 0.812 . . . . 0.0 110.313 173.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 41.3 mt -132.68 143.61 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 123.018 0.527 . . . . 0.0 110.375 -175.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.316 3.8 p90 -140.32 154.65 46.86 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 115.718 1.748 . . . . 0.0 115.718 176.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -126.59 16.79 7.56 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.309 0.643 . . . . 0.0 110.06 -174.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -64.43 -31.91 73.31 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -169.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -130.46 8.62 5.03 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 118.346 0.521 . . . . 0.0 112.096 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 157.62 -124.12 1.37 Allowed Glycine 0 C--N 1.334 0.444 0 N-CA-C 108.336 -1.905 . . . . 0.0 108.336 -173.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 24.9 t -142.15 114.65 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-N 116.846 0.323 . . . . 0.0 110.18 176.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 8.4 mp0 -143.45 166.69 24.09 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.119 0.485 . . . . 0.0 110.671 -177.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.41 163.7 35.65 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.725 0.81 . . . . 0.0 109.788 176.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 56.0 mmm -130.76 151.31 51.34 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 41.4 t -140.74 144.26 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.067 0 C-N-CA 122.945 0.498 . . . . 0.0 110.399 -178.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -130.5 133.21 46.09 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.83 0.452 . . . . 0.0 110.64 178.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -104.21 163.21 12.57 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 116.334 1.975 . . . . 0.0 116.334 -177.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -78.92 -14.51 59.18 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 85.2 p -154.71 157.64 38.38 Favored 'General case' 0 N--CA 1.457 -0.081 0 O-C-N 121.744 -0.598 . . . . 0.0 111.262 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 53.4 t -67.76 -32.33 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -66.84 -34.83 78.68 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 121.878 -0.514 . . . . 0.0 110.733 -177.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 69.1 m -72.56 -31.05 64.95 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 176.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.421 ' HB1' HD21 ' A' ' 192' ' ' LEU . . . -74.08 -31.51 62.85 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 122.577 0.351 . . . . 0.0 111.441 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -71.79 -46.99 56.47 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 117.944 0.338 . . . . 0.0 111.788 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -73.19 -26.3 61.11 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 118.04 0.382 . . . . 0.0 111.345 -177.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -71.11 -41.4 70.64 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.92 -23.63 55.5 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.482 0.313 . . . . 0.0 110.998 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -91.32 -10.01 42.89 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 40.0 t -118.7 -35.08 3.79 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -177.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 66.0 mt -87.94 -7.27 57.36 Favored 'General case' 0 N--CA 1.457 -0.076 0 CA-C-N 118.118 0.417 . . . . 0.0 111.862 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -70.01 136.36 50.33 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 74.65 -4.98 32.68 Favored Glycine 0 CA--C 1.533 1.201 0 CA-C-O 119.769 -0.462 . . . . 0.0 112.431 -178.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -76.72 166.32 23.52 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 117.848 0.824 . . . . 0.0 110.302 177.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -123.6 140.47 52.97 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 67.4 mt -75.04 -42.5 45.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-O 120.92 0.391 . . . . 0.0 110.012 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.365 53.5 m-85 -82.66 -11.4 58.39 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 117.084 2.253 . . . . 0.0 117.084 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 30.7 t 65.99 35.1 6.61 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.664 0.786 . . . . 0.0 111.313 -175.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 176.52 -23.58 0.05 OUTLIER Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 178.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' CYS . . . . . 0.402 ' HB3' HD12 ' A' ' 200' ' ' ILE . 81.6 m -145.93 -176.63 5.22 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.61 1.164 . . . . 0.0 108.876 178.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 87.5 m 57.84 38.71 27.24 Favored 'General case' 0 CA--C 1.527 0.087 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -176.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.96 141.56 21.8 Favored 'General case' 0 C--O 1.23 0.067 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 174.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 95.9 mt -102.09 158.24 16.3 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.49 0.662 . . . . 0.0 112.27 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -139.29 137.18 35.63 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 169.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 19.6 mt -138.23 139.51 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-O 121.089 0.471 . . . . 0.0 111.62 -173.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -159.48 161.9 35.48 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.242 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.262 41.0 m-85 -60.97 135.92 57.93 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 177.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 265' ' ' ALA . . . . . 0.426 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -92.6 155.89 17.46 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.525 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.433 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 22.9 pttp -88.49 -29.93 0.37 Allowed Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 117.216 -1.373 . . . . 0.0 114.611 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 48.9 Cg_endo -79.87 165.12 22.37 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 CA-C-N 122.063 1.773 . . . . 0.0 110.093 176.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.279 0.2 OUTLIER -138.03 8.86 2.76 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 118.19 2.663 . . . . 0.0 118.19 -174.628 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.71 127.05 6.52 Favored 'General case' 0 C--N 1.338 0.073 0 O-C-N 121.408 -0.807 . . . . 0.0 111.858 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.421 ' HG ' ' C5 ' ' B' ' 3' ' ' ' A' . 24.6 mt -92.04 156.45 17.39 Favored 'General case' 0 C--N 1.337 0.052 0 C-N-CA 123.772 0.829 . . . . 0.0 111.107 176.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.464 ' C ' ' H61' ' B' ' 5' ' ' ' A' . 57.2 m-80 -117.31 53.42 0.92 Allowed 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.517 0.727 . . . . 0.0 109.594 172.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.41 ' H ' HG23 ' A' ' 272' ' ' VAL . 2.4 t -53.04 145.35 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -176.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -130.12 -7.31 4.36 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 117.637 2.458 . . . . 0.0 117.637 -177.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -161.9 173.72 14.12 Favored 'General case' 0 N--CA 1.458 -0.07 0 C-N-CA 122.739 0.416 . . . . 0.0 110.281 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.496 ' H ' ' NE2' ' A' ' 290' ' ' GLN . 99.4 m-20 -125.69 117.75 24.15 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.025 0.93 . . . . 0.0 110.006 175.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 46.6 p30 -159.54 -166.22 1.73 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.979 0.912 . . . . 0.0 108.922 177.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -70.11 -9.62 56.12 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -174.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -115.98 -17.46 10.93 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.72 140.87 33.25 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.799 0.84 . . . . 0.0 112.966 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 19.4 t-105 -160.78 156.71 25.66 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 119.764 -0.774 . . . . 0.0 110.4 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -138.03 116.55 12.06 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.469 0.708 . . . . 0.0 110.977 174.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.284 66.7 m-85 -81.31 8.94 7.92 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 117.318 2.34 . . . . 0.0 117.318 -172.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 7.1 t -137.99 -20.39 1.12 Allowed 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -95.12 113.28 61.09 Favored Pre-proline 0 CA--C 1.531 0.235 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 174.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -81.08 -13.26 11.47 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.485 2.79 . . . . 0.0 112.318 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -72.65 -19.45 61.44 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -174.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 54.3 mt -82.82 -6.7 59.55 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.927 -0.483 . . . . 0.0 111.569 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 73.9 m -87.71 5.74 38.36 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 122.951 0.501 . . . . 0.0 111.373 176.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -76.27 13.3 7.9 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 123.853 0.739 . . . . 0.0 112.736 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 290' ' ' GLN . . . . . 0.496 ' NE2' ' H ' ' A' ' 275' ' ' ASN . 4.3 pp0? -143.55 163.38 33.34 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.676 0.79 . . . . 0.0 110.537 -177.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.166 0 CA-C-O 117.294 -1.837 . . . . 0.0 110.84 -179.616 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.078 0 C3'-C2'-C1' 104.079 2.866 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.426 ' N3 ' ' HA ' ' A' ' 265' ' ' ALA . . . . . . . . 0 O4'--C4' 1.42 -2.752 0 C3'-C2'-C1' 98.356 -3.493 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.421 ' C5 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.42 -2.758 0 C5'-C4'-C3' 110.444 -3.371 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.873 0 C5'-C4'-C3' 109.893 -3.738 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.464 ' H61' ' C ' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.419 -2.81 1 C3'-C2'-C1' 105.337 4.264 OUTLIER-DELTA 0.013 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.731 0 O4'-C1'-N19 112.053 3.853 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.09 5.12 4.62 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -177.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 18.2 tt -153.94 154.36 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 C-N-CA 123.372 0.669 . . . . 0.0 109.459 178.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 93.4 p -155.85 170.43 22.11 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 122.744 0.418 . . . . 0.0 110.517 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 5.6 ppt_? -149.33 160.79 33.84 Favored Pre-proline 0 CA--C 1.531 0.24 0 C-N-CA 123.286 0.635 . . . . 0.0 109.966 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -58.54 154.21 43.68 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 124.04 3.16 . . . . 0.0 113.351 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -80.53 -4.27 90.11 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -74.66 -13.17 60.6 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.652 0.781 . . . . 0.0 109.855 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 73.3 m -67.25 148.25 51.97 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 121.72 -0.612 . . . . 0.0 109.72 175.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 16.2 p30 -60.68 -16.5 39.99 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 -175.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -72.52 -1.16 14.85 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 176.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 74.5 m -141.42 3.66 1.73 Allowed 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 113.612 0.968 . . . . 0.0 113.612 -177.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? -146.96 6.83 0.9 Allowed 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 56.2 m -147.07 12.38 1.08 Allowed 'General case' 0 CA--C 1.527 0.087 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 178.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 1.6 m -70.21 103.54 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -130.46 10.41 5.23 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.772 0.829 . . . . 0.0 111.822 177.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 55.9 m 64.81 21.34 12.34 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -176.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 28.3 t -130.02 134.07 63.43 Favored 'Isoleucine or valine' 0 C--N 1.339 0.115 0 CA-C-N 118.194 0.452 . . . . 0.0 111.089 177.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.422 ' N ' HD22 ' A' ' 192' ' ' LEU . 2.4 mm? -121.14 153.59 37.3 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.053 0.541 . . . . 0.0 110.831 -177.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 25.0 tp -106.11 132.68 51.89 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 171.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -107.86 133.94 51.5 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.633 1.173 . . . . 0.0 114.141 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.29 133.27 55.5 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 174.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 3.8 mp -104.52 117.06 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -88.35 -18.04 29.29 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.165 -171.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -141.48 79.02 17.72 Favored Pre-proline 0 CA--C 1.529 0.138 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.9 44.25 1.53 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 125.2 3.933 . . . . 0.0 112.542 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.465 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -70.05 -4.76 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 121.693 -0.629 . . . . 0.0 110.523 179.453 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -138.47 158.33 44.47 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 177.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 45.2 t -70.83 117.87 12.9 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.0 mm -78.38 144.41 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.08 159.11 41.82 Favored 'General case' 0 N--CA 1.458 -0.064 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 43.3 p -66.87 -19.72 65.79 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -75.88 -47.24 26.23 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.7 m -70.29 -32.69 51.4 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.0 mt -70.94 -33.99 71.03 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 176.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -73.19 -29.11 62.59 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 174.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 7.2 m -67.99 -33.18 74.13 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 41.4 pt -91.68 -24.07 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 118.225 0.466 . . . . 0.0 111.785 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 94.6 m -89.0 -24.53 22.36 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.478 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.1 t30 -63.57 -42.37 72.43 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 73.7 Cg_endo -69.31 -16.42 39.45 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 CA-C-N 120.873 1.347 . . . . 0.0 111.192 177.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 80.5 m -84.01 -14.62 50.23 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 122.175 -0.328 . . . . 0.0 111.337 177.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 153.2 172.92 21.94 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.8 101.5 0.92 Allowed 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 124.007 3.138 . . . . 0.0 110.45 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 75.8 t -71.21 147.52 11.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -118.74 -35.98 3.57 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 119.178 -0.439 . . . . 0.0 111.721 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 25.8 mtm180 -150.37 151.72 33.28 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.693 0.679 . . . . 0.0 112.767 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 25.1 mt -148.74 137.92 15.59 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 124.132 0.973 . . . . 0.0 110.109 177.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.2 m -143.44 161.31 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 C-N-CA 124.127 0.971 . . . . 0.0 109.983 173.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 52.6 mt -131.36 143.27 41.11 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 C-N-CA 122.793 0.437 . . . . 0.0 110.737 -175.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.262 5.1 p90 -146.72 158.96 44.02 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 175.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -138.53 30.22 2.36 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.115 0.566 . . . . 0.0 111.82 -177.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -66.17 -30.11 70.52 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.323 0.861 . . . . 0.0 113.323 -174.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -130.55 1.24 4.49 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 171.85 -128.51 1.59 Allowed Glycine 0 CA--C 1.522 0.473 0 N-CA-C 108.65 -1.78 . . . . 0.0 108.65 -174.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 17.3 t -138.51 115.11 10.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 117.44 0.62 . . . . 0.0 110.351 174.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 9.4 mp0 -143.64 169.78 17.08 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.552 0.692 . . . . 0.0 111.924 -172.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -152.82 168.52 25.47 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.083 0.953 . . . . 0.0 108.818 175.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 68.9 mmm -134.34 151.5 51.27 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.767 -0.456 . . . . 0.0 109.767 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 40.3 t -141.62 144.5 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 C-N-CA 123.0 0.52 . . . . 0.0 110.433 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -131.92 136.28 47.27 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.616 0.366 . . . . 0.0 110.775 178.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -108.67 162.65 13.96 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 -177.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -83.98 -6.54 59.44 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 29.2 t -153.66 149.54 27.65 Favored 'General case' 0 N--CA 1.456 -0.13 0 O-C-N 121.954 -0.466 . . . . 0.0 111.785 -176.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 55.2 t -68.75 -35.69 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -68.16 -28.29 67.16 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.06 -0.4 . . . . 0.0 110.775 -178.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 61.4 m -74.88 -31.2 61.53 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 176.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.418 ' HB1' HD21 ' A' ' 192' ' ' LEU . . . -75.46 -33.53 60.85 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 122.411 0.284 . . . . 0.0 111.083 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -69.59 -43.94 71.78 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 117.904 0.32 . . . . 0.0 111.538 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -75.27 -25.17 57.77 Favored 'General case' 0 N--CA 1.457 -0.084 0 CA-C-N 117.815 0.28 . . . . 0.0 110.866 -177.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -71.48 -42.49 68.03 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 176.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.428 ' HE3' ' HB3' ' A' ' 245' ' ' LYS . 1.0 OUTLIER -75.4 -20.49 58.89 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.739 0.416 . . . . 0.0 111.262 -179.669 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -94.87 -12.07 27.61 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 45.1 t -113.58 -34.96 5.37 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 68.6 mt -89.95 -6.84 55.26 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 118.176 0.444 . . . . 0.0 111.963 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -71.9 131.96 43.7 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 177.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.59 -4.08 52.35 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.744 -0.476 . . . . 0.0 112.171 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.61 166.45 21.86 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 117.818 0.809 . . . . 0.0 110.303 178.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -123.33 139.9 53.57 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 84.8 mt -74.7 -41.36 47.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 N-CA-C 109.668 -0.494 . . . . 0.0 109.668 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.363 44.1 m-85 -82.8 -12.02 57.81 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 117.316 2.339 . . . . 0.0 117.316 178.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.7 t 66.31 34.66 6.31 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.627 0.727 . . . . 0.0 110.685 -174.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 175.97 -23.65 0.06 OUTLIER Glycine 0 CA--C 1.529 0.96 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' CYS . . . . . 0.465 ' HB3' HD12 ' A' ' 200' ' ' ILE . 77.2 m -146.63 -177.15 5.49 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.711 1.204 . . . . 0.0 109.536 178.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 91.4 m 57.85 37.55 26.99 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -176.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.88 148.2 13.71 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 175.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 74.2 mt -115.98 156.04 26.96 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -172.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -138.57 140.15 38.92 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.398 1.479 . . . . 0.0 107.482 169.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 37.4 mt -141.79 141.49 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 CA-C-O 120.976 0.417 . . . . 0.0 111.72 -172.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 6.9 pm0 -156.59 164.21 38.45 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 174.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.273 41.2 m-85 -61.46 137.67 58.25 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 177.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 265' ' ' ALA . . . . . 0.447 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -91.51 156.79 17.43 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.663 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.445 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 63.9 pttt -88.56 -31.57 0.39 Allowed Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 48.7 Cg_endo -79.65 167.73 20.38 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.006 1.804 . . . . 0.0 110.172 176.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.278 0.2 OUTLIER -137.25 8.45 2.92 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -175.829 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.66 128.46 7.24 Favored 'General case' 0 C--O 1.227 -0.12 0 O-C-N 121.416 -0.803 . . . . 0.0 111.942 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.408 ' HG ' ' C5 ' ' B' ' 3' ' ' ' A' . 20.1 mt -92.33 157.28 16.72 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 123.893 0.877 . . . . 0.0 110.722 176.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.464 ' C ' ' H61' ' B' ' 5' ' ' ' A' . 55.6 m-80 -117.34 54.52 0.88 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.704 0.802 . . . . 0.0 109.473 173.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.4 t -55.76 147.38 4.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -176.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -132.61 -2.94 3.35 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 116.934 2.198 . . . . 0.0 116.934 -176.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -161.89 160.85 28.48 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.316 0.246 . . . . 0.0 110.812 -174.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -123.18 111.02 16.0 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.606 0.762 . . . . 0.0 109.564 173.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 56.6 p30 -157.81 -169.98 3.03 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.334 1.054 . . . . 0.0 108.372 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -68.59 -10.8 58.16 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -174.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -111.58 -22.27 11.32 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.1 p -142.58 138.92 31.13 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.686 1.195 . . . . 0.0 112.295 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 21.0 t-105 -158.44 155.55 28.78 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 119.724 -0.791 . . . . 0.0 110.932 -177.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -135.39 116.49 14.34 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.725 0.81 . . . . 0.0 111.108 173.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.292 66.1 m-85 -79.99 9.17 5.74 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 117.524 2.416 . . . . 0.0 117.524 -172.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 8.9 t -139.72 -20.68 0.91 Allowed 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -95.36 113.14 61.0 Favored Pre-proline 0 CA--C 1.532 0.264 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 174.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -82.04 -14.46 9.73 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.504 2.803 . . . . 0.0 112.462 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -72.26 -18.52 61.81 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -174.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 63.8 mt -84.38 -6.65 59.41 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.229 0.468 . . . . 0.0 111.904 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 73.0 m -76.84 -13.06 60.04 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 111.971 0.359 . . . . 0.0 111.971 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -84.41 -10.4 79.95 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -88.07 161.5 17.3 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.095 0.558 . . . . 0.0 110.959 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.133 0 CA-C-O 117.429 -1.762 . . . . 0.0 111.104 179.794 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . 0.406 ' C8 ' H5'' ' B' ' 1' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -3.022 0 C5'-C4'-C3' 110.508 -3.328 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.447 ' N3 ' ' HA ' ' A' ' 265' ' ' ALA . . . . . . . . 0 O4'--C4' 1.422 -2.613 0 C3'-C2'-C1' 98.367 -3.482 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.408 ' C5 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.421 -2.665 2 C5'-C4'-C3' 108.823 -4.452 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.735 0 C5'-C4'-C3' 109.523 -3.985 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.464 ' H61' ' C ' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.416 -3.065 1 C3'-C2'-C1' 105.299 4.221 OUTLIER-DELTA 0.044 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.62 0 O4'-C1'-N19 111.68 3.48 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 110.704 -0.11 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? 61.48 154.48 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.113 1.365 . . . . 0.0 112.517 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 84.6 mt -70.68 147.34 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 122.948 0.499 . . . . 0.0 110.239 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 97.6 p -153.5 162.75 40.96 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 122.951 0.5 . . . . 0.0 110.143 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.407 ' N ' ' CD ' ' A' ' 179' ' ' PRO . 78.4 mtt85 -72.53 -38.35 5.11 Favored Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -177.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 178' ' ' ARG . 50.4 Cg_exo -57.78 145.55 89.8 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.624 2.216 . . . . 0.0 112.333 177.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 73.9 -3.0 38.98 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.405 -0.664 . . . . 0.0 113.491 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -81.55 -11.81 59.02 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.295 1.048 . . . . 0.0 109.566 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 71.0 m -67.36 149.35 50.43 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 121.955 -0.466 . . . . 0.0 110.184 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 27.3 p-10 -61.31 -23.1 65.47 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -175.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -81.55 8.26 10.07 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 70.7 m -137.44 -1.2 2.11 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -148.93 8.43 0.75 Allowed 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 57.8 m -145.74 17.39 1.45 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 122.981 0.512 . . . . 0.0 111.886 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.7 m -69.96 105.88 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 -178.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -130.44 10.48 5.25 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.757 0.823 . . . . 0.0 112.324 177.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 70.1 m 64.18 21.09 12.44 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 -176.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 39.8 t -130.54 132.77 64.36 Favored 'Isoleucine or valine' 0 C--N 1.338 0.091 0 CA-C-N 118.215 0.461 . . . . 0.0 111.17 177.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 8.1 mp -122.07 149.88 42.93 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 123.949 0.899 . . . . 0.0 110.563 -174.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 27.0 tp -102.56 135.8 43.53 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 170.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -115.93 104.18 11.35 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.102 1.361 . . . . 0.0 114.071 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.87 133.19 34.88 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 175.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.5 mp -102.76 124.23 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -90.49 -19.26 24.04 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -173.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -141.96 78.87 16.96 Favored Pre-proline 0 CA--C 1.53 0.178 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -77.34 45.73 1.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.764 1 C-N-CA 125.444 4.096 . . . . 0.0 112.275 -177.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.42 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -69.76 -4.09 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 O-C-N 121.818 -0.552 . . . . 0.0 110.508 179.363 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -137.39 156.55 48.07 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 175.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 66.4 m -69.11 112.95 6.05 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.3 mm -78.36 141.77 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.02 161.34 35.09 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.4 p -64.03 -17.67 63.58 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -75.07 -46.75 32.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.712 0.291 . . . . 0.0 111.572 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 1.6 m -70.1 -32.12 49.99 Favored 'Isoleucine or valine' 0 C--N 1.338 0.107 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.69 -34.93 70.06 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 176.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -71.08 -29.66 65.59 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 174.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 10.1 m -68.29 -34.19 75.71 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 42.0 pt -91.41 -22.98 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 118.41 0.55 . . . . 0.0 111.907 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 97.4 m -90.1 -23.6 21.34 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.474 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 26.6 t30 -63.88 -43.24 75.15 Favored Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 73.9 Cg_endo -69.51 -14.45 36.9 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.416 1.41 . . . . 0.0 111.32 177.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 96.8 m -85.43 -16.12 40.75 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 118.011 0.369 . . . . 0.0 111.48 176.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 154.75 171.71 21.81 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.613 -0.595 . . . . 0.0 111.613 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.27 98.86 0.66 Allowed 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.744 2.962 . . . . 0.0 110.633 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 63.9 t -69.45 145.91 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -115.12 -37.85 4.0 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 119.365 -0.35 . . . . 0.0 111.233 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 63.4 mtm-85 -147.66 152.34 37.69 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 25.5 mt -148.0 137.7 16.37 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 C-N-CA 124.144 0.978 . . . . 0.0 109.706 176.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 12.8 m -143.95 161.65 15.71 Favored 'Isoleucine or valine' 0 C--N 1.338 0.082 0 C-N-CA 123.553 0.741 . . . . 0.0 110.115 174.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 35.8 mt -135.67 141.91 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 122.824 0.45 . . . . 0.0 110.628 -175.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.316 4.1 p90 -138.15 156.84 47.34 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 176.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -128.5 15.59 6.55 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.425 0.69 . . . . 0.0 110.522 -173.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -63.58 -31.92 73.23 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -169.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -130.65 6.47 4.75 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 118.686 0.675 . . . . 0.0 112.494 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 163.02 -124.82 1.32 Allowed Glycine 0 CA--C 1.521 0.419 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 -174.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 45.5 t -141.97 114.93 4.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -142.45 166.07 25.68 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.904 0.383 . . . . 0.0 110.578 -177.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.15 164.88 30.82 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.583 0.753 . . . . 0.0 109.416 175.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 62.9 mmm -133.06 153.21 51.71 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 39.1 t -139.79 145.5 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 C-N-CA 122.838 0.455 . . . . 0.0 110.409 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -130.22 133.08 46.3 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.918 0.487 . . . . 0.0 110.529 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -108.02 161.35 15.03 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -82.92 -8.18 59.59 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 29.2 t -155.01 149.49 26.31 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 121.916 -0.49 . . . . 0.0 111.554 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 51.1 t -67.76 -35.9 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -68.14 -28.57 67.42 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.112 0.415 . . . . 0.0 111.137 -177.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 58.3 m -74.32 -32.34 62.8 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 176.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.71 -29.73 56.38 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.621 0.369 . . . . 0.0 110.934 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -69.98 -44.07 70.2 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.147 -0.345 . . . . 0.0 111.439 178.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -75.39 -25.09 57.33 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.878 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -70.97 -39.35 72.56 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.127 0.422 . . . . 0.0 110.255 176.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.08 -25.59 58.69 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 122.639 0.376 . . . . 0.0 110.298 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -91.2 -10.29 42.23 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 46.1 t -117.04 -36.48 3.8 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -176.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 78.7 mt -88.36 -8.29 55.31 Favored 'General case' 0 C--N 1.338 0.108 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -71.47 133.36 45.81 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.54 -5.28 46.28 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 119.681 -0.511 . . . . 0.0 112.298 -178.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.67 166.45 22.5 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 117.833 0.817 . . . . 0.0 110.253 177.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -123.65 139.84 53.6 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 87.0 mt -74.92 -41.53 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.373 42.7 m-85 -82.88 -11.81 57.9 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 117.151 2.278 . . . . 0.0 117.151 178.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 29.9 t 65.25 35.52 7.64 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.385 0.674 . . . . 0.0 110.74 -174.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 175.56 -23.98 0.06 OUTLIER Glycine 0 CA--C 1.53 1.028 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' CYS . . . . . 0.42 ' HB3' HD12 ' A' ' 200' ' ' ILE . 72.0 m -145.32 -176.87 5.28 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.686 1.195 . . . . 0.0 109.199 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 84.3 m 57.74 36.93 27.04 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -176.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.35 149.55 9.96 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 114.471 1.285 . . . . 0.0 114.471 175.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 79.0 mt -116.87 154.35 30.92 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -172.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -137.0 137.65 39.66 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.276 1.43 . . . . 0.0 107.414 169.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 56.7 mt -139.57 142.78 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 CA-C-O 120.566 0.222 . . . . 0.0 111.578 -170.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -160.63 162.88 32.86 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.295 0.638 . . . . 0.0 109.622 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.264 50.8 m-85 -59.43 139.75 56.8 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 176.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 265' ' ' ALA . . . . . 0.476 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -88.32 165.3 15.08 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -176.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.403 ' HB2' ' HD3' ' A' ' 267' ' ' PRO . 78.2 mttt -79.21 -51.55 1.26 Allowed Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 118.445 -0.788 . . . . 0.0 112.065 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' A' ' 266' ' ' LYS . 68.3 Cg_endo -76.27 175.16 11.7 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.859 2.373 . . . . 0.0 111.303 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.45 -3.54 3.01 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -176.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -158.28 130.22 6.83 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 118.92 0.782 . . . . 0.0 112.564 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.453 ' HG ' ' C5 ' ' B' ' 3' ' ' ' A' . 23.7 mt -84.57 164.46 18.7 Favored 'General case' 0 N--CA 1.458 -0.055 0 C-N-CA 124.378 1.071 . . . . 0.0 111.651 176.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.419 ' C ' ' H61' ' B' ' 5' ' ' ' A' . 53.9 m-80 -120.77 54.06 1.09 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.386 170.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.416 HG23 ' H ' ' A' ' 272' ' ' VAL . 2.7 t -53.0 147.44 2.07 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -175.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -138.07 -1.35 1.97 Allowed 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 116.92 2.193 . . . . 0.0 116.92 -176.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -159.11 161.57 36.38 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -172.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -125.6 108.35 11.49 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.199 0.999 . . . . 0.0 109.681 174.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -158.31 -166.17 1.87 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 177.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -68.64 -9.97 53.2 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -174.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -117.42 -17.32 10.1 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.16 141.85 34.09 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.772 0.829 . . . . 0.0 113.016 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 17.8 t-105 -163.63 156.63 18.43 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 118.554 0.615 . . . . 0.0 110.445 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -142.11 120.44 12.33 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.305 172.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -81.95 5.59 18.63 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 117.192 2.293 . . . . 0.0 117.192 -173.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 3.6 t -141.18 -11.83 0.95 Allowed 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -178.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -95.37 113.34 61.44 Favored Pre-proline 0 CA--C 1.534 0.365 0 O-C-N 121.951 -0.468 . . . . 0.0 110.097 177.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -82.28 -13.72 9.83 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.649 2.899 . . . . 0.0 112.566 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -73.54 -7.18 50.82 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -173.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 46.3 mt -79.92 0.26 32.1 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 122.026 -0.421 . . . . 0.0 112.077 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 99.5 p -71.4 -3.31 20.15 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 122.834 0.453 . . . . 0.0 111.822 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -73.79 -9.52 79.23 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 119.869 -0.406 . . . . 0.0 112.342 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 43.2 mm-40 -72.17 161.63 30.6 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 117.87 0.835 . . . . 0.0 111.506 177.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.205 0 CA-C-O 117.38 -1.789 . . . . 0.0 110.814 179.928 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.009 0 C3'-C2'-C1' 104.435 3.261 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.476 ' N3 ' ' HA ' ' A' ' 265' ' ' ALA . . . . . . . . 0 O4'--C4' 1.418 -2.927 0 C3'-C2'-C1' 98.21 -3.656 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.453 ' C5 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.419 -2.804 0 O4'-C1'-N19 112.056 3.856 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.76 0 C5'-C4'-C3' 109.765 -3.823 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.419 ' H61' ' C ' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.417 -2.994 1 C3'-C2'-C1' 105.194 4.104 OUTLIER-DELTA 0.038 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.517 1 O4'-C1'-N19 112.318 4.118 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 . . . . . 0 N--CA 1.477 0.91 0 N-CA-C 110.858 -0.052 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -153.79 148.42 26.29 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 1.2 mt 54.62 22.02 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.652 0.781 . . . . 0.0 111.304 -173.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 68.5 m -70.71 156.73 39.12 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 122.028 -0.42 . . . . 0.0 110.837 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -141.36 151.71 61.97 Favored Pre-proline 0 CA--C 1.528 0.123 0 C-N-CA 123.567 0.747 . . . . 0.0 110.032 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -70.92 -13.25 31.64 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.562 2.841 . . . . 0.0 111.642 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -71.0 -1.41 40.28 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 123.302 0.477 . . . . 0.0 112.489 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -68.83 -20.28 64.3 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 117.601 0.701 . . . . 0.0 111.526 -178.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 34.2 t -157.95 151.17 23.2 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.302 0.641 . . . . 0.0 109.95 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.5 p30 -75.42 -7.22 53.49 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -71.83 0.88 7.96 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 99.2 p -146.82 7.49 0.94 Allowed 'General case' 0 C--O 1.231 0.131 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -177.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 4.5 ppt_? -146.42 5.09 0.93 Allowed 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 65.9 m -148.21 13.01 0.97 Allowed 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.407 ' H ' HG22 ' A' ' 188' ' ' VAL . 2.4 m -70.75 104.63 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -177.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 49.8 p30 -130.77 10.54 5.11 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.718 0.807 . . . . 0.0 112.237 177.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 57.8 m 66.24 19.58 11.06 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -177.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 37.2 t -128.4 143.55 40.67 Favored 'Isoleucine or valine' 0 C--N 1.339 0.116 0 C-N-CA 123.167 0.587 . . . . 0.0 110.79 178.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 82.6 mt -135.61 149.0 49.24 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.868 0.467 . . . . 0.0 111.104 -175.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 39.2 tp -101.11 135.45 42.54 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 172.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -113.57 101.37 9.27 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 125.148 1.379 . . . . 0.0 114.6 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.2 m -86.8 133.84 33.61 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 175.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.0 mp -103.94 126.0 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -94.06 -18.42 21.84 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -172.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -141.24 78.99 18.22 Favored Pre-proline 0 CA--C 1.529 0.164 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -77.41 49.03 2.74 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 125.003 3.802 . . . . 0.0 112.278 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.45 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -69.23 -6.78 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 O-C-N 121.787 -0.571 . . . . 0.0 110.224 178.163 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -141.73 154.68 45.45 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.158 1.383 . . . . 0.0 112.394 175.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.4 t -74.15 131.46 41.3 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.157 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 21.9 mm -81.14 148.37 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 122.923 0.489 . . . . 0.0 109.913 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.89 157.89 44.83 Favored 'General case' 0 C--O 1.231 0.079 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 177.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.3 p -63.88 -18.75 64.49 Favored 'General case' 0 N--CA 1.458 -0.057 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -73.4 -47.3 43.05 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.717 0.294 . . . . 0.0 111.544 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.5 m -71.06 -32.31 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.16 -36.61 72.09 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 176.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -70.82 -30.14 66.49 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 175.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 8.9 m -67.59 -33.76 75.66 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 38.6 pt -92.38 -24.31 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 118.585 0.63 . . . . 0.0 111.77 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 95.6 m -88.49 -26.39 22.08 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.478 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 35.1 t30 -64.71 -42.53 64.86 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 71.9 Cg_endo -70.29 -12.74 32.42 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.493 1.462 . . . . 0.0 111.262 177.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 96.4 m -90.43 -9.23 48.29 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.031 0.378 . . . . 0.0 111.665 176.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 151.41 167.72 15.16 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 178.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.26 103.03 1.01 Allowed 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.903 3.069 . . . . 0.0 110.584 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 71.9 t -70.67 145.25 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -113.74 -39.27 4.05 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 119.205 -0.426 . . . . 0.0 111.28 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -149.15 152.8 36.72 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.267 0.485 . . . . 0.0 112.046 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 23.6 mt -147.28 135.72 15.34 Favored 'Isoleucine or valine' 0 C--N 1.338 0.073 0 C-N-CA 124.025 0.93 . . . . 0.0 109.912 177.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 1.6 m -140.38 160.61 25.16 Favored 'Isoleucine or valine' 0 C--N 1.337 0.062 0 C-N-CA 123.55 0.74 . . . . 0.0 111.715 174.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 53.7 mt -135.82 144.02 34.71 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 C-N-CA 123.127 0.571 . . . . 0.0 110.163 -175.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.299 3.5 p90 -143.35 156.47 44.7 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 175.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 5.8 mmt180 -127.35 17.68 7.04 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.32 0.648 . . . . 0.0 110.002 -174.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -64.89 -31.74 73.12 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -169.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -130.47 5.89 4.79 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 118.606 0.639 . . . . 0.0 111.893 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 163.04 -124.35 1.28 Allowed Glycine 0 C--N 1.334 0.442 0 N-CA-C 108.696 -1.761 . . . . 0.0 108.696 -173.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 49.1 t -142.6 114.04 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 -142.86 166.07 25.65 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.117 0.484 . . . . 0.0 110.845 -176.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.09 164.99 31.29 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.487 175.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 57.9 mmm -132.42 152.82 51.33 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 39.1 t -141.12 146.03 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 C-N-CA 123.116 0.566 . . . . 0.0 110.37 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -132.52 135.59 46.09 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 122.536 0.335 . . . . 0.0 110.593 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -107.78 162.92 13.55 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 -176.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -75.74 -17.21 59.99 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 86.5 p -155.13 159.63 40.34 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.175 0.512 . . . . 0.0 111.263 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 54.8 t -67.34 -35.22 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -66.56 -28.18 68.32 Favored 'General case' 0 N--CA 1.456 -0.139 0 O-C-N 122.18 -0.325 . . . . 0.0 111.021 -177.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 74.4 m -75.94 -32.68 59.67 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 177.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.54 -32.63 58.34 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.416 -0.177 . . . . 0.0 111.086 178.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -66.76 -44.03 82.51 Favored 'General case' 0 C--N 1.338 0.09 0 O-C-N 122.036 -0.415 . . . . 0.0 111.558 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -75.59 -26.34 57.8 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.898 -178.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -74.16 -40.85 62.3 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.03 0.377 . . . . 0.0 110.148 178.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -73.57 -23.22 59.93 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.862 0.465 . . . . 0.0 111.063 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -92.4 -17.04 25.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 48.2 t -106.67 -36.17 6.8 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -176.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 76.7 mt -88.67 -8.03 55.3 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -70.78 134.27 47.26 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.65 -6.45 39.32 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 119.676 -0.513 . . . . 0.0 112.458 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -77.41 166.34 23.25 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 117.759 0.78 . . . . 0.0 110.187 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 5.0 p30 -123.24 140.56 52.89 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 80.8 mt -74.98 -43.03 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.071 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.36 50.2 m-85 -82.78 -10.05 59.05 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 29.1 t 66.38 34.78 6.11 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.629 0.772 . . . . 0.0 111.126 -175.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 175.47 -24.45 0.06 OUTLIER Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 178.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' CYS . . . . . 0.45 ' HB3' HD12 ' A' ' 200' ' ' ILE . 81.4 m -144.69 -176.97 5.27 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.692 1.197 . . . . 0.0 109.264 178.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 96.2 m 57.4 39.18 28.41 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -175.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.04 146.4 18.18 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 175.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 89.1 mt -110.78 154.41 23.98 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -172.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -137.92 135.98 36.59 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.865 1.666 . . . . 0.0 106.679 169.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 44.6 mt -138.43 141.67 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-O 120.618 0.247 . . . . 0.0 111.142 -172.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -158.76 164.11 36.14 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 175.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.288 43.4 m-85 -61.75 135.38 57.58 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 177.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 265' ' ' ALA . . . . . 0.445 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -85.35 162.85 18.89 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.369 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.468 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 63.4 pttt -94.06 -32.56 0.3 Allowed Pre-proline 0 CA--C 1.54 0.567 0 CA-C-O 117.29 -1.338 . . . . 0.0 114.225 178.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 86.3 Cg_endo -76.3 171.52 17.93 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 CA-C-N 122.04 1.764 . . . . 0.0 110.055 175.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.21 -1.91 2.33 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 117.72 2.489 . . . . 0.0 117.72 -175.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.15 130.95 9.98 Favored 'General case' 0 C--N 1.338 0.075 0 CA-C-N 119.145 0.884 . . . . 0.0 111.888 -177.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.429 ' HG ' ' C6 ' ' B' ' 3' ' ' ' A' . 25.1 mt -90.97 157.05 17.52 Favored 'General case' 0 C--N 1.338 0.069 0 C-N-CA 124.125 0.97 . . . . 0.0 111.408 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.458 ' C ' ' H61' ' B' ' 5' ' ' ' A' . 65.6 m-80 -120.85 50.99 1.28 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.836 0.854 . . . . 0.0 109.41 173.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.401 HG23 ' H ' ' A' ' 272' ' ' VAL . 3.0 t -51.63 144.74 2.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -177.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.425 ' CZ ' ' C2 ' ' B' ' 5' ' ' ' A' . 6.6 p90 -131.26 -0.15 4.08 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 116.472 2.027 . . . . 0.0 116.472 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -159.06 166.44 31.66 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.839 0.456 . . . . 0.0 111.374 -175.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -125.9 113.58 17.39 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.062 0.945 . . . . 0.0 109.05 172.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 57.1 p30 -156.3 -167.09 2.33 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -69.56 -13.83 62.53 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -176.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -100.02 -34.05 10.24 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.3 p -141.26 148.66 40.19 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 18.9 t-105 -157.54 154.98 29.47 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -176.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -135.07 118.92 17.26 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 122.873 0.469 . . . . 0.0 111.711 175.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.252 68.6 m-85 -84.19 6.44 22.59 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 117.263 2.32 . . . . 0.0 117.263 -171.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 3.8 t -142.99 -16.25 0.68 Allowed 'General case' 0 C--O 1.232 0.143 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -176.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -95.26 113.22 61.08 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 118.399 0.545 . . . . 0.0 110.556 177.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -83.12 -12.18 9.54 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.613 2.875 . . . . 0.0 112.568 177.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -72.8 -9.59 58.83 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -173.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 80.2 mt -73.65 -24.72 60.04 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 118.386 0.539 . . . . 0.0 110.749 178.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 67.7 m 52.83 10.28 0.15 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.818 1.247 . . . . 0.0 114.151 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 62.9 17.43 58.39 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 118.534 0.606 . . . . 0.0 111.688 -177.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 56.02 20.82 4.56 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.079 0.951 . . . . 0.0 112.758 -173.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.133 0 CA-C-O 117.465 -1.742 . . . . 0.0 111.164 179.754 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.912 0 C5'-C4'-C3' 110.043 -3.638 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.445 ' N3 ' ' HA ' ' A' ' 265' ' ' ALA . . . . . . . . 0 O4'--C4' 1.422 -2.544 0 O4'-C1'-N19 111.801 3.601 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.429 ' C6 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.422 -2.613 1 C5'-C4'-C3' 109.164 -4.224 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.178 0 C5'-C4'-C3' 110.163 -3.558 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.458 ' H61' ' C ' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.417 -3.034 0 C3'-C2'-C1' 104.777 3.641 . 0.016 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.607 0 O4'-C1'-N19 112.157 3.957 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 32.6 tp60 . . . . . 0 N--CA 1.476 0.838 0 CA-C-O 120.386 0.136 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -70.23 140.38 52.41 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.011 0.524 . . . . 0.0 110.558 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 47.3 mm -73.02 143.81 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 C-N-CA 122.953 0.501 . . . . 0.0 110.21 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 46.8 t -156.88 157.72 35.4 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 123.071 0.548 . . . . 0.0 109.768 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 86.1 mtt-85 -68.74 145.54 96.97 Favored Pre-proline 0 CA--C 1.529 0.166 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.22 167.68 26.61 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.48 2.787 . . . . 0.0 109.656 173.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -67.88 -8.79 54.65 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 177.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -78.45 -5.86 53.69 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 38.1 m -69.6 153.94 42.73 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-O 120.987 0.422 . . . . 0.0 111.188 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -54.11 -34.13 59.47 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -75.31 6.74 4.11 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 70.9 m -140.98 1.35 1.65 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -175.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -147.86 10.25 0.92 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 178.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 58.8 m -143.01 4.64 1.46 Allowed 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.2 m -76.46 123.67 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -130.88 10.39 5.04 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.282 0.633 . . . . 0.0 112.216 177.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 41.2 p 60.93 24.39 14.43 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.523 1.529 . . . . 0.0 113.518 -175.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 45.1 t -130.27 139.56 51.08 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 123.516 0.727 . . . . 0.0 109.523 174.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 89.4 mt -128.51 158.04 39.51 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.843 0.354 . . . . 0.0 111.536 -173.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 9.7 tt -115.92 135.85 53.59 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.255 174.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -114.37 106.26 14.1 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 114.684 1.365 . . . . 0.0 114.684 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -88.23 142.8 27.46 Favored 'General case' 0 N--CA 1.458 -0.072 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 174.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.3 mp -115.34 124.14 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 21.0 mt -85.24 -24.92 27.6 Favored 'General case' 0 C--N 1.337 0.064 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -173.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -141.22 79.06 18.17 Favored Pre-proline 0 N--CA 1.456 -0.171 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -177.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -76.86 49.97 2.92 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 125.137 3.891 . . . . 0.0 112.153 -177.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.441 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -68.55 -7.23 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 O-C-N 121.954 -0.466 . . . . 0.0 110.019 177.867 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -140.2 152.15 45.77 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.238 1.415 . . . . 0.0 112.193 175.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 35.9 t -74.4 133.08 42.47 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 117.851 0.296 . . . . 0.0 110.56 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 24.2 mm -83.32 150.06 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 123.028 0.531 . . . . 0.0 109.841 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.87 155.73 49.35 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 177.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.5 p -64.38 -21.72 66.72 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -79.01 -35.97 41.95 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 75.8 t -72.97 -40.81 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.3 mt -69.01 -32.0 71.24 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -70.28 -29.52 66.31 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 174.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.2 m -69.47 -32.82 71.97 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 45.0 pt -92.32 -21.75 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 118.422 0.555 . . . . 0.0 112.264 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 97.7 m -92.56 -26.57 17.84 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -178.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.488 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 36.3 t30 -64.04 -40.87 58.11 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 73.3 Cg_endo -69.44 -10.98 30.22 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 121.535 1.49 . . . . 0.0 111.887 177.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 91.0 m -95.99 -6.26 39.3 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 177.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 151.0 167.59 14.82 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 111.801 -0.519 . . . . 0.0 111.801 178.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.38 101.66 0.88 Allowed 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 123.965 3.11 . . . . 0.0 110.408 178.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 83.5 t -70.79 144.63 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -112.51 -39.45 4.36 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 119.363 -0.351 . . . . 0.0 111.262 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 65.8 mtm-85 -148.01 153.08 38.49 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 25.2 mt -145.13 139.9 22.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 124.308 1.043 . . . . 0.0 109.18 176.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 41.0 t -145.38 153.02 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.066 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 48.8 mt -134.34 142.24 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 C-N-CA 123.087 0.555 . . . . 0.0 110.178 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.305 2.7 p90 -143.19 156.1 44.69 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 176.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 6.2 mmt180 -127.75 18.22 6.78 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.274 0.63 . . . . 0.0 110.134 -173.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -66.22 -30.92 71.47 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 114.717 1.376 . . . . 0.0 114.717 -169.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -130.48 5.46 4.75 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 118.61 0.641 . . . . 0.0 112.129 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 164.35 -126.51 1.52 Allowed Glycine 0 CA--C 1.521 0.461 0 N-CA-C 108.043 -2.023 . . . . 0.0 108.043 -173.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.5 t -142.5 114.67 3.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 175.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -144.42 168.91 18.99 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.271 0.558 . . . . 0.0 110.718 -176.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.04 167.79 22.51 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.372 174.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 79.4 mmm -134.01 150.6 51.25 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 32.5 t -140.21 147.46 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 C-N-CA 122.895 0.478 . . . . 0.0 110.727 -177.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -133.31 134.87 44.4 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.03 0.532 . . . . 0.0 110.49 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -108.59 163.31 13.35 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 116.479 2.029 . . . . 0.0 116.479 -176.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -74.43 -16.79 60.86 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 84.9 p -157.12 161.23 39.39 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.275 0.559 . . . . 0.0 111.235 -178.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 45.7 t -66.62 -33.92 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -67.28 -30.21 70.02 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 117.886 0.312 . . . . 0.0 110.82 -177.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 68.7 m -75.49 -31.32 60.17 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 177.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.83 -33.32 60.07 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 119.629 -0.224 . . . . 0.0 111.172 178.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -67.48 -43.49 80.87 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 118.445 0.566 . . . . 0.0 111.487 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -74.42 -28.32 61.02 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.166 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -74.38 -39.8 62.48 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 118.094 0.406 . . . . 0.0 110.69 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -74.64 -23.54 58.7 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 122.748 0.419 . . . . 0.0 111.165 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -93.9 -15.57 24.85 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 47.8 t -106.7 -36.23 6.77 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 75.9 mt -89.35 -8.15 53.8 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -176.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -70.88 135.88 48.28 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.53 -6.76 36.27 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.621 -0.544 . . . . 0.0 112.308 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -76.82 166.49 23.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 117.69 0.745 . . . . 0.0 109.727 176.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -123.49 138.6 54.54 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 84.2 mt -72.29 -43.83 64.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.372 41.4 m-85 -82.79 -11.15 58.5 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 117.336 2.347 . . . . 0.0 117.336 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.9 t 64.79 37.19 7.5 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.692 0.758 . . . . 0.0 110.817 -175.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 174.52 -23.95 0.07 OUTLIER Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.001 0.81 . . . . 0.0 111.086 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' CYS . . . . . 0.441 ' HB3' HD12 ' A' ' 200' ' ' ILE . 90.8 m -146.62 -177.16 5.49 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.122 1.369 . . . . 0.0 109.159 178.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 95.2 m 58.62 37.62 25.28 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -177.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.59 146.05 10.74 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 175.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 86.1 mt -109.56 154.68 22.39 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -173.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -139.76 136.77 34.47 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.772 1.629 . . . . 0.0 106.913 169.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 37.0 mt -137.94 141.15 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-O 120.715 0.293 . . . . 0.0 111.277 -172.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -158.53 163.67 36.85 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.785 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.25 47.8 m-85 -63.02 136.36 57.78 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 176.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 265' ' ' ALA . . . . . 0.41 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -86.76 159.55 19.09 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.611 0.364 . . . . 0.0 110.751 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.465 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 23.1 pttp -92.79 -31.76 0.32 Allowed Pre-proline 0 CA--C 1.538 0.513 0 CA-C-O 117.363 -1.304 . . . . 0.0 114.066 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 69.2 Cg_endo -77.51 170.17 19.77 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 CA-C-N 121.966 1.738 . . . . 0.0 109.781 173.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.7 -1.07 3.11 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 117.798 2.518 . . . . 0.0 117.798 -174.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.55 130.65 9.42 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 118.873 0.76 . . . . 0.0 111.421 -178.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.476 ' HG ' ' C6 ' ' B' ' 3' ' ' ' A' . 20.1 mt -90.76 156.95 17.68 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 123.78 0.832 . . . . 0.0 111.017 177.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.457 ' C ' ' H61' ' B' ' 5' ' ' ' A' . 59.2 m-80 -115.42 50.88 0.96 Allowed 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.367 0.667 . . . . 0.0 109.86 173.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 3.1 t -52.23 145.22 2.69 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -134.54 -3.63 2.64 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 -177.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -159.32 162.62 36.01 Favored 'General case' 0 N--CA 1.456 -0.132 0 O-C-N 122.225 -0.297 . . . . 0.0 111.277 -171.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -125.39 110.81 14.4 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.769 0.828 . . . . 0.0 109.629 174.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 54.6 p30 -159.04 -165.95 1.73 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -67.84 -8.94 40.37 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -174.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -120.77 -15.35 8.39 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.34 140.9 35.69 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 123.923 0.889 . . . . 0.0 113.073 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 -163.55 156.91 18.93 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.644 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -141.52 118.58 11.27 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.654 171.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -81.94 4.35 22.95 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 -172.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 3.0 t -140.89 -12.94 0.96 Allowed 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -177.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -95.2 113.48 61.62 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 118.014 0.37 . . . . 0.0 110.049 178.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -83.44 -14.28 8.15 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.646 2.898 . . . . 0.0 112.175 178.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -71.43 -8.83 56.37 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -172.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 69.8 mt -75.46 -18.54 59.84 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 118.234 0.47 . . . . 0.0 111.02 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 75.0 m 53.17 12.89 0.35 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.419 1.088 . . . . 0.0 113.728 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 67.36 5.74 37.14 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 119.676 -0.514 . . . . 0.0 112.371 -178.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 53.51 22.93 3.17 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.787 0.835 . . . . 0.0 112.564 -175.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.115 0 CA-C-O 117.42 -1.767 . . . . 0.0 111.089 -179.797 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.066 0 C5'-C4'-C3' 109.852 -3.765 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.41 ' N3 ' ' HA ' ' A' ' 265' ' ' ALA . . . . . . . . 0 O4'--C4' 1.42 -2.727 0 O4'-C1'-N19 111.202 3.002 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.476 ' C6 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.42 -2.709 1 C5'-C4'-C3' 109.07 -4.286 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.797 1 C5'-C4'-C3' 109.185 -4.21 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.457 ' H61' ' C ' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.42 -2.755 1 C3'-C2'-C1' 105.187 4.097 OUTLIER-DELTA 0.054 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.615 0 O4'-C1'-N19 112.191 3.991 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 120.386 0.136 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -154.98 151.64 28.74 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 122.864 0.465 . . . . 0.0 109.84 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 85.1 mt -68.34 145.88 13.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 C-N-CA 122.839 0.456 . . . . 0.0 109.932 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 94.2 p -154.27 161.81 41.57 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.023 0.529 . . . . 0.0 109.712 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -145.16 157.99 52.56 Favored Pre-proline 0 CA--C 1.529 0.165 0 C-N-CA 123.59 0.756 . . . . 0.0 109.677 -178.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.01 -15.5 27.98 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.468 2.778 . . . . 0.0 113.382 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -82.09 -13.68 78.66 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 120.034 -0.315 . . . . 0.0 112.479 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -80.42 -64.28 1.22 Allowed 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 37.7 t -70.12 147.93 49.34 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 122.536 0.334 . . . . 0.0 110.606 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 8.2 p30 -74.14 -9.28 58.46 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -70.56 -2.83 15.39 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 67.1 m -141.93 6.32 1.78 Allowed 'General case' 0 C--O 1.231 0.119 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -176.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -148.47 5.15 0.71 Allowed 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 64.2 m -147.44 12.11 1.03 Allowed 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.401 ' H ' HG22 ' A' ' 188' ' ' VAL . 1.9 m -69.11 104.36 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -178.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -130.58 10.54 5.19 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.515 0.726 . . . . 0.0 111.956 177.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 54.5 m 65.22 21.21 12.06 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -177.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.1 t -131.85 133.71 60.84 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 CA-C-N 118.038 0.381 . . . . 0.0 111.018 176.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.445 HD21 ' HB1' ' A' ' 241' ' ' ALA . 2.3 mm? -121.56 153.32 38.18 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 122.817 0.447 . . . . 0.0 110.926 -176.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 22.8 tp -103.9 135.95 44.47 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 170.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -111.57 132.17 54.73 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.92 1.288 . . . . 0.0 114.419 176.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -121.58 130.09 53.28 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 175.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.4 mp -101.84 118.31 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -84.9 -19.37 32.38 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.027 0.531 . . . . 0.0 111.939 -171.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -141.72 78.99 17.3 Favored Pre-proline 0 CA--C 1.529 0.137 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -78.42 47.22 2.34 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 124.957 3.771 . . . . 0.0 111.926 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.403 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -70.24 -4.42 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 O-C-N 121.862 -0.524 . . . . 0.0 110.813 179.68 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -137.03 156.48 48.37 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 176.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 69.0 m -69.68 113.41 6.92 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 37.5 mm -78.26 141.8 14.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 177.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.11 160.88 36.45 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.5 p -64.84 -15.67 62.13 Favored 'General case' 0 CA--C 1.527 0.062 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -76.27 -44.98 34.8 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.785 0.326 . . . . 0.0 111.45 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 1.5 m -71.38 -32.62 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 179.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.4 mt -72.03 -34.16 68.58 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 176.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -71.64 -30.45 65.76 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 173.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.3 m -66.68 -33.92 76.72 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 42.9 pt -91.14 -24.94 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 118.352 0.523 . . . . 0.0 112.027 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 99.3 m -88.49 -25.54 22.52 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.093 0.86 . . . . 0.0 113.285 -178.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.479 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 31.9 t30 -64.51 -43.57 71.74 Favored Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 73.6 Cg_endo -69.85 -11.87 31.58 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.415 1.41 . . . . 0.0 111.519 177.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 94.4 m -92.28 -10.71 37.46 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.6 0.36 . . . . 0.0 111.847 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 155.09 169.56 19.76 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.767 -0.533 . . . . 0.0 111.767 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.88 96.88 0.7 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 124.138 3.226 . . . . 0.0 110.611 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 70.2 t -68.25 145.41 13.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -116.25 -39.93 3.33 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 119.147 -0.454 . . . . 0.0 111.32 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 63.4 mtm-85 -147.93 152.01 36.81 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 21.5 mt -148.42 137.14 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.272 1.029 . . . . 0.0 110.183 177.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 8.0 m -143.05 162.43 17.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 C-N-CA 123.778 0.831 . . . . 0.0 110.315 174.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 43.1 mt -134.34 143.18 38.77 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.075 0 C-N-CA 123.157 0.583 . . . . 0.0 110.486 -174.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.293 4.2 p90 -142.32 156.36 45.25 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 176.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -127.49 14.75 7.11 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.208 0.603 . . . . 0.0 110.905 -173.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -61.76 -32.58 72.84 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 -169.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -130.6 7.01 4.81 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.594 0.633 . . . . 0.0 112.278 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 163.41 -125.56 1.41 Allowed Glycine 0 C--N 1.336 0.551 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -174.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 24.2 t -140.99 112.02 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.152 0 C-N-CA 122.785 0.434 . . . . 0.0 109.915 175.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -141.8 168.03 20.72 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.212 0.529 . . . . 0.0 110.948 -175.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.98 169.2 21.14 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.75 0.82 . . . . 0.0 109.052 176.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 64.4 mmm -136.03 153.96 51.2 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 27.1 t -140.25 144.6 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.095 0 C-N-CA 123.063 0.545 . . . . 0.0 110.953 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -130.05 133.53 46.77 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.026 0.531 . . . . 0.0 110.252 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -108.9 161.32 15.25 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -177.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -80.62 -10.88 59.71 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 43.1 t -155.27 153.37 30.5 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 118.202 0.456 . . . . 0.0 111.864 -175.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 59.0 t -68.47 -38.52 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 123.0 0.52 . . . . 0.0 109.743 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -67.5 -26.61 66.43 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 122.153 -0.342 . . . . 0.0 111.08 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 48.8 m -75.88 -30.8 58.98 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 175.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.445 ' HB1' HD21 ' A' ' 192' ' ' LEU . . . -76.76 -33.21 58.09 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.579 0.352 . . . . 0.0 111.017 179.086 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -69.24 -44.14 72.56 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 122.228 -0.295 . . . . 0.0 111.665 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -74.12 -27.76 61.02 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 117.935 0.334 . . . . 0.0 111.105 -178.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -72.55 -39.82 67.18 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.177 0.444 . . . . 0.0 110.58 177.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.42 -23.75 54.0 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.433 0.293 . . . . 0.0 111.149 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -90.34 -14.73 32.51 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 48.2 t -109.51 -34.46 6.51 Favored 'General case' 0 C--N 1.338 0.068 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -177.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 78.3 mt -90.42 -7.92 51.92 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -70.93 132.57 45.41 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 75.66 -4.62 42.81 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.74 -0.478 . . . . 0.0 112.164 -177.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.26 166.4 22.18 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.859 0.829 . . . . 0.0 110.193 177.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -123.49 139.88 53.56 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 86.3 mt -73.71 -42.25 54.7 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.352 44.4 m-85 -82.86 -12.33 57.5 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 117.355 2.354 . . . . 0.0 117.355 178.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 23.1 t 65.14 36.34 7.29 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.69 0.757 . . . . 0.0 110.722 -174.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 176.05 -24.54 0.06 OUTLIER Glycine 0 CA--C 1.528 0.856 0 C-N-CA 123.792 0.71 . . . . 0.0 111.35 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' CYS . . . . . 0.403 ' HB3' HD12 ' A' ' 200' ' ' ILE . 82.4 m -146.74 -176.57 5.24 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.897 1.279 . . . . 0.0 109.173 178.156 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 89.7 m 58.06 37.08 26.47 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.69 148.98 11.68 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 176.007 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 76.2 mt -115.54 155.31 27.8 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -172.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -139.08 138.17 36.85 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.141 1.376 . . . . 0.0 107.959 169.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 29.2 mt -140.17 143.69 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 CA-C-O 120.935 0.398 . . . . 0.0 111.388 -171.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -159.28 162.94 36.14 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.865 0.866 . . . . 0.0 109.518 175.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -62.22 138.5 58.43 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 115.933 1.827 . . . . 0.0 115.933 177.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -87.55 162.31 17.27 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 122.674 0.39 . . . . 0.0 111.722 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.423 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 53.7 mtmt -80.82 -52.62 0.87 Allowed Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 118.351 -0.833 . . . . 0.0 112.665 178.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 90.5 Cg_endo -72.28 171.09 17.63 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.104 2.536 . . . . 0.0 111.251 177.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.262 0.2 OUTLIER -136.16 2.72 2.82 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 117.844 2.535 . . . . 0.0 117.844 -175.6 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -157.7 130.35 7.37 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 121.635 -0.666 . . . . 0.0 112.106 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.437 ' HG ' ' C6 ' ' B' ' 3' ' ' ' A' . 36.4 mt -85.8 166.67 15.87 Favored 'General case' 0 CA--C 1.527 0.068 0 C-N-CA 124.445 1.098 . . . . 0.0 111.538 176.168 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.504 ' C ' ' H61' ' B' ' 5' ' ' ' A' . 0.7 OUTLIER -120.22 49.79 1.38 Allowed 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 169.909 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.42 ' HA ' ' N1 ' ' B' ' 5' ' ' ' A' . 2.5 t -49.32 143.05 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.249 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -176.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -127.4 -7.4 5.8 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 117.945 2.572 . . . . 0.0 117.945 -176.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -162.87 174.72 12.04 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 122.77 0.428 . . . . 0.0 110.523 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -125.82 116.22 21.23 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.86 0.864 . . . . 0.0 109.628 174.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 52.7 p30 -157.74 -168.4 2.53 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.284 1.034 . . . . 0.0 109.718 178.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -68.97 -11.44 60.72 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -175.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -113.33 -17.56 12.26 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -144.6 141.13 29.19 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.864 0.866 . . . . 0.0 112.768 -178.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 18.9 t-105 -160.89 158.24 27.92 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 119.671 -0.812 . . . . 0.0 110.738 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -139.21 116.44 11.12 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.557 0.743 . . . . 0.0 109.774 172.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.266 67.7 m-85 -79.36 6.24 10.57 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 117.297 2.332 . . . . 0.0 117.297 -173.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 5.6 t -136.03 -20.49 1.47 Allowed 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -95.33 113.11 60.9 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 174.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -80.55 -15.18 11.19 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.606 2.871 . . . . 0.0 112.319 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -74.16 -16.07 61.0 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -173.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 51.4 mt -85.07 -4.06 59.02 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -178.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 74.2 m -80.45 -0.87 39.14 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 122.588 0.355 . . . . 0.0 111.681 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 76.32 -173.79 53.9 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 61.0 mm-40 -71.14 159.33 34.87 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 122.548 -0.384 . . . . 0.0 110.922 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 CA-C-O 117.174 -1.903 . . . . 0.0 111.294 179.262 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.866 0 C3'-C2'-C1' 104.451 3.279 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.691 0 C3'-C2'-C1' 98.348 -3.503 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.437 ' C6 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.422 -2.551 1 O4'-C1'-N19 112.228 4.028 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.921 0 C5'-C4'-C3' 109.575 -3.95 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.504 ' H61' ' C ' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.42 -2.784 1 C3'-C2'-C1' 105.407 4.341 OUTLIER-DELTA 0.04 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.623 0 O4'-C1'-N19 112.023 3.823 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 . . . . . 0 N--CA 1.475 0.82 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -74.03 -9.83 59.02 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.005 0.522 . . . . 0.0 111.61 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 7.0 tp -153.09 155.15 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 123.38 0.672 . . . . 0.0 109.511 -176.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 47.6 t -155.39 156.85 36.13 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.269 0.628 . . . . 0.0 110.062 178.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -144.88 152.61 52.36 Favored Pre-proline 0 C--O 1.232 0.153 0 C-N-CA 123.701 0.8 . . . . 0.0 109.785 -177.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -66.24 148.38 84.71 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 123.008 2.472 . . . . 0.0 110.083 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 76.3 -13.5 7.73 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-O 119.502 -0.61 . . . . 0.0 112.429 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -106.21 -14.58 15.09 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 177.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 85.1 p -79.08 155.76 28.63 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.133 0.573 . . . . 0.0 110.413 178.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -60.47 -24.14 65.03 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -74.03 6.65 3.23 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 178.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 36.3 t -143.51 -6.28 0.81 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -177.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 4.1 ppt_? -145.68 10.15 1.21 Allowed 'General case' 0 C--N 1.339 0.138 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 58.3 m -143.96 9.89 1.52 Allowed 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.5 m -64.85 123.82 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 122.665 0.386 . . . . 0.0 111.951 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -130.82 4.53 4.54 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -176.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 69.6 m 57.02 12.21 1.17 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -174.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 90.2 t -141.0 134.27 31.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.438 ' N ' HD22 ' A' ' 192' ' ' LEU . 2.0 mm? -122.14 153.07 39.23 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 122.663 0.385 . . . . 0.0 111.299 -175.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 24.8 tp -100.03 136.73 39.49 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 169.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -113.07 112.47 23.91 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 176.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.72 125.8 45.66 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 175.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.6 mp -96.96 124.81 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 22.0 mt -86.2 -25.94 25.37 Favored 'General case' 0 N--CA 1.458 -0.056 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -174.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -141.33 79.04 17.98 Favored Pre-proline 0 N--CA 1.455 -0.218 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -176.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -76.71 46.63 1.93 Allowed 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 125.182 3.921 . . . . 0.0 112.278 -177.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.408 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -69.99 -4.68 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 O-C-N 121.845 -0.534 . . . . 0.0 110.703 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -135.75 158.48 44.29 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 176.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 68.6 m -68.94 112.57 5.68 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 42.6 mm -78.5 139.72 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 176.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.06 159.95 39.25 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.4 p -64.92 -17.05 64.01 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 176.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -75.18 -45.97 37.15 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.366 0.266 . . . . 0.0 111.378 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.1 m -71.19 -32.05 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.53 -34.68 70.25 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 176.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -71.47 -30.97 66.61 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 174.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 10.7 m -66.92 -33.84 76.47 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 42.8 pt -91.74 -22.44 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 119.012 -0.518 . . . . 0.0 112.042 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 92.8 m -91.27 -25.57 19.41 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -178.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.493 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 32.2 t30 -64.0 -41.83 65.38 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-O 118.412 -0.804 . . . . 0.0 113.087 -179.115 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 72.9 Cg_endo -69.13 -13.44 36.27 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 CA-C-N 120.938 1.371 . . . . 0.0 111.669 178.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 97.1 m -89.39 -8.03 53.96 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 177.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 146.88 168.75 13.97 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.469 -0.653 . . . . 0.0 111.469 176.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.55 104.35 0.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.678 2.919 . . . . 0.0 111.966 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 75.8 t -75.53 143.77 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 175.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -115.64 -39.45 3.53 Favored 'General case' 0 C--O 1.227 -0.115 0 CA-C-O 119.431 -0.318 . . . . 0.0 111.39 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 66.8 mtm-85 -147.81 152.23 37.33 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 20.3 mt -148.51 137.15 15.14 Favored 'Isoleucine or valine' 0 C--N 1.339 0.13 0 C-N-CA 124.15 0.98 . . . . 0.0 109.927 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 3.9 m -142.73 160.79 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.087 0 C-N-CA 123.632 0.773 . . . . 0.0 110.568 174.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 45.4 mt -133.84 142.26 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 C-N-CA 122.591 0.356 . . . . 0.0 110.369 -175.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.295 4.1 p90 -140.96 157.24 45.63 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 177.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -128.03 15.61 6.8 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.271 0.628 . . . . 0.0 110.626 -174.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -62.85 -30.92 71.87 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -169.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -130.62 6.48 4.77 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.518 0.599 . . . . 0.0 112.144 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 161.62 -123.36 1.2 Allowed Glycine 0 C--N 1.333 0.373 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -173.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 50.9 t -143.23 114.94 2.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 175.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 8.3 mp0 -143.85 167.57 22.01 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.172 0.511 . . . . 0.0 110.786 -176.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.02 165.39 30.03 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.58 0.752 . . . . 0.0 109.215 175.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 59.5 mmm -133.36 152.13 51.9 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 39.4 t -139.39 142.64 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 122.788 0.435 . . . . 0.0 110.389 -178.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -128.06 131.87 49.09 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.842 0.457 . . . . 0.0 110.522 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -105.73 161.42 14.42 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 116.35 1.981 . . . . 0.0 116.35 -176.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -77.72 -13.03 60.02 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 45.2 t -155.81 155.82 33.67 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 121.813 -0.555 . . . . 0.0 111.872 -176.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 38.4 t -64.91 -42.11 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -67.7 -25.87 65.89 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 117.877 0.308 . . . . 0.0 111.657 -176.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 59.2 m -74.62 -31.8 62.11 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 175.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.422 ' HB1' HD21 ' A' ' 192' ' ' LEU . . . -76.04 -30.33 58.39 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.518 0.327 . . . . 0.0 111.157 178.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -68.64 -47.7 65.91 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 117.934 0.334 . . . . 0.0 111.297 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -73.75 -25.2 60.05 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 119.423 -0.322 . . . . 0.0 111.436 -177.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -71.87 -40.85 68.67 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.187 0.449 . . . . 0.0 110.087 176.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.26 -24.96 54.52 Favored 'General case' 0 N--CA 1.458 -0.045 0 C-N-CA 122.961 0.504 . . . . 0.0 110.993 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -90.69 -13.58 33.9 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 39.5 t -112.59 -35.26 5.58 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 118.631 0.651 . . . . 0.0 112.739 -177.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 59.8 mt -90.0 -7.16 54.62 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -177.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -70.78 133.19 46.34 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.78 -5.25 48.46 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 119.932 -0.371 . . . . 0.0 112.369 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.39 166.39 22.7 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 117.711 0.756 . . . . 0.0 110.131 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -123.44 139.61 53.85 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 88.5 mt -73.67 -41.47 55.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.356 45.3 m-85 -82.64 -11.79 58.11 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 117.114 2.265 . . . . 0.0 117.114 178.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 29.4 t 65.94 32.53 8.47 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.699 0.799 . . . . 0.0 111.012 -173.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 179.37 -24.61 0.05 OUTLIER Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' CYS . . . . . 0.408 ' HB3' HD12 ' A' ' 200' ' ' ILE . 74.7 m -145.58 -177.38 5.54 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.707 1.203 . . . . 0.0 109.465 178.129 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 84.3 m 59.42 35.6 23.02 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -177.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.73 150.4 5.27 Favored 'General case' 0 C--N 1.338 0.095 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 175.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 78.3 mt -118.47 156.09 29.66 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -173.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -138.39 139.2 38.85 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.562 1.545 . . . . 0.0 107.14 169.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 31.9 mt -139.34 141.73 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 CA-C-O 120.747 0.308 . . . . 0.0 111.364 -172.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -158.9 161.19 36.77 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.962 176.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -60.55 136.15 57.97 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 177.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 265' ' ' ALA . . . . . 0.437 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -88.28 162.32 16.67 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 122.973 0.509 . . . . 0.0 111.856 -178.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -85.99 -52.82 0.45 Allowed Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 118.505 -0.759 . . . . 0.0 112.808 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -72.07 165.43 32.64 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.759 2.306 . . . . 0.0 110.27 176.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 1.5 t -138.95 7.38 2.47 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 -174.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -152.81 126.41 8.82 Favored 'General case' 0 C--N 1.338 0.068 0 O-C-N 121.778 -0.576 . . . . 0.0 111.771 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.478 ' HG ' ' C6 ' ' B' ' 3' ' ' ' A' . 24.6 mt -87.13 162.85 17.29 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 123.943 0.897 . . . . 0.0 111.467 176.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.455 ' C ' ' H61' ' B' ' 5' ' ' ' A' . 60.7 m-80 -121.77 54.67 1.14 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.804 0.842 . . . . 0.0 109.356 171.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.443 ' HA ' ' N1 ' ' B' ' 5' ' ' ' A' . 2.6 t -54.02 146.34 3.45 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -175.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -127.83 -7.23 5.57 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 117.625 2.454 . . . . 0.0 117.625 -176.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -164.48 172.87 12.76 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 117.995 0.362 . . . . 0.0 110.676 -178.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -125.5 116.8 22.36 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.017 0.927 . . . . 0.0 109.916 173.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 55.9 p30 -159.74 -166.95 1.87 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -68.35 -11.42 59.52 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -174.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -111.98 -20.34 12.02 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -143.39 143.31 31.58 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.691 0.796 . . . . 0.0 112.762 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 18.4 t-105 -161.0 156.11 24.25 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.277 -178.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -136.81 117.92 14.41 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.498 0.719 . . . . 0.0 110.165 173.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.256 64.1 m-85 -82.08 7.01 14.5 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 117.39 2.367 . . . . 0.0 117.39 -173.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 5.8 t -139.61 -18.81 0.95 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -95.34 113.3 61.34 Favored Pre-proline 0 N--CA 1.453 -0.277 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 175.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.21 -16.77 13.7 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 123.341 2.694 . . . . 0.0 112.113 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -72.24 -15.05 61.92 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -176.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 78.7 mt -93.37 -8.29 42.29 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 46.6 t -78.55 -26.99 45.82 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.297 0.239 . . . . 0.0 111.423 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -81.73 -2.88 90.68 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-O 119.883 -0.398 . . . . 0.0 112.267 -179.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -81.47 -2.93 51.51 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 117.509 0.654 . . . . 0.0 111.646 -177.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.216 0 CA-C-O 117.324 -1.82 . . . . 0.0 111.458 179.999 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.869 0 C3'-C2'-C1' 104.355 3.172 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.437 ' N3 ' ' HA ' ' A' ' 265' ' ' ALA . . . . . . . . 0 O4'--C4' 1.422 -2.621 2 O4'-C1'-N19 112.639 4.439 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.478 ' C6 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.423 -2.47 2 C5'-C4'-C3' 106.928 -5.714 . 0.01 4s . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.619 2.587 1 C5'-C4'-C3' 109.084 -4.277 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.455 ' H61' ' C ' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.418 -2.889 1 C3'-C2'-C1' 105.331 4.257 OUTLIER-DELTA 0.019 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.688 2 O4'-C1'-N19 113.451 5.251 . 0.087 2[ . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -67.53 148.39 51.53 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.025 0.53 . . . . 0.0 110.797 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.44 HG22 ' H ' ' A' ' 178' ' ' ARG . 32.2 mt -127.79 147.41 32.5 Favored 'Isoleucine or valine' 0 C--O 1.23 0.068 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 73.1 m -96.25 8.11 44.74 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -175.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.44 ' H ' HG22 ' A' ' 176' ' ' ILE . 3.8 mpt_? -83.71 -41.24 0.78 Allowed Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' A' ' 178' ' ' ARG . 46.5 Cg_exo -60.4 156.28 42.07 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.171 2.58 . . . . 0.0 112.207 176.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -71.98 -15.5 76.32 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 178.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -77.19 -3.41 39.44 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 176.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 30.5 t -67.17 148.03 52.32 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 122.967 0.507 . . . . 0.0 110.655 178.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -61.55 -17.22 53.96 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -81.41 0.86 35.64 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 176.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 69.8 m -139.61 0.34 1.83 Allowed 'General case' 0 C--N 1.341 0.204 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -174.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -147.59 10.62 0.96 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 67.2 p -150.89 15.57 0.75 Allowed 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 176.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.7 m -71.68 109.72 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -130.46 10.39 5.23 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.345 0.658 . . . . 0.0 112.197 177.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 54.5 m 65.58 19.91 11.56 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.338 1.055 . . . . 0.0 113.639 -176.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 35.8 t -126.56 143.05 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 C-N-CA 123.036 0.534 . . . . 0.0 110.483 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 84.5 mt -136.53 146.07 45.77 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 122.712 0.405 . . . . 0.0 111.162 -176.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 48.7 tp -95.36 136.53 35.61 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 172.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -116.13 101.22 8.53 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.003 1.321 . . . . 0.0 114.315 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.07 140.51 36.45 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 174.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 3.9 mp -110.66 116.24 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -90.46 -18.09 25.98 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -170.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -143.18 78.86 14.73 Favored Pre-proline 0 CA--C 1.528 0.127 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -76.98 42.7 1.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 125.206 3.937 . . . . 0.0 112.625 -177.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.469 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -69.77 -5.11 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 O-C-N 121.747 -0.595 . . . . 0.0 110.693 -179.504 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -138.99 156.69 47.03 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 176.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 69.0 m -68.82 117.48 10.56 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 28.0 mm -78.28 145.41 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.02 160.42 37.8 Favored 'General case' 0 C--O 1.23 0.043 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 6.7 p -67.84 -22.98 65.11 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -73.63 -47.14 42.35 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.9 m -70.19 -31.91 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.9 mt -71.12 -35.25 71.68 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -71.36 -29.58 65.14 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 174.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.1 m -69.22 -33.43 73.29 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 42.2 pt -91.7 -22.06 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.95 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 95.1 m -93.42 -25.44 17.66 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -177.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.508 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 38.5 t30 -63.59 -39.56 49.16 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 67.0 Cg_endo -68.56 -14.15 38.96 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 CA-C-N 121.113 1.433 . . . . 0.0 111.954 177.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 92.8 m -89.23 -8.13 54.12 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.106 0.412 . . . . 0.0 111.57 176.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 147.8 166.95 13.0 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 178.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -68.61 105.25 1.25 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.535 2.823 . . . . 0.0 110.472 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 80.3 t -72.35 145.59 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -111.04 -36.81 5.54 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 119.369 -0.348 . . . . 0.0 111.58 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 25.6 mtm180 -149.52 154.02 38.11 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 118.128 0.422 . . . . 0.0 112.035 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 34.3 mt -144.7 143.8 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.035 0.934 . . . . 0.0 109.369 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 55.2 t -145.15 154.61 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 60.2 mt -133.43 140.13 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 C-N-CA 123.423 0.689 . . . . 0.0 109.65 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.253 4.8 p90 -148.18 160.62 42.74 Favored 'General case' 0 N--CA 1.458 -0.026 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 176.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.01 31.31 2.2 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.811 0.444 . . . . 0.0 111.985 -176.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -67.07 -29.81 69.69 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -174.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -130.52 3.32 4.6 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 167.83 -127.12 1.51 Allowed Glycine 0 C--N 1.334 0.443 0 N-CA-C 108.381 -1.888 . . . . 0.0 108.381 -173.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.2 t -139.6 117.94 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-N 117.252 0.526 . . . . 0.0 110.244 173.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 11.5 mp0 -144.19 168.7 19.42 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.651 0.739 . . . . 0.0 111.164 -175.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -150.18 163.96 36.9 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.95 175.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 59.6 mmm -134.54 152.55 51.86 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.633 0.373 . . . . 0.0 110.199 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.3 t -142.42 145.19 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 123.117 0.567 . . . . 0.0 110.047 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -129.06 132.5 47.45 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 122.555 0.342 . . . . 0.0 110.284 176.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -102.36 161.71 13.49 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -177.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -81.27 -10.44 59.58 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 30.6 t -154.51 151.34 28.8 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 121.761 -0.587 . . . . 0.0 112.106 -176.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 50.3 t -68.13 -38.22 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -178.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -67.06 -24.93 66.02 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.123 0.42 . . . . 0.0 111.151 -178.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 55.3 m -75.77 -32.84 60.12 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 176.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -78.08 -31.86 50.39 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 122.361 -0.212 . . . . 0.0 110.961 178.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -66.55 -41.74 88.19 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 121.993 -0.442 . . . . 0.0 111.474 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -77.08 -28.15 54.5 Favored 'General case' 0 CA--C 1.527 0.07 0 CA-C-N 117.937 0.335 . . . . 0.0 110.872 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -69.95 -41.24 74.81 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.05 0.387 . . . . 0.0 109.959 177.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -74.24 -20.63 60.1 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.618 0.367 . . . . 0.0 111.023 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -98.77 -5.08 31.96 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 42.6 t -124.16 -30.44 3.46 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 56.3 mt -93.83 -6.66 45.33 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.247 0.476 . . . . 0.0 111.479 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -72.45 131.66 42.87 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.97 -4.64 53.09 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 119.85 -0.417 . . . . 0.0 112.259 -178.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.9 166.56 22.25 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 117.817 0.809 . . . . 0.0 110.169 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -123.67 139.3 54.13 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 89.5 mt -74.43 -41.66 49.71 Favored 'Isoleucine or valine' 0 C--O 1.23 0.071 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.355 35.9 m-85 -82.82 -11.88 57.9 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 117.065 2.246 . . . . 0.0 117.065 178.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 30.1 t 65.74 34.02 7.82 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.533 0.733 . . . . 0.0 111.171 -173.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 177.44 -24.35 0.05 OUTLIER Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.11 0.862 . . . . 0.0 111.123 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' CYS . . . . . 0.469 ' HB3' HD12 ' A' ' 200' ' ' ILE . 75.0 m -145.43 -175.74 4.84 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.527 1.131 . . . . 0.0 109.383 178.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 88.8 m 57.84 36.04 26.0 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -176.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.3 147.53 13.26 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 176.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 78.9 mt -114.35 156.85 23.68 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -173.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -139.32 138.2 36.47 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 169.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 46.5 mt -137.1 142.48 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.066 0 CA-C-O 120.66 0.267 . . . . 0.0 111.56 -172.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -159.51 161.82 35.39 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.094 176.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.287 35.6 m-85 -61.44 135.54 57.72 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 177.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 265' ' ' ALA . . . . . 0.447 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -93.16 157.18 16.4 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.999 -177.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.447 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 23.2 pttp -91.19 -31.33 0.34 Allowed Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 50.3 Cg_endo -79.46 161.4 25.37 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 CA-C-N 121.766 1.666 . . . . 0.0 110.154 176.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.298 0.2 OUTLIER -135.5 13.56 3.47 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 -178.056 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -156.36 126.37 6.46 Favored 'General case' 0 C--O 1.227 -0.1 0 O-C-N 121.871 -0.518 . . . . 0.0 111.521 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 23.1 mt -88.32 163.99 15.79 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.69 0.796 . . . . 0.0 110.546 174.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.468 ' C ' ' H61' ' B' ' 5' ' ' ' A' . 0.5 OUTLIER -122.89 44.24 2.71 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.342 0.591 . . . . 0.0 110.361 171.14 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.1 t -48.1 140.0 2.41 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -176.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.418 ' CZ ' ' C2 ' ' B' ' 5' ' ' ' A' 0.277 5.3 p90 -122.87 -6.27 8.5 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 117.267 2.321 . . . . 0.0 117.267 -177.949 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -163.37 167.98 21.01 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 122.956 0.503 . . . . 0.0 110.176 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -119.09 123.46 44.49 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.351 0.66 . . . . 0.0 109.734 174.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 50.6 p30 -159.32 -168.29 2.28 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.829 0.852 . . . . 0.0 108.93 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -70.41 -10.13 58.26 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -177.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -102.41 -33.63 9.47 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.5 p -142.68 145.75 33.72 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 124.257 1.023 . . . . 0.0 113.188 176.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 21.7 t-105 -153.62 153.73 32.87 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -176.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -131.32 116.8 18.05 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.252 0.621 . . . . 0.0 111.607 175.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.253 67.1 m-85 -83.16 7.67 15.4 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 117.449 2.388 . . . . 0.0 117.449 -172.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 9.9 t -137.32 -21.85 1.17 Allowed 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -95.46 113.28 61.39 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 174.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.6 -16.19 15.04 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.273 2.649 . . . . 0.0 112.403 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -74.21 -15.71 60.99 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -174.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 81.4 mt -89.84 -4.98 57.31 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 117.889 0.313 . . . . 0.0 111.518 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 47.6 t -75.93 145.73 40.19 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 122.454 0.301 . . . . 0.0 110.738 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 69.92 2.57 39.0 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-O 119.653 -0.526 . . . . 0.0 113.39 176.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -69.35 149.81 48.01 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 118.33 1.065 . . . . 0.0 111.074 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 CA-C-O 117.195 -1.891 . . . . 0.0 110.87 178.883 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.818 0 C3'-C2'-C1' 104.342 3.158 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.447 ' N3 ' ' HA ' ' A' ' 265' ' ' ALA . . . . . . . . 0 O4'--C4' 1.42 -2.735 0 O4'-C1'-N19 111.575 3.375 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.933 2 O4'-C1'-N19 112.96 4.76 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 4' ' ' ' C' . . . . . 0.401 ' C2 ' ' OD1' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.42 -2.756 1 C5'-C4'-C3' 108.032 -4.979 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.468 ' H61' ' C ' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.416 -3.075 1 C3'-C2'-C1' 105.148 4.054 OUTLIER-DELTA 0.136 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.704 0 O4'-C1'-N19 111.773 3.573 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 CA--C 1.532 0.273 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.6 t -128.71 142.08 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 C-N-CA 122.988 0.515 . . . . 0.0 110.924 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 84.7 mt -135.02 149.49 50.17 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 122.663 0.385 . . . . 0.0 111.884 -174.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 32.0 tp -102.72 136.67 42.12 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.576 0.75 . . . . 0.0 109.223 172.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -115.27 107.05 14.76 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.938 1.295 . . . . 0.0 114.465 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.05 127.76 38.69 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 175.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.5 mp -97.95 127.53 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 20.7 mt -89.37 -26.34 21.1 Favored 'General case' 0 CA--C 1.527 0.062 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -174.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -141.17 79.1 18.23 Favored Pre-proline 0 N--CA 1.453 -0.284 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -176.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -77.34 45.31 1.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 125.251 3.967 . . . . 0.0 111.988 -177.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.446 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -69.47 -4.2 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 O-C-N 121.877 -0.515 . . . . 0.0 110.597 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -136.52 155.84 49.41 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 66.3 m -67.85 113.2 5.39 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 33.6 mm -78.39 141.53 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.99 159.76 39.77 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.6 p -64.8 -15.41 61.68 Favored 'General case' 0 C--O 1.23 0.05 0 N-CA-C 114.314 1.228 . . . . 0.0 114.314 177.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -76.12 -46.52 28.41 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.676 0.274 . . . . 0.0 111.541 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.0 m -70.85 -31.1 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.1 mt -72.39 -35.17 68.37 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 176.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -70.6 -30.65 67.38 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 173.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.1 m -67.26 -34.56 77.7 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 43.9 pt -91.46 -21.73 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 118.405 0.548 . . . . 0.0 112.239 178.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 91.3 m -91.21 -25.87 19.31 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.499 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 31.8 t30 -63.82 -41.37 63.73 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 74.4 Cg_endo -69.27 -13.84 36.59 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 CA-C-N 120.857 1.342 . . . . 0.0 111.645 177.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 91.7 m -91.96 -4.49 54.53 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.787 0.435 . . . . 0.0 111.701 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 146.95 166.79 12.57 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 177.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.53 103.14 1.08 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.587 2.858 . . . . 0.0 110.17 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 64.8 t -69.51 146.82 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -114.44 -37.53 4.3 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 119.244 -0.408 . . . . 0.0 111.579 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 39.2 mtm-85 -149.95 151.87 34.06 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.574 0.625 . . . . 0.0 112.035 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 17.8 mt -146.12 140.97 21.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 C-N-CA 124.211 1.004 . . . . 0.0 109.527 177.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 59.7 t -146.78 156.51 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 47.6 mt -134.45 142.22 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 123.698 0.799 . . . . 0.0 110.009 -178.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.297 3.2 p90 -143.28 159.22 42.75 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 176.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -128.76 15.52 6.41 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.989 0.516 . . . . 0.0 111.137 -173.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -62.86 -32.46 73.7 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -169.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -130.49 8.84 5.03 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 118.597 0.635 . . . . 0.0 112.239 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 159.92 -125.11 1.43 Allowed Glycine 0 C--N 1.335 0.516 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 -174.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.4 t -141.18 115.3 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -142.29 166.89 23.45 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.268 0.556 . . . . 0.0 110.956 -176.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.37 165.47 29.23 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.405 175.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 76.5 mmm -133.42 153.25 51.77 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 28.2 t -141.79 145.64 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 C-N-CA 123.292 0.637 . . . . 0.0 110.667 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -132.61 133.93 44.25 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.727 0.411 . . . . 0.0 110.126 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -105.51 161.75 14.07 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 -176.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -78.25 -14.65 59.35 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 82.6 p -155.11 157.98 38.32 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.25 0.548 . . . . 0.0 111.548 -177.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 53.8 t -66.38 -36.08 76.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -65.44 -32.17 73.65 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 122.354 -0.216 . . . . 0.0 110.711 -176.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 63.8 m -72.65 -34.84 67.53 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 121.27 -0.172 . . . . 0.0 110.639 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -73.45 -31.54 63.85 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 119.732 -0.175 . . . . 0.0 111.114 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -68.32 -44.14 76.02 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 118.199 0.454 . . . . 0.0 111.831 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 -77.29 -25.29 51.17 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 118.102 0.41 . . . . 0.0 111.34 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -72.06 -41.13 67.78 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 122.065 -0.397 . . . . 0.0 110.077 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -74.65 -21.26 59.53 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 122.974 0.51 . . . . 0.0 111.194 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -97.18 -10.52 25.73 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 44.2 t -116.12 -34.01 4.84 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 118.62 0.645 . . . . 0.0 112.594 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 50.7 mt -90.73 -6.95 53.76 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 122.139 -0.35 . . . . 0.0 111.837 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -72.26 132.4 44.01 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.25 -4.53 47.87 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 112.156 -0.378 . . . . 0.0 112.156 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.22 166.39 22.78 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 117.52 0.66 . . . . 0.0 110.187 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -123.61 139.61 53.83 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 85.1 mt -74.42 -41.51 49.77 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.36 44.0 m-85 -82.87 -11.47 58.18 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 117.037 2.236 . . . . 0.0 117.037 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 29.0 t 65.51 34.48 7.9 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.604 0.762 . . . . 0.0 111.059 -173.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 177.15 -23.96 0.05 OUTLIER Glycine 0 CA--C 1.528 0.881 0 C-N-CA 123.972 0.796 . . . . 0.0 111.158 177.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' CYS . . . . . 0.446 ' HB3' HD12 ' A' ' 200' ' ' ILE . 96.8 m -145.92 -177.29 5.52 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.702 1.201 . . . . 0.0 109.52 178.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 88.0 m 58.64 37.0 25.33 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -176.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.96 151.39 6.76 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 175.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 73.6 mt -119.67 157.64 28.1 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -173.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -139.54 140.38 37.12 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.786 1.634 . . . . 0.0 107.294 168.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 38.4 mt -138.1 142.74 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 CA-C-O 120.848 0.356 . . . . 0.0 111.668 -173.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -158.57 161.87 37.31 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.04 176.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.265 41.5 m-85 -61.96 134.81 57.12 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 177.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -88.58 157.0 18.73 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.178 -178.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.476 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 23.2 pttp -90.14 -32.25 0.37 Allowed Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 117.413 -1.279 . . . . 0.0 114.307 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 68.2 Cg_endo -76.55 166.95 26.44 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 CA-C-N 121.893 1.712 . . . . 0.0 109.462 174.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.3 0.2 OUTLIER -130.04 0.47 4.73 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 -175.811 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 20.3 ttp180 -160.55 140.97 11.53 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.775 -0.578 . . . . 0.0 110.952 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 25.8 mt -85.25 171.47 11.91 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.115 0.966 . . . . 0.0 110.668 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -126.19 46.63 2.4 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 169.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.5 t -48.58 139.68 2.94 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -175.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . 0.278 6.2 p90 -120.37 -12.12 9.04 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 117.391 2.367 . . . . 0.0 117.391 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -163.6 173.91 12.41 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 122.853 0.461 . . . . 0.0 110.811 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -119.99 129.23 54.18 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.403 0.681 . . . . 0.0 110.544 176.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 39.5 p30 -160.5 -166.63 1.69 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.529 1.132 . . . . 0.0 108.824 176.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -68.36 -15.05 63.42 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -174.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -115.07 -12.19 11.98 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.49 139.17 35.06 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.832 0.853 . . . . 0.0 112.513 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 21.2 t-105 -161.17 154.48 21.53 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.473 -177.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -132.32 117.1 17.71 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.42 173.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.272 63.8 m-85 -81.71 8.6 9.58 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 117.362 2.356 . . . . 0.0 117.362 -172.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 11.3 t . . . . . 0 CA--C 1.527 0.08 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -179.296 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 66.7 m . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 25.1 t -130.9 140.53 48.46 Favored 'Isoleucine or valine' 0 C--N 1.338 0.108 0 C-N-CA 122.83 0.452 . . . . 0.0 110.777 176.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 93.7 mt -130.76 159.2 38.02 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 122.961 0.504 . . . . 0.0 111.128 -176.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.1 tt -115.87 135.61 53.83 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.109 174.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -115.99 105.7 12.94 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -87.18 137.08 32.65 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 174.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.3 mp -106.94 118.21 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -88.48 -17.87 29.44 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -171.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -142.56 78.9 15.78 Favored Pre-proline 0 CA--C 1.529 0.156 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -77.98 46.55 2.1 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 125.132 3.888 . . . . 0.0 112.405 -177.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.424 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -71.42 -3.83 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 O-C-N 121.873 -0.517 . . . . 0.0 110.505 179.322 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -136.67 159.08 42.88 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 176.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 70.2 m -70.91 113.11 7.63 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.638 0.256 . . . . 0.0 110.373 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 33.8 mm -78.27 140.47 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.96 159.36 40.96 Favored 'General case' 0 C--O 1.23 0.058 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.4 p -65.2 -14.89 61.72 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 176.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -76.91 -45.49 27.75 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.589 0.356 . . . . 0.0 110.657 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 1.7 m -71.2 -32.42 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.88 -34.57 69.28 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 177.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -71.57 -29.71 65.03 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 174.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 8.2 m -67.29 -35.02 78.62 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 37.9 pt -91.32 -24.08 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 119.177 -0.44 . . . . 0.0 111.758 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 86.9 m -88.99 -25.46 22.01 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.474 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 31.4 t30 -63.13 -44.82 85.2 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-O 118.518 -0.753 . . . . 0.0 112.907 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 68.7 Cg_endo -68.18 -15.69 43.17 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.356 1.371 . . . . 0.0 111.478 178.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 95.2 m -84.12 -15.34 47.61 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 117.918 0.327 . . . . 0.0 111.715 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 152.4 169.3 17.6 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -61.42 104.82 0.32 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.768 2.979 . . . . 0.0 111.922 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 73.6 t -76.34 145.13 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -116.81 -38.38 3.45 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-O 119.394 -0.336 . . . . 0.0 111.579 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 41.3 mtm-85 -148.88 151.48 34.77 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 21.7 mt -147.71 136.48 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 124.036 0.934 . . . . 0.0 109.748 177.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.41 160.21 22.13 Favored 'Isoleucine or valine' 0 C--N 1.337 0.062 0 C-N-CA 123.592 0.757 . . . . 0.0 110.9 174.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 48.4 mt -134.43 141.51 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 123.189 0.596 . . . . 0.0 110.491 -175.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.292 5.8 p90 -140.82 157.78 44.91 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -127.21 14.26 7.23 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.449 0.699 . . . . 0.0 110.755 -174.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -61.97 -31.56 71.92 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -169.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -130.7 7.88 4.85 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 118.634 0.652 . . . . 0.0 112.289 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 161.38 -124.33 1.3 Allowed Glycine 0 CA--C 1.521 0.465 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 -174.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 47.9 t -142.73 115.07 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -143.95 167.73 21.66 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.324 0.583 . . . . 0.0 110.589 -176.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.25 164.29 32.77 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.879 0.871 . . . . 0.0 109.067 175.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 81.6 mmm -131.71 153.01 50.48 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 26.3 t -139.6 143.38 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.097 0 C-N-CA 122.786 0.434 . . . . 0.0 111.067 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -127.49 132.17 50.02 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.035 0.534 . . . . 0.0 110.337 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -108.27 161.94 14.54 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -176.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -80.95 -11.81 59.5 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 30.7 t -155.28 152.45 29.25 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.386 0.539 . . . . 0.0 111.893 -175.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 54.1 t -67.74 -38.27 80.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -67.78 -27.33 66.67 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 122.348 -0.22 . . . . 0.0 110.953 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 69.0 m -72.59 -34.35 67.35 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 176.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -77.48 -29.86 52.86 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 111.425 0.157 . . . . 0.0 111.425 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -67.75 -43.27 80.3 Favored 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 121.932 -0.48 . . . . 0.0 111.539 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -77.85 -24.23 48.65 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-N 117.842 0.292 . . . . 0.0 110.797 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -72.81 -41.19 65.18 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.098 0.408 . . . . 0.0 110.283 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -74.98 -23.39 58.27 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.814 0.446 . . . . 0.0 111.392 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -92.39 -17.21 24.94 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 48.1 t -106.16 -36.51 6.88 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -177.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 72.1 mt -89.42 -9.11 51.44 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -69.95 133.8 47.67 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.28 -5.54 42.51 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 119.748 -0.473 . . . . 0.0 112.205 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.4 166.41 22.67 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.792 0.796 . . . . 0.0 110.289 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -123.52 138.37 54.58 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 82.3 mt -72.66 -41.65 62.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.346 45.8 m-85 -82.9 -12.27 57.51 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.9 t 66.08 33.93 7.22 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.709 0.766 . . . . 0.0 110.936 -174.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 178.23 -24.7 0.05 OUTLIER Glycine 0 CA--C 1.528 0.856 0 C-N-CA 123.986 0.803 . . . . 0.0 111.289 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' CYS . . . . . 0.424 ' HB3' HD12 ' A' ' 200' ' ' ILE . 72.8 m -145.74 -176.97 5.34 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.532 1.133 . . . . 0.0 109.422 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 89.8 m 57.64 37.88 27.54 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.856 0.462 . . . . 0.0 112.04 -176.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.2 147.49 13.01 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 175.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 79.6 mt -114.11 155.58 25.75 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -173.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -138.77 138.63 37.79 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.163 1.385 . . . . 0.0 107.597 169.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 37.0 mt -139.02 142.69 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-O 120.744 0.307 . . . . 0.0 111.75 -171.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -158.49 163.13 37.4 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.348 0.659 . . . . 0.0 109.478 175.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.266 44.1 m-85 -62.51 138.17 58.41 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 176.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -87.37 154.31 20.77 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.484 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.436 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 23.2 pttp -88.35 -31.76 0.39 Allowed Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 117.489 -1.243 . . . . 0.0 114.255 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 48.1 Cg_endo -79.94 162.56 23.58 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.743 1.629 . . . . 0.0 109.861 174.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.282 0.2 OUTLIER -137.79 18.75 2.86 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 116.747 2.129 . . . . 0.0 116.747 -176.462 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.469 ' CZ ' ' HA ' ' A' ' 269' ' ' ARG . 1.3 tpm_? -155.37 106.48 2.56 Favored 'General case' 0 C--N 1.34 0.169 0 O-C-N 121.734 -0.604 . . . . 0.0 112.301 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 9.4 mt -75.96 158.41 32.0 Favored 'General case' 0 N--CA 1.458 -0.062 0 C-N-CA 122.747 0.419 . . . . 0.0 110.161 173.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -127.02 54.56 1.63 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.685 0.794 . . . . 0.0 109.781 172.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 272' ' ' VAL . 2.5 t -54.61 143.93 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -177.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -126.94 -7.7 6.05 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 117.557 2.429 . . . . 0.0 117.557 -176.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -162.17 173.04 14.83 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 122.809 0.444 . . . . 0.0 110.001 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -125.46 123.05 38.37 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.589 0.756 . . . . 0.0 110.05 175.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 46.5 p30 -159.99 -166.39 1.71 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.959 0.904 . . . . 0.0 108.575 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -68.11 -15.13 63.46 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -175.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -114.76 -12.88 12.09 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.64 139.77 34.9 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.631 0.772 . . . . 0.0 112.547 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 20.2 t-105 -161.02 156.86 25.31 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.446 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -136.46 116.32 13.16 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.553 172.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.275 66.4 m-85 -79.05 7.22 7.73 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 117.26 2.318 . . . . 0.0 117.26 -173.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.456 -0.169 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -179.798 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 CA--C 1.53 0.194 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 38.8 t -130.51 133.76 63.2 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 C-N-CA 122.88 0.472 . . . . 0.0 111.292 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.429 HD21 ' HB1' ' A' ' 241' ' ' ALA . 2.5 mm? -122.63 152.86 40.06 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 122.987 0.515 . . . . 0.0 111.066 -177.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 28.4 tp -103.31 134.04 47.37 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 170.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -111.86 110.97 21.6 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.49 131.55 40.09 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 173.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.6 mp -102.1 120.4 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -88.42 -20.38 25.31 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 119.307 -0.378 . . . . 0.0 111.898 -172.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -142.19 78.94 16.46 Favored Pre-proline 0 CA--C 1.529 0.156 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.89 46.4 2.05 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 125.086 3.857 . . . . 0.0 112.249 -177.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.415 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -70.66 -3.58 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 O-C-N 121.86 -0.525 . . . . 0.0 110.822 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -136.85 158.04 45.36 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 176.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 69.3 m -69.47 111.22 5.18 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 41.0 mm -78.34 139.06 19.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.14 161.82 33.82 Favored 'General case' 0 CA--C 1.523 -0.094 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.3 p -64.45 -18.44 64.75 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 177.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -73.41 -39.75 64.81 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 1.5 m -75.89 -33.79 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 97.0 mt -71.37 -33.07 69.21 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 176.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -72.15 -30.53 65.11 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 175.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 20.6 m -67.23 -34.79 78.22 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 43.5 pt -90.89 -22.13 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 119.045 -0.503 . . . . 0.0 111.887 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 84.1 m -91.26 -26.62 18.91 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.506 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 32.7 t30 -63.99 -40.44 54.42 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 70.3 Cg_endo -69.32 -14.52 37.62 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.494 1.462 . . . . 0.0 111.477 177.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 98.8 m -89.88 -8.56 51.63 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.575 0.35 . . . . 0.0 111.614 177.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 149.54 170.32 16.91 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 177.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.68 102.56 1.03 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.933 3.089 . . . . 0.0 110.736 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 73.4 t -71.17 146.81 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 176.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -115.47 -36.17 4.37 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 119.377 -0.344 . . . . 0.0 111.651 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -149.68 151.9 34.46 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.417 0.553 . . . . 0.0 112.192 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 25.3 mt -147.2 136.76 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 124.195 0.998 . . . . 0.0 109.883 177.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 1.2 m -140.47 160.7 24.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.08 0 C-N-CA 123.485 0.714 . . . . 0.0 111.803 174.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 55.3 mt -135.78 144.08 34.59 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 C-N-CA 123.434 0.693 . . . . 0.0 109.832 -176.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.291 3.3 p90 -144.54 157.18 44.34 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 177.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -127.7 15.22 7.0 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.18 0.592 . . . . 0.0 110.883 -172.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -64.09 -30.94 71.97 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -169.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -130.54 4.91 4.69 Favored 'General case' 0 CA--C 1.527 0.074 0 CA-C-N 118.596 0.634 . . . . 0.0 112.262 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 163.76 -124.47 1.28 Allowed Glycine 0 C--N 1.334 0.459 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 -173.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 61.8 t -142.99 114.63 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 175.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 -142.83 168.17 20.36 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.021 0.439 . . . . 0.0 111.009 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.15 165.74 29.96 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.675 0.79 . . . . 0.0 109.456 177.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 61.4 mmm -134.36 153.47 51.87 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 42.6 t -141.59 144.19 26.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 C-N-CA 122.676 0.39 . . . . 0.0 110.116 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -131.67 132.82 44.27 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 122.395 0.278 . . . . 0.0 110.571 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -104.42 162.54 13.14 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -81.89 -8.21 59.66 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 44.8 t -154.5 150.74 28.13 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.811 -0.556 . . . . 0.0 111.973 -176.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 52.0 t -67.66 -36.1 74.99 Favored 'Isoleucine or valine' 0 C--N 1.338 0.096 0 C-N-CA 123.279 0.632 . . . . 0.0 109.356 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -67.22 -28.65 68.25 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 118.295 0.498 . . . . 0.0 110.866 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 63.2 m -75.43 -30.45 60.02 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.429 ' HB1' HD21 ' A' ' 192' ' ' LEU . . . -75.83 -31.94 59.58 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.342 0.257 . . . . 0.0 111.3 178.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -70.69 -43.84 68.21 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -74.59 -26.45 59.93 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 117.792 0.269 . . . . 0.0 111.05 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -71.98 -41.51 67.6 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 118.087 0.403 . . . . 0.0 110.042 177.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -75.6 -20.57 58.47 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 122.603 0.361 . . . . 0.0 111.399 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -95.93 -13.12 24.13 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 47.1 t -113.28 -33.6 5.91 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 59.7 mt -90.56 -7.78 51.96 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 118.003 0.365 . . . . 0.0 111.816 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -71.87 133.69 45.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 177.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.36 -5.87 40.94 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.924 -0.47 . . . . 0.0 111.924 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.87 166.44 22.41 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.793 0.796 . . . . 0.0 110.473 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -123.7 139.65 53.78 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 84.4 mt -74.22 -41.69 51.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.351 42.8 m-85 -82.97 -11.82 57.81 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 178.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 23.2 t 65.71 35.48 6.87 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.631 0.772 . . . . 0.0 111.087 -174.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 176.17 -23.76 0.06 OUTLIER Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.127 0.87 . . . . 0.0 111.266 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' CYS . . . . . 0.415 ' HB3' HD12 ' A' ' 200' ' ' ILE . 98.5 m -146.37 -177.23 5.51 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.628 1.171 . . . . 0.0 109.47 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 89.1 m 58.19 36.23 25.62 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -176.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.1 148.98 10.04 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 175.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 75.9 mt -116.28 154.75 29.61 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -173.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -138.45 138.32 38.03 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.065 1.346 . . . . 0.0 107.596 169.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 33.1 mt -137.74 143.28 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-O 120.685 0.278 . . . . 0.0 111.514 -171.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -158.23 163.25 37.64 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.312 0.645 . . . . 0.0 109.374 175.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.268 37.8 m-85 -62.63 134.31 56.16 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 177.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -84.38 161.03 20.52 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.351 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.487 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 64.0 pttt -93.56 -31.58 0.3 Allowed Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 178.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 86.1 Cg_endo -75.88 171.12 18.77 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.913 1.742 . . . . 0.0 110.295 175.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.96 -1.61 2.67 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 117.26 2.319 . . . . 0.0 117.26 -175.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.35 133.55 11.6 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-N 118.766 0.712 . . . . 0.0 111.727 -178.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 19.2 mt -92.31 157.76 16.47 Favored 'General case' 0 C--O 1.228 -0.04 0 C-N-CA 124.137 0.975 . . . . 0.0 111.516 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -120.97 47.76 1.76 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.734 0.813 . . . . 0.0 109.86 174.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.414 HG23 ' H ' ' A' ' 272' ' ' VAL . 2.5 t -53.09 143.91 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.092 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -177.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . 0.26 10.2 p90 -128.22 -4.57 5.53 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 116.868 2.173 . . . . 0.0 116.868 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.14 172.35 18.26 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 123.245 0.618 . . . . 0.0 111.689 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -125.68 121.82 34.57 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.752 0.821 . . . . 0.0 109.65 175.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 49.3 p30 -159.27 -166.71 1.88 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.643 0.777 . . . . 0.0 109.653 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -68.21 -14.56 63.07 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -177.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -99.53 -34.91 10.05 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.15 150.46 42.82 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 178.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 22.2 t-105 -157.86 155.59 29.93 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -176.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -131.24 119.17 21.44 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.972 0.509 . . . . 0.0 111.629 175.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.28 67.1 m-85 -83.02 9.35 10.4 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -171.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 9.3 t . . . . . 0 CA--C 1.528 0.126 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -178.531 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 N--CA 1.464 0.226 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 38.4 t -131.8 142.47 42.95 Favored 'Isoleucine or valine' 0 C--N 1.337 0.059 0 C-N-CA 123.362 0.665 . . . . 0.0 110.505 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 83.5 mt -134.6 148.3 50.4 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 122.615 0.366 . . . . 0.0 111.236 -175.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 28.5 tp -99.54 134.36 42.54 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 172.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -112.7 106.76 15.21 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.2 m -90.06 139.99 30.08 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 174.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 3.9 mp -110.34 122.48 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -91.79 -18.47 23.81 Favored 'General case' 0 C--O 1.23 0.06 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -171.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -141.66 78.93 17.47 Favored Pre-proline 0 CA--C 1.529 0.158 0 C-N-CA 122.95 0.5 . . . . 0.0 109.679 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -77.29 50.07 3.04 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 124.926 3.751 . . . . 0.0 112.179 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.45 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -69.72 -6.5 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 O-C-N 121.761 -0.587 . . . . 0.0 110.011 178.41 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -142.67 155.43 44.91 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.148 1.379 . . . . 0.0 112.337 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 28.5 t -74.97 131.86 40.97 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 25.4 mm -78.66 152.06 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 122.983 0.513 . . . . 0.0 110.338 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.96 157.58 45.68 Favored 'General case' 0 C--N 1.338 0.076 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 39.4 p -68.73 -18.27 64.2 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -77.59 -47.23 19.91 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 118.192 0.451 . . . . 0.0 111.748 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 3.5 m -71.12 -32.2 47.08 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 99.2 mt -70.47 -35.63 73.41 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -71.06 -30.18 66.27 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 175.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.6 m -67.35 -33.38 75.11 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 36.7 pt -93.63 -22.29 5.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 118.486 0.585 . . . . 0.0 111.787 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 89.1 m -90.17 -26.02 20.36 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.494 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 32.4 t30 -63.46 -42.57 74.62 Favored Pre-proline 0 CA--C 1.535 0.38 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 -178.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 70.9 Cg_endo -69.1 -13.19 35.86 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 121.784 1.656 . . . . 0.0 111.644 178.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 91.5 m -88.68 -8.38 54.67 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.041 0.382 . . . . 0.0 111.788 176.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 145.02 169.72 13.63 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 177.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.34 107.61 0.5 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.715 2.943 . . . . 0.0 111.949 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 72.3 t -76.56 146.6 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -117.01 -40.54 3.11 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 119.259 -0.4 . . . . 0.0 111.556 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 65.8 mtm-85 -148.88 152.55 36.64 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 25.4 mt -148.28 136.85 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 C-N-CA 124.305 1.042 . . . . 0.0 110.054 176.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 3.8 m -142.4 159.76 19.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 123.9 0.88 . . . . 0.0 110.519 174.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 48.0 mt -132.13 142.93 41.55 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 122.575 0.35 . . . . 0.0 110.676 -175.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.298 4.8 p90 -142.76 158.39 43.69 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 116.002 1.853 . . . . 0.0 116.002 176.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -130.45 17.68 5.37 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.469 0.708 . . . . 0.0 110.991 -174.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -64.29 -31.21 72.32 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -169.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -130.42 7.47 4.93 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.584 0.629 . . . . 0.0 112.161 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 161.0 -123.62 1.23 Allowed Glycine 0 C--N 1.334 0.451 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 -175.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 41.2 t -140.68 113.97 5.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -144.13 167.24 22.86 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.3 0.571 . . . . 0.0 111.094 -176.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -149.1 165.88 30.42 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.137 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 72.6 mmm -131.68 152.79 50.61 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 39.8 t -140.89 145.1 25.81 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 123.003 0.521 . . . . 0.0 110.385 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -131.23 134.98 46.97 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.007 0.523 . . . . 0.0 110.11 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -109.1 161.96 14.7 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 116.5 2.037 . . . . 0.0 116.5 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -80.23 -10.22 59.75 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 41.0 t -155.59 151.75 27.93 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.694 -0.628 . . . . 0.0 112.131 -176.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 43.5 t -66.39 -38.93 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -68.05 -24.17 65.05 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.784 0.265 . . . . 0.0 111.141 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 65.2 m -75.48 -33.53 60.81 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 175.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -77.51 -31.61 53.62 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 122.37 -0.206 . . . . 0.0 110.96 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -66.2 -43.77 85.82 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 121.931 -0.481 . . . . 0.0 111.358 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -77.12 -25.24 51.9 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.817 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -71.82 -41.39 68.26 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.911 0.323 . . . . 0.0 110.271 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.49 -28.34 62.83 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 122.634 0.374 . . . . 0.0 110.717 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -90.25 -12.94 36.48 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 41.0 t -113.7 -35.71 5.1 Favored 'General case' 0 C--N 1.339 0.122 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -176.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 68.5 mt -88.19 -7.45 56.84 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.024 0.375 . . . . 0.0 111.628 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -71.32 134.66 46.9 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 75.79 -5.47 39.0 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 119.795 -0.447 . . . . 0.0 112.48 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.46 166.35 22.71 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 117.797 0.799 . . . . 0.0 110.408 177.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -123.42 140.83 52.61 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 84.8 mt -75.99 -42.25 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.379 45.2 m-85 -82.89 -10.58 58.76 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 27.3 t 65.71 36.5 6.28 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.6 0.76 . . . . 0.0 110.864 -175.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 174.36 -24.25 0.07 OUTLIER Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 178.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' CYS . . . . . 0.45 ' HB3' HD12 ' A' ' 200' ' ' ILE . 75.9 m -145.62 -177.21 5.46 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.922 1.289 . . . . 0.0 109.367 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 98.6 m 58.26 37.83 26.09 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.83 148.15 13.69 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 175.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 82.2 mt -114.31 156.19 24.85 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -172.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -139.45 138.28 36.32 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.598 1.559 . . . . 0.0 107.2 169.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 31.8 mt -139.23 142.83 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 CA-C-O 120.686 0.279 . . . . 0.0 111.316 -171.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -157.69 160.49 38.01 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 122.927 0.491 . . . . 0.0 109.771 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.283 40.6 m-85 -59.88 135.42 57.69 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 176.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -89.24 159.11 17.59 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.173 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.443 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 23.4 pttp -94.24 -31.8 0.29 Allowed Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 49.1 Cg_endo -79.83 159.12 24.58 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 CA-C-N 121.881 1.708 . . . . 0.0 109.505 174.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.31 0.2 OUTLIER -134.8 15.33 3.62 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 -174.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -158.45 123.0 4.16 Favored 'General case' 0 C--N 1.338 0.074 0 O-C-N 121.931 -0.481 . . . . 0.0 111.559 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 18.9 mt -86.05 161.06 19.12 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 123.583 0.753 . . . . 0.0 110.408 174.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -121.2 51.24 1.29 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.846 171.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.403 ' H ' HG23 ' A' ' 272' ' ' VAL . 2.3 t -51.8 144.87 2.56 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -176.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -129.62 -5.78 4.66 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 117.653 2.464 . . . . 0.0 117.653 -176.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -160.66 170.91 19.85 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 122.558 0.343 . . . . 0.0 110.609 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -125.81 119.6 28.32 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.743 0.817 . . . . 0.0 110.038 174.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -162.69 -167.98 1.69 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.362 1.065 . . . . 0.0 109.087 176.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -70.23 -8.18 48.05 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -176.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -109.26 -26.28 10.15 Favored 'General case' 0 C--N 1.338 0.092 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.08 140.8 31.06 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.275 1.03 . . . . 0.0 112.499 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 21.6 t-105 -157.95 156.26 30.93 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.418 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -137.19 114.08 10.53 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.397 173.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.259 66.0 m-85 -78.29 6.72 7.66 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 -173.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 5.4 t . . . . . 0 N--CA 1.455 -0.209 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -178.901 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 56.0 m . . . . . 0 CA--C 1.53 0.184 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 28.6 t -128.8 142.34 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.095 0 C-N-CA 122.833 0.453 . . . . 0.0 110.889 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 91.2 mt -133.95 149.14 51.25 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 122.832 0.453 . . . . 0.0 111.278 -175.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 32.2 tp -102.0 135.01 44.3 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 172.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -114.57 107.04 14.97 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.93 138.27 31.68 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 174.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.1 mp -108.73 118.18 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -90.92 -18.83 24.07 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 119.255 -0.403 . . . . 0.0 112.018 -171.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -142.12 79.01 16.51 Favored Pre-proline 0 CA--C 1.529 0.156 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -77.61 44.56 1.56 Allowed 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 125.19 3.927 . . . . 0.0 112.48 -176.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.437 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -70.06 -4.55 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 O-C-N 121.59 -0.693 . . . . 0.0 110.641 179.767 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -137.95 156.18 48.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 42.3 t -70.39 117.02 11.41 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 120.717 0.294 . . . . 0.0 110.212 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.1 mm -78.55 143.73 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 122.876 0.471 . . . . 0.0 109.807 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.99 159.16 41.6 Favored 'General case' 0 CA--C 1.526 0.031 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.5 p -66.01 -15.69 63.24 Favored 'General case' 0 C--N 1.335 -0.062 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -76.38 -44.93 34.16 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.504 0.192 . . . . 0.0 110.848 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 1.9 m -72.88 -32.01 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.9 mt -70.64 -34.75 72.41 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 175.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -72.02 -30.29 65.05 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 174.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.6 m -66.82 -34.44 77.81 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 45.4 pt -91.27 -23.24 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 118.201 0.455 . . . . 0.0 111.902 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 89.0 m -89.87 -25.34 21.06 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.479 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 30.1 t30 -63.69 -42.59 72.97 Favored Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 73.8 Cg_endo -69.34 -12.56 33.98 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.338 1.359 . . . . 0.0 111.474 177.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 89.4 m -91.92 -7.45 49.1 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 122.502 0.321 . . . . 0.0 111.673 176.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 149.47 168.81 15.26 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.54 101.08 0.84 Allowed 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.9 3.067 . . . . 0.0 110.51 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 87.4 t -69.11 145.69 13.16 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 123.37 0.668 . . . . 0.0 109.257 177.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -115.04 -40.6 3.46 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 119.064 -0.493 . . . . 0.0 111.6 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 63.0 mtm-85 -148.05 152.43 37.38 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 21.4 mt -149.16 137.73 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 124.093 0.957 . . . . 0.0 110.273 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.3 m -143.48 163.15 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 C-N-CA 123.846 0.858 . . . . 0.0 110.338 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 54.1 mt -133.68 142.63 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 C-N-CA 122.757 0.423 . . . . 0.0 110.528 -175.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.264 6.3 p90 -146.92 159.34 43.67 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 115.819 1.785 . . . . 0.0 115.819 176.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.64 31.91 2.05 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.163 0.585 . . . . 0.0 111.777 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -67.9 -29.45 68.55 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -174.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -130.57 3.61 4.6 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 123.307 0.643 . . . . 0.0 112.514 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 167.19 -127.04 1.51 Allowed Glycine 0 CA--C 1.522 0.472 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 -173.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.1 t -138.79 117.8 13.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 117.103 0.452 . . . . 0.0 110.239 174.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 11.1 mp0 -144.1 168.56 19.72 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.476 0.655 . . . . 0.0 111.119 -175.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -150.66 167.16 28.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.828 1.251 . . . . 0.0 108.643 175.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 73.1 mmm -135.06 154.04 51.84 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 38.2 t -140.9 144.29 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 122.946 0.499 . . . . 0.0 110.517 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -129.88 135.07 47.94 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.87 0.468 . . . . 0.0 110.099 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -108.55 163.83 12.88 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 116.264 1.95 . . . . 0.0 116.264 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -81.2 -12.74 59.09 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 92.2 p -155.73 155.58 33.37 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.11 0.481 . . . . 0.0 111.455 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 49.7 t -67.84 -34.77 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -64.21 -33.72 76.45 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 122.254 -0.279 . . . . 0.0 110.8 -177.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 57.7 m -72.86 -33.74 66.3 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 117.464 0.12 . . . . 0.0 110.723 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -74.17 -30.12 62.09 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 119.707 -0.187 . . . . 0.0 111.373 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -68.85 -45.11 71.93 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 118.343 0.519 . . . . 0.0 111.724 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -76.44 -25.61 54.58 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 118.046 0.384 . . . . 0.0 111.553 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -72.32 -40.39 67.48 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.034 0.379 . . . . 0.0 110.171 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.82 -22.91 58.45 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.565 0.346 . . . . 0.0 111.316 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -95.08 -12.12 27.08 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 45.4 t -111.4 -34.95 5.97 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 118.622 0.646 . . . . 0.0 112.567 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 66.9 mt -89.79 -7.95 53.22 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -70.61 133.29 46.56 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 75.94 -4.12 47.59 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 119.651 -0.527 . . . . 0.0 112.215 -177.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.99 166.28 21.74 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 117.878 0.839 . . . . 0.0 110.281 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -123.56 140.06 53.38 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 115.016 1.488 . . . . 0.0 115.016 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 89.9 mt -74.24 -41.27 51.06 Favored 'Isoleucine or valine' 0 C--N 1.339 0.135 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.364 44.0 m-85 -82.86 -10.57 58.78 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 23.3 t 65.8 33.2 8.3 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.513 0.725 . . . . 0.0 110.577 -173.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 176.84 -22.52 0.05 OUTLIER Glycine 0 CA--C 1.531 1.037 0 C-N-CA 123.677 0.656 . . . . 0.0 111.491 177.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' CYS . . . . . 0.437 ' HB3' HD12 ' A' ' 200' ' ' ILE . 96.4 m -145.99 -177.9 5.84 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.567 1.147 . . . . 0.0 109.814 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 90.9 m 58.68 37.67 25.14 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -176.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.24 148.33 11.62 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 176.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 79.2 mt -115.71 155.75 27.18 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -172.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -138.85 138.16 37.23 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.37 1.468 . . . . 0.0 107.454 169.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 36.1 mt -138.67 142.91 33.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-O 120.842 0.353 . . . . 0.0 111.728 -171.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -158.38 163.0 37.67 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 175.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.267 42.5 m-85 -62.28 135.51 57.5 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 176.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -85.11 160.44 19.96 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.303 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.473 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 63.8 pttt -92.66 -31.81 0.32 Allowed Pre-proline 0 CA--C 1.537 0.452 0 CA-C-O 117.493 -1.241 . . . . 0.0 114.21 178.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 91.1 Cg_endo -76.45 173.48 14.41 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 CA-C-N 122.096 1.784 . . . . 0.0 110.088 173.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.8 -5.05 2.83 Favored 'General case' 0 N--CA 1.461 0.089 0 N-CA-C 117.699 2.481 . . . . 0.0 117.699 -175.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -157.75 131.21 7.78 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.988 0.813 . . . . 0.0 111.761 -178.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 30.4 mt -83.75 162.57 20.62 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.434 1.094 . . . . 0.0 111.065 175.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -115.53 49.38 1.09 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 169.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.406 ' H ' HG23 ' A' ' 272' ' ' VAL . 2.4 t -49.73 142.42 2.43 Favored 'Isoleucine or valine' 0 C--N 1.341 0.233 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -177.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -127.42 -9.03 5.75 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 117.819 2.526 . . . . 0.0 117.819 -175.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -161.18 173.85 14.5 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.808 0.443 . . . . 0.0 110.356 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -125.72 119.96 29.38 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.327 0.651 . . . . 0.0 110.182 175.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 47.6 p30 -159.33 -167.92 2.18 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.263 1.025 . . . . 0.0 109.271 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -69.95 -10.56 59.01 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -175.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -113.26 -18.55 12.06 Favored 'General case' 0 N--CA 1.461 0.093 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.14 141.08 29.77 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 124.29 1.036 . . . . 0.0 112.51 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 20.4 t-105 -160.35 158.76 30.21 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 118.886 0.767 . . . . 0.0 110.871 -178.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -139.59 115.81 10.45 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.398 172.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.252 65.1 m-85 -79.17 5.42 12.14 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 -173.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.456 -0.134 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -178.93 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 59.6 m . . . . . 0 CA--C 1.53 0.183 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.1 t -129.63 135.57 61.12 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 C-N-CA 123.086 0.555 . . . . 0.0 111.209 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -124.83 150.6 46.22 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 123.015 0.526 . . . . 0.0 110.646 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 40.3 tp -100.03 136.15 40.37 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 170.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -114.25 107.37 15.51 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 178.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.54 136.42 33.0 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 173.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.0 mp -106.8 118.34 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.029 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -90.67 -18.16 25.55 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -171.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -142.1 79.01 16.56 Favored Pre-proline 0 CA--C 1.529 0.139 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -76.91 44.71 1.51 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 125.115 3.877 . . . . 0.0 112.673 -177.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.444 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -70.04 -5.01 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 O-C-N 121.542 -0.724 . . . . 0.0 110.6 -179.651 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -138.89 156.54 47.2 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 43.6 t -69.8 118.75 13.04 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 31.0 mm -78.42 143.81 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 123.025 0.53 . . . . 0.0 109.58 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.02 158.24 44.04 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.4 p -65.64 -16.75 64.03 Favored 'General case' 0 CA--C 1.523 -0.096 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -76.09 -45.59 33.19 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.616 0.246 . . . . 0.0 110.713 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.1 m -72.32 -32.56 43.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.93 -34.56 71.62 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 175.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -72.46 -29.0 63.27 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 174.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.6 m -67.95 -34.0 75.74 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 44.7 pt -91.22 -23.6 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 118.399 0.545 . . . . 0.0 111.798 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 89.0 m -89.38 -26.58 20.96 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -178.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.484 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 33.8 t30 -64.14 -42.0 65.5 Favored Pre-proline 0 CA--C 1.537 0.457 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -178.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 71.9 Cg_endo -68.79 -12.92 35.8 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 121.335 1.357 . . . . 0.0 111.407 177.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 95.8 m -91.82 -6.25 52.01 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.531 0.332 . . . . 0.0 111.673 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 147.13 166.66 12.55 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.72 104.12 1.1 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 123.849 3.032 . . . . 0.0 110.663 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 74.3 t -71.49 147.11 11.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -115.82 -36.33 4.21 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 119.199 -0.429 . . . . 0.0 111.716 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 21.3 mtm180 -150.78 151.54 32.5 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.526 0.603 . . . . 0.0 112.275 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 20.6 mt -147.4 136.54 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 C-N-CA 124.323 1.049 . . . . 0.0 110.219 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 1.3 m -140.24 159.85 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.065 0 C-N-CA 123.548 0.739 . . . . 0.0 111.765 174.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 57.0 mt -132.08 142.62 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 C-N-CA 122.929 0.492 . . . . 0.0 110.021 -177.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.261 4.0 p90 -147.84 159.86 43.39 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 115.629 1.714 . . . . 0.0 115.629 176.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.1 31.35 2.18 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.017 0.527 . . . . 0.0 111.68 -177.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -67.63 -30.35 69.89 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -174.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -130.54 4.29 4.65 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 123.105 0.562 . . . . 0.0 112.498 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 166.36 -127.83 1.66 Allowed Glycine 0 C--N 1.333 0.368 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 -174.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 19.3 t -139.69 116.72 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-N 117.415 0.608 . . . . 0.0 110.336 174.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 9.6 mp0 -144.78 169.05 18.78 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.677 0.751 . . . . 0.0 111.123 -175.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -150.86 167.47 27.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.224 1.01 . . . . 0.0 108.621 175.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 53.5 mmm -135.01 154.83 51.59 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.618 0.367 . . . . 0.0 110.03 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 35.8 t -142.34 143.26 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 C-N-CA 123.219 0.608 . . . . 0.0 110.496 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -130.07 134.36 47.32 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 123.216 0.323 . . . . 0.0 110.263 177.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -105.01 163.62 12.41 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 -176.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -77.93 -16.48 58.15 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 86.4 p -153.48 157.15 39.42 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.222 0.534 . . . . 0.0 111.503 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 54.8 t -67.23 -33.98 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -64.9 -34.81 79.28 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 122.063 -0.398 . . . . 0.0 110.613 -177.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 65.6 m -72.58 -31.51 65.28 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 110.624 -0.139 . . . . 0.0 110.624 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -72.52 -31.68 65.53 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 111.328 0.122 . . . . 0.0 111.328 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -72.21 -45.82 58.74 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 117.979 0.354 . . . . 0.0 111.843 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 17.1 ptt180 -75.04 -26.02 59.13 Favored 'General case' 0 C--N 1.338 0.089 0 C-N-CA 120.659 -0.417 . . . . 0.0 111.317 -177.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -70.63 -40.73 72.94 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 117.934 0.334 . . . . 0.0 110.196 177.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -75.79 -25.87 56.8 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.494 0.317 . . . . 0.0 111.059 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -89.25 -10.46 46.87 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 47.0 t -115.92 -35.74 4.36 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 66.8 mt -89.31 -6.7 56.5 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -177.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -70.94 133.97 46.83 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.19 -4.6 47.09 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 119.767 -0.463 . . . . 0.0 112.346 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.61 166.43 22.54 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 117.872 0.836 . . . . 0.0 110.249 177.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -123.45 139.16 54.31 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 86.8 mt -73.77 -41.74 54.29 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.358 44.0 m-85 -82.83 -11.39 58.28 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.8 t 65.38 35.92 7.18 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 122.101 0.953 . . . . 0.0 110.685 -174.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 176.38 -24.55 0.06 OUTLIER Glycine 0 CA--C 1.528 0.877 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.202 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' CYS . . . . . 0.444 ' HB3' HD12 ' A' ' 200' ' ' ILE . 87.2 m -147.21 -177.16 5.53 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.943 1.297 . . . . 0.0 109.659 178.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 94.9 m 58.54 37.7 25.47 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -175.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.93 147.43 12.26 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 175.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 80.1 mt -115.26 154.41 29.14 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -173.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -137.53 138.31 39.51 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.16 1.384 . . . . 0.0 107.448 169.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 36.6 mt -138.31 143.29 33.15 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.085 0 CA-C-O 120.781 0.324 . . . . 0.0 111.381 -171.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -158.71 161.66 37.09 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.789 175.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.272 33.5 m-85 -59.18 134.43 56.99 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 176.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . 0.407 ' HB1' ' HD2' ' A' ' 267' ' ' PRO . . . -87.74 163.33 16.55 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.854 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.494 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 23.3 pttp -97.95 -29.83 0.25 Allowed Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 84.2 Cg_endo -76.23 170.88 19.15 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 CA-C-N 122.04 1.764 . . . . 0.0 110.277 175.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.41 -2.62 2.75 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 117.584 2.438 . . . . 0.0 117.584 -177.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.26 131.61 10.34 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 118.691 0.678 . . . . 0.0 111.879 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 17.0 mt -89.84 158.16 17.59 Favored 'General case' 0 C--N 1.337 0.065 0 C-N-CA 123.652 0.781 . . . . 0.0 111.325 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -121.84 46.04 2.18 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.549 0.739 . . . . 0.0 109.834 175.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 272' ' ' VAL . 2.5 t -52.08 144.7 2.89 Favored 'Isoleucine or valine' 0 C--N 1.338 0.093 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . 0.317 8.2 p90 -123.54 -5.73 8.16 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 117.099 2.259 . . . . 0.0 117.099 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.84 172.33 16.28 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 123.382 0.673 . . . . 0.0 111.264 178.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -124.15 118.89 27.9 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.71 0.804 . . . . 0.0 110.067 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -159.09 -168.74 2.44 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.907 0.883 . . . . 0.0 109.379 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -69.63 -10.77 59.58 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -176.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -98.96 -38.35 9.03 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.4 p -143.04 146.05 33.48 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.66 0.784 . . . . 0.0 113.003 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 20.3 t-105 -154.73 152.85 30.39 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.165 0.507 . . . . 0.0 109.998 -174.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -127.6 117.42 21.99 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.559 174.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.286 65.0 m-85 -81.64 8.41 9.89 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 117.511 2.412 . . . . 0.0 117.511 -171.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 6.4 t . . . . . 0 CA--C 1.529 0.147 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -178.836 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 CA--C 1.531 0.224 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.5 t -133.08 134.57 57.73 Favored 'Isoleucine or valine' 0 C--N 1.341 0.198 0 C-N-CA 122.752 0.421 . . . . 0.0 110.672 177.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.41 ' N ' HD22 ' A' ' 192' ' ' LEU . 2.4 mm? -123.14 152.49 41.09 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 122.781 0.433 . . . . 0.0 111.137 -176.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 28.0 tp -100.91 135.8 41.78 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 169.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -113.29 111.06 21.39 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.863 1.265 . . . . 0.0 114.248 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.31 132.69 38.65 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 173.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.3 mp -103.7 120.55 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -89.74 -18.1 27.0 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -171.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -143.08 78.95 14.79 Favored Pre-proline 0 CA--C 1.53 0.181 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -78.37 45.92 1.98 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 125.061 3.84 . . . . 0.0 112.131 -177.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.433 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -70.38 -3.86 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 O-C-N 121.924 -0.485 . . . . 0.0 110.553 179.779 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -137.32 157.74 45.96 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 176.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 67.5 m -69.88 113.6 7.27 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 33.7 mm -78.4 141.81 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.079 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.24 161.02 36.09 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.6 p -62.45 -21.04 65.13 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -74.02 -46.21 44.92 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.63 0.372 . . . . 0.0 111.717 -178.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 1.7 m -69.28 -32.74 54.75 Favored 'Isoleucine or valine' 0 C--O 1.23 0.043 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.9 mt -72.09 -35.82 69.32 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -69.2 -31.05 69.39 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 174.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 9.4 m -67.69 -34.05 76.13 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 38.6 pt -93.16 -21.32 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 119.027 -0.511 . . . . 0.0 111.916 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 92.0 m -90.34 -27.32 19.47 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 119.139 0.881 . . . . 0.0 113.278 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.496 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 35.1 t30 -63.36 -39.78 52.99 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -178.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 74.0 Cg_endo -69.35 -15.77 38.83 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 CA-C-N 121.216 1.47 . . . . 0.0 111.635 178.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 95.0 m -84.67 -13.29 51.92 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.041 0.382 . . . . 0.0 111.456 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 149.58 169.42 15.95 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.03 112.84 1.64 Allowed 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 123.578 2.852 . . . . 0.0 111.309 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.8 t -79.38 144.34 11.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 176.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -112.99 -39.57 4.19 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 119.381 -0.342 . . . . 0.0 111.189 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 23.3 mtm180 -150.06 153.16 35.98 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.131 0.423 . . . . 0.0 112.066 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 24.6 mt -144.07 143.6 23.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.261 1.024 . . . . 0.0 109.659 178.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 38.3 t -145.94 155.89 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 46.6 mt -138.65 141.52 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 123.894 0.878 . . . . 0.0 109.375 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.287 3.2 p90 -143.98 157.52 44.29 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 177.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -126.53 15.98 7.62 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.272 0.629 . . . . 0.0 110.733 -173.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -63.35 -33.18 74.96 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -169.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -130.35 7.86 5.0 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.568 0.622 . . . . 0.0 112.265 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 161.96 -125.35 1.41 Allowed Glycine 0 CA--C 1.522 0.469 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -174.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 47.0 t -141.9 114.9 4.16 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 174.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -142.16 168.31 20.04 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.256 0.551 . . . . 0.0 110.989 -176.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.05 164.26 34.37 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.951 176.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 67.4 mmm -132.39 151.27 51.94 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 41.2 t -141.63 144.31 26.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 C-N-CA 122.77 0.428 . . . . 0.0 110.326 -178.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -130.58 134.23 46.84 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 122.838 0.455 . . . . 0.0 110.498 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -106.6 163.43 12.89 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 116.765 2.135 . . . . 0.0 116.765 -175.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -76.64 -17.04 59.38 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.784 0.433 . . . . 0.0 109.879 178.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 83.8 p -154.87 158.34 39.21 Favored 'General case' 0 C--O 1.232 0.157 0 O-C-N 121.819 -0.551 . . . . 0.0 111.648 -178.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 54.4 t -66.29 -33.61 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -68.34 -30.05 68.92 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 121.918 -0.489 . . . . 0.0 110.719 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 68.9 m -73.48 -31.43 63.75 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 175.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.49 -34.51 58.64 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 122.482 0.313 . . . . 0.0 111.546 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -70.54 -42.26 71.42 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 118.104 0.411 . . . . 0.0 111.445 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -76.84 -25.66 53.45 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.489 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -70.44 -41.27 73.09 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -75.08 -19.93 59.74 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.567 0.347 . . . . 0.0 111.012 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -99.51 -4.24 31.69 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 38.6 t -124.28 -31.91 3.25 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.864 0.756 . . . . 0.0 112.803 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 61.6 mt -91.59 -6.66 51.96 Favored 'General case' 0 CA--C 1.527 0.071 0 O-C-N 121.998 -0.439 . . . . 0.0 111.527 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -73.28 134.75 44.32 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 74.44 -5.9 26.28 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 111.984 -0.447 . . . . 0.0 111.984 -178.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.19 166.46 22.17 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 117.663 0.731 . . . . 0.0 110.122 177.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -123.64 139.68 53.76 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 87.7 mt -73.33 -41.58 57.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.182 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.367 39.6 m-85 -82.93 -12.01 57.69 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 117.257 2.317 . . . . 0.0 117.257 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.7 t 65.8 35.26 6.85 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.748 0.785 . . . . 0.0 110.754 -174.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 176.0 -23.68 0.06 OUTLIER Glycine 0 CA--C 1.527 0.812 0 C-N-CA 123.947 0.784 . . . . 0.0 111.198 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' CYS . . . . . 0.433 ' HB3' HD12 ' A' ' 200' ' ' ILE . 93.0 m -147.2 -177.02 5.45 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.916 1.286 . . . . 0.0 109.466 178.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 86.7 m 58.07 36.95 26.41 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -176.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.59 148.95 11.44 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 175.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 76.3 mt -115.9 155.23 28.33 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -173.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -138.38 138.38 38.21 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.313 1.445 . . . . 0.0 107.587 168.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 34.3 mt -138.34 142.37 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-O 120.657 0.265 . . . . 0.0 111.611 -170.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -158.67 162.25 37.21 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.38 0.672 . . . . 0.0 109.844 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -61.13 137.45 58.23 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -88.6 162.34 16.41 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.942 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -82.41 -54.25 0.61 Allowed Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 118.493 -0.765 . . . . 0.0 112.742 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -73.46 164.97 33.68 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.269 2.646 . . . . 0.0 111.347 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.274 0.2 OUTLIER -135.41 10.11 3.46 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 117.247 2.314 . . . . 0.0 117.247 -176.056 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.12 129.16 8.79 Favored 'General case' 0 C--N 1.339 0.11 0 O-C-N 121.646 -0.659 . . . . 0.0 111.642 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 30.9 mt -92.57 156.37 17.17 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 123.882 0.873 . . . . 0.0 110.916 177.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -118.58 49.12 1.33 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.861 0.864 . . . . 0.0 109.585 174.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.409 HG23 ' H ' ' A' ' 272' ' ' VAL . 2.1 t -52.31 142.12 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -176.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -130.08 0.7 4.71 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 116.551 2.056 . . . . 0.0 116.551 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -160.58 164.31 32.03 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 122.89 0.476 . . . . 0.0 110.926 -176.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -125.73 118.72 26.19 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.617 0.767 . . . . 0.0 109.198 174.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 40.0 p30 -157.19 -168.04 2.5 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.823 0.849 . . . . 0.0 109.904 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -69.3 -11.95 61.25 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -104.29 -30.66 10.0 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 3.5 p -141.49 145.31 35.05 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 19.2 t-105 -157.67 153.24 26.4 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -176.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . 0.251 7.0 t0 -132.95 121.15 22.38 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 122.94 0.496 . . . . 0.0 112.197 176.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.25 67.2 m-85 -87.25 8.97 21.76 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 117.58 2.437 . . . . 0.0 117.58 -171.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 5.0 t . . . . . 0 C--O 1.231 0.11 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 -177.208 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 CA--C 1.529 0.151 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 20.2 t -128.09 140.37 49.35 Favored 'Isoleucine or valine' 0 C--N 1.338 0.081 0 C-N-CA 122.813 0.445 . . . . 0.0 111.192 176.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.7 mt -131.88 157.44 43.95 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.241 0.616 . . . . 0.0 110.958 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.0 tt -113.8 136.04 53.3 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.412 0.685 . . . . 0.0 109.288 174.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -114.34 102.59 10.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -85.96 135.72 33.55 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 174.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.2 mp -106.06 122.41 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -90.27 -20.34 23.07 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -172.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -141.23 78.87 18.37 Favored Pre-proline 0 CA--C 1.529 0.163 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -78.6 44.2 1.59 Allowed 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 124.984 3.789 . . . . 0.0 112.147 -177.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.438 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -69.05 -4.72 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 O-C-N 121.91 -0.494 . . . . 0.0 110.803 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -136.3 157.82 45.9 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 70.9 m -68.87 113.28 6.16 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.84 0.352 . . . . 0.0 110.32 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 40.0 mm -78.42 141.23 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 176.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.1 157.18 46.81 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.0 p -66.38 -15.86 63.62 Favored 'General case' 0 C--N 1.334 -0.088 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 175.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -79.87 -42.19 24.74 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.5 p -75.18 -32.41 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.1 mt -69.83 -33.95 73.0 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -71.23 -29.25 64.9 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 174.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.0 m -68.09 -32.2 72.35 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 45.3 pt -93.56 -22.36 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 118.291 0.496 . . . . 0.0 112.058 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 94.0 m -89.99 -26.07 20.55 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.494 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 35.1 t30 -63.89 -41.44 63.58 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 74.0 Cg_endo -69.09 -15.98 40.01 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.521 1.48 . . . . 0.0 111.27 177.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 97.6 m -86.15 -11.7 51.86 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.457 0.303 . . . . 0.0 111.467 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 151.5 167.69 15.17 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -68.01 103.67 0.92 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.913 3.075 . . . . 0.0 110.248 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.1 t -70.61 146.96 11.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -114.9 -39.0 3.77 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 119.13 -0.462 . . . . 0.0 111.561 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 22.5 mtm180 -149.54 151.45 33.89 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 118.61 0.641 . . . . 0.0 112.263 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 24.2 mt -148.66 137.65 15.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 124.053 0.941 . . . . 0.0 109.929 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 5.4 m -143.55 161.99 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 124.248 1.019 . . . . 0.0 110.559 174.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 46.4 mt -134.74 143.01 38.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 C-N-CA 122.929 0.491 . . . . 0.0 110.472 -175.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.3 4.4 p90 -142.3 158.44 43.71 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 176.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -128.61 15.14 6.51 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.591 0.756 . . . . 0.0 110.909 -173.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -62.6 -31.34 72.15 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 -169.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -130.41 4.0 4.69 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.609 0.64 . . . . 0.0 112.119 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 165.86 -124.45 1.24 Allowed Glycine 0 CA--C 1.521 0.429 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 -174.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.2 t -141.63 115.38 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.121 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 174.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -143.15 166.09 25.64 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.242 0.544 . . . . 0.0 111.11 -177.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -143.73 165.1 28.59 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.957 0.903 . . . . 0.0 108.836 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 80.7 mmm -133.13 150.82 52.02 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 31.6 t -140.49 145.65 25.51 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.061 0 C-N-CA 122.689 0.395 . . . . 0.0 110.882 -177.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -132.74 135.07 45.51 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 122.622 0.369 . . . . 0.0 110.628 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -107.42 163.84 12.7 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 115.934 1.828 . . . . 0.0 115.934 -176.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -78.32 -15.86 58.3 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 79.1 p -154.91 159.65 40.61 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.304 0.573 . . . . 0.0 111.665 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 54.3 t -67.51 -35.22 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -66.24 -30.88 71.41 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 122.375 -0.203 . . . . 0.0 110.954 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 74.4 m -72.83 -34.04 66.55 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 176.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.16 -31.34 58.5 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 122.43 -0.169 . . . . 0.0 111.2 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -68.51 -42.58 78.34 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 121.825 -0.547 . . . . 0.0 111.459 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -76.52 -26.57 55.38 Favored 'General case' 0 C--N 1.338 0.1 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.816 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -72.07 -41.55 67.23 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.186 0.448 . . . . 0.0 110.173 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -73.69 -20.11 60.63 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.742 0.417 . . . . 0.0 111.184 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -99.01 -9.3 24.13 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 46.4 t -116.32 -32.93 5.13 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 72.8 mt -91.9 -7.89 47.93 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.059 0.391 . . . . 0.0 111.902 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -73.04 133.04 44.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 77.06 -5.84 46.49 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.707 -0.496 . . . . 0.0 111.957 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.32 166.41 22.13 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 117.782 0.791 . . . . 0.0 110.384 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -123.49 140.65 52.79 Favored 'General case' 0 C--N 1.334 -0.099 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 87.1 mt -74.61 -42.39 48.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.359 39.7 m-85 -82.79 -12.16 57.71 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 32.6 t 65.54 36.12 6.78 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.658 0.742 . . . . 0.0 111.239 -174.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 175.6 -24.26 0.06 OUTLIER Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' CYS . . . . . 0.438 ' HB3' HD12 ' A' ' 200' ' ' ILE . 96.9 m -145.81 -177.2 5.46 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.185 1.394 . . . . 0.0 109.801 177.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 88.1 m 57.89 37.93 26.96 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.22 148.96 13.38 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 175.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 81.2 mt -116.09 154.78 29.35 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -173.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 54.1 mttp -138.19 137.06 37.23 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.715 1.606 . . . . 0.0 107.484 169.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 56.0 mt -136.87 143.3 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-O 120.94 0.4 . . . . 0.0 111.384 -172.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -159.23 164.02 35.38 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.739 175.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.266 45.3 m-85 -61.71 135.46 57.62 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 176.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -88.27 156.36 19.24 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.347 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.446 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 64.6 pttt -89.44 -31.51 0.37 Allowed Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 50.1 Cg_endo -79.28 168.39 20.26 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 121.835 1.69 . . . . 0.0 110.136 175.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.281 0.2 OUTLIER -137.78 8.86 2.82 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 117.883 2.549 . . . . 0.0 117.883 -176.015 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.32 126.84 6.69 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 118.778 0.717 . . . . 0.0 111.799 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 27.4 mt -92.22 156.95 16.96 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 123.858 0.863 . . . . 0.0 110.747 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -116.67 53.31 0.89 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.504 0.722 . . . . 0.0 109.788 172.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.6 t -54.68 145.26 4.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -175.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -135.67 -0.25 2.63 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 117.022 2.23 . . . . 0.0 117.022 -176.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -160.53 159.08 30.26 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.584 0.354 . . . . 0.0 111.372 -173.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -123.12 112.23 17.48 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.834 0.854 . . . . 0.0 109.404 173.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 53.1 p30 -157.87 -166.28 1.94 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -66.9 -16.33 64.25 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -174.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -115.17 -13.36 11.79 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.29 139.29 37.29 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 123.815 0.846 . . . . 0.0 113.041 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 16.3 t-105 -162.95 155.34 18.62 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.25 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . 0.259 5.8 t0 -140.79 119.57 12.54 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.194 0.598 . . . . 0.0 112.102 172.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.252 66.8 m-85 -82.18 7.62 13.16 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 117.536 2.421 . . . . 0.0 117.536 -171.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 6.0 t . . . . . 0 C--O 1.232 0.143 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -177.381 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 71.2 m . . . . . 0 CA--C 1.532 0.27 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.3 t -132.97 133.26 58.92 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 CA-C-N 118.162 0.437 . . . . 0.0 110.875 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.431 HD21 ' HB1' ' A' ' 241' ' ' ALA . 2.3 mm? -121.76 155.01 36.17 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 122.954 0.502 . . . . 0.0 110.995 -176.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 29.1 tp -104.98 131.18 52.82 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 170.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -107.72 101.74 11.02 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 177.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.78 136.21 33.17 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 174.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.4 mp -105.67 130.61 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -92.65 -24.2 18.74 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -175.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -138.82 78.92 29.33 Favored Pre-proline 0 CA--C 1.529 0.147 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -77.01 49.59 2.84 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 124.865 3.71 . . . . 0.0 112.346 -178.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.464 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -69.13 -7.05 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 O-C-N 121.775 -0.578 . . . . 0.0 110.314 178.467 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -140.14 153.67 46.75 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.082 1.353 . . . . 0.0 113.081 175.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.4 t -73.55 128.14 34.68 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 120.811 0.338 . . . . 0.0 110.517 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 19.7 mm -78.71 148.69 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 122.724 0.409 . . . . 0.0 109.947 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.0 156.15 48.71 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 177.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.5 p -65.57 -16.37 63.63 Favored 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -74.73 -47.16 32.85 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.7 0.286 . . . . 0.0 111.703 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.5 m -71.41 -32.43 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.6 mt -69.91 -36.15 75.17 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 176.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -71.21 -30.67 66.66 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 12.6 m -66.31 -32.99 74.73 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 37.5 pt -94.05 -24.3 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 118.178 0.444 . . . . 0.0 112.02 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 90.1 m -88.29 -25.44 22.81 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.49 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 35.3 t30 -64.19 -43.16 72.66 Favored Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 67.4 Cg_endo -68.38 -15.3 41.88 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 121.411 1.407 . . . . 0.0 111.512 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 95.4 m -83.86 -15.14 49.29 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.047 0.385 . . . . 0.0 111.379 177.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 151.02 170.47 18.05 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -61.12 104.82 0.3 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.774 2.983 . . . . 0.0 111.732 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 72.5 t -75.72 145.54 10.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -117.79 -39.75 3.09 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 119.287 -0.387 . . . . 0.0 111.477 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 66.1 mtm-85 -148.05 151.22 35.32 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.484 0.584 . . . . 0.0 112.547 179.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 20.3 mt -148.27 137.58 15.89 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 C-N-CA 124.105 0.962 . . . . 0.0 109.628 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 8.1 m -143.07 162.84 17.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 C-N-CA 123.735 0.814 . . . . 0.0 110.23 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 47.8 mt -135.96 142.88 37.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.093 0 C-N-CA 123.224 0.609 . . . . 0.0 110.409 -174.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.299 6.2 p90 -141.39 155.38 45.91 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 177.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -128.37 14.3 6.62 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.242 0.617 . . . . 0.0 110.788 -174.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -64.98 -30.68 71.68 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -169.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -130.37 5.8 4.82 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.793 0.724 . . . . 0.0 111.812 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 162.38 -126.29 1.54 Allowed Glycine 0 C--N 1.335 0.515 0 N-CA-C 107.966 -2.054 . . . . 0.0 107.966 -174.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 38.5 t -142.78 116.98 4.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 175.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -144.02 166.84 23.84 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.289 0.566 . . . . 0.0 110.631 -176.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.97 166.37 26.99 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.113 175.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 74.6 mmm -133.96 154.2 51.26 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 29.6 t -142.11 142.8 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 C-N-CA 122.781 0.432 . . . . 0.0 110.905 -178.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -129.36 133.16 47.26 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.155 0.582 . . . . 0.0 110.274 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -108.5 160.97 15.48 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 -176.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -79.55 -11.95 59.87 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 37.7 t -154.81 153.48 31.25 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 121.812 -0.555 . . . . 0.0 111.549 -176.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 56.6 t -68.01 -37.36 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -67.09 -27.53 67.43 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 122.039 -0.413 . . . . 0.0 111.025 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 52.2 m -74.32 -32.39 62.82 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 175.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.431 ' HB1' HD21 ' A' ' 192' ' ' LEU . . . -76.52 -31.74 57.84 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 122.567 0.347 . . . . 0.0 111.305 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -69.74 -45.39 68.24 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 117.949 0.34 . . . . 0.0 111.345 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -74.6 -26.57 60.0 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 117.953 0.342 . . . . 0.0 111.24 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -69.32 -42.81 74.86 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.435 ' HE3' ' HB3' ' A' ' 245' ' ' LYS . 0.8 OUTLIER -75.39 -21.24 58.42 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.825 0.45 . . . . 0.0 111.161 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -94.32 -9.0 37.32 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 40.9 t -118.4 -34.21 4.12 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -177.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 70.8 mt -89.1 -8.07 54.55 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 118.161 0.437 . . . . 0.0 111.999 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -71.15 136.3 48.07 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.58 -5.66 21.43 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 119.756 -0.469 . . . . 0.0 112.159 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -77.83 166.5 22.83 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 117.955 0.878 . . . . 0.0 110.003 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -122.59 139.17 54.22 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 86.2 mt -74.48 -41.58 49.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.361 44.8 m-85 -82.86 -9.96 59.07 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 117.045 2.239 . . . . 0.0 117.045 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 30.8 t 65.57 35.25 7.25 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.479 0.712 . . . . 0.0 111.08 -175.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 175.95 -24.6 0.06 OUTLIER Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.053 0.835 . . . . 0.0 111.243 177.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' CYS . . . . . 0.464 ' HB3' HD12 ' A' ' 200' ' ' ILE . 82.0 m -145.83 -177.87 5.81 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.6 1.16 . . . . 0.0 109.354 178.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 97.3 m 58.6 38.96 25.16 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -174.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.32 150.37 8.79 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 174.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 97.1 mt -110.96 157.3 20.06 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -173.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.96 130.13 26.76 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.711 2.005 . . . . 0.0 106.331 170.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 30.7 mt -138.3 139.69 41.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-O 120.908 0.385 . . . . 0.0 111.295 -172.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -161.31 163.75 30.62 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.421 175.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.25 48.7 m-85 -59.89 141.91 54.58 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 177.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -96.21 162.08 13.68 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -176.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.401 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 59.2 mttm -78.14 -50.33 1.79 Allowed Pre-proline 0 CA--C 1.532 0.286 0 CA-C-O 118.318 -0.849 . . . . 0.0 112.282 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 87.6 Cg_endo -75.51 169.01 23.26 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.656 2.237 . . . . 0.0 111.191 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.259 0.2 OUTLIER -134.51 3.13 3.29 Favored 'General case' 0 CA--C 1.527 0.071 0 N-CA-C 117.73 2.493 . . . . 0.0 117.73 -176.328 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -157.85 127.47 5.97 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 118.764 0.711 . . . . 0.0 112.063 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 21.9 mt -82.81 163.24 21.34 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.975 0.91 . . . . 0.0 111.015 175.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -121.8 51.98 1.29 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.69 0.796 . . . . 0.0 109.103 171.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.408 ' H ' HG23 ' A' ' 272' ' ' VAL . 2.3 t -51.96 144.49 2.94 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -176.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -128.36 -7.52 5.27 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 117.476 2.399 . . . . 0.0 117.476 -177.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -161.46 171.37 18.28 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 122.728 0.411 . . . . 0.0 110.517 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -124.69 122.99 39.05 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.774 0.83 . . . . 0.0 109.667 174.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 45.1 p30 -160.58 -166.12 1.57 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.99 0.916 . . . . 0.0 108.728 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -68.17 -14.98 63.39 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -174.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -114.01 -13.18 12.52 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.01 139.87 34.23 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 123.68 0.792 . . . . 0.0 112.736 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 17.2 t-105 -160.34 156.14 25.78 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.328 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -135.86 116.04 13.43 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.542 172.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.267 67.2 m-85 -80.4 8.0 8.52 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 116.898 2.184 . . . . 0.0 116.898 -173.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.457 -0.118 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -179.516 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 CA--C 1.536 0.418 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 92.7 t -132.51 143.3 40.19 Favored 'Isoleucine or valine' 0 C--N 1.339 0.124 0 C-N-CA 123.669 0.788 . . . . 0.0 109.207 177.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 75.9 mt -136.38 149.64 48.43 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -173.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 38.8 tp -100.02 135.54 41.28 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 172.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -114.97 102.2 9.74 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.138 1.375 . . . . 0.0 114.485 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.42 134.33 33.6 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 174.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.2 mp -103.5 122.44 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -91.99 -18.12 24.12 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -171.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -143.29 78.72 14.69 Favored Pre-proline 0 CA--C 1.529 0.148 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -78.23 45.83 1.94 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 125.136 3.891 . . . . 0.0 112.102 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.424 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -70.95 -4.55 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 O-C-N 121.952 -0.467 . . . . 0.0 110.909 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -136.27 157.6 46.42 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 177.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 66.9 m -71.34 112.81 7.77 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 120.636 0.255 . . . . 0.0 110.466 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.3 mm -78.46 142.15 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.96 160.58 37.28 Favored 'General case' 0 N--CA 1.458 -0.064 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.2 p -66.6 -14.52 62.5 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 176.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -75.98 -44.29 40.41 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 120.813 0.339 . . . . 0.0 110.675 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.0 m -72.53 -33.52 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.8 mt -70.85 -35.11 72.28 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -69.74 -31.5 69.51 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 174.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.8 m -67.31 -31.81 72.36 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 43.4 pt -94.58 -25.47 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-O 118.982 -0.533 . . . . 0.0 112.027 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 98.0 m -86.59 -28.59 23.18 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 119.283 0.947 . . . . 0.0 113.263 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.496 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 38.8 t30 -68.12 -40.49 21.95 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -178.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 74.4 Cg_endo -69.42 -14.29 36.93 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 CA-C-N 121.045 1.409 . . . . 0.0 111.434 176.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 91.7 m -87.28 -8.97 56.17 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 117.896 0.317 . . . . 0.0 111.46 176.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 150.53 171.1 18.45 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 178.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -66.63 85.45 0.29 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 124.632 3.554 . . . . 0.0 110.928 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 10.7 p -68.39 148.48 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 123.874 0.87 . . . . 0.0 109.609 175.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -121.75 -36.23 3.07 Favored 'General case' 0 C--O 1.228 -0.077 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -174.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 66.2 mtm-85 -146.1 148.73 32.93 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.582 0.628 . . . . 0.0 112.353 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 35.2 mt -147.99 135.07 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 C-N-CA 123.998 0.919 . . . . 0.0 109.504 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 2.3 m -141.3 160.81 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.105 0 C-N-CA 123.633 0.773 . . . . 0.0 111.614 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 53.1 mt -134.6 144.17 35.69 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.046 0 C-N-CA 123.332 0.653 . . . . 0.0 110.327 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.297 4.6 p90 -143.31 155.99 44.6 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -127.13 13.13 7.21 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.509 0.724 . . . . 0.0 111.087 -173.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -64.31 -31.04 72.09 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -169.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -130.32 7.49 4.98 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 118.889 0.768 . . . . 0.0 112.114 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 161.08 -124.54 1.33 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 108.559 -1.816 . . . . 0.0 108.559 -174.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 59.4 t -144.25 114.63 2.11 Favored 'Isoleucine or valine' 0 C--O 1.23 0.051 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 175.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -142.89 168.05 20.63 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.123 0.487 . . . . 0.0 110.904 -176.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.65 166.99 24.9 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.846 0.858 . . . . 0.0 109.152 175.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 71.3 mmm -134.06 156.08 48.88 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 38.5 t -141.23 147.05 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 122.89 0.476 . . . . 0.0 110.747 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -135.55 134.93 39.93 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.005 0.522 . . . . 0.0 110.326 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -108.16 163.05 13.5 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -77.45 -14.52 59.67 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 84.9 p -154.54 153.43 31.43 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.462 0.649 . . . . 0.0 111.581 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 51.9 t -65.23 -32.11 56.82 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.347 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -65.54 -33.95 77.12 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.014 0.37 . . . . 0.0 110.454 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 69.1 m -72.13 -33.5 67.84 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 177.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -72.63 -31.8 65.41 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 122.376 -0.202 . . . . 0.0 111.206 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -68.93 -43.77 74.45 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.931 -0.481 . . . . 0.0 111.523 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -77.78 -25.77 49.29 Favored 'General case' 0 N--CA 1.458 -0.036 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.497 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -72.5 -40.73 66.62 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 118.084 0.402 . . . . 0.0 110.035 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -72.6 -25.34 61.28 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 122.416 0.286 . . . . 0.0 110.864 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -91.86 -10.31 40.18 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 47.1 t -114.08 -34.12 5.48 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 80.3 mt -90.12 -9.36 48.63 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -70.74 134.63 47.62 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 74.73 -3.22 44.59 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 119.72 -0.489 . . . . 0.0 112.151 -178.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.52 166.48 21.14 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 117.869 0.834 . . . . 0.0 110.069 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -123.6 140.08 53.36 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 81.9 mt -74.99 -41.17 45.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.365 40.7 m-85 -82.85 -12.01 57.77 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 117.4 2.371 . . . . 0.0 117.4 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 32.1 t 65.39 34.89 7.82 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.495 0.718 . . . . 0.0 110.926 -173.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 177.15 -24.44 0.05 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' CYS . . . . . 0.424 ' HB3' HD12 ' A' ' 200' ' ' ILE . 86.0 m -146.89 -176.13 5.08 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.661 1.184 . . . . 0.0 109.5 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 89.1 m 58.2 37.24 26.2 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -176.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.27 149.08 13.36 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 176.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 81.2 mt -116.25 153.81 31.24 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -173.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -137.24 137.36 38.98 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 169.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 46.4 mt -139.6 141.64 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-O 120.734 0.302 . . . . 0.0 111.615 -170.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -161.36 163.92 30.36 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.043 176.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.277 49.8 m-85 -59.28 139.45 56.97 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 177.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -95.85 164.31 12.79 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -175.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.408 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 61.0 mttm -78.46 -50.05 1.69 Allowed Pre-proline 0 CA--C 1.535 0.395 0 CA-C-O 118.624 -0.703 . . . . 0.0 112.486 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 90.1 Cg_endo -74.7 174.21 13.05 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.619 2.213 . . . . 0.0 110.686 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 2.1 t -138.56 -2.48 1.77 Allowed 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 116.493 2.034 . . . . 0.0 116.493 -174.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.92 130.55 9.03 Favored 'General case' 0 C--N 1.34 0.176 0 O-C-N 121.546 -0.721 . . . . 0.0 111.624 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 17.0 mt -86.46 157.63 19.76 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 123.667 0.787 . . . . 0.0 111.127 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -119.74 47.36 1.74 Allowed 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.633 0.773 . . . . 0.0 109.59 173.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 272' ' ' VAL . 2.2 t -50.38 143.03 2.52 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 -176.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -132.5 1.22 3.72 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 116.15 1.907 . . . . 0.0 116.15 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -156.4 153.32 28.72 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.163 0.585 . . . . 0.0 110.355 -171.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -122.18 118.65 29.13 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.364 0.666 . . . . 0.0 109.675 172.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 54.9 p30 -157.58 -167.28 2.23 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -69.21 -13.38 62.37 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -175.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -109.51 -22.6 11.92 Favored 'General case' 0 C--N 1.338 0.102 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.65 142.08 35.01 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 177.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 20.2 t-105 -159.3 155.55 27.09 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.155 0.502 . . . . 0.0 110.01 -175.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -129.93 117.22 19.78 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.496 171.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.277 66.5 m-85 -80.0 8.44 7.04 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 117.269 2.322 . . . . 0.0 117.269 -172.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 8.7 t . . . . . 0 C--O 1.231 0.105 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -179.438 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 70.9 m . . . . . 0 CA--C 1.532 0.265 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 96.3 t -142.37 136.63 28.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 C-N-CA 123.976 0.911 . . . . 0.0 108.655 -178.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.451 ' N ' HD22 ' A' ' 192' ' ' LEU . 1.8 mm? -125.04 151.91 44.98 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 122.68 0.392 . . . . 0.0 111.309 -176.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 39.2 tp -95.54 136.29 36.12 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 169.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -113.95 102.77 10.51 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.899 1.279 . . . . 0.0 114.292 177.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.74 133.12 33.91 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 174.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.2 mp -104.06 121.31 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -89.03 -18.62 26.98 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -172.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -144.22 79.03 13.21 Favored Pre-proline 0 CA--C 1.529 0.142 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.74 46.03 1.93 Allowed 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.838 3.692 . . . . 0.0 112.247 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.419 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -70.88 -4.09 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 O-C-N 121.953 -0.467 . . . . 0.0 110.764 179.625 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -136.74 157.59 46.4 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 176.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 70.5 m -70.77 111.9 6.57 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.273 0.229 . . . . 0.0 110.552 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 32.2 mm -78.83 141.15 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 176.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.03 158.31 43.88 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 177.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.67 -19.79 66.04 Favored 'General case' 0 C--O 1.23 0.057 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -77.63 -34.52 53.26 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 96.4 t -75.46 -41.22 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.27 -31.52 70.1 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -70.85 -29.53 65.67 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 174.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.4 m -68.42 -32.79 73.09 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 45.0 pt -92.88 -22.51 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 118.379 0.536 . . . . 0.0 112.073 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 92.5 m -90.61 -26.53 19.6 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.49 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 32.0 t30 -63.06 -42.83 79.35 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 74.3 Cg_endo -69.25 -11.8 32.35 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.378 1.386 . . . . 0.0 111.604 177.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 92.5 m -91.78 -5.82 52.87 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 145.44 168.66 13.18 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 177.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.21 104.63 0.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.851 3.034 . . . . 0.0 111.581 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 55.4 t -75.7 143.61 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -115.36 -40.08 3.49 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 119.415 -0.326 . . . . 0.0 111.045 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 65.2 mtm-85 -147.99 151.31 35.55 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 19.0 mt -146.72 135.9 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 124.144 0.978 . . . . 0.0 109.448 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 1.4 m -139.87 159.31 26.94 Favored 'Isoleucine or valine' 0 C--O 1.23 0.049 0 C-N-CA 123.301 0.64 . . . . 0.0 111.88 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 56.0 mt -135.23 142.78 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 C-N-CA 123.159 0.583 . . . . 0.0 109.628 -176.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.29 3.7 p90 -143.13 158.21 43.82 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 176.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -128.43 16.68 6.53 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.267 0.627 . . . . 0.0 110.393 -172.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -64.72 -30.7 71.72 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -169.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -130.43 5.8 4.8 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 118.563 0.62 . . . . 0.0 112.133 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 161.2 -122.41 1.11 Allowed Glycine 0 CA--C 1.522 0.472 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 -173.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 57.2 t -143.26 116.41 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 175.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -143.73 167.13 23.01 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.158 0.504 . . . . 0.0 110.557 -176.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.41 167.48 24.28 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 53.4 mmm -137.88 153.78 49.52 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 44.5 t -139.99 140.77 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 C-N-CA 122.791 0.436 . . . . 0.0 110.318 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -124.52 130.03 51.7 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.047 0.539 . . . . 0.0 110.421 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -105.84 163.34 12.8 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 -175.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -76.35 -15.59 59.93 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.5 0.32 . . . . 0.0 110.499 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 84.8 p -155.84 160.5 40.26 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.273 0.559 . . . . 0.0 111.694 -177.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 25.6 t -65.1 -35.25 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -66.61 -34.97 79.07 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 122.309 -0.244 . . . . 0.0 111.037 -176.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 60.7 m -71.58 -30.24 65.61 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 121.242 -0.183 . . . . 0.0 110.534 176.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.48 -29.85 59.71 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 119.806 -0.14 . . . . 0.0 111.175 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -69.75 -48.38 59.6 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 118.127 0.421 . . . . 0.0 111.805 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -72.82 -27.46 61.97 Favored 'General case' 0 C--N 1.337 0.053 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.087 -177.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -69.76 -40.8 75.89 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -76.15 -19.63 58.31 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 122.915 0.486 . . . . 0.0 110.988 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -102.16 -0.3 33.47 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 42.9 t -127.07 -30.42 2.69 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 118.68 0.673 . . . . 0.0 112.512 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 70.0 mt -92.96 -8.2 43.8 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.097 0.408 . . . . 0.0 111.618 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -73.19 134.23 44.3 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.09 -5.04 44.09 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 119.717 -0.49 . . . . 0.0 112.108 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.7 166.34 21.9 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 117.801 0.8 . . . . 0.0 110.017 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -123.02 136.61 54.91 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 178.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 95.9 mt -70.92 -43.25 76.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.358 34.4 m-85 -82.8 -11.38 58.31 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 117.232 2.308 . . . . 0.0 117.232 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.7 t 65.76 36.11 6.42 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.954 0.883 . . . . 0.0 111.285 -174.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 174.42 -23.45 0.06 OUTLIER Glycine 0 CA--C 1.529 0.954 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.077 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' CYS . . . . . 0.419 ' HB3' HD12 ' A' ' 200' ' ' ILE . 93.5 m -146.51 -177.51 5.67 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.744 1.218 . . . . 0.0 109.212 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 89.0 m 58.46 35.72 24.88 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -176.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.86 148.21 10.7 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 175.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 84.1 mt -114.95 153.97 29.6 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -173.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -137.58 136.87 37.97 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.057 1.343 . . . . 0.0 107.426 169.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 40.9 mt -137.61 142.67 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 CA-C-O 120.723 0.297 . . . . 0.0 111.423 -171.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -159.67 161.88 35.0 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 122.988 0.515 . . . . 0.0 110.17 175.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.27 38.3 m-85 -59.2 135.77 57.75 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 176.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -88.57 164.83 15.21 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -89.18 -53.0 0.35 Allowed Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 123.617 0.767 . . . . 0.0 112.933 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -71.59 159.45 51.12 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.717 2.278 . . . . 0.0 110.503 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 1.4 t -127.15 0.25 6.46 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 -173.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -154.69 131.26 10.6 Favored 'General case' 0 C--N 1.339 0.134 0 O-C-N 121.857 -0.527 . . . . 0.0 111.472 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 29.1 mt -85.61 166.89 15.85 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.193 0.997 . . . . 0.0 111.304 177.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -121.87 44.76 2.49 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.434 170.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.415 ' H ' HG23 ' A' ' 272' ' ' VAL . 2.2 t -48.02 140.3 2.21 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -177.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -129.52 0.93 5.02 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 -178.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -158.19 166.33 32.68 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.93 0.395 . . . . 0.0 110.965 -174.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -125.91 111.69 15.08 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.956 0.902 . . . . 0.0 109.063 171.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 56.9 p30 -154.31 -169.97 3.4 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -69.65 -11.73 61.08 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -176.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -99.53 -37.3 9.23 Favored 'General case' 0 CA--C 1.528 0.096 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.81 147.01 38.37 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 178.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 18.9 t-105 -157.32 155.84 31.35 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -175.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -128.37 117.97 22.35 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.85 0.46 . . . . 0.0 109.9 173.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.295 67.8 m-85 -80.6 8.61 7.52 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 117.032 2.234 . . . . 0.0 117.032 -173.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 CA--C 1.529 0.14 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 178.992 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 55.1 m . . . . . 0 CA--C 1.531 0.215 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 39.1 t -128.62 142.59 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 123.147 0.579 . . . . 0.0 110.867 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.0 mt -132.66 150.06 52.21 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.793 0.437 . . . . 0.0 110.37 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.0 tt -106.93 139.51 41.22 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -113.99 139.61 49.1 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -129.44 143.16 50.72 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 176.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.3 mp -119.86 117.73 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 20.5 mt -81.07 -24.35 37.85 Favored 'General case' 0 C--N 1.338 0.096 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -173.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -138.0 79.01 33.79 Favored Pre-proline 0 N--CA 1.455 -0.193 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -176.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -76.93 48.56 2.52 Favored 'Trans proline' 0 N--CA 1.455 -0.769 1 C-N-CA 125.357 4.038 . . . . 0.0 112.017 -177.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.57 -5.39 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 O-C-N 121.963 -0.46 . . . . 0.0 110.513 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -137.92 156.46 47.86 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 175.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 66.8 m -68.9 116.01 8.89 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 110.525 -0.176 . . . . 0.0 110.525 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.2 mm -78.79 142.72 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.16 162.49 31.99 Favored 'General case' 0 C--O 1.231 0.097 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 21.2 p -66.87 -20.38 65.91 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -72.7 -47.64 45.51 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.17 -33.03 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 97.0 mt -72.2 -34.67 68.57 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -70.79 -31.77 68.64 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 174.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 12.5 m -66.59 -33.94 76.78 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 36.7 pt -92.37 -23.59 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 118.497 0.59 . . . . 0.0 111.996 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 98.8 m -89.34 -25.99 21.32 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.489 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 33.7 t30 -63.51 -42.24 71.99 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 73.5 Cg_endo -70.53 -15.43 34.22 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.489 1.46 . . . . 0.0 111.488 177.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 94.0 m -83.12 -15.27 51.38 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 122.236 -0.29 . . . . 0.0 111.357 176.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 151.94 170.79 19.01 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.17 108.01 0.53 Allowed 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.505 2.803 . . . . 0.0 111.423 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 81.9 t -77.5 145.76 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -117.21 -34.33 4.38 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 119.163 -0.446 . . . . 0.0 111.179 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 83.2 mtt85 -151.52 156.1 39.87 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 118.437 0.562 . . . . 0.0 112.0 177.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 25.8 mt -144.7 142.51 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.298 1.039 . . . . 0.0 109.199 174.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 96.6 t -143.36 155.19 16.64 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.102 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 53.9 mt -138.14 141.09 39.1 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 C-N-CA 123.494 0.717 . . . . 0.0 109.455 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.295 5.3 p90 -144.47 155.87 43.92 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 176.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -126.31 15.49 7.76 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.3 0.64 . . . . 0.0 110.58 -173.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -66.18 -31.96 73.12 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -169.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -130.36 8.67 5.08 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 118.455 0.57 . . . . 0.0 112.113 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 160.37 -125.57 1.49 Allowed Glycine 0 C--N 1.336 0.533 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 -174.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 45.8 t -142.74 113.23 2.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -142.35 170.42 15.74 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.467 0.651 . . . . 0.0 111.426 -174.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -149.2 169.01 21.71 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.669 176.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 86.6 mmm -135.55 152.16 51.02 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 42.8 t -141.02 147.56 22.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 122.665 0.386 . . . . 0.0 110.208 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -134.62 135.37 42.1 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.616 0.366 . . . . 0.0 110.215 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -111.78 161.78 15.95 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 -175.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -81.29 -11.9 59.22 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.963 0.505 . . . . 0.0 109.742 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 41.1 t -154.67 153.72 31.78 Favored 'General case' 0 C--O 1.232 0.144 0 O-C-N 121.909 -0.494 . . . . 0.0 111.888 -175.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 55.3 t -67.8 -40.26 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -66.57 -26.22 67.01 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 117.811 0.278 . . . . 0.0 110.948 -178.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 67.6 m -73.78 -33.44 64.25 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 176.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -77.41 -30.86 53.74 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 122.485 -0.135 . . . . 0.0 111.23 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -67.56 -42.47 82.57 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 121.913 -0.492 . . . . 0.0 111.621 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -77.88 -26.61 49.32 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.922 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -70.16 -43.27 71.19 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.207 0.458 . . . . 0.0 109.787 176.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.442 ' HE3' ' HB3' ' A' ' 245' ' ' LYS . 1.2 tmmt? -72.8 -21.94 60.9 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.99 0.516 . . . . 0.0 111.294 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -95.55 -11.35 27.51 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 44.7 t -115.23 -33.39 5.35 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 112.783 0.661 . . . . 0.0 112.783 -177.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 81.4 mt -91.79 -10.68 39.01 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -71.15 135.66 47.73 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 121.999 -0.438 . . . . 0.0 109.888 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.49 -3.77 31.11 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 119.63 -0.539 . . . . 0.0 112.847 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -81.03 166.45 20.77 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 118.011 0.906 . . . . 0.0 110.507 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -108.45 140.0 42.39 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 74.2 mt -74.2 -42.59 51.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 174.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.351 51.4 m-85 -82.75 -12.72 57.32 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 117.26 2.318 . . . . 0.0 117.26 178.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 27.6 t 66.06 38.72 4.68 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.676 0.791 . . . . 0.0 110.748 -172.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 174.31 -21.34 0.06 OUTLIER Glycine 0 CA--C 1.529 0.93 0 C-N-CA 123.53 0.586 . . . . 0.0 111.903 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 78.2 m -147.46 -174.08 4.43 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.547 1.139 . . . . 0.0 109.096 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 93.4 m 57.44 43.16 23.48 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.71 0.634 . . . . 0.0 112.71 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -50.47 133.3 24.95 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 177.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 96.0 mt -95.64 152.01 18.83 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.465 0.65 . . . . 0.0 112.167 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -141.03 132.66 27.15 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.345 1.458 . . . . 0.0 107.071 169.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 47.8 mt -140.64 141.15 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 CA-C-O 120.641 0.258 . . . . 0.0 111.316 -172.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -161.75 165.44 28.01 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.271 0.628 . . . . 0.0 109.417 174.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -59.85 138.91 57.68 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 115.586 1.698 . . . . 0.0 115.586 177.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -93.91 160.03 14.92 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -176.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.402 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 58.7 mttm -76.89 -49.7 2.49 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 118.429 -0.796 . . . . 0.0 112.878 -179.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 65.9 Cg_endo -76.32 169.13 22.57 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.718 2.279 . . . . 0.0 111.104 -178.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.282 0.2 OUTLIER -136.46 12.79 3.24 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 117.37 2.359 . . . . 0.0 117.37 -176.904 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -159.96 126.03 4.23 Favored 'General case' 0 C--N 1.338 0.096 0 O-C-N 121.677 -0.639 . . . . 0.0 111.805 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 28.5 mt -86.13 159.54 19.5 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 123.463 0.705 . . . . 0.0 110.944 174.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -125.23 47.7 2.13 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.826 0.85 . . . . 0.0 109.817 174.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.403 HG23 ' H ' ' A' ' 272' ' ' VAL . 2.3 t -52.19 142.15 5.14 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -176.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . 0.253 6.1 p90 -120.81 -7.7 9.52 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 117.282 2.327 . . . . 0.0 117.282 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -162.52 168.04 22.5 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 122.689 0.396 . . . . 0.0 111.029 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -119.99 127.01 52.23 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.566 0.746 . . . . 0.0 110.03 176.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 41.0 p30 -161.03 -167.39 1.8 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.245 1.018 . . . . 0.0 109.542 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -70.4 -10.9 60.36 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -176.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -105.6 -29.57 10.05 Favored 'General case' 0 C--N 1.337 0.064 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -141.04 146.46 37.22 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 178.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 19.3 t-105 -156.53 154.15 29.86 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -176.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -132.76 117.58 17.99 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.201 0.6 . . . . 0.0 111.512 175.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.288 68.3 m-85 -83.26 10.41 8.53 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 117.366 2.358 . . . . 0.0 117.366 -171.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 12.9 t . . . . . 0 N--CA 1.455 -0.191 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -179.544 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 CA--C 1.53 0.174 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 30.7 t -130.76 134.3 62.09 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.092 0 C-N-CA 122.858 0.463 . . . . 0.0 111.103 177.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.421 HD21 ' HB1' ' A' ' 241' ' ' ALA . 2.7 mm? -122.94 154.2 38.69 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.098 0.559 . . . . 0.0 110.779 -176.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 39.0 tp -104.01 136.26 43.98 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 170.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -113.86 107.92 16.36 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.71 1.204 . . . . 0.0 114.122 177.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.99 141.01 29.02 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 174.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.4 mp -110.56 126.83 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -90.43 -23.67 20.96 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -173.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -140.34 78.98 21.81 Favored Pre-proline 0 CA--C 1.53 0.188 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -76.74 49.89 2.86 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 124.804 3.669 . . . . 0.0 112.113 -178.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.402 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -68.87 -5.86 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 O-C-N 121.749 -0.595 . . . . 0.0 110.251 178.241 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -142.1 154.58 45.02 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.2 1.4 . . . . 0.0 112.538 175.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.3 t -73.38 129.93 39.07 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.291 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 23.0 mm -79.16 148.4 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 123.073 0.549 . . . . 0.0 109.993 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.02 156.38 48.32 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.4 p -64.1 -17.3 63.29 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 177.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -76.52 -46.25 27.32 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.79 0.329 . . . . 0.0 111.812 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.6 m -71.29 -31.6 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.059 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.31 -36.95 74.64 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 176.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -70.83 -30.48 66.91 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 175.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 12.5 m -66.78 -33.4 75.55 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 41.1 pt -93.85 -21.59 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 118.399 0.545 . . . . 0.0 112.13 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 97.4 m -91.54 -25.73 19.1 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.502 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 35.4 t30 -64.65 -39.19 37.78 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 74.3 Cg_endo -69.94 -13.04 33.7 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 CA-C-N 121.023 1.401 . . . . 0.0 111.575 177.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 95.9 m -91.95 -5.41 53.16 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.669 0.388 . . . . 0.0 111.663 177.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 146.74 166.83 12.51 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 178.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.18 103.77 1.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.635 2.89 . . . . 0.0 110.657 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 75.6 t -70.37 146.28 12.29 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -114.34 -37.14 4.44 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 119.212 -0.423 . . . . 0.0 111.765 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -150.21 151.64 33.36 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 20.7 mt -147.87 136.96 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 C-N-CA 124.055 0.942 . . . . 0.0 109.975 177.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 6.1 m -142.61 159.43 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 123.729 0.812 . . . . 0.0 110.313 173.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 41.3 mt -132.68 143.61 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 123.018 0.527 . . . . 0.0 110.375 -175.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.316 3.8 p90 -140.32 154.65 46.86 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 115.718 1.748 . . . . 0.0 115.718 176.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -126.59 16.79 7.56 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.309 0.643 . . . . 0.0 110.06 -174.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -64.43 -31.91 73.31 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -169.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -130.46 8.62 5.03 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 118.346 0.521 . . . . 0.0 112.096 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 157.62 -124.12 1.37 Allowed Glycine 0 C--N 1.334 0.444 0 N-CA-C 108.336 -1.905 . . . . 0.0 108.336 -173.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 24.9 t -142.15 114.65 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-N 116.846 0.323 . . . . 0.0 110.18 176.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 8.4 mp0 -143.45 166.69 24.09 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.119 0.485 . . . . 0.0 110.671 -177.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.41 163.7 35.65 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.725 0.81 . . . . 0.0 109.788 176.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 56.0 mmm -130.76 151.31 51.34 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 41.4 t -140.74 144.26 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.067 0 C-N-CA 122.945 0.498 . . . . 0.0 110.399 -178.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -130.5 133.21 46.09 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.83 0.452 . . . . 0.0 110.64 178.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -104.21 163.21 12.57 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 116.334 1.975 . . . . 0.0 116.334 -177.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -78.92 -14.51 59.18 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 85.2 p -154.71 157.64 38.38 Favored 'General case' 0 N--CA 1.457 -0.081 0 O-C-N 121.744 -0.598 . . . . 0.0 111.262 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 53.4 t -67.76 -32.33 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -66.84 -34.83 78.68 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 121.878 -0.514 . . . . 0.0 110.733 -177.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 69.1 m -72.56 -31.05 64.95 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 176.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.421 ' HB1' HD21 ' A' ' 192' ' ' LEU . . . -74.08 -31.51 62.85 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 122.577 0.351 . . . . 0.0 111.441 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -71.79 -46.99 56.47 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 117.944 0.338 . . . . 0.0 111.788 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -73.19 -26.3 61.11 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 118.04 0.382 . . . . 0.0 111.345 -177.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -71.11 -41.4 70.64 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.92 -23.63 55.5 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.482 0.313 . . . . 0.0 110.998 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -91.32 -10.01 42.89 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 40.0 t -118.7 -35.08 3.79 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -177.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 66.0 mt -87.94 -7.27 57.36 Favored 'General case' 0 N--CA 1.457 -0.076 0 CA-C-N 118.118 0.417 . . . . 0.0 111.862 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -70.01 136.36 50.33 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 74.65 -4.98 32.68 Favored Glycine 0 CA--C 1.533 1.201 0 CA-C-O 119.769 -0.462 . . . . 0.0 112.431 -178.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -76.72 166.32 23.52 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 117.848 0.824 . . . . 0.0 110.302 177.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -123.6 140.47 52.97 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 67.4 mt -75.04 -42.5 45.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-O 120.92 0.391 . . . . 0.0 110.012 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.365 53.5 m-85 -82.66 -11.4 58.39 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 117.084 2.253 . . . . 0.0 117.084 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 30.7 t 65.99 35.1 6.61 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.664 0.786 . . . . 0.0 111.313 -175.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 176.52 -23.58 0.05 OUTLIER Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 178.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' CYS . . . . . 0.402 ' HB3' HD12 ' A' ' 200' ' ' ILE . 81.6 m -145.93 -176.63 5.22 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.61 1.164 . . . . 0.0 108.876 178.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 87.5 m 57.84 38.71 27.24 Favored 'General case' 0 CA--C 1.527 0.087 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -176.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.96 141.56 21.8 Favored 'General case' 0 C--O 1.23 0.067 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 174.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 95.9 mt -102.09 158.24 16.3 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.49 0.662 . . . . 0.0 112.27 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -139.29 137.18 35.63 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 169.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 19.6 mt -138.23 139.51 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-O 121.089 0.471 . . . . 0.0 111.62 -173.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -159.48 161.9 35.48 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.242 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.262 41.0 m-85 -60.97 135.92 57.93 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 177.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -92.6 155.89 17.46 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.525 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.433 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 22.9 pttp -88.49 -29.93 0.37 Allowed Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 117.216 -1.373 . . . . 0.0 114.611 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 48.9 Cg_endo -79.87 165.12 22.37 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 CA-C-N 122.063 1.773 . . . . 0.0 110.093 176.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.279 0.2 OUTLIER -138.03 8.86 2.76 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 118.19 2.663 . . . . 0.0 118.19 -174.628 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.71 127.05 6.52 Favored 'General case' 0 C--N 1.338 0.073 0 O-C-N 121.408 -0.807 . . . . 0.0 111.858 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 24.6 mt -92.04 156.45 17.39 Favored 'General case' 0 C--N 1.337 0.052 0 C-N-CA 123.772 0.829 . . . . 0.0 111.107 176.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -117.31 53.42 0.92 Allowed 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.517 0.727 . . . . 0.0 109.594 172.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.41 ' H ' HG23 ' A' ' 272' ' ' VAL . 2.4 t -53.04 145.35 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -176.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -130.12 -7.31 4.36 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 117.637 2.458 . . . . 0.0 117.637 -177.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -161.9 173.72 14.12 Favored 'General case' 0 N--CA 1.458 -0.07 0 C-N-CA 122.739 0.416 . . . . 0.0 110.281 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -125.69 117.75 24.15 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.025 0.93 . . . . 0.0 110.006 175.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 46.6 p30 -159.54 -166.22 1.73 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.979 0.912 . . . . 0.0 108.922 177.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -70.11 -9.62 56.12 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -174.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -115.98 -17.46 10.93 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.72 140.87 33.25 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.799 0.84 . . . . 0.0 112.966 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 19.4 t-105 -160.78 156.71 25.66 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 119.764 -0.774 . . . . 0.0 110.4 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -138.03 116.55 12.06 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.469 0.708 . . . . 0.0 110.977 174.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.284 66.7 m-85 -81.31 8.94 7.92 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 117.318 2.34 . . . . 0.0 117.318 -172.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.457 -0.096 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -179.538 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 55.9 m . . . . . 0 CA--C 1.531 0.233 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 28.3 t -130.02 134.07 63.43 Favored 'Isoleucine or valine' 0 C--N 1.339 0.115 0 CA-C-N 118.194 0.452 . . . . 0.0 111.089 177.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.422 ' N ' HD22 ' A' ' 192' ' ' LEU . 2.4 mm? -121.14 153.59 37.3 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.053 0.541 . . . . 0.0 110.831 -177.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 25.0 tp -106.11 132.68 51.89 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 171.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -107.86 133.94 51.5 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.633 1.173 . . . . 0.0 114.141 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.29 133.27 55.5 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 174.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 3.8 mp -104.52 117.06 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -88.35 -18.04 29.29 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.165 -171.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -141.48 79.02 17.72 Favored Pre-proline 0 CA--C 1.529 0.138 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.9 44.25 1.53 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 125.2 3.933 . . . . 0.0 112.542 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.465 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -70.05 -4.76 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 121.693 -0.629 . . . . 0.0 110.523 179.453 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -138.47 158.33 44.47 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 177.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 45.2 t -70.83 117.87 12.9 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.0 mm -78.38 144.41 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.08 159.11 41.82 Favored 'General case' 0 N--CA 1.458 -0.064 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 43.3 p -66.87 -19.72 65.79 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -75.88 -47.24 26.23 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.7 m -70.29 -32.69 51.4 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.0 mt -70.94 -33.99 71.03 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 176.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -73.19 -29.11 62.59 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 174.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 7.2 m -67.99 -33.18 74.13 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 41.4 pt -91.68 -24.07 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 118.225 0.466 . . . . 0.0 111.785 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 94.6 m -89.0 -24.53 22.36 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.478 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.1 t30 -63.57 -42.37 72.43 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 73.7 Cg_endo -69.31 -16.42 39.45 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 CA-C-N 120.873 1.347 . . . . 0.0 111.192 177.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 80.5 m -84.01 -14.62 50.23 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 122.175 -0.328 . . . . 0.0 111.337 177.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 153.2 172.92 21.94 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.8 101.5 0.92 Allowed 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 124.007 3.138 . . . . 0.0 110.45 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 75.8 t -71.21 147.52 11.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -118.74 -35.98 3.57 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 119.178 -0.439 . . . . 0.0 111.721 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 25.8 mtm180 -150.37 151.72 33.28 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.693 0.679 . . . . 0.0 112.767 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 25.1 mt -148.74 137.92 15.59 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 124.132 0.973 . . . . 0.0 110.109 177.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.2 m -143.44 161.31 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 C-N-CA 124.127 0.971 . . . . 0.0 109.983 173.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 52.6 mt -131.36 143.27 41.11 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 C-N-CA 122.793 0.437 . . . . 0.0 110.737 -175.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.262 5.1 p90 -146.72 158.96 44.02 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 175.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -138.53 30.22 2.36 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.115 0.566 . . . . 0.0 111.82 -177.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -66.17 -30.11 70.52 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.323 0.861 . . . . 0.0 113.323 -174.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -130.55 1.24 4.49 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 171.85 -128.51 1.59 Allowed Glycine 0 CA--C 1.522 0.473 0 N-CA-C 108.65 -1.78 . . . . 0.0 108.65 -174.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 17.3 t -138.51 115.11 10.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 117.44 0.62 . . . . 0.0 110.351 174.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 9.4 mp0 -143.64 169.78 17.08 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.552 0.692 . . . . 0.0 111.924 -172.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -152.82 168.52 25.47 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.083 0.953 . . . . 0.0 108.818 175.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 68.9 mmm -134.34 151.5 51.27 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.767 -0.456 . . . . 0.0 109.767 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 40.3 t -141.62 144.5 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 C-N-CA 123.0 0.52 . . . . 0.0 110.433 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -131.92 136.28 47.27 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.616 0.366 . . . . 0.0 110.775 178.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -108.67 162.65 13.96 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 -177.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -83.98 -6.54 59.44 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 29.2 t -153.66 149.54 27.65 Favored 'General case' 0 N--CA 1.456 -0.13 0 O-C-N 121.954 -0.466 . . . . 0.0 111.785 -176.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 55.2 t -68.75 -35.69 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -68.16 -28.29 67.16 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.06 -0.4 . . . . 0.0 110.775 -178.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 61.4 m -74.88 -31.2 61.53 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 176.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.418 ' HB1' HD21 ' A' ' 192' ' ' LEU . . . -75.46 -33.53 60.85 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 122.411 0.284 . . . . 0.0 111.083 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -69.59 -43.94 71.78 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 117.904 0.32 . . . . 0.0 111.538 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -75.27 -25.17 57.77 Favored 'General case' 0 N--CA 1.457 -0.084 0 CA-C-N 117.815 0.28 . . . . 0.0 110.866 -177.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -71.48 -42.49 68.03 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 176.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.428 ' HE3' ' HB3' ' A' ' 245' ' ' LYS . 1.0 OUTLIER -75.4 -20.49 58.89 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.739 0.416 . . . . 0.0 111.262 -179.669 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -94.87 -12.07 27.61 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 45.1 t -113.58 -34.96 5.37 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 68.6 mt -89.95 -6.84 55.26 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 118.176 0.444 . . . . 0.0 111.963 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -71.9 131.96 43.7 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 177.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.59 -4.08 52.35 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.744 -0.476 . . . . 0.0 112.171 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.61 166.45 21.86 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 117.818 0.809 . . . . 0.0 110.303 178.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -123.33 139.9 53.57 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 84.8 mt -74.7 -41.36 47.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 N-CA-C 109.668 -0.494 . . . . 0.0 109.668 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.363 44.1 m-85 -82.8 -12.02 57.81 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 117.316 2.339 . . . . 0.0 117.316 178.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.7 t 66.31 34.66 6.31 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.627 0.727 . . . . 0.0 110.685 -174.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 175.97 -23.65 0.06 OUTLIER Glycine 0 CA--C 1.529 0.96 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' CYS . . . . . 0.465 ' HB3' HD12 ' A' ' 200' ' ' ILE . 77.2 m -146.63 -177.15 5.49 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.711 1.204 . . . . 0.0 109.536 178.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 91.4 m 57.85 37.55 26.99 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -176.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.88 148.2 13.71 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 175.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 74.2 mt -115.98 156.04 26.96 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -172.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -138.57 140.15 38.92 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.398 1.479 . . . . 0.0 107.482 169.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 37.4 mt -141.79 141.49 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 CA-C-O 120.976 0.417 . . . . 0.0 111.72 -172.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 6.9 pm0 -156.59 164.21 38.45 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 174.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.273 41.2 m-85 -61.46 137.67 58.25 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 177.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -91.51 156.79 17.43 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.663 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.445 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 63.9 pttt -88.56 -31.57 0.39 Allowed Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 48.7 Cg_endo -79.65 167.73 20.38 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.006 1.804 . . . . 0.0 110.172 176.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.278 0.2 OUTLIER -137.25 8.45 2.92 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -175.829 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.66 128.46 7.24 Favored 'General case' 0 C--O 1.227 -0.12 0 O-C-N 121.416 -0.803 . . . . 0.0 111.942 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 20.1 mt -92.33 157.28 16.72 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 123.893 0.877 . . . . 0.0 110.722 176.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -117.34 54.52 0.88 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.704 0.802 . . . . 0.0 109.473 173.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.4 t -55.76 147.38 4.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -176.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -132.61 -2.94 3.35 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 116.934 2.198 . . . . 0.0 116.934 -176.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -161.89 160.85 28.48 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.316 0.246 . . . . 0.0 110.812 -174.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -123.18 111.02 16.0 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.606 0.762 . . . . 0.0 109.564 173.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 56.6 p30 -157.81 -169.98 3.03 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.334 1.054 . . . . 0.0 108.372 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -68.59 -10.8 58.16 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -174.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -111.58 -22.27 11.32 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.1 p -142.58 138.92 31.13 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.686 1.195 . . . . 0.0 112.295 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 21.0 t-105 -158.44 155.55 28.78 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 119.724 -0.791 . . . . 0.0 110.932 -177.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -135.39 116.49 14.34 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.725 0.81 . . . . 0.0 111.108 173.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.292 66.1 m-85 -79.99 9.17 5.74 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 117.524 2.416 . . . . 0.0 117.524 -172.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.456 -0.149 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -179.611 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 CA--C 1.529 0.165 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 39.8 t -130.54 132.77 64.36 Favored 'Isoleucine or valine' 0 C--N 1.338 0.091 0 CA-C-N 118.215 0.461 . . . . 0.0 111.17 177.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 8.1 mp -122.07 149.88 42.93 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 123.949 0.899 . . . . 0.0 110.563 -174.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 27.0 tp -102.56 135.8 43.53 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 170.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -115.93 104.18 11.35 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.102 1.361 . . . . 0.0 114.071 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.87 133.19 34.88 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 175.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.5 mp -102.76 124.23 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -90.49 -19.26 24.04 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -173.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -141.96 78.87 16.96 Favored Pre-proline 0 CA--C 1.53 0.178 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -77.34 45.73 1.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.764 1 C-N-CA 125.444 4.096 . . . . 0.0 112.275 -177.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.42 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -69.76 -4.09 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 O-C-N 121.818 -0.552 . . . . 0.0 110.508 179.363 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -137.39 156.55 48.07 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 175.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 66.4 m -69.11 112.95 6.05 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.3 mm -78.36 141.77 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.02 161.34 35.09 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.4 p -64.03 -17.67 63.58 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -75.07 -46.75 32.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.712 0.291 . . . . 0.0 111.572 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 1.6 m -70.1 -32.12 49.99 Favored 'Isoleucine or valine' 0 C--N 1.338 0.107 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.69 -34.93 70.06 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 176.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -71.08 -29.66 65.59 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 174.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 10.1 m -68.29 -34.19 75.71 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 42.0 pt -91.41 -22.98 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 118.41 0.55 . . . . 0.0 111.907 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 97.4 m -90.1 -23.6 21.34 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.474 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 26.6 t30 -63.88 -43.24 75.15 Favored Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 73.9 Cg_endo -69.51 -14.45 36.9 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.416 1.41 . . . . 0.0 111.32 177.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 96.8 m -85.43 -16.12 40.75 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 118.011 0.369 . . . . 0.0 111.48 176.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 154.75 171.71 21.81 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.613 -0.595 . . . . 0.0 111.613 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.27 98.86 0.66 Allowed 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.744 2.962 . . . . 0.0 110.633 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 63.9 t -69.45 145.91 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -115.12 -37.85 4.0 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 119.365 -0.35 . . . . 0.0 111.233 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 63.4 mtm-85 -147.66 152.34 37.69 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 25.5 mt -148.0 137.7 16.37 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 C-N-CA 124.144 0.978 . . . . 0.0 109.706 176.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 12.8 m -143.95 161.65 15.71 Favored 'Isoleucine or valine' 0 C--N 1.338 0.082 0 C-N-CA 123.553 0.741 . . . . 0.0 110.115 174.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 35.8 mt -135.67 141.91 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 122.824 0.45 . . . . 0.0 110.628 -175.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.316 4.1 p90 -138.15 156.84 47.34 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 176.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -128.5 15.59 6.55 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.425 0.69 . . . . 0.0 110.522 -173.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -63.58 -31.92 73.23 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -169.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -130.65 6.47 4.75 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 118.686 0.675 . . . . 0.0 112.494 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 163.02 -124.82 1.32 Allowed Glycine 0 CA--C 1.521 0.419 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 -174.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 45.5 t -141.97 114.93 4.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -142.45 166.07 25.68 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.904 0.383 . . . . 0.0 110.578 -177.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.15 164.88 30.82 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.583 0.753 . . . . 0.0 109.416 175.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 62.9 mmm -133.06 153.21 51.71 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 39.1 t -139.79 145.5 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 C-N-CA 122.838 0.455 . . . . 0.0 110.409 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -130.22 133.08 46.3 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.918 0.487 . . . . 0.0 110.529 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -108.02 161.35 15.03 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -82.92 -8.18 59.59 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 29.2 t -155.01 149.49 26.31 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 121.916 -0.49 . . . . 0.0 111.554 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 51.1 t -67.76 -35.9 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -68.14 -28.57 67.42 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.112 0.415 . . . . 0.0 111.137 -177.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 58.3 m -74.32 -32.34 62.8 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 176.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.71 -29.73 56.38 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.621 0.369 . . . . 0.0 110.934 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -69.98 -44.07 70.2 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.147 -0.345 . . . . 0.0 111.439 178.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -75.39 -25.09 57.33 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.878 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -70.97 -39.35 72.56 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.127 0.422 . . . . 0.0 110.255 176.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.08 -25.59 58.69 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 122.639 0.376 . . . . 0.0 110.298 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -91.2 -10.29 42.23 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 46.1 t -117.04 -36.48 3.8 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -176.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 78.7 mt -88.36 -8.29 55.31 Favored 'General case' 0 C--N 1.338 0.108 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -71.47 133.36 45.81 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.54 -5.28 46.28 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 119.681 -0.511 . . . . 0.0 112.298 -178.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.67 166.45 22.5 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 117.833 0.817 . . . . 0.0 110.253 177.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -123.65 139.84 53.6 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 87.0 mt -74.92 -41.53 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.373 42.7 m-85 -82.88 -11.81 57.9 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 117.151 2.278 . . . . 0.0 117.151 178.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 29.9 t 65.25 35.52 7.64 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.385 0.674 . . . . 0.0 110.74 -174.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 175.56 -23.98 0.06 OUTLIER Glycine 0 CA--C 1.53 1.028 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' CYS . . . . . 0.42 ' HB3' HD12 ' A' ' 200' ' ' ILE . 72.0 m -145.32 -176.87 5.28 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.686 1.195 . . . . 0.0 109.199 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 84.3 m 57.74 36.93 27.04 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -176.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.35 149.55 9.96 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 114.471 1.285 . . . . 0.0 114.471 175.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 79.0 mt -116.87 154.35 30.92 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -172.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -137.0 137.65 39.66 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.276 1.43 . . . . 0.0 107.414 169.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 56.7 mt -139.57 142.78 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 CA-C-O 120.566 0.222 . . . . 0.0 111.578 -170.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -160.63 162.88 32.86 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.295 0.638 . . . . 0.0 109.622 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.264 50.8 m-85 -59.43 139.75 56.8 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 176.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -88.32 165.3 15.08 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -176.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.403 ' HB2' ' HD3' ' A' ' 267' ' ' PRO . 78.2 mttt -79.21 -51.55 1.26 Allowed Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 118.445 -0.788 . . . . 0.0 112.065 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' A' ' 266' ' ' LYS . 68.3 Cg_endo -76.27 175.16 11.7 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.859 2.373 . . . . 0.0 111.303 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.45 -3.54 3.01 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -176.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -158.28 130.22 6.83 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 118.92 0.782 . . . . 0.0 112.564 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 23.7 mt -84.57 164.46 18.7 Favored 'General case' 0 N--CA 1.458 -0.055 0 C-N-CA 124.378 1.071 . . . . 0.0 111.651 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -120.77 54.06 1.09 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.386 170.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.416 HG23 ' H ' ' A' ' 272' ' ' VAL . 2.7 t -53.0 147.44 2.07 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -175.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -138.07 -1.35 1.97 Allowed 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 116.92 2.193 . . . . 0.0 116.92 -176.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -159.11 161.57 36.38 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -172.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -125.6 108.35 11.49 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.199 0.999 . . . . 0.0 109.681 174.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -158.31 -166.17 1.87 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 177.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -68.64 -9.97 53.2 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -174.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -117.42 -17.32 10.1 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.16 141.85 34.09 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.772 0.829 . . . . 0.0 113.016 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 17.8 t-105 -163.63 156.63 18.43 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 118.554 0.615 . . . . 0.0 110.445 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -142.11 120.44 12.33 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.305 172.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -81.95 5.59 18.63 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 117.192 2.293 . . . . 0.0 117.192 -173.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 3.6 t . . . . . 0 CA--C 1.53 0.205 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -178.012 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 CA--C 1.532 0.268 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 37.2 t -128.4 143.55 40.67 Favored 'Isoleucine or valine' 0 C--N 1.339 0.116 0 C-N-CA 123.167 0.587 . . . . 0.0 110.79 178.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 82.6 mt -135.61 149.0 49.24 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.868 0.467 . . . . 0.0 111.104 -175.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 39.2 tp -101.11 135.45 42.54 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 172.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -113.57 101.37 9.27 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 125.148 1.379 . . . . 0.0 114.6 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.2 m -86.8 133.84 33.61 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 175.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.0 mp -103.94 126.0 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -94.06 -18.42 21.84 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -172.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -141.24 78.99 18.22 Favored Pre-proline 0 CA--C 1.529 0.164 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -77.41 49.03 2.74 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 125.003 3.802 . . . . 0.0 112.278 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.45 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -69.23 -6.78 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 O-C-N 121.787 -0.571 . . . . 0.0 110.224 178.163 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -141.73 154.68 45.45 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.158 1.383 . . . . 0.0 112.394 175.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.4 t -74.15 131.46 41.3 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.157 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 21.9 mm -81.14 148.37 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 122.923 0.489 . . . . 0.0 109.913 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.89 157.89 44.83 Favored 'General case' 0 C--O 1.231 0.079 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 177.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.3 p -63.88 -18.75 64.49 Favored 'General case' 0 N--CA 1.458 -0.057 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -73.4 -47.3 43.05 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.717 0.294 . . . . 0.0 111.544 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.5 m -71.06 -32.31 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.16 -36.61 72.09 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 176.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -70.82 -30.14 66.49 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 175.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 8.9 m -67.59 -33.76 75.66 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 38.6 pt -92.38 -24.31 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 118.585 0.63 . . . . 0.0 111.77 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 95.6 m -88.49 -26.39 22.08 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.478 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 35.1 t30 -64.71 -42.53 64.86 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 71.9 Cg_endo -70.29 -12.74 32.42 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.493 1.462 . . . . 0.0 111.262 177.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 96.4 m -90.43 -9.23 48.29 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.031 0.378 . . . . 0.0 111.665 176.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 151.41 167.72 15.16 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 178.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.26 103.03 1.01 Allowed 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.903 3.069 . . . . 0.0 110.584 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 71.9 t -70.67 145.25 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -113.74 -39.27 4.05 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 119.205 -0.426 . . . . 0.0 111.28 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -149.15 152.8 36.72 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.267 0.485 . . . . 0.0 112.046 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 23.6 mt -147.28 135.72 15.34 Favored 'Isoleucine or valine' 0 C--N 1.338 0.073 0 C-N-CA 124.025 0.93 . . . . 0.0 109.912 177.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 1.6 m -140.38 160.61 25.16 Favored 'Isoleucine or valine' 0 C--N 1.337 0.062 0 C-N-CA 123.55 0.74 . . . . 0.0 111.715 174.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 53.7 mt -135.82 144.02 34.71 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 C-N-CA 123.127 0.571 . . . . 0.0 110.163 -175.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.299 3.5 p90 -143.35 156.47 44.7 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 175.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 5.8 mmt180 -127.35 17.68 7.04 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.32 0.648 . . . . 0.0 110.002 -174.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -64.89 -31.74 73.12 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -169.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -130.47 5.89 4.79 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 118.606 0.639 . . . . 0.0 111.893 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 163.04 -124.35 1.28 Allowed Glycine 0 C--N 1.334 0.442 0 N-CA-C 108.696 -1.761 . . . . 0.0 108.696 -173.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 49.1 t -142.6 114.04 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 -142.86 166.07 25.65 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.117 0.484 . . . . 0.0 110.845 -176.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.09 164.99 31.29 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.487 175.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 57.9 mmm -132.42 152.82 51.33 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 39.1 t -141.12 146.03 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 C-N-CA 123.116 0.566 . . . . 0.0 110.37 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -132.52 135.59 46.09 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 122.536 0.335 . . . . 0.0 110.593 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -107.78 162.92 13.55 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 -176.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -75.74 -17.21 59.99 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 86.5 p -155.13 159.63 40.34 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.175 0.512 . . . . 0.0 111.263 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 54.8 t -67.34 -35.22 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -66.56 -28.18 68.32 Favored 'General case' 0 N--CA 1.456 -0.139 0 O-C-N 122.18 -0.325 . . . . 0.0 111.021 -177.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 74.4 m -75.94 -32.68 59.67 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 177.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.54 -32.63 58.34 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.416 -0.177 . . . . 0.0 111.086 178.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -66.76 -44.03 82.51 Favored 'General case' 0 C--N 1.338 0.09 0 O-C-N 122.036 -0.415 . . . . 0.0 111.558 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -75.59 -26.34 57.8 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.898 -178.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -74.16 -40.85 62.3 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.03 0.377 . . . . 0.0 110.148 178.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -73.57 -23.22 59.93 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.862 0.465 . . . . 0.0 111.063 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -92.4 -17.04 25.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 48.2 t -106.67 -36.17 6.8 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -176.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 76.7 mt -88.67 -8.03 55.3 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -70.78 134.27 47.26 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.65 -6.45 39.32 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 119.676 -0.513 . . . . 0.0 112.458 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -77.41 166.34 23.25 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 117.759 0.78 . . . . 0.0 110.187 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 5.0 p30 -123.24 140.56 52.89 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 80.8 mt -74.98 -43.03 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.071 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.36 50.2 m-85 -82.78 -10.05 59.05 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 29.1 t 66.38 34.78 6.11 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.629 0.772 . . . . 0.0 111.126 -175.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 175.47 -24.45 0.06 OUTLIER Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 178.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' CYS . . . . . 0.45 ' HB3' HD12 ' A' ' 200' ' ' ILE . 81.4 m -144.69 -176.97 5.27 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.692 1.197 . . . . 0.0 109.264 178.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 96.2 m 57.4 39.18 28.41 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -175.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.04 146.4 18.18 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 175.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 89.1 mt -110.78 154.41 23.98 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -172.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -137.92 135.98 36.59 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.865 1.666 . . . . 0.0 106.679 169.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 44.6 mt -138.43 141.67 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-O 120.618 0.247 . . . . 0.0 111.142 -172.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -158.76 164.11 36.14 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 175.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.288 43.4 m-85 -61.75 135.38 57.58 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 177.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -85.35 162.85 18.89 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.369 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.468 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 63.4 pttt -94.06 -32.56 0.3 Allowed Pre-proline 0 CA--C 1.54 0.567 0 CA-C-O 117.29 -1.338 . . . . 0.0 114.225 178.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 86.3 Cg_endo -76.3 171.52 17.93 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 CA-C-N 122.04 1.764 . . . . 0.0 110.055 175.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.21 -1.91 2.33 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 117.72 2.489 . . . . 0.0 117.72 -175.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.15 130.95 9.98 Favored 'General case' 0 C--N 1.338 0.075 0 CA-C-N 119.145 0.884 . . . . 0.0 111.888 -177.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 25.1 mt -90.97 157.05 17.52 Favored 'General case' 0 C--N 1.338 0.069 0 C-N-CA 124.125 0.97 . . . . 0.0 111.408 178.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -120.85 50.99 1.28 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.836 0.854 . . . . 0.0 109.41 173.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.401 HG23 ' H ' ' A' ' 272' ' ' VAL . 3.0 t -51.63 144.74 2.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -177.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -131.26 -0.15 4.08 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 116.472 2.027 . . . . 0.0 116.472 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -159.06 166.44 31.66 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.839 0.456 . . . . 0.0 111.374 -175.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -125.9 113.58 17.39 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.062 0.945 . . . . 0.0 109.05 172.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 57.1 p30 -156.3 -167.09 2.33 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -69.56 -13.83 62.53 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -176.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -100.02 -34.05 10.24 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.3 p -141.26 148.66 40.19 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 18.9 t-105 -157.54 154.98 29.47 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -176.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -135.07 118.92 17.26 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 122.873 0.469 . . . . 0.0 111.711 175.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.252 68.6 m-85 -84.19 6.44 22.59 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 117.263 2.32 . . . . 0.0 117.263 -171.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 C--O 1.232 0.143 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -176.326 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 41.2 p . . . . . 0 CA--C 1.535 0.368 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 45.1 t -130.27 139.56 51.08 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 123.516 0.727 . . . . 0.0 109.523 174.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 89.4 mt -128.51 158.04 39.51 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.843 0.354 . . . . 0.0 111.536 -173.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 9.7 tt -115.92 135.85 53.59 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.255 174.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -114.37 106.26 14.1 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 114.684 1.365 . . . . 0.0 114.684 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -88.23 142.8 27.46 Favored 'General case' 0 N--CA 1.458 -0.072 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 174.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.3 mp -115.34 124.14 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 21.0 mt -85.24 -24.92 27.6 Favored 'General case' 0 C--N 1.337 0.064 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -173.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -141.22 79.06 18.17 Favored Pre-proline 0 N--CA 1.456 -0.171 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -177.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -76.86 49.97 2.92 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 125.137 3.891 . . . . 0.0 112.153 -177.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.441 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -68.55 -7.23 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 O-C-N 121.954 -0.466 . . . . 0.0 110.019 177.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -140.2 152.15 45.77 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.238 1.415 . . . . 0.0 112.193 175.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 35.9 t -74.4 133.08 42.47 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 117.851 0.296 . . . . 0.0 110.56 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 24.2 mm -83.32 150.06 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 123.028 0.531 . . . . 0.0 109.841 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.87 155.73 49.35 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 177.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.5 p -64.38 -21.72 66.72 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -79.01 -35.97 41.95 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 75.8 t -72.97 -40.81 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.3 mt -69.01 -32.0 71.24 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -70.28 -29.52 66.31 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 174.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.2 m -69.47 -32.82 71.97 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 45.0 pt -92.32 -21.75 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 118.422 0.555 . . . . 0.0 112.264 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 97.7 m -92.56 -26.57 17.84 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -178.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.488 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 36.3 t30 -64.04 -40.87 58.11 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 73.3 Cg_endo -69.44 -10.98 30.22 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 121.535 1.49 . . . . 0.0 111.887 177.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 91.0 m -95.99 -6.26 39.3 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 177.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 151.0 167.59 14.82 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 111.801 -0.519 . . . . 0.0 111.801 178.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.38 101.66 0.88 Allowed 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 123.965 3.11 . . . . 0.0 110.408 178.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 83.5 t -70.79 144.63 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -112.51 -39.45 4.36 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 119.363 -0.351 . . . . 0.0 111.262 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 65.8 mtm-85 -148.01 153.08 38.49 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 25.2 mt -145.13 139.9 22.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 124.308 1.043 . . . . 0.0 109.18 176.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 41.0 t -145.38 153.02 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.066 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 48.8 mt -134.34 142.24 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 C-N-CA 123.087 0.555 . . . . 0.0 110.178 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.305 2.7 p90 -143.19 156.1 44.69 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 176.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 6.2 mmt180 -127.75 18.22 6.78 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.274 0.63 . . . . 0.0 110.134 -173.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -66.22 -30.92 71.47 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 114.717 1.376 . . . . 0.0 114.717 -169.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -130.48 5.46 4.75 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 118.61 0.641 . . . . 0.0 112.129 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 164.35 -126.51 1.52 Allowed Glycine 0 CA--C 1.521 0.461 0 N-CA-C 108.043 -2.023 . . . . 0.0 108.043 -173.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.5 t -142.5 114.67 3.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 175.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -144.42 168.91 18.99 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.271 0.558 . . . . 0.0 110.718 -176.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.04 167.79 22.51 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.372 174.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 79.4 mmm -134.01 150.6 51.25 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 32.5 t -140.21 147.46 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 C-N-CA 122.895 0.478 . . . . 0.0 110.727 -177.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -133.31 134.87 44.4 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.03 0.532 . . . . 0.0 110.49 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -108.59 163.31 13.35 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 116.479 2.029 . . . . 0.0 116.479 -176.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -74.43 -16.79 60.86 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 84.9 p -157.12 161.23 39.39 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.275 0.559 . . . . 0.0 111.235 -178.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 45.7 t -66.62 -33.92 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -67.28 -30.21 70.02 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 117.886 0.312 . . . . 0.0 110.82 -177.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 68.7 m -75.49 -31.32 60.17 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 177.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.83 -33.32 60.07 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 119.629 -0.224 . . . . 0.0 111.172 178.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -67.48 -43.49 80.87 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 118.445 0.566 . . . . 0.0 111.487 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -74.42 -28.32 61.02 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.166 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -74.38 -39.8 62.48 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 118.094 0.406 . . . . 0.0 110.69 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -74.64 -23.54 58.7 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 122.748 0.419 . . . . 0.0 111.165 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -93.9 -15.57 24.85 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 47.8 t -106.7 -36.23 6.77 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 75.9 mt -89.35 -8.15 53.8 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -176.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -70.88 135.88 48.28 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.53 -6.76 36.27 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.621 -0.544 . . . . 0.0 112.308 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -76.82 166.49 23.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 117.69 0.745 . . . . 0.0 109.727 176.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -123.49 138.6 54.54 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 84.2 mt -72.29 -43.83 64.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.372 41.4 m-85 -82.79 -11.15 58.5 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 117.336 2.347 . . . . 0.0 117.336 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.9 t 64.79 37.19 7.5 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.692 0.758 . . . . 0.0 110.817 -175.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 174.52 -23.95 0.07 OUTLIER Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.001 0.81 . . . . 0.0 111.086 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' CYS . . . . . 0.441 ' HB3' HD12 ' A' ' 200' ' ' ILE . 90.8 m -146.62 -177.16 5.49 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.122 1.369 . . . . 0.0 109.159 178.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 95.2 m 58.62 37.62 25.28 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -177.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.59 146.05 10.74 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 175.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 86.1 mt -109.56 154.68 22.39 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -173.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -139.76 136.77 34.47 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.772 1.629 . . . . 0.0 106.913 169.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 37.0 mt -137.94 141.15 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-O 120.715 0.293 . . . . 0.0 111.277 -172.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -158.53 163.67 36.85 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.785 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.25 47.8 m-85 -63.02 136.36 57.78 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 176.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -86.76 159.55 19.09 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.611 0.364 . . . . 0.0 110.751 -179.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.465 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 23.1 pttp -92.79 -31.76 0.32 Allowed Pre-proline 0 CA--C 1.538 0.513 0 CA-C-O 117.363 -1.304 . . . . 0.0 114.066 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 69.2 Cg_endo -77.51 170.17 19.77 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 CA-C-N 121.966 1.738 . . . . 0.0 109.781 173.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.7 -1.07 3.11 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 117.798 2.518 . . . . 0.0 117.798 -174.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.55 130.65 9.42 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 118.873 0.76 . . . . 0.0 111.421 -178.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 20.1 mt -90.76 156.95 17.68 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 123.78 0.832 . . . . 0.0 111.017 177.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -115.42 50.88 0.96 Allowed 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.367 0.667 . . . . 0.0 109.86 173.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 3.1 t -52.23 145.22 2.69 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -134.54 -3.63 2.64 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 -177.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -159.32 162.62 36.01 Favored 'General case' 0 N--CA 1.456 -0.132 0 O-C-N 122.225 -0.297 . . . . 0.0 111.277 -171.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -125.39 110.81 14.4 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.769 0.828 . . . . 0.0 109.629 174.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 54.6 p30 -159.04 -165.95 1.73 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -67.84 -8.94 40.37 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -174.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -120.77 -15.35 8.39 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.34 140.9 35.69 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 123.923 0.889 . . . . 0.0 113.073 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 -163.55 156.91 18.93 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.644 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -141.52 118.58 11.27 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.654 171.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -81.94 4.35 22.95 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 -172.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 CA--C 1.529 0.152 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -177.494 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 54.5 m . . . . . 0 CA--C 1.531 0.241 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.1 t -131.85 133.71 60.84 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 CA-C-N 118.038 0.381 . . . . 0.0 111.018 176.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.445 HD21 ' HB1' ' A' ' 241' ' ' ALA . 2.3 mm? -121.56 153.32 38.18 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 122.817 0.447 . . . . 0.0 110.926 -176.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 22.8 tp -103.9 135.95 44.47 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 170.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -111.57 132.17 54.73 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.92 1.288 . . . . 0.0 114.419 176.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -121.58 130.09 53.28 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 175.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.4 mp -101.84 118.31 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -84.9 -19.37 32.38 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.027 0.531 . . . . 0.0 111.939 -171.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -141.72 78.99 17.3 Favored Pre-proline 0 CA--C 1.529 0.137 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -78.42 47.22 2.34 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 124.957 3.771 . . . . 0.0 111.926 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.403 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -70.24 -4.42 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 O-C-N 121.862 -0.524 . . . . 0.0 110.813 179.68 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -137.03 156.48 48.37 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 176.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 69.0 m -69.68 113.41 6.92 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 37.5 mm -78.26 141.8 14.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 177.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.11 160.88 36.45 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.5 p -64.84 -15.67 62.13 Favored 'General case' 0 CA--C 1.527 0.062 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -76.27 -44.98 34.8 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.785 0.326 . . . . 0.0 111.45 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 1.5 m -71.38 -32.62 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 179.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.4 mt -72.03 -34.16 68.58 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 176.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -71.64 -30.45 65.76 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 173.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.3 m -66.68 -33.92 76.72 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 42.9 pt -91.14 -24.94 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 118.352 0.523 . . . . 0.0 112.027 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 99.3 m -88.49 -25.54 22.52 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.093 0.86 . . . . 0.0 113.285 -178.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.479 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 31.9 t30 -64.51 -43.57 71.74 Favored Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 73.6 Cg_endo -69.85 -11.87 31.58 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.415 1.41 . . . . 0.0 111.519 177.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 94.4 m -92.28 -10.71 37.46 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.6 0.36 . . . . 0.0 111.847 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 155.09 169.56 19.76 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.767 -0.533 . . . . 0.0 111.767 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.88 96.88 0.7 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 124.138 3.226 . . . . 0.0 110.611 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 70.2 t -68.25 145.41 13.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -116.25 -39.93 3.33 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 119.147 -0.454 . . . . 0.0 111.32 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 63.4 mtm-85 -147.93 152.01 36.81 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 21.5 mt -148.42 137.14 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.272 1.029 . . . . 0.0 110.183 177.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 8.0 m -143.05 162.43 17.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 C-N-CA 123.778 0.831 . . . . 0.0 110.315 174.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 43.1 mt -134.34 143.18 38.77 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.075 0 C-N-CA 123.157 0.583 . . . . 0.0 110.486 -174.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.293 4.2 p90 -142.32 156.36 45.25 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 176.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -127.49 14.75 7.11 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.208 0.603 . . . . 0.0 110.905 -173.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -61.76 -32.58 72.84 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 -169.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -130.6 7.01 4.81 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.594 0.633 . . . . 0.0 112.278 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 163.41 -125.56 1.41 Allowed Glycine 0 C--N 1.336 0.551 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -174.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 24.2 t -140.99 112.02 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.152 0 C-N-CA 122.785 0.434 . . . . 0.0 109.915 175.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -141.8 168.03 20.72 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.212 0.529 . . . . 0.0 110.948 -175.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.98 169.2 21.14 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.75 0.82 . . . . 0.0 109.052 176.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 64.4 mmm -136.03 153.96 51.2 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 27.1 t -140.25 144.6 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.095 0 C-N-CA 123.063 0.545 . . . . 0.0 110.953 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -130.05 133.53 46.77 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.026 0.531 . . . . 0.0 110.252 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -108.9 161.32 15.25 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -177.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -80.62 -10.88 59.71 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 43.1 t -155.27 153.37 30.5 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 118.202 0.456 . . . . 0.0 111.864 -175.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 59.0 t -68.47 -38.52 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 123.0 0.52 . . . . 0.0 109.743 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -67.5 -26.61 66.43 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 122.153 -0.342 . . . . 0.0 111.08 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 48.8 m -75.88 -30.8 58.98 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 175.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.445 ' HB1' HD21 ' A' ' 192' ' ' LEU . . . -76.76 -33.21 58.09 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.579 0.352 . . . . 0.0 111.017 179.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -69.24 -44.14 72.56 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 122.228 -0.295 . . . . 0.0 111.665 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -74.12 -27.76 61.02 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 117.935 0.334 . . . . 0.0 111.105 -178.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -72.55 -39.82 67.18 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.177 0.444 . . . . 0.0 110.58 177.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.42 -23.75 54.0 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.433 0.293 . . . . 0.0 111.149 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -90.34 -14.73 32.51 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 48.2 t -109.51 -34.46 6.51 Favored 'General case' 0 C--N 1.338 0.068 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -177.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 78.3 mt -90.42 -7.92 51.92 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -70.93 132.57 45.41 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 75.66 -4.62 42.81 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.74 -0.478 . . . . 0.0 112.164 -177.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.26 166.4 22.18 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.859 0.829 . . . . 0.0 110.193 177.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -123.49 139.88 53.56 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 86.3 mt -73.71 -42.25 54.7 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.352 44.4 m-85 -82.86 -12.33 57.5 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 117.355 2.354 . . . . 0.0 117.355 178.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 23.1 t 65.14 36.34 7.29 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.69 0.757 . . . . 0.0 110.722 -174.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 176.05 -24.54 0.06 OUTLIER Glycine 0 CA--C 1.528 0.856 0 C-N-CA 123.792 0.71 . . . . 0.0 111.35 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' CYS . . . . . 0.403 ' HB3' HD12 ' A' ' 200' ' ' ILE . 82.4 m -146.74 -176.57 5.24 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.897 1.279 . . . . 0.0 109.173 178.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 89.7 m 58.06 37.08 26.47 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.69 148.98 11.68 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 176.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 76.2 mt -115.54 155.31 27.8 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -172.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -139.08 138.17 36.85 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.141 1.376 . . . . 0.0 107.959 169.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 29.2 mt -140.17 143.69 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 CA-C-O 120.935 0.398 . . . . 0.0 111.388 -171.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -159.28 162.94 36.14 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.865 0.866 . . . . 0.0 109.518 175.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -62.22 138.5 58.43 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 115.933 1.827 . . . . 0.0 115.933 177.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -87.55 162.31 17.27 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 122.674 0.39 . . . . 0.0 111.722 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.423 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 53.7 mtmt -80.82 -52.62 0.87 Allowed Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 118.351 -0.833 . . . . 0.0 112.665 178.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 90.5 Cg_endo -72.28 171.09 17.63 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.104 2.536 . . . . 0.0 111.251 177.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.262 0.2 OUTLIER -136.16 2.72 2.82 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 117.844 2.535 . . . . 0.0 117.844 -175.6 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -157.7 130.35 7.37 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 121.635 -0.666 . . . . 0.0 112.106 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 36.4 mt -85.8 166.67 15.87 Favored 'General case' 0 CA--C 1.527 0.068 0 C-N-CA 124.445 1.098 . . . . 0.0 111.538 176.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -120.22 49.79 1.38 Allowed 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 169.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . 0.419 ' H ' HG23 ' A' ' 272' ' ' VAL . 2.5 t -49.32 143.05 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.249 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -176.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -127.4 -7.4 5.8 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 117.945 2.572 . . . . 0.0 117.945 -176.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -162.87 174.72 12.04 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 122.77 0.428 . . . . 0.0 110.523 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -125.82 116.22 21.23 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.86 0.864 . . . . 0.0 109.628 174.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 52.7 p30 -157.74 -168.4 2.53 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.284 1.034 . . . . 0.0 109.718 178.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -68.97 -11.44 60.72 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -175.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -113.33 -17.56 12.26 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -144.6 141.13 29.19 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.864 0.866 . . . . 0.0 112.768 -178.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 18.9 t-105 -160.89 158.24 27.92 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 119.671 -0.812 . . . . 0.0 110.738 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -139.21 116.44 11.12 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.557 0.743 . . . . 0.0 109.774 172.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.266 67.7 m-85 -79.36 6.24 10.57 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 117.297 2.332 . . . . 0.0 117.297 -173.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 5.6 t . . . . . 0 CA--C 1.53 0.185 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -179.565 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 69.6 m . . . . . 0 CA--C 1.533 0.305 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 90.2 t -141.0 134.27 31.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.438 ' N ' HD22 ' A' ' 192' ' ' LEU . 2.0 mm? -122.14 153.07 39.23 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 122.663 0.385 . . . . 0.0 111.299 -175.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 24.8 tp -100.03 136.73 39.49 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 169.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -113.07 112.47 23.91 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 176.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.72 125.8 45.66 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 175.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.6 mp -96.96 124.81 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 22.0 mt -86.2 -25.94 25.37 Favored 'General case' 0 N--CA 1.458 -0.056 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -174.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -141.33 79.04 17.98 Favored Pre-proline 0 N--CA 1.455 -0.218 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -176.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -76.71 46.63 1.93 Allowed 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 125.182 3.921 . . . . 0.0 112.278 -177.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.408 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -69.99 -4.68 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 O-C-N 121.845 -0.534 . . . . 0.0 110.703 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -135.75 158.48 44.29 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 176.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 68.6 m -68.94 112.57 5.68 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 42.6 mm -78.5 139.72 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 176.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.06 159.95 39.25 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.4 p -64.92 -17.05 64.01 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 176.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -75.18 -45.97 37.15 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.366 0.266 . . . . 0.0 111.378 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.1 m -71.19 -32.05 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.53 -34.68 70.25 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 176.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -71.47 -30.97 66.61 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 174.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 10.7 m -66.92 -33.84 76.47 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 42.8 pt -91.74 -22.44 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 119.012 -0.518 . . . . 0.0 112.042 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 92.8 m -91.27 -25.57 19.41 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -178.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.493 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 32.2 t30 -64.0 -41.83 65.38 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-O 118.412 -0.804 . . . . 0.0 113.087 -179.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 72.9 Cg_endo -69.13 -13.44 36.27 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 CA-C-N 120.938 1.371 . . . . 0.0 111.669 178.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 97.1 m -89.39 -8.03 53.96 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 177.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 146.88 168.75 13.97 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.469 -0.653 . . . . 0.0 111.469 176.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.55 104.35 0.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.678 2.919 . . . . 0.0 111.966 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 75.8 t -75.53 143.77 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 175.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -115.64 -39.45 3.53 Favored 'General case' 0 C--O 1.227 -0.115 0 CA-C-O 119.431 -0.318 . . . . 0.0 111.39 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 66.8 mtm-85 -147.81 152.23 37.33 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 20.3 mt -148.51 137.15 15.14 Favored 'Isoleucine or valine' 0 C--N 1.339 0.13 0 C-N-CA 124.15 0.98 . . . . 0.0 109.927 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 3.9 m -142.73 160.79 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.087 0 C-N-CA 123.632 0.773 . . . . 0.0 110.568 174.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 45.4 mt -133.84 142.26 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 C-N-CA 122.591 0.356 . . . . 0.0 110.369 -175.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.295 4.1 p90 -140.96 157.24 45.63 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 177.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -128.03 15.61 6.8 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.271 0.628 . . . . 0.0 110.626 -174.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -62.85 -30.92 71.87 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -169.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -130.62 6.48 4.77 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.518 0.599 . . . . 0.0 112.144 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 161.62 -123.36 1.2 Allowed Glycine 0 C--N 1.333 0.373 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -173.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 50.9 t -143.23 114.94 2.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 175.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 8.3 mp0 -143.85 167.57 22.01 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.172 0.511 . . . . 0.0 110.786 -176.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.02 165.39 30.03 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.58 0.752 . . . . 0.0 109.215 175.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 59.5 mmm -133.36 152.13 51.9 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 39.4 t -139.39 142.64 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 122.788 0.435 . . . . 0.0 110.389 -178.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -128.06 131.87 49.09 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.842 0.457 . . . . 0.0 110.522 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -105.73 161.42 14.42 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 116.35 1.981 . . . . 0.0 116.35 -176.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -77.72 -13.03 60.02 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 45.2 t -155.81 155.82 33.67 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 121.813 -0.555 . . . . 0.0 111.872 -176.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 38.4 t -64.91 -42.11 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -67.7 -25.87 65.89 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 117.877 0.308 . . . . 0.0 111.657 -176.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 59.2 m -74.62 -31.8 62.11 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 175.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.422 ' HB1' HD21 ' A' ' 192' ' ' LEU . . . -76.04 -30.33 58.39 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.518 0.327 . . . . 0.0 111.157 178.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -68.64 -47.7 65.91 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 117.934 0.334 . . . . 0.0 111.297 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -73.75 -25.2 60.05 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 119.423 -0.322 . . . . 0.0 111.436 -177.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -71.87 -40.85 68.67 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.187 0.449 . . . . 0.0 110.087 176.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.26 -24.96 54.52 Favored 'General case' 0 N--CA 1.458 -0.045 0 C-N-CA 122.961 0.504 . . . . 0.0 110.993 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -90.69 -13.58 33.9 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 39.5 t -112.59 -35.26 5.58 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 118.631 0.651 . . . . 0.0 112.739 -177.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 59.8 mt -90.0 -7.16 54.62 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -177.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -70.78 133.19 46.34 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.78 -5.25 48.46 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 119.932 -0.371 . . . . 0.0 112.369 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.39 166.39 22.7 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 117.711 0.756 . . . . 0.0 110.131 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -123.44 139.61 53.85 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 88.5 mt -73.67 -41.47 55.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.356 45.3 m-85 -82.64 -11.79 58.11 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 117.114 2.265 . . . . 0.0 117.114 178.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 29.4 t 65.94 32.53 8.47 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.699 0.799 . . . . 0.0 111.012 -173.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 179.37 -24.61 0.05 OUTLIER Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' CYS . . . . . 0.408 ' HB3' HD12 ' A' ' 200' ' ' ILE . 74.7 m -145.58 -177.38 5.54 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.707 1.203 . . . . 0.0 109.465 178.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 84.3 m 59.42 35.6 23.02 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -177.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.73 150.4 5.27 Favored 'General case' 0 C--N 1.338 0.095 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 175.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 78.3 mt -118.47 156.09 29.66 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -173.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -138.39 139.2 38.85 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.562 1.545 . . . . 0.0 107.14 169.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 31.9 mt -139.34 141.73 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 CA-C-O 120.747 0.308 . . . . 0.0 111.364 -172.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -158.9 161.19 36.77 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.962 176.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -60.55 136.15 57.97 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 177.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -88.28 162.32 16.67 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 122.973 0.509 . . . . 0.0 111.856 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -85.99 -52.82 0.45 Allowed Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 118.505 -0.759 . . . . 0.0 112.808 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -72.07 165.43 32.64 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.759 2.306 . . . . 0.0 110.27 176.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 1.5 t -138.95 7.38 2.47 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 -174.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -152.81 126.41 8.82 Favored 'General case' 0 C--N 1.338 0.068 0 O-C-N 121.778 -0.576 . . . . 0.0 111.771 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 24.6 mt -87.13 162.85 17.29 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 123.943 0.897 . . . . 0.0 111.467 176.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -121.77 54.67 1.14 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.804 0.842 . . . . 0.0 109.356 171.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.6 t -54.02 146.34 3.45 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -175.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -127.83 -7.23 5.57 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 117.625 2.454 . . . . 0.0 117.625 -176.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -164.48 172.87 12.76 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 117.995 0.362 . . . . 0.0 110.676 -178.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -125.5 116.8 22.36 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.017 0.927 . . . . 0.0 109.916 173.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 55.9 p30 -159.74 -166.95 1.87 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -68.35 -11.42 59.52 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -174.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -111.98 -20.34 12.02 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -143.39 143.31 31.58 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.691 0.796 . . . . 0.0 112.762 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 18.4 t-105 -161.0 156.11 24.25 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.277 -178.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -136.81 117.92 14.41 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.498 0.719 . . . . 0.0 110.165 173.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.256 64.1 m-85 -82.08 7.01 14.5 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 117.39 2.367 . . . . 0.0 117.39 -173.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.455 -0.223 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -178.113 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 54.5 m . . . . . 0 CA--C 1.53 0.211 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 35.8 t -126.56 143.05 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 C-N-CA 123.036 0.534 . . . . 0.0 110.483 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 84.5 mt -136.53 146.07 45.77 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 122.712 0.405 . . . . 0.0 111.162 -176.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 48.7 tp -95.36 136.53 35.61 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 172.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -116.13 101.22 8.53 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.003 1.321 . . . . 0.0 114.315 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.07 140.51 36.45 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 174.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 3.9 mp -110.66 116.24 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -90.46 -18.09 25.98 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -170.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -143.18 78.86 14.73 Favored Pre-proline 0 CA--C 1.528 0.127 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -76.98 42.7 1.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 125.206 3.937 . . . . 0.0 112.625 -177.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.469 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -69.77 -5.11 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 O-C-N 121.747 -0.595 . . . . 0.0 110.693 -179.504 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -138.99 156.69 47.03 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 176.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 69.0 m -68.82 117.48 10.56 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 28.0 mm -78.28 145.41 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.02 160.42 37.8 Favored 'General case' 0 C--O 1.23 0.043 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 6.7 p -67.84 -22.98 65.11 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -73.63 -47.14 42.35 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.9 m -70.19 -31.91 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.9 mt -71.12 -35.25 71.68 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -71.36 -29.58 65.14 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 174.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.1 m -69.22 -33.43 73.29 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 42.2 pt -91.7 -22.06 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.95 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 95.1 m -93.42 -25.44 17.66 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -177.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.508 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 38.5 t30 -63.59 -39.56 49.16 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 67.0 Cg_endo -68.56 -14.15 38.96 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 CA-C-N 121.113 1.433 . . . . 0.0 111.954 177.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 92.8 m -89.23 -8.13 54.12 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.106 0.412 . . . . 0.0 111.57 176.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 147.8 166.95 13.0 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 178.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -68.61 105.25 1.25 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.535 2.823 . . . . 0.0 110.472 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 80.3 t -72.35 145.59 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -111.04 -36.81 5.54 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 119.369 -0.348 . . . . 0.0 111.58 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 25.6 mtm180 -149.52 154.02 38.11 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 118.128 0.422 . . . . 0.0 112.035 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 34.3 mt -144.7 143.8 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.035 0.934 . . . . 0.0 109.369 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 55.2 t -145.15 154.61 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 60.2 mt -133.43 140.13 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 C-N-CA 123.423 0.689 . . . . 0.0 109.65 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.253 4.8 p90 -148.18 160.62 42.74 Favored 'General case' 0 N--CA 1.458 -0.026 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 176.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.01 31.31 2.2 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.811 0.444 . . . . 0.0 111.985 -176.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -67.07 -29.81 69.69 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -174.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -130.52 3.32 4.6 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 167.83 -127.12 1.51 Allowed Glycine 0 C--N 1.334 0.443 0 N-CA-C 108.381 -1.888 . . . . 0.0 108.381 -173.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.2 t -139.6 117.94 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-N 117.252 0.526 . . . . 0.0 110.244 173.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 11.5 mp0 -144.19 168.7 19.42 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.651 0.739 . . . . 0.0 111.164 -175.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -150.18 163.96 36.9 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.95 175.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 59.6 mmm -134.54 152.55 51.86 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.633 0.373 . . . . 0.0 110.199 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.3 t -142.42 145.19 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 123.117 0.567 . . . . 0.0 110.047 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -129.06 132.5 47.45 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 122.555 0.342 . . . . 0.0 110.284 176.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -102.36 161.71 13.49 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -177.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -81.27 -10.44 59.58 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 30.6 t -154.51 151.34 28.8 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 121.761 -0.587 . . . . 0.0 112.106 -176.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 50.3 t -68.13 -38.22 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -178.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -67.06 -24.93 66.02 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.123 0.42 . . . . 0.0 111.151 -178.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 55.3 m -75.77 -32.84 60.12 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 176.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -78.08 -31.86 50.39 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 122.361 -0.212 . . . . 0.0 110.961 178.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -66.55 -41.74 88.19 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 121.993 -0.442 . . . . 0.0 111.474 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -77.08 -28.15 54.5 Favored 'General case' 0 CA--C 1.527 0.07 0 CA-C-N 117.937 0.335 . . . . 0.0 110.872 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -69.95 -41.24 74.81 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.05 0.387 . . . . 0.0 109.959 177.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -74.24 -20.63 60.1 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.618 0.367 . . . . 0.0 111.023 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -98.77 -5.08 31.96 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 42.6 t -124.16 -30.44 3.46 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 56.3 mt -93.83 -6.66 45.33 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.247 0.476 . . . . 0.0 111.479 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -72.45 131.66 42.87 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.97 -4.64 53.09 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 119.85 -0.417 . . . . 0.0 112.259 -178.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.9 166.56 22.25 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 117.817 0.809 . . . . 0.0 110.169 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -123.67 139.3 54.13 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 89.5 mt -74.43 -41.66 49.71 Favored 'Isoleucine or valine' 0 C--O 1.23 0.071 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.355 35.9 m-85 -82.82 -11.88 57.9 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 117.065 2.246 . . . . 0.0 117.065 178.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 30.1 t 65.74 34.02 7.82 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.533 0.733 . . . . 0.0 111.171 -173.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 177.44 -24.35 0.05 OUTLIER Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.11 0.862 . . . . 0.0 111.123 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' CYS . . . . . 0.469 ' HB3' HD12 ' A' ' 200' ' ' ILE . 75.0 m -145.43 -175.74 4.84 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.527 1.131 . . . . 0.0 109.383 178.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 88.8 m 57.84 36.04 26.0 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -176.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.3 147.53 13.26 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 176.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 78.9 mt -114.35 156.85 23.68 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -173.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -139.32 138.2 36.47 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 169.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 46.5 mt -137.1 142.48 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.066 0 CA-C-O 120.66 0.267 . . . . 0.0 111.56 -172.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -159.51 161.82 35.39 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.094 176.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.287 35.6 m-85 -61.44 135.54 57.72 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 177.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . 0.408 ' HB1' ' HD2' ' A' ' 267' ' ' PRO . . . -93.16 157.18 16.4 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.999 -177.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.447 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 23.2 pttp -91.19 -31.33 0.34 Allowed Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 50.3 Cg_endo -79.46 161.4 25.37 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 CA-C-N 121.766 1.666 . . . . 0.0 110.154 176.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.298 0.2 OUTLIER -135.5 13.56 3.47 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 -178.056 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -156.36 126.37 6.46 Favored 'General case' 0 C--O 1.227 -0.1 0 O-C-N 121.871 -0.518 . . . . 0.0 111.521 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 23.1 mt -88.32 163.99 15.79 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.69 0.796 . . . . 0.0 110.546 174.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -122.89 44.24 2.71 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.342 0.591 . . . . 0.0 110.361 171.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.1 t -48.1 140.0 2.41 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -176.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . 0.277 5.3 p90 -122.87 -6.27 8.5 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 117.267 2.321 . . . . 0.0 117.267 -177.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -163.37 167.98 21.01 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 122.956 0.503 . . . . 0.0 110.176 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -119.09 123.46 44.49 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.351 0.66 . . . . 0.0 109.734 174.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 50.6 p30 -159.32 -168.29 2.28 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.829 0.852 . . . . 0.0 108.93 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -70.41 -10.13 58.26 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -177.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -102.41 -33.63 9.47 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.5 p -142.68 145.75 33.72 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 124.257 1.023 . . . . 0.0 113.188 176.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 21.7 t-105 -153.62 153.73 32.87 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -176.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -131.32 116.8 18.05 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.252 0.621 . . . . 0.0 111.607 175.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.253 67.1 m-85 -83.16 7.67 15.4 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 117.449 2.388 . . . . 0.0 117.449 -172.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 CA--C 1.528 0.121 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -178.409 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 . . . . . 0 N--CA 1.475 0.778 0 CA-C-O 120.364 0.126 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -68.51 127.57 33.48 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 122.669 0.388 . . . . 0.0 110.484 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 94.4 mt -83.34 142.83 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 63.1 m -69.01 115.55 8.43 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 122.345 0.258 . . . . 0.0 110.724 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 61.3 mtt180 -150.93 145.86 18.64 Favored Pre-proline 0 C--N 1.337 0.062 0 C-N-CA 123.733 0.813 . . . . 0.0 110.281 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.82 149.58 60.38 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.136 2.557 . . . . 0.0 109.443 174.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 68.57 9.82 59.32 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 119.607 -0.552 . . . . 0.0 112.619 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -140.37 -45.6 0.41 Allowed 'General case' 0 C--O 1.232 0.181 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 74.2 m -69.52 153.3 43.7 Favored 'General case' 0 C--O 1.231 0.091 0 O-C-N 121.906 -0.496 . . . . 0.0 110.719 176.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -53.91 -36.57 62.86 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -76.73 7.29 4.81 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 116.158 1.911 . . . . 0.0 116.158 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 75.7 m -140.65 2.82 1.83 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -176.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -149.22 10.99 0.79 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 176.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 54.5 m -137.31 1.77 2.44 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.67 0.388 . . . . 0.0 111.973 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 1.9 m -80.08 122.3 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -130.84 10.41 5.06 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.7 0.8 . . . . 0.0 112.681 178.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 50.9 m 67.0 19.7 10.54 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -173.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.6 t -128.71 142.08 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 C-N-CA 122.988 0.515 . . . . 0.0 110.924 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 84.7 mt -135.02 149.49 50.17 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 122.663 0.385 . . . . 0.0 111.884 -174.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 32.0 tp -102.72 136.67 42.12 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.576 0.75 . . . . 0.0 109.223 172.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -115.27 107.05 14.76 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.938 1.295 . . . . 0.0 114.465 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.05 127.76 38.69 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 175.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.5 mp -97.95 127.53 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 20.7 mt -89.37 -26.34 21.1 Favored 'General case' 0 CA--C 1.527 0.062 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -174.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -141.17 79.1 18.23 Favored Pre-proline 0 N--CA 1.453 -0.284 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -176.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -77.34 45.31 1.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 125.251 3.967 . . . . 0.0 111.988 -177.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.446 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -69.47 -4.2 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 O-C-N 121.877 -0.515 . . . . 0.0 110.597 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -136.52 155.84 49.41 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 66.3 m -67.85 113.2 5.39 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 33.6 mm -78.39 141.53 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.99 159.76 39.77 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.6 p -64.8 -15.41 61.68 Favored 'General case' 0 C--O 1.23 0.05 0 N-CA-C 114.314 1.228 . . . . 0.0 114.314 177.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -76.12 -46.52 28.41 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.676 0.274 . . . . 0.0 111.541 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.0 m -70.85 -31.1 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.1 mt -72.39 -35.17 68.37 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 176.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -70.6 -30.65 67.38 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 173.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.1 m -67.26 -34.56 77.7 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 43.9 pt -91.46 -21.73 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 118.405 0.548 . . . . 0.0 112.239 178.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 91.3 m -91.21 -25.87 19.31 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.499 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 31.8 t30 -63.82 -41.37 63.73 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 74.4 Cg_endo -69.27 -13.84 36.59 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 CA-C-N 120.857 1.342 . . . . 0.0 111.645 177.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 91.7 m -91.96 -4.49 54.53 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.787 0.435 . . . . 0.0 111.701 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 146.95 166.79 12.57 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 177.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.53 103.14 1.08 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.587 2.858 . . . . 0.0 110.17 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 64.8 t -69.51 146.82 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -114.44 -37.53 4.3 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 119.244 -0.408 . . . . 0.0 111.579 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 39.2 mtm-85 -149.95 151.87 34.06 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.574 0.625 . . . . 0.0 112.035 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 17.8 mt -146.12 140.97 21.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 C-N-CA 124.211 1.004 . . . . 0.0 109.527 177.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 59.7 t -146.78 156.51 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 47.6 mt -134.45 142.22 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 123.698 0.799 . . . . 0.0 110.009 -178.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.297 3.2 p90 -143.28 159.22 42.75 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 176.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -128.76 15.52 6.41 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.989 0.516 . . . . 0.0 111.137 -173.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -62.86 -32.46 73.7 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -169.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -130.49 8.84 5.03 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 118.597 0.635 . . . . 0.0 112.239 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 159.92 -125.11 1.43 Allowed Glycine 0 C--N 1.335 0.516 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 -174.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.4 t -141.18 115.3 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -142.29 166.89 23.45 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.268 0.556 . . . . 0.0 110.956 -176.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.37 165.47 29.23 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.405 175.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 76.5 mmm -133.42 153.25 51.77 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 28.2 t -141.79 145.64 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 C-N-CA 123.292 0.637 . . . . 0.0 110.667 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -132.61 133.93 44.25 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.727 0.411 . . . . 0.0 110.126 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -105.51 161.75 14.07 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 -176.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -78.25 -14.65 59.35 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 82.6 p -155.11 157.98 38.32 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.25 0.548 . . . . 0.0 111.548 -177.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 53.8 t -66.38 -36.08 76.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -65.44 -32.17 73.65 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 122.354 -0.216 . . . . 0.0 110.711 -176.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 63.8 m -72.65 -34.84 67.53 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 121.27 -0.172 . . . . 0.0 110.639 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -73.45 -31.54 63.85 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 119.732 -0.175 . . . . 0.0 111.114 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -68.32 -44.14 76.02 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 118.199 0.454 . . . . 0.0 111.831 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 -77.29 -25.29 51.17 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 118.102 0.41 . . . . 0.0 111.34 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -72.06 -41.13 67.78 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 122.065 -0.397 . . . . 0.0 110.077 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -74.65 -21.26 59.53 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 122.974 0.51 . . . . 0.0 111.194 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -97.18 -10.52 25.73 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 44.2 t -116.12 -34.01 4.84 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 118.62 0.645 . . . . 0.0 112.594 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 50.7 mt -90.73 -6.95 53.76 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 122.139 -0.35 . . . . 0.0 111.837 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -72.26 132.4 44.01 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.25 -4.53 47.87 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 112.156 -0.378 . . . . 0.0 112.156 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.22 166.39 22.78 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 117.52 0.66 . . . . 0.0 110.187 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -123.61 139.61 53.83 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 85.1 mt -74.42 -41.51 49.77 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.36 44.0 m-85 -82.87 -11.47 58.18 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 117.037 2.236 . . . . 0.0 117.037 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 29.0 t 65.51 34.48 7.9 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.604 0.762 . . . . 0.0 111.059 -173.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 177.15 -23.96 0.05 OUTLIER Glycine 0 CA--C 1.528 0.881 0 C-N-CA 123.972 0.796 . . . . 0.0 111.158 177.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . 0.446 ' HB3' HD12 ' A' ' 200' ' ' ILE . 96.8 m -145.92 -177.29 5.52 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.702 1.201 . . . . 0.0 109.52 178.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 88.0 m 58.64 37.0 25.33 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -176.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.96 151.39 6.76 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 175.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 73.6 mt -119.67 157.64 28.1 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -173.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -139.54 140.38 37.12 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.786 1.634 . . . . 0.0 107.294 168.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 38.4 mt -138.1 142.74 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 CA-C-O 120.848 0.356 . . . . 0.0 111.668 -173.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -158.57 161.87 37.31 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.04 176.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.265 41.5 m-85 -61.96 134.81 57.12 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 177.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . 0.432 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -88.58 157.0 18.73 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.178 -178.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.476 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 23.2 pttp -90.14 -32.25 0.37 Allowed Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 117.413 -1.279 . . . . 0.0 114.307 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 68.2 Cg_endo -76.55 166.95 26.44 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 CA-C-N 121.893 1.712 . . . . 0.0 109.462 174.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.3 0.2 OUTLIER -130.04 0.47 4.73 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 -175.811 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 20.3 ttp180 -160.55 140.97 11.53 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.775 -0.578 . . . . 0.0 110.952 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 25.8 mt -85.25 171.47 11.91 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.115 0.966 . . . . 0.0 110.668 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.545 ' ND2' ' C2 ' ' B' ' 4' ' ' ' C' . 18.4 p30 -126.19 46.63 2.4 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 169.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.5 t -48.58 139.68 2.94 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -175.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . 0.278 6.2 p90 -120.37 -12.12 9.04 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 117.391 2.367 . . . . 0.0 117.391 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -163.6 173.91 12.41 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 122.853 0.461 . . . . 0.0 110.811 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -119.99 129.23 54.18 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.403 0.681 . . . . 0.0 110.544 176.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 39.5 p30 -160.5 -166.63 1.69 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.529 1.132 . . . . 0.0 108.824 176.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -68.36 -15.05 63.42 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -174.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -115.07 -12.19 11.98 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.49 139.17 35.06 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.832 0.853 . . . . 0.0 112.513 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 21.2 t-105 -161.17 154.48 21.53 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.473 -177.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -132.32 117.1 17.71 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.42 173.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.272 63.8 m-85 -81.71 8.6 9.58 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 117.362 2.356 . . . . 0.0 117.362 -172.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 11.3 t -138.06 -23.76 1.02 Allowed 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -95.41 113.25 61.29 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -80.44 -16.5 10.64 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.317 2.678 . . . . 0.0 112.245 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -71.91 -16.38 62.12 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -174.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 77.1 mt -86.03 -4.56 59.19 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.237 0.471 . . . . 0.0 111.886 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 46.1 t -72.5 -27.34 62.2 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 121.971 -0.456 . . . . 0.0 111.567 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -92.45 -4.58 65.95 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 119.715 -0.492 . . . . 0.0 112.643 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 63.8 mm-40 -89.18 5.38 44.95 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 117.577 0.688 . . . . 0.0 112.005 -177.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.123 0 CA-C-O 117.205 -1.886 . . . . 0.0 111.953 -177.25 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.742 0 C5'-C4'-C3' 110.385 -3.41 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.432 ' N3 ' ' HA ' ' A' ' 265' ' ' ALA . . . . . . . . 0 O4'--C4' 1.423 -2.468 0 O4'-C1'-N19 111.978 3.778 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.927 3 O4'-C1'-N19 112.733 4.533 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ' C' . . . . . 0.545 ' C2 ' ' ND2' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.42 -2.791 1 C5'-C4'-C3' 108.825 -4.45 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.424 ' H61' ' C ' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.42 -2.732 0 C3'-C2'-C1' 105.01 3.9 OUTLIER-DELTA 0.016 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.591 0 O4'-C1'-N19 111.792 3.592 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 45.3 mm-40 . . . . . 0 N--CA 1.478 0.956 0 CA-C-O 120.473 0.178 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -67.63 150.36 48.86 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.959 0.504 . . . . 0.0 110.474 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 58.9 mt -65.79 142.99 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 122.876 0.471 . . . . 0.0 110.37 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 57.7 m -67.91 152.6 45.29 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.708 0.403 . . . . 0.0 111.153 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.405 ' N ' ' CD ' ' A' ' 179' ' ' PRO . 75.9 mtp85 -72.34 -40.65 7.38 Favored Pre-proline 0 CA--C 1.534 0.327 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.405 ' CD ' ' N ' ' A' ' 178' ' ' ARG . 52.3 Cg_exo -58.54 157.25 27.92 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.973 2.449 . . . . 0.0 112.519 178.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 77.39 0.96 73.96 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 119.722 -0.488 . . . . 0.0 112.622 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -149.14 -54.66 0.18 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 117.963 0.882 . . . . 0.0 112.861 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 44.0 t -68.31 152.65 45.14 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.459 0.304 . . . . 0.0 110.474 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -72.87 -5.44 38.31 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -69.46 -7.31 36.8 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 68.7 m -141.84 8.07 1.89 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -175.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -148.6 5.59 0.71 Allowed 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 65.5 m -147.16 10.5 1.0 Allowed 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.407 ' H ' HG22 ' A' ' 188' ' ' VAL . 1.4 m -70.53 107.32 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -177.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 -130.62 10.38 5.16 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.187 0.595 . . . . 0.0 112.143 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 66.7 m 66.31 22.2 10.89 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.061 0.945 . . . . 0.0 113.435 -175.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 25.1 t -130.9 140.53 48.46 Favored 'Isoleucine or valine' 0 C--N 1.338 0.108 0 C-N-CA 122.83 0.452 . . . . 0.0 110.777 176.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 93.7 mt -130.76 159.2 38.02 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 122.961 0.504 . . . . 0.0 111.128 -176.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.1 tt -115.87 135.61 53.83 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.109 174.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -115.99 105.7 12.94 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -87.18 137.08 32.65 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 174.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.3 mp -106.94 118.21 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -88.48 -17.87 29.44 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -171.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -142.56 78.9 15.78 Favored Pre-proline 0 CA--C 1.529 0.156 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -77.98 46.55 2.1 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 125.132 3.888 . . . . 0.0 112.405 -177.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.424 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -71.42 -3.83 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 O-C-N 121.873 -0.517 . . . . 0.0 110.505 179.322 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -136.67 159.08 42.88 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 176.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 70.2 m -70.91 113.11 7.63 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.638 0.256 . . . . 0.0 110.373 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 33.8 mm -78.27 140.47 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.96 159.36 40.96 Favored 'General case' 0 C--O 1.23 0.058 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.4 p -65.2 -14.89 61.72 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 176.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -76.91 -45.49 27.75 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.589 0.356 . . . . 0.0 110.657 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 1.7 m -71.2 -32.42 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.88 -34.57 69.28 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 177.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -71.57 -29.71 65.03 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 174.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 8.2 m -67.29 -35.02 78.62 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 37.9 pt -91.32 -24.08 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 119.177 -0.44 . . . . 0.0 111.758 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 86.9 m -88.99 -25.46 22.01 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.474 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 31.4 t30 -63.13 -44.82 85.2 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-O 118.518 -0.753 . . . . 0.0 112.907 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 68.7 Cg_endo -68.18 -15.69 43.17 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.356 1.371 . . . . 0.0 111.478 178.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 95.2 m -84.12 -15.34 47.61 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 117.918 0.327 . . . . 0.0 111.715 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 152.4 169.3 17.6 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -61.42 104.82 0.32 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.768 2.979 . . . . 0.0 111.922 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 73.6 t -76.34 145.13 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -116.81 -38.38 3.45 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-O 119.394 -0.336 . . . . 0.0 111.579 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 41.3 mtm-85 -148.88 151.48 34.77 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 21.7 mt -147.71 136.48 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 124.036 0.934 . . . . 0.0 109.748 177.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.41 160.21 22.13 Favored 'Isoleucine or valine' 0 C--N 1.337 0.062 0 C-N-CA 123.592 0.757 . . . . 0.0 110.9 174.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 48.4 mt -134.43 141.51 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 123.189 0.596 . . . . 0.0 110.491 -175.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.292 5.8 p90 -140.82 157.78 44.91 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -127.21 14.26 7.23 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.449 0.699 . . . . 0.0 110.755 -174.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -61.97 -31.56 71.92 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -169.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -130.7 7.88 4.85 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 118.634 0.652 . . . . 0.0 112.289 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 161.38 -124.33 1.3 Allowed Glycine 0 CA--C 1.521 0.465 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 -174.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 47.9 t -142.73 115.07 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -143.95 167.73 21.66 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.324 0.583 . . . . 0.0 110.589 -176.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.25 164.29 32.77 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.879 0.871 . . . . 0.0 109.067 175.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 81.6 mmm -131.71 153.01 50.48 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 26.3 t -139.6 143.38 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.097 0 C-N-CA 122.786 0.434 . . . . 0.0 111.067 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -127.49 132.17 50.02 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.035 0.534 . . . . 0.0 110.337 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -108.27 161.94 14.54 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -176.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -80.95 -11.81 59.5 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 30.7 t -155.28 152.45 29.25 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.386 0.539 . . . . 0.0 111.893 -175.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 54.1 t -67.74 -38.27 80.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -67.78 -27.33 66.67 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 122.348 -0.22 . . . . 0.0 110.953 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 69.0 m -72.59 -34.35 67.35 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 176.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -77.48 -29.86 52.86 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 111.425 0.157 . . . . 0.0 111.425 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -67.75 -43.27 80.3 Favored 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 121.932 -0.48 . . . . 0.0 111.539 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -77.85 -24.23 48.65 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-N 117.842 0.292 . . . . 0.0 110.797 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -72.81 -41.19 65.18 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.098 0.408 . . . . 0.0 110.283 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -74.98 -23.39 58.27 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.814 0.446 . . . . 0.0 111.392 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -92.39 -17.21 24.94 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 48.1 t -106.16 -36.51 6.88 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -177.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 72.1 mt -89.42 -9.11 51.44 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -69.95 133.8 47.67 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.28 -5.54 42.51 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 119.748 -0.473 . . . . 0.0 112.205 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.4 166.41 22.67 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.792 0.796 . . . . 0.0 110.289 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -123.52 138.37 54.58 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 82.3 mt -72.66 -41.65 62.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.346 45.8 m-85 -82.9 -12.27 57.51 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.9 t 66.08 33.93 7.22 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.709 0.766 . . . . 0.0 110.936 -174.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 178.23 -24.7 0.05 OUTLIER Glycine 0 CA--C 1.528 0.856 0 C-N-CA 123.986 0.803 . . . . 0.0 111.289 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . 0.424 ' HB3' HD12 ' A' ' 200' ' ' ILE . 72.8 m -145.74 -176.97 5.34 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.532 1.133 . . . . 0.0 109.422 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 89.8 m 57.64 37.88 27.54 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.856 0.462 . . . . 0.0 112.04 -176.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.2 147.49 13.01 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 175.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 79.6 mt -114.11 155.58 25.75 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -173.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -138.77 138.63 37.79 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.163 1.385 . . . . 0.0 107.597 169.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 37.0 mt -139.02 142.69 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-O 120.744 0.307 . . . . 0.0 111.75 -171.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -158.49 163.13 37.4 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.348 0.659 . . . . 0.0 109.478 175.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.266 44.1 m-85 -62.51 138.17 58.41 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 176.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -87.37 154.31 20.77 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.484 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.436 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 23.2 pttp -88.35 -31.76 0.39 Allowed Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 117.489 -1.243 . . . . 0.0 114.255 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 48.1 Cg_endo -79.94 162.56 23.58 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.743 1.629 . . . . 0.0 109.861 174.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.282 0.2 OUTLIER -137.79 18.75 2.86 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 116.747 2.129 . . . . 0.0 116.747 -176.462 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.469 ' CZ ' ' HA ' ' A' ' 269' ' ' ARG . 1.3 tpm_? -155.37 106.48 2.56 Favored 'General case' 0 C--N 1.34 0.169 0 O-C-N 121.734 -0.604 . . . . 0.0 112.301 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.474 ' HG ' ' C5 ' ' B' ' 3' ' ' ' A' . 9.4 mt -75.96 158.41 32.0 Favored 'General case' 0 N--CA 1.458 -0.062 0 C-N-CA 122.747 0.419 . . . . 0.0 110.161 173.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -127.02 54.56 1.63 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.685 0.794 . . . . 0.0 109.781 172.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 272' ' ' VAL . 2.5 t -54.61 143.93 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -177.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -126.94 -7.7 6.05 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 117.557 2.429 . . . . 0.0 117.557 -176.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -162.17 173.04 14.83 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 122.809 0.444 . . . . 0.0 110.001 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -125.46 123.05 38.37 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.589 0.756 . . . . 0.0 110.05 175.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 46.5 p30 -159.99 -166.39 1.71 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.959 0.904 . . . . 0.0 108.575 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -68.11 -15.13 63.46 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -175.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -114.76 -12.88 12.09 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.64 139.77 34.9 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.631 0.772 . . . . 0.0 112.547 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 20.2 t-105 -161.02 156.86 25.31 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.446 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -136.46 116.32 13.16 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.553 172.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.275 66.4 m-85 -79.05 7.22 7.73 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 117.26 2.318 . . . . 0.0 117.26 -173.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 5.8 t -137.77 -20.64 1.14 Allowed 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -95.4 113.11 60.97 Favored Pre-proline 0 CA--C 1.532 0.267 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 174.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -80.88 -15.22 10.74 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.582 2.854 . . . . 0.0 112.257 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -73.3 -12.6 60.9 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -174.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 54.3 mt -89.72 -9.07 50.79 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.249 0.477 . . . . 0.0 111.789 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 72.1 m -80.69 -17.96 49.44 Favored 'General case' 0 CA--C 1.526 0.037 0 CA-C-N 118.233 0.47 . . . . 0.0 112.056 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -91.27 -3.98 69.03 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 112.041 -0.424 . . . . 0.0 112.041 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -77.44 161.14 28.2 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.023 0.529 . . . . 0.0 111.217 -177.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 CA-C-O 117.516 -1.714 . . . . 0.0 111.43 -179.622 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.843 0 C3'-C2'-C1' 104.543 3.381 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.788 0 O4'-C1'-N19 111.167 2.967 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.474 ' C5 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.421 -2.672 2 C5'-C4'-C3' 109.424 -4.051 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.843 0 C5'-C4'-C3' 109.564 -3.957 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.437 ' N3 ' " H2'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.741 1 C3'-C2'-C1' 105.347 4.275 OUTLIER-DELTA 0.011 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.558 0 O4'-C1'-N19 112.033 3.833 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 . . . . . 0 N--CA 1.476 0.85 0 N-CA-C 110.754 -0.091 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -153.04 146.87 25.27 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 123.568 0.747 . . . . 0.0 109.789 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 46.9 mm -70.06 143.23 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 C-N-CA 122.431 0.292 . . . . 0.0 110.353 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 47.1 t -158.02 158.58 35.12 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 122.878 0.471 . . . . 0.0 110.064 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 33.5 ptt-85 -155.69 154.48 28.1 Favored Pre-proline 0 CA--C 1.53 0.194 0 C-N-CA 123.274 0.63 . . . . 0.0 109.765 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.31 160.47 49.43 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.368 2.712 . . . . 0.0 110.309 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -71.94 -12.8 75.41 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -85.06 -1.04 56.39 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 117.551 0.676 . . . . 0.0 109.33 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 42.7 t -68.05 149.3 49.85 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 121.794 -0.566 . . . . 0.0 111.122 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -57.63 -27.77 63.1 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.954 0.407 . . . . 0.0 110.252 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -84.1 9.82 11.66 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 74.6 m -141.79 -1.55 1.26 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -176.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 4.5 ppt_? -147.06 11.13 1.04 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.152 0.887 . . . . 0.0 113.283 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 52.8 m -140.74 5.8 2.0 Allowed 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.0 m -78.46 119.29 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -177.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 42.8 p30 -130.76 10.33 5.08 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.119 0.967 . . . . 0.0 112.773 177.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 57.8 m 66.26 19.77 11.05 Favored 'General case' 0 C--N 1.341 0.201 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -173.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 38.8 t -130.51 133.76 63.2 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 C-N-CA 122.88 0.472 . . . . 0.0 111.292 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.429 HD21 ' HB1' ' A' ' 241' ' ' ALA . 2.5 mm? -122.63 152.86 40.06 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 122.987 0.515 . . . . 0.0 111.066 -177.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 28.4 tp -103.31 134.04 47.37 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 170.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -111.86 110.97 21.6 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.49 131.55 40.09 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 173.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.6 mp -102.1 120.4 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -88.42 -20.38 25.31 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 119.307 -0.378 . . . . 0.0 111.898 -172.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -142.19 78.94 16.46 Favored Pre-proline 0 CA--C 1.529 0.156 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.89 46.4 2.05 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 125.086 3.857 . . . . 0.0 112.249 -177.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.415 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -70.66 -3.58 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 O-C-N 121.86 -0.525 . . . . 0.0 110.822 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -136.85 158.04 45.36 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 176.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 69.3 m -69.47 111.22 5.18 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 41.0 mm -78.34 139.06 19.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.14 161.82 33.82 Favored 'General case' 0 CA--C 1.523 -0.094 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.3 p -64.45 -18.44 64.75 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 177.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -73.41 -39.75 64.81 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 1.5 m -75.89 -33.79 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 97.0 mt -71.37 -33.07 69.21 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 176.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -72.15 -30.53 65.11 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 175.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 20.6 m -67.23 -34.79 78.22 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 43.5 pt -90.89 -22.13 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 119.045 -0.503 . . . . 0.0 111.887 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 84.1 m -91.26 -26.62 18.91 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.506 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 32.7 t30 -63.99 -40.44 54.42 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 70.3 Cg_endo -69.32 -14.52 37.62 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.494 1.462 . . . . 0.0 111.477 177.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 98.8 m -89.88 -8.56 51.63 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.575 0.35 . . . . 0.0 111.614 177.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 149.54 170.32 16.91 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 177.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.68 102.56 1.03 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.933 3.089 . . . . 0.0 110.736 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 73.4 t -71.17 146.81 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 176.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -115.47 -36.17 4.37 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 119.377 -0.344 . . . . 0.0 111.651 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -149.68 151.9 34.46 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.417 0.553 . . . . 0.0 112.192 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 25.3 mt -147.2 136.76 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 124.195 0.998 . . . . 0.0 109.883 177.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 1.2 m -140.47 160.7 24.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.08 0 C-N-CA 123.485 0.714 . . . . 0.0 111.803 174.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 55.3 mt -135.78 144.08 34.59 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 C-N-CA 123.434 0.693 . . . . 0.0 109.832 -176.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.291 3.3 p90 -144.54 157.18 44.34 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 177.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -127.7 15.22 7.0 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.18 0.592 . . . . 0.0 110.883 -172.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -64.09 -30.94 71.97 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -169.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -130.54 4.91 4.69 Favored 'General case' 0 CA--C 1.527 0.074 0 CA-C-N 118.596 0.634 . . . . 0.0 112.262 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 163.76 -124.47 1.28 Allowed Glycine 0 C--N 1.334 0.459 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 -173.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 61.8 t -142.99 114.63 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 175.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 -142.83 168.17 20.36 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.021 0.439 . . . . 0.0 111.009 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.15 165.74 29.96 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.675 0.79 . . . . 0.0 109.456 177.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 61.4 mmm -134.36 153.47 51.87 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 42.6 t -141.59 144.19 26.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 C-N-CA 122.676 0.39 . . . . 0.0 110.116 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -131.67 132.82 44.27 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 122.395 0.278 . . . . 0.0 110.571 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -104.42 162.54 13.14 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -81.89 -8.21 59.66 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 44.8 t -154.5 150.74 28.13 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.811 -0.556 . . . . 0.0 111.973 -176.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 52.0 t -67.66 -36.1 74.99 Favored 'Isoleucine or valine' 0 C--N 1.338 0.096 0 C-N-CA 123.279 0.632 . . . . 0.0 109.356 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -67.22 -28.65 68.25 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 118.295 0.498 . . . . 0.0 110.866 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 63.2 m -75.43 -30.45 60.02 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.429 ' HB1' HD21 ' A' ' 192' ' ' LEU . . . -75.83 -31.94 59.58 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.342 0.257 . . . . 0.0 111.3 178.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -70.69 -43.84 68.21 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -74.59 -26.45 59.93 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 117.792 0.269 . . . . 0.0 111.05 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -71.98 -41.51 67.6 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 118.087 0.403 . . . . 0.0 110.042 177.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -75.6 -20.57 58.47 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 122.603 0.361 . . . . 0.0 111.399 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -95.93 -13.12 24.13 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 47.1 t -113.28 -33.6 5.91 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 59.7 mt -90.56 -7.78 51.96 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 118.003 0.365 . . . . 0.0 111.816 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -71.87 133.69 45.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 177.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.36 -5.87 40.94 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.924 -0.47 . . . . 0.0 111.924 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.87 166.44 22.41 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.793 0.796 . . . . 0.0 110.473 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -123.7 139.65 53.78 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 84.4 mt -74.22 -41.69 51.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.351 42.8 m-85 -82.97 -11.82 57.81 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 178.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 23.2 t 65.71 35.48 6.87 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.631 0.772 . . . . 0.0 111.087 -174.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 176.17 -23.76 0.06 OUTLIER Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.127 0.87 . . . . 0.0 111.266 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . 0.415 ' HB3' HD12 ' A' ' 200' ' ' ILE . 98.5 m -146.37 -177.23 5.51 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.628 1.171 . . . . 0.0 109.47 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 89.1 m 58.19 36.23 25.62 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -176.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.1 148.98 10.04 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 175.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 75.9 mt -116.28 154.75 29.61 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -173.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -138.45 138.32 38.03 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.065 1.346 . . . . 0.0 107.596 169.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 33.1 mt -137.74 143.28 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-O 120.685 0.278 . . . . 0.0 111.514 -171.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -158.23 163.25 37.64 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.312 0.645 . . . . 0.0 109.374 175.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.268 37.8 m-85 -62.63 134.31 56.16 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 177.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . 0.449 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -84.38 161.03 20.52 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.351 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.487 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 64.0 pttt -93.56 -31.58 0.3 Allowed Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 178.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 86.1 Cg_endo -75.88 171.12 18.77 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.913 1.742 . . . . 0.0 110.295 175.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.96 -1.61 2.67 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 117.26 2.319 . . . . 0.0 117.26 -175.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.35 133.55 11.6 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-N 118.766 0.712 . . . . 0.0 111.727 -178.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.431 ' HG ' ' C6 ' ' B' ' 3' ' ' ' A' . 19.2 mt -92.31 157.76 16.47 Favored 'General case' 0 C--O 1.228 -0.04 0 C-N-CA 124.137 0.975 . . . . 0.0 111.516 177.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.411 ' C ' ' H61' ' B' ' 5' ' ' ' A' . 65.2 m-80 -120.97 47.76 1.76 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.734 0.813 . . . . 0.0 109.86 174.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.414 HG23 ' H ' ' A' ' 272' ' ' VAL . 2.5 t -53.09 143.91 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.092 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -177.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . 0.26 10.2 p90 -128.22 -4.57 5.53 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 116.868 2.173 . . . . 0.0 116.868 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.14 172.35 18.26 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 123.245 0.618 . . . . 0.0 111.689 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -125.68 121.82 34.57 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.752 0.821 . . . . 0.0 109.65 175.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 49.3 p30 -159.27 -166.71 1.88 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.643 0.777 . . . . 0.0 109.653 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -68.21 -14.56 63.07 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -177.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -99.53 -34.91 10.05 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.15 150.46 42.82 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 178.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 22.2 t-105 -157.86 155.59 29.93 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -176.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -131.24 119.17 21.44 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.972 0.509 . . . . 0.0 111.629 175.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.28 67.1 m-85 -83.02 9.35 10.4 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -171.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 9.3 t -141.05 -23.06 0.77 Allowed 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -178.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -95.29 113.27 61.22 Favored Pre-proline 0 CA--C 1.532 0.273 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 174.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -79.65 -15.81 12.03 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.331 2.688 . . . . 0.0 112.357 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 66.1 m-80 -73.55 -15.37 61.3 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -173.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 70.7 mt -85.76 -2.42 58.2 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 117.928 0.331 . . . . 0.0 111.882 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 47.7 t -75.68 143.44 42.16 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.291 0.236 . . . . 0.0 110.682 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 70.53 -0.46 26.36 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 119.454 -0.637 . . . . 0.0 113.43 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 55.6 mm-40 -71.99 157.86 37.05 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 118.315 1.058 . . . . 0.0 110.962 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.31 0 CA-C-O 117.471 -1.739 . . . . 0.0 111.442 179.437 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.879 0 C5'-C4'-C3' 110.1 -3.6 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.449 ' N3 ' ' HA ' ' A' ' 265' ' ' ALA . . . . . . . . 0 O4'--C4' 1.42 -2.723 0 C3'-C2'-C1' 98.25 -3.611 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.431 ' C6 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.417 -2.962 2 O4'-C1'-N19 112.527 4.327 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.915 1 C5'-C4'-C3' 109.321 -4.12 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.411 ' H61' ' C ' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.413 -3.301 0 C3'-C2'-C1' 105.02 3.911 OUTLIER-DELTA 0.113 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.786 0 O4'-C1'-N19 111.291 3.091 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 110.639 -0.134 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -67.85 139.39 56.54 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 122.641 0.376 . . . . 0.0 110.153 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 81.9 mt -74.15 142.47 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 122.7 0.4 . . . . 0.0 110.619 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 28.8 t -158.1 136.71 11.18 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.289 0.635 . . . . 0.0 110.32 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 32.0 ptt-85 -162.58 156.73 18.16 Favored Pre-proline 0 C--O 1.232 0.153 0 C-N-CA 122.844 0.458 . . . . 0.0 110.309 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -58.91 152.18 59.8 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 123.198 2.599 . . . . 0.0 111.569 175.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 76.25 5.67 81.88 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 119.775 -0.458 . . . . 0.0 112.194 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -142.67 -45.81 0.32 Allowed 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 75.5 m -66.95 152.18 46.22 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 176.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -61.23 -21.33 63.77 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 -172.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -79.92 8.48 6.85 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 99.7 p -146.39 3.24 0.88 Allowed 'General case' 0 C--O 1.233 0.186 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.45 9.19 0.54 Allowed 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 53.3 m -145.25 9.82 1.26 Allowed 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.5 m -70.53 123.45 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 38.8 p-10 -130.88 10.41 5.04 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.732 0.813 . . . . 0.0 112.44 177.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.5 m 66.34 22.0 10.88 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.261 1.024 . . . . 0.0 113.308 -173.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 38.4 t -131.8 142.47 42.95 Favored 'Isoleucine or valine' 0 C--N 1.337 0.059 0 C-N-CA 123.362 0.665 . . . . 0.0 110.505 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 83.5 mt -134.6 148.3 50.4 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 122.615 0.366 . . . . 0.0 111.236 -175.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 28.5 tp -99.54 134.36 42.54 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 172.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -112.7 106.76 15.21 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.2 m -90.06 139.99 30.08 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 174.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 3.9 mp -110.34 122.48 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -91.79 -18.47 23.81 Favored 'General case' 0 C--O 1.23 0.06 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -171.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -141.66 78.93 17.47 Favored Pre-proline 0 CA--C 1.529 0.158 0 C-N-CA 122.95 0.5 . . . . 0.0 109.679 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -77.29 50.07 3.04 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 124.926 3.751 . . . . 0.0 112.179 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.45 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -69.72 -6.5 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 O-C-N 121.761 -0.587 . . . . 0.0 110.011 178.41 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -142.67 155.43 44.91 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.148 1.379 . . . . 0.0 112.337 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 28.5 t -74.97 131.86 40.97 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 25.4 mm -78.66 152.06 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 122.983 0.513 . . . . 0.0 110.338 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.96 157.58 45.68 Favored 'General case' 0 C--N 1.338 0.076 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 39.4 p -68.73 -18.27 64.2 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -77.59 -47.23 19.91 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 118.192 0.451 . . . . 0.0 111.748 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 3.5 m -71.12 -32.2 47.08 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 99.2 mt -70.47 -35.63 73.41 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -71.06 -30.18 66.27 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 175.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.6 m -67.35 -33.38 75.11 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 36.7 pt -93.63 -22.29 5.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 118.486 0.585 . . . . 0.0 111.787 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 89.1 m -90.17 -26.02 20.36 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.494 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 32.4 t30 -63.46 -42.57 74.62 Favored Pre-proline 0 CA--C 1.535 0.38 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 -178.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 70.9 Cg_endo -69.1 -13.19 35.86 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 121.784 1.656 . . . . 0.0 111.644 178.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 91.5 m -88.68 -8.38 54.67 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.041 0.382 . . . . 0.0 111.788 176.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 145.02 169.72 13.63 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 177.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.34 107.61 0.5 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.715 2.943 . . . . 0.0 111.949 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 72.3 t -76.56 146.6 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -117.01 -40.54 3.11 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 119.259 -0.4 . . . . 0.0 111.556 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 65.8 mtm-85 -148.88 152.55 36.64 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 25.4 mt -148.28 136.85 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 C-N-CA 124.305 1.042 . . . . 0.0 110.054 176.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 3.8 m -142.4 159.76 19.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 123.9 0.88 . . . . 0.0 110.519 174.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 48.0 mt -132.13 142.93 41.55 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 122.575 0.35 . . . . 0.0 110.676 -175.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.298 4.8 p90 -142.76 158.39 43.69 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 116.002 1.853 . . . . 0.0 116.002 176.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -130.45 17.68 5.37 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.469 0.708 . . . . 0.0 110.991 -174.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -64.29 -31.21 72.32 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -169.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -130.42 7.47 4.93 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.584 0.629 . . . . 0.0 112.161 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 161.0 -123.62 1.23 Allowed Glycine 0 C--N 1.334 0.451 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 -175.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 41.2 t -140.68 113.97 5.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -144.13 167.24 22.86 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.3 0.571 . . . . 0.0 111.094 -176.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -149.1 165.88 30.42 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.137 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 72.6 mmm -131.68 152.79 50.61 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 39.8 t -140.89 145.1 25.81 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 123.003 0.521 . . . . 0.0 110.385 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -131.23 134.98 46.97 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.007 0.523 . . . . 0.0 110.11 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -109.1 161.96 14.7 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 116.5 2.037 . . . . 0.0 116.5 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -80.23 -10.22 59.75 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 41.0 t -155.59 151.75 27.93 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.694 -0.628 . . . . 0.0 112.131 -176.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 43.5 t -66.39 -38.93 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -68.05 -24.17 65.05 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.784 0.265 . . . . 0.0 111.141 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 65.2 m -75.48 -33.53 60.81 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 175.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -77.51 -31.61 53.62 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 122.37 -0.206 . . . . 0.0 110.96 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -66.2 -43.77 85.82 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 121.931 -0.481 . . . . 0.0 111.358 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -77.12 -25.24 51.9 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.817 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -71.82 -41.39 68.26 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.911 0.323 . . . . 0.0 110.271 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.49 -28.34 62.83 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 122.634 0.374 . . . . 0.0 110.717 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -90.25 -12.94 36.48 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 41.0 t -113.7 -35.71 5.1 Favored 'General case' 0 C--N 1.339 0.122 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -176.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 68.5 mt -88.19 -7.45 56.84 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.024 0.375 . . . . 0.0 111.628 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -71.32 134.66 46.9 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 75.79 -5.47 39.0 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 119.795 -0.447 . . . . 0.0 112.48 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.46 166.35 22.71 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 117.797 0.799 . . . . 0.0 110.408 177.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -123.42 140.83 52.61 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 84.8 mt -75.99 -42.25 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.379 45.2 m-85 -82.89 -10.58 58.76 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 27.3 t 65.71 36.5 6.28 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.6 0.76 . . . . 0.0 110.864 -175.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 174.36 -24.25 0.07 OUTLIER Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 178.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . 0.45 ' HB3' HD12 ' A' ' 200' ' ' ILE . 75.9 m -145.62 -177.21 5.46 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.922 1.289 . . . . 0.0 109.367 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 98.6 m 58.26 37.83 26.09 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.83 148.15 13.69 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 175.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 82.2 mt -114.31 156.19 24.85 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -172.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -139.45 138.28 36.32 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.598 1.559 . . . . 0.0 107.2 169.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 31.8 mt -139.23 142.83 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 CA-C-O 120.686 0.279 . . . . 0.0 111.316 -171.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -157.69 160.49 38.01 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 122.927 0.491 . . . . 0.0 109.771 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.283 40.6 m-85 -59.88 135.42 57.69 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 176.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . 0.427 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -89.24 159.11 17.59 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.173 -178.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.443 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 23.4 pttp -94.24 -31.8 0.29 Allowed Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 49.1 Cg_endo -79.83 159.12 24.58 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 CA-C-N 121.881 1.708 . . . . 0.0 109.505 174.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.31 0.2 OUTLIER -134.8 15.33 3.62 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 -174.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -158.45 123.0 4.16 Favored 'General case' 0 C--N 1.338 0.074 0 O-C-N 121.931 -0.481 . . . . 0.0 111.559 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.443 ' HG ' ' C5 ' ' B' ' 3' ' ' ' A' . 18.9 mt -86.05 161.06 19.12 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 123.583 0.753 . . . . 0.0 110.408 174.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.443 ' C ' ' H61' ' B' ' 5' ' ' ' A' . 51.5 m-80 -121.2 51.24 1.29 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.846 171.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.403 ' H ' HG23 ' A' ' 272' ' ' VAL . 2.3 t -51.8 144.87 2.56 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -176.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -129.62 -5.78 4.66 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 117.653 2.464 . . . . 0.0 117.653 -176.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -160.66 170.91 19.85 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 122.558 0.343 . . . . 0.0 110.609 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -125.81 119.6 28.32 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.743 0.817 . . . . 0.0 110.038 174.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -162.69 -167.98 1.69 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.362 1.065 . . . . 0.0 109.087 176.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -70.23 -8.18 48.05 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -176.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -109.26 -26.28 10.15 Favored 'General case' 0 C--N 1.338 0.092 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.08 140.8 31.06 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.275 1.03 . . . . 0.0 112.499 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 21.6 t-105 -157.95 156.26 30.93 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.418 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -137.19 114.08 10.53 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.397 173.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.259 66.0 m-85 -78.29 6.72 7.66 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 -173.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 5.4 t -137.3 -19.9 1.24 Allowed 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -95.37 113.2 61.14 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 174.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -80.49 -14.02 11.86 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.515 2.81 . . . . 0.0 112.368 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -75.25 -14.25 60.5 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -173.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 59.2 mt -88.97 -7.42 56.04 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 71.6 m -72.69 147.6 45.54 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 117.761 0.255 . . . . 0.0 110.698 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 74.26 -5.54 26.88 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 119.724 -0.486 . . . . 0.0 112.11 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 57.42 177.79 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.243 1.417 . . . . 0.0 112.76 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.189 0 CA-C-O 117.396 -1.78 . . . . 0.0 110.849 -179.952 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.816 0 C3'-C2'-C1' 104.187 2.986 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.427 ' N3 ' ' HA ' ' A' ' 265' ' ' ALA . . . . . . . . 0 O4'--C4' 1.421 -2.648 0 O4'-C1'-N19 111.426 3.226 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.443 ' C5 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.423 -2.52 1 C5'-C4'-C3' 109.485 -4.01 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.783 0 C5'-C4'-C3' 109.644 -3.904 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.443 ' H61' ' C ' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.42 -2.759 1 C3'-C2'-C1' 105.483 4.425 OUTLIER-DELTA 0.024 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.669 0 O4'-C1'-N19 111.665 3.465 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -65.55 -29.95 70.64 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -173.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 20.0 tt -154.77 164.46 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 CA-C-N 118.35 0.523 . . . . 0.0 110.182 -175.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 67.3 m 53.53 42.25 31.96 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 122.951 0.5 . . . . 0.0 111.264 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.476 ' N ' ' HD2' ' A' ' 179' ' ' PRO . 75.7 mtt180 -56.9 -38.84 72.99 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -176.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 178' ' ' ARG . 69.6 Cg_endo -69.15 -13.24 35.85 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 CA-C-N 121.332 1.511 . . . . 0.0 111.373 177.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -91.98 8.71 77.77 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 174.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -130.97 -53.63 1.05 Allowed 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -176.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 93.7 p -70.77 157.02 38.78 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 7.8 p30 -84.15 -5.61 59.27 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -71.71 -0.48 11.04 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 116.288 1.958 . . . . 0.0 116.288 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 89.4 p -149.75 11.04 0.74 Allowed 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -177.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -146.9 5.52 0.87 Allowed 'General case' 0 C--N 1.34 0.154 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 58.6 m -147.73 12.72 1.02 Allowed 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.411 ' H ' HG22 ' A' ' 188' ' ' VAL . 2.3 m -70.82 103.58 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -177.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 46.0 p30 -130.67 10.33 5.13 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.837 0.855 . . . . 0.0 112.085 177.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 56.0 m 66.06 21.28 11.24 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -176.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 28.6 t -128.8 142.34 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.095 0 C-N-CA 122.833 0.453 . . . . 0.0 110.889 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 91.2 mt -133.95 149.14 51.25 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 122.832 0.453 . . . . 0.0 111.278 -175.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 32.2 tp -102.0 135.01 44.3 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 172.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -114.57 107.04 14.97 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.93 138.27 31.68 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 174.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.1 mp -108.73 118.18 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -90.92 -18.83 24.07 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 119.255 -0.403 . . . . 0.0 112.018 -171.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -142.12 79.01 16.51 Favored Pre-proline 0 CA--C 1.529 0.156 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -77.61 44.56 1.56 Allowed 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 125.19 3.927 . . . . 0.0 112.48 -176.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.437 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -70.06 -4.55 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 O-C-N 121.59 -0.693 . . . . 0.0 110.641 179.767 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -137.95 156.18 48.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 42.3 t -70.39 117.02 11.41 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 120.717 0.294 . . . . 0.0 110.212 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.1 mm -78.55 143.73 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 122.876 0.471 . . . . 0.0 109.807 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.99 159.16 41.6 Favored 'General case' 0 CA--C 1.526 0.031 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.5 p -66.01 -15.69 63.24 Favored 'General case' 0 C--N 1.335 -0.062 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -76.38 -44.93 34.16 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.504 0.192 . . . . 0.0 110.848 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 1.9 m -72.88 -32.01 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.9 mt -70.64 -34.75 72.41 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 175.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -72.02 -30.29 65.05 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 174.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.6 m -66.82 -34.44 77.81 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 45.4 pt -91.27 -23.24 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 118.201 0.455 . . . . 0.0 111.902 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 89.0 m -89.87 -25.34 21.06 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.479 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 30.1 t30 -63.69 -42.59 72.97 Favored Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 73.8 Cg_endo -69.34 -12.56 33.98 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.338 1.359 . . . . 0.0 111.474 177.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 89.4 m -91.92 -7.45 49.1 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 122.502 0.321 . . . . 0.0 111.673 176.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 149.47 168.81 15.26 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.54 101.08 0.84 Allowed 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.9 3.067 . . . . 0.0 110.51 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 87.4 t -69.11 145.69 13.16 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 123.37 0.668 . . . . 0.0 109.257 177.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -115.04 -40.6 3.46 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 119.064 -0.493 . . . . 0.0 111.6 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 63.0 mtm-85 -148.05 152.43 37.38 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 21.4 mt -149.16 137.73 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 124.093 0.957 . . . . 0.0 110.273 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.3 m -143.48 163.15 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 C-N-CA 123.846 0.858 . . . . 0.0 110.338 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 54.1 mt -133.68 142.63 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 C-N-CA 122.757 0.423 . . . . 0.0 110.528 -175.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.264 6.3 p90 -146.92 159.34 43.67 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 115.819 1.785 . . . . 0.0 115.819 176.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.64 31.91 2.05 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.163 0.585 . . . . 0.0 111.777 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -67.9 -29.45 68.55 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -174.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -130.57 3.61 4.6 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 123.307 0.643 . . . . 0.0 112.514 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 167.19 -127.04 1.51 Allowed Glycine 0 CA--C 1.522 0.472 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 -173.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.1 t -138.79 117.8 13.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 117.103 0.452 . . . . 0.0 110.239 174.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 11.1 mp0 -144.1 168.56 19.72 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.476 0.655 . . . . 0.0 111.119 -175.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -150.66 167.16 28.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.828 1.251 . . . . 0.0 108.643 175.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 73.1 mmm -135.06 154.04 51.84 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 38.2 t -140.9 144.29 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 122.946 0.499 . . . . 0.0 110.517 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -129.88 135.07 47.94 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.87 0.468 . . . . 0.0 110.099 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -108.55 163.83 12.88 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 116.264 1.95 . . . . 0.0 116.264 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -81.2 -12.74 59.09 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 92.2 p -155.73 155.58 33.37 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.11 0.481 . . . . 0.0 111.455 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 49.7 t -67.84 -34.77 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -64.21 -33.72 76.45 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 122.254 -0.279 . . . . 0.0 110.8 -177.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 57.7 m -72.86 -33.74 66.3 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 117.464 0.12 . . . . 0.0 110.723 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -74.17 -30.12 62.09 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 119.707 -0.187 . . . . 0.0 111.373 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -68.85 -45.11 71.93 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 118.343 0.519 . . . . 0.0 111.724 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -76.44 -25.61 54.58 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 118.046 0.384 . . . . 0.0 111.553 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -72.32 -40.39 67.48 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.034 0.379 . . . . 0.0 110.171 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.82 -22.91 58.45 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.565 0.346 . . . . 0.0 111.316 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -95.08 -12.12 27.08 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 45.4 t -111.4 -34.95 5.97 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 118.622 0.646 . . . . 0.0 112.567 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 66.9 mt -89.79 -7.95 53.22 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -70.61 133.29 46.56 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 75.94 -4.12 47.59 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 119.651 -0.527 . . . . 0.0 112.215 -177.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.99 166.28 21.74 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 117.878 0.839 . . . . 0.0 110.281 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -123.56 140.06 53.38 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 115.016 1.488 . . . . 0.0 115.016 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 89.9 mt -74.24 -41.27 51.06 Favored 'Isoleucine or valine' 0 C--N 1.339 0.135 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.364 44.0 m-85 -82.86 -10.57 58.78 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 23.3 t 65.8 33.2 8.3 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.513 0.725 . . . . 0.0 110.577 -173.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 176.84 -22.52 0.05 OUTLIER Glycine 0 CA--C 1.531 1.037 0 C-N-CA 123.677 0.656 . . . . 0.0 111.491 177.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . 0.437 ' HB3' HD12 ' A' ' 200' ' ' ILE . 96.4 m -145.99 -177.9 5.84 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.567 1.147 . . . . 0.0 109.814 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 90.9 m 58.68 37.67 25.14 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -176.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.24 148.33 11.62 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 176.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 79.2 mt -115.71 155.75 27.18 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -172.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -138.85 138.16 37.23 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.37 1.468 . . . . 0.0 107.454 169.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 36.1 mt -138.67 142.91 33.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-O 120.842 0.353 . . . . 0.0 111.728 -171.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -158.38 163.0 37.67 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 175.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.267 42.5 m-85 -62.28 135.51 57.5 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 176.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . 0.447 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -85.11 160.44 19.96 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.303 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.473 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 63.8 pttt -92.66 -31.81 0.32 Allowed Pre-proline 0 CA--C 1.537 0.452 0 CA-C-O 117.493 -1.241 . . . . 0.0 114.21 178.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 91.1 Cg_endo -76.45 173.48 14.41 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 CA-C-N 122.096 1.784 . . . . 0.0 110.088 173.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.8 -5.05 2.83 Favored 'General case' 0 N--CA 1.461 0.089 0 N-CA-C 117.699 2.481 . . . . 0.0 117.699 -175.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -157.75 131.21 7.78 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.988 0.813 . . . . 0.0 111.761 -178.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.435 ' HG ' ' C6 ' ' B' ' 3' ' ' ' A' . 30.4 mt -83.75 162.57 20.62 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.434 1.094 . . . . 0.0 111.065 175.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.541 ' ND2' ' C2 ' ' B' ' 4' ' ' ' C' . 19.9 p30 -115.53 49.38 1.09 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 169.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.414 ' HA ' ' N1 ' ' B' ' 5' ' ' ' A' . 2.4 t -49.73 142.42 2.43 Favored 'Isoleucine or valine' 0 C--N 1.341 0.233 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -177.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -127.42 -9.03 5.75 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 117.819 2.526 . . . . 0.0 117.819 -175.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -161.18 173.85 14.5 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.808 0.443 . . . . 0.0 110.356 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -125.72 119.96 29.38 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.327 0.651 . . . . 0.0 110.182 175.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 47.6 p30 -159.33 -167.92 2.18 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.263 1.025 . . . . 0.0 109.271 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -69.95 -10.56 59.01 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -175.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -113.26 -18.55 12.06 Favored 'General case' 0 N--CA 1.461 0.093 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.14 141.08 29.77 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 124.29 1.036 . . . . 0.0 112.51 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 20.4 t-105 -160.35 158.76 30.21 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 118.886 0.767 . . . . 0.0 110.871 -178.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -139.59 115.81 10.45 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.398 172.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.252 65.1 m-85 -79.17 5.42 12.14 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 -173.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 4.2 t -137.41 -18.2 1.29 Allowed 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -95.23 113.18 60.96 Favored Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 174.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.01 -15.68 12.93 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.347 2.698 . . . . 0.0 112.296 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -73.92 -15.05 61.14 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -175.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 44.4 mt -91.27 -5.01 55.37 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 64.8 m -78.29 151.71 32.85 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 120.599 0.238 . . . . 0.0 110.946 176.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 73.63 -2.52 39.18 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.784 -0.454 . . . . 0.0 112.588 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 52.2 mm-40 -75.43 164.87 25.94 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 117.776 0.788 . . . . 0.0 109.975 177.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.13 0 CA-C-O 117.202 -1.888 . . . . 0.0 111.165 -179.974 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.928 0 C3'-C2'-C1' 104.264 3.071 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.447 ' N3 ' ' HA ' ' A' ' 265' ' ' ALA . . . . . . . . 0 O4'--C4' 1.422 -2.559 0 O4'-C1'-N19 112.123 3.923 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.435 ' C6 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.422 -2.542 1 C5'-C4'-C3' 109.178 -4.215 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' ' C' . . . . . 0.541 ' C2 ' ' ND2' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.419 -2.858 1 C5'-C4'-C3' 109.472 -4.018 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.503 ' H61' ' C ' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.418 -2.911 0 C3'-C2'-C1' 105.06 3.956 OUTLIER-DELTA 0.015 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.583 0 O4'-C1'-N19 112.132 3.932 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 110.549 -0.167 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -69.17 154.46 42.02 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.058 0.543 . . . . 0.0 111.194 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 47.5 mm -68.51 111.56 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 174.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 46.5 t 59.84 152.3 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.814 1.245 . . . . 0.0 113.224 -175.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.654 ' H ' ' HD2' ' A' ' 179' ' ' PRO . 48.1 mtm105 -146.1 -53.53 0.02 OUTLIER Pre-proline 0 CA--C 1.529 0.171 0 CA-C-O 118.54 -0.743 . . . . 0.0 112.107 -178.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.654 ' HD2' ' H ' ' A' ' 178' ' ' ARG . 61.1 Cg_endo -67.6 140.48 51.99 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 121.216 1.277 . . . . 0.0 109.412 174.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 70.19 7.59 60.26 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 111.891 -0.483 . . . . 0.0 111.891 -176.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.84 -18.98 2.34 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 38.1 t -151.45 146.84 26.21 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.352 0.661 . . . . 0.0 109.427 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -65.14 -16.91 64.01 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -70.26 0.96 5.41 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 70.2 m -142.69 7.48 1.68 Allowed 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -177.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.54 4.52 0.68 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 35.8 m -141.95 6.99 1.81 Allowed 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 3.4 m -72.0 123.99 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-O 121.009 0.433 . . . . 0.0 112.062 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 42.2 p30 -130.68 10.38 5.13 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.984 0.914 . . . . 0.0 112.979 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 59.6 m 66.09 20.67 11.22 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -174.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.1 t -129.63 135.57 61.12 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 C-N-CA 123.086 0.555 . . . . 0.0 111.209 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -124.83 150.6 46.22 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 123.015 0.526 . . . . 0.0 110.646 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 40.3 tp -100.03 136.15 40.37 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 170.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -114.25 107.37 15.51 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 178.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.54 136.42 33.0 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 173.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.0 mp -106.8 118.34 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.029 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -90.67 -18.16 25.55 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -171.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -142.1 79.01 16.56 Favored Pre-proline 0 CA--C 1.529 0.139 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -76.91 44.71 1.51 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 125.115 3.877 . . . . 0.0 112.673 -177.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.444 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -70.04 -5.01 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 O-C-N 121.542 -0.724 . . . . 0.0 110.6 -179.651 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -138.89 156.54 47.2 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 43.6 t -69.8 118.75 13.04 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 31.0 mm -78.42 143.81 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 123.025 0.53 . . . . 0.0 109.58 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.02 158.24 44.04 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.4 p -65.64 -16.75 64.03 Favored 'General case' 0 CA--C 1.523 -0.096 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -76.09 -45.59 33.19 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.616 0.246 . . . . 0.0 110.713 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.1 m -72.32 -32.56 43.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.93 -34.56 71.62 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 175.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -72.46 -29.0 63.27 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 174.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.6 m -67.95 -34.0 75.74 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 44.7 pt -91.22 -23.6 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 118.399 0.545 . . . . 0.0 111.798 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 89.0 m -89.38 -26.58 20.96 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -178.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.484 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 33.8 t30 -64.14 -42.0 65.5 Favored Pre-proline 0 CA--C 1.537 0.457 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -178.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 71.9 Cg_endo -68.79 -12.92 35.8 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 121.335 1.357 . . . . 0.0 111.407 177.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 95.8 m -91.82 -6.25 52.01 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.531 0.332 . . . . 0.0 111.673 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 147.13 166.66 12.55 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.72 104.12 1.1 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 123.849 3.032 . . . . 0.0 110.663 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 74.3 t -71.49 147.11 11.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -115.82 -36.33 4.21 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 119.199 -0.429 . . . . 0.0 111.716 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 21.3 mtm180 -150.78 151.54 32.5 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.526 0.603 . . . . 0.0 112.275 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 20.6 mt -147.4 136.54 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 C-N-CA 124.323 1.049 . . . . 0.0 110.219 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 1.3 m -140.24 159.85 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.065 0 C-N-CA 123.548 0.739 . . . . 0.0 111.765 174.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 57.0 mt -132.08 142.62 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 C-N-CA 122.929 0.492 . . . . 0.0 110.021 -177.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.261 4.0 p90 -147.84 159.86 43.39 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 115.629 1.714 . . . . 0.0 115.629 176.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.1 31.35 2.18 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.017 0.527 . . . . 0.0 111.68 -177.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -67.63 -30.35 69.89 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -174.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -130.54 4.29 4.65 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 123.105 0.562 . . . . 0.0 112.498 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 166.36 -127.83 1.66 Allowed Glycine 0 C--N 1.333 0.368 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 -174.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 19.3 t -139.69 116.72 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-N 117.415 0.608 . . . . 0.0 110.336 174.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 9.6 mp0 -144.78 169.05 18.78 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.677 0.751 . . . . 0.0 111.123 -175.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -150.86 167.47 27.42 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.224 1.01 . . . . 0.0 108.621 175.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 53.5 mmm -135.01 154.83 51.59 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.618 0.367 . . . . 0.0 110.03 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 35.8 t -142.34 143.26 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 C-N-CA 123.219 0.608 . . . . 0.0 110.496 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -130.07 134.36 47.32 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 123.216 0.323 . . . . 0.0 110.263 177.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -105.01 163.62 12.41 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 -176.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -77.93 -16.48 58.15 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 86.4 p -153.48 157.15 39.42 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.222 0.534 . . . . 0.0 111.503 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 54.8 t -67.23 -33.98 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -64.9 -34.81 79.28 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 122.063 -0.398 . . . . 0.0 110.613 -177.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 65.6 m -72.58 -31.51 65.28 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 110.624 -0.139 . . . . 0.0 110.624 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -72.52 -31.68 65.53 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 111.328 0.122 . . . . 0.0 111.328 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -72.21 -45.82 58.74 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 117.979 0.354 . . . . 0.0 111.843 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 17.1 ptt180 -75.04 -26.02 59.13 Favored 'General case' 0 C--N 1.338 0.089 0 C-N-CA 120.659 -0.417 . . . . 0.0 111.317 -177.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -70.63 -40.73 72.94 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 117.934 0.334 . . . . 0.0 110.196 177.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -75.79 -25.87 56.8 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.494 0.317 . . . . 0.0 111.059 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -89.25 -10.46 46.87 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 47.0 t -115.92 -35.74 4.36 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 66.8 mt -89.31 -6.7 56.5 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -177.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -70.94 133.97 46.83 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.19 -4.6 47.09 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 119.767 -0.463 . . . . 0.0 112.346 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.61 166.43 22.54 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 117.872 0.836 . . . . 0.0 110.249 177.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -123.45 139.16 54.31 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 86.8 mt -73.77 -41.74 54.29 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.358 44.0 m-85 -82.83 -11.39 58.28 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.8 t 65.38 35.92 7.18 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 122.101 0.953 . . . . 0.0 110.685 -174.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 176.38 -24.55 0.06 OUTLIER Glycine 0 CA--C 1.528 0.877 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.202 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . 0.444 ' HB3' HD12 ' A' ' 200' ' ' ILE . 87.2 m -147.21 -177.16 5.53 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.943 1.297 . . . . 0.0 109.659 178.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 94.9 m 58.54 37.7 25.47 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -175.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.93 147.43 12.26 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 175.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 80.1 mt -115.26 154.41 29.14 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -173.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -137.53 138.31 39.51 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.16 1.384 . . . . 0.0 107.448 169.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 36.6 mt -138.31 143.29 33.15 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.085 0 CA-C-O 120.781 0.324 . . . . 0.0 111.381 -171.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -158.71 161.66 37.09 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.789 175.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.272 33.5 m-85 -59.18 134.43 56.99 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 176.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . 0.456 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -87.74 163.33 16.55 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.854 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.494 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 23.3 pttp -97.95 -29.83 0.25 Allowed Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 84.2 Cg_endo -76.23 170.88 19.15 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 CA-C-N 122.04 1.764 . . . . 0.0 110.277 175.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.41 -2.62 2.75 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 117.584 2.438 . . . . 0.0 117.584 -177.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.26 131.61 10.34 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 118.691 0.678 . . . . 0.0 111.879 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.421 ' HG ' ' C5 ' ' B' ' 3' ' ' ' A' . 17.0 mt -89.84 158.16 17.59 Favored 'General case' 0 C--N 1.337 0.065 0 C-N-CA 123.652 0.781 . . . . 0.0 111.325 178.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -121.84 46.04 2.18 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.549 0.739 . . . . 0.0 109.834 175.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 272' ' ' VAL . 2.5 t -52.08 144.7 2.89 Favored 'Isoleucine or valine' 0 C--N 1.338 0.093 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . 0.317 8.2 p90 -123.54 -5.73 8.16 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 117.099 2.259 . . . . 0.0 117.099 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.84 172.33 16.28 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 123.382 0.673 . . . . 0.0 111.264 178.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -124.15 118.89 27.9 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.71 0.804 . . . . 0.0 110.067 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -159.09 -168.74 2.44 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.907 0.883 . . . . 0.0 109.379 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -69.63 -10.77 59.58 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -176.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -98.96 -38.35 9.03 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.4 p -143.04 146.05 33.48 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.66 0.784 . . . . 0.0 113.003 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 20.3 t-105 -154.73 152.85 30.39 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.165 0.507 . . . . 0.0 109.998 -174.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -127.6 117.42 21.99 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.559 174.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.286 65.0 m-85 -81.64 8.41 9.89 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 117.511 2.412 . . . . 0.0 117.511 -171.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 6.4 t -140.54 -21.66 0.82 Allowed 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -95.34 113.37 61.49 Favored Pre-proline 0 CA--C 1.531 0.246 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 174.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -79.97 -15.38 11.84 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 123.418 2.746 . . . . 0.0 112.344 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -74.0 -16.29 61.07 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -175.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 82.3 mt -86.31 -7.4 58.52 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 74.5 m -75.36 143.73 42.69 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 122.09 -0.382 . . . . 0.0 110.901 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 73.15 -1.09 43.21 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 119.628 -0.54 . . . . 0.0 113.172 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 52.2 mm-40 -74.33 159.88 31.8 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 118.108 0.954 . . . . 0.0 110.89 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.248 0 CA-C-O 117.43 -1.761 . . . . 0.0 110.89 179.137 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.682 0 C3'-C2'-C1' 104.515 3.35 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.456 ' N3 ' ' HA ' ' A' ' 265' ' ' ALA . . . . . . . . 0 O4'--C4' 1.421 -2.682 0 C3'-C2'-C1' 98.358 -3.491 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.421 ' C5 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.418 -2.92 1 C5'-C4'-C3' 109.257 -4.162 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' ' C' . . . . . 0.4 " H4'" " H5'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.876 1 C5'-C4'-C3' 108.655 -4.564 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.4 " H5'" " H4'" ' B' ' 4' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.414 -3.239 1 C3'-C2'-C1' 105.118 4.02 OUTLIER-DELTA 0.177 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.753 0 O4'-C1'-N19 111.638 3.438 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 33.7 tp60 . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 111.437 0.162 . . . . 0.0 111.437 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -68.2 -24.59 64.96 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 122.682 0.393 . . . . 0.0 111.727 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 40.5 mm -131.68 150.19 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 123.552 0.741 . . . . 0.0 109.751 -178.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 90.4 p -155.05 164.22 39.18 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.757 0.823 . . . . 0.0 109.45 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.679 ' H ' ' CD ' ' A' ' 179' ' ' PRO . 88.3 mtt-85 -138.33 -38.24 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 CA-C-O 118.371 -0.823 . . . . 0.0 112.556 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.679 ' CD ' ' H ' ' A' ' 178' ' ' ARG . 52.0 Cg_exo -58.99 166.96 6.15 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.762 2.308 . . . . 0.0 111.842 175.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 73.24 18.4 79.24 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -178.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . 0.285 69.1 m-20 60.77 35.4 19.57 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -178.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 36.0 t -59.62 150.84 26.23 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -57.92 -22.25 47.75 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -176.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -73.16 6.73 2.56 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 90.3 p -147.18 -0.79 0.67 Allowed 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -144.35 9.77 1.43 Allowed 'General case' 0 C--N 1.341 0.234 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 37.1 m -142.38 2.54 1.46 Allowed 'General case' 0 C--O 1.231 0.128 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 3.6 m -73.03 129.29 36.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 122.581 0.352 . . . . 0.0 111.461 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -130.64 10.46 5.16 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.9 m 64.65 20.64 12.2 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -174.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.5 t -133.08 134.57 57.73 Favored 'Isoleucine or valine' 0 C--N 1.341 0.198 0 C-N-CA 122.752 0.421 . . . . 0.0 110.672 177.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.41 ' N ' HD22 ' A' ' 192' ' ' LEU . 2.4 mm? -123.14 152.49 41.09 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 122.781 0.433 . . . . 0.0 111.137 -176.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.404 HD22 ' C6 ' ' B' ' 2' ' ' ' C' . 28.0 tp -100.91 135.8 41.78 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 169.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -113.29 111.06 21.39 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.863 1.265 . . . . 0.0 114.248 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.31 132.69 38.65 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 173.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.3 mp -103.7 120.55 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -89.74 -18.1 27.0 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -171.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -143.08 78.95 14.79 Favored Pre-proline 0 CA--C 1.53 0.181 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -78.37 45.92 1.98 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 125.061 3.84 . . . . 0.0 112.131 -177.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.433 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -70.38 -3.86 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 O-C-N 121.924 -0.485 . . . . 0.0 110.553 179.779 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -137.32 157.74 45.96 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 176.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 67.5 m -69.88 113.6 7.27 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 33.7 mm -78.4 141.81 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.079 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.24 161.02 36.09 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.6 p -62.45 -21.04 65.13 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -74.02 -46.21 44.92 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.63 0.372 . . . . 0.0 111.717 -178.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 1.7 m -69.28 -32.74 54.75 Favored 'Isoleucine or valine' 0 C--O 1.23 0.043 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.9 mt -72.09 -35.82 69.32 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -69.2 -31.05 69.39 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 174.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 9.4 m -67.69 -34.05 76.13 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 38.6 pt -93.16 -21.32 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 119.027 -0.511 . . . . 0.0 111.916 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 92.0 m -90.34 -27.32 19.47 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 119.139 0.881 . . . . 0.0 113.278 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.496 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 35.1 t30 -63.36 -39.78 52.99 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -178.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 74.0 Cg_endo -69.35 -15.77 38.83 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 CA-C-N 121.216 1.47 . . . . 0.0 111.635 178.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 95.0 m -84.67 -13.29 51.92 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.041 0.382 . . . . 0.0 111.456 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 149.58 169.42 15.95 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.03 112.84 1.64 Allowed 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 123.578 2.852 . . . . 0.0 111.309 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.8 t -79.38 144.34 11.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 176.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -112.99 -39.57 4.19 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 119.381 -0.342 . . . . 0.0 111.189 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 23.3 mtm180 -150.06 153.16 35.98 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.131 0.423 . . . . 0.0 112.066 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 24.6 mt -144.07 143.6 23.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.261 1.024 . . . . 0.0 109.659 178.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 38.3 t -145.94 155.89 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 46.6 mt -138.65 141.52 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 123.894 0.878 . . . . 0.0 109.375 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.287 3.2 p90 -143.98 157.52 44.29 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 177.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -126.53 15.98 7.62 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.272 0.629 . . . . 0.0 110.733 -173.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -63.35 -33.18 74.96 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -169.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -130.35 7.86 5.0 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.568 0.622 . . . . 0.0 112.265 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 161.96 -125.35 1.41 Allowed Glycine 0 CA--C 1.522 0.469 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -174.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 47.0 t -141.9 114.9 4.16 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 174.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -142.16 168.31 20.04 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.256 0.551 . . . . 0.0 110.989 -176.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.05 164.26 34.37 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.951 176.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 67.4 mmm -132.39 151.27 51.94 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 41.2 t -141.63 144.31 26.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 C-N-CA 122.77 0.428 . . . . 0.0 110.326 -178.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -130.58 134.23 46.84 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 122.838 0.455 . . . . 0.0 110.498 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -106.6 163.43 12.89 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 116.765 2.135 . . . . 0.0 116.765 -175.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -76.64 -17.04 59.38 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.784 0.433 . . . . 0.0 109.879 178.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 83.8 p -154.87 158.34 39.21 Favored 'General case' 0 C--O 1.232 0.157 0 O-C-N 121.819 -0.551 . . . . 0.0 111.648 -178.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 54.4 t -66.29 -33.61 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -68.34 -30.05 68.92 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 121.918 -0.489 . . . . 0.0 110.719 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 68.9 m -73.48 -31.43 63.75 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 175.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.49 -34.51 58.64 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 122.482 0.313 . . . . 0.0 111.546 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -70.54 -42.26 71.42 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 118.104 0.411 . . . . 0.0 111.445 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -76.84 -25.66 53.45 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.489 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -70.44 -41.27 73.09 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -75.08 -19.93 59.74 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.567 0.347 . . . . 0.0 111.012 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -99.51 -4.24 31.69 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 38.6 t -124.28 -31.91 3.25 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.864 0.756 . . . . 0.0 112.803 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 61.6 mt -91.59 -6.66 51.96 Favored 'General case' 0 CA--C 1.527 0.071 0 O-C-N 121.998 -0.439 . . . . 0.0 111.527 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -73.28 134.75 44.32 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 74.44 -5.9 26.28 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 111.984 -0.447 . . . . 0.0 111.984 -178.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.19 166.46 22.17 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 117.663 0.731 . . . . 0.0 110.122 177.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -123.64 139.68 53.76 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 87.7 mt -73.33 -41.58 57.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.182 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.367 39.6 m-85 -82.93 -12.01 57.69 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 117.257 2.317 . . . . 0.0 117.257 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.7 t 65.8 35.26 6.85 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.748 0.785 . . . . 0.0 110.754 -174.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 176.0 -23.68 0.06 OUTLIER Glycine 0 CA--C 1.527 0.812 0 C-N-CA 123.947 0.784 . . . . 0.0 111.198 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . 0.433 ' HB3' HD12 ' A' ' 200' ' ' ILE . 93.0 m -147.2 -177.02 5.45 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.916 1.286 . . . . 0.0 109.466 178.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 86.7 m 58.07 36.95 26.41 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -176.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.59 148.95 11.44 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 175.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 76.3 mt -115.9 155.23 28.33 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -173.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -138.38 138.38 38.21 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.313 1.445 . . . . 0.0 107.587 168.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 34.3 mt -138.34 142.37 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-O 120.657 0.265 . . . . 0.0 111.611 -170.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -158.67 162.25 37.21 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.38 0.672 . . . . 0.0 109.844 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -61.13 137.45 58.23 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -88.6 162.34 16.41 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.942 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -82.41 -54.25 0.61 Allowed Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 118.493 -0.765 . . . . 0.0 112.742 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -73.46 164.97 33.68 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.269 2.646 . . . . 0.0 111.347 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.274 0.2 OUTLIER -135.41 10.11 3.46 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 117.247 2.314 . . . . 0.0 117.247 -176.056 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.12 129.16 8.79 Favored 'General case' 0 C--N 1.339 0.11 0 O-C-N 121.646 -0.659 . . . . 0.0 111.642 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.427 ' HG ' ' C6 ' ' B' ' 3' ' ' ' A' . 30.9 mt -92.57 156.37 17.17 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 123.882 0.873 . . . . 0.0 110.916 177.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.417 ' C ' ' H61' ' B' ' 5' ' ' ' A' . 63.5 m-80 -118.58 49.12 1.33 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.861 0.864 . . . . 0.0 109.585 174.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.409 HG23 ' H ' ' A' ' 272' ' ' VAL . 2.1 t -52.31 142.12 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -176.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -130.08 0.7 4.71 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 116.551 2.056 . . . . 0.0 116.551 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -160.58 164.31 32.03 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 122.89 0.476 . . . . 0.0 110.926 -176.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -125.73 118.72 26.19 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.617 0.767 . . . . 0.0 109.198 174.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 40.0 p30 -157.19 -168.04 2.5 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.823 0.849 . . . . 0.0 109.904 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -69.3 -11.95 61.25 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -104.29 -30.66 10.0 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 3.5 p -141.49 145.31 35.05 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 19.2 t-105 -157.67 153.24 26.4 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -176.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . 0.251 7.0 t0 -132.95 121.15 22.38 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 122.94 0.496 . . . . 0.0 112.197 176.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.25 67.2 m-85 -87.25 8.97 21.76 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 117.58 2.437 . . . . 0.0 117.58 -171.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 5.0 t -142.49 -17.45 0.71 Allowed 'General case' 0 C--O 1.231 0.11 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 -177.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -94.82 113.36 61.02 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 176.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -77.59 -16.72 14.77 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.381 2.721 . . . . 0.0 111.986 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -73.33 -13.68 61.15 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -175.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 88.8 mt -90.89 -2.24 57.76 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 117.667 0.212 . . . . 0.0 111.561 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 46.2 t -77.19 146.59 36.95 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 117.768 0.258 . . . . 0.0 110.637 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 71.87 1.55 47.76 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.668 -0.518 . . . . 0.0 113.272 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 53.8 mm-40 -70.38 159.67 33.74 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.064 0.932 . . . . 0.0 111.023 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.186 0 CA-C-O 117.382 -1.788 . . . . 0.0 111.151 -179.701 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.922 0 C5'-C4'-C3' 110.939 -3.041 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.404 ' C6 ' HD22 ' A' ' 193' ' ' LEU . . . . . . . . 0 O4'--C4' 1.421 -2.642 0 C3'-C2'-C1' 98.523 -3.308 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.427 ' C6 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.42 -2.73 1 C5'-C4'-C3' 109.486 -4.01 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.167 0 C5'-C4'-C3' 110.258 -3.494 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.417 ' H61' ' C ' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.416 -3.109 0 C3'-C2'-C1' 104.985 3.872 . 0.043 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.841 1 O4'-C1'-N19 116.147 7.947 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 . . . . . 0 N--CA 1.474 0.767 0 N-CA-C 110.712 -0.107 . . . . 0.0 110.712 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -67.19 144.56 55.92 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.803 0.441 . . . . 0.0 110.043 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 86.3 mt -70.56 142.92 15.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 122.448 0.299 . . . . 0.0 110.684 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 95.0 p -156.08 158.72 38.23 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.321 0.648 . . . . 0.0 109.866 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 22.0 mtm180 -145.2 145.62 27.45 Favored Pre-proline 0 C--O 1.231 0.098 0 C-N-CA 123.122 0.569 . . . . 0.0 110.519 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.17 145.78 55.77 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 123.474 2.783 . . . . 0.0 110.199 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 70.71 10.52 67.53 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 112.024 -0.43 . . . . 0.0 112.024 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -138.49 -53.25 0.6 Allowed 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 71.1 m -71.08 151.02 44.94 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 175.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 13.2 p30 -63.16 -18.06 63.05 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -177.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -71.57 3.58 3.83 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 97.2 p -144.88 2.13 1.03 Allowed 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -176.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -148.77 8.74 0.77 Allowed 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 58.1 m -145.18 9.52 1.26 Allowed 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.412 ' H ' HG22 ' A' ' 188' ' ' VAL . 2.2 m -71.6 104.27 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -130.49 10.43 5.22 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.425 0.69 . . . . 0.0 112.213 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 50.0 m 65.84 20.73 11.44 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -176.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 20.2 t -128.09 140.37 49.35 Favored 'Isoleucine or valine' 0 C--N 1.338 0.081 0 C-N-CA 122.813 0.445 . . . . 0.0 111.192 176.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.7 mt -131.88 157.44 43.95 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.241 0.616 . . . . 0.0 110.958 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.0 tt -113.8 136.04 53.3 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.412 0.685 . . . . 0.0 109.288 174.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -114.34 102.59 10.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -85.96 135.72 33.55 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 174.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.2 mp -106.06 122.41 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -90.27 -20.34 23.07 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -172.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -141.23 78.87 18.37 Favored Pre-proline 0 CA--C 1.529 0.163 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -78.6 44.2 1.59 Allowed 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 124.984 3.789 . . . . 0.0 112.147 -177.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.438 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -69.05 -4.72 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 O-C-N 121.91 -0.494 . . . . 0.0 110.803 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -136.3 157.82 45.9 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 70.9 m -68.87 113.28 6.16 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.84 0.352 . . . . 0.0 110.32 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 40.0 mm -78.42 141.23 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 176.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.1 157.18 46.81 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.0 p -66.38 -15.86 63.62 Favored 'General case' 0 C--N 1.334 -0.088 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 175.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -79.87 -42.19 24.74 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.5 p -75.18 -32.41 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.1 mt -69.83 -33.95 73.0 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -71.23 -29.25 64.9 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 174.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.0 m -68.09 -32.2 72.35 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 45.3 pt -93.56 -22.36 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 118.291 0.496 . . . . 0.0 112.058 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 94.0 m -89.99 -26.07 20.55 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.494 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 35.1 t30 -63.89 -41.44 63.58 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 74.0 Cg_endo -69.09 -15.98 40.01 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.521 1.48 . . . . 0.0 111.27 177.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 97.6 m -86.15 -11.7 51.86 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.457 0.303 . . . . 0.0 111.467 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 151.5 167.69 15.17 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -68.01 103.67 0.92 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.913 3.075 . . . . 0.0 110.248 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 79.1 t -70.61 146.96 11.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -114.9 -39.0 3.77 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 119.13 -0.462 . . . . 0.0 111.561 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 22.5 mtm180 -149.54 151.45 33.89 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 118.61 0.641 . . . . 0.0 112.263 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 24.2 mt -148.66 137.65 15.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 124.053 0.941 . . . . 0.0 109.929 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 5.4 m -143.55 161.99 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 124.248 1.019 . . . . 0.0 110.559 174.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 46.4 mt -134.74 143.01 38.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 C-N-CA 122.929 0.491 . . . . 0.0 110.472 -175.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.3 4.4 p90 -142.3 158.44 43.71 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 176.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -128.61 15.14 6.51 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.591 0.756 . . . . 0.0 110.909 -173.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -62.6 -31.34 72.15 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 -169.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -130.41 4.0 4.69 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.609 0.64 . . . . 0.0 112.119 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 165.86 -124.45 1.24 Allowed Glycine 0 CA--C 1.521 0.429 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 -174.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.2 t -141.63 115.38 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.121 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 174.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -143.15 166.09 25.64 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.242 0.544 . . . . 0.0 111.11 -177.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -143.73 165.1 28.59 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.957 0.903 . . . . 0.0 108.836 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 80.7 mmm -133.13 150.82 52.02 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 31.6 t -140.49 145.65 25.51 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.061 0 C-N-CA 122.689 0.395 . . . . 0.0 110.882 -177.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -132.74 135.07 45.51 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 122.622 0.369 . . . . 0.0 110.628 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -107.42 163.84 12.7 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 115.934 1.828 . . . . 0.0 115.934 -176.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -78.32 -15.86 58.3 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 79.1 p -154.91 159.65 40.61 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.304 0.573 . . . . 0.0 111.665 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 54.3 t -67.51 -35.22 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -66.24 -30.88 71.41 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 122.375 -0.203 . . . . 0.0 110.954 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 74.4 m -72.83 -34.04 66.55 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 176.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.16 -31.34 58.5 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 122.43 -0.169 . . . . 0.0 111.2 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -68.51 -42.58 78.34 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 121.825 -0.547 . . . . 0.0 111.459 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -76.52 -26.57 55.38 Favored 'General case' 0 C--N 1.338 0.1 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.816 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -72.07 -41.55 67.23 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.186 0.448 . . . . 0.0 110.173 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -73.69 -20.11 60.63 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.742 0.417 . . . . 0.0 111.184 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -99.01 -9.3 24.13 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 46.4 t -116.32 -32.93 5.13 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 72.8 mt -91.9 -7.89 47.93 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.059 0.391 . . . . 0.0 111.902 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -73.04 133.04 44.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 77.06 -5.84 46.49 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.707 -0.496 . . . . 0.0 111.957 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.32 166.41 22.13 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 117.782 0.791 . . . . 0.0 110.384 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -123.49 140.65 52.79 Favored 'General case' 0 C--N 1.334 -0.099 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 87.1 mt -74.61 -42.39 48.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.359 39.7 m-85 -82.79 -12.16 57.71 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 32.6 t 65.54 36.12 6.78 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.658 0.742 . . . . 0.0 111.239 -174.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 175.6 -24.26 0.06 OUTLIER Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . 0.438 ' HB3' HD12 ' A' ' 200' ' ' ILE . 96.9 m -145.81 -177.2 5.46 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.185 1.394 . . . . 0.0 109.801 177.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 88.1 m 57.89 37.93 26.96 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.22 148.96 13.38 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 175.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 81.2 mt -116.09 154.78 29.35 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -173.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 54.1 mttp -138.19 137.06 37.23 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.715 1.606 . . . . 0.0 107.484 169.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 56.0 mt -136.87 143.3 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-O 120.94 0.4 . . . . 0.0 111.384 -172.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -159.23 164.02 35.38 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.739 175.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.266 45.3 m-85 -61.71 135.46 57.62 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 176.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . 0.424 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -88.27 156.36 19.24 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.347 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.446 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 64.6 pttt -89.44 -31.51 0.37 Allowed Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 50.1 Cg_endo -79.28 168.39 20.26 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 121.835 1.69 . . . . 0.0 110.136 175.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.281 0.2 OUTLIER -137.78 8.86 2.82 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 117.883 2.549 . . . . 0.0 117.883 -176.015 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.32 126.84 6.69 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 118.778 0.717 . . . . 0.0 111.799 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.425 ' HG ' ' C5 ' ' B' ' 3' ' ' ' A' . 27.4 mt -92.22 156.95 16.96 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 123.858 0.863 . . . . 0.0 110.747 176.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.438 ' C ' ' H61' ' B' ' 5' ' ' ' A' . 57.8 m-80 -116.67 53.31 0.89 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.504 0.722 . . . . 0.0 109.788 172.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.6 t -54.68 145.26 4.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -175.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -135.67 -0.25 2.63 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 117.022 2.23 . . . . 0.0 117.022 -176.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -160.53 159.08 30.26 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.584 0.354 . . . . 0.0 111.372 -173.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -123.12 112.23 17.48 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.834 0.854 . . . . 0.0 109.404 173.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 53.1 p30 -157.87 -166.28 1.94 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -66.9 -16.33 64.25 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -174.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -115.17 -13.36 11.79 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.29 139.29 37.29 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 123.815 0.846 . . . . 0.0 113.041 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 16.3 t-105 -162.95 155.34 18.62 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.25 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . 0.259 5.8 t0 -140.79 119.57 12.54 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.194 0.598 . . . . 0.0 112.102 172.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.252 66.8 m-85 -82.18 7.62 13.16 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 117.536 2.421 . . . . 0.0 117.536 -171.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 6.0 t -140.6 -14.65 0.95 Allowed 'General case' 0 C--O 1.232 0.143 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -177.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -95.27 113.44 61.58 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 175.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -80.95 -14.33 11.09 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.737 2.958 . . . . 0.0 112.744 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -73.19 -14.69 61.4 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -173.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 48.4 mt -75.5 2.22 12.15 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 97.2 p -71.76 -8.29 53.31 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.623 0.369 . . . . 0.0 111.507 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 178.86 -5.17 0.03 OUTLIER Glycine 0 CA--C 1.527 0.842 0 CA-C-O 119.769 -0.462 . . . . 0.0 112.94 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 33.1 tp60 56.51 23.9 8.06 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.045 0.938 . . . . 0.0 111.71 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 CA-C-O 117.257 -1.857 . . . . 0.0 110.832 -179.5 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.086 0 C5'-C4'-C3' 110.256 -3.496 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.424 ' N3 ' ' HA ' ' A' ' 265' ' ' ALA . . . . . . . . 0 O4'--C4' 1.418 -2.925 0 C3'-C2'-C1' 98.531 -3.299 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.425 ' C5 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.422 -2.616 1 C5'-C4'-C3' 109.31 -4.127 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.74 1 C5'-C4'-C3' 109.472 -4.019 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.438 ' H61' ' C ' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.417 -3.01 0 C3'-C2'-C1' 105.017 3.907 OUTLIER-DELTA 0.054 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.62 1 O4'-C1'-N19 112.219 4.019 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 111.199 0.074 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -151.62 145.54 25.17 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 123.153 0.581 . . . . 0.0 109.977 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 31.8 mm -138.5 149.04 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 C-N-CA 124.023 0.929 . . . . 0.0 109.284 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 48.3 t -155.65 157.48 36.76 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.115 0.566 . . . . 0.0 109.975 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 48.3 mtm180 -144.66 149.35 43.17 Favored Pre-proline 0 CA--C 1.529 0.157 0 C-N-CA 123.578 0.751 . . . . 0.0 110.038 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.94 -12.57 32.82 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.48 2.787 . . . . 0.0 111.781 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -74.19 -10.6 81.63 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 112.202 -0.359 . . . . 0.0 112.202 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -79.29 -19.13 51.26 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 62.4 m -71.4 149.54 45.87 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 121.846 -0.534 . . . . 0.0 109.668 178.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -61.9 -15.97 47.02 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -176.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -70.97 -3.0 17.12 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 68.0 m -140.25 3.84 1.98 Allowed 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 5.9 ppt_? -149.3 7.88 0.7 Allowed 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 58.9 m -147.2 12.4 1.07 Allowed 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.404 ' H ' HG22 ' A' ' 188' ' ' VAL . 1.7 m -69.44 102.17 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -177.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 51.8 p-10 -130.39 10.51 5.27 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.234 0.614 . . . . 0.0 112.232 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 71.2 m 65.05 20.57 12.09 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 -177.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.3 t -132.97 133.26 58.92 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 CA-C-N 118.162 0.437 . . . . 0.0 110.875 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.431 HD21 ' HB1' ' A' ' 241' ' ' ALA . 2.3 mm? -121.76 155.01 36.17 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 122.954 0.502 . . . . 0.0 110.995 -176.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 29.1 tp -104.98 131.18 52.82 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 170.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -107.72 101.74 11.02 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 177.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.78 136.21 33.17 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 174.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.4 mp -105.67 130.61 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -92.65 -24.2 18.74 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -175.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -138.82 78.92 29.33 Favored Pre-proline 0 CA--C 1.529 0.147 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -77.01 49.59 2.84 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 124.865 3.71 . . . . 0.0 112.346 -178.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.464 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -69.13 -7.05 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 O-C-N 121.775 -0.578 . . . . 0.0 110.314 178.467 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -140.14 153.67 46.75 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.082 1.353 . . . . 0.0 113.081 175.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.4 t -73.55 128.14 34.68 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 120.811 0.338 . . . . 0.0 110.517 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 19.7 mm -78.71 148.69 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 122.724 0.409 . . . . 0.0 109.947 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.0 156.15 48.71 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 177.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.5 p -65.57 -16.37 63.63 Favored 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -74.73 -47.16 32.85 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.7 0.286 . . . . 0.0 111.703 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.5 m -71.41 -32.43 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.6 mt -69.91 -36.15 75.17 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 176.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -71.21 -30.67 66.66 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 12.6 m -66.31 -32.99 74.73 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 37.5 pt -94.05 -24.3 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 118.178 0.444 . . . . 0.0 112.02 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 90.1 m -88.29 -25.44 22.81 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.49 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 35.3 t30 -64.19 -43.16 72.66 Favored Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 67.4 Cg_endo -68.38 -15.3 41.88 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 121.411 1.407 . . . . 0.0 111.512 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 95.4 m -83.86 -15.14 49.29 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.047 0.385 . . . . 0.0 111.379 177.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 151.02 170.47 18.05 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -61.12 104.82 0.3 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.774 2.983 . . . . 0.0 111.732 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 72.5 t -75.72 145.54 10.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -117.79 -39.75 3.09 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 119.287 -0.387 . . . . 0.0 111.477 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 66.1 mtm-85 -148.05 151.22 35.32 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.484 0.584 . . . . 0.0 112.547 179.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 20.3 mt -148.27 137.58 15.89 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 C-N-CA 124.105 0.962 . . . . 0.0 109.628 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 8.1 m -143.07 162.84 17.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 C-N-CA 123.735 0.814 . . . . 0.0 110.23 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 47.8 mt -135.96 142.88 37.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.093 0 C-N-CA 123.224 0.609 . . . . 0.0 110.409 -174.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.299 6.2 p90 -141.39 155.38 45.91 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 177.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -128.37 14.3 6.62 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.242 0.617 . . . . 0.0 110.788 -174.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -64.98 -30.68 71.68 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -169.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -130.37 5.8 4.82 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.793 0.724 . . . . 0.0 111.812 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 162.38 -126.29 1.54 Allowed Glycine 0 C--N 1.335 0.515 0 N-CA-C 107.966 -2.054 . . . . 0.0 107.966 -174.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 38.5 t -142.78 116.98 4.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 175.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -144.02 166.84 23.84 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.289 0.566 . . . . 0.0 110.631 -176.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.97 166.37 26.99 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.113 175.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 74.6 mmm -133.96 154.2 51.26 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 29.6 t -142.11 142.8 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 C-N-CA 122.781 0.432 . . . . 0.0 110.905 -178.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -129.36 133.16 47.26 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.155 0.582 . . . . 0.0 110.274 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -108.5 160.97 15.48 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 -176.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -79.55 -11.95 59.87 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 37.7 t -154.81 153.48 31.25 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 121.812 -0.555 . . . . 0.0 111.549 -176.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 56.6 t -68.01 -37.36 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -67.09 -27.53 67.43 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 122.039 -0.413 . . . . 0.0 111.025 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 52.2 m -74.32 -32.39 62.82 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 175.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.431 ' HB1' HD21 ' A' ' 192' ' ' LEU . . . -76.52 -31.74 57.84 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 122.567 0.347 . . . . 0.0 111.305 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -69.74 -45.39 68.24 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 117.949 0.34 . . . . 0.0 111.345 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -74.6 -26.57 60.0 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 117.953 0.342 . . . . 0.0 111.24 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -69.32 -42.81 74.86 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.435 ' HE3' ' HB3' ' A' ' 245' ' ' LYS . 0.8 OUTLIER -75.39 -21.24 58.42 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.825 0.45 . . . . 0.0 111.161 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -94.32 -9.0 37.32 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 40.9 t -118.4 -34.21 4.12 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -177.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 70.8 mt -89.1 -8.07 54.55 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 118.161 0.437 . . . . 0.0 111.999 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -71.15 136.3 48.07 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.58 -5.66 21.43 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 119.756 -0.469 . . . . 0.0 112.159 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -77.83 166.5 22.83 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 117.955 0.878 . . . . 0.0 110.003 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -122.59 139.17 54.22 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 86.2 mt -74.48 -41.58 49.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.361 44.8 m-85 -82.86 -9.96 59.07 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 117.045 2.239 . . . . 0.0 117.045 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 30.8 t 65.57 35.25 7.25 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.479 0.712 . . . . 0.0 111.08 -175.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 175.95 -24.6 0.06 OUTLIER Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.053 0.835 . . . . 0.0 111.243 177.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . 0.464 ' HB3' HD12 ' A' ' 200' ' ' ILE . 82.0 m -145.83 -177.87 5.81 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.6 1.16 . . . . 0.0 109.354 178.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 97.3 m 58.6 38.96 25.16 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -174.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.32 150.37 8.79 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 174.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 97.1 mt -110.96 157.3 20.06 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -173.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.96 130.13 26.76 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.711 2.005 . . . . 0.0 106.331 170.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 30.7 mt -138.3 139.69 41.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-O 120.908 0.385 . . . . 0.0 111.295 -172.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -161.31 163.75 30.62 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.421 175.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.25 48.7 m-85 -59.89 141.91 54.58 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 177.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . 0.418 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -96.21 162.08 13.68 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -176.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.401 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 59.2 mttm -78.14 -50.33 1.79 Allowed Pre-proline 0 CA--C 1.532 0.286 0 CA-C-O 118.318 -0.849 . . . . 0.0 112.282 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 87.6 Cg_endo -75.51 169.01 23.26 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.656 2.237 . . . . 0.0 111.191 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.259 0.2 OUTLIER -134.51 3.13 3.29 Favored 'General case' 0 CA--C 1.527 0.071 0 N-CA-C 117.73 2.493 . . . . 0.0 117.73 -176.328 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -157.85 127.47 5.97 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 118.764 0.711 . . . . 0.0 112.063 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.451 ' HG ' ' C5 ' ' B' ' 3' ' ' ' A' . 21.9 mt -82.81 163.24 21.34 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.975 0.91 . . . . 0.0 111.015 175.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.437 ' C ' ' H61' ' B' ' 5' ' ' ' A' . 58.6 m-80 -121.8 51.98 1.29 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.69 0.796 . . . . 0.0 109.103 171.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.408 ' H ' HG23 ' A' ' 272' ' ' VAL . 2.3 t -51.96 144.49 2.94 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -176.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -128.36 -7.52 5.27 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 117.476 2.399 . . . . 0.0 117.476 -177.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -161.46 171.37 18.28 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 122.728 0.411 . . . . 0.0 110.517 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -124.69 122.99 39.05 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.774 0.83 . . . . 0.0 109.667 174.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 45.1 p30 -160.58 -166.12 1.57 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.99 0.916 . . . . 0.0 108.728 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -68.17 -14.98 63.39 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -174.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -114.01 -13.18 12.52 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.01 139.87 34.23 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 123.68 0.792 . . . . 0.0 112.736 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 17.2 t-105 -160.34 156.14 25.78 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.328 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -135.86 116.04 13.43 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.542 172.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.267 67.2 m-85 -80.4 8.0 8.52 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 116.898 2.184 . . . . 0.0 116.898 -173.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 5.8 t -137.8 -22.19 1.09 Allowed 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -95.29 113.17 61.0 Favored Pre-proline 0 N--CA 1.453 -0.318 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 174.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -80.93 -15.18 10.69 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.585 2.857 . . . . 0.0 112.681 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -74.29 -17.05 60.91 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -173.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 59.6 mt -83.71 -7.85 59.39 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 73.7 m -70.85 -11.45 60.97 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 122.034 -0.416 . . . . 0.0 111.87 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -82.17 -5.71 89.43 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 176.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 55.07 25.13 6.69 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.102 0.961 . . . . 0.0 112.758 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.173 0 CA-C-O 117.174 -1.903 . . . . 0.0 111.695 -179.786 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . 0.404 ' C8 ' H5'' ' B' ' 1' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.774 0 C5'-C4'-C3' 110.345 -3.436 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.418 ' N3 ' ' HA ' ' A' ' 265' ' ' ALA . . . . . . . . 0 O4'--C4' 1.421 -2.69 0 O4'-C1'-N19 112.059 3.859 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.451 ' C5 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.42 -2.779 0 O4'-C1'-N19 111.615 3.415 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.839 0 C5'-C4'-C3' 109.959 -3.694 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.444 ' N3 ' " H2'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.805 0 C3'-C2'-C1' 104.923 3.804 OUTLIER-DELTA 0.01 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.531 1 O4'-C1'-N19 112.309 4.109 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 . . . . . 0 N--CA 1.477 0.878 0 CA-C-O 120.426 0.155 . . . . 0.0 110.667 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -152.54 146.42 25.22 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 122.92 0.488 . . . . 0.0 110.02 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 82.1 mt -71.34 144.8 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 122.753 0.421 . . . . 0.0 110.49 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 97.8 p -157.34 162.2 39.09 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 122.96 0.504 . . . . 0.0 110.267 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 67.2 mtt85 -75.19 151.55 85.89 Favored Pre-proline 0 CA--C 1.53 0.173 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.25 -19.43 33.82 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.75 2.3 . . . . 0.0 110.857 177.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -88.47 -7.17 72.69 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 119.655 -0.525 . . . . 0.0 112.347 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -78.46 -5.61 52.98 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.5 t -71.2 155.45 40.71 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.816 0.446 . . . . 0.0 110.389 177.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -59.55 -22.6 61.93 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.287 -0.258 . . . . 0.0 111.646 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -78.67 2.46 19.42 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 58.7 m -140.96 -0.41 1.49 Allowed 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -176.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -148.18 10.49 0.89 Allowed 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 47.5 m -142.32 7.77 1.77 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 3.6 m -78.83 129.24 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 122.943 0.497 . . . . 0.0 111.824 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 42.3 p30 -130.73 10.31 5.1 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 23.2 t 64.43 23.01 12.87 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -175.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 92.7 t -132.51 143.3 40.19 Favored 'Isoleucine or valine' 0 C--N 1.339 0.124 0 C-N-CA 123.669 0.788 . . . . 0.0 109.207 177.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 75.9 mt -136.38 149.64 48.43 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -173.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 38.8 tp -100.02 135.54 41.28 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 172.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -114.97 102.2 9.74 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.138 1.375 . . . . 0.0 114.485 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.42 134.33 33.6 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 174.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.2 mp -103.5 122.44 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -91.99 -18.12 24.12 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -171.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -143.29 78.72 14.69 Favored Pre-proline 0 CA--C 1.529 0.148 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -78.23 45.83 1.94 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 125.136 3.891 . . . . 0.0 112.102 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.424 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -70.95 -4.55 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 O-C-N 121.952 -0.467 . . . . 0.0 110.909 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -136.27 157.6 46.42 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 177.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 66.9 m -71.34 112.81 7.77 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 120.636 0.255 . . . . 0.0 110.466 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.3 mm -78.46 142.15 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.96 160.58 37.28 Favored 'General case' 0 N--CA 1.458 -0.064 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.2 p -66.6 -14.52 62.5 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 176.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -75.98 -44.29 40.41 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 120.813 0.339 . . . . 0.0 110.675 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.0 m -72.53 -33.52 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.8 mt -70.85 -35.11 72.28 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -69.74 -31.5 69.51 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 174.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.8 m -67.31 -31.81 72.36 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 43.4 pt -94.58 -25.47 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-O 118.982 -0.533 . . . . 0.0 112.027 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 98.0 m -86.59 -28.59 23.18 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 119.283 0.947 . . . . 0.0 113.263 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.496 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 38.8 t30 -68.12 -40.49 21.95 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -178.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 74.4 Cg_endo -69.42 -14.29 36.93 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 CA-C-N 121.045 1.409 . . . . 0.0 111.434 176.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 91.7 m -87.28 -8.97 56.17 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 117.896 0.317 . . . . 0.0 111.46 176.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 150.53 171.1 18.45 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 178.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -66.63 85.45 0.29 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 124.632 3.554 . . . . 0.0 110.928 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 10.7 p -68.39 148.48 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 123.874 0.87 . . . . 0.0 109.609 175.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -121.75 -36.23 3.07 Favored 'General case' 0 C--O 1.228 -0.077 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -174.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 66.2 mtm-85 -146.1 148.73 32.93 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.582 0.628 . . . . 0.0 112.353 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 35.2 mt -147.99 135.07 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 C-N-CA 123.998 0.919 . . . . 0.0 109.504 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 2.3 m -141.3 160.81 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.105 0 C-N-CA 123.633 0.773 . . . . 0.0 111.614 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 53.1 mt -134.6 144.17 35.69 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.046 0 C-N-CA 123.332 0.653 . . . . 0.0 110.327 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.297 4.6 p90 -143.31 155.99 44.6 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -127.13 13.13 7.21 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.509 0.724 . . . . 0.0 111.087 -173.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -64.31 -31.04 72.09 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -169.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -130.32 7.49 4.98 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 118.889 0.768 . . . . 0.0 112.114 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 161.08 -124.54 1.33 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 108.559 -1.816 . . . . 0.0 108.559 -174.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 59.4 t -144.25 114.63 2.11 Favored 'Isoleucine or valine' 0 C--O 1.23 0.051 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 175.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -142.89 168.05 20.63 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.123 0.487 . . . . 0.0 110.904 -176.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.65 166.99 24.9 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.846 0.858 . . . . 0.0 109.152 175.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 71.3 mmm -134.06 156.08 48.88 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 38.5 t -141.23 147.05 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 122.89 0.476 . . . . 0.0 110.747 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -135.55 134.93 39.93 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.005 0.522 . . . . 0.0 110.326 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -108.16 163.05 13.5 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -77.45 -14.52 59.67 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 84.9 p -154.54 153.43 31.43 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.462 0.649 . . . . 0.0 111.581 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 51.9 t -65.23 -32.11 56.82 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.347 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -65.54 -33.95 77.12 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.014 0.37 . . . . 0.0 110.454 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 69.1 m -72.13 -33.5 67.84 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 177.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -72.63 -31.8 65.41 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 122.376 -0.202 . . . . 0.0 111.206 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -68.93 -43.77 74.45 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.931 -0.481 . . . . 0.0 111.523 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -77.78 -25.77 49.29 Favored 'General case' 0 N--CA 1.458 -0.036 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.497 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -72.5 -40.73 66.62 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 118.084 0.402 . . . . 0.0 110.035 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -72.6 -25.34 61.28 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 122.416 0.286 . . . . 0.0 110.864 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -91.86 -10.31 40.18 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 47.1 t -114.08 -34.12 5.48 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 80.3 mt -90.12 -9.36 48.63 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -70.74 134.63 47.62 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 74.73 -3.22 44.59 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 119.72 -0.489 . . . . 0.0 112.151 -178.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.52 166.48 21.14 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 117.869 0.834 . . . . 0.0 110.069 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -123.6 140.08 53.36 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 81.9 mt -74.99 -41.17 45.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.365 40.7 m-85 -82.85 -12.01 57.77 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 117.4 2.371 . . . . 0.0 117.4 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 32.1 t 65.39 34.89 7.82 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.495 0.718 . . . . 0.0 110.926 -173.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 177.15 -24.44 0.05 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . 0.424 ' HB3' HD12 ' A' ' 200' ' ' ILE . 86.0 m -146.89 -176.13 5.08 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.661 1.184 . . . . 0.0 109.5 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 89.1 m 58.2 37.24 26.2 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -176.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.27 149.08 13.36 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 176.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 81.2 mt -116.25 153.81 31.24 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -173.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -137.24 137.36 38.98 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 169.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 46.4 mt -139.6 141.64 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-O 120.734 0.302 . . . . 0.0 111.615 -170.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -161.36 163.92 30.36 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.043 176.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.277 49.8 m-85 -59.28 139.45 56.97 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 177.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . 0.44 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -95.85 164.31 12.79 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -175.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.408 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 61.0 mttm -78.46 -50.05 1.69 Allowed Pre-proline 0 CA--C 1.535 0.395 0 CA-C-O 118.624 -0.703 . . . . 0.0 112.486 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 90.1 Cg_endo -74.7 174.21 13.05 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.619 2.213 . . . . 0.0 110.686 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 2.1 t -138.56 -2.48 1.77 Allowed 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 116.493 2.034 . . . . 0.0 116.493 -174.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.92 130.55 9.03 Favored 'General case' 0 C--N 1.34 0.176 0 O-C-N 121.546 -0.721 . . . . 0.0 111.624 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.478 ' HG ' ' C5 ' ' B' ' 3' ' ' ' A' . 17.0 mt -86.46 157.63 19.76 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 123.667 0.787 . . . . 0.0 111.127 177.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -119.74 47.36 1.74 Allowed 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.633 0.773 . . . . 0.0 109.59 173.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 272' ' ' VAL . 2.2 t -50.38 143.03 2.52 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 -176.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -132.5 1.22 3.72 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 116.15 1.907 . . . . 0.0 116.15 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -156.4 153.32 28.72 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.163 0.585 . . . . 0.0 110.355 -171.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -122.18 118.65 29.13 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.364 0.666 . . . . 0.0 109.675 172.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 54.9 p30 -157.58 -167.28 2.23 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -69.21 -13.38 62.37 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -175.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -109.51 -22.6 11.92 Favored 'General case' 0 C--N 1.338 0.102 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.65 142.08 35.01 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 177.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 20.2 t-105 -159.3 155.55 27.09 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.155 0.502 . . . . 0.0 110.01 -175.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -129.93 117.22 19.78 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.496 171.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.277 66.5 m-85 -80.0 8.44 7.04 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 117.269 2.322 . . . . 0.0 117.269 -172.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 8.7 t -139.93 -22.51 0.86 Allowed 'General case' 0 C--O 1.231 0.105 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -95.35 113.22 61.17 Favored Pre-proline 0 CA--C 1.531 0.234 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 174.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -81.68 -14.35 10.22 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.571 2.847 . . . . 0.0 112.136 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -74.32 -12.14 60.46 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -173.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 55.1 mt -88.09 -10.08 51.25 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.275 0.489 . . . . 0.0 111.835 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 75.0 m -69.47 129.34 39.46 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 67.24 0.65 10.92 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.677 -0.513 . . . . 0.0 112.219 -176.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 55.2 19.77 3.07 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.46 1.104 . . . . 0.0 112.184 -177.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.183 0 CA-C-O 117.366 -1.796 . . . . 0.0 110.969 -179.462 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.784 0 C3'-C2'-C1' 104.583 3.425 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.44 ' N3 ' ' HA ' ' A' ' 265' ' ' ALA . . . . . . . . 0 O4'--C4' 1.419 -2.819 1 C3'-C2'-C1' 97.883 -4.019 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.478 ' C5 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.417 -3.003 0 O4'-C1'-N19 111.663 3.463 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.742 0 C5'-C4'-C3' 109.758 -3.828 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.419 ' N3 ' " H2'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.884 0 C3'-C2'-C1' 104.809 3.677 OUTLIER-DELTA 0.01 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.606 0 O4'-C1'-N19 111.726 3.526 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 . . . . . 0 N--CA 1.477 0.921 0 CA-C-O 120.405 0.145 . . . . 0.0 110.748 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -154.09 156.41 37.22 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.259 0.624 . . . . 0.0 109.823 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 84.0 mt -63.38 146.53 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 122.947 0.499 . . . . 0.0 110.032 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 43.9 t -67.59 164.44 19.08 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.573 0.749 . . . . 0.0 112.307 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.638 ' H ' ' CD ' ' A' ' 179' ' ' PRO . 83.3 mmt-85 -136.18 -39.06 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.225 0 CA-C-O 118.173 -0.917 . . . . 0.0 113.223 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.638 ' CD ' ' H ' ' A' ' 178' ' ' ARG . 44.0 Cg_exo -60.01 143.61 99.55 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.596 2.197 . . . . 0.0 111.412 175.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -83.29 -8.91 84.58 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 119.676 -0.513 . . . . 0.0 112.986 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -100.76 -3.18 30.56 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 117.844 0.822 . . . . 0.0 110.009 -178.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 74.1 m -83.84 142.21 30.78 Favored 'General case' 0 C--O 1.231 0.088 0 O-C-N 121.693 -0.629 . . . . 0.0 110.061 176.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -58.64 -25.27 62.55 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -73.64 10.52 1.07 Allowed 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 114.698 1.369 . . . . 0.0 114.698 177.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 32.8 t -143.9 -0.73 1.02 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -148.13 1.95 0.66 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 58.1 m -136.52 8.69 3.12 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 123.257 0.623 . . . . 0.0 111.932 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 33.0 m -66.29 132.0 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 C-N-CA 122.759 0.424 . . . . 0.0 109.892 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -130.75 5.25 4.62 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -177.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 70.9 m 56.14 13.85 1.32 Allowed 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -175.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 96.3 t -142.37 136.63 28.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 C-N-CA 123.976 0.911 . . . . 0.0 108.655 -178.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.451 ' N ' HD22 ' A' ' 192' ' ' LEU . 1.8 mm? -125.04 151.91 44.98 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 122.68 0.392 . . . . 0.0 111.309 -176.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 39.2 tp -95.54 136.29 36.12 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 169.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -113.95 102.77 10.51 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.899 1.279 . . . . 0.0 114.292 177.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.74 133.12 33.91 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 174.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.2 mp -104.06 121.31 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -89.03 -18.62 26.98 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -172.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -144.22 79.03 13.21 Favored Pre-proline 0 CA--C 1.529 0.142 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.74 46.03 1.93 Allowed 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.838 3.692 . . . . 0.0 112.247 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.419 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -70.88 -4.09 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 O-C-N 121.953 -0.467 . . . . 0.0 110.764 179.625 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -136.74 157.59 46.4 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 176.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 70.5 m -70.77 111.9 6.57 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.273 0.229 . . . . 0.0 110.552 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 32.2 mm -78.83 141.15 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 176.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.03 158.31 43.88 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 177.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.67 -19.79 66.04 Favored 'General case' 0 C--O 1.23 0.057 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -77.63 -34.52 53.26 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 96.4 t -75.46 -41.22 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.27 -31.52 70.1 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -70.85 -29.53 65.67 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 174.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.4 m -68.42 -32.79 73.09 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 45.0 pt -92.88 -22.51 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 118.379 0.536 . . . . 0.0 112.073 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 92.5 m -90.61 -26.53 19.6 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.49 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 32.0 t30 -63.06 -42.83 79.35 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 74.3 Cg_endo -69.25 -11.8 32.35 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.378 1.386 . . . . 0.0 111.604 177.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 92.5 m -91.78 -5.82 52.87 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 145.44 168.66 13.18 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 177.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.21 104.63 0.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.851 3.034 . . . . 0.0 111.581 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 55.4 t -75.7 143.61 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -115.36 -40.08 3.49 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 119.415 -0.326 . . . . 0.0 111.045 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 65.2 mtm-85 -147.99 151.31 35.55 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 19.0 mt -146.72 135.9 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 124.144 0.978 . . . . 0.0 109.448 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 1.4 m -139.87 159.31 26.94 Favored 'Isoleucine or valine' 0 C--O 1.23 0.049 0 C-N-CA 123.301 0.64 . . . . 0.0 111.88 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 56.0 mt -135.23 142.78 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 C-N-CA 123.159 0.583 . . . . 0.0 109.628 -176.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.29 3.7 p90 -143.13 158.21 43.82 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 176.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -128.43 16.68 6.53 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.267 0.627 . . . . 0.0 110.393 -172.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -64.72 -30.7 71.72 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -169.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -130.43 5.8 4.8 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 118.563 0.62 . . . . 0.0 112.133 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 161.2 -122.41 1.11 Allowed Glycine 0 CA--C 1.522 0.472 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 -173.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 57.2 t -143.26 116.41 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 175.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -143.73 167.13 23.01 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.158 0.504 . . . . 0.0 110.557 -176.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.41 167.48 24.28 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 53.4 mmm -137.88 153.78 49.52 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 44.5 t -139.99 140.77 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 C-N-CA 122.791 0.436 . . . . 0.0 110.318 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -124.52 130.03 51.7 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.047 0.539 . . . . 0.0 110.421 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -105.84 163.34 12.8 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 -175.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -76.35 -15.59 59.93 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.5 0.32 . . . . 0.0 110.499 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 84.8 p -155.84 160.5 40.26 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.273 0.559 . . . . 0.0 111.694 -177.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 25.6 t -65.1 -35.25 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -66.61 -34.97 79.07 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 122.309 -0.244 . . . . 0.0 111.037 -176.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 60.7 m -71.58 -30.24 65.61 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 121.242 -0.183 . . . . 0.0 110.534 176.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.48 -29.85 59.71 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 119.806 -0.14 . . . . 0.0 111.175 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -69.75 -48.38 59.6 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 118.127 0.421 . . . . 0.0 111.805 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -72.82 -27.46 61.97 Favored 'General case' 0 C--N 1.337 0.053 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.087 -177.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -69.76 -40.8 75.89 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -76.15 -19.63 58.31 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 122.915 0.486 . . . . 0.0 110.988 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -102.16 -0.3 33.47 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 42.9 t -127.07 -30.42 2.69 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 118.68 0.673 . . . . 0.0 112.512 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 70.0 mt -92.96 -8.2 43.8 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.097 0.408 . . . . 0.0 111.618 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -73.19 134.23 44.3 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.09 -5.04 44.09 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 119.717 -0.49 . . . . 0.0 112.108 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.7 166.34 21.9 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 117.801 0.8 . . . . 0.0 110.017 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -123.02 136.61 54.91 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 178.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 95.9 mt -70.92 -43.25 76.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.358 34.4 m-85 -82.8 -11.38 58.31 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 117.232 2.308 . . . . 0.0 117.232 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.7 t 65.76 36.11 6.42 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.954 0.883 . . . . 0.0 111.285 -174.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 174.42 -23.45 0.06 OUTLIER Glycine 0 CA--C 1.529 0.954 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.077 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . 0.419 ' HB3' HD12 ' A' ' 200' ' ' ILE . 93.5 m -146.51 -177.51 5.67 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.744 1.218 . . . . 0.0 109.212 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 89.0 m 58.46 35.72 24.88 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -176.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.86 148.21 10.7 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 175.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 84.1 mt -114.95 153.97 29.6 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -173.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -137.58 136.87 37.97 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.057 1.343 . . . . 0.0 107.426 169.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 40.9 mt -137.61 142.67 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 CA-C-O 120.723 0.297 . . . . 0.0 111.423 -171.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -159.67 161.88 35.0 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 122.988 0.515 . . . . 0.0 110.17 175.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.27 38.3 m-85 -59.2 135.77 57.75 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 176.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . 0.436 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -88.57 164.83 15.21 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -89.18 -53.0 0.35 Allowed Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 123.617 0.767 . . . . 0.0 112.933 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -71.59 159.45 51.12 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.717 2.278 . . . . 0.0 110.503 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 1.4 t -127.15 0.25 6.46 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 -173.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -154.69 131.26 10.6 Favored 'General case' 0 C--N 1.339 0.134 0 O-C-N 121.857 -0.527 . . . . 0.0 111.472 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.479 ' HG ' ' C6 ' ' B' ' 3' ' ' ' A' . 29.1 mt -85.61 166.89 15.85 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.193 0.997 . . . . 0.0 111.304 177.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.547 ' ND2' ' C2 ' ' B' ' 4' ' ' ' C' . 19.0 p30 -121.87 44.76 2.49 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.434 170.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.415 ' H ' HG23 ' A' ' 272' ' ' VAL . 2.2 t -48.02 140.3 2.21 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -177.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.435 ' CZ ' ' C2 ' ' B' ' 5' ' ' ' A' . 6.5 p90 -129.52 0.93 5.02 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 -178.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -158.19 166.33 32.68 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.93 0.395 . . . . 0.0 110.965 -174.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -125.91 111.69 15.08 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.956 0.902 . . . . 0.0 109.063 171.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 56.9 p30 -154.31 -169.97 3.4 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -69.65 -11.73 61.08 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -176.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -99.53 -37.3 9.23 Favored 'General case' 0 CA--C 1.528 0.096 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.81 147.01 38.37 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 178.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 18.9 t-105 -157.32 155.84 31.35 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -175.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -128.37 117.97 22.35 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.85 0.46 . . . . 0.0 109.9 173.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.295 67.8 m-85 -80.6 8.61 7.52 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 117.032 2.234 . . . . 0.0 117.032 -173.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 5.3 t -137.62 -24.09 1.06 Allowed 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -95.39 113.12 60.98 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 174.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -82.62 -13.08 9.77 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 123.708 2.939 . . . . 0.0 112.637 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -73.71 -16.45 61.19 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -172.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 45.2 mt -79.65 -8.12 59.01 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.186 0.448 . . . . 0.0 111.986 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 73.5 m -78.73 0.03 28.39 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.668 0.387 . . . . 0.0 111.582 176.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -76.52 -6.67 84.7 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 119.672 -0.516 . . . . 0.0 112.883 -178.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -70.4 158.88 35.2 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 117.978 0.889 . . . . 0.0 110.88 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 CA-C-O 117.512 -1.715 . . . . 0.0 110.876 -179.484 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.738 0 C5'-C4'-C3' 109.998 -3.668 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.436 ' N3 ' ' HA ' ' A' ' 265' ' ' ALA . . . . . . . . 0 O4'--C4' 1.422 -2.57 2 C3'-C2'-C1' 97.649 -4.279 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.479 ' C6 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.425 -2.347 2 C5'-C4'-C3' 107.285 -5.477 . 0.01 4s . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' ' C' . . . . . 0.547 ' C2 ' ' ND2' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.42 -2.771 1 C5'-C4'-C3' 108.337 -4.775 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.483 ' H61' ' C ' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.415 -3.165 1 C3'-C2'-C1' 105.152 4.058 OUTLIER-DELTA 0.154 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.597 0 O4'-C1'-N19 111.947 3.747 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 . . . . . 0 N--CA 1.476 0.866 0 N-CA-C 111.345 0.128 . . . . 0.0 111.345 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -151.46 146.68 26.1 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.085 0.554 . . . . 0.0 110.372 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 30.4 mm -138.77 147.98 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 124.529 1.132 . . . . 0.0 108.716 178.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 73.2 m -145.55 158.0 43.91 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.167 0.587 . . . . 0.0 110.553 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 82.2 mtt85 -144.19 151.46 51.82 Favored Pre-proline 0 CA--C 1.528 0.117 0 C-N-CA 123.942 0.897 . . . . 0.0 109.758 -178.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -68.79 -17.39 42.14 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.331 2.687 . . . . 0.0 111.622 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.56 -6.25 84.13 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 119.81 -0.439 . . . . 0.0 112.128 178.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -84.62 -6.82 59.39 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 41.0 t -73.01 141.82 47.7 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 121.669 -0.644 . . . . 0.0 110.077 177.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 16.4 p30 -67.77 -15.04 63.44 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -74.04 2.35 8.99 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 97.2 p -149.31 8.44 0.71 Allowed 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -178.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -144.15 -1.78 0.93 Allowed 'General case' 0 C--N 1.341 0.219 0 CA-C-N 118.388 0.54 . . . . 0.0 112.447 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 70.0 m -138.88 9.36 2.58 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 123.099 0.56 . . . . 0.0 111.947 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 10.6 m -70.57 104.79 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 -176.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -130.68 10.47 5.14 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.51 0.724 . . . . 0.0 112.019 177.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 55.1 m 65.05 21.73 12.29 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.262 1.025 . . . . 0.0 113.668 -177.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 39.1 t -128.62 142.59 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 123.147 0.579 . . . . 0.0 110.867 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 96.0 mt -132.66 150.06 52.21 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.793 0.437 . . . . 0.0 110.37 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 10.0 tt -106.93 139.51 41.22 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -113.99 139.61 49.1 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -129.44 143.16 50.72 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 176.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.3 mp -119.86 117.73 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 20.5 mt -81.07 -24.35 37.85 Favored 'General case' 0 C--N 1.338 0.096 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -173.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -138.0 79.01 33.79 Favored Pre-proline 0 N--CA 1.455 -0.193 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -176.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -76.93 48.56 2.52 Favored 'Trans proline' 0 N--CA 1.455 -0.769 1 C-N-CA 125.357 4.038 . . . . 0.0 112.017 -177.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.57 -5.39 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 O-C-N 121.963 -0.46 . . . . 0.0 110.513 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -137.92 156.46 47.86 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 175.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 66.8 m -68.9 116.01 8.89 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 110.525 -0.176 . . . . 0.0 110.525 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.2 mm -78.79 142.72 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.16 162.49 31.99 Favored 'General case' 0 C--O 1.231 0.097 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 21.2 p -66.87 -20.38 65.91 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -72.7 -47.64 45.51 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.17 -33.03 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 97.0 mt -72.2 -34.67 68.57 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -70.79 -31.77 68.64 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 174.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 12.5 m -66.59 -33.94 76.78 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 36.7 pt -92.37 -23.59 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 118.497 0.59 . . . . 0.0 111.996 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 98.8 m -89.34 -25.99 21.32 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.489 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 33.7 t30 -63.51 -42.24 71.99 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 73.5 Cg_endo -70.53 -15.43 34.22 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.489 1.46 . . . . 0.0 111.488 177.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 94.0 m -83.12 -15.27 51.38 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 122.236 -0.29 . . . . 0.0 111.357 176.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 151.94 170.79 19.01 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.17 108.01 0.53 Allowed 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.505 2.803 . . . . 0.0 111.423 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 81.9 t -77.5 145.76 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -117.21 -34.33 4.38 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 119.163 -0.446 . . . . 0.0 111.179 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 83.2 mtt85 -151.52 156.1 39.87 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 118.437 0.562 . . . . 0.0 112.0 177.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 25.8 mt -144.7 142.51 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.298 1.039 . . . . 0.0 109.199 174.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 96.6 t -143.36 155.19 16.64 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.102 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 53.9 mt -138.14 141.09 39.1 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 C-N-CA 123.494 0.717 . . . . 0.0 109.455 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.295 5.3 p90 -144.47 155.87 43.92 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 176.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -126.31 15.49 7.76 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.3 0.64 . . . . 0.0 110.58 -173.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -66.18 -31.96 73.12 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -169.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -130.36 8.67 5.08 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 118.455 0.57 . . . . 0.0 112.113 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 160.37 -125.57 1.49 Allowed Glycine 0 C--N 1.336 0.533 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 -174.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 45.8 t -142.74 113.23 2.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -142.35 170.42 15.74 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.467 0.651 . . . . 0.0 111.426 -174.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -149.2 169.01 21.71 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.669 176.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 86.6 mmm -135.55 152.16 51.02 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 42.8 t -141.02 147.56 22.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 122.665 0.386 . . . . 0.0 110.208 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -134.62 135.37 42.1 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.616 0.366 . . . . 0.0 110.215 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -111.78 161.78 15.95 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 -175.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -81.29 -11.9 59.22 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.963 0.505 . . . . 0.0 109.742 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 41.1 t -154.67 153.72 31.78 Favored 'General case' 0 C--O 1.232 0.144 0 O-C-N 121.909 -0.494 . . . . 0.0 111.888 -175.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 55.3 t -67.8 -40.26 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -66.57 -26.22 67.01 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 117.811 0.278 . . . . 0.0 110.948 -178.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 67.6 m -73.78 -33.44 64.25 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 176.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -77.41 -30.86 53.74 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 122.485 -0.135 . . . . 0.0 111.23 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -67.56 -42.47 82.57 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 121.913 -0.492 . . . . 0.0 111.621 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -77.88 -26.61 49.32 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.922 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -70.16 -43.27 71.19 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.207 0.458 . . . . 0.0 109.787 176.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.442 ' HE3' ' HB3' ' A' ' 245' ' ' LYS . 1.2 tmmt? -72.8 -21.94 60.9 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.99 0.516 . . . . 0.0 111.294 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -95.55 -11.35 27.51 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 44.7 t -115.23 -33.39 5.35 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 112.783 0.661 . . . . 0.0 112.783 -177.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 81.4 mt -91.79 -10.68 39.01 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -71.15 135.66 47.73 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 121.999 -0.438 . . . . 0.0 109.888 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 73.49 -3.77 31.11 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 119.63 -0.539 . . . . 0.0 112.847 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -81.03 166.45 20.77 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 118.011 0.906 . . . . 0.0 110.507 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -108.45 140.0 42.39 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 74.2 mt -74.2 -42.59 51.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 174.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.351 51.4 m-85 -82.75 -12.72 57.32 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 117.26 2.318 . . . . 0.0 117.26 178.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 27.6 t 66.06 38.72 4.68 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.676 0.791 . . . . 0.0 110.748 -172.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 174.31 -21.34 0.06 OUTLIER Glycine 0 CA--C 1.529 0.93 0 C-N-CA 123.53 0.586 . . . . 0.0 111.903 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . . . . . . . . . 78.2 m -147.46 -174.08 4.43 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.547 1.139 . . . . 0.0 109.096 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 93.4 m 57.44 43.16 23.48 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.71 0.634 . . . . 0.0 112.71 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -50.47 133.3 24.95 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 177.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 96.0 mt -95.64 152.01 18.83 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.465 0.65 . . . . 0.0 112.167 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -141.03 132.66 27.15 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.345 1.458 . . . . 0.0 107.071 169.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 47.8 mt -140.64 141.15 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 CA-C-O 120.641 0.258 . . . . 0.0 111.316 -172.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -161.75 165.44 28.01 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.271 0.628 . . . . 0.0 109.417 174.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -59.85 138.91 57.68 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 115.586 1.698 . . . . 0.0 115.586 177.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -93.91 160.03 14.92 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -176.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.402 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 58.7 mttm -76.89 -49.7 2.49 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 118.429 -0.796 . . . . 0.0 112.878 -179.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 65.9 Cg_endo -76.32 169.13 22.57 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.718 2.279 . . . . 0.0 111.104 -178.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.282 0.2 OUTLIER -136.46 12.79 3.24 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 117.37 2.359 . . . . 0.0 117.37 -176.904 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.447 ' N ' ' H62' ' B' ' 3' ' ' ' A' . 10.6 tpt180 -159.96 126.03 4.23 Favored 'General case' 0 C--N 1.338 0.096 0 O-C-N 121.677 -0.639 . . . . 0.0 111.805 178.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.422 ' HG ' ' C5 ' ' B' ' 3' ' ' ' A' . 28.5 mt -86.13 159.54 19.5 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 123.463 0.705 . . . . 0.0 110.944 174.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -125.23 47.7 2.13 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.826 0.85 . . . . 0.0 109.817 174.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.403 HG23 ' H ' ' A' ' 272' ' ' VAL . 2.3 t -52.19 142.15 5.14 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -176.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . 0.253 6.1 p90 -120.81 -7.7 9.52 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 117.282 2.327 . . . . 0.0 117.282 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -162.52 168.04 22.5 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 122.689 0.396 . . . . 0.0 111.029 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -119.99 127.01 52.23 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.566 0.746 . . . . 0.0 110.03 176.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 41.0 p30 -161.03 -167.39 1.8 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.245 1.018 . . . . 0.0 109.542 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -70.4 -10.9 60.36 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -176.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -105.6 -29.57 10.05 Favored 'General case' 0 C--N 1.337 0.064 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -141.04 146.46 37.22 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 178.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 19.3 t-105 -156.53 154.15 29.86 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -176.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -132.76 117.58 17.99 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.201 0.6 . . . . 0.0 111.512 175.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.288 68.3 m-85 -83.26 10.41 8.53 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 117.366 2.358 . . . . 0.0 117.366 -171.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 12.9 t -138.83 -23.77 0.93 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -95.21 113.17 60.93 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 173.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -80.69 -14.2 11.51 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.471 2.781 . . . . 0.0 112.29 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -76.03 -15.43 60.13 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -174.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 68.4 mt -85.16 -6.71 59.28 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 118.111 0.414 . . . . 0.0 111.962 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 75.1 m -75.62 144.38 41.77 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 122.182 -0.324 . . . . 0.0 110.74 177.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 75.85 -1.37 58.93 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 119.946 -0.363 . . . . 0.0 112.732 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 43.0 mm-40 -85.23 10.14 13.22 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 117.742 0.771 . . . . 0.0 111.363 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.244 0 CA-C-O 116.981 -2.01 . . . . 0.0 111.929 -177.495 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.834 0 C3'-C2'-C1' 105.078 3.976 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.083 0 C3'-C2'-C1' 98.449 -3.39 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.447 ' H62' ' N ' ' A' ' 269' ' ' ARG . . . . . . . . 0 O4'--C4' 1.42 -2.789 0 O4'-C1'-N19 111.689 3.489 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.763 0 C5'-C4'-C3' 110.304 -3.464 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.406 ' N3 ' " H2'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.93 0 C3'-C2'-C1' 104.913 3.792 OUTLIER-DELTA 0.01 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.643 0 O4'-C1'-N19 112.014 3.814 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 . . . . . 0 N--CA 1.477 0.882 0 CA-C-O 120.49 0.186 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 63.2 mmtt -68.24 168.07 13.06 Favored 'General case' 0 N--CA 1.457 -0.085 0 CA-C-O 121.179 0.514 . . . . 0.0 112.232 178.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.403 HG23 ' H ' ' A' ' 176' ' ' ILE . 3.1 pt -65.47 -17.8 22.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.46 0.704 . . . . 0.0 110.527 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 70.0 m -83.08 11.44 6.34 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 123.449 0.7 . . . . 0.0 112.554 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.82 148.01 83.73 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 122.87 0.468 . . . . 0.0 111.023 178.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -77.33 -4.13 14.4 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 124.08 3.187 . . . . 0.0 112.641 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -59.41 141.47 47.37 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 172.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 21.6 t0 62.43 21.02 12.31 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 30.2 t -68.58 146.39 53.1 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 121.385 -0.822 . . . . 0.0 109.8 175.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 13.9 p30 -70.64 -9.06 56.14 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -77.6 2.37 16.77 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 96.7 p -148.99 5.71 0.67 Allowed 'General case' 0 C--O 1.232 0.161 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -176.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -145.87 9.31 1.15 Allowed 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 64.2 p -155.12 17.88 0.42 Allowed 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 178.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.1 m -71.64 109.32 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -130.56 10.35 5.18 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.37 0.668 . . . . 0.0 112.267 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.1 m 65.49 21.16 11.79 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -176.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 30.7 t -130.76 134.3 62.09 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.092 0 C-N-CA 122.858 0.463 . . . . 0.0 111.103 177.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.421 HD21 ' HB1' ' A' ' 241' ' ' ALA . 2.7 mm? -122.94 154.2 38.69 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.098 0.559 . . . . 0.0 110.779 -176.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 39.0 tp -104.01 136.26 43.98 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 170.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -113.86 107.92 16.36 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.71 1.204 . . . . 0.0 114.122 177.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.99 141.01 29.02 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 174.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.4 mp -110.56 126.83 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -90.43 -23.67 20.96 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -173.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -140.34 78.98 21.81 Favored Pre-proline 0 CA--C 1.53 0.188 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -76.74 49.89 2.86 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 124.804 3.669 . . . . 0.0 112.113 -178.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.402 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -68.87 -5.86 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 O-C-N 121.749 -0.595 . . . . 0.0 110.251 178.241 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -142.1 154.58 45.02 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.2 1.4 . . . . 0.0 112.538 175.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.3 t -73.38 129.93 39.07 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.291 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 23.0 mm -79.16 148.4 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 123.073 0.549 . . . . 0.0 109.993 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.02 156.38 48.32 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.4 p -64.1 -17.3 63.29 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 177.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -76.52 -46.25 27.32 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.79 0.329 . . . . 0.0 111.812 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.6 m -71.29 -31.6 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.059 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.31 -36.95 74.64 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 176.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -70.83 -30.48 66.91 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 175.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 12.5 m -66.78 -33.4 75.55 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 41.1 pt -93.85 -21.59 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 118.399 0.545 . . . . 0.0 112.13 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 97.4 m -91.54 -25.73 19.1 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.502 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 35.4 t30 -64.65 -39.19 37.78 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 74.3 Cg_endo -69.94 -13.04 33.7 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 CA-C-N 121.023 1.401 . . . . 0.0 111.575 177.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 95.9 m -91.95 -5.41 53.16 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.669 0.388 . . . . 0.0 111.663 177.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 146.74 166.83 12.51 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 178.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.18 103.77 1.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.635 2.89 . . . . 0.0 110.657 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 75.6 t -70.37 146.28 12.29 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -114.34 -37.14 4.44 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 119.212 -0.423 . . . . 0.0 111.765 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -150.21 151.64 33.36 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 20.7 mt -147.87 136.96 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 C-N-CA 124.055 0.942 . . . . 0.0 109.975 177.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 6.1 m -142.61 159.43 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 123.729 0.812 . . . . 0.0 110.313 173.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 41.3 mt -132.68 143.61 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 123.018 0.527 . . . . 0.0 110.375 -175.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.316 3.8 p90 -140.32 154.65 46.86 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 115.718 1.748 . . . . 0.0 115.718 176.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -126.59 16.79 7.56 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.309 0.643 . . . . 0.0 110.06 -174.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -64.43 -31.91 73.31 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -169.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -130.46 8.62 5.03 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 118.346 0.521 . . . . 0.0 112.096 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 157.62 -124.12 1.37 Allowed Glycine 0 C--N 1.334 0.444 0 N-CA-C 108.336 -1.905 . . . . 0.0 108.336 -173.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 24.9 t -142.15 114.65 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-N 116.846 0.323 . . . . 0.0 110.18 176.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 8.4 mp0 -143.45 166.69 24.09 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.119 0.485 . . . . 0.0 110.671 -177.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.41 163.7 35.65 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.725 0.81 . . . . 0.0 109.788 176.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 56.0 mmm -130.76 151.31 51.34 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 41.4 t -140.74 144.26 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.067 0 C-N-CA 122.945 0.498 . . . . 0.0 110.399 -178.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -130.5 133.21 46.09 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.83 0.452 . . . . 0.0 110.64 178.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -104.21 163.21 12.57 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 116.334 1.975 . . . . 0.0 116.334 -177.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -78.92 -14.51 59.18 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 85.2 p -154.71 157.64 38.38 Favored 'General case' 0 N--CA 1.457 -0.081 0 O-C-N 121.744 -0.598 . . . . 0.0 111.262 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 53.4 t -67.76 -32.33 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -66.84 -34.83 78.68 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 121.878 -0.514 . . . . 0.0 110.733 -177.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 69.1 m -72.56 -31.05 64.95 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 176.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.421 ' HB1' HD21 ' A' ' 192' ' ' LEU . . . -74.08 -31.51 62.85 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 122.577 0.351 . . . . 0.0 111.441 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -71.79 -46.99 56.47 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 117.944 0.338 . . . . 0.0 111.788 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -73.19 -26.3 61.11 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 118.04 0.382 . . . . 0.0 111.345 -177.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -71.11 -41.4 70.64 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.92 -23.63 55.5 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.482 0.313 . . . . 0.0 110.998 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -91.32 -10.01 42.89 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 40.0 t -118.7 -35.08 3.79 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -177.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 66.0 mt -87.94 -7.27 57.36 Favored 'General case' 0 N--CA 1.457 -0.076 0 CA-C-N 118.118 0.417 . . . . 0.0 111.862 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -70.01 136.36 50.33 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 74.65 -4.98 32.68 Favored Glycine 0 CA--C 1.533 1.201 0 CA-C-O 119.769 -0.462 . . . . 0.0 112.431 -178.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -76.72 166.32 23.52 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 117.848 0.824 . . . . 0.0 110.302 177.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -123.6 140.47 52.97 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 67.4 mt -75.04 -42.5 45.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-O 120.92 0.391 . . . . 0.0 110.012 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.365 53.5 m-85 -82.66 -11.4 58.39 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 117.084 2.253 . . . . 0.0 117.084 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 30.7 t 65.99 35.1 6.61 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.664 0.786 . . . . 0.0 111.313 -175.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 176.52 -23.58 0.05 OUTLIER Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 178.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . 0.402 ' HB3' HD12 ' A' ' 200' ' ' ILE . 81.6 m -145.93 -176.63 5.22 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.61 1.164 . . . . 0.0 108.876 178.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 87.5 m 57.84 38.71 27.24 Favored 'General case' 0 CA--C 1.527 0.087 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -176.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.96 141.56 21.8 Favored 'General case' 0 C--O 1.23 0.067 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 174.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 95.9 mt -102.09 158.24 16.3 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.49 0.662 . . . . 0.0 112.27 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -139.29 137.18 35.63 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 169.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 19.6 mt -138.23 139.51 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-O 121.089 0.471 . . . . 0.0 111.62 -173.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -159.48 161.9 35.48 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.242 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.262 41.0 m-85 -60.97 135.92 57.93 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 177.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . 0.426 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -92.6 155.89 17.46 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.525 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.433 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 22.9 pttp -88.49 -29.93 0.37 Allowed Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 117.216 -1.373 . . . . 0.0 114.611 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 48.9 Cg_endo -79.87 165.12 22.37 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 CA-C-N 122.063 1.773 . . . . 0.0 110.093 176.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.279 0.2 OUTLIER -138.03 8.86 2.76 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 118.19 2.663 . . . . 0.0 118.19 -174.628 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.71 127.05 6.52 Favored 'General case' 0 C--N 1.338 0.073 0 O-C-N 121.408 -0.807 . . . . 0.0 111.858 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.421 ' HG ' ' C5 ' ' B' ' 3' ' ' ' A' . 24.6 mt -92.04 156.45 17.39 Favored 'General case' 0 C--N 1.337 0.052 0 C-N-CA 123.772 0.829 . . . . 0.0 111.107 176.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.464 ' C ' ' H61' ' B' ' 5' ' ' ' A' . 57.2 m-80 -117.31 53.42 0.92 Allowed 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.517 0.727 . . . . 0.0 109.594 172.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.41 ' H ' HG23 ' A' ' 272' ' ' VAL . 2.4 t -53.04 145.35 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -176.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -130.12 -7.31 4.36 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 117.637 2.458 . . . . 0.0 117.637 -177.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -161.9 173.72 14.12 Favored 'General case' 0 N--CA 1.458 -0.07 0 C-N-CA 122.739 0.416 . . . . 0.0 110.281 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.496 ' H ' ' NE2' ' A' ' 290' ' ' GLN . 99.4 m-20 -125.69 117.75 24.15 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.025 0.93 . . . . 0.0 110.006 175.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 46.6 p30 -159.54 -166.22 1.73 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.979 0.912 . . . . 0.0 108.922 177.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -70.11 -9.62 56.12 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -174.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -115.98 -17.46 10.93 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.72 140.87 33.25 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.799 0.84 . . . . 0.0 112.966 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 19.4 t-105 -160.78 156.71 25.66 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 119.764 -0.774 . . . . 0.0 110.4 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -138.03 116.55 12.06 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.469 0.708 . . . . 0.0 110.977 174.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.284 66.7 m-85 -81.31 8.94 7.92 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 117.318 2.34 . . . . 0.0 117.318 -172.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 7.1 t -137.99 -20.39 1.12 Allowed 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -95.12 113.28 61.09 Favored Pre-proline 0 CA--C 1.531 0.235 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 174.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -81.08 -13.26 11.47 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.485 2.79 . . . . 0.0 112.318 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -72.65 -19.45 61.44 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -174.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 54.3 mt -82.82 -6.7 59.55 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.927 -0.483 . . . . 0.0 111.569 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 73.9 m -87.71 5.74 38.36 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 122.951 0.501 . . . . 0.0 111.373 176.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -76.27 13.3 7.9 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 123.853 0.739 . . . . 0.0 112.736 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . 0.496 ' NE2' ' H ' ' A' ' 275' ' ' ASN . 4.3 pp0? -143.55 163.38 33.34 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.676 0.79 . . . . 0.0 110.537 -177.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.166 0 CA-C-O 117.294 -1.837 . . . . 0.0 110.84 -179.616 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.078 0 C3'-C2'-C1' 104.079 2.866 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.426 ' N3 ' ' HA ' ' A' ' 265' ' ' ALA . . . . . . . . 0 O4'--C4' 1.42 -2.752 0 C3'-C2'-C1' 98.356 -3.493 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.421 ' C5 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.42 -2.758 0 C5'-C4'-C3' 110.444 -3.371 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.873 0 C5'-C4'-C3' 109.893 -3.738 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.464 ' H61' ' C ' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.419 -2.81 1 C3'-C2'-C1' 105.337 4.264 OUTLIER-DELTA 0.013 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.731 0 O4'-C1'-N19 112.053 3.853 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.09 5.12 4.62 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -177.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 18.2 tt -153.94 154.36 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 C-N-CA 123.372 0.669 . . . . 0.0 109.459 178.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 93.4 p -155.85 170.43 22.11 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 122.744 0.418 . . . . 0.0 110.517 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 5.6 ppt_? -149.33 160.79 33.84 Favored Pre-proline 0 CA--C 1.531 0.24 0 C-N-CA 123.286 0.635 . . . . 0.0 109.966 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -58.54 154.21 43.68 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 124.04 3.16 . . . . 0.0 113.351 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -80.53 -4.27 90.11 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -74.66 -13.17 60.6 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.652 0.781 . . . . 0.0 109.855 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 73.3 m -67.25 148.25 51.97 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 121.72 -0.612 . . . . 0.0 109.72 175.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 16.2 p30 -60.68 -16.5 39.99 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 -175.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -72.52 -1.16 14.85 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 176.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 74.5 m -141.42 3.66 1.73 Allowed 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 113.612 0.968 . . . . 0.0 113.612 -177.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? -146.96 6.83 0.9 Allowed 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 56.2 m -147.07 12.38 1.08 Allowed 'General case' 0 CA--C 1.527 0.087 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 178.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 1.6 m -70.21 103.54 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -130.46 10.41 5.23 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.772 0.829 . . . . 0.0 111.822 177.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 55.9 m 64.81 21.34 12.34 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -176.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 28.3 t -130.02 134.07 63.43 Favored 'Isoleucine or valine' 0 C--N 1.339 0.115 0 CA-C-N 118.194 0.452 . . . . 0.0 111.089 177.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.422 ' N ' HD22 ' A' ' 192' ' ' LEU . 2.4 mm? -121.14 153.59 37.3 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.053 0.541 . . . . 0.0 110.831 -177.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 25.0 tp -106.11 132.68 51.89 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 171.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -107.86 133.94 51.5 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.633 1.173 . . . . 0.0 114.141 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.29 133.27 55.5 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 174.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 3.8 mp -104.52 117.06 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -88.35 -18.04 29.29 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.165 -171.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -141.48 79.02 17.72 Favored Pre-proline 0 CA--C 1.529 0.138 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.9 44.25 1.53 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 125.2 3.933 . . . . 0.0 112.542 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.465 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -70.05 -4.76 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 121.693 -0.629 . . . . 0.0 110.523 179.453 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -138.47 158.33 44.47 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 177.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 45.2 t -70.83 117.87 12.9 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.0 mm -78.38 144.41 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.08 159.11 41.82 Favored 'General case' 0 N--CA 1.458 -0.064 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 43.3 p -66.87 -19.72 65.79 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -75.88 -47.24 26.23 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.7 m -70.29 -32.69 51.4 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.0 mt -70.94 -33.99 71.03 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 176.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -73.19 -29.11 62.59 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 174.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 7.2 m -67.99 -33.18 74.13 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 41.4 pt -91.68 -24.07 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 118.225 0.466 . . . . 0.0 111.785 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 94.6 m -89.0 -24.53 22.36 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.478 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 27.1 t30 -63.57 -42.37 72.43 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 73.7 Cg_endo -69.31 -16.42 39.45 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 CA-C-N 120.873 1.347 . . . . 0.0 111.192 177.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 80.5 m -84.01 -14.62 50.23 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 122.175 -0.328 . . . . 0.0 111.337 177.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 153.2 172.92 21.94 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.8 101.5 0.92 Allowed 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 124.007 3.138 . . . . 0.0 110.45 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 75.8 t -71.21 147.52 11.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -118.74 -35.98 3.57 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 119.178 -0.439 . . . . 0.0 111.721 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 25.8 mtm180 -150.37 151.72 33.28 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.693 0.679 . . . . 0.0 112.767 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 25.1 mt -148.74 137.92 15.59 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 124.132 0.973 . . . . 0.0 110.109 177.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 7.2 m -143.44 161.31 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 C-N-CA 124.127 0.971 . . . . 0.0 109.983 173.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 52.6 mt -131.36 143.27 41.11 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 C-N-CA 122.793 0.437 . . . . 0.0 110.737 -175.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.262 5.1 p90 -146.72 158.96 44.02 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 175.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -138.53 30.22 2.36 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.115 0.566 . . . . 0.0 111.82 -177.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -66.17 -30.11 70.52 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.323 0.861 . . . . 0.0 113.323 -174.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -130.55 1.24 4.49 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 171.85 -128.51 1.59 Allowed Glycine 0 CA--C 1.522 0.473 0 N-CA-C 108.65 -1.78 . . . . 0.0 108.65 -174.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 17.3 t -138.51 115.11 10.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 117.44 0.62 . . . . 0.0 110.351 174.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 9.4 mp0 -143.64 169.78 17.08 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.552 0.692 . . . . 0.0 111.924 -172.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -152.82 168.52 25.47 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.083 0.953 . . . . 0.0 108.818 175.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 68.9 mmm -134.34 151.5 51.27 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.767 -0.456 . . . . 0.0 109.767 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 40.3 t -141.62 144.5 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 C-N-CA 123.0 0.52 . . . . 0.0 110.433 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -131.92 136.28 47.27 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.616 0.366 . . . . 0.0 110.775 178.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -108.67 162.65 13.96 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 -177.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -83.98 -6.54 59.44 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 29.2 t -153.66 149.54 27.65 Favored 'General case' 0 N--CA 1.456 -0.13 0 O-C-N 121.954 -0.466 . . . . 0.0 111.785 -176.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 55.2 t -68.75 -35.69 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -68.16 -28.29 67.16 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.06 -0.4 . . . . 0.0 110.775 -178.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 61.4 m -74.88 -31.2 61.53 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 176.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.418 ' HB1' HD21 ' A' ' 192' ' ' LEU . . . -75.46 -33.53 60.85 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 122.411 0.284 . . . . 0.0 111.083 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -69.59 -43.94 71.78 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 117.904 0.32 . . . . 0.0 111.538 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -75.27 -25.17 57.77 Favored 'General case' 0 N--CA 1.457 -0.084 0 CA-C-N 117.815 0.28 . . . . 0.0 110.866 -177.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -71.48 -42.49 68.03 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 176.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.428 ' HE3' ' HB3' ' A' ' 245' ' ' LYS . 1.0 OUTLIER -75.4 -20.49 58.89 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.739 0.416 . . . . 0.0 111.262 -179.669 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -94.87 -12.07 27.61 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 45.1 t -113.58 -34.96 5.37 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 68.6 mt -89.95 -6.84 55.26 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 118.176 0.444 . . . . 0.0 111.963 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -71.9 131.96 43.7 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 177.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.59 -4.08 52.35 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.744 -0.476 . . . . 0.0 112.171 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.61 166.45 21.86 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 117.818 0.809 . . . . 0.0 110.303 178.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -123.33 139.9 53.57 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 84.8 mt -74.7 -41.36 47.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 N-CA-C 109.668 -0.494 . . . . 0.0 109.668 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.363 44.1 m-85 -82.8 -12.02 57.81 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 117.316 2.339 . . . . 0.0 117.316 178.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.7 t 66.31 34.66 6.31 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.627 0.727 . . . . 0.0 110.685 -174.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 175.97 -23.65 0.06 OUTLIER Glycine 0 CA--C 1.529 0.96 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . 0.465 ' HB3' HD12 ' A' ' 200' ' ' ILE . 77.2 m -146.63 -177.15 5.49 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.711 1.204 . . . . 0.0 109.536 178.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 91.4 m 57.85 37.55 26.99 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -176.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.88 148.2 13.71 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 175.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 74.2 mt -115.98 156.04 26.96 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -172.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -138.57 140.15 38.92 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.398 1.479 . . . . 0.0 107.482 169.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 37.4 mt -141.79 141.49 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 CA-C-O 120.976 0.417 . . . . 0.0 111.72 -172.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 6.9 pm0 -156.59 164.21 38.45 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 174.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.273 41.2 m-85 -61.46 137.67 58.25 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 177.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . 0.447 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -91.51 156.79 17.43 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.663 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.445 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 63.9 pttt -88.56 -31.57 0.39 Allowed Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 48.7 Cg_endo -79.65 167.73 20.38 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.006 1.804 . . . . 0.0 110.172 176.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.278 0.2 OUTLIER -137.25 8.45 2.92 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -175.829 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.66 128.46 7.24 Favored 'General case' 0 C--O 1.227 -0.12 0 O-C-N 121.416 -0.803 . . . . 0.0 111.942 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.408 ' HG ' ' C5 ' ' B' ' 3' ' ' ' A' . 20.1 mt -92.33 157.28 16.72 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 123.893 0.877 . . . . 0.0 110.722 176.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.464 ' C ' ' H61' ' B' ' 5' ' ' ' A' . 55.6 m-80 -117.34 54.52 0.88 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.704 0.802 . . . . 0.0 109.473 173.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.4 t -55.76 147.38 4.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -176.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -132.61 -2.94 3.35 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 116.934 2.198 . . . . 0.0 116.934 -176.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -161.89 160.85 28.48 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.316 0.246 . . . . 0.0 110.812 -174.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -123.18 111.02 16.0 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.606 0.762 . . . . 0.0 109.564 173.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 56.6 p30 -157.81 -169.98 3.03 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.334 1.054 . . . . 0.0 108.372 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -68.59 -10.8 58.16 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -174.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -111.58 -22.27 11.32 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.1 p -142.58 138.92 31.13 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.686 1.195 . . . . 0.0 112.295 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 21.0 t-105 -158.44 155.55 28.78 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 119.724 -0.791 . . . . 0.0 110.932 -177.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -135.39 116.49 14.34 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.725 0.81 . . . . 0.0 111.108 173.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.292 66.1 m-85 -79.99 9.17 5.74 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 117.524 2.416 . . . . 0.0 117.524 -172.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 8.9 t -139.72 -20.68 0.91 Allowed 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -95.36 113.14 61.0 Favored Pre-proline 0 CA--C 1.532 0.264 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 174.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -82.04 -14.46 9.73 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.504 2.803 . . . . 0.0 112.462 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -72.26 -18.52 61.81 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -174.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 63.8 mt -84.38 -6.65 59.41 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.229 0.468 . . . . 0.0 111.904 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 73.0 m -76.84 -13.06 60.04 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 111.971 0.359 . . . . 0.0 111.971 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -84.41 -10.4 79.95 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -88.07 161.5 17.3 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.095 0.558 . . . . 0.0 110.959 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.133 0 CA-C-O 117.429 -1.762 . . . . 0.0 111.104 179.794 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . 0.406 ' C8 ' H5'' ' B' ' 1' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -3.022 0 C5'-C4'-C3' 110.508 -3.328 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.447 ' N3 ' ' HA ' ' A' ' 265' ' ' ALA . . . . . . . . 0 O4'--C4' 1.422 -2.613 0 C3'-C2'-C1' 98.367 -3.482 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.408 ' C5 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.421 -2.665 2 C5'-C4'-C3' 108.823 -4.452 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.735 0 C5'-C4'-C3' 109.523 -3.985 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.464 ' H61' ' C ' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.416 -3.065 1 C3'-C2'-C1' 105.299 4.221 OUTLIER-DELTA 0.044 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.62 0 O4'-C1'-N19 111.68 3.48 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 110.704 -0.11 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? 61.48 154.48 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.113 1.365 . . . . 0.0 112.517 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 84.6 mt -70.68 147.34 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 122.948 0.499 . . . . 0.0 110.239 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 97.6 p -153.5 162.75 40.96 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 122.951 0.5 . . . . 0.0 110.143 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.407 ' N ' ' CD ' ' A' ' 179' ' ' PRO . 78.4 mtt85 -72.53 -38.35 5.11 Favored Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -177.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 178' ' ' ARG . 50.4 Cg_exo -57.78 145.55 89.8 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.624 2.216 . . . . 0.0 112.333 177.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 73.9 -3.0 38.98 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.405 -0.664 . . . . 0.0 113.491 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -81.55 -11.81 59.02 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.295 1.048 . . . . 0.0 109.566 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 71.0 m -67.36 149.35 50.43 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 121.955 -0.466 . . . . 0.0 110.184 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 27.3 p-10 -61.31 -23.1 65.47 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -175.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -81.55 8.26 10.07 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 70.7 m -137.44 -1.2 2.11 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -148.93 8.43 0.75 Allowed 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 57.8 m -145.74 17.39 1.45 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 122.981 0.512 . . . . 0.0 111.886 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.7 m -69.96 105.88 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 -178.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -130.44 10.48 5.25 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.757 0.823 . . . . 0.0 112.324 177.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 70.1 m 64.18 21.09 12.44 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 -176.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 39.8 t -130.54 132.77 64.36 Favored 'Isoleucine or valine' 0 C--N 1.338 0.091 0 CA-C-N 118.215 0.461 . . . . 0.0 111.17 177.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 8.1 mp -122.07 149.88 42.93 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 123.949 0.899 . . . . 0.0 110.563 -174.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 27.0 tp -102.56 135.8 43.53 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 170.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -115.93 104.18 11.35 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.102 1.361 . . . . 0.0 114.071 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.87 133.19 34.88 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 175.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.5 mp -102.76 124.23 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -90.49 -19.26 24.04 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -173.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -141.96 78.87 16.96 Favored Pre-proline 0 CA--C 1.53 0.178 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -77.34 45.73 1.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.764 1 C-N-CA 125.444 4.096 . . . . 0.0 112.275 -177.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.42 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -69.76 -4.09 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 O-C-N 121.818 -0.552 . . . . 0.0 110.508 179.363 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -137.39 156.55 48.07 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 175.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 66.4 m -69.11 112.95 6.05 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.3 mm -78.36 141.77 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.02 161.34 35.09 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.4 p -64.03 -17.67 63.58 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -75.07 -46.75 32.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.712 0.291 . . . . 0.0 111.572 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 1.6 m -70.1 -32.12 49.99 Favored 'Isoleucine or valine' 0 C--N 1.338 0.107 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.69 -34.93 70.06 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 176.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -71.08 -29.66 65.59 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 174.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 10.1 m -68.29 -34.19 75.71 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 42.0 pt -91.41 -22.98 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 118.41 0.55 . . . . 0.0 111.907 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 97.4 m -90.1 -23.6 21.34 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.474 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 26.6 t30 -63.88 -43.24 75.15 Favored Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 73.9 Cg_endo -69.51 -14.45 36.9 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.416 1.41 . . . . 0.0 111.32 177.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 96.8 m -85.43 -16.12 40.75 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 118.011 0.369 . . . . 0.0 111.48 176.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 154.75 171.71 21.81 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.613 -0.595 . . . . 0.0 111.613 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.27 98.86 0.66 Allowed 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.744 2.962 . . . . 0.0 110.633 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 63.9 t -69.45 145.91 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -115.12 -37.85 4.0 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 119.365 -0.35 . . . . 0.0 111.233 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 63.4 mtm-85 -147.66 152.34 37.69 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 25.5 mt -148.0 137.7 16.37 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 C-N-CA 124.144 0.978 . . . . 0.0 109.706 176.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 12.8 m -143.95 161.65 15.71 Favored 'Isoleucine or valine' 0 C--N 1.338 0.082 0 C-N-CA 123.553 0.741 . . . . 0.0 110.115 174.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 35.8 mt -135.67 141.91 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 C-N-CA 122.824 0.45 . . . . 0.0 110.628 -175.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.316 4.1 p90 -138.15 156.84 47.34 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 176.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -128.5 15.59 6.55 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.425 0.69 . . . . 0.0 110.522 -173.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -63.58 -31.92 73.23 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -169.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -130.65 6.47 4.75 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 118.686 0.675 . . . . 0.0 112.494 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 163.02 -124.82 1.32 Allowed Glycine 0 CA--C 1.521 0.419 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 -174.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 45.5 t -141.97 114.93 4.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -142.45 166.07 25.68 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.904 0.383 . . . . 0.0 110.578 -177.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.15 164.88 30.82 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.583 0.753 . . . . 0.0 109.416 175.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 62.9 mmm -133.06 153.21 51.71 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 39.1 t -139.79 145.5 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 C-N-CA 122.838 0.455 . . . . 0.0 110.409 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -130.22 133.08 46.3 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.918 0.487 . . . . 0.0 110.529 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -108.02 161.35 15.03 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -82.92 -8.18 59.59 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 29.2 t -155.01 149.49 26.31 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 121.916 -0.49 . . . . 0.0 111.554 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 51.1 t -67.76 -35.9 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -68.14 -28.57 67.42 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.112 0.415 . . . . 0.0 111.137 -177.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 58.3 m -74.32 -32.34 62.8 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 176.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.71 -29.73 56.38 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.621 0.369 . . . . 0.0 110.934 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -69.98 -44.07 70.2 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.147 -0.345 . . . . 0.0 111.439 178.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -75.39 -25.09 57.33 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.878 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -70.97 -39.35 72.56 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.127 0.422 . . . . 0.0 110.255 176.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.08 -25.59 58.69 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 122.639 0.376 . . . . 0.0 110.298 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -91.2 -10.29 42.23 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 46.1 t -117.04 -36.48 3.8 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -176.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 78.7 mt -88.36 -8.29 55.31 Favored 'General case' 0 C--N 1.338 0.108 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -71.47 133.36 45.81 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.54 -5.28 46.28 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 119.681 -0.511 . . . . 0.0 112.298 -178.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.67 166.45 22.5 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 117.833 0.817 . . . . 0.0 110.253 177.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -123.65 139.84 53.6 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 87.0 mt -74.92 -41.53 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.373 42.7 m-85 -82.88 -11.81 57.9 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 117.151 2.278 . . . . 0.0 117.151 178.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 29.9 t 65.25 35.52 7.64 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.385 0.674 . . . . 0.0 110.74 -174.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 175.56 -23.98 0.06 OUTLIER Glycine 0 CA--C 1.53 1.028 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . 0.42 ' HB3' HD12 ' A' ' 200' ' ' ILE . 72.0 m -145.32 -176.87 5.28 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.686 1.195 . . . . 0.0 109.199 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 84.3 m 57.74 36.93 27.04 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -176.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.35 149.55 9.96 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 114.471 1.285 . . . . 0.0 114.471 175.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 79.0 mt -116.87 154.35 30.92 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -172.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -137.0 137.65 39.66 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.276 1.43 . . . . 0.0 107.414 169.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 56.7 mt -139.57 142.78 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 CA-C-O 120.566 0.222 . . . . 0.0 111.578 -170.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -160.63 162.88 32.86 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.295 0.638 . . . . 0.0 109.622 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.264 50.8 m-85 -59.43 139.75 56.8 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 176.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . 0.476 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -88.32 165.3 15.08 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -176.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.403 ' HB2' ' HD3' ' A' ' 267' ' ' PRO . 78.2 mttt -79.21 -51.55 1.26 Allowed Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 118.445 -0.788 . . . . 0.0 112.065 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' A' ' 266' ' ' LYS . 68.3 Cg_endo -76.27 175.16 11.7 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.859 2.373 . . . . 0.0 111.303 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.45 -3.54 3.01 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -176.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -158.28 130.22 6.83 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 118.92 0.782 . . . . 0.0 112.564 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.453 ' HG ' ' C5 ' ' B' ' 3' ' ' ' A' . 23.7 mt -84.57 164.46 18.7 Favored 'General case' 0 N--CA 1.458 -0.055 0 C-N-CA 124.378 1.071 . . . . 0.0 111.651 176.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.419 ' C ' ' H61' ' B' ' 5' ' ' ' A' . 53.9 m-80 -120.77 54.06 1.09 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.386 170.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.416 HG23 ' H ' ' A' ' 272' ' ' VAL . 2.7 t -53.0 147.44 2.07 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -175.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -138.07 -1.35 1.97 Allowed 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 116.92 2.193 . . . . 0.0 116.92 -176.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -159.11 161.57 36.38 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -172.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -125.6 108.35 11.49 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.199 0.999 . . . . 0.0 109.681 174.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -158.31 -166.17 1.87 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 177.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -68.64 -9.97 53.2 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -174.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -117.42 -17.32 10.1 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.16 141.85 34.09 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.772 0.829 . . . . 0.0 113.016 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 17.8 t-105 -163.63 156.63 18.43 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 118.554 0.615 . . . . 0.0 110.445 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -142.11 120.44 12.33 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.305 172.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -81.95 5.59 18.63 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 117.192 2.293 . . . . 0.0 117.192 -173.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 3.6 t -141.18 -11.83 0.95 Allowed 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -178.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -95.37 113.34 61.44 Favored Pre-proline 0 CA--C 1.534 0.365 0 O-C-N 121.951 -0.468 . . . . 0.0 110.097 177.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -82.28 -13.72 9.83 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.649 2.899 . . . . 0.0 112.566 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -73.54 -7.18 50.82 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -173.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 46.3 mt -79.92 0.26 32.1 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 122.026 -0.421 . . . . 0.0 112.077 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 99.5 p -71.4 -3.31 20.15 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 122.834 0.453 . . . . 0.0 111.822 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -73.79 -9.52 79.23 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 119.869 -0.406 . . . . 0.0 112.342 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 43.2 mm-40 -72.17 161.63 30.6 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 117.87 0.835 . . . . 0.0 111.506 177.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.205 0 CA-C-O 117.38 -1.789 . . . . 0.0 110.814 179.928 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.009 0 C3'-C2'-C1' 104.435 3.261 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.476 ' N3 ' ' HA ' ' A' ' 265' ' ' ALA . . . . . . . . 0 O4'--C4' 1.418 -2.927 0 C3'-C2'-C1' 98.21 -3.656 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.453 ' C5 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.419 -2.804 0 O4'-C1'-N19 112.056 3.856 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.76 0 C5'-C4'-C3' 109.765 -3.823 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.419 ' H61' ' C ' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.417 -2.994 1 C3'-C2'-C1' 105.194 4.104 OUTLIER-DELTA 0.038 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.517 1 O4'-C1'-N19 112.318 4.118 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 . . . . . 0 N--CA 1.477 0.91 0 N-CA-C 110.858 -0.052 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -153.79 148.42 26.29 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 1.2 mt 54.62 22.02 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.652 0.781 . . . . 0.0 111.304 -173.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 68.5 m -70.71 156.73 39.12 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 122.028 -0.42 . . . . 0.0 110.837 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -141.36 151.71 61.97 Favored Pre-proline 0 CA--C 1.528 0.123 0 C-N-CA 123.567 0.747 . . . . 0.0 110.032 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -70.92 -13.25 31.64 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.562 2.841 . . . . 0.0 111.642 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -71.0 -1.41 40.28 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 123.302 0.477 . . . . 0.0 112.489 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -68.83 -20.28 64.3 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 117.601 0.701 . . . . 0.0 111.526 -178.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 34.2 t -157.95 151.17 23.2 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.302 0.641 . . . . 0.0 109.95 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.5 p30 -75.42 -7.22 53.49 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -71.83 0.88 7.96 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 99.2 p -146.82 7.49 0.94 Allowed 'General case' 0 C--O 1.231 0.131 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -177.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 4.5 ppt_? -146.42 5.09 0.93 Allowed 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 65.9 m -148.21 13.01 0.97 Allowed 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.407 ' H ' HG22 ' A' ' 188' ' ' VAL . 2.4 m -70.75 104.63 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -177.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 49.8 p30 -130.77 10.54 5.11 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.718 0.807 . . . . 0.0 112.237 177.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 57.8 m 66.24 19.58 11.06 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -177.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 37.2 t -128.4 143.55 40.67 Favored 'Isoleucine or valine' 0 C--N 1.339 0.116 0 C-N-CA 123.167 0.587 . . . . 0.0 110.79 178.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 82.6 mt -135.61 149.0 49.24 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.868 0.467 . . . . 0.0 111.104 -175.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 39.2 tp -101.11 135.45 42.54 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 172.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -113.57 101.37 9.27 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 125.148 1.379 . . . . 0.0 114.6 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.2 m -86.8 133.84 33.61 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 175.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.0 mp -103.94 126.0 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -94.06 -18.42 21.84 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -172.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -141.24 78.99 18.22 Favored Pre-proline 0 CA--C 1.529 0.164 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -77.41 49.03 2.74 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 125.003 3.802 . . . . 0.0 112.278 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.45 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -69.23 -6.78 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 O-C-N 121.787 -0.571 . . . . 0.0 110.224 178.163 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -141.73 154.68 45.45 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.158 1.383 . . . . 0.0 112.394 175.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.4 t -74.15 131.46 41.3 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.157 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 21.9 mm -81.14 148.37 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 122.923 0.489 . . . . 0.0 109.913 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.89 157.89 44.83 Favored 'General case' 0 C--O 1.231 0.079 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 177.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.3 p -63.88 -18.75 64.49 Favored 'General case' 0 N--CA 1.458 -0.057 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -73.4 -47.3 43.05 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.717 0.294 . . . . 0.0 111.544 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.5 m -71.06 -32.31 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.16 -36.61 72.09 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 176.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -70.82 -30.14 66.49 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 175.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 8.9 m -67.59 -33.76 75.66 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 38.6 pt -92.38 -24.31 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 118.585 0.63 . . . . 0.0 111.77 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 95.6 m -88.49 -26.39 22.08 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.478 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 35.1 t30 -64.71 -42.53 64.86 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 71.9 Cg_endo -70.29 -12.74 32.42 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.493 1.462 . . . . 0.0 111.262 177.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 96.4 m -90.43 -9.23 48.29 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.031 0.378 . . . . 0.0 111.665 176.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 151.41 167.72 15.16 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 178.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.26 103.03 1.01 Allowed 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.903 3.069 . . . . 0.0 110.584 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 71.9 t -70.67 145.25 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -113.74 -39.27 4.05 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 119.205 -0.426 . . . . 0.0 111.28 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -149.15 152.8 36.72 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.267 0.485 . . . . 0.0 112.046 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 23.6 mt -147.28 135.72 15.34 Favored 'Isoleucine or valine' 0 C--N 1.338 0.073 0 C-N-CA 124.025 0.93 . . . . 0.0 109.912 177.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 1.6 m -140.38 160.61 25.16 Favored 'Isoleucine or valine' 0 C--N 1.337 0.062 0 C-N-CA 123.55 0.74 . . . . 0.0 111.715 174.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 53.7 mt -135.82 144.02 34.71 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 C-N-CA 123.127 0.571 . . . . 0.0 110.163 -175.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.299 3.5 p90 -143.35 156.47 44.7 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 175.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 5.8 mmt180 -127.35 17.68 7.04 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.32 0.648 . . . . 0.0 110.002 -174.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -64.89 -31.74 73.12 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -169.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -130.47 5.89 4.79 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 118.606 0.639 . . . . 0.0 111.893 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 163.04 -124.35 1.28 Allowed Glycine 0 C--N 1.334 0.442 0 N-CA-C 108.696 -1.761 . . . . 0.0 108.696 -173.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 49.1 t -142.6 114.04 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 -142.86 166.07 25.65 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.117 0.484 . . . . 0.0 110.845 -176.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.09 164.99 31.29 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.487 175.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 57.9 mmm -132.42 152.82 51.33 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 39.1 t -141.12 146.03 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 C-N-CA 123.116 0.566 . . . . 0.0 110.37 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -132.52 135.59 46.09 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 122.536 0.335 . . . . 0.0 110.593 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -107.78 162.92 13.55 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 -176.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -75.74 -17.21 59.99 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 86.5 p -155.13 159.63 40.34 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.175 0.512 . . . . 0.0 111.263 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 54.8 t -67.34 -35.22 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -66.56 -28.18 68.32 Favored 'General case' 0 N--CA 1.456 -0.139 0 O-C-N 122.18 -0.325 . . . . 0.0 111.021 -177.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 74.4 m -75.94 -32.68 59.67 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 177.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.54 -32.63 58.34 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.416 -0.177 . . . . 0.0 111.086 178.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -66.76 -44.03 82.51 Favored 'General case' 0 C--N 1.338 0.09 0 O-C-N 122.036 -0.415 . . . . 0.0 111.558 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -75.59 -26.34 57.8 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.898 -178.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -74.16 -40.85 62.3 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.03 0.377 . . . . 0.0 110.148 178.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -73.57 -23.22 59.93 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.862 0.465 . . . . 0.0 111.063 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -92.4 -17.04 25.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 48.2 t -106.67 -36.17 6.8 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -176.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 76.7 mt -88.67 -8.03 55.3 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -70.78 134.27 47.26 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.65 -6.45 39.32 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 119.676 -0.513 . . . . 0.0 112.458 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -77.41 166.34 23.25 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 117.759 0.78 . . . . 0.0 110.187 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 5.0 p30 -123.24 140.56 52.89 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 80.8 mt -74.98 -43.03 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.071 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.36 50.2 m-85 -82.78 -10.05 59.05 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 29.1 t 66.38 34.78 6.11 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.629 0.772 . . . . 0.0 111.126 -175.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 175.47 -24.45 0.06 OUTLIER Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 178.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . 0.45 ' HB3' HD12 ' A' ' 200' ' ' ILE . 81.4 m -144.69 -176.97 5.27 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.692 1.197 . . . . 0.0 109.264 178.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 96.2 m 57.4 39.18 28.41 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -175.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.04 146.4 18.18 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 175.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 89.1 mt -110.78 154.41 23.98 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -172.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -137.92 135.98 36.59 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.865 1.666 . . . . 0.0 106.679 169.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 44.6 mt -138.43 141.67 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-O 120.618 0.247 . . . . 0.0 111.142 -172.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -158.76 164.11 36.14 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 175.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.288 43.4 m-85 -61.75 135.38 57.58 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 177.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . 0.445 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -85.35 162.85 18.89 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.369 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.468 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 63.4 pttt -94.06 -32.56 0.3 Allowed Pre-proline 0 CA--C 1.54 0.567 0 CA-C-O 117.29 -1.338 . . . . 0.0 114.225 178.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 86.3 Cg_endo -76.3 171.52 17.93 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 CA-C-N 122.04 1.764 . . . . 0.0 110.055 175.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.21 -1.91 2.33 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 117.72 2.489 . . . . 0.0 117.72 -175.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.15 130.95 9.98 Favored 'General case' 0 C--N 1.338 0.075 0 CA-C-N 119.145 0.884 . . . . 0.0 111.888 -177.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.429 ' HG ' ' C6 ' ' B' ' 3' ' ' ' A' . 25.1 mt -90.97 157.05 17.52 Favored 'General case' 0 C--N 1.338 0.069 0 C-N-CA 124.125 0.97 . . . . 0.0 111.408 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.458 ' C ' ' H61' ' B' ' 5' ' ' ' A' . 65.6 m-80 -120.85 50.99 1.28 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.836 0.854 . . . . 0.0 109.41 173.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.401 HG23 ' H ' ' A' ' 272' ' ' VAL . 3.0 t -51.63 144.74 2.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -177.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.425 ' CZ ' ' C2 ' ' B' ' 5' ' ' ' A' . 6.6 p90 -131.26 -0.15 4.08 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 116.472 2.027 . . . . 0.0 116.472 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -159.06 166.44 31.66 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.839 0.456 . . . . 0.0 111.374 -175.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -125.9 113.58 17.39 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.062 0.945 . . . . 0.0 109.05 172.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 57.1 p30 -156.3 -167.09 2.33 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -69.56 -13.83 62.53 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -176.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -100.02 -34.05 10.24 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.3 p -141.26 148.66 40.19 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 18.9 t-105 -157.54 154.98 29.47 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -176.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -135.07 118.92 17.26 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 122.873 0.469 . . . . 0.0 111.711 175.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.252 68.6 m-85 -84.19 6.44 22.59 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 117.263 2.32 . . . . 0.0 117.263 -171.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 3.8 t -142.99 -16.25 0.68 Allowed 'General case' 0 C--O 1.232 0.143 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -176.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -95.26 113.22 61.08 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 118.399 0.545 . . . . 0.0 110.556 177.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -83.12 -12.18 9.54 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.613 2.875 . . . . 0.0 112.568 177.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -72.8 -9.59 58.83 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -173.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 80.2 mt -73.65 -24.72 60.04 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 118.386 0.539 . . . . 0.0 110.749 178.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 67.7 m 52.83 10.28 0.15 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.818 1.247 . . . . 0.0 114.151 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 62.9 17.43 58.39 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 118.534 0.606 . . . . 0.0 111.688 -177.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 56.02 20.82 4.56 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.079 0.951 . . . . 0.0 112.758 -173.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.133 0 CA-C-O 117.465 -1.742 . . . . 0.0 111.164 179.754 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.912 0 C5'-C4'-C3' 110.043 -3.638 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.445 ' N3 ' ' HA ' ' A' ' 265' ' ' ALA . . . . . . . . 0 O4'--C4' 1.422 -2.544 0 O4'-C1'-N19 111.801 3.601 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.429 ' C6 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.422 -2.613 1 C5'-C4'-C3' 109.164 -4.224 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.178 0 C5'-C4'-C3' 110.163 -3.558 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.458 ' H61' ' C ' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.417 -3.034 0 C3'-C2'-C1' 104.777 3.641 . 0.016 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.607 0 O4'-C1'-N19 112.157 3.957 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 32.6 tp60 . . . . . 0 N--CA 1.476 0.838 0 CA-C-O 120.386 0.136 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -70.23 140.38 52.41 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.011 0.524 . . . . 0.0 110.558 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 47.3 mm -73.02 143.81 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 C-N-CA 122.953 0.501 . . . . 0.0 110.21 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 46.8 t -156.88 157.72 35.4 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 123.071 0.548 . . . . 0.0 109.768 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 86.1 mtt-85 -68.74 145.54 96.97 Favored Pre-proline 0 CA--C 1.529 0.166 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.22 167.68 26.61 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.48 2.787 . . . . 0.0 109.656 173.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -67.88 -8.79 54.65 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 177.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -78.45 -5.86 53.69 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 38.1 m -69.6 153.94 42.73 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-O 120.987 0.422 . . . . 0.0 111.188 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -54.11 -34.13 59.47 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -75.31 6.74 4.11 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 70.9 m -140.98 1.35 1.65 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -175.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -147.86 10.25 0.92 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 178.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 58.8 m -143.01 4.64 1.46 Allowed 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.2 m -76.46 123.67 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -130.88 10.39 5.04 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.282 0.633 . . . . 0.0 112.216 177.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 41.2 p 60.93 24.39 14.43 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.523 1.529 . . . . 0.0 113.518 -175.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 45.1 t -130.27 139.56 51.08 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 123.516 0.727 . . . . 0.0 109.523 174.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 89.4 mt -128.51 158.04 39.51 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.843 0.354 . . . . 0.0 111.536 -173.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 9.7 tt -115.92 135.85 53.59 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.255 174.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -114.37 106.26 14.1 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 114.684 1.365 . . . . 0.0 114.684 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -88.23 142.8 27.46 Favored 'General case' 0 N--CA 1.458 -0.072 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 174.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.3 mp -115.34 124.14 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 21.0 mt -85.24 -24.92 27.6 Favored 'General case' 0 C--N 1.337 0.064 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -173.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -141.22 79.06 18.17 Favored Pre-proline 0 N--CA 1.456 -0.171 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -177.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -76.86 49.97 2.92 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 125.137 3.891 . . . . 0.0 112.153 -177.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.441 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -68.55 -7.23 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 O-C-N 121.954 -0.466 . . . . 0.0 110.019 177.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -140.2 152.15 45.77 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.238 1.415 . . . . 0.0 112.193 175.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 35.9 t -74.4 133.08 42.47 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 117.851 0.296 . . . . 0.0 110.56 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 24.2 mm -83.32 150.06 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 123.028 0.531 . . . . 0.0 109.841 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.87 155.73 49.35 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 177.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.5 p -64.38 -21.72 66.72 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -79.01 -35.97 41.95 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 75.8 t -72.97 -40.81 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.3 mt -69.01 -32.0 71.24 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -70.28 -29.52 66.31 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 174.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.2 m -69.47 -32.82 71.97 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 45.0 pt -92.32 -21.75 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 118.422 0.555 . . . . 0.0 112.264 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 97.7 m -92.56 -26.57 17.84 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -178.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.488 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 36.3 t30 -64.04 -40.87 58.11 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 73.3 Cg_endo -69.44 -10.98 30.22 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 121.535 1.49 . . . . 0.0 111.887 177.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 91.0 m -95.99 -6.26 39.3 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 177.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 151.0 167.59 14.82 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 111.801 -0.519 . . . . 0.0 111.801 178.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.38 101.66 0.88 Allowed 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 123.965 3.11 . . . . 0.0 110.408 178.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 83.5 t -70.79 144.63 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -112.51 -39.45 4.36 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 119.363 -0.351 . . . . 0.0 111.262 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 65.8 mtm-85 -148.01 153.08 38.49 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 25.2 mt -145.13 139.9 22.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 124.308 1.043 . . . . 0.0 109.18 176.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 41.0 t -145.38 153.02 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.066 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 48.8 mt -134.34 142.24 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 C-N-CA 123.087 0.555 . . . . 0.0 110.178 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.305 2.7 p90 -143.19 156.1 44.69 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 176.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 6.2 mmt180 -127.75 18.22 6.78 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.274 0.63 . . . . 0.0 110.134 -173.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -66.22 -30.92 71.47 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 114.717 1.376 . . . . 0.0 114.717 -169.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -130.48 5.46 4.75 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 118.61 0.641 . . . . 0.0 112.129 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 164.35 -126.51 1.52 Allowed Glycine 0 CA--C 1.521 0.461 0 N-CA-C 108.043 -2.023 . . . . 0.0 108.043 -173.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.5 t -142.5 114.67 3.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 175.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -144.42 168.91 18.99 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.271 0.558 . . . . 0.0 110.718 -176.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -146.04 167.79 22.51 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.372 174.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 79.4 mmm -134.01 150.6 51.25 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 32.5 t -140.21 147.46 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 C-N-CA 122.895 0.478 . . . . 0.0 110.727 -177.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -133.31 134.87 44.4 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.03 0.532 . . . . 0.0 110.49 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -108.59 163.31 13.35 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 116.479 2.029 . . . . 0.0 116.479 -176.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -74.43 -16.79 60.86 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 84.9 p -157.12 161.23 39.39 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.275 0.559 . . . . 0.0 111.235 -178.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 45.7 t -66.62 -33.92 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -67.28 -30.21 70.02 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 117.886 0.312 . . . . 0.0 110.82 -177.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 68.7 m -75.49 -31.32 60.17 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 177.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.83 -33.32 60.07 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 119.629 -0.224 . . . . 0.0 111.172 178.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -67.48 -43.49 80.87 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 118.445 0.566 . . . . 0.0 111.487 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -74.42 -28.32 61.02 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.166 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -74.38 -39.8 62.48 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 118.094 0.406 . . . . 0.0 110.69 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -74.64 -23.54 58.7 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 122.748 0.419 . . . . 0.0 111.165 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -93.9 -15.57 24.85 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 47.8 t -106.7 -36.23 6.77 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 75.9 mt -89.35 -8.15 53.8 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -176.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -70.88 135.88 48.28 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.53 -6.76 36.27 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.621 -0.544 . . . . 0.0 112.308 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -76.82 166.49 23.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 117.69 0.745 . . . . 0.0 109.727 176.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -123.49 138.6 54.54 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 84.2 mt -72.29 -43.83 64.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.372 41.4 m-85 -82.79 -11.15 58.5 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 117.336 2.347 . . . . 0.0 117.336 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.9 t 64.79 37.19 7.5 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.692 0.758 . . . . 0.0 110.817 -175.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 174.52 -23.95 0.07 OUTLIER Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.001 0.81 . . . . 0.0 111.086 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . 0.441 ' HB3' HD12 ' A' ' 200' ' ' ILE . 90.8 m -146.62 -177.16 5.49 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.122 1.369 . . . . 0.0 109.159 178.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 95.2 m 58.62 37.62 25.28 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -177.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.59 146.05 10.74 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 175.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 86.1 mt -109.56 154.68 22.39 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -173.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -139.76 136.77 34.47 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.772 1.629 . . . . 0.0 106.913 169.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 37.0 mt -137.94 141.15 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-O 120.715 0.293 . . . . 0.0 111.277 -172.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -158.53 163.67 36.85 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.785 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.25 47.8 m-85 -63.02 136.36 57.78 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 176.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . 0.41 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -86.76 159.55 19.09 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.611 0.364 . . . . 0.0 110.751 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.465 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 23.1 pttp -92.79 -31.76 0.32 Allowed Pre-proline 0 CA--C 1.538 0.513 0 CA-C-O 117.363 -1.304 . . . . 0.0 114.066 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 69.2 Cg_endo -77.51 170.17 19.77 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 CA-C-N 121.966 1.738 . . . . 0.0 109.781 173.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.7 -1.07 3.11 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 117.798 2.518 . . . . 0.0 117.798 -174.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.55 130.65 9.42 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 118.873 0.76 . . . . 0.0 111.421 -178.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.476 ' HG ' ' C6 ' ' B' ' 3' ' ' ' A' . 20.1 mt -90.76 156.95 17.68 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 123.78 0.832 . . . . 0.0 111.017 177.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.457 ' C ' ' H61' ' B' ' 5' ' ' ' A' . 59.2 m-80 -115.42 50.88 0.96 Allowed 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.367 0.667 . . . . 0.0 109.86 173.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 3.1 t -52.23 145.22 2.69 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -134.54 -3.63 2.64 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 -177.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -159.32 162.62 36.01 Favored 'General case' 0 N--CA 1.456 -0.132 0 O-C-N 122.225 -0.297 . . . . 0.0 111.277 -171.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -125.39 110.81 14.4 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.769 0.828 . . . . 0.0 109.629 174.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 54.6 p30 -159.04 -165.95 1.73 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -67.84 -8.94 40.37 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -174.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -120.77 -15.35 8.39 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.34 140.9 35.69 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 123.923 0.889 . . . . 0.0 113.073 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 -163.55 156.91 18.93 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.644 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -141.52 118.58 11.27 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.654 171.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -81.94 4.35 22.95 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 -172.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 3.0 t -140.89 -12.94 0.96 Allowed 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -177.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -95.2 113.48 61.62 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 118.014 0.37 . . . . 0.0 110.049 178.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -83.44 -14.28 8.15 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.646 2.898 . . . . 0.0 112.175 178.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -71.43 -8.83 56.37 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -172.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 69.8 mt -75.46 -18.54 59.84 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 118.234 0.47 . . . . 0.0 111.02 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 75.0 m 53.17 12.89 0.35 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.419 1.088 . . . . 0.0 113.728 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 67.36 5.74 37.14 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 119.676 -0.514 . . . . 0.0 112.371 -178.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 53.51 22.93 3.17 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.787 0.835 . . . . 0.0 112.564 -175.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.115 0 CA-C-O 117.42 -1.767 . . . . 0.0 111.089 -179.797 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.066 0 C5'-C4'-C3' 109.852 -3.765 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.41 ' N3 ' ' HA ' ' A' ' 265' ' ' ALA . . . . . . . . 0 O4'--C4' 1.42 -2.727 0 O4'-C1'-N19 111.202 3.002 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.476 ' C6 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.42 -2.709 1 C5'-C4'-C3' 109.07 -4.286 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.797 1 C5'-C4'-C3' 109.185 -4.21 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.457 ' H61' ' C ' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.42 -2.755 1 C3'-C2'-C1' 105.187 4.097 OUTLIER-DELTA 0.054 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.615 0 O4'-C1'-N19 112.191 3.991 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 120.386 0.136 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -154.98 151.64 28.74 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 122.864 0.465 . . . . 0.0 109.84 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 85.1 mt -68.34 145.88 13.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 C-N-CA 122.839 0.456 . . . . 0.0 109.932 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 94.2 p -154.27 161.81 41.57 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.023 0.529 . . . . 0.0 109.712 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -145.16 157.99 52.56 Favored Pre-proline 0 CA--C 1.529 0.165 0 C-N-CA 123.59 0.756 . . . . 0.0 109.677 -178.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.01 -15.5 27.98 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.468 2.778 . . . . 0.0 113.382 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -82.09 -13.68 78.66 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 120.034 -0.315 . . . . 0.0 112.479 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -80.42 -64.28 1.22 Allowed 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 37.7 t -70.12 147.93 49.34 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 122.536 0.334 . . . . 0.0 110.606 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 8.2 p30 -74.14 -9.28 58.46 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -70.56 -2.83 15.39 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 67.1 m -141.93 6.32 1.78 Allowed 'General case' 0 C--O 1.231 0.119 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -176.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -148.47 5.15 0.71 Allowed 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 64.2 m -147.44 12.11 1.03 Allowed 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.401 ' H ' HG22 ' A' ' 188' ' ' VAL . 1.9 m -69.11 104.36 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -178.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -130.58 10.54 5.19 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.515 0.726 . . . . 0.0 111.956 177.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 54.5 m 65.22 21.21 12.06 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -177.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.1 t -131.85 133.71 60.84 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 CA-C-N 118.038 0.381 . . . . 0.0 111.018 176.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.445 HD21 ' HB1' ' A' ' 241' ' ' ALA . 2.3 mm? -121.56 153.32 38.18 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 122.817 0.447 . . . . 0.0 110.926 -176.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 22.8 tp -103.9 135.95 44.47 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 170.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -111.57 132.17 54.73 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.92 1.288 . . . . 0.0 114.419 176.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -121.58 130.09 53.28 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 175.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.4 mp -101.84 118.31 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -84.9 -19.37 32.38 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.027 0.531 . . . . 0.0 111.939 -171.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -141.72 78.99 17.3 Favored Pre-proline 0 CA--C 1.529 0.137 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -78.42 47.22 2.34 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 124.957 3.771 . . . . 0.0 111.926 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.403 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -70.24 -4.42 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 O-C-N 121.862 -0.524 . . . . 0.0 110.813 179.68 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -137.03 156.48 48.37 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 176.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 69.0 m -69.68 113.41 6.92 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 37.5 mm -78.26 141.8 14.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 177.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.11 160.88 36.45 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.5 p -64.84 -15.67 62.13 Favored 'General case' 0 CA--C 1.527 0.062 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -76.27 -44.98 34.8 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.785 0.326 . . . . 0.0 111.45 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 1.5 m -71.38 -32.62 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 179.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 95.4 mt -72.03 -34.16 68.58 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 176.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -71.64 -30.45 65.76 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 173.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.3 m -66.68 -33.92 76.72 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 42.9 pt -91.14 -24.94 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 118.352 0.523 . . . . 0.0 112.027 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 99.3 m -88.49 -25.54 22.52 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.093 0.86 . . . . 0.0 113.285 -178.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.479 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 31.9 t30 -64.51 -43.57 71.74 Favored Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 73.6 Cg_endo -69.85 -11.87 31.58 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.415 1.41 . . . . 0.0 111.519 177.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 94.4 m -92.28 -10.71 37.46 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.6 0.36 . . . . 0.0 111.847 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 155.09 169.56 19.76 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.767 -0.533 . . . . 0.0 111.767 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.88 96.88 0.7 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 124.138 3.226 . . . . 0.0 110.611 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 70.2 t -68.25 145.41 13.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -116.25 -39.93 3.33 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 119.147 -0.454 . . . . 0.0 111.32 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 63.4 mtm-85 -147.93 152.01 36.81 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 21.5 mt -148.42 137.14 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.272 1.029 . . . . 0.0 110.183 177.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 8.0 m -143.05 162.43 17.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 C-N-CA 123.778 0.831 . . . . 0.0 110.315 174.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 43.1 mt -134.34 143.18 38.77 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.075 0 C-N-CA 123.157 0.583 . . . . 0.0 110.486 -174.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.293 4.2 p90 -142.32 156.36 45.25 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 176.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -127.49 14.75 7.11 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.208 0.603 . . . . 0.0 110.905 -173.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -61.76 -32.58 72.84 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 -169.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -130.6 7.01 4.81 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.594 0.633 . . . . 0.0 112.278 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 163.41 -125.56 1.41 Allowed Glycine 0 C--N 1.336 0.551 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -174.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 24.2 t -140.99 112.02 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.152 0 C-N-CA 122.785 0.434 . . . . 0.0 109.915 175.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -141.8 168.03 20.72 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.212 0.529 . . . . 0.0 110.948 -175.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.98 169.2 21.14 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.75 0.82 . . . . 0.0 109.052 176.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 64.4 mmm -136.03 153.96 51.2 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 27.1 t -140.25 144.6 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.095 0 C-N-CA 123.063 0.545 . . . . 0.0 110.953 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -130.05 133.53 46.77 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.026 0.531 . . . . 0.0 110.252 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -108.9 161.32 15.25 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -177.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -80.62 -10.88 59.71 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 43.1 t -155.27 153.37 30.5 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 118.202 0.456 . . . . 0.0 111.864 -175.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 59.0 t -68.47 -38.52 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 123.0 0.52 . . . . 0.0 109.743 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -67.5 -26.61 66.43 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 122.153 -0.342 . . . . 0.0 111.08 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 48.8 m -75.88 -30.8 58.98 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 175.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.445 ' HB1' HD21 ' A' ' 192' ' ' LEU . . . -76.76 -33.21 58.09 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.579 0.352 . . . . 0.0 111.017 179.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -69.24 -44.14 72.56 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 122.228 -0.295 . . . . 0.0 111.665 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -74.12 -27.76 61.02 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 117.935 0.334 . . . . 0.0 111.105 -178.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -72.55 -39.82 67.18 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.177 0.444 . . . . 0.0 110.58 177.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.42 -23.75 54.0 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.433 0.293 . . . . 0.0 111.149 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -90.34 -14.73 32.51 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 48.2 t -109.51 -34.46 6.51 Favored 'General case' 0 C--N 1.338 0.068 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -177.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 78.3 mt -90.42 -7.92 51.92 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -70.93 132.57 45.41 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 75.66 -4.62 42.81 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.74 -0.478 . . . . 0.0 112.164 -177.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -79.26 166.4 22.18 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.859 0.829 . . . . 0.0 110.193 177.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -123.49 139.88 53.56 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 86.3 mt -73.71 -42.25 54.7 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.352 44.4 m-85 -82.86 -12.33 57.5 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 117.355 2.354 . . . . 0.0 117.355 178.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 23.1 t 65.14 36.34 7.29 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.69 0.757 . . . . 0.0 110.722 -174.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 176.05 -24.54 0.06 OUTLIER Glycine 0 CA--C 1.528 0.856 0 C-N-CA 123.792 0.71 . . . . 0.0 111.35 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . 0.403 ' HB3' HD12 ' A' ' 200' ' ' ILE . 82.4 m -146.74 -176.57 5.24 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.897 1.279 . . . . 0.0 109.173 178.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 89.7 m 58.06 37.08 26.47 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.69 148.98 11.68 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 176.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 76.2 mt -115.54 155.31 27.8 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -172.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -139.08 138.17 36.85 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.141 1.376 . . . . 0.0 107.959 169.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 29.2 mt -140.17 143.69 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 CA-C-O 120.935 0.398 . . . . 0.0 111.388 -171.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -159.28 162.94 36.14 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.865 0.866 . . . . 0.0 109.518 175.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -62.22 138.5 58.43 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 115.933 1.827 . . . . 0.0 115.933 177.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -87.55 162.31 17.27 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 122.674 0.39 . . . . 0.0 111.722 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.423 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 53.7 mtmt -80.82 -52.62 0.87 Allowed Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 118.351 -0.833 . . . . 0.0 112.665 178.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 90.5 Cg_endo -72.28 171.09 17.63 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.104 2.536 . . . . 0.0 111.251 177.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.262 0.2 OUTLIER -136.16 2.72 2.82 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 117.844 2.535 . . . . 0.0 117.844 -175.6 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -157.7 130.35 7.37 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 121.635 -0.666 . . . . 0.0 112.106 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.437 ' HG ' ' C6 ' ' B' ' 3' ' ' ' A' . 36.4 mt -85.8 166.67 15.87 Favored 'General case' 0 CA--C 1.527 0.068 0 C-N-CA 124.445 1.098 . . . . 0.0 111.538 176.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.543 ' ND2' ' C2 ' ' B' ' 4' ' ' ' C' . 20.2 p30 -120.22 49.79 1.38 Allowed 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 169.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.42 ' HA ' ' N1 ' ' B' ' 5' ' ' ' A' . 2.5 t -49.32 143.05 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.249 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -176.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -127.4 -7.4 5.8 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 117.945 2.572 . . . . 0.0 117.945 -176.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -162.87 174.72 12.04 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 122.77 0.428 . . . . 0.0 110.523 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -125.82 116.22 21.23 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.86 0.864 . . . . 0.0 109.628 174.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 52.7 p30 -157.74 -168.4 2.53 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.284 1.034 . . . . 0.0 109.718 178.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -68.97 -11.44 60.72 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -175.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -113.33 -17.56 12.26 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -144.6 141.13 29.19 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.864 0.866 . . . . 0.0 112.768 -178.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 18.9 t-105 -160.89 158.24 27.92 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 119.671 -0.812 . . . . 0.0 110.738 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -139.21 116.44 11.12 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.557 0.743 . . . . 0.0 109.774 172.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.266 67.7 m-85 -79.36 6.24 10.57 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 117.297 2.332 . . . . 0.0 117.297 -173.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 5.6 t -136.03 -20.49 1.47 Allowed 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -95.33 113.11 60.9 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 174.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -80.55 -15.18 11.19 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.606 2.871 . . . . 0.0 112.319 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -74.16 -16.07 61.0 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -173.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 51.4 mt -85.07 -4.06 59.02 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -178.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 74.2 m -80.45 -0.87 39.14 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 122.588 0.355 . . . . 0.0 111.681 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 76.32 -173.79 53.9 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 61.0 mm-40 -71.14 159.33 34.87 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 122.548 -0.384 . . . . 0.0 110.922 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 CA-C-O 117.174 -1.903 . . . . 0.0 111.294 179.262 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.866 0 C3'-C2'-C1' 104.451 3.279 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.691 0 C3'-C2'-C1' 98.348 -3.503 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.437 ' C6 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.422 -2.551 1 O4'-C1'-N19 112.228 4.028 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' ' C' . . . . . 0.543 ' C2 ' ' ND2' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.418 -2.921 0 C5'-C4'-C3' 109.575 -3.95 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.504 ' H61' ' C ' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.42 -2.784 1 C3'-C2'-C1' 105.407 4.341 OUTLIER-DELTA 0.04 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.623 0 O4'-C1'-N19 112.023 3.823 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 . . . . . 0 N--CA 1.475 0.82 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -74.03 -9.83 59.02 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.005 0.522 . . . . 0.0 111.61 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 7.0 tp -153.09 155.15 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 123.38 0.672 . . . . 0.0 109.511 -176.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 47.6 t -155.39 156.85 36.13 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.269 0.628 . . . . 0.0 110.062 178.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -144.88 152.61 52.36 Favored Pre-proline 0 C--O 1.232 0.153 0 C-N-CA 123.701 0.8 . . . . 0.0 109.785 -177.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -66.24 148.38 84.71 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 123.008 2.472 . . . . 0.0 110.083 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 76.3 -13.5 7.73 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-O 119.502 -0.61 . . . . 0.0 112.429 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -106.21 -14.58 15.09 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 177.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 85.1 p -79.08 155.76 28.63 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.133 0.573 . . . . 0.0 110.413 178.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -60.47 -24.14 65.03 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -74.03 6.65 3.23 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 178.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 36.3 t -143.51 -6.28 0.81 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -177.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 4.1 ppt_? -145.68 10.15 1.21 Allowed 'General case' 0 C--N 1.339 0.138 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 58.3 m -143.96 9.89 1.52 Allowed 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.5 m -64.85 123.82 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 122.665 0.386 . . . . 0.0 111.951 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -130.82 4.53 4.54 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -176.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 69.6 m 57.02 12.21 1.17 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -174.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 90.2 t -141.0 134.27 31.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.438 ' N ' HD22 ' A' ' 192' ' ' LEU . 2.0 mm? -122.14 153.07 39.23 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 122.663 0.385 . . . . 0.0 111.299 -175.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 24.8 tp -100.03 136.73 39.49 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 169.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -113.07 112.47 23.91 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 176.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.72 125.8 45.66 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 175.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 4.6 mp -96.96 124.81 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 22.0 mt -86.2 -25.94 25.37 Favored 'General case' 0 N--CA 1.458 -0.056 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -174.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -141.33 79.04 17.98 Favored Pre-proline 0 N--CA 1.455 -0.218 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -176.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -76.71 46.63 1.93 Allowed 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 125.182 3.921 . . . . 0.0 112.278 -177.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.408 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -69.99 -4.68 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 O-C-N 121.845 -0.534 . . . . 0.0 110.703 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -135.75 158.48 44.29 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 176.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 68.6 m -68.94 112.57 5.68 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 42.6 mm -78.5 139.72 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 176.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.06 159.95 39.25 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.4 p -64.92 -17.05 64.01 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 176.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -75.18 -45.97 37.15 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.366 0.266 . . . . 0.0 111.378 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.1 m -71.19 -32.05 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.53 -34.68 70.25 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 176.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -71.47 -30.97 66.61 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 174.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 10.7 m -66.92 -33.84 76.47 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 42.8 pt -91.74 -22.44 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 119.012 -0.518 . . . . 0.0 112.042 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 92.8 m -91.27 -25.57 19.41 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -178.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.493 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 32.2 t30 -64.0 -41.83 65.38 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-O 118.412 -0.804 . . . . 0.0 113.087 -179.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 72.9 Cg_endo -69.13 -13.44 36.27 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 CA-C-N 120.938 1.371 . . . . 0.0 111.669 178.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 97.1 m -89.39 -8.03 53.96 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 177.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 146.88 168.75 13.97 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.469 -0.653 . . . . 0.0 111.469 176.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.55 104.35 0.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.678 2.919 . . . . 0.0 111.966 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 75.8 t -75.53 143.77 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 175.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -115.64 -39.45 3.53 Favored 'General case' 0 C--O 1.227 -0.115 0 CA-C-O 119.431 -0.318 . . . . 0.0 111.39 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 66.8 mtm-85 -147.81 152.23 37.33 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 20.3 mt -148.51 137.15 15.14 Favored 'Isoleucine or valine' 0 C--N 1.339 0.13 0 C-N-CA 124.15 0.98 . . . . 0.0 109.927 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 3.9 m -142.73 160.79 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.087 0 C-N-CA 123.632 0.773 . . . . 0.0 110.568 174.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 45.4 mt -133.84 142.26 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 C-N-CA 122.591 0.356 . . . . 0.0 110.369 -175.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.295 4.1 p90 -140.96 157.24 45.63 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 177.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -128.03 15.61 6.8 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.271 0.628 . . . . 0.0 110.626 -174.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -62.85 -30.92 71.87 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -169.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -130.62 6.48 4.77 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.518 0.599 . . . . 0.0 112.144 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 161.62 -123.36 1.2 Allowed Glycine 0 C--N 1.333 0.373 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -173.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 50.9 t -143.23 114.94 2.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 175.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 8.3 mp0 -143.85 167.57 22.01 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.172 0.511 . . . . 0.0 110.786 -176.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.02 165.39 30.03 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.58 0.752 . . . . 0.0 109.215 175.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 59.5 mmm -133.36 152.13 51.9 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 39.4 t -139.39 142.64 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 122.788 0.435 . . . . 0.0 110.389 -178.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -128.06 131.87 49.09 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.842 0.457 . . . . 0.0 110.522 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -105.73 161.42 14.42 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 116.35 1.981 . . . . 0.0 116.35 -176.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -77.72 -13.03 60.02 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 45.2 t -155.81 155.82 33.67 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 121.813 -0.555 . . . . 0.0 111.872 -176.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 38.4 t -64.91 -42.11 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -67.7 -25.87 65.89 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 117.877 0.308 . . . . 0.0 111.657 -176.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 59.2 m -74.62 -31.8 62.11 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 175.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.422 ' HB1' HD21 ' A' ' 192' ' ' LEU . . . -76.04 -30.33 58.39 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.518 0.327 . . . . 0.0 111.157 178.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -68.64 -47.7 65.91 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 117.934 0.334 . . . . 0.0 111.297 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -73.75 -25.2 60.05 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 119.423 -0.322 . . . . 0.0 111.436 -177.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -71.87 -40.85 68.67 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.187 0.449 . . . . 0.0 110.087 176.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.26 -24.96 54.52 Favored 'General case' 0 N--CA 1.458 -0.045 0 C-N-CA 122.961 0.504 . . . . 0.0 110.993 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -90.69 -13.58 33.9 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 39.5 t -112.59 -35.26 5.58 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 118.631 0.651 . . . . 0.0 112.739 -177.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 59.8 mt -90.0 -7.16 54.62 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -177.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -70.78 133.19 46.34 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.78 -5.25 48.46 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 119.932 -0.371 . . . . 0.0 112.369 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.39 166.39 22.7 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 117.711 0.756 . . . . 0.0 110.131 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -123.44 139.61 53.85 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 88.5 mt -73.67 -41.47 55.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.356 45.3 m-85 -82.64 -11.79 58.11 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 117.114 2.265 . . . . 0.0 117.114 178.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 29.4 t 65.94 32.53 8.47 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.699 0.799 . . . . 0.0 111.012 -173.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 179.37 -24.61 0.05 OUTLIER Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . 0.408 ' HB3' HD12 ' A' ' 200' ' ' ILE . 74.7 m -145.58 -177.38 5.54 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.707 1.203 . . . . 0.0 109.465 178.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 84.3 m 59.42 35.6 23.02 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -177.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.73 150.4 5.27 Favored 'General case' 0 C--N 1.338 0.095 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 175.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 78.3 mt -118.47 156.09 29.66 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -173.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -138.39 139.2 38.85 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.562 1.545 . . . . 0.0 107.14 169.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 31.9 mt -139.34 141.73 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 CA-C-O 120.747 0.308 . . . . 0.0 111.364 -172.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -158.9 161.19 36.77 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.962 176.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -60.55 136.15 57.97 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 177.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . 0.437 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -88.28 162.32 16.67 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 122.973 0.509 . . . . 0.0 111.856 -178.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -85.99 -52.82 0.45 Allowed Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 118.505 -0.759 . . . . 0.0 112.808 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -72.07 165.43 32.64 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.759 2.306 . . . . 0.0 110.27 176.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 1.5 t -138.95 7.38 2.47 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 -174.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -152.81 126.41 8.82 Favored 'General case' 0 C--N 1.338 0.068 0 O-C-N 121.778 -0.576 . . . . 0.0 111.771 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.478 ' HG ' ' C6 ' ' B' ' 3' ' ' ' A' . 24.6 mt -87.13 162.85 17.29 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 123.943 0.897 . . . . 0.0 111.467 176.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.455 ' C ' ' H61' ' B' ' 5' ' ' ' A' . 60.7 m-80 -121.77 54.67 1.14 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.804 0.842 . . . . 0.0 109.356 171.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.443 ' HA ' ' N1 ' ' B' ' 5' ' ' ' A' . 2.6 t -54.02 146.34 3.45 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -175.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -127.83 -7.23 5.57 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 117.625 2.454 . . . . 0.0 117.625 -176.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -164.48 172.87 12.76 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 117.995 0.362 . . . . 0.0 110.676 -178.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -125.5 116.8 22.36 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.017 0.927 . . . . 0.0 109.916 173.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 55.9 p30 -159.74 -166.95 1.87 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -68.35 -11.42 59.52 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -174.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -111.98 -20.34 12.02 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -143.39 143.31 31.58 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.691 0.796 . . . . 0.0 112.762 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 18.4 t-105 -161.0 156.11 24.25 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.277 -178.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -136.81 117.92 14.41 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.498 0.719 . . . . 0.0 110.165 173.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.256 64.1 m-85 -82.08 7.01 14.5 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 117.39 2.367 . . . . 0.0 117.39 -173.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 5.8 t -139.61 -18.81 0.95 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -95.34 113.3 61.34 Favored Pre-proline 0 N--CA 1.453 -0.277 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 175.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.21 -16.77 13.7 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 123.341 2.694 . . . . 0.0 112.113 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -72.24 -15.05 61.92 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -176.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 78.7 mt -93.37 -8.29 42.29 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 46.6 t -78.55 -26.99 45.82 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.297 0.239 . . . . 0.0 111.423 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -81.73 -2.88 90.68 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-O 119.883 -0.398 . . . . 0.0 112.267 -179.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -81.47 -2.93 51.51 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 117.509 0.654 . . . . 0.0 111.646 -177.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.216 0 CA-C-O 117.324 -1.82 . . . . 0.0 111.458 179.999 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.869 0 C3'-C2'-C1' 104.355 3.172 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.437 ' N3 ' ' HA ' ' A' ' 265' ' ' ALA . . . . . . . . 0 O4'--C4' 1.422 -2.621 2 O4'-C1'-N19 112.639 4.439 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.478 ' C6 ' ' HG ' ' A' ' 270' ' ' LEU . . . . . . . . 0 O4'--C4' 1.423 -2.47 2 C5'-C4'-C3' 106.928 -5.714 . 0.01 4s . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.619 2.587 1 C5'-C4'-C3' 109.084 -4.277 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.455 ' H61' ' C ' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.418 -2.889 1 C3'-C2'-C1' 105.331 4.257 OUTLIER-DELTA 0.019 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.688 2 O4'-C1'-N19 113.451 5.251 . 0.087 2[ . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -67.53 148.39 51.53 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.025 0.53 . . . . 0.0 110.797 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.44 HG22 ' H ' ' A' ' 178' ' ' ARG . 32.2 mt -127.79 147.41 32.5 Favored 'Isoleucine or valine' 0 C--O 1.23 0.068 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 73.1 m -96.25 8.11 44.74 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -175.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.44 ' H ' HG22 ' A' ' 176' ' ' ILE . 3.8 mpt_? -83.71 -41.24 0.78 Allowed Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' A' ' 178' ' ' ARG . 46.5 Cg_exo -60.4 156.28 42.07 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.171 2.58 . . . . 0.0 112.207 176.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -71.98 -15.5 76.32 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 178.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -77.19 -3.41 39.44 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 176.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 30.5 t -67.17 148.03 52.32 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 122.967 0.507 . . . . 0.0 110.655 178.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -61.55 -17.22 53.96 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -81.41 0.86 35.64 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 176.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 69.8 m -139.61 0.34 1.83 Allowed 'General case' 0 C--N 1.341 0.204 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -174.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -147.59 10.62 0.96 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 67.2 p -150.89 15.57 0.75 Allowed 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 176.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.7 m -71.68 109.72 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -130.46 10.39 5.23 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.345 0.658 . . . . 0.0 112.197 177.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 54.5 m 65.58 19.91 11.56 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.338 1.055 . . . . 0.0 113.639 -176.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 35.8 t -126.56 143.05 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 C-N-CA 123.036 0.534 . . . . 0.0 110.483 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 84.5 mt -136.53 146.07 45.77 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 122.712 0.405 . . . . 0.0 111.162 -176.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 48.7 tp -95.36 136.53 35.61 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 172.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -116.13 101.22 8.53 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.003 1.321 . . . . 0.0 114.315 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.07 140.51 36.45 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 174.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 3.9 mp -110.66 116.24 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -90.46 -18.09 25.98 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -170.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -143.18 78.86 14.73 Favored Pre-proline 0 CA--C 1.528 0.127 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -76.98 42.7 1.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 125.206 3.937 . . . . 0.0 112.625 -177.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.469 HD12 ' HB3' ' A' ' 257' ' ' CYS . 0.1 OUTLIER -69.77 -5.11 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 O-C-N 121.747 -0.595 . . . . 0.0 110.693 -179.504 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -138.99 156.69 47.03 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 176.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 69.0 m -68.82 117.48 10.56 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 28.0 mm -78.28 145.41 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.02 160.42 37.8 Favored 'General case' 0 C--O 1.23 0.043 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 6.7 p -67.84 -22.98 65.11 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -73.63 -47.14 42.35 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 2.9 m -70.19 -31.91 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 96.9 mt -71.12 -35.25 71.68 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -71.36 -29.58 65.14 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 174.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.1 m -69.22 -33.43 73.29 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 42.2 pt -91.7 -22.06 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.95 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 95.1 m -93.42 -25.44 17.66 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -177.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.508 ' N ' ' HD2' ' A' ' 214' ' ' PRO . 38.5 t30 -63.59 -39.56 49.16 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 213' ' ' ASN . 67.0 Cg_endo -68.56 -14.15 38.96 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 CA-C-N 121.113 1.433 . . . . 0.0 111.954 177.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 92.8 m -89.23 -8.13 54.12 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.106 0.412 . . . . 0.0 111.57 176.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 147.8 166.95 13.0 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 178.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -68.61 105.25 1.25 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.535 2.823 . . . . 0.0 110.472 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 80.3 t -72.35 145.59 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -111.04 -36.81 5.54 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 119.369 -0.348 . . . . 0.0 111.58 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 25.6 mtm180 -149.52 154.02 38.11 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 118.128 0.422 . . . . 0.0 112.035 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 34.3 mt -144.7 143.8 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.035 0.934 . . . . 0.0 109.369 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 55.2 t -145.15 154.61 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 60.2 mt -133.43 140.13 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 C-N-CA 123.423 0.689 . . . . 0.0 109.65 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . 0.253 4.8 p90 -148.18 160.62 42.74 Favored 'General case' 0 N--CA 1.458 -0.026 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 176.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.01 31.31 2.2 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.811 0.444 . . . . 0.0 111.985 -176.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -67.07 -29.81 69.69 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -174.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -130.52 3.32 4.6 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 167.83 -127.12 1.51 Allowed Glycine 0 C--N 1.334 0.443 0 N-CA-C 108.381 -1.888 . . . . 0.0 108.381 -173.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.2 t -139.6 117.94 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-N 117.252 0.526 . . . . 0.0 110.244 173.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 11.5 mp0 -144.19 168.7 19.42 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.651 0.739 . . . . 0.0 111.164 -175.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -150.18 163.96 36.9 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.95 175.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' MET . . . . . . . . . . . . . 59.6 mmm -134.54 152.55 51.86 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.633 0.373 . . . . 0.0 110.199 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 47.3 t -142.42 145.19 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 123.117 0.567 . . . . 0.0 110.047 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -129.06 132.5 47.45 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 122.555 0.342 . . . . 0.0 110.284 176.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -102.36 161.71 13.49 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -177.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -81.27 -10.44 59.58 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 30.6 t -154.51 151.34 28.8 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 121.761 -0.587 . . . . 0.0 112.106 -176.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 50.3 t -68.13 -38.22 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -178.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -67.06 -24.93 66.02 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.123 0.42 . . . . 0.0 111.151 -178.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 55.3 m -75.77 -32.84 60.12 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 176.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -78.08 -31.86 50.39 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 122.361 -0.212 . . . . 0.0 110.961 178.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -66.55 -41.74 88.19 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 121.993 -0.442 . . . . 0.0 111.474 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -77.08 -28.15 54.5 Favored 'General case' 0 CA--C 1.527 0.07 0 CA-C-N 117.937 0.335 . . . . 0.0 110.872 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -69.95 -41.24 74.81 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.05 0.387 . . . . 0.0 109.959 177.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -74.24 -20.63 60.1 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.618 0.367 . . . . 0.0 111.023 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -98.77 -5.08 31.96 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 42.6 t -124.16 -30.44 3.46 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 56.3 mt -93.83 -6.66 45.33 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.247 0.476 . . . . 0.0 111.479 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -72.45 131.66 42.87 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 76.97 -4.64 53.09 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 119.85 -0.417 . . . . 0.0 112.259 -178.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -78.9 166.56 22.25 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 117.817 0.809 . . . . 0.0 110.169 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -123.67 139.3 54.13 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 89.5 mt -74.43 -41.66 49.71 Favored 'Isoleucine or valine' 0 C--O 1.23 0.071 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . 0.355 35.9 m-85 -82.82 -11.88 57.9 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 117.065 2.246 . . . . 0.0 117.065 178.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 30.1 t 65.74 34.02 7.82 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.533 0.733 . . . . 0.0 111.171 -173.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 177.44 -24.35 0.05 OUTLIER Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.11 0.862 . . . . 0.0 111.123 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' CYS . . . . . 0.469 ' HB3' HD12 ' A' ' 200' ' ' ILE . 75.0 m -145.43 -175.74 4.84 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.527 1.131 . . . . 0.0 109.383 178.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 88.8 m 57.84 36.04 26.0 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -176.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.3 147.53 13.26 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 176.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 78.9 mt -114.35 156.85 23.68 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -173.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -139.32 138.2 36.47 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 169.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 46.5 mt -137.1 142.48 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.066 0 CA-C-O 120.66 0.267 . . . . 0.0 111.56 -172.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -159.51 161.82 35.39 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.094 176.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . 0.287 35.6 m-85 -61.44 135.54 57.72 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 177.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . 0.447 ' HA ' ' N3 ' ' B' ' 2' ' ' ' C' . . . -93.16 157.18 16.4 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.999 -177.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.447 ' N ' ' HD2' ' A' ' 267' ' ' PRO . 23.2 pttp -91.19 -31.33 0.34 Allowed Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 50.3 Cg_endo -79.46 161.4 25.37 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 CA-C-N 121.766 1.666 . . . . 0.0 110.154 176.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . 0.298 0.2 OUTLIER -135.5 13.56 3.47 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 -178.056 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -156.36 126.37 6.46 Favored 'General case' 0 C--O 1.227 -0.1 0 O-C-N 121.871 -0.518 . . . . 0.0 111.521 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 23.1 mt -88.32 163.99 15.79 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.69 0.796 . . . . 0.0 110.546 174.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.542 ' ND2' ' C2 ' ' B' ' 4' ' ' ' C' . 19.5 p30 -122.89 44.24 2.71 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.342 0.591 . . . . 0.0 110.361 171.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 2.1 t -48.1 140.0 2.41 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -176.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.418 ' CZ ' ' C2 ' ' B' ' 5' ' ' ' A' 0.277 5.3 p90 -122.87 -6.27 8.5 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 117.267 2.321 . . . . 0.0 117.267 -177.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -163.37 167.98 21.01 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 122.956 0.503 . . . . 0.0 110.176 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -119.09 123.46 44.49 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.351 0.66 . . . . 0.0 109.734 174.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 50.6 p30 -159.32 -168.29 2.28 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.829 0.852 . . . . 0.0 108.93 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -70.41 -10.13 58.26 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -177.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -102.41 -33.63 9.47 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 1.5 p -142.68 145.75 33.72 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 124.257 1.023 . . . . 0.0 113.188 176.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' TRP . . . . . . . . . . . . . 21.7 t-105 -153.62 153.73 32.87 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -176.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -131.32 116.8 18.05 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.252 0.621 . . . . 0.0 111.607 175.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' TYR . . . . . . . . . . . . 0.253 67.1 m-85 -83.16 7.67 15.4 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 117.449 2.388 . . . . 0.0 117.449 -172.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 9.9 t -137.32 -21.85 1.17 Allowed 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -95.46 113.28 61.39 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 174.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.6 -16.19 15.04 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.273 2.649 . . . . 0.0 112.403 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -74.21 -15.71 60.99 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -174.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 81.4 mt -89.84 -4.98 57.31 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 117.889 0.313 . . . . 0.0 111.518 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 47.6 t -75.93 145.73 40.19 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 122.454 0.301 . . . . 0.0 110.738 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . 69.92 2.57 39.0 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-O 119.653 -0.526 . . . . 0.0 113.39 176.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -69.35 149.81 48.01 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 118.33 1.065 . . . . 0.0 111.074 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 CA-C-O 117.195 -1.891 . . . . 0.0 110.87 178.883 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.818 0 C3'-C2'-C1' 104.342 3.158 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.447 ' N3 ' ' HA ' ' A' ' 265' ' ' ALA . . . . . . . . 0 O4'--C4' 1.42 -2.735 0 O4'-C1'-N19 111.575 3.375 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.933 2 O4'-C1'-N19 112.96 4.76 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' ' C' . . . . . 0.542 ' C2 ' ' ND2' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.42 -2.756 1 C5'-C4'-C3' 108.032 -4.979 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.468 ' H61' ' C ' ' A' ' 271' ' ' ASN . . . . . . . . 0 O4'--C4' 1.416 -3.075 1 C3'-C2'-C1' 105.148 4.054 OUTLIER-DELTA 0.136 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.704 0 O4'-C1'-N19 111.773 3.573 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 stop_ save_